"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,GB,A,GB 1275371 A,174-261-788-487-155,1972-05-24,1972,GB 608670 A,1970-02-09,GB 608670 A,1970-02-09,IMPROVED SKIN GRAFTING KNIFE,"1275371 Skin grafting knife CHAS F THACKRAY Ltd 19 April 1971 [9 Feb 1970] 6086/70 Heading A5R A skin grafting knife with a handle comprises a holder composed of two parts 2 and 3, which are hinged together, for a removable blade, means for retaining the parts in a closed position, a carrier-bar extending from the handle parallel with the holder, a guide member carried by said bar in a parallel relationship so that the bar can rotate and turn the guide member in an arc about the bar. The two parts 2 and 3 of the holder are hinged together at the front edge about end-lugs 4 and 5, and the rear edge 8 of the upper part is curled around a bar 7 for which it provides a bearing so that the bar may rotate within the curled part. The guide rod 26 is rigidly attached to the bar by means of cross pieces. The blade is fitted to the upper part 2 by means of locating means 23, and retaining means 16-17, serve to secure the two parts 2 and 3 in a closed position. The retaining means are formed integrally with a thin bar 15 which is inserted between the bar 7 and the rear edge 8 of the upper part 2. The bar 15 is spring-loaded and can be moved longitudinally by a trigger 20 in order that the projections 17 be locked in corresponding slots in the lower part 3. A lug 40 attached to bar 7 is threadedly located around a screw 39 from which a projection 37 on a resilient pad 38 abuts a cam surface 36, rotation of which thus imparts a moment to the bar 7 through the lug 40 and causes the bar to rotate. The cam surface is rotated around a pin 41 by a lever 31, which is spring-loaded to turn at right angles to the plane of rotation of the cam and lock the cam in position by engaging grooves 43 on an attachment 11 of the handle.",THACKRAY C F LTD,CLARK BERNARD,,https://lens.org/174-261-788-487-155,Granted Patent,no,0,1,8,8,0,A61B17/322,A61B17/322,A5R REC           REC;;A5R RECX          RECX;;A5R R51           R51,0,0,,,,EXPIRED
2,AU,A,AU 1971/025093 A,157-042-546-827-755,1972-08-10,1972,AU 1971/025093 A,1971-02-05,GB 608570 A,1970-02-09,IMPROVEMENTS RELATING TO SURGICAL VETERINARY AND DENTAL INSTRUMENTS.,,THACKRAY C F LTD,CLARK BERNARD,,https://lens.org/157-042-546-827-755,Patent Application,no,0,0,6,6,0,A61B17/3211,A61B17/32,87.4;;87.7.,0,0,,,,DISCONTINUED
3,CA,A,CA 944644 A,183-366-199-328-874,1974-04-02,1974,CA 104848 A,1971-02-09,GB 608670 A,1970-02-09,SKIN GRAFTING KNIFE,,THACKRAY C F LTD,CLARK BERNARD,,https://lens.org/183-366-199-328-874,Granted Patent,no,0,0,8,8,0,A61B17/322,A61B17/322,128-115,0,0,,,,EXPIRED
4,AU,A,AU 1972/045431 A,011-953-613-792-39X,1974-02-14,1974,AU 1972/045431 A,1972-08-09,GB 3724771 A,1971-08-09,FEMORAL PROSTHESES,,THACKRAY C F LTD,CLARK BERNARD,,https://lens.org/011-953-613-792-39X,Patent Application,no,0,0,6,6,0,A61F2/4607;;A61F2/4607;;A61F2/0095;;A61F2/0095;;A61F2/3609;;A61F2/3609;;A61F2002/30331;;A61F2002/30331;;A61F2002/30718;;A61F2002/30718;;A61F2002/30975;;A61F2002/30975;;A61F2002/3625;;A61F2002/3625;;A61F2002/4628;;A61F2002/4628;;A61F2220/0033;;A61F2220/0033,A61F2/00;;A61F2/30;;A61F2/36;;A61F2/46,,0,0,,,,EXPIRED
5,US,A,US 926242 A,174-426-847-876-162,1909-06-29,1909,US 1908/0451378 A,1908-09-02,US 1908/0451378 A,1908-09-02,"METHOD OF HANDLING SLAG, CINDER, &C.",,CLARK JOHN BERNARD,CLARK JOHN BERNARD,,https://lens.org/174-426-847-876-162,Granted Patent,no,0,2,1,1,0,B02C25/00;;B02C25/00,,,0,0,,,,EXPIRED
6,US,A,US 3620342 A,193-599-335-065-678,1971-11-16,1971,US 3620342D A,1969-08-25,US 85270469 A,1969-08-25,MECHANICAL ROTARY COIN ACCEPTOR,,UNIVERSAL COIN METER CO INC,PRESCOTT BERNARD CLARK,,https://lens.org/193-599-335-065-678,Granted Patent,no,3,4,1,1,0,G07F5/02;;G07F5/02,G07F5/02,194/61,0,0,,,,EXPIRED
7,US,A,US 2092049 A,196-968-742-973-526,1937-09-07,1937,US 7144036 A,1936-03-28,US 7144036 A,1936-03-28,Method of reducing quartz crystal activity,,WESTINGHOUSE ELECTRIC & MFG CO,CLARK BERNARD L,,https://lens.org/196-968-742-973-526,Granted Patent,no,0,0,1,1,0,H03B5/34;;H03B5/34,H03B5/34,,0,0,,,,EXPIRED
8,GB,B,GB 2190882 B,022-926-579-710-068,1990-02-21,1990,GB 8712322 A,1987-05-26,GB 8612839 A,1986-05-27,METHODS AND APPARATUS SUITABLE FOR APPLYING A MOTIF TO A FABRIC,,CLARK THOMAS BERNARD,CLARK THOMAS BERNARD,,https://lens.org/022-926-579-710-068,Granted Patent,no,4,0,4,4,0,D06M17/06;;D06Q1/00,D06M17/06;;D06Q1/00,B6G GNB           GNB(101-2);;B6G G102          GNB(101-2);;U1S S2299,0,0,,,,EXPIRED
9,US,A,US 926719 A,163-054-640-279-295,1909-06-29,1909,US 1908/0447353 A,1908-08-07,US 1908/0447353 A,1908-08-07,SLAG-NET.,,CLARK JOHN BERNARD,CLARK JOHN BERNARD,,https://lens.org/163-054-640-279-295,Granted Patent,no,0,1,1,1,0,B66C1/127;;B66C1/127,,,0,0,,,,EXPIRED
10,CA,A,CA 389281 A,185-528-840-132-845,1940-06-11,1940,CA 389281D A,,CA 389281T A,,QUARTZ CRYSTAL ACTIVITY REDUCING METHOD,,WESTINGHOUSE CANADA LTD,CLARK BERNARD L,,https://lens.org/185-528-840-132-845,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
11,US,A,US 2093829 A,078-080-253-812-975,1937-09-21,1937,US 72396234 A,1934-05-04,US 72396234 A,1934-05-04,Construction of beach chairs and the like,,BERNARD CLARK WILLIAM,BERNARD CLARK WILLIAM,,https://lens.org/078-080-253-812-975,Granted Patent,no,0,3,1,1,0,A47C4/08;;A47C4/08,A47C4/08,,0,0,,,,EXPIRED
12,GB,A,GB 2190882 A,113-446-363-241-393,1987-12-02,1987,GB 8712322 A,1987-05-26,GB 8612839 A,1986-05-27,Methods and apparatus suitable for applying a motif to a fabric,"Pile surfaced motifs e.g. chenille-type motifs with loop pile surface are customarily sewn to garments. In the invention adhesive-coated motifs (28) are pressed to apply heat and pressure to activate the adhesive and adhere the motifs (28) to material (42) by a presser member (19, 40, 32) having a multiplicity of spaced heat-conductive pins (22) which penetrate the pile of the motif (28) without substantial flattening or otherwise damaging the pile. Conveniently the pins (22) are angled so that they fluff the pile of the motif (28) as they are withdrawn. At least one of the presser members (16, 18) is heated for applying adhesive in film form the motifs may be pressed by platens (16, 18) or rolls or for application by a hot-melt adhesive applicator, between the applicator and roll with the pins (22) adjacent the pile. <IMAGE>",CLARK THOMAS BERNARD,CLARK THOMAS BERNARD,,https://lens.org/113-446-363-241-393,Patent Application,no,4,0,4,4,0,D06M17/06;;D06Q1/00,D06M17/06;;D06Q1/00,B6G GNB           GNB(101-2);;B6G G102          GNB(101-2);;U1S S2299,0,0,,,,EXPIRED
13,CA,A,CA 331380 A,064-376-134-148-631,1933-04-04,1933,CA 331380D A,,CA 331380T A,,ACOUSTICAL WALL OR CEILING,,CLARK BERNARD E,CLARK BERNARD E,,https://lens.org/064-376-134-148-631,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
14,GB,A,GB 2369853 A,094-941-240-536-758,2002-06-12,2002,GB 0029005 A,2000-11-28,GB 0029005 A,2000-11-28,A safety mechanism for aerial scaffolding,"A safety mechanism for aerial scaffolding comprising and elongate track 2 which is connected to a hollow tube 12. The tube 12 is secured to a scaffold pole 16 with securing means 18. The track 2 has an anchor point 20 which is slidable along the length of the track 2. In use, a construction worker is able to connect a safety harness to the rolling anchor point so as to freely work on the scaffolding while being continually secured thereto. Stopping means (fig.8) are provided to stop the rolling anchor point 20 running off the end of the track 2.",AERIAL SCAFFOLDING LTD,CLARK BERNARD ROBERT,,https://lens.org/094-941-240-536-758,Patent Application,no,2,4,2,2,0,E04G5/00;;E04G5/001,E04G5/00,E1S SL            SL,0,0,,,,DISCONTINUED
15,CA,A,CA 273248 A,103-649-996-162-289,1927-08-23,1927,CA 273248D A,,CA 273248T A,,DYEING APPARATUS,,CLARK CHARLES;;CLARK ARTHUR BERNARD;;CLARK ROBERT CHARLES,CLARK ROBERT CHARLES;;CLARK ARTHUR BERNARD;;CLARK CHARLES,,https://lens.org/103-649-996-162-289,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
16,US,A,US 1649445 A,174-088-094-297-49X,1927-11-15,1927,US 12200526 A,1926-07-12,GB 3094325 A,1925-12-08,"Apparatus for dyeing articles of clothing, fabric, and the like",,CHARLES CLARK;;CHARLES CLARK ROBERT;;BERNARD CLARK ARTHUR,CHARLES CLARK;;CHARLES CLARK ROBERT;;BERNARD CLARK ARTHUR,,https://lens.org/174-088-094-297-49X,Granted Patent,no,0,4,2,2,0,D06B5/00;;D06B5/00;;D06B2700/17;;D06B2700/17,D06B5/00,,0,0,,,,EXPIRED
17,DE,D1,DE 69501723 D1,045-215-768-710-626,1998-04-09,1998,DE 69501723 T,1995-01-12,US 20902194 A;;US 9500420 W,1994-03-10,POLYMER ENTGASUNGSEINRICHTUNG MIT VERBESSERTEM SCHEIBENWÄRMETAUSCHER ENTWURF,,DOW CHEMICAL CO,CUMMINGS CLARK;;MEISTER BERNARD,,https://lens.org/045-215-768-710-626,Granted Patent,no,0,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,EXPIRED
18,US,A,US 5078469 A,012-457-910-052-789,1992-01-07,1992,US 41976189 A,1989-10-11,US 41976189 A,1989-10-11,"OPTICAL SYSTEM WHICH ALLOWS COINCIDENT VIEWING, ILLUMINATING AND PHOTOGRAPHING","A binocular surgical loupe which enhances the illumination of the viewed field while avoiding flare effects of illuminating light within the loupe optics. The binocular system utilizes circularly polarized illumination and viewing to prevent flare effects and additionally enhances the illumination of the field of view by utilization of the illumination source waste beam that results from the presence of a beam splitter in the illumination path within the loupe. In addition, a camera system is provided which permits remote viewing of the user's field of view. In one embodiment the camera and view paths include separate, identical zoom lenses which are synchronously controlled so that the fields of illumination and view are kept coextensive. In another embodiment for a binocular loupe, the loupe optics for one eye combines illumination and viewing functions while the loupe for the other eye combines camera and viewing functions.",LUXTEC CORP,CLARK BERNARD;;WU DAU,ARK CLO 2000-1 LIMITED (2001-03-01);;LUXTEC CORPORATION TECHNOLOGY PARK A CORP. OF MASSACHUSETTS (1990-03-20);;FIRST NATIONAL BANK OF BOSTON THE (1995-10-24),https://lens.org/012-457-910-052-789,Granted Patent,yes,9,49,3,3,0,A61B3/132;;G02B7/002;;G02B21/18;;G02B25/004;;G02B25/02;;G02C7/088;;G03B15/14;;A61B2090/502;;A61B90/36;;A61B90/361;;A61B2090/3616;;G02B7/002;;G02C7/088;;G02B25/02;;A61B3/132;;G02B21/18;;G02B25/004;;G03B15/14;;A61B2090/502;;A61B90/36;;A61B2090/3616;;A61B90/361,A61B3/13;;A61B19/00;;G02B21/18;;G02B25/02;;G02C7/08;;G03B15/14,359/481;;351/158;;359/482;;359/409;;359/799,6,0,,,"Luxtec Corporation brochure, Illuminating Magnifying Extending and Audio/Video Recording of the Surgeon s Vision with Product Ordering and Customer Information and including the following brochures:;;Luxtec Fiber Optic Headlights: Have You Seen the Light , 1988 Luxtec Corporation ( 8803).;;Luxtec Fiber Optic Lightsources: Light Years Ahead , 1988 Luxtec Corporation ( 8802).;;Luxtec Fiber Optic Cables: Clearly the Best , 1988 Luxtec Corporation ( 8801).;;A New Dimension in 20/20 Surgical Visualization , 1985 Luxtec Corporation.;;Isn t There a Better Way , Luxtec Videolux, 1987 Luxtec Corporation ( 8703).",EXPIRED
19,WO,A1,WO 1991/006025 A1,134-970-921-214-545,1991-05-02,1991,US 9005830 W,1990-10-11,US 41976189 A,1989-10-11,"OPTICAL SYSTEM WHICH ALLOWS COINCIDENT VIEWING, ILLUMINATING AND PHOTOGRAPHING","A binocular surgical loupe (12, 14, 84, 86, 130, 132) which enhances the illumination of the viewed field while avoiding flare effects of illuminating light within the loupe optics. The binocular system utilizes circularly polarized illumination and viewing to prevent flare effects and additionally enhances the illumination of the field of view by utilization of the illumination source waste beam that results from the presence of a beam splitter in the illumination path within the loupe. In addition, a camera system (80, 142) is provided which permits remote viewing of the user's field of view. In one embodiment the camera and view paths include separate, identical zoom lenses (98, 112) which are synchronously controlled so that the fields of illumination and view are kept coextensive. In another embodiment for a binocular loupe, the loupe optics for one eye combines illumination and viewing functions while the loupe for the other eye combines camera and viewing functions.",LUXTEC CORP,CLARK BERNARD;;WU DAU,,https://lens.org/134-970-921-214-545,Patent Application,yes,7,4,3,3,0,A61B3/132;;G02B7/002;;G02B21/18;;G02B25/004;;G02B25/02;;G02C7/088;;G03B15/14;;A61B2090/502;;A61B90/36;;A61B90/361;;A61B2090/3616;;G02B7/002;;G02C7/088;;G02B25/02;;A61B3/132;;G02B21/18;;G02B25/004;;G03B15/14;;A61B2090/502;;A61B90/36;;A61B2090/3616;;A61B90/361,A61B3/13;;A61B19/00;;G02B21/18;;G02B25/02;;G02C7/08;;G03B15/14,G2J J8B           J8Z;;G2J J8K1          J8Z;;G2J J8M5          J8Z;;U1S S1032,0,0,,,,PENDING
20,US,A,US 5384607 A,009-192-296-870-503,1995-01-24,1995,US 92308192 A,1992-07-31,US 92308192 A,1992-07-31,Telescopic spectacles,"A pair of telescopic spectacles includes a frame having a top bar and a bottom rim disposed to provide an aperture and a lens having a bore therein disposed in the aperture of the frame. The telescopic spectacles further include a telescope assembly disposed through the bore of the lens at a predetermined convergence and declination angle. The telescope assembly includes a first housing having a first aperture, a first region with a bore therein and a second region having a cavity therein, a second aperture and a first surface. The telescope assembly further includes a lens retainer disposed in the first aperture of the first housing, and an eyepiece assembly disposed in the first region of the first housing. The eyepiece assembly includes a lens housing having a first end with a first aperture and having a second opposing end with a second aperture. A first lens is disposed in the first aperture of the lens housing, a second lens is disposed in the second aperture of the lens housing a predetermined distance from the first lens. The telescope assembly further includes a prism, disposed in the second region of the first housing with a first surface of the prism spaced a predetermined distance from the eyepiece assembly. The telescope assembly further includes a second housing having a third lens disposed therein with a first surface of the third lens spaced a predetermined distance from a first surface of the prism.",LUXTEC CORP,MORRIS FREDERICK;;CLARK BERNARD,ARK CLO 2000-1 LIMITED (2001-03-01);;LUXTEC CORPORATION (1992-09-22);;FIRST NATIONAL BANK OF BOSTON THE (1995-10-24),https://lens.org/009-192-296-870-503,Granted Patent,yes,27,15,1,1,0,G02B7/002;;G02B7/002;;G02B25/004;;G02B25/004;;G02C7/088;;G02C7/088,G02C7/08,G2J JS2AX1        JS2AZ;;G2J JS2A2         JS2AZ;;G2J JS2A2A1       JS2AZ,0,0,,,,EXPIRED
21,WO,A1,WO 2015/017883 A1,014-141-069-676-541,2015-02-12,2015,AU 2014/000783 W,2014-08-06,AU 2013/902946 A,2013-08-06,DRIVING INFRINGEMENT FLAGGING SYSTEM,A potential driving infringement flagging system comprises an image source that captures or receives an image of a driver of a vehicle or another person within the vehicle; a processor configured to analyse the image to determine whether the driver is using a mobile telephone while driving or whether the driver or the person is wearing a seatbelt; and an output that indicates the result of the analysis.,FLETCHER DAVID;;CLARK BERNARD,FLETCHER DAVID;;CLARK BERNARD,,https://lens.org/014-141-069-676-541,Patent Application,yes,3,4,3,3,0,G06V40/171;;G06V20/597,G08G1/017;;G06K9/00;;G06T7/00;;G08G1/04,,0,0,,,,PENDING
22,AU,A,AU 1990/066068 A,020-813-194-123-571,1991-05-16,1991,AU 1990/066068 A,1990-10-11,US 41976189 A,1989-10-11,"LUMINATING AND PHOTOGRAPHING OPTICAL SYSTEM WHICH ALLOWS COINCIDENT VIEWING, IL",,LUXTEC CORP,CLARK BERNARD;;WU DAU,,https://lens.org/020-813-194-123-571,Patent Application,no,0,0,3,3,0,A61B3/132;;G02B7/002;;G02B21/18;;G02B25/004;;G02B25/02;;G02C7/088;;G03B15/14;;A61B2090/502;;A61B90/36;;A61B90/361;;A61B2090/3616;;G02B7/002;;G02C7/088;;G02B25/02;;A61B3/132;;G02B21/18;;G02B25/004;;G03B15/14;;A61B2090/502;;A61B90/36;;A61B2090/3616;;A61B90/361,A61B3/13;;A61B19/00;;G02B21/18;;G02B25/02;;G02C7/08;;G03B15/14,,0,0,,,,PENDING
23,US,S,US D0345368 S,145-766-581-642-703,1994-03-22,1994,US 92316992 F,1992-07-31,US 92316992 F,1992-07-31,Surgical telescope,,LUXTEC CORP,CLARK BERNARD;;MORRIS FREDERICK,ARK CLO 2000-1 LIMITED (2001-03-01);;LUXTEC CORPORATION (1992-09-22);;FIRST NATIONAL BANK OF BOSTON THE (1995-10-24),https://lens.org/145-766-581-642-703,Design Right,yes,50,2,1,1,0,,,D16/132,3,0,,,"Am. J. Optom. and Arch. Am. Acad. Opgom. (USA); vol. 50, No. 1; Jan. 1973; p. 56; Modified Surgical Binoculars; (359-480).;;Circon Corporation brochure; Feb. 1, 1973, Microloupe; (359-481).;;Yak Works; Fall/Winter 1982/1983; p. 27; Monocular Doubles as 4 oz. Microscope; (D16-132).",EXPIRED
24,US,A1,US 2010/0122483 A1,031-721-086-082-574,2010-05-20,2010,US 39083909 A,2009-02-23,US 39083909 A;;US 58378406 A,2006-10-20,FIREARM BOLT,An improved bolt carrier for a firearm is provided that improves the overall reliability and performance of the firearm bolt assembly. The bolt carrier includes a bolt with a body having a number of lugs extending therefrom. The bolt includes an extractor recess sized and configured to avoid any undercut of the lugs adjacent the recess. The bolt also includes an extractor pivotably engaged in a recess formed in the bolt. The extractor has a pair nipples on flanges configured to engage a pair of integrally buffered springs disposed on a tapered spring well on either side of a firing pin bore extending through the bolt.,CLARK ROBERT BERNARD IREDALE,CLARK ROBERT BERNARD IREDALE,,https://lens.org/031-721-086-082-574,Patent Application,yes,4,35,3,3,0,F41A3/26;;F41A15/14;;F41A15/14;;F41A3/26,F41A3/26,42/69.02,0,0,,,,ACTIVE
25,US,B2,US 7735410 B2,098-485-608-561-943,2010-06-15,2010,US 39083909 A,2009-02-23,US 39083909 A;;US 58378406 A,2006-10-20,Firearm bolt,An improved bolt carrier for a firearm is provided that improves the overall reliability and performance of the firearm bolt assembly. The bolt carrier includes a bolt with a body having a number of lugs extending therefrom. The bolt includes an extractor recess sized and configured to avoid any undercut of the lugs adjacent the recess. The bolt also includes an extractor pivotably engaged in a recess formed in the bolt. The extractor has a pair nipples on flanges configured to engage a pair of integrally buffered springs disposed on a tapered spring well on either side of a firing pin bore extending through the bolt.,CLARK ROBERT BERNARD IREDALE,CLARK ROBERT BERNARD IREDALE,,https://lens.org/098-485-608-561-943,Granted Patent,yes,4,42,3,3,0,F41A3/26;;F41A15/14;;F41A15/14;;F41A3/26,F41A15/00;;F41A19/64,89/138;;42/25;;42/69.02;;89/174,0,0,,,,ACTIVE
26,SG,A,SG 11201600924W A,119-881-404-480-484,2016-03-30,2016,SG 11201600924W A,2014-08-06,AU 2013/902946 A;;AU 2014/000783 W,2013-08-06,DRIVING INFRINGEMENT FLAGGING SYSTEM,,FLETCHER DAVID;;CLARK BERNARD,FLETCHER DAVID;;CLARK BERNARD,,https://lens.org/119-881-404-480-484,Unknown,no,0,0,3,3,0,G06V40/171;;G06V20/597,G08G1/017;;G06K9/00;;G06T7/00;;G08G1/04,,0,0,,,,PENDING
27,AU,A1,AU 2014/305641 A1,041-327-960-143-52X,2016-03-03,2016,AU 2014/305641 A,2014-08-06,AU 2013/902946 A;;AU 2014/000783 W;;AU 2014/305641 A,2013-08-06,Driving infringement flagging system,A potential driving infringement flagging system comprises an image source that captures or receives an image of a driver of a vehicle or another person within the vehicle; a processor configured to analyse the image to determine whether the driver is using a mobile telephone while driving or whether the driver or the person is wearing a seatbelt; and an output that indicates the result of the analysis.,CLARK BERNARD;;FLETCHER DAVID,FLETCHER DAVID;;CLARK BERNARD,,https://lens.org/041-327-960-143-52X,Patent Application,no,0,1,3,3,0,G06V40/171;;G06V20/597,G08G1/017;;G06K9/00;;G06T7/00;;G08G1/04,,0,0,,,,DISCONTINUED
28,DE,T2,DE 69501723 T2,119-299-145-121-140,1998-10-15,1998,DE 69501723 T,1995-01-12,US 20902194 A;;US 9500420 W,1994-03-10,POLYMER ENTGASUNGSEINRICHTUNG MIT VERBESSERTEM SCHEIBENWÄRMETAUSCHER ENTWURF,,DOW CHEMICAL CO,CUMMINGS CLARK;;MEISTER BERNARD,,https://lens.org/119-299-145-121-140,Granted Patent,no,0,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,EXPIRED
29,US,B2,US 7910110 B2,005-541-942-207-640,2011-03-22,2011,US 52991703 A,2003-10-02,GB 0222824 A;;GB 0304267 W,2002-10-02,Bacteriophage-mediated immunisation against hepatitis,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,BIGDNA LTD,MARCH JOHN BERNARD;;CLARK JASON,MOREDUN RESEARCH INSTITUTE (2005-05-26);;BIGDNA LIMITED (2010-06-29),https://lens.org/005-541-942-207-640,Granted Patent,yes,14,1,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/29;;A61K39/00;;A61K39/295;;C07K14/02;;C12N7/04;;C12N15/86,424/199.1;;424/193.1;;424/194.1;;424/196.11;;424/202.1;;424/204.1;;424/226.1;;424/227.1;;530/806;;530/810,18,17,082-213-298-968-106;;108-436-608-069-246;;000-492-925-278-279;;068-055-226-867-72X;;075-046-178-487-616;;072-538-188-964-860;;021-569-517-912-378;;005-880-637-937-598;;002-430-141-439-686;;021-723-494-069-084;;133-765-514-831-184;;018-144-237-259-990;;080-894-355-004-711;;097-379-671-908-959;;043-401-765-680-245;;062-885-033-937-597;;030-407-860-677-293,10.1002/jmv.1890200305;;2946812;;6854629;;10.1016/s0022-2836(83)80274-5;;19249975;;10.1586/14760584.8.3.333;;pmc2966876;;pmc2716888;;10.1007/s12072-008-9071-4;;19669259;;10868286;;10.2144/00286rr01;;9234952;;10.1006/viro.1997.8632;;10932158;;10.1038/78490;;10.1089/104454903321112451;;12590733;;10.1073/pnas.72.9.3531;;242006;;pmc433029;;pmc369836;;10.1128/mcb.2.6.607-616.1982;;10.1128/mcb.2.6.607;;14582156;;11249662;;10.1128/mcb.5.5.1136-1142.1985;;10.1128/mcb.5.5.1136;;3158804;;pmc366832;;6237889;;10.1159/000132065;;10.1016/s0162-3109(00)80266-0;;9601137;;pmc2194326;;2529979;;10.1247/csf.14.495;;10.1254/jjp.83.167;;10952064,"Pugh, et al. Expression of the X Gene of Hepatitis B Virus. Journal of Medical Virology. 1986; vol. 20 Issue 3, pp. 229-246.;;Gough, NM. Core and E antigen synthesis in rodent cells transformed with hepatitis B virus DNA is associated with greater than genome length viral messenger RNAs. J Mol Biol. Apr. 25, 1983;165(4):683-99.;;Stoller-Keller, et al. Development of hepatitis C virus vaccines: challenges and progress. Expert Rev Vaccines. Mar. 2009; 8(3):333-45 (abstract only cited).;;Aggarwal and Jameel, Hepatitis E vaccine. Hepatol Int. Sep. 2008; 2(3): 308-315.;;Aujame et al. ""Experimental Design Optimization of Filamentous Phage Transfection into Mammalian Cells by Cationic Lipids"", Biotechniques 28:1202-1213 (2000).;;Bastien et al. ""protective Immune Responses Induced by the Immunization of Mice with a Recombinant Bacteriophage Displaying a Epitope of the Human Respiratory Syncytial Virus"" Virology 234: 118-122 (1997).;;De Berardinis et al. ""Phage Display of Peptide Epitopes from HIV-1 Elicits Strong Cytolytic Response"" Nature Biotechnology 18:2000.;;Gaubin et al. ""Processing of Filamentous Bacteriphage Virions in Antigen-Presenting Cells Targets Both HLA Class I and Class II Petptide Loading Compartments"" DNA and Cell Biology 22(1): 11-18 (2003).;;Horst et al. ""Gene Transfer to Human Cells: Transducing Phage lambdaplac Gene Expression in GMl-gangliosidosis fibroblasts"" PNAS 72(9): 3531-3535 (1975).;;International Search Report Corresponding to PCT/GB02/01413 mailed Jun. 13, 2003.;;Ishiura et al. ""Phage Particle-Mediated Gene Transfer to Cultured Mammalian Cells"" Molecular and cellular Biology 2(6): 607-616 (1982).;;Monahan et al. ""Viral Vectors for Gene Transfer into Antigen Presenting Cells"" Current Opinion in Molecular Therapeutics 1(5): 558-564 (1999).;;Okayama et al. ""Bacteriophage Lambda Vector for Transducing a cDNA Clone Library into Mammalian Cells"", Molecular and Cellular Biology 5:1136-1142 (1985).;;Srivatsan et al. ""Plasmid, phage, and genomic DNA-mediated transfer and expression of prokaryotic and eukaryotic genes in cultured human cells"", Cytogenet Cell Genet 38:227-234 (1984).;;Vincent et al. ""An In Vitro, Complement-Dependent Model of Particle Transfer from Erythrocytes to Macrophages"" Immunopharmacology 49(1-2): 90 (2000).;;Douglas, R.G. ""The Jeremiah Metzger Lecture, Vaccine Prophylaxis Today: Its Science, Application and Politics"" Transactions of the American Clinical and Climatological Association vol. 109, p. 185-198 (1998).;;Ishiura et al. ""Stability of the Transformants Obtained by Phage Particle-Mediated Gene Transfer"" Cell Structure and Function 14:495-499 (1989).;;Koide et al. ""DNA Vaccines"" Jpn J Pharmacol 83:167-174 (2000).",INACTIVE
30,US,A,US 1180594 A,055-506-372-076-545,1916-04-25,1916,US 5792615 A,1915-10-26,US 5792615 A,1915-10-26,METHOD OF FORMING WATCH-PENDANTS.,,KEYSTONE WATCH CASE COMPANY,LEVY BERNARD;;CLARK WILLIAM B,,https://lens.org/055-506-372-076-545,Granted Patent,no,0,0,1,1,0,G04B37/1446;;G04B37/1446;;Y10T29/49586;;Y10T29/49586,G04B37/14,,0,0,,,,EXPIRED
31,WO,A1,WO 2006/005943 A1,098-640-322-055-09X,2006-01-19,2006,GB 2005002732 W,2005-07-11,GB 0415425 A,2004-07-09,PHAGE SCREENING ASSAY,"The present invention relates to a method for identifying an agent for potential use in a vaccine. The present invention also provides agents identified by this method for use in a vaccine. The present further describes peptides of the pathogen Mycoplasma for use as a vaccine to treat or present diseases caused by Mycoplasma species, such as, Contagious bovine pleuropneumonia (CBPP).",MOREDUN RES INST;;MARCH JOHN BERNARD;;CLARK JASON,MARCH JOHN BERNARD;;CLARK JASON,,https://lens.org/098-640-322-055-09X,Patent Application,yes,0,2,3,3,18,A61K39/0241;;C07K14/30;;C12N2710/00043,A61K39/02;;C07K14/30,,9,8,055-994-864-344-329;;051-625-325-480-402;;063-157-621-353-88X;;002-769-821-977-94X;;115-453-123-295-374;;012-262-262-883-364;;073-225-244-090-643;;131-294-960-329-548,12738371;;10.1016/s0022-1759(03)00104-2;;10.1128/jvi.75.7.3277-3290.2001;;11238854;;pmc114121;;10.1074/jbc.m110275200;;11825896;;10.1016/j.vaccine.2003.10.047;;15068849;;10.1016/j.vaccine.2003.11.065;;15193403;;14746771;;10.1051/vetres:2003035;;10.1101/gr.1673304;;14762060;;pmc327097;;pmc538986;;10.1128/iai.73.1.444-452.2005;;15618183,"MUELLER M ET AL: ""IDENITIFICATION AND CLONING OF IMMUNODOMINANT PROTEINS OF BORRELIA BURGDORFERI USING PHAGE DISPLAY LIBRARIES"", NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY, SPRINGER, BERLIN, DE, vol. 363, no. 4, SUPPL, 13 March 2001 (2001-03-13), pages R83, XP008018561, ISSN: 0028-1298;;YANG W-J ET AL: ""Plaque reduction test: an alternative method to assess specific antibody response to pIII-displayed peptide of filamentous phage M13"", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 276, no. 1-2, 1 May 2003 (2003-05-01), pages 175 - 183, XP004422653, ISSN: 0022-1759;;OLEKSIEWICZ M B ET AL: ""Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: The nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes"", JOURNAL OF VIROLOGY, vol. 75, no. 7, April 2001 (2001-04-01), pages 3277 - 3290, XP002349325, ISSN: 0022-538X;;ROBBEN JOHAN ET AL: ""Selection and identification of dense granule antigen GRA3 by Toxoplasma gondii whole genome phage display"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, no. 20, 17 May 2002 (2002-05-17), pages 17544 - 17547, XP002349326, ISSN: 0021-9258;;MARCH J B ET AL: ""Genetic immunisation against hepatitis B using whole bacteriophage lambda particles"", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 13-14, 16 April 2004 (2004-04-16), pages 1666 - 1671, XP004500420, ISSN: 0264-410X;;JEPSON C D ET AL: ""Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle"", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 19, 23 June 2004 (2004-06-23), pages 2413 - 2419, XP004515458, ISSN: 0264-410X;;PILO PAOLA ET AL: ""Antigenic and genetic characterisation of lipoprotein LppC from Mycoplasma mycoides subsp. mycoides SC."", VETERINARY RESEARCH (LES ULIS), vol. 34, no. 6, November 2003 (2003-11-01), november 2003, pages 761 - 775, XP002349327, ISSN: 0928-4249;;WESTBERG JOAKIM ET AL: ""The genome sequence of Mycoplasma mycoides subsp. mycoides SC type strain PG1T, the causative agent of contagious bovine pleuropneumonia (CBPP)."", GENOME RESEARCH, vol. 14, no. 2, February 2004 (2004-02-01), pages 221 - 227, XP002349328, ISSN: 1088-9051;;BECKMANN CHRISTIANE ET AL: ""Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections"", INFECTION AND IMMUNITY, vol. 73, no. 1, January 2005 (2005-01-01), pages 444 - 452, XP002349329, ISSN: 0019-9567",PENDING
32,SI,T1,SI 1545594 T1,008-388-895-348-360,2010-05-31,2010,SI 200331717 T,2003-10-02,GB 0222824 A;;GB 0304267 W;;EP 03769616 A,2002-10-02,BACTERIOPHAGE-MEDIATED IMMUNISATION AGAINST HEPATITIS,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,BIGDNA LTD CALEDONIAN EXCHANGE,MARCH JOHN BERNARD;;CLARK JASON,,https://lens.org/008-388-895-348-360,Granted Patent,no,0,0,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/00;;A61K39/00;;C07K14/02;;C12N7/04;;C12N15/86,,0,0,,,,EXPIRED
33,PT,E,PT 1545594 E,040-828-391-867-390,2010-01-19,2010,PT 03769616 T,2003-10-02,GB 0222824 A,2002-10-02,BACTERIOPHAGE-MEDIATED IMMUNISATION AGAINST HEPATITIS,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,BIGDNA LTD,MARCH JOHN BERNARD;;CLARK JASON,,https://lens.org/040-828-391-867-390,Granted Patent,no,0,0,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/00;;A61K39/12;;A61K39/29;;C07K14/02;;C12N7/04;;C12N15/86,,0,0,,,,EXPIRED
34,CA,A,CA 772676 A,174-389-666-306-953,1967-11-28,1967,CA 772676D A,,CA 772676T A,,SILICONE-ORGANIC RESINS WITH IMPROVED ELECTRICAL PROPERTIES,,DOW CORNING,VANWERT BERNARD;;CLARK HAROLD A,,https://lens.org/174-389-666-306-953,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
35,EP,B1,EP 1545594 B1,056-763-154-956-230,2009-11-25,2009,EP 03769616 A,2003-10-02,GB 0304267 W;;GB 0222824 A,2002-10-02,BACTERIOPHAGE-MEDIATED IMMUNISATION AGAINST HEPATITIS,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,BIGDNA LTD,MARCH JOHN BERNARD;;CLARK JASON,BIGDNA LTD. (2009-09-30),https://lens.org/056-763-154-956-230,Granted Patent,yes,3,0,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/00;;A61K39/12;;A61K39/29;;C07K14/02;;C12N7/04;;C12N15/86,,4,0,,,"MEOLA A ET AL: ""Derivation of vaccines from mimotopes immunologic properties of human hepatitis B virus surface antigen mimotypes displayed on filamentous phage"" JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 154, 1995, pages 3162-3172, XP002955791 ISSN: 0022-1767;;DELMASTRO P ET AL: ""Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration"" VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 15, no. 11, 1 August 1997 (1997-08-01), pages 1276-1285, XP004086601 ISSN: 0264-410X;;WAN Y ET AL: ""Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine"" VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 19, no. 20-22, 6 April 2001 (2001-04-06), pages 2918-2923, XP004231808 ISSN: 0264-410X;;AUJAME LUC ET AL: ""Experimental design optimization of filamentous phage transfection into mammalian cells by cationic lipids"" BIOTECHNIQUES, vol. 28, no. 6, June 2000 (2000-06), pages 1202-1213, XP001179320 ISSN: 0736-6205 cited in the application",EXPIRED
36,EP,A1,EP 1766008 A1,066-228-538-817-502,2007-03-28,2007,EP 05759229 A,2005-07-11,GB 2005002732 W;;GB 0415425 A,2004-07-09,PHAGE SCREENING ASSAY,,MOREDUN RES INST,MARCH JOHN BERNARD;;CLARK JASON,,https://lens.org/066-228-538-817-502,Patent Application,yes,0,1,3,3,0,A61K39/0241;;C07K14/30;;C12N2710/00043,C12N15/10;;A61K39/02;;C07K14/30;;C12N7/00;;C12Q1/68,,1,0,,,See references of WO 2006005943A1,DISCONTINUED
37,US,A,US 3433760 A,137-688-603-345-929,1969-03-18,1969,US 3433760D A,1965-12-09,US 51279865 A,1965-12-09,BLENDS OF LIQUID VINYL UNSATURATED HYDROCARBON POLYMERS WITH ORGANOPOLYSILOXANES,,DOW CORNING,CLARK HAROLD A;;VANWERT BERNARD,,https://lens.org/137-688-603-345-929,Granted Patent,no,3,18,10,10,0,C08L25/10;;C08L25/10;;C08L9/00;;C08L9/00;;Y10S525/914;;Y10S525/914,C08L9/00;;C08L23/16;;C08L25/10,260/37,0,0,,,,EXPIRED
38,DE,B1,DE 1669936 B1,149-206-083-433-255,1971-05-13,1971,DE 1669936 A,1966-12-07,US 51279865 A,1965-12-09,IN DER HITZE ZU HARZARTIGEN UEBERZUEGEN UND FORMTEILEN HAERTBARE FORMMASSEN AUF ORGANOPOLYSILOXANGRUNDLAGE,,DOW CORNING,ARTHUR CLARK HAROLD;;VANWERT BERNARD,,https://lens.org/149-206-083-433-255,Patent Application,no,1,2,10,10,0,C08L25/10;;C08L25/10;;C08L9/00;;C08L9/00;;Y10S525/914;;Y10S525/914,C08L9/00;;C08L23/16;;C08L25/10,,0,0,,,,DISCONTINUED
39,DE,D1,DE 60330256 D1,029-065-190-547-437,2010-01-07,2010,DE 60330256 T,2003-10-02,GB 0222824 A;;GB 0304267 W,2002-10-02,BAKTERIOPHAGEN-VERMITTELTE IMMUNISIERUNG GEGEN HEPATITIS,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,BIGDNA LTD,MARCH JOHN BERNARD;;CLARK JASON,,https://lens.org/029-065-190-547-437,Granted Patent,no,0,0,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/00;;A61K39/12;;A61K39/29;;C07K14/02;;C12N7/04;;C12N15/86,,0,0,,,,EXPIRED
40,CH,A,CH 479641 A,034-445-452-830-079,1969-10-15,1969,CH 1734166 A,1966-12-05,US 51279865 A,1965-12-09,Härtbare Harzmischung,,DOW CORNING,HAROLD ARTHUR CLARK;;BERNARD VANWERT,,https://lens.org/034-445-452-830-079,Granted Patent,no,0,0,10,10,0,C08L25/10;;C08L25/10;;C08L9/00;;C08L9/00;;Y10S525/914;;Y10S525/914,C08L9/00;;C08L23/16;;C08L25/10,,0,0,,,,EXPIRED
41,DK,T3,DK 1545594 T3,066-656-936-397-153,2010-03-08,2010,DK 03769616 T,2003-10-02,GB 0222824 A;;GB 0304267 W,2002-10-02,Bakteriofag-medieret immunisering mod Hepatitis,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,BIGDNA LTD,CLARK JASON;;MARCH JOHN BERNARD,,https://lens.org/066-656-936-397-153,Granted Patent,no,0,0,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/00;;A61K39/12;;A61K39/29;;C07K14/02;;C12N7/04;;C12N15/86,,0,0,,,,EXPIRED
42,AT,T1,AT E449611 T1,117-767-671-094-017,2009-12-15,2009,AT 03769616 T,2003-10-02,GB 0222824 A;;GB 0304267 W,2002-10-02,BAKTERIOPHAGEN-VERMITTELTE IMMUNISIERUNG GEGEN HEPATITIS,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,BIGDNA LTD,MARCH JOHN BERNARD;;CLARK JASON,,https://lens.org/117-767-671-094-017,Granted Patent,no,0,0,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/00;;C07K14/02;;C12N7/04;;C12N15/86,,0,0,,,,EXPIRED
43,US,A1,US 2009/0010960 A1,041-172-064-667-698,2009-01-08,2009,US 52991703 A,2003-10-02,GB 0222824 A;;GB 0304267 W,2002-10-02,Bacteriophage-mediated immunisation against hepatitis,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,MARCH JOHN BERNARD;;CLARK JASON,MARCH JOHN BERNARD;;CLARK JASON,MOREDUN RESEARCH INSTITUTE (2005-05-26);;BIGDNA LIMITED (2010-06-29),https://lens.org/041-172-064-667-698,Patent Application,yes,4,0,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/00;;A61P31/00;;C07K14/02;;C12N7/04;;C12N15/86,424/199.1,0,0,,,,EXPIRED
44,US,B1,US 6177254 B1,046-575-702-762-349,2001-01-23,2001,US 21141798 A,1998-12-15,US 21141798 A,1998-12-15,Nucleolus autoantigenic marker for systemic lupus erthyematosus,"A novel nucleolus protein has been identified and cloned using human autoimmune serum. Its cDNA and amino acid sequences have been determined and are disclosed. This antigenic protein, termed ASE-1, has an approximate molecular mass of 55 kDa. Immunoblot analysis indicates that both the native protein and the in vitro translation products of the cDNA migrate on SDS-PAGE at an apparent molecular mass of 90 kDa. Indirect immunofluorescence analysis using antibodies generated to cloned regions of ASE-1 indicates that this protein occurs at the fibrillar centers of the nucleolus in the putative sites of rDNA transcription. During cell division ASE-1 localizes to the nucleolus organizer regions of the chromosomes, where it is closely associated with RNA polymerase 1. As an autoantigenic nucleolar protein, ASE-1 has been found to be a reliable serum marker for systemic lupus erthyematosus (SLE). This finding makes ASE-1 useful in the clinical detection and characterization of the disease. To identify the presence of SLE in an individual patient, a serum samples is taken and screened against the cloned ASE-1 protein to identify sera with anti-ASE-1 autoantibodies. This screening can be done using an ELISA assay, western blot techniques, or by binding the antigen to microspheres and identifying reactive sera by flow cytometry.",RATTNER JEROME BERNARD;;WHITEHEAD CLARK,RATTNER JEROME BERNARD;;WHITEHEAD CLARK,,https://lens.org/046-575-702-762-349,Granted Patent,yes,4,30,5,5,4,C07K14/4713;;C07K14/4713,C07K14/47;;C12N1/21;;C12N15/12,435/7.1;;435/7.72;;435/7.9;;435/7.92;;435/7.93;;530/350;;530/387.1;;530/387.9;;530/388.1,40,40,044-391-055-556-485;;107-950-619-551-13X;;125-362-904-570-200;;006-913-102-067-287;;033-871-178-129-954;;056-201-471-905-934;;037-551-232-351-496;;093-736-233-687-137;;066-141-497-990-023;;063-446-802-372-001;;017-919-563-115-620;;114-691-803-424-501;;099-462-040-125-851;;034-865-191-264-523;;052-686-426-571-165;;108-842-463-585-04X;;002-395-955-835-820;;033-515-397-430-834;;048-205-859-799-304;;082-721-332-226-343;;057-351-409-161-92X;;067-865-822-710-620;;194-098-174-652-185;;132-220-007-888-585;;077-786-627-219-411;;013-779-017-825-847;;012-546-174-201-09X;;087-755-147-393-278;;001-419-272-985-667;;046-607-789-512-097;;180-213-823-210-17X;;020-723-492-599-034;;056-502-345-921-983;;040-837-288-885-720;;045-775-709-701-75X;;088-981-031-912-824;;107-950-619-551-13X;;115-735-506-782-036;;092-475-560-545-217;;086-579-631-845-006,10.1006/bbrc.1995.2269;;7545391;;8843853;;10.1002/art.1780391005;;9426281;;10.1007/s004120050271;;3547652;;10.1126/science.3547652;;2007859;;pmc2190817;;10.1084/jem.173.4.941;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1084/jem.174.5.1239;;1940801;;pmc2119007;;10.1038/329721a0;;3118208;;10.1093/nar/12.1part1.387;;6546423;;pmc321012;;10.1002/j.1460-2075.1987.tb04720.x;;2884102;;pmc553358;;9211968;;10.1007/bf02510477;;10.1007/s004120050202;;7783073;;1737751;;10.1016/s0021-9258(19)50679-2;;8794854;;pmc2120978;;10.1083/jcb.134.5.1097;;3079672;;10.1016/0092-8674(86)90482-4;;pmc304456;;3470736;;10.1073/pnas.84.6.1472;;1706724;;pmc2288927;;10.1083/jcb.113.1.1;;10.1038/ng0492-34;;1301997;;pmc276062;;9017598;;10.1091/mbc.8.1.97;;10.1016/0092-8674(92)90539-o;;1623516;;7662360;;10.1016/0955-0674(95)80085-9;;pmc308092;;8208617;;10.1093/nar/22.10.1903;;10.1016/b978-044482383-0/50088-1;;2988941;;pmc554330;;10.1002/j.1460-2075.1985.tb03766.x;;3024965;;10.1002/j.1460-2075.1986.tb04580.x;;pmc1167235;;10.1016/0014-4827(83)90332-4;;6345184;;2933102;;10.1111/j.1768-322x.1985.tb00387.x;;10.1091/mbc.7.7.1015;;pmc275955;;8862517;;10.1172/jci112809;;pmc423987;;2432091;;pmc2120807;;8609158;;10.1083/jcb.133.2.235;;10.1016/0955-0674(94)90026-4;;7917325;;10.1083/jcb.126.4.853;;8051210;;pmc2120118;;10.1126/science.3003910;;3003910;;10.1038/322279a0;;2874495;;9211974;;10.1007/s004120050208;;10.1007/bf02510483;;10.1242/jcs.105.1.33;;7689575;;8843853;;10.1002/art.1780391005;;2420469;;10.1016/0092-8674(86)90014-0;;pmc362600;;10.1128/mcb.9.4.1794;;10.1128/mcb.9.4.1794-1798.1989;;2471070;;pmc359746;;10.1128/mcb.11.2.906;;1899288;;10.1128/mcb.11.2.906-912.1991,"Dawson et al, Biochem, Biophys. Res. Comm., vol. 214(1), pp. 152-162, 1995.;;Whitehead et al, Arthritis & Rheum., vol. 39(10), pp. 1635-1642, 1995.;;Whitehead, Clark M., et al.; ASE-1: a novel protein of the fibrillar centres of the nucleolus and nucleolus organizer region of mitotic chromosomes; 1997, Chromosoma 106:493-502.;;Adelman JP, Hand CT, Douglas J, Herbert E (1987) Two Mammalian Genes Transcribed from Opposite Strands of The Same Locus, Science 235:1514-1517.;;Alderuccio F, Chan EKL, Tan EM (1991) Molecular Characterization of an Autoantigen of PM-Scl in the Polymyosin Scleroderma Overlap Syndrome: A Unique and Complete Human cDNA Encoding an Apparent 75-Kd Acidic Protein of the Nucleolar Complex, J. Exp. Mod. 173:941-951.;;Altschul SF, Gish WM, Myers EW, Lipman DI (1990) Basic Local Alignment Search Tool, J. Mol. Biol. 215:403-410.;;Chan EK, Imai H, Hamel JC, Tan EM (1991) Human Autoantibody to RNA Polymerase Transcription Factor Hubf. Molecular Identity of Human Nucleolus Organizer Region Autoantigen NOR-90 And Ribosomal RNA Transcription Upstream Binding Factor, J. Exp. Med. 174:1239-1244.;;Chen C, Malone T, Beckendorf SK Davis RL (1987) At Least Two Genes Reside Within A Large Intron of the Dwwe Gene of Drosophila, Nature 329:721-724.;;Devereux J, Haeberli P, Smithies O (1984) A Comprehensive Set of Sequence Analysis for the VAX, Nucleic Acids Res. 12:387-395.;;Dingwall C, Dilworth SM, Black SJ, Kersey SF, Cox LS, Laskey RA (1987) Nucleoplasmin cDNA Sequence Reveals Polyglutamic Acid Tracts and a Cluster of Sequences Homologous to Putative Nuclear Localization Signals, EMBO 160:69-74.;;Dundr K, Meier UT, Lewis N. Rekosh D, Harnmarskjold M, Olson MOJ (1997) A Class of Non-Ribosomal Nucleolar Components is Located in the Chromosome Periphery and in NucleolusDerived Foci During Anaphase and Telophase, Chromosoma 105:407-417.;;Ftitzler MJ, von Muhlen CA, Toffoli SM, Staub HL, Laxer RM (1995) Autoantibodies; to the Nucleolar Organizer Antigen NOR-90 in Children with Systemic Rheumatic Diseases, J. Rheumatol. 22:521-524.;;Ghisolfi L, Joseph G, Amalric F, Emrd M (1992) The Glycine-Rich Domain of Nucleolin has an Unusual Super-Secondary Structure Responsible for its RNA-Helix-Destabilizing Properties, J. Biol. Chem. 267:2955-2959.;;Hendzel JB, MI., Furbee CS, Muller MT, Bazett-Jones DP (1996) Topoisomerase II A is Associated with the Mammalian Centromere in a Cell Cycle-and Species-Specific Manner and is Required for Proper Centromere Kinetochore Structure, J. Cell Biol. 134:1097-1107.;;Henikoff S, Deene M, Fechtel K, Fristrom L, (1986) Gene within a Gene: Nested Drosophila Genes Encode Unrelated Proteins on Opposite Strands, Cell 44:33-42.;;Lapeyre B, Bourbon K, Amaldric F (1987) Nucleolin, The Major Nucleolar Protein of Growing Eukaryotic Cells, an Unusual Protein Structure Revealed by the Nucleotide Sequence, Proc. Natl. Acad. Sci. USA 94:1472-1776.;;Lee WC, Xue Z, Melese T (1991) The NSRI Gene Encodes a Protein that Specifically Binds Nuclear Localization Sequences and has Two RNA Recognition Motifs, J. Cell Biol. 113:1-12.;;Martin-Gallardo A, McCombie W.R., Gocayne JD, FitzGerald MG, Wallace S, Lee BMB, Lamerdin J, Kelly JM., Trapp S, Liu L, et al., (1992) Automated DNA Sequencing and Analysis of 106 Kilobases from Human Chromosome 19qi3.3, Nat. Genet. 1:34-39.;;McGrath K.E., Smothers J.F., Dadd CA, Madireddi MT, Gorovsky MA, Allis CD (1997) An Abundant Nucleolar Phosphoprotein is Associated with Ribosomal DNA in Terrahymena Macronuclei, Mol. Biol. Cell 8:97-108.;;Meier UT, Blobel LG (1992) Nopp140 Shuttles on Tracks Between Nucleolus and Cytoplasm, Cell 70:1-20.;;Melese T, Xue Z (1995) The Nucleolus, An Organelle Formed by the Act of Building a Ribosome, Curr. Opin. Cell Biol. 7:319-324.;;Merino E, Balbas P, Puente JL, Bolivar F (1994) Antisense Overlapping Open Reading frames in Genes from Bacteria to Humans, Nucleic Acids Res. 22:1903-1908.;;Monestier M, Nucleolar Autoantibodies in, Autoantibodies(Peter J.B., and Shoenfeld Y. eds.), Elsevier. Amsterdam, pp 567-573 (1996).;;Muller MT, Pfund WP, Mehta VB, Trask DK (1985) Eukaryotic Type 1 Topoisomerase Is Enriched In The Nucleolus And Catalytic Ally Active on Ribosomal DNA, EMBO J. 4:1237-1243.;;Neqveu A, Marcu KB (1986) Intragenic Pausing and Antisense Transcription Within the Murine c-Myc Locus, EMBO J. 15:2859-2565.;;Och R, Lischwe M, O'Leary P, Busch H (1983) Localization of Nucleolar Phosphoproteins B23 and C23 During Mitosis, Exp. Cell Res. 146:139-149.;;Ochs RL, Lischwe MA, Spohn WH, Busch H (1985) Fibrillarin: A New Protein of the Nucleolus Identified by Autoimmune Sera, Biol. Cell 54:123-34.;;Ochs RL, Stein TW, Chan EKL, Ruutu M, Tan EM (1996) cDNA Cloning and Characterization of a Novel Nucleolar Protein, Mol. Biol. Cell 7:1015-1024.;;Reimer G, Rose KM, Scheer U, Tan EM (1987) Autoantibody to RNA Polymerase 1-in Scleroderma Sera, J. Clin Invest 79:65-72.;;Roussel P, Andre C, Comai L, Hernandez-Verdun D (1996) The rDNA Transcription, Machinery Is Assembled During Mitosis in Active NORs and Absent In Inactive NORs, J. Cell Biol. 133:235-246.;;Scheer U, Weisenberger D (1994) 11e Nucleolus. Curr. Opin. Cell Biol. 6:654-359.;;Shan X, Xue Z, Melese T (1994) Yeast NP146 Encodes a Novel Proline Cis-Trans Isomerase that is Located in the Nucleolus, J. Cell Biol. 126:863-862.;;Shero JH, Bordwell B, Rothfield NF, Eamshaw WC (1986) High Titers of Autoantibodies to Topoisomerase I (Scl-70) in Sera from Scleroderma Patients, Science 231:737-740.;;Spencer CA, Cietz RD, Hodgetts RB (1986) Overlapping Transcription Units in the Dopa Decarboxylase Region of Drosophila, Nature 322:279-281.;;Suja JA, Gebrane-Younes J, Geraud G, Hernandez-Verdun D (1997) Relative Distribution of rDNA and Proteins of the RNA Polymerase I Transcription Machinery at Chromosomal NORs, Chromosoma 105:459-469.;;Thiry M (1993) Ultrastructural Distribution of DNA and RNA Within the Nucleolus of Human Sertoli Cells as Seen by Molecular Immunocytochemistry, J. Cell Sci. 105:33-39.;;Whitehead C.M., Winkfein R.J., Fritzler M.J., and Rattner J.B., (1996) The Spindle Kinesin-Like Protien HsEg5 is an Autoantigen in Systemic Lupus Erythematosus, Arthritis and Rheumatism 39:1635-1642.;;Van Duin M, De Wit J, Odlijk K, Westerveld A, Yasui A, Koken MHM, Hoeijmakers IN. Bootsma D (1986) Molecular Characterization of the Human Excision Repair Gene ERCC-1: cDNA Cloning and Amino Acid Homology with the Yeast DNA Repair Gene Radio. Cell 44:913-923.;;Van Duin M, Van Den Tol J, Hoeijmakers JHJ, Bootsma D. Rupp IP, Reynolds P, Prakash L, Prakash S (1989) Conserved Pattern of Antisense Overlapping Transcription in we Homologous Human ERCC-1 and Yeast Radio DNA Repair Gene Regions, Mol. Cell Biol. 9:1794-1798.;;Viskochil D, Cawthon R, O'Connell P, Xu G, Stevens J, Culver M, Carey I, White R (1991) The Gene Encoding the Oligodendrocyte-Myelin Glycoprotein is Embedded Within the Neurofibromatosis Type I Gene, Mol. Cell Biol. 11:906-912.",EXPIRED
45,EP,A1,EP 1545594 A1,116-445-870-643-762,2005-06-29,2005,EP 03769616 A,2003-10-02,GB 0304267 W;;GB 0222824 A,2002-10-02,BACTERIOPHAGE-MEDIATED IMMUNISATION AGAINST HEPATITIS,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,MOREDUN RES INST,MARCH JOHN BERNARD;;CLARK JASON,BIGDNA LTD. (2009-09-30),https://lens.org/116-445-870-643-762,Patent Application,yes,0,0,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/00;;C07K14/02;;C12N7/04;;C12N15/86,,0,0,,,,EXPIRED
46,US,A1,US 2008/0226661 A1,009-416-801-252-715,2008-09-18,2008,US 57185505 A,2005-07-11,GB 0415428 A;;GB 2005002732 W,2004-07-09,Phage Screening Assay,"The present invention relates to a method for identifying an agent for potential use in a vaccine. The present invention also provides agents identified by this method for use in a vaccine. The present further describes peptides of the pathogen Mycoplasma for use as a vaccine to treat or present diseases caused by Mycoplasma species, such as, Contagious bovine pleuropneumonia (CBPP).",MARCH JOHN BERNARD;;CLARK JASON,MARCH JOHN BERNARD;;CLARK JASON,MOREDUN RESEARCH INSTITUTE (2007-10-03),https://lens.org/009-416-801-252-715,Patent Application,yes,0,0,1,1,18,A61K38/164;;A61K38/164;;A61P31/04,A61K39/00;;A61K31/7052;;A61K35/66;;A61K38/02;;A61K38/16;;A61P31/04;;C12N15/63;;C12Q1/70,424/184.1;;435/5;;424/93.6;;514/2;;435/320.1;;514/12;;514/44,0,0,,,,DISCONTINUED
47,ES,T3,ES 2334994 T3,084-939-997-060-362,2010-03-18,2010,ES 03769616 T,2003-10-02,GB 0222824 A,2002-10-02,INMUNIZACION MEDIADA POR BACTERIOFAGOS CONTRA LA HEPATITIS.,The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.,BIGDNA LTD,MARCH JOHN BERNARD;;CLARK JASON,,https://lens.org/084-939-997-060-362,Granted Patent,no,0,0,15,15,0,A61K39/00;;A61K2039/5256;;A61K2039/53;;C07K14/005;;C12N7/00;;C12N15/86;;C12N2730/10122;;C12N2730/10123;;Y10S530/806;;Y10S530/81;;A61P31/00;;A61P31/04;;A61P31/10;;A61P31/14;;A61P31/20;;A61P33/00;;A61P33/14;;A61P35/00;;C07K14/005;;A61K39/00;;A61K2039/53;;C12N15/86;;C12N2730/10123;;C12N7/00;;C12N2730/10122;;A61K2039/5256;;Y10S530/806;;Y10S530/81,A61K39/00;;A61K39/12;;A61K39/29;;C07K14/02;;C12N7/04;;C12N15/86,,0,0,,,,EXPIRED
48,US,B2,US 11547522 B2,056-009-735-480-061,2023-01-10,2023,US 201916702860 A,2019-12-04,US 201916702860 A;;US 201962799096 P;;US 201962799100 P;;US 201962799113 P;;US 201962799202 P,2019-01-31,Knuckle joint assembly for medical device support system,"Knuckle joint assembly for a medical device support system. The knuckle joint assembly includes a cartridge assembly that includes a cartridge housing and a rotary bearing. The cartridge housing includes a bore having a central axis and a bearing mount in the bore. The rotary bearing is press fitted in the bearing mount and configured to receive axially therethrough a spindle to rotatably support the spindle about the central axis. The knuckle joint assembly includes a retaining clip and a retaining pin. The retaining clip is selectively movable to disengage and engage a groove in a spindle to respectively support or release the spindle along a central axis. The retaining pin is movable between a first position to allow movement of the retaining clip between positions but prevent removal of the retaining clip, and a second position to block movement of the retaining clip from the engaged position.",AMERICAN STERILIZER CO,MOSS BERNARD JOHN;;BELLOWS LANCE CLARK,AMERICAN STERILIZER COMPANY (2019-11-04),https://lens.org/056-009-735-480-061,Granted Patent,yes,15,4,33,94,0,A61B90/50;;A61B50/28;;A61B2090/506;;A61B2090/5025;;F16C11/04;;F16C35/042;;F16M13/027;;A61B90/35;;F16M11/06;;F16M11/2014;;F16M11/2092;;F16M11/24;;F16M2200/044;;F16M2200/063;;F16M2200/065;;A61B90/50;;A61B2090/5025;;A61B2090/506;;F16M13/022;;F16M2200/041;;F16M2200/066;;A61B34/71;;A61B2034/715;;A61B2090/508;;F16M2200/022;;A61B90/35;;F16D65/065,F16D3/00;;A61B34/00;;A61B90/35;;A61B90/50;;F16D65/06;;F16M13/02,,2,0,,,"International Search Report and Written Opinion for corresponding International Application PCT/US2019/064379 dated Mar. 26, 2020.;;International Preliminary Report on Patentability for corresponding International Application PCT/US2019/064379 dated Apr. 30, 2021.",ACTIVE
49,CA,A,CA 572880 A,060-625-518-722-46X,1959-03-24,1959,CA 572880D A,,CA 572880T A,,TOASTER APPARATUS,,WESTINGHOUSE ELECTRIC CORP,CLARK EARL K;;PARR BERNARD F,,https://lens.org/060-625-518-722-46X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
50,WO,A1,WO 2020/159615 A1,104-413-506-047-006,2020-08-06,2020,US 2019/0064379 W,2019-12-04,US 201962799096 P;;US 201962799100 P;;US 201962799113 P;;US 201962799202 P,2019-01-31,KNUCKLE JOINT ASSEMBLY FOR MEDICAL DEVICE SUPPORT SYSTEM,"Knuckle joint assembly for a medical device support system. The knuckle joint assembly includes a cartridge assembly that includes a cartridge housing and a rotary bearing. The cartridge housing includes a bore having a central axis and a bearing mount in the bore. The rotary bearing is press fitted in the bearing mount and configured to receive axially therethrough a spindle to rotatably support the spindle about the central axis. The knuckle joint assembly includes a retaining clip and a retaining pin. The retaining clip is selectively movable to disengage and engage a groove in a spindle to respectively support or release the spindle along a central axis. The retaining pin is movable between a first position to allow movement of the retaining clip between positions but prevent removal of the retaining clip, and a second position to block movement of the retaining clip from the engaged position.",AMERICAN STERILIZER CO,MOSS BERNARD JOHN;;BELLOWS LANCE CLARK,,https://lens.org/104-413-506-047-006,Patent Application,yes,10,1,33,94,0,A61B90/50;;A61B50/28;;A61B2090/506;;A61B2090/5025;;F16C11/04;;F16C35/042;;F16M13/027;;A61B90/35;;F16M11/06;;F16M11/2014;;F16M11/2092;;F16M11/24;;F16M2200/044;;F16M2200/063;;F16M2200/065;;A61B90/50;;A61B2090/5025;;A61B2090/506;;F16M13/022;;F16M2200/041;;F16M2200/066;;A61B34/71;;A61B2034/715;;A61B2090/508;;F16M2200/022;;A61B90/35;;F16D65/065,A61B90/50;;A61B50/28;;F16D49/08;;F16D49/16;;F16D65/06;;F16M11/08;;F16M11/20;;F16M13/02,,0,0,,,,PENDING
51,DE,C,DE 938374 C,112-206-653-817-865,1956-01-26,1956,DE N0005582 A,1952-05-28,US 938374X A,1951-06-20,Umlaufende Trommel,,NORANDA MINES LTD,CLARK CHARLES WILLIAM;;MORRISON BERNARD HERMON,,https://lens.org/112-206-653-817-865,Granted Patent,no,0,0,1,1,0,C22B1/216;;F27B7/00;;F26B11/04;;F27B7/18,C22B1/216;;F26B11/04;;F27B7/00;;F27B7/18,,0,0,,,,EXPIRED
52,AU,A1,AU 2015/340359 A1,159-646-411-400-121,2017-04-27,2017,AU 2015/340359 A,2015-10-27,GB 201500681 A;;GB 201506673 A;;GB 201419311 A;;GB 2015053215 W,2014-10-30,Combination therapy,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a β-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,,https://lens.org/159-646-411-400-121,Patent Application,no,0,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,C07D303/36;;A61K31/365;;A61K31/69;;A61K38/04;;A61K38/12;;A61P35/00,,0,0,,,,INACTIVE
53,DE,T2,DE 69101061 T2,156-870-663-177-71X,1994-08-18,1994,DE 69101061 T,1991-05-11,EP 9100898 W;;GB 9010967 A,1990-05-16,HYDROPHILE KOLLOIDZUSAMMENSETZUNG FÜR PHOTOGRAPHISCHES MATERIAL.,"A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula CF3(CF2)nCH2O(glycidyl)mH wherein n is an integer from 4 to 7; and, m is an integer from 6 to 45.",KODAK LTD;;EASTMAN KODAK CO,PITT ALAN;;CLARK BERNARD;;PADDAY JOHN,,https://lens.org/156-870-663-177-71X,Granted Patent,no,0,0,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,C09D7/12;;C09D189/00;;G03C1/38;;G03C1/85,,0,0,,,,EXPIRED
54,US,A,US 3697427 A,140-855-323-297-84X,1972-10-10,1972,US 3697427D A,1971-04-30,US 13918271 A,1971-04-30,LUBRICANTS HAVING IMPROVED ANTI-WEAR AND ANTI-CORROSION PROPERTIES,,BRITISH PETROLEUM CO,BYFORD DEREK CLARK;;SILVER HOWARD BERNARD,,https://lens.org/140-855-323-297-84X,Granted Patent,no,0,16,1,1,0,C10M3/00;;C10M3/00;;C10M2207/025;;C10M2207/025;;C10M2207/123;;C10M2207/123;;C10M2207/129;;C10M2207/129;;C10M2207/22;;C10M2207/22;;C10M2207/281;;C10M2207/281;;C10M2207/282;;C10M2207/282;;C10M2207/283;;C10M2207/283;;C10M2207/284;;C10M2207/284;;C10M2207/285;;C10M2207/285;;C10M2207/286;;C10M2207/286;;C10M2207/30;;C10M2207/30;;C10M2209/109;;C10M2209/109;;C10M2215/064;;C10M2215/064;;C10M2215/065;;C10M2215/065;;C10M2215/10;;C10M2215/10;;C10M2215/14;;C10M2215/14;;C10M2215/18;;C10M2215/18;;C10M2215/22;;C10M2215/22;;C10M2215/221;;C10M2215/221;;C10M2215/224;;C10M2215/224;;C10M2215/225;;C10M2215/225;;C10M2215/226;;C10M2215/226;;C10M2215/30;;C10M2215/30;;C10M2219/10;;C10M2219/10;;C10M2219/102;;C10M2219/102;;C10M2219/104;;C10M2219/104;;C10M2219/106;;C10M2219/106;;C10M2223/04;;C10M2223/04;;C10M2223/041;;C10M2223/041;;C10M2223/042;;C10M2223/042;;C10N2030/08;;C10N2030/08;;C10N2040/12;;C10N2040/12;;C10N2040/13;;C10N2040/13,,C5F F485          -;;C5F F519          -;;C5F F531          -;;C5F F536          -;;C5F F538          -;;C5F F539          -;;C5F F585          -;;C5F F588          -;;C5F F594          -;;C5F F595          -;;C5F F60X          -;;C5F F603          -;;C5F F610          -;;C5F F651          -;;C5F F672          -;;C5F F673          -;;C5F F733          -,0,0,,,,EXPIRED
55,DE,D1,DE 69101061 D1,169-267-907-004-555,1994-03-03,1994,DE 69101061 T,1991-05-11,EP 9100898 W;;GB 9010967 A,1990-05-16,HYDROPHILE KOLLOIDZUSAMMENSETZUNG FÜR PHOTOGRAPHISCHES MATERIAL.,"A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula CF3(CF2)nCH2O(glycidyl)mH wherein n is an integer from 4 to 7; and, m is an integer from 6 to 45.",KODAK LTD;;EASTMAN KODAK CO,PITT ALAN;;CLARK BERNARD;;PADDAY JOHN,,https://lens.org/169-267-907-004-555,Granted Patent,no,0,0,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,C09D7/12;;C09D189/00;;G03C1/38;;G03C1/85,,0,0,,,,EXPIRED
56,US,B2,US 10328116 B2,064-740-447-424-631,2019-06-25,2019,US 201515523188 A,2015-10-27,GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;GB 2015053215 W,2014-10-30,Combinations of proteasome inhibitors and cyclic peptides,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a β-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,BIG DNA LTD (2017-05-17),https://lens.org/064-740-447-424-631,Granted Patent,yes,9,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K38/12;;A61K31/4015;;A61K31/407;;A61K31/69;;A61K38/00;;A61K38/05;;A61K38/06;;A61K38/07;;A61K45/06,,14,10,032-196-731-619-738;;082-437-970-082-198;;174-555-394-272-438;;049-632-060-820-021;;103-839-278-584-863;;073-986-079-471-173;;019-421-060-623-302;;016-783-528-742-446;;104-868-616-071-518;;016-400-360-502-025,20369394;;10.1038/nrd3144;;10.1172/jci68340;;pmc3754257;;23999436;;10.3390/cancers9090116;;17379504;;10.1016/j.ejca.2007.01.038;;12431963;;10.1200/jco.2002.01.133;;21724551;;pmc3156932;;10.1158/1078-0432.ccr-11-0476;;pmc3411133;;10.1177/1947601912450586;;22866207;;10.1016/j.ejca.2005.02.008;;15808960;;10.1053/j.seminhematol.2012.04.010;;22726546;;pmc3597231;;22284358;;pmc3503453;;10.1016/j.chembiol.2012.01.003,"Cilengitide, from https://www.medchemexpress.com/Cilengitide.html, p. 1, accessed Nov. 28, 2017.;;Cellular and Molecular Basis of Cancer, from http://www.merckmanuals.com/professional/print/hematology_and_oncology/overview_of . . . , pp. 1-5, accessed Nov. 7, 2012.;;Hait, Anticancer drug development: the grand challenges, Nature Reviews/Drug Disvovery, 2010, 9, pp. 253-254.;;Herter-Sprie et al, New cast for a new era: preclinical cancer drug development revisited, The Journal of Clinical Investigation, 2013, 123, pp. 3639-3645.;;Nieberler et al, Exploring the Role of RGD—Recognizing Integrins in Cancer, Cancers, 2017, 9, pp. 1-33.;;Milano et al, The proteasome: A worthwhile target for the treatment of solid tumours?, 2007, European Journal of Cancer, 2007, 43, pp. 1125-1133.;;Orlowski et al, Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies, J Clin Oncol, 2002, 20, pp. 4420-4427.;;Chauhan et al, In Vitro and in Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells, Clin Cancer Res, 2011, 17, pp. 5311-5321.;;Ria et al, αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma, Haematologica, 2002, 87, pp. 836-845.;;Reardon et al, Cilengitide: A Prototypic Integrin Inhibitor for the Treatment of Glioblastoma and Other Malignancies, Genes & Cancer, 2011, 2, pp. 1159-1165.;;Bhandari, M.S. et al., “Clinical Trials in Metastatic Prostate Cancer—Has there been Real Progress in the Past Decade?”, Euro. J. of Cancer, vol. 41, p. 941-953 (2005).;;Kapoor, P. et al., “Bortezomib Combination Therapy in Multiple Myeloma”, Seminars in Hematology., vol. 49, No. 3, p. 228-242 (2012).;;Kisselev, A.F.et al., “Proteasome Inhibitors: An Expanding Army Attacking a Unique Target”, Chemistry and Biology, vol. 19, No. 1, p. 99-115, (2012).;;Patentscope English Translation of WO2014/084378.",ACTIVE
57,WO,A1,WO 1989/003578 A1,092-250-024-420-86X,1989-04-20,1989,GB 8800819 W,1988-10-05,GB 8723394 A,1987-10-06,DEVICES AND PROCESS FOR PRODUCING MICROFILM AND MICROFICHE RECORDS,"An updatable optical storage device, which may be in microfiche configuration, comprises two electrically conductive layers (2, 6) between which a layer (5) of a liquid crystal storage material and a layer (3) of a photoconductive material are sandwiched. In order to record an image on the device, the image is projected on to the photoconductive layer through one of the conductive layers, a voltage is applied between the conductive layers, and the storage material is heated at least over regions where the image is to be stored. Projection of the image is continued until the storage material has cooled. The storage material may, for example, be a liquid crystal polymer or a glassy nematic liquid crystal material. The process can be repeated any number of times to update any part or all of the image.",GEN ELECTRIC CO PLC,CLARK MICHAEL GEORGE;;MCARDLE CIARAN BERNARD,,https://lens.org/092-250-024-420-86X,Patent Application,yes,7,6,6,13,0,G02F1/135;;G02F1/135;;G11B7/25;;G11B7/25;;G11C7/005;;G11C7/005;;H04N1/2179;;H04N1/2179,G02F1/135;;G11B7/25;;G11C7/00;;H04N1/21,,3,0,,,"1983 SID International Symposium, Digest of Technical Papers, edition 1, May 1983, Lewis Winner, (Coral Gables, FL, US), K. Kubota et al.: ""An 8' x 8' display using a laser-addressed white-on-black mode liquid crystal light valve"", pages 44-45;;Photographic Science and Engineering, volume 20, no. 6, November/December 1976, Society of Photographic Scientists and Engineers, K.F. Nelson: ""Model for a photoconductor-liguid crystal image storage panel"", pages 268-271;;Ber. Bunsenges. Phys. Chem., volume 89, 1985, Verlagsgesellschaft mbH, (Weinheim, DE), G. K{mpf: ""Polymere als Tr{ger und Speicher von Informationen"", pages 1179-1190",PENDING
58,US,A,US 5453158 A,101-688-856-840-681,1995-09-26,1995,US 20902194 A,1994-03-10,US 20902194 A,1994-03-10,Polymer devolatilizer,"An improved polymer devolatilization apparatus including a flat plate heater having a multiplicity of flat plates defining a plurality of channels, each channel having a substantially uniform height but varying width over its length, each channel including three zones: a first zone in operative communication with the polymer solution supply device, characterized by decreasing width as a function of distance from its beginning, a second zone beginning at the terminus of the first zone, characterized by at least one occurrence of a restrictive cross-sectional area, and a third zone beginning at the end of the second zone and terminating at a liquid/vapor collection and separation region operating at reduced pressure, said third zone characterized by increasing width as a function of distance from its beginning, and provided further that the ratio of maximum width of the third zone to the maximum width of the second zone is from 2:1 to 20:1.",DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,DOW CHEMICAL COMPANY THE (1994-03-10),https://lens.org/101-688-856-840-681,Granted Patent,yes,12,37,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,159/47.1;;159/2.1;;159/28.6;;X159DIG 10;;165/146;;165/147;;165/167;;203/88;;523/324;;523/340;;528/501,1,1,126-487-749-460-399,10.1002/aic.690370510,"AlChE Jor., Slit Devolatilization of Polymers vol. 37, pp. 724 734, May, 1991 Maffettone, et al.",EXPIRED
59,FR,A1,FR 2610855 A1,121-441-423-467-026,1988-08-19,1988,FR 8801886 A,1988-02-17,GB 8703620 A,1987-02-17,PROCEDE POUR LA COULEE D'ALLIAGES FERREUX,"<P>POUR OPTIMISER LA DUREE DE SOLIDIFICATION DU METAL DANS UNE COQUILLE 10, 12 ET POUR AUTOMATISER LE PROCESSUS, ON PREVOIT UNE SONDE LASER 18, 20 POUR SURVEILLER LE NIVEAU DU METAL DANS LA COQUILLE LORS DU REMPLISSAGE ET DES CAPTEURS DE TEMPERATURE 22, 24 POUR LE JET DE METAL VERSE ET POUR LA COQUILLE. LES SIGNAUX DE LA SONDE ET DES CAPTEURS SONT INTRODUITS AVEC D'AUTRES PARAMETRES DANS UN ORDINATEUR COMMANDANT L'ENSEMBLE DES OPERATIONS DE COULEE.</P><P>L'INVENTION EST APPLICABLE A LA COULEE EN COQUILLES PAR GRAVITE, LA COULEE CONTINUE ET LA COULEE CENTRIFUGE PAR EXEMPLE.</P>",CAST TEC INTERNATIONAL INC,CLARK ANTONY PHILLIP;;GODSELL BERNARD CHARLES,,https://lens.org/121-441-423-467-026,Patent Application,no,0,0,7,7,0,B22D11/18;;B22D11/185;;B22D13/12;;B22D46/00,B22D11/18;;B22D13/12;;B22D46/00,,0,0,,,,DISCONTINUED
60,WO,A1,WO 1995/024252 A1,127-849-399-365-19X,1995-09-14,1995,US 9500420 W,1995-01-12,US 20902194 A,1994-03-10,POLYMER DEVOLATILIZER INCORPORATING IMPROVED FLAT PLATE HEAT EXCHANGER DESIGN,"An improved polymer devolatilization apparatus comprising a flat plate heater (22) comprising a polymer solution supply means (20), and a liquid/vapor collection and separation means, said flat plate heater further comprising a multiplicity of flat plates defining a plurality of channels (10), each channel having a substantially uniform height, but varying width over the total channel length, each channel comprising three zones: a first zone (12), having a beginning (18) and a terminus, said beginning in operative communication with the polymer solution supply means, characterized by decreasing width as a function of distance from its beginning, a second zone (14) having a beginning at the terminus of the first zone and a terminus, characterized by at least one occurrence of a restrictive cross-sectional area, and a third zone (16) having a beginning at the terminus of the second zone and terminating at a liquid/vapor collection and separation region operating at reduced pressure, said third zone characterized by increasing width as a function of distance from its beginning, and provided further that the ratio of maximum width of the third zone to the maximum width of the second zone is from 2:1 to 20:1.",DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,,https://lens.org/127-849-399-365-19X,Patent Application,yes,4,8,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,PATENTED
61,CH,A,CH 490481 A,052-077-206-161-208,1970-05-15,1970,CH 1042867 A,1967-07-21,GB 3274266 A,1966-07-21,Schmiermittel,,BRITISH PETROLEUM CO,DEREK CLARK BYFORD;;HOWARD BERNARD SILVER,,https://lens.org/052-077-206-161-208,Granted Patent,no,0,0,5,6,0,C10M3/00;;C10M2207/023;;C10M2207/025;;C10M2207/123;;C10M2207/129;;C10M2207/22;;C10M2207/281;;C10M2207/282;;C10M2207/283;;C10M2207/284;;C10M2207/285;;C10M2207/286;;C10M2207/287;;C10M2207/30;;C10M2207/302;;C10M2207/304;;C10M2207/34;;C10M2209/103;;C10M2209/109;;C10M2215/064;;C10M2215/065;;C10M2215/066;;C10M2215/08;;C10M2215/082;;C10M2215/10;;C10M2215/14;;C10M2215/18;;C10M2215/22;;C10M2215/221;;C10M2215/224;;C10M2215/225;;C10M2215/226;;C10M2215/28;;C10M2215/30;;C10M2219/108;;C10M2223/04;;C10M2223/041;;C10M2223/042;;C10M2223/043;;C10N2030/08;;C10N2040/12;;C10N2040/13;;C10N2050/02;;C10N2050/10,,,0,0,,,,EXPIRED
62,US,B2,US 11730563 B2,080-149-637-497-112,2023-08-22,2023,US 202218063749 A,2022-12-09,US 202218063749 A;;US 201916702860 A;;US 201962799096 P;;US 201962799100 P;;US 201962799113 P;;US 201962799202 P,2019-01-31,Knuckle joint assembly for medical device support system,"Knuckle joint assembly for a medical device support system. The knuckle joint assembly includes a cartridge assembly that includes a cartridge housing and a rotary bearing. The cartridge housing includes a bore having a central axis and a bearing mount in the bore. The rotary bearing is press fitted in the bearing mount and configured to receive axially therethrough a spindle to rotatably support the spindle about the central axis. The knuckle joint assembly includes a retaining clip and a retaining pin. The retaining clip is selectively movable to disengage and engage a groove in a spindle to respectively support or release the spindle along a central axis. The retaining pin is movable between a first position to allow movement of the retaining clip between positions but prevent removal of the retaining clip, and a second position to block movement of the retaining clip from the engaged position.",AMERICAN STERILIZER CO,MOSS BERNARD JOHN;;BELLOWS LANCE CLARK,,https://lens.org/080-149-637-497-112,Granted Patent,yes,16,0,33,94,0,A61B90/50;;A61B50/28;;A61B2090/506;;A61B2090/5025;;F16C11/04;;F16C35/042;;F16M13/027;;A61B90/35;;F16M11/06;;F16M11/2014;;F16M11/2092;;F16M11/24;;F16M2200/044;;F16M2200/063;;F16M2200/065;;A61B90/50;;A61B2090/5025;;A61B2090/506;;F16M13/022;;F16M2200/041;;F16M2200/066;;A61B34/71;;A61B2034/715;;A61B2090/508;;F16M2200/022;;A61B90/35;;F16D65/065,A61B90/50;;A61B34/00;;A61B90/35;;F16D65/06;;F16M13/02,,3,0,,,"International Search Report and Written Opinion for corresponding International Application PCT/US2019/064379 dated Mar. 26, 2020.;;Written Opinion of the International Preliminary Examining Authority (Second Written Opinion) for corresponding International Application PCT/US2019/064379 dated Feb. 16, 2021.;;International Preliminary Report on Patentability for corresponding International Application PCT/US2019/064379 dated Apr. 30, 2021.",ACTIVE
63,WO,A1,WO 2016/067010 A1,104-454-818-415-112,2016-05-06,2016,GB 2015053215 W,2015-10-27,GB 201419311 A;;GB 201500681 A;;GB 201506673 A,2014-10-30,COMBINATION THERAPY,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a β-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,,https://lens.org/104-454-818-415-112,Patent Application,yes,5,6,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K38/04;;A61K31/365;;A61K31/69;;A61K38/12;;A61P35/00;;C07D303/36,,3,3,016-400-360-502-025;;104-868-616-071-518;;016-783-528-742-446,22284358;;pmc3503453;;10.1016/j.chembiol.2012.01.003;;10.1053/j.seminhematol.2012.04.010;;22726546;;pmc3597231;;10.1016/j.ejca.2005.02.008;;15808960,"ALEXEIF KISSELEV ET AL: ""Proteasome Inhibitors: An Expanding Army Attacking a Unique Target"", CHEMISTRY AND BIOLOGY, vol. 19, no. 1, 27 January 2012 (2012-01-27), pages 99 - 115, XP028453093, ISSN: 1074-5521, [retrieved on 20120112], DOI: 10.1016/J.CHEMBIOL.2012.01.003;;PRASHANT KAPOOR ET AL: ""Bortezomib Combination Therapy in Multiple Myeloma"", SEMINARS IN HEMATOLOGY, vol. 49, no. 3, 1 July 2012 (2012-07-01), US, pages 228 - 242, XP055236438, ISSN: 0037-1963, DOI: 10.1053/j.seminhematol.2012.04.010;;BHANDARI M S ET AL: ""Clinical trials in metastatic prostate cancer - Has there been real progress in the past decade?"", EUROPEAN JOURNAL OF CANCER, PERGAMON, GB, vol. 41, no. 6, 1 April 2005 (2005-04-01), pages 941 - 953, XP027785732, ISSN: 0959-8049, [retrieved on 20050401]",PENDING
64,GB,A,GB 743729 A,110-358-961-110-319,1956-01-25,1956,GB 1089453 A,1953-04-21,GB 1089453 A,1953-04-21,Improvements relating to adjustable metal props and the like,"743,729. Props for building, mining &c. MABEY & JOHNSON, Ltd. Nov. 2, 1953 [April 21, 1953], No. 10894/53. Class 20(2). [Also in Group XXX] In a telescopic prop for building, mining, &c., the length of which is adjustable by a rotatable threaded collar 1 engaging an external screw thread on one of the members and engaging a part of the other member, the collar 1 has a lug 2 with a bore transverse to the prop axis in which fits the shorter arm of a cranked operating lever 6 which can be turned to transverse positions on either side of the lug to enable the collar to be rotated through a complete revolution when the prop is near an obstruction. The collar 1 may engage a screw thread on the outer member and a pin passing through a hole in the inner member and slots in the outer member, or the collar may be mounted on the outer member and engage a screw thread on the inner member.",MABEY & JOHNSON LTD,CLARK BERNARD LEONARD;;MABEY BEVIL GUY,,https://lens.org/110-358-961-110-319,Granted Patent,no,0,2,1,1,0,E21D15/24;;E04G25/06;;E04G25/061;;E04G25/065,E04G25/06;;E21D15/24,,0,0,,,,EXPIRED
65,US,A,US 2233582 A,118-122-968-586-045,1941-03-04,1941,US 21956438 A,1938-07-16,US 21956438 A,1938-07-16,Door,,MURRAY CORP,CLARK NOBLE C;;BENZ BERNARD W,,https://lens.org/118-122-968-586-045,Granted Patent,no,0,2,1,1,0,B60J5/0406;;B60J5/0406,B60J5/04,,0,0,,,,EXPIRED
66,DE,A1,DE 3804897 A1,158-089-051-158-697,1988-09-22,1988,DE 3804897 A,1988-02-17,GB 8703620 A,1987-02-17,VERFAHREN ZUM GIESSEN EISENHALTIGER LEGIERUNGEN,"A method of casting ferrous alloys in a gravity-poured permanent mold, centrifugal casting machine, continuous casting machine or horizontal bar casting machine, comprises controlling Et, (the time for which molten alloy is allowed to solidify in a non-continuous casting mold, or the ratio of stroke frequency to stroke length in continuous casting), whore Et is determined in accordance with the formula:- <IMAGE> Et = Solidification time to eject castings (secs). [Stroke frequency in seconds and stroke length in millimetres]. T.C = total carbon and where all other elements are kept within ranges to produce castings which are substantially carbide and shrinkage free. Am = maximum mold thickness (ins). t2 = Liquid temperature in the pouring vessel at commencement of pouring. t1 = Mold temperature at commencement of pouring. J = Specific heat for liquid iron Mc = Conductivity of mold (as hereinbefore defined). Q Factor selected from graph of Figure 2 in accordance with metallurgical structure and required hardness. Data appertaining to the various factors in the formula are used by a computer to determine Et and control the mould opening a frequency/stroke length as the case may be. <IMAGE>",CAST TEC INTERNATIONAL INC,CLARK ANTONY PHILLIP;;GODSELL BERNARD CHARLES,,https://lens.org/158-089-051-158-697,Patent Application,no,0,1,7,7,0,B22D11/18;;B22D11/185;;B22D13/12;;B22D46/00,B22D11/18;;B22D13/12;;B22D46/00,,0,0,,,,DISCONTINUED
67,EP,A1,EP 3917437 A1,193-711-189-168-114,2021-12-08,2021,EP 19828071 A,2019-12-04,US 201962799096 P;;US 201962799100 P;;US 201962799113 P;;US 201962799202 P;;US 2019/0064379 W,2019-01-31,KNUCKLE JOINT ASSEMBLY FOR MEDICAL DEVICE SUPPORT SYSTEM,,AMERICAN STERILIZER CO,MOSS BERNARD JOHN;;BELLOWS LANCE CLARK,,https://lens.org/193-711-189-168-114,Patent Application,yes,0,0,33,94,0,A61B90/50;;A61B50/28;;A61B2090/506;;A61B2090/5025;;F16C11/04;;F16C35/042;;F16M13/027;;A61B90/35;;F16M11/06;;F16M11/2014;;F16M11/2092;;F16M11/24;;F16M2200/044;;F16M2200/063;;F16M2200/065;;A61B90/50;;A61B2090/5025;;A61B2090/506;;F16M13/022;;F16M2200/041;;F16M2200/066;;A61B34/71;;A61B2034/715;;A61B2090/508;;F16M2200/022;;A61B90/35;;F16D65/065,A61B90/50;;A61B50/28;;F16D49/08;;F16D49/16;;F16D65/06;;F16M11/08;;F16M11/20;;F16M13/02,,0,0,,,,PENDING
68,EP,A1,EP 0351422 A1,194-493-950-303-755,1990-01-24,1990,EP 88908967 A,1988-10-05,GB 8723394 A,1987-10-06,DEVICES FOR PRODUCING MICROFILM AND MICROFICHE RECORDS.,"Un dispositif de mémorisation optique actualisable, qui peut présenter une configuration de microfiches, comporte deux couches électroconductrices (2, 6) entre lesquelles sont agencées en sandwich une couche (5) d'un matériau de mémorisation à cristaux liquides et une couche (3) d'un matériau thermoconducteur. Afin d'enregistrer une image sur le dispositif, on projette l'image sur la couche photoconductrice en passant par une des couches conductrices, on applique une tension entre les couches conductrices, et on chauffe un matériau de mémorisation au moins sur les régions où l'image doit être mémorisée. On continue à projeter l'image jusqu'au refroidissement du matériau de mémorisation. Ce dernier peut par exemple être un polymère à cristaux liquides ou un matériau vitreux à cristaux liquides nématiques. On peut répéter le procédé un nombre de fois indéterminé pour actualiser tout ou partie de l'image.",GEN ELECTRIC CO PLC,CLARK MICHAEL GEORGE;;MCARDLE CIARAN BERNARD,,https://lens.org/194-493-950-303-755,Patent Application,yes,0,0,6,13,0,G02F1/135;;G02F1/135;;G11B7/25;;G11B7/25;;G11C7/005;;G11C7/005;;H04N1/2179;;H04N1/2179,G02F1/135;;G11B7/25;;G11C7/00;;H04N1/21,,1,0,,,See references of WO 8903578A1,DISCONTINUED
69,US,A,US 3390294 A,004-738-949-653-777,1968-06-25,1968,US 53474866 A,1966-03-16,US 53474866 A,1966-03-16,Target vibration isolation mount,,GEN ELECTRIC,DAY BERNARD E;;CLARK WILBUR M,,https://lens.org/004-738-949-653-777,Granted Patent,no,3,2,1,1,0,H01J29/026;;H01J29/026,H01J29/02,313/67,0,0,,,,EXPIRED
70,ES,T3,ES 2113187 T3,032-249-345-883-14X,1998-04-16,1998,ES 95909230 T,1995-01-12,US 20902194 A,1994-03-10,DISPOSITIVO DESVOLATIZADOR DE POLIMEROS QUE INCORPORA UN INTERCAMBIADOR DE CALOR DE PLACAS PLANAS.,"UN APARATO DE DESVOLATILIZACION DE POLIMERO PERFECCIONADO QUE COMPRENDE UN INTERCAMBIADOR DE PLACA PLANA (22) QUE COMPRENDE UN ELEMENTO DE SUMINISTRO DE SOLUCION DE POLIMERO (20), Y UN ELEMENTO DE RECOGIDA Y SEPARACION DE LIQUIDO/VAPOR, DICHO CALENTADOR DE PLACA PLANA COMPRENDIENDO ADEMAS UNA MULTIPLICIDAD DE PLACAS PLANAS QUE DEFINEN UNA PLURALIDAD DE CANALES (10), CADA CANAL TENIENDO UNA ALTURA SUSTANCIALMENTE UNIFORME, PERO ANCHURA QUE VARIA SOBRE LA LONGITUD TOTAL DEL CANAL, CADA CANAL COMPRENDIENDO TRES ZONAS: UNA PRIMERA ZONA (12), QUE TIENE UN INICIO (18) Y UN TERMINO, DICHO INICIO EN COMUNICACION OPERATIVA CON EL ELEMENTO DE SUMINISTRO DE SOLUCION DE POLIMERO, CARACTERIZADO POR LA REDUCCION DE LA ANCHURA COMO UNA FUNCION DE DISTANCIA DESDE SU INICIO, UNA SEGUNDA ZONA (14) QUE TIENE UN INICIO EN EL TERMINO DE LA PRIMERA ZONA Y UN TERMINO, CARACTERIZADO POR AL MENOS UNA APARICION DE UN AREA DE SECCION TRANSVERSAL RESTRICTIVA, Y UNA TERCERA ZONA (16) QUE TIENE UN INICIO EN EL TERMINO DE LA SEGUNDA ZONA Y QUE TERMINA EN UNA REGION DE RECOGIDA Y SEPARACION DE LIQUIDO/VAPOR QUE OPERA A UNA PRESION REDUCIDA, DICHA TERCERA ZONA CARACTERIZADA POR EL INCREMENTO DE LA ANCHURA COMO UNA FUNCION DE DISTANCIA DESDE SU INICIO, Y CON TAL DE QUE LA PROPORCION DE ANCHURA MAXIMA DE LA TERCERA ZONA A LA ANCHURA MAXIMA DE LA SEGUNDA ZONA SEA DE 2:1 A 20:1.",DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,,https://lens.org/032-249-345-883-14X,Granted Patent,no,0,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,EXPIRED
71,GB,A,GB 2554333 A,106-094-605-216-036,2018-04-04,2018,GB 201607279 A,2016-04-26,GB 201607279 A,2016-04-26,Combination therapy,"A combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety; wherein the combination is formulated for oral administration of both the proteasome inhibitor and cyclic peptide components. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a beta-lactone protease inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib and the cyclic peptide cilengitide.",BIG DNA LTD,JOHN BERNARD MARCH;;EWAN MCINTOSH CLARK,,https://lens.org/106-094-605-216-036,Patent Application,no,2,0,4,4,0,A61K38/12;;A61K38/12;;A61K38/12;;A61K9/0053;;A61K31/4015;;A61K31/4015;;A61K31/4015;;A61K31/407;;A61K31/407;;A61K31/427;;A61K31/427;;A61K31/69;;A61K31/69;;A61K31/69;;A61K38/05;;A61K38/05;;A61K38/06;;A61K38/06;;A61K38/06;;A61K45/06;;A61K45/06;;A61K45/06;;A61K2300/00;;A61P35/00;;A61P35/00,A61K38/12;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K45/06;;A61P35/00,,1,1,016-400-360-502-025,22284358;;pmc3503453;;10.1016/j.chembiol.2012.01.003,"Chem. Biol., Vol.19, 2012, Kisselev, A. F. et al., ""Proteasome inhibitors..."", pp.99-115",DISCONTINUED
72,WO,A1,WO 2017/187156 A1,118-042-271-618-06X,2017-11-02,2017,GB 2017051148 W,2017-04-25,GB 201607279 A,2016-04-26,COMBINATION THERAPY,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprisesan exposed Arg-Gly-Asp (RGD)moiety;wherein the combination is formulated for oral administration of both the proteasome inhibitor and cyclic peptide components. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, anepoxyketone, a peptide aldehydeand a β-lactone protease inhibitor; and a cyclic peptidethat comprisesan exposed Arg-Gly-Asp (RGD)moiety; wherein the combination is formulated for oral administration of both the proteasome inhibitor and cyclic peptide components. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of:bortezomib, delanzomib,ixazomib, carfilzomib, oprozomib, MG132and marizomib; and a cyclic peptidethat comprisesan exposed Arg-Gly-Asp (RGD)moiety; wherein the combination is formulated for oral administration of both the proteasome inhibitor and cyclic peptide components.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,,https://lens.org/118-042-271-618-06X,Patent Application,yes,19,0,4,4,0,A61K38/12;;A61K38/12;;A61K38/12;;A61K9/0053;;A61K31/4015;;A61K31/4015;;A61K31/4015;;A61K31/407;;A61K31/407;;A61K31/427;;A61K31/427;;A61K31/69;;A61K31/69;;A61K31/69;;A61K38/05;;A61K38/05;;A61K38/06;;A61K38/06;;A61K38/06;;A61K45/06;;A61K45/06;;A61K45/06;;A61K2300/00;;A61P35/00;;A61P35/00,A61K38/04;;A61K31/365;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61P35/00;;C07D303/36,,36,28,016-400-360-502-025;;104-868-616-071-518;;016-783-528-742-446;;003-579-843-427-462;;056-777-932-485-613;;019-421-060-623-302;;071-237-125-208-00X;;029-995-830-216-275;;049-262-891-312-882;;079-640-250-128-00X;;071-768-758-761-836;;016-400-360-502-025;;006-455-927-370-55X;;034-567-328-906-641;;047-247-259-122-964;;048-067-133-818-657;;045-551-002-987-210;;008-385-256-064-173;;026-830-798-060-789;;028-051-576-170-35X;;078-698-821-306-734;;010-213-588-950-017;;002-241-325-147-239;;079-703-822-923-312;;102-996-220-656-53X;;028-245-833-117-353;;064-696-832-279-105;;072-787-302-601-869,22284358;;pmc3503453;;10.1016/j.chembiol.2012.01.003;;10.1053/j.seminhematol.2012.04.010;;22726546;;pmc3597231;;10.1016/j.ejca.2005.02.008;;15808960;;10.1002/prp2.217;;27069630;;pmc4804314;;pmc4890615;;26822833;;10.1038/nrd.2015.10;;pmc3411133;;10.1177/1947601912450586;;22866207;;18247547;;10.1021/jm7010589;;18057228;;10.1182/blood-2007-07-100651;;10.1111/j.1365-2141.2009.08008.x;;19958357;;20160034;;10.1158/0008-5472.can-09-2766;;pmc3443972;;21903769;;10.1158/1078-0432.ccr-11-0636;;22284358;;pmc3503453;;10.1016/j.chembiol.2012.01.003;;22019514;;10.1158/1078-0432.ccr-11-0853;;19348473;;10.1021/jm801329v;;16286248;;10.1016/j.ccr.2005.10.013;;10.1021/ja058320b;;16608349;;8995245;;10.1074/jbc.272.1.182;;21247382;;pmc3712795;;10.2174/156800911794519716;;16309948;;10.1016/j.drup.2005.10.002;;15615512;;10.1021/jm049486a;;10.1021/jm049486a.s001;;15780905;;10.1016/j.critrevonc.2004.10.011;;10.1093/jnci/82.13.1107;;2359136;;pmc3476254;;10.1074/jbc.m112.369389;;22915587;;22951279;;pmc3553581;;10.1016/j.molonc.2012.08.001;;24042097;;pmc3775094;;10.1038/srep02679;;10906183;;10.1128/jvi.74.16.7298-7306.2000;;pmc112250;;11504778;;15585635;;10.1158/1078-0432.ccr-04-1087,"ALEXEIF KISSELEV ET AL: ""Proteasome Inhibitors: An Expanding Army Attacking a Unique Target"", CHEMISTRY AND BIOLOGY, vol. 19, no. 1, 27 January 2012 (2012-01-27), pages 99 - 115, XP028453093, ISSN: 1074-5521, [retrieved on 20120112], DOI: 10.1016/J.CHEMBIOL.2012.01.003;;PRASHANT KAPOOR ET AL: ""Bortezomib Combination Therapy in Multiple Myeloma"", SEMINARS IN HEMATOLOGY, vol. 49, no. 3, 1 July 2012 (2012-07-01), US, pages 228 - 242, XP055236438, ISSN: 0037-1963, DOI: 10.1053/j.seminhematol.2012.04.010;;BHANDARI M S ET AL: ""Clinical trials in metastatic prostate cancer - Has there been real progress in the past decade?"", EUROPEAN JOURNAL OF CANCER, PERGAMON, GB, vol. 41, no. 6, 1 April 2005 (2005-04-01), pages 941 - 953, XP027785732, ISSN: 0959-8049, [retrieved on 20050401];;HUGUES DOLGOS ET AL: ""In vitro and in vivo drug disposition of cilengitide in animals and human"", PHARMACOLOGY RESEARCH & PERSPECTIVES, vol. 4, no. 2, 17 March 2016 (2016-03-17), GB, pages e00217, XP055390578, ISSN: 2052-1707, DOI: 10.1002/prp2.217;;LEY K ET AL: ""Integrin-based therapeutics: Biological basis, clinical use and new drugs"", NATURE REVIEWS. DRUG DISCO, NATURE PUBLISHING GROUP, GB, vol. 15, no. 3, 1 March 2016 (2016-03-01), pages 173 - 183, XP009190337, ISSN: 1474-1776;;D. A. REARDON ET AL: ""Cilengitide: A Prototypic Integrin Inhibitor for the Treatment of Glioblastoma and Other Malignancies"", GENES AND CANCER, vol. 2, no. 12, 1 December 2011 (2011-12-01), US, pages 1159 - 1165, XP055227020, ISSN: 1947-6019, DOI: 10.1177/1947601912450586;;DORSEY ET AL., J. MED CHEM., vol. 51, 2008, pages 1068 - 72;;ZHU ET AL., J. MED CHEM, vol. 53, 2010, pages 1990 - 9;;PIVA ET AL., BLOOD, vol. 111, 2008, pages 2765 - 75;;DORSEY ET AL., J. MED CHEM, vol. 51, 2008, pages 1068 - 72;;SANCHEZ ET AL., BR. J. HAEMATOL, vol. 148, 2010, pages 569 - 81;;KUPPERMAN ET AL., CANCER RES., vol. 70, 2010, pages 1970 - 80;;LEE ET AL., CLIN. CANCER RES., vol. 17, 2011, pages 7313 - 23;;ALLEGRA ET AL., LEUKEMIA RESEARCH, vol. 38, 2014, pages 1 - 9;;O'CONNER ET AL., CLIN. CANCER RES., vol. 15, 2009, pages 7085 - 7091;;KISSELEV ET AL., CHEMISTRY & BIOLOGY, vol. 19, 27 January 2012 (2012-01-27), pages 99 - 115;;MOLINEAUX, S.M., CLIN. CANCER RES., vol. 18, 2012, pages 15 - 20;;ZHOU, H.J. ET AL., J. MED. CHEM., vol. 52, 2009, pages 3028 - 3038;;CHAUHAN ET AL., CANCER CELL, vol. 8, pages 407 - 419;;GROLL ET AL., J. AM. CHEM. SOC., vol. 128, pages 5136 - 5141;;DICK ET AL., J. BIOL. CHEM., vol. 272, pages 182 - 188;;POTTS ET AL., CURR. CANCER DRUG TARGETS, vol. 11, pages 254 - 284;;TEMMING ET AL., DRUG RESISTANCE UPDATES, vol. 8, 2005, pages 381 - 402;;E.W. MARTIN: ""Remington's Pharmaceutical Sciences"";;BERGE ET AL.: ""Pharmaceutical Salts"", J. PHARMA. SCI., vol. 66, 1977, pages 1, XP002675560, DOI: doi:10.1002/jps.2600660104;;J. MED. CHEM., vol. 47, 2004, pages 6658 - 6661;;STERN ET AL., CRITICAL REVIEWS IN ONCOLOGY/HAEMATOLOGY, vol. 54, 2005, pages 1 1 - 29;;""Remington, The Science and Practice of Pharmacy"", 2000, pages: 858 - 914;;""Remington's Pharmaceutical Sciences"", 1985, MACK PUBLISHING CO;;SKEHAN ET AL., J. NAT. CANCER INST., vol. 82, 1990, pages 1107 - 1112;;STONEHAM CA ET AL.: ""Clathrin-mediated endocytosis and subsequent endo-lysosomal trafficking of Adeno-associated virus/phage"", J. BIOL. CHEMISTRY, vol. 287, no. 43, 2012, pages 35849 - 35859;;PRZYSTAL JM ET AL.: ""Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage"", MOLECULAR ONCOLOGY, vol. 7, no. 1, 2013, pages 55 - 66;;XU ET AL., SCIENTIFIC REPORTS, vol. 3, 2013, pages 2679;;NEFF S ET AL.: ""High-Efficiency Utilization of the Bovine Integrin ? ? a Receptor for Foot-and-Mouth Disease Virus Is Dependent on the Bovine ?3 Subunit"", J VIROL., vol. 74, no. 16, August 2000 (2000-08-01), pages 7298 - 7306;;TALLARIDA, J PHARMACOL EXP THER., vol. 298, 2001, pages 865 - 72;;ZHAO ET AL., CLIN. CANCER RES., vol. 10, 2004, pages 7994 - 8004",PENDING
73,CA,A,CA 517202 A,168-949-766-718-715,1955-10-04,1955,CA 517202D A,,CA 517202T A,,ROTARY DRUM APPARATUS AND MEANS FOR PREVENTING MATERIAL BEING TREATED FROM ACCUMULATING THEREON,,NORANDA MINES,MORRISON BERNARD H;;CLARK CHARLES W,,https://lens.org/168-949-766-718-715,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
74,EP,A1,EP 3448408 A1,132-649-058-037-272,2019-03-06,2019,EP 17722497 A,2017-04-25,GB 201607279 A;;GB 2017051148 W,2016-04-26,COMBINATION THERAPY,,BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,BIG DNA LTD (2019-11-06),https://lens.org/132-649-058-037-272,Patent Application,yes,0,0,4,4,0,A61K38/12;;A61K38/12;;A61K38/12;;A61K9/0053;;A61K31/4015;;A61K31/4015;;A61K31/4015;;A61K31/407;;A61K31/407;;A61K31/427;;A61K31/427;;A61K31/69;;A61K31/69;;A61K31/69;;A61K38/05;;A61K38/05;;A61K38/06;;A61K38/06;;A61K38/06;;A61K45/06;;A61K45/06;;A61K45/06;;A61K2300/00;;A61P35/00;;A61P35/00,A61K38/04;;A61K31/365;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61P35/00;;C07D303/36,,1,0,,,See references of WO 2017187156A1,DISCONTINUED
75,AU,B2,AU 2015/340359 B2,107-351-483-108-379,2019-11-21,2019,AU 2015/340359 A,2015-10-27,GB 201500681 A;;GB 201506673 A;;GB 201419311 A;;GB 2015053215 W,2014-10-30,Combination therapy,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a β-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,,https://lens.org/107-351-483-108-379,Granted Patent,no,6,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,C07D303/36;;A61K31/365;;A61K31/69;;A61K38/04;;A61K38/12;;A61P35/00,,1,1,016-400-360-502-025,22284358;;pmc3503453;;10.1016/j.chembiol.2012.01.003,"ALEXEIF KISSELEV ET AL, ""Proteasome Inhibitors: An Expanding Army Attacking a Unique Target"", CHEMISTRY AND BIOLOGY, vol. 19, no. 1, doi:10.1016/J.CHEMBIOL.2012.01.003, ISSN 1074-5521, (2012-01-27), pages 99 - 115, (2012-01-12)",INACTIVE
76,CA,A1,CA 2180557 A1,093-462-246-052-119,1995-09-14,1995,CA 2180557 A,1995-01-12,US 20902194 A;;US 9500420 W,1994-03-10,POLYMER DEVOLATILIZER INCORPORATING IMPROVED FLAT PLATE HEAT EXCHANGER DESIGN,"An improved polymer devolatilization apparatus comprising a flat plate heater (22) comprising a polymer solution supply means (20), and a liquid/vapor collection and separation means, said flat plate heater further comprising a multiplicity of flat plates defining a plurality of channels (10), each channel having a substantially uniform height, but varying width over the total channel length, each channel comprising three zones: a first zone (12), having a beginning (18) and a terminus, said beginning in operative communication with the polymer solution supply means characterized by decreasing width as a function of distance from its beginning, a second zone (14) having a beginning at the terminus of the first zone and a terminus, characterized by at least one occurrence of a restrictive cross-sectional area, and a third zone (16) having a beginning at the terminus of the second zone and terminating at a liquid/vapor collection and separation region operating at reduced pressure, said third zone characterized by increasing width as a function of distance from its beginning, and provided further that the ratio of maximum width of the third zone to the maximum width of the second zone is from 2:1 to 20:1.",,CUMMINGS CLARK J;;MEISTER BERNARD J,,https://lens.org/093-462-246-052-119,Patent Application,no,0,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,DISCONTINUED
77,WO,A2,WO 2009/138752 A2,122-361-111-430-36X,2009-11-19,2009,GB 2009001215 W,2009-05-15,GB 0808780 A,2008-05-15,FISH VACCINE,"Viral and bacterial diseases in fin-fish, shellfish or other aquatic life-forms pose a serious problem for the aquaculture industry. Owing to the high density of animals in the hatchery tanks or enclosed marine farming areas, infectious diseases may eradicate a large proportion of the stock in, for example, a fin-fish, shellfish, or other aquatic lifeforms facility. Prevention of disease is a more desired remedy to these threats to fish than intervention once the disease is in progress. Vaccination of fish is the only preventative method which may offer long-term protection through immunity.",BIG DNA LTD;;MARCH JOHN BERNARD;;CLARK JASON RICHARD,MARCH JOHN BERNARD;;CLARK JASON RICHARD,,https://lens.org/122-361-111-430-36X,Patent Application,yes,0,3,3,3,0,A61K39/205;;A61K39/00;;A61K39/12;;A61K2039/5256;;A61K2039/53;;A61K2039/54;;A61K2039/542;;A61K2039/552;;C12N2760/20034;;C12N2795/10343,A61K39/00,,0,0,,,,PENDING
78,GB,A,GB 2210703 A,113-325-660-848-211,1989-06-14,1989,GB 8723394 A,1987-10-06,GB 8723394 A,1987-10-06,OPTICAL STORAGE DEVICE,,GEN ELECTRIC CO PLC,CLARK MICHAEL GEORGE;;MCARDLE CIARAN BERNARD,,https://lens.org/113-325-660-848-211,Patent Application,no,3,3,6,13,0,G02F1/135;;G02F1/135;;G11B7/25;;G11B7/25;;G11C7/005;;G11C7/005;;H04N1/2179;;H04N1/2179,G02F1/135;;G11B7/25;;G11C7/00;;H04N1/21,G2F FCD           CD;;G2F F23E          CD;;G2F F23R          CD;;G2F F25A          CD;;G2F F25F          CD;;G2F F25T          CD;;G2F F26R          CD;;G2F F28M          CD;;U1S S2120;;U1S S2276,0,0,,,,EXPIRED
79,ZA,B,ZA 201702522 B,139-155-408-672-925,2019-10-30,2019,ZA 201702522 A,2017-04-10,GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;GB 2015053215 W,2014-10-30,COMBINATION THERAPY,,BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,,https://lens.org/139-155-408-672-925,Granted Patent,no,0,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,,,0,0,,,,ACTIVE
80,DE,A1,DE 1644861 A1,143-929-321-947-130,1970-09-17,1970,DE 1644861 A,1967-07-20,GB 3274266 A,1966-07-21,Synthetische Schmiermittelgemische,,BRITISH PETROLEUM CO,CLARK BYFORD DEREK;;BERNARD SILVER HOWARD,,https://lens.org/143-929-321-947-130,Patent Application,no,0,0,5,6,0,C10M3/00;;C10M2207/023;;C10M2207/025;;C10M2207/123;;C10M2207/129;;C10M2207/22;;C10M2207/281;;C10M2207/282;;C10M2207/283;;C10M2207/284;;C10M2207/285;;C10M2207/286;;C10M2207/287;;C10M2207/30;;C10M2207/302;;C10M2207/304;;C10M2207/34;;C10M2209/103;;C10M2209/109;;C10M2215/064;;C10M2215/065;;C10M2215/066;;C10M2215/08;;C10M2215/082;;C10M2215/10;;C10M2215/14;;C10M2215/18;;C10M2215/22;;C10M2215/221;;C10M2215/224;;C10M2215/225;;C10M2215/226;;C10M2215/28;;C10M2215/30;;C10M2219/108;;C10M2223/04;;C10M2223/041;;C10M2223/042;;C10M2223/043;;C10N2030/08;;C10N2040/12;;C10N2040/13;;C10N2050/02;;C10N2050/10,,,0,0,,,,DISCONTINUED
81,AU,B2,AU 682254 B2,179-258-920-856-347,1997-09-25,1997,AU 1995/017261 A,1995-01-12,US 20902194 A;;US 9500420 W,1994-03-10,Polymer devolatilizer incorporating improved flat plate heat exchanger design,,DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,,https://lens.org/179-258-920-856-347,Granted Patent,no,3,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,EXPIRED
82,US,A1,US 2020/0246107 A1,012-267-057-090-448,2020-08-06,2020,US 201916702860 A,2019-12-04,US 201916702860 A;;US 201962799096 P;;US 201962799100 P;;US 201962799113 P;;US 201962799202 P,2019-01-31,KNUCKLE JOINT ASSEMBLY FOR MEDICAL DEVICE SUPPORT SYSTEM,"Knuckle joint assembly for a medical device support system. The knuckle joint assembly includes a cartridge assembly that includes a cartridge housing and a rotary bearing. The cartridge housing includes a bore having a central axis and a bearing mount in the bore. The rotary bearing is press fitted in the bearing mount and configured to receive axially therethrough a spindle to rotatably support the spindle about the central axis. The knuckle joint assembly includes a retaining clip and a retaining pin. The retaining clip is selectively movable to disengage and engage a groove in a spindle to respectively support or release the spindle along a central axis. The retaining pin is movable between a first position to allow movement of the retaining clip between positions but prevent removal of the retaining clip, and a second position to block movement of the retaining clip from the engaged position.",AMERICAN STERILIZER CO,MOSS BERNARD JOHN;;BELLOWS LANCE CLARK,AMERICAN STERILIZER COMPANY (2019-11-04),https://lens.org/012-267-057-090-448,Patent Application,yes,6,0,33,94,0,A61B90/50;;A61B50/28;;A61B2090/506;;A61B2090/5025;;F16C11/04;;F16C35/042;;F16M13/027;;A61B90/35;;F16M11/06;;F16M11/2014;;F16M11/2092;;F16M11/24;;F16M2200/044;;F16M2200/063;;F16M2200/065;;A61B90/50;;A61B2090/5025;;A61B2090/506;;F16M13/022;;F16M2200/041;;F16M2200/066;;A61B34/71;;A61B2034/715;;A61B2090/508;;F16M2200/022;;A61B90/35;;F16D65/065,A61B90/50;;F16M13/02,,0,0,,,,ACTIVE
83,AU,A,AU 1995/017261 A,060-229-475-964-893,1995-09-25,1995,AU 1995/017261 A,1995-01-12,US 20902194 A;;US 9500420 W,1994-03-10,Polymer devolatilizer incorporating improved flat plate heat exchanger design,,DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,,https://lens.org/060-229-475-964-893,Patent Application,no,0,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,EXPIRED
84,GB,A,GB 2202771 A,062-918-983-757-934,1988-10-05,1988,GB 8803614 A,1988-02-17,GB 8703620 A,1987-02-17,Method of casting ferrous alloys,,CAST TEC LIMITED,CLARK ANTHONY PHILIP;;GODSELL BERNARD CHARLES,,https://lens.org/062-918-983-757-934,Patent Application,no,0,0,7,7,0,B22D11/18;;B22D11/185;;B22D13/12;;B22D46/00,B22D11/18;;B22D13/12;;B22D46/00,B3F FBA           FBA;;B3F F200          FBA;;B3F F214          FBA;;B3F F216          FBA;;B3F F224          FBA,0,0,,,,DISCONTINUED
85,US,B2,US 10166269 B2,101-897-404-768-712,2019-01-01,2019,US 15523188,2015-10-27,GB 1419311.4;;GB 1500681.0;;GB 1506673.1,2014-10-30,Combinations of proteasome inhibitors and cyclic peptides,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a β-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,John Bernard March;;Ewan McIntosh Clark,,https://lens.org/101-897-404-768-712,Granted Patent,yes,6,0,1,1,0,A61K38/12;;A61K31/407;;A61K31/4015;;A61K31/69;;A61K38/005;;A61K38/05;;A61K38/06;;A61K38/07;;A61K45/06,A61K38/12;;A61K38/06;;A61K31/407;;A61K38/07;;A61K38/05;;A61K38/00;;A61K31/69;;A61K45/06;;A61K31/4015,,13,0,,,"Cilengitide, from https://www.medchemexpress.com/Cilengitide.html, p. 1, accessed Nov. 28, 2017.;;Cellular and Molecular Basis of Cancer, from http://www.merckmanuals.com/professional/print/hematology_and_oncology/overview_of . . . , pp. 1-5, accessed Nov. 7, 2012.;;Hait, Anticancer drug development: the grand challenges, Nature Reviews/Drug Disvovery, 2010, 9, pp. 253-254.;;Herter-Sprie et al, New cast for a new era: preclinical cancer drug development revisited, The Journal of Clinical Investigation, 2013 , 123, pp. 3639-3645.;;Nieberler et al, Exploring the Role of RGD—Recognizing Integrins in Cancer, Cancers, 2017, 9, pp. 1-33.;;Milano et al, The proteasome: A worthwhile target for the treatment of solid tumours?, 2007, European Journal of Cancer, 2007, 43, pp. 1125-1133.;;Orlowski et al, Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies, J Clin Oncol , 2002, 20, pp. 4420-4427.;;Chauhan et al, In Vitro and in Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells, Clin Cancer Res, 2011, 17, pp. 5311-5321.;;Ria et al, αvβ3 integrin engagement enhances cell invasiveness in human multiple myeloma, Haematologica, 2002, 87, pp. 836-845.;;Reardon et al, Cilengitide: A Prototypic Integrin Inhibitor for the Treatment of Glioblastoma and Other Malignancies, Genes & Cancer, 2011, 2, pp. 1159-1165.;;Bhandari, M.S. et al., “Clinical Trials in Metastatic Prostate Cancer—Has there been Real Progress in the Past Decade?”, Euro. J. of Cancer, vol. 41, p. 941-953 (2005).;;Kapoor, P. et al., “Bortezomib Combination Therapy in Multiple Myeloma”, Seminars in Hematology., vol. 49, No. 3, p. 228-242 (2012).;;Kisselev, A.F.et al., “Proteasome Inhibitors: An Expanding Army Attacking a Unique Target”, Chemistry and Biology, vol. 19, No. 1, p. 99-115, (2012).",UNKNOWN
86,EP,A1,EP 0749343 A1,118-666-967-347-849,1996-12-27,1996,EP 95909230 A,1995-01-12,US 9500420 W;;US 20902194 A,1994-03-10,POLYMER DEVOLATILIZER INCORPORATING IMPROVED FLAT PLATE HEAT EXCHANGER DESIGN,,DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,THE DOW CHEMICAL COMPANY (1997-11-26),https://lens.org/118-666-967-347-849,Patent Application,yes,0,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,EXPIRED
87,WO,A3,WO 2011/080505 A3,113-563-174-800-216,2011-08-25,2011,GB 2010002341 W,2010-12-24,US 29036209 P,2009-12-28,METHOD OF GROWING PHAGE FOR COMMERCIAL USE,"The present invention relates to methods of obtaining bacteriophage ('phage'), such as lambda phage, for industrial uses, such as for use in commercial vaccine production. There is also provided a novel bacterium, such as Escherichia coli (E. coli ) which has been modified for growing phage in a manner which improves the general and environmental safety of said phage. The invention also relates to the use of a modified bacterium for growing phage for industrial purposes. Finally, the invention also provides modified phage, which are designed for growth in industrial and/or environmental safety.",BIGDNA LTD;;MARCH JOHN BERNARD;;CLARK JASON RICHARD,MARCH JOHN BERNARD;;CLARK JASON RICHARD,,https://lens.org/113-563-174-800-216,Search Report,yes,2,0,2,2,0,A61K35/13;;C12N7/00;;C07K14/245;;C12N1/08;;C12N15/70;;C12N2795/10351;;Y02A50/30,C12N7/00;;A61K35/13;;A61K35/76;;C12N1/08;;C12N1/20,,9,7,109-645-998-094-830;;054-395-987-186-569;;075-142-348-224-908;;012-873-842-450-920;;071-642-033-064-853;;046-310-532-544-504;;115-453-123-295-374,16738554;;10.1038/msb4100050;;pmc1681482;;4562392;;pmc251391;;10.1128/jb.112.1.161-169.1972;;16237019;;10.1128/jb.187.21.7362-7373.2005;;pmc1272966;;17448169;;10.1111/j.1365-2672.2006.03182.x;;pmc2063594;;19459966;;10.1111/j.1574-6968.2009.01620.x;;10.1016/j.jmb.2003.09.033;;14607116;;10.1016/j.vaccine.2003.11.065;;15193403,"BABA TOMOYA ET AL: ""Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection."", MOLECULAR SYSTEMS BIOLOGY, vol. 2, 21 February 2006 (2006-02-21), XP002628975, ISSN: 1744-4292, DOI: 10.1038/msb4100050;;SAMBROOK JOSEPH ET AL: ""Molecular cloning: A laboratory manual"", vol. 1, 2001, COLD SPRING HARBOR LABORATORY PRESS, 10 SKYLINE DRIVE, PLAINVIEW, NY, 11803-2500, USA, ISBN: 0-87969-577-3, ISSN: null, article ""Chapter 2: Bacteriophage Lambda and its vectors"", pages: 2.28 - 2.29, XP002628976;;NOVAGEN: ""Bacteriophage CE6"", NOVAGEN TECHNICAL BULLETIN, no. 7, February 1994 (1994-02-01), pages 1 - 2, XP002628977, Retrieved from the Internet <URL:http://www.ebiotrade.com/buyf/productsf/Novagen/69390-000.pdf> [retrieved on 20110315];;SIMMON V F ET AL: ""Degradation of bacteriophage lambda deoxyribonucleic acid after restriction by Escherichia coli K-12."", JOURNAL OF BACTERIOLOGY, vol. 112, no. 1, October 1972 (1972-10-01), pages 161 - 169, XP002628978, ISSN: 0021-9193;;HANDA NAOFUMI ET AL: ""Type III restriction is alleviated by bacteriophage (RecE) homologous recombination function but enhanced by bacterial (RecBCD) function"", JOURNAL OF BACTERIOLOGY, vol. 187, no. 21, November 2005 (2005-11-01), pages 7362 - 7373, XP002628979, ISSN: 0021-9193;;LANKES H A ET AL: ""In vivo gene delivery and expression by bacteriophage lambda vectors"", JOURNAL OF APPLIED MICROBIOLOGY, vol. 102, no. 5, May 2007 (2007-05-01), pages 1337 - 1349, XP002628981, ISSN: 1364-5072;;MORADPOUR ZAHRA ET AL: ""Genetically engineered phage harbouring the lethal catabolite gene activator protein gene with an inducer-independent promoter for biocontrol of Escherichia coli."", FEMS MICROBIOLOGY LETTERS JUL 2009 LNKD- PUBMED:19459966, vol. 296, no. 1, July 2009 (2009-07-01), pages 67 - 71, XP002628982, ISSN: 1574-6968;;GUPTA A ET AL: ""High-density Functional Display of Proteins on Bacteriophage Lambda"", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 334, no. 2, 21 November 2003 (2003-11-21), pages 241 - 254, XP004470972, ISSN: 0022-2836, DOI: DOI:10.1016/J.JMB.2003.09.033;;JEPSON C D ET AL: ""Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle"", VACCINE, ELSEVIER LTD, GB, vol. 22, no. 19, 23 June 2004 (2004-06-23), pages 2413 - 2419, XP004515458, ISSN: 0264-410X, DOI: DOI:10.1016/J.VACCINE.2003.11.065",PENDING
88,CO,A1,CO 4440472 A1,154-404-955-463-16X,1997-05-07,1997,CO 95009412 A,1995-03-09,US 20902194 A,1994-03-10,DEVOLATILIZADOR DE POLIMEROS QUE INCORPORA UN DISENO MEJORADO DE UN INTERCAMBIADOR DE CALOR DE PLACA PLANA,"1. UN APARATO DE DESVOLATILIZACION DE POLIMEROS MEJORADA COMPRENDE UN CALENTADOR DE PLACA PLANA QUE COMPRENDE UN MEDIO DE SUMINISTRO DE SOLUCION DE POLIMERO, Y UN MEDIO DE SEPARACION Y RECOLEC- CION DE LIQUIDO/VAPOR, DICHO CALENTADOR DE PLACA PLANA COMPRENDE ADICIONALMENTE UNA MULTIPLICIDAD DE PLACAS PLANAS QUE DEFINEN UNA PLURALIDAD DE CANALES, CADA CANAL TENIENDO UNA ALTURA UNIFORME SUSTANCIALMENTE PERO VARIANDO EN SU ANCHO A LO LARGO DE LA LONGITUD TOTAL DEL CANAL, CADA CANAL COMPRENDE TRES ZONAS: UNA PRIMERA ZONA, QUE TIENE UN INICIO Y UN FINAL, DICHO INICIO ESTA EN COMUNICACION OPERATIVA CON LOS MEDIOS DE SUMINISTRO DE SOLUCION DE POLIMERO, CARACTERIZADO POR SU ANCHO DECRECIENTE EN FUNCION DE LA DISTANCIA DESDE SU INICIO, UNA SEGUNDA ZONA QUE TIENE UN INICIO EN EL FIN DE LA PRIMERA DE LA ZONA Y UN FINAL, CARACTERIZADO PORQUE AL MENOS EXISTE UNA OCURRENCIA DE UN AREA DE SECCION TRANSVERSAL RESTRICTIVA, Y UNA TERCERA ZONA QUE TIENE UN INICIO AL FINAL DE LA SEGUNDA ZONA Y TERMINA EN UNA REGION DE SEPARA- CION Y RECOLECCION DE LIQUIDO/VAPOR OPERANDO A PRESION REDUCIDA, DICHA TERCERA ZONA ESTA CARACTE- RIZADA POR SU ANCHO INCREMENTAL COMO FUNCION DE LA DISTANCIA DESDE SU INICIO, Y SIEMPRE QUE ADICIO- NALMENTE SU RADIO SU PROPORCION DE ANCHO MAXIMO DE LA TERCERA ZONA AL ANCHO MAXIMO DE LA SEGUNDA ESTE ENTRE 2:1 A 20:1. FIGURA 1",DOW CHEMICAL CO,CLARK J CUMMINGS;;MEISTER BERNARD J,,https://lens.org/154-404-955-463-16X,Patent Application,no,0,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D5/00;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,PENDING
89,BR,A,BR 9507430 A,179-112-004-449-349,1997-09-16,1997,BR 9507430 A,1995-01-12,US 20909194 A;;US 9500420 W,1994-03-10,Aparelho e processo melhorados de desvolatilização de polimeros,,DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,,https://lens.org/179-112-004-449-349,Patent Application,no,0,0,10,10,0,B41J2/16505;;B41J2/1754;;B41J2/1754;;B41J2/16505,B41J2/165;;B41J2/175,,0,0,,,,DISCONTINUED
90,IT,A0,IT 8819450 A0,183-906-794-195-767,1988-02-17,1988,IT 1945088 A,1988-02-17,GB 8703620 A,1987-02-17,METODO DI COLATA DI LEGHE DI FERRO.,,CAST TEC INTERNATIONAL INC,CLARK ANTONY PHILLIP;;GODSELL BERNARD CHARLES,,https://lens.org/183-906-794-195-767,Patent Application,no,0,0,7,7,0,B22D11/18;;B22D11/185;;B22D13/12;;B22D46/00,B22D11/18;;B22D13/12;;B22D46/00,,0,0,,,,EXPIRED
91,US,B1,US 6591228 B1,184-181-047-360-424,2003-07-08,2003,US 78290101 A,2001-02-13,US 78290101 A,2001-02-13,Centralized diagnostic logging service,"
    A logging service logs diagnostic messages from applications executing in a mainframe computing environment to a centralized log. A mainframe computing environment has a plurality of mainframes coupled to a coupling facility. The coupling facility has a data storage area called a logstream. Each mainframe has one or more subsystems executing applications. Each application preferably contains an API block, which is populated by the application and passed to a logging service API when the application desires to store a diagnostic message in the logstream. The logging service API writes the diagnostic messages to the logstream. In one subsystem, the logging service API contacts an alert facility in response to certain diagnostic messages received from applications. The logging service API in this subsystem also uses a message queue to pass the diagnostic messages to a subsystem able to write to the logstream. 
",CHARLES SCHWAB & CO INC,HALL IAN G;;CLARK BERNARD F,CHARLES SCHWAB & CO. INC (2001-04-04),https://lens.org/184-181-047-360-424,Granted Patent,yes,2,59,1,1,0,G06F11/0709;;G06F11/0775;;G06F11/0781;;G06F11/0784;;G06F11/366;;G06F11/0775;;G06F11/0709;;G06F11/0784;;G06F11/0781;;G06F11/366,G06F17/30;;G06F17/40,702/187;;370/321;;707/200,0,0,,,,EXPIRED
92,WO,A3,WO 2006/102132 A3,032-866-762-788-710,2007-07-19,2007,US 2006/0009813 W,2006-03-17,US 90707405 A,2005-03-18,VACUUM PACKAGING MACHINE,"A vacuum packaging machine (10) is provided having a base (12) and a pivotally mounted lid (14) which cooperatively define a package air evacuation chamber (76) adapted to receive the open end (98) of a filled flexible package (100), thereby allowing evacuation of air from the package (100) and heat sealing of end (98). The machine (10) is characterized by an essentially flat and interrupted, easily cleanable base upper wall (28) which eliminates concavities in the like which can lead to unsanitary collection of fluids or solids. The machine (10) also has a vacuum source (16) and a vacuum conduit assembly (18) the latter having conduits within base (12) and lid (14).",HANTOVER INC;;LEVSEN CLARK A;;HUFF BERNARD G,LEVSEN CLARK A;;HUFF BERNARD G,,https://lens.org/032-866-762-788-710,Search Report,yes,3,0,4,4,0,B65B31/046;;B65B31/046,B65B31/00,,0,0,,,,PENDING
93,EP,B1,EP 3212210 B1,048-640-476-241-238,2019-12-11,2019,EP 15791346 A,2015-10-27,GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;GB 2015053215 W,2014-10-30,COMBINATION THERAPY,,BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,BIG DNA LTD (2019-05-15),https://lens.org/048-640-476-241-238,Granted Patent,yes,5,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K38/00;;A61K31/4015;;A61K31/407;;A61K31/69;;A61K38/05;;A61K38/06;;A61K38/07;;A61K38/12;;A61K45/06,,3,0,,,"ALEXEIF KISSELEV ET AL: ""Proteasome Inhibitors: An Expanding Army Attacking a Unique Target"", CHEMISTRY AND BIOLOGY, vol. 19, no. 1, 27 January 2012 (2012-01-27), pages 99-115, XP028453093, ISSN: 1074-5521, DOI: 10.1016/J.CHEMBIOL.2012.01.003 [retrieved on 2012-01-12];;PRASHANT KAPOOR ET AL: ""Bortezomib Combination Therapy in Multiple Myeloma"", SEMINARS IN HEMATOLOGY, vol. 49, no. 3, 1 July 2012 (2012-07-01), pages 228-242, XP055236438, US ISSN: 0037-1963, DOI: 10.1053/j.seminhematol.2012.04.010;;BHANDARI M S ET AL: ""Clinical trials in metastatic prostate cancer - Has there been real progress in the past decade?"", EUROPEAN JOURNAL OF CANCER, PERGAMON, GB, vol. 41, no. 6, 1 April 2005 (2005-04-01), pages 941-953, XP027785732, ISSN: 0959-8049 [retrieved on 2005-04-01]",ACTIVE
94,CA,A1,CA 2966288 A1,055-341-018-880-677,2016-05-06,2016,CA 2966288 A,2015-10-27,GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;GB 2015053215 W,2014-10-30,COMBINATION THERAPY,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a ß-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,,https://lens.org/055-341-018-880-677,Patent Application,no,0,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K38/12;;A61K31/69;;C07D303/36,,0,0,,,,DISCONTINUED
95,US,A1,US 2018/0021403 A1,049-704-676-957-675,2018-01-25,2018,US 201515523188 A,2015-10-27,GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;GB 2015053215 W,2014-10-30,Combination Therapy,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a β-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCLNTOSH,BIG DNA LTD (2017-05-17),https://lens.org/049-704-676-957-675,Patent Application,yes,0,1,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K38/12;;A61K31/407;;A61K38/00;;A61K38/05;;A61K38/06;;A61K38/07,,0,0,,,,ACTIVE
96,EP,B1,EP 0749343 B1,057-516-580-304-313,1998-03-04,1998,EP 95909230 A,1995-01-12,US 9500420 W;;US 20902194 A,1994-03-10,POLYMER DEVOLATILIZER INCORPORATING IMPROVED FLAT PLATE HEAT EXCHANGER DESIGN,,DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,THE DOW CHEMICAL COMPANY (1997-11-26),https://lens.org/057-516-580-304-313,Granted Patent,yes,4,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,EXPIRED
97,US,A1,US 2019/0134148 A1,088-946-928-966-604,2019-05-09,2019,US 201716096470 A,2017-04-25,GB 201607279 A;;GB 2017051148 W,2016-04-26,COMBINATION THERAPY,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety; wherein the combination is formulated for oral administration of both the proteasome inhibitor and cyclic peptide components. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, anepoxyketone, a peptide aldehyde and a β-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety; wherein the combination is formulated for oral administration of both the proteasome inhibitor and cyclic peptide components. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety; wherein the combination is formulated for oral administration of both the proteasome inhibitor and cyclic peptide components.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,BIG DNA LTD (2019-05-02),https://lens.org/088-946-928-966-604,Patent Application,yes,0,0,4,4,0,A61K38/12;;A61K38/12;;A61K38/12;;A61K9/0053;;A61K31/4015;;A61K31/4015;;A61K31/4015;;A61K31/407;;A61K31/407;;A61K31/427;;A61K31/427;;A61K31/69;;A61K31/69;;A61K31/69;;A61K38/05;;A61K38/05;;A61K38/06;;A61K38/06;;A61K38/06;;A61K45/06;;A61K45/06;;A61K45/06;;A61K2300/00;;A61P35/00;;A61P35/00,A61K38/12;;A61K9/00;;A61K31/407;;A61K38/05;;A61P35/00,,0,0,,,,DISCONTINUED
98,US,S,US D0536355 S,118-012-924-235-756,2007-02-06,2007,US 22562605 F,2005-03-18,US 22562605 F,2005-03-18,Vacuum packaging machine,,HANTOVER INC,LEVSEN CLARK A;;HUFF BERNARD G,HANTOVER INC (2005-03-18),https://lens.org/118-012-924-235-756,Design Right,yes,7,18,3,3,0,,,1599;;D15/146,0,0,,,,EXPIRED
99,BR,A2,BR 112017008290 A2,109-773-048-535-31X,2017-12-19,2017,BR 112017008290 A,2015-10-27,GB 2015053215 W;;GB 201419311 A;;GB 201500681 A;;GB 201506673 A,2014-10-30,terapia de combinação,"a presente invenção refere-se a uma combinação que compreende um inibidor de proteossoma e um peptídeo cíclico que compreende uma porção arg-gly-asp (rgd) exposta. em particular, a presente invenção refere-se a uma combinação que compreende um inibidor de proteossoma selecionado do grupo consistindo em: um boronato, uma epoxicetona, um aldeído peptídico e um inibidor da ß-lactona protease; e um peptídeo cíclico que compreende uma porção arg-gly-asp (rgd) exposta. mais particularmente, a presente invenção refere-se a uma combinação que compreende um inibidor do proteossoma selecionado do grupo consistindo em: bortezomibe, delanzomibe, ixazomibe, carfilzomibe, oprozomibe, mg132 e marizomibe; e um peptídeo cíclico que compreende uma porção arg-gly-asp (rgd) exposta.",BIG DNA LTD,EWAN MACINTOSH CLARK;;JOHN BERNARD MARCH,BIG DNA LTD (GB) (2020-02-04),https://lens.org/109-773-048-535-31X,Patent Application,no,0,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K31/365;;A61K31/69;;A61K38/04;;A61K38/12;;A61P35/00;;C07D303/36,,0,0,,,,DISCONTINUED
100,CA,A1,CA 3128339 A1,127-822-241-658-881,2020-08-06,2020,CA 3128339 A,2019-12-04,US 201962799096 P;;US 201962799100 P;;US 201962799113 P;;US 201962799202 P;;US 2019/0064379 W,2019-01-31,KNUCKLE JOINT ASSEMBLY FOR MEDICAL DEVICE SUPPORT SYSTEM,"Knuckle joint assembly for a medical device support system. The knuckle joint assembly includes a cartridge assembly that includes a cartridge housing and a rotary bearing. The cartridge housing includes a bore having a central axis and a bearing mount in the bore. The rotary bearing is press fitted in the bearing mount and configured to receive axially therethrough a spindle to rotatably support the spindle about the central axis. The knuckle joint assembly includes a retaining clip and a retaining pin. The retaining clip is selectively movable to disengage and engage a groove in a spindle to respectively support or release the spindle along a central axis. The retaining pin is movable between a first position to allow movement of the retaining clip between positions but prevent removal of the retaining clip, and a second position to block movement of the retaining clip from the engaged position.",AMERICAN STERILIZER CO,MOSS BERNARD JOHN;;BELLOWS LANCE CLARK,,https://lens.org/127-822-241-658-881,Patent Application,no,0,0,33,94,0,A61B90/50;;A61B50/28;;A61B2090/506;;A61B2090/5025;;F16C11/04;;F16C35/042;;F16M13/027;;A61B90/35;;F16M11/06;;F16M11/2014;;F16M11/2092;;F16M11/24;;F16M2200/044;;F16M2200/063;;F16M2200/065;;A61B90/50;;A61B2090/5025;;A61B2090/506;;F16M13/022;;F16M2200/041;;F16M2200/066;;A61B34/71;;A61B2034/715;;A61B2090/508;;F16M2200/022;;A61B90/35;;F16D65/065,A61B90/50;;A61B50/28;;F16D49/08;;F16D49/16;;F16D65/06;;F16M11/08;;F16M11/20;;F16M13/02,,0,0,,,,PENDING
101,MX,A,MX 2017005530 A,157-245-933-101-751,2017-12-20,2017,MX 2017005530 A,2015-10-27,GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;GB 2015053215 W,2014-10-30,COMBINATION THERAPY.,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a P-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,JOHN BERNARD MARCH;;EWAN MCLNTOSH CLARK,,https://lens.org/157-245-933-101-751,Patent Application,no,0,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K38/04;;A61K31/365;;A61K31/69;;A61K38/12;;A61P35/00;;C07D303/36,,0,0,,,,PENDING
102,US,A1,US 2006/0207226 A1,139-373-559-071-911,2006-09-21,2006,US 90707405 A,2005-03-18,US 90707405 A,2005-03-18,VACUUM PACKAGING MACHINE,"A vacuum packaging machine ( 10 ) is provided having a base ( 12 ) and a pivotally mounted lid ( 14 ) which cooperatively define a package air evacuation chamber ( 76 ) adapted to receive the open end ( 98 ) of a filled flexible package ( 100 ), thereby allowing evacuation of air from the package ( 100 ) and heat sealing of end ( 98 ). The machine ( 10 ) is characterized by an essentially flat and interrupted, easily cleanable base upper wall ( 28 ) which eliminates concavities in the like which can lead to unsanitary collection of fluids or solids. The machine ( 10 ) also has a vacuum source ( 16 ) and a vacuum conduit assembly ( 18 ) the latter having conduits within base ( 12 ) and lid ( 14 ).",HANTOVER INC,LEVSEN CLARK A;;HUFF BERNARD G,HANTOVER INC (2005-03-18),https://lens.org/139-373-559-071-911,Patent Application,yes,9,13,4,4,0,B65B31/046;;B65B31/046,B65B31/02,53/512;;53/374.9,0,0,,,,ACTIVE
103,US,S,US D0640115 S,004-679-562-308-429,2011-06-21,2011,US 32700008 F,2008-10-28,US 32700008 F,2008-10-28,Manual knife dressing tool,,HANTOVER INC,HUFF BERNARD G;;LEVSEN CLARK A,HANTOVER INC (2008-11-24),https://lens.org/004-679-562-308-429,Design Right,no,0,2,1,1,0,,,0805;;D 8 93,0,0,,,,ACTIVE
104,US,A1,US 2023/0105016 A1,040-011-355-161-589,2023-04-06,2023,US 202218063749 A,2022-12-09,US 202218063749 A;;US 201916702860 A;;US 201962799096 P;;US 201962799100 P;;US 201962799113 P;;US 201962799202 P,2019-01-31,KNUCKLE JOINT ASSEMBLY FOR MEDICAL DEVICE SUPPORT SYSTEM,"Knuckle joint assembly for a medical device support system. The knuckle joint assembly includes a cartridge assembly that includes a cartridge housing and a rotary bearing. The cartridge housing includes a bore having a central axis and a bearing mount in the bore. The rotary bearing is press fitted in the bearing mount and configured to receive axially therethrough a spindle to rotatably support the spindle about the central axis. The knuckle joint assembly includes a retaining clip and a retaining pin. The retaining clip is selectively movable to disengage and engage a groove in a spindle to respectively support or release the spindle along a central axis. The retaining pin is movable between a first position to allow movement of the retaining clip between positions but prevent removal of the retaining clip, and a second position to block movement of the retaining clip from the engaged position.",AMERICAN STERILIZER CO,MOSS BERNARD JOHN;;BELLOWS LANCE CLARK,,https://lens.org/040-011-355-161-589,Patent Application,yes,7,0,33,94,0,A61B90/50;;A61B50/28;;A61B2090/506;;A61B2090/5025;;F16C11/04;;F16C35/042;;F16M13/027;;A61B90/35;;F16M11/06;;F16M11/2014;;F16M11/2092;;F16M11/24;;F16M2200/044;;F16M2200/063;;F16M2200/065;;A61B90/50;;A61B2090/5025;;A61B2090/506;;F16M13/022;;F16M2200/041;;F16M2200/066;;A61B34/71;;A61B2034/715;;A61B2090/508;;F16M2200/022;;A61B90/35;;F16D65/065,A61B90/50;;A61B90/35;;F16M13/02,,0,0,,,,ACTIVE
105,GB,B,GB 2210703 B,041-156-141-817-902,1991-03-20,1991,GB 8723394 A,1987-10-06,GB 8723394 A,1987-10-06,APPARATUS AND PROCESS FOR PRODUCING MICROFILM AND MICROFICHE RECORDS.,,GEN ELECTRIC CO PLC,CLARK MICHAEL GEORGE;;MCARDLE CIARAN BERNARD,,https://lens.org/041-156-141-817-902,Granted Patent,no,3,0,6,13,0,G02F1/135;;G02F1/135;;G11B7/25;;G11B7/25;;G11C7/005;;G11C7/005;;H04N1/2179;;H04N1/2179,G02F1/135;;G11B7/25;;G11C7/00;;H04N1/21,G2F FCD           CD;;G2F F23E          CD;;G2F F23R          CD;;G2F F25A          CD;;G2F F25F          CD;;G2F F25T          CD;;G2F F26R          CD;;G2F F28M          CD;;U1S S2120;;U1S S2276,0,0,,,,EXPIRED
106,AU,A1,AU 2019/426889 A1,094-277-508-237-394,2021-07-22,2021,AU 2019/426889 A,2019-12-04,US 201962799096 P;;US 201962799100 P;;US 201962799113 P;;US 201962799202 P;;US 2019/0064379 W,2019-01-31,Knuckle joint assembly for medical device support system,"Knuckle joint assembly for a medical device support system. The knuckle joint assembly includes a cartridge assembly that includes a cartridge housing and a rotary bearing. The cartridge housing includes a bore having a central axis and a bearing mount in the bore. The rotary bearing is press fitted in the bearing mount and configured to receive axially therethrough a spindle to rotatably support the spindle about the central axis. The knuckle joint assembly includes a retaining clip and a retaining pin. The retaining clip is selectively movable to disengage and engage a groove in a spindle to respectively support or release the spindle along a central axis. The retaining pin is movable between a first position to allow movement of the retaining clip between positions but prevent removal of the retaining clip, and a second position to block movement of the retaining clip from the engaged position.",AMERICAN STERILIZER CO,MOSS BERNARD JOHN;;BELLOWS LANCE CLARK,,https://lens.org/094-277-508-237-394,Patent Application,no,0,0,33,94,0,A61B90/50;;A61B50/28;;A61B2090/506;;A61B2090/5025;;F16C11/04;;F16C35/042;;F16M13/027;;A61B90/35;;F16M11/06;;F16M11/2014;;F16M11/2092;;F16M11/24;;F16M2200/044;;F16M2200/063;;F16M2200/065;;A61B90/50;;A61B2090/5025;;A61B2090/506;;F16M13/022;;F16M2200/041;;F16M2200/066;;A61B34/71;;A61B2034/715;;A61B2090/508;;F16M2200/022;;A61B90/35;;F16D65/065,A61B90/50;;A61B50/28;;F16D49/08;;F16D49/16;;F16D65/06;;F16M11/08;;F16M11/20;;F16M13/02,,0,0,,,,PENDING
107,US,A,US 2029471 A,097-609-928-840-568,1936-02-04,1936,US 692835 A,1935-02-18,US 692835 A,1935-02-18,Gas burner,,BERNARD FIELD;;CLARK GEORGE J J,BERNARD FIELD;;CLARK GEORGE J J,,https://lens.org/097-609-928-840-568,Granted Patent,no,0,6,1,1,0,F23D14/04;;F23D14/04,F23D14/04,,0,0,,,,EXPIRED
108,FR,A,FR 491399 A,125-466-195-074-971,1919-05-31,1919,FR 491399D A,1918-08-19,GB 491399X A,1917-08-01,"Appareil pour la manutention de loupes, billettes, lingots et autres fardeaux",,JAMES STANLEY ATKINSON;;STEIN AND ATKINSON LTD;;BERNARD FRANCIS CLARK,ATKINSON JAMES STANLEY;;CLARK BERNARD FRANCIS,,https://lens.org/125-466-195-074-971,Granted Patent,no,0,0,1,1,0,B21J13/08,B21J13/08,"VIII, 2",0,0,,,,EXPIRED
109,GB,A,GB 1180389 A,133-292-987-422-244,1970-02-04,1970,GB 3274266 A,1966-07-21,GB 3274266 A,1966-07-21,Lubricants having improved Anti-Wear and Anti-Corrosion Properties,"1,180,389. Lubricants. BRITISH PETROLEUM CO. Ltd. 10 July, 1967 [21 July, 1966], No. 32742/66. Heading C5F. A lubricating composition comprises an ester basestock consisting of one or more liquid neutral polyesters that have been prepared by reacting together under esterification conditions and in one or more stages: (i) a mono- and/or polyhydric alcohol having 5-15 carbon atoms per molecule and having no hydrogen atoms attached to any carbon atom in a 2-position with respect to any -OH group; and (ii) a mono- and/or polycarboxylic acid having 2-14 carbon atoms per molecule, the base oil having dissolved therein: (a) 0À005 to 0À15% wt. of dihydrocarbon hydrogen phosphate of the formula (RO) 2 P(O)OH where the groups R (which are not necessarily the same in any given molecule) are alkyl, cycloalkyl, aryl, alkaryl or aralkyl groups having up to 20 carbon atoms; (b) 0À005 to 1À5% wt. of a copper passivator; and (c) 0À5 to 6À0% wt. of an aromatic amine antioxidant. The ester may be prepared by reacting one or more of the following: 2: 2: 4-trimethylpentanol, neopentyl alcohol, neopentyl glycol, trimethylolpropane, trimethylolethane, pentaerythritol and dipentaerythritol with one or more of the following: caprylic acid, capric acid, caproic acid, enanthic acid, pelargonic acid, valeric acid, pivalic acid, propionic acid, butyric acid, 2-ethylhexanoic acid, adipic acid, sebacic acid and azelaic acid. The copper passivator may be imidazoles, pyrazoles, triazoles, salicylaldehyde semicarbazone or a C 1 -C 20 alkyl derivative thereof, and condensation products of salicylaldehyde and a hydrazine derivative or a fatty acid salt thereof such as a C 13 -C 18 fatty acid salt of 1-salicylalaminoguanidine. The antioxidant may be phenothiazine, iminodibenzyl, diphenylamine, phenyl- α- and #-naphthylamines and alkyl derivatives thereof (examples are given). The lubricant may also contain a load-carrying agent of formula (R<SP>2</SP>O) 3 PO where R<SP>2</SP> is alkyl, cycloalkyl, aryl, alkaryl or aralkyl, the total number of carbon atoms being 3-60 (examples are given); and a lead corrosion inhibitor, e.g. a C 1 -C 20 alkyl gallate, neopentyl glycol disebacate, sebacic acid and quinazarin; and hydrolytic stabilizers, e.g. amines of formula R<SP>4</SP>(R<SP>5</SP>)NR<SP>6</SP>, where R<SP>4</SP> and R<SP>5</SP> are C 1 -C 4 alkyl groups and R<SP>6</SP> is an alkaryl or hydroxy-substituted alkaryl group having up to 20 carbon atoms such as 2,6-ditertiarybutyl-4- dimethyl aminomethyl phenol.",BRITISH PETROLEUM CO,BYFORD DEREK CLARK;;SILVER HOWARD BERNARD,,https://lens.org/133-292-987-422-244,Granted Patent,no,0,18,5,6,0,C10M3/00;;C10M2207/023;;C10M2207/025;;C10M2207/123;;C10M2207/129;;C10M2207/22;;C10M2207/281;;C10M2207/282;;C10M2207/283;;C10M2207/284;;C10M2207/285;;C10M2207/286;;C10M2207/287;;C10M2207/30;;C10M2207/302;;C10M2207/304;;C10M2207/34;;C10M2209/103;;C10M2209/109;;C10M2215/064;;C10M2215/065;;C10M2215/066;;C10M2215/08;;C10M2215/082;;C10M2215/10;;C10M2215/14;;C10M2215/18;;C10M2215/22;;C10M2215/221;;C10M2215/224;;C10M2215/225;;C10M2215/226;;C10M2215/28;;C10M2215/30;;C10M2219/108;;C10M2223/04;;C10M2223/041;;C10M2223/042;;C10M2223/043;;C10N2030/08;;C10N2040/12;;C10N2040/13;;C10N2050/02;;C10N2050/10,,C5F FB            B;;C5F F485          B;;C5F F519          B;;C5F F53Y          B;;C5F F531          B;;C5F F532          B;;C5F F538          B;;C5F F586          B;;C5F F588          B;;C5F F594          B;;C5F F595          B;;C5F F596          B;;C5F F60X          B;;C5F F610          B;;C5F F654          B;;C5F F672          B;;C5F F673          B;;C5F F674          B;;C5F F733          B;;C5F F80Y          B;;C5F F802          B,0,0,,,,EXPIRED
110,CA,A,CA 508179 A,146-364-080-320-292,1954-12-14,1954,CA 508179D A,,CA 508179T A,,METHOD OF AND APPARATUS FOR SEPARATING AND CLASSIFYING SUBSTANTIALLY SPHERICAL BODIES INTO DIFFERENT SIZE GROUPS,,NORANDA MINES,CLARK CHARLES W;;MORRISON BERNARD H,,https://lens.org/146-364-080-320-292,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
111,US,A,US 2662641 A,165-058-671-872-48X,1953-12-15,1953,US 23256751 A,1951-06-20,US 23256751 A,1951-06-20,Method and apparatus for separating and classifying substantially spherical bodies into different size groups,,NORANDA MINES LTD,CLARK CHARLES W;;MORRISON BERNARD H,,https://lens.org/165-058-671-872-48X,Granted Patent,no,2,10,1,1,0,B07B13/11;;B07B13/11,B07B13/11,,0,0,,,,EXPIRED
112,WO,A2,WO 2011/080505 A2,157-373-657-104-310,2011-07-07,2011,GB 2010002341 W,2010-12-24,US 29036209 P,2009-12-28,METHOD OF GROWING PHAGE FOR COMMERCIAL USE,"The present invention relates to methods of obtaining bacteriophage ('phage'), such as lambda phage, for industrial uses, such as for use in commercial vaccine production. There is also provided a novel bacterium, such as Escherichia coli (E. coli ) which has been modified for growing phage in a manner which improves the general and environmental safety of said phage. The invention also relates to the use of a modified bacterium for growing phage for industrial purposes. Finally, the invention also provides modified phage, which are designed for growth in industrial and/or environmental safety.",BIGDNA LTD;;MARCH JOHN BERNARD;;CLARK JASON RICHARD,MARCH JOHN BERNARD;;CLARK JASON RICHARD,,https://lens.org/157-373-657-104-310,Patent Application,yes,13,4,2,2,11,A61K35/13;;C12N7/00;;C07K14/245;;C12N1/08;;C12N15/70;;C12N2795/10351;;Y02A50/30,C12N7/00;;A61K35/13,,17,14,006-262-512-717-979;;006-262-512-717-979;;048-753-558-938-339;;015-947-199-986-598;;003-576-596-093-990;;038-789-717-245-751;;021-713-125-986-435;;049-408-163-626-874;;068-323-121-311-627;;083-165-566-036-632;;045-341-646-477-712;;035-981-278-358-279;;046-717-292-713-990;;151-614-122-349-22X,10.1126/science.277.5331.1453;;9278503;;10.1126/science.277.5331.1453;;9278503;;10.1016/s0145-305x(02)00071-x;;12543123;;16051357;;10.1016/j.dci.2005.06.010;;pmc391866;;10.1073/pnas.81.19.6095;;6091134;;19804637;;10.1186/1471-2148-9-241;;pmc2762979;;10.1126/science.1439823;;1439823;;10.1271/bbb.70274;;18071259;;pmc98998;;10.1128/mmbr.64.2.412-434.2000;;10839821;;10.1038/316371a0;;2991768;;10.1126/science.1126439;;16645050;;10.1093/nar/29.20.4195;;11600708;;pmc60208;;17302150;;10.1007/s00430-009-0116-7;;pmc2714450;;19529959,"BLATTNER ET AL., SCIENCE, vol. 277, no. 5331, 1997, pages 1453 - 62;;BLATTNER FR; PLUNKETT G 3RD; BLOCH CA; PERNA NT; BURLAND V; RILEY M; COLLADO-VIDES J; GLASNER JD; RODE CK; MAYHEW GF: ""The complete genome sequence of Escherichia coli K-12"", SCIENCE, vol. 277, 1997, pages 1453 - 62;;CLARK JR; MARCH JB.: ""Bacteriophage-mediated nucleic acid immunization"", FEMS LMM. MED. MICRO., vol. 1652, 2001, pages 1 - 6;;CONRATH KE; WERNERY U; MUYLDERMANS S; NGUYEN VK.: ""Emergence and evolution of functional heavy-chain antibodies in Camelidae"", DEV COMP IMMUNOL., vol. 27, 2003, pages 87 - 103;;DE GENST E; SAERENS D; MUYLDERMANS S; CONRATH K.: ""Antibody repertoire development in camelids"", DEV COMP IMMUNOL., vol. 30, 2006, pages 187 - 98, XP025088320, DOI: doi:10.1016/j.dci.2005.06.010;;FULLER-PACE FV; BULLAS LR DELIUS H; MURRAY, NE.: ""Genetic recombination can generate altered restriction specificity"", PNAS, vol. 81, 1984, pages 6095 - 99;;GALLET R; SHAO Y; WANG IN.: ""High adsorption rate is detrimental to bacteriophage fitness in a biofilm-like environment"", BMC EVOL. BIOL., vol. 9, 2009, pages 241 - 253;;HENDRIX RW; DUDA RL.: ""Bacteriophage lambda PaPa: not the mother of all lambda phages"", SCIENCE, vol. 258, 1992, pages 1145 - 8;;MIZOGUCHI H TANAKA-MASUDA K; MORI H.: ""A simple method for multiple modification of the Escherichia coli K-12 chromosome"", BIOSCI BIOTECHNOL BIOCHEM., vol. 71, 2007, pages 2905 - 11;;MURRAY NE.: ""Lambda"", vol. II, 1983, COLD SPRING HARBOR LABORATORY PRESS, pages: 395 - 431;;MURRAY NE.: ""Type I Restriction Systems: Sophisticated Molecular Machines (a Legacy of Bertani and Weigle)"", MICROBIOL MOL. BIOL. REV., vol. 64, 2000, pages 412 - 34, XP002190814, DOI: doi:10.1128/MMBR.64.2.412-434.2000;;NAGARAJA V; SHEPHERD JC; BICKLE TA.: ""A hybrid recognition sequence in a recombinant restriction enzyme and the evolution of DNA sequence specificity"", NATURE, vol. 316, 1985, pages 371 - 2;;POSFAI G; PLUNKETT G 3RD; FEH6R T; FRISCH D; KEIL GM; UMENHOFFER K; KOLISNYCHENKO V; STAHL B; SHARMA SS; DE ARRUDA M: ""Emergent properties of reduced-genome Escherichia coli"", SCIENCE, vol. 312, 2006, pages 1044 - 6, XP002410684, DOI: doi:10.1126/science.1126439;;SAMBROOK; FRITSCH; MANIATIS: ""Molecular Cloning A Laboratory manual"", 1989, COLD SPRING HARBOUR LABORATORY PRESS;;TITHERADGE AJB; KING J; RYU J; MURRAY NE.: ""Families of restriction enzymes: an analysis presented by molecular and genetic data for type ID restriction and modification systems"", NUCLEIC ACIDS RES., vol. 29, 2001, pages 4195 - 205;;WANG K; LIU CQ; CAO H; CHEN XF.: ""Insight into relationship among mRNA coding region length, folding tendency and codon usage bias in Escherichia coli"", WEI SHENG WU XUE BAO, vol. 46, 2006, pages 895 - 9;;WESOLOWSKI J; ALZOGARAY V; REYELT J; UNGER M; JUAREZ K; URRUTIA M; CAUERHFF A; DANQUAH W; RISSIEK B; SCHEUPLEIN F: ""Single domain antibodies: promising experimental and therapeutic tools in infection and immunity"", MED MICROBIOL IMMUNOL., vol. 198, 2009, pages 157 - 74, XP009124313, DOI: doi:10.1007/s00430-009-0116-7",PENDING
113,US,B2,US 7146783 B2,177-552-187-475-668,2006-12-12,2006,US 90707405 A,2005-03-18,US 90707405 A,2005-03-18,Vacuum packaging machine,"A vacuum packaging machine ( 10 ) is provided having a base ( 12 ) and a pivotally mounted lid ( 14 ) which cooperatively define a package air evacuation chamber ( 76 ) adapted to receive the open end ( 98 ) of a filled flexible package ( 100 ), thereby allowing evacuation of air from the package ( 100 ) and heat sealing of end ( 98 ). The machine ( 10 ) is characterized by an essentially flat and uninterrupted, easily cleanable base upper wall ( 28 ) which eliminates concavities in the like which can lead to unsanitary collection of fluids or solids. The machine ( 10 ) also has a vacuum source ( 16 ) and a vacuum conduit assembly ( 18 ) the latter having conduits within base ( 12 ) and lid ( 14 ).",HANTOVER INC,LEVSEN CLARK A;;HUFF BERNARD G,HANTOVER INC (2005-03-18),https://lens.org/177-552-187-475-668,Granted Patent,yes,10,10,4,4,0,B65B31/046;;B65B31/046,B65B31/00,53/512;;53/374.9,0,0,,,,ACTIVE
114,CN,A,CN 106999540 A,110-791-656-048-624,2017-08-01,2017,CN 201580059567 A,2015-10-27,GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;GB 2015053215 W,2014-10-30,Combination therapy,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a [beta]-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,,https://lens.org/110-791-656-048-624,Patent Application,no,5,2,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K38/12;;A61K38/06;;A61P35/00;;A61P35/02,,0,0,,,,ACTIVE
115,WO,A2,WO 2006/102132 A2,028-110-504-118-023,2006-09-28,2006,US 2006/0009813 W,2006-03-17,US 90707405 A,2005-03-18,VACUUM PACKAGING MACHINE,"A vacuum packaging machine (10) is provided having a base (12) and a pivotally mounted lid (14) which cooperatively define a package air evacuation chamber (76) adapted to receive the open end (98) of a filled flexible package (100), thereby allowing evacuation of air from the package (100) and heat sealing of end (98). The machine (10) is characterized by an essentially flat and interrupted, easily cleanable base upper wall (28) which eliminates concavities in the like which can lead to unsanitary collection of fluids or solids. The machine (10) also has a vacuum source (16) and a vacuum conduit assembly (18) the latter having conduits within base (12) and lid (14).",HANTOVER INC;;LEVSEN CLARK A;;HUFF BERNARD G,LEVSEN CLARK A;;HUFF BERNARD G,,https://lens.org/028-110-504-118-023,Patent Application,yes,0,4,4,4,0,B65B31/046;;B65B31/046,B65B31/02,,0,0,,,,PENDING
116,IT,B,IT 1215907 B,032-912-890-560-416,1990-02-22,1990,IT 1945088 A,1988-02-17,GB 8703620 A,1987-02-17,METODO DI COLATA DI LEGHE DI FERRO.,,CAST TEC INTERNATIONAL INC,CLARK ANTONY PHILLIP;;GODSELL BERNARD CHARLES,,https://lens.org/032-912-890-560-416,Granted Patent,no,0,0,7,7,0,B22D11/18;;B22D11/185;;B22D13/12;;B22D46/00,B22D11/18;;B22D13/12;;B22D46/00,,0,0,,,,EXPIRED
117,HK,A1,HK 1004774 A1,039-663-455-854-559,1998-12-04,1998,HK 98103877 A,1998-05-06,US 20902194 A,1994-03-10,Polymer devolatilizer incorporating improved flat plate heat exchanger design,,DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,,https://lens.org/039-663-455-854-559,Patent Application,no,0,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,DISCONTINUED
118,EP,A1,EP 3212210 A1,082-855-762-128-202,2017-09-06,2017,EP 15791346 A,2015-10-27,GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;GB 2015053215 W,2014-10-30,COMBINATION THERAPY,,BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,BIG DNA LTD (2019-05-15),https://lens.org/082-855-762-128-202,Patent Application,yes,0,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K38/04;;A61K31/365;;A61K31/69;;A61K38/12;;A61P35/00;;C07D303/36,,0,0,,,,ACTIVE
119,US,A,US 2838989 A,130-406-093-368-22X,1958-06-17,1958,US 47790254 A,1954-12-27,US 47790254 A,1954-12-27,Toaster apparatus,,WESTINGHOUSE ELECTRIC CORP,CLARK EARL K;;PARR BERNARD F,,https://lens.org/130-406-093-368-22X,Granted Patent,no,8,11,1,1,0,A47J37/0814;;A47J37/0814,A47J37/08,,0,0,,,,EXPIRED
120,MX,A,MX 9604000 A,145-726-116-409-301,1997-12-31,1997,MX 9604000 A,1995-01-12,US 9500420 W;;US 20902194 A,1994-03-10,POLYMER DEVOLATILIZER INCORPORATING IMPROVED FLAT PLATE HEAT EXCHANGER DESIGN.,"An improved polymer devolatilization apparatus comprising a flat plate heater (22) comprising a polymer solution supply means (20), and a liquid/vapor collection and separation means, said flat plate heater further comprising a multiplicity of flat plates defining a plurality of channels (10), each channel having a substantially uniform height, but varying width over the total channel length, each channel comprising three zones: a first zone (12), having a beginning (18) and a terminus, said beginning in operative communication with the polymer solution supply means, characterized by decreasing width as a function of distance from its beginning, a second zone (14) having a beginning at the terminus of the first zone and a terminus, characterized by at least one occurrence of a restrictive cross-sectional area, and a third zone (16) having a beginning at the terminus of the second zone and terminating at a liquid/vapor collection and separation region operating at reduced pressure, said third zone characterized by increasing width as a function of distance from its beginning, and provided further that the ratio of maximum width of the third zone to the maximum width of the second zone is from 2:1 to 20:1.",DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,,https://lens.org/145-726-116-409-301,Patent Application,no,0,0,17,17,0,B01D1/221;;B01D3/06;;C08F6/00;;F28D7/0041;;F28D9/0018;;F28D9/0062;;F28F3/086;;F28F13/08;;Y10S159/10;;F28D9/0062;;F28D7/0041;;B01D3/06;;F28F13/08;;F28D9/0018;;B01D1/221;;C08F6/00;;F28F3/086;;Y10S159/10,B01D1/22;;B01D3/06;;C08F2/00;;C08F6/00;;C08F6/10;;F28D1/06;;F28D7/00;;F28D9/00;;F28F3/08;;F28F13/08,,0,0,,,,PENDING
121,US,A,US 2603832 A,004-553-412-466-858,1952-07-22,1952,US 23256851 A,1951-06-20,US 23256851 A,1951-06-20,Rotary drum apparatus and means for preventing material being treated from accumulating thereon,,NORANDA MINES LTD,CLARK CHARLES W;;MORRISON BERNARD H,,https://lens.org/004-553-412-466-858,Granted Patent,no,0,19,4,4,0,B01J2/12;;B01J2/30;;C01B17/06;;C22B1/2406;;F26B11/0463;;F27B7/00;;Y10S241/30;;B01F29/4023;;C01B17/06;;F26B11/0463;;B01J2/12;;B01J2/30;;C22B1/2406;;F27B7/00;;Y10S241/30;;B01F29/4023,B01F9/00;;B01J2/12;;B01J2/30;;C01B17/06;;C12C11/00;;C22B1/24;;F26B11/04;;F27B7/00,,0,0,,,,EXPIRED
122,WO,A3,WO 2009/138752 A3,034-004-912-364-002,2010-03-18,2010,GB 2009001215 W,2009-05-15,GB 0808780 A,2008-05-15,FISH VACCINE,"Viral and bacterial diseases in fin-fish, shellfish or other aquatic life-forms pose a serious problem for the aquaculture industry. Owing to the high density of animals in the hatchery tanks or enclosed marine farming areas, infectious diseases may eradicate a large proportion of the stock in, for example, a fin-fish, shellfish, or other aquatic lifeforms facility. Prevention of disease is a more desired remedy to these threats to fish than intervention once the disease is in progress. Vaccination of fish is the only preventative method which may offer long-term protection through immunity.",BIG DNA LTD;;MARCH JOHN BERNARD;;CLARK JASON RICHARD,MARCH JOHN BERNARD;;CLARK JASON RICHARD,,https://lens.org/034-004-912-364-002,Search Report,yes,4,1,3,3,0,A61K39/205;;A61K39/00;;A61K39/12;;A61K2039/5256;;A61K2039/53;;A61K2039/54;;A61K2039/542;;A61K2039/552;;C12N2760/20034;;C12N2795/10343,A61K39/00;;C12N7/04;;C12N15/86,,10,10,002-769-821-977-94X;;001-403-102-711-675;;069-556-926-393-387;;002-071-311-307-941;;043-771-339-467-239;;016-320-436-192-706;;015-572-437-658-525;;050-407-212-258-280;;115-453-123-295-374;;047-747-254-816-538,10.1016/j.vaccine.2003.10.047;;15068849;;15270651;;10.1586/14760584.3.4.463;;10.1016/j.tibtech.2006.03.003;;16567009;;14734182;;10.1016/s0928-8244(03)00344-4;;10.1016/j.molimm.2005.12.005;;16426680;;16154239;;10.1016/j.vaccine.2005.07.068;;10.1016/s0145-305x(01)00059-3;;11696382;;10.1586/14760584.5.6.753;;17184214;;10.1016/j.vaccine.2003.11.065;;15193403;;10.1016/s0923-2508(01)01280-3;;11881893,"MARCH J B ET AL: ""Genetic immunisation against hepatitis B using whole bacteriophage lambda particles"", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 13-14, 16 April 2004 (2004-04-16), pages 1666 - 1671, XP004500420, ISSN: 0264-410X;;CLARK J R ET AL: ""BACTERIAL VIRUSES AS HUMAN VACCINES?"", EXPERT REVIEW OF VACCINES, FUTURE DRUGS, LONDON, GB, vol. 3, no. 4, 1 August 2004 (2004-08-01), pages 463 - 476, XP008050350, ISSN: 1476-0584;;CLARK J R ET AL: ""Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials"", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 24, no. 5, 1 May 2006 (2006-05-01), pages 212 - 218, XP025052284, ISSN: 0167-7799, [retrieved on 20060501];;CLARK JASON R ET AL: ""Bacteriophage-mediated nucleic acid immunisation"", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY,, vol. 40, no. 1, 15 January 2004 (2004-01-15), pages 21 - 26, XP002562512;;PURCELL M K ET AL: ""Comprehensive gene expression profiling following DNA vaccination of rainbow trout against infectious hematopoietic necrosis virus"", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 43, no. 13, 1 May 2006 (2006-05-01), pages 2089 - 2106, XP025037277, ISSN: 0161-5890, [retrieved on 20060501];;KURATH G ET AL: ""Protective immunity and lack of histopathological damage two years after DNA vaccination against infectious hematopoietic necrosis virus in trout"", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 24, no. 3, 16 January 2006 (2006-01-16), pages 345 - 354, XP025151080, ISSN: 0264-410X, [retrieved on 20060116];;LORENZEN NIELS ET AL: ""Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens"", DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, vol. 26, no. 2, March 2002 (2002-03-01), pages 173 - 179, XP002563022, ISSN: 0145-305X;;MARCH JOHN B: ""Modern Vaccine Adjuvants and Delivery Systems-- Second International Conference: September 12-14 2006, London, UK"", EXPERT REVIEW OF VACCINES, FUTURE DRUGS, LONDON, GB, vol. 5, no. 6, 1 December 2006 (2006-12-01), pages 753 - 759, XP009094234, ISSN: 1476-0584;;JEPSON C D ET AL: ""Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle"", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 19, 23 June 2004 (2004-06-23), pages 2413 - 2419, XP004515458, ISSN: 0264-410X;;NAKAI TOSHIHIRO ET AL: ""Bacteriophage therapy of infectious diseases in aquaculture"", RESEARCH IN MICROBIOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 153, no. 1, 1 January 2002 (2002-01-01), pages 13 - 18, XP002401837, ISSN: 0923-2508",PENDING
123,IN,B,IN 188139 B,057-792-298-487-014,2002-08-24,2002,IN 282MA1995 A,1995-03-09,IN 282MA1995 A,1995-03-09,An improved polymer devolitilization apparatus,,DOW CHEMICAL CO,CUMMINGS CLARK J;;MEISTER BERNARD J,,https://lens.org/057-792-298-487-014,Granted Patent,no,0,0,1,1,0,,C08C2/02;;C08F6/00;;F28F13/08,,0,0,,,,EXPIRED
124,US,A1,US 2019/0175687 A1,131-155-876-385-678,2019-06-13,2019,US 201816189877 A,2018-11-13,US 201816189877 A;;GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;US 201715523188 A;;GB 2015053215 W,2014-10-30,Combination Therapy,"The present invention relates to a combination comprising a proteasome inhibitor and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. In particular, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: a boronate, an epoxyketone, a peptide aldehyde and a β-lactone protease inhibitor; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety. More particularly, the present invention relates to a combination comprising a proteasome inhibitor selected from the group consisting of: bortezomib, delanzomib, ixazomib, carfilzomib, oprozomib, MG132 and marizomib; and a cyclic peptide that comprises an exposed Arg-Gly-Asp (RGD) moiety.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,BIG DNA LTD (2017-05-17),https://lens.org/131-155-876-385-678,Patent Application,yes,0,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K38/12;;A61K31/4015;;A61K31/407;;A61K31/69;;A61K38/00;;A61K38/05;;A61K38/06;;A61K38/07;;A61K45/06,,0,0,,,,DISCONTINUED
125,KR,A,KR 20170082523 A,138-346-624-377-109,2017-07-14,2017,KR 20177011910 A,2015-10-27,GB 201419311 A;;GB 201500681 A;;GB 201506673 A;;GB 2015053215 W,2014-10-30,COMBINATION THERAPY,"본 발명은 프로테아좀 억제제, 및 노출된 Arg-Gly-Asp(RGD) 모이어티를 포함하는 고리형 펩타이드를 포함하는 병용제와 관련된다. 구체적으로, 본 발명은 보로네이트, 에폭시케톤, 펩타이드 알데히드 및 β-락톤 프로테아제 억제제로 이루어진 군에서 선택된 프로테아좀 억제제; 및 노출된 Arg-Gly-Asp(RGD) 모이어티를 포함하는 고리형 펩타이드를 포함하는 병용제와 관련된다. 더욱 구체적으로, 본 발명은 보르테조밉, 델란조밉, 익사조밉, 카필조밉, 오프로조밉, MG132 및 마리조밉으로 이루어진 군에서 선택된 프로테아좀 억제제; 및 노출된 Arg-Gly-Asp(RGD) 모이어티를 포함하는 고리형 펩타이드를 포함하는 병용제와 관련된다.",BIG DNA LTD,MARCH JOHN BERNARD;;CLARK EWAN MCINTOSH,,https://lens.org/138-346-624-377-109,Patent Application,no,0,0,17,20,0,A61K38/06;;A61K38/12;;A61K31/69;;A61K38/06;;A61K45/06;;A61K31/4015;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K45/06;;A61K2300/00;;A61K45/06;;A61K31/4015;;A61K31/69;;A61K38/06;;A61K38/12;;A61K31/407;;A61K38/005;;A61K38/05;;A61K38/07,A61K31/69;;A61K31/4015;;A61K38/06;;A61K38/12;;A61K45/06,,0,0,,,,PENDING
126,ZA,B,ZA 918139 B,035-357-457-484-896,1992-07-29,1992,ZA 918139 A,1991-10-11,ZA 918139 A;;ZA 909098 A,1990-11-13,METHOD AND MEANS FOR ODOUR-REMOVAL FROM A GASEOUS MEDIUM,,CSIR,CLARK RICHARD CALDWELL;;RICHARD CALDWELL CLARK;;WNOROWSKI ALEKSANDRA URSZULA;;ALEKSANDRA URSZULA WNOROWSKI;;HEYMANN BERNARD;;BERNARD HEYMANN,,https://lens.org/035-357-457-484-896,Granted Patent,no,0,0,1,1,0,,A61L/;;B01D/;;C12S/,,0,0,,,,EXPIRED
127,ZA,B,ZA 891680 B,077-384-441-018-046,1990-10-31,1990,ZA 891680 A,1989-03-06,US 8800733 W,1988-03-08,HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,STEVEN WYNE GOLDSTEIN;;DAVID ALAN CLARK;;CLARK DAVID ALAN;;GOLDSTEIN STEVEN WYNE;;HULIN BERNARD;;BERNARD HULIN,,https://lens.org/077-384-441-018-046,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
128,ZA,B,ZA 891681 B,114-728-690-898-554,1990-10-31,1990,ZA 891681 A,1989-03-06,US 8800745 W,1988-03-08,THIAZOLIDINEDIONE DERIVATIVES AS HYPOGLYCEMIC AGENTS,,PFIZER,CLARK DAVID ALAN;;DAVID ALAN CLARK;;GOLDSTEIN STEVEN WAYNE;;STEVEN WAYNE GOLDSTEIN;;HULIN BERNARD;;BERNARD HULIN,,https://lens.org/114-728-690-898-554,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;C07D277/14;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
129,US,A1,US 2004/0062259 A1,145-301-800-693-181,2004-04-01,2004,US 25915302 A,2002-09-27,US 25915302 A,2002-09-27,Token-based active queue management,"
    Methods and apparatus are provided for managing a data packet queue corresponding to a resource of a network device. A token count T _{C } is maintained for a predefined flow of data packets, and the transmission of packets in the flow into the queue is controlled in dependence on this token count. The token count is decremented when packets in the flow are transmitted into the queue, and the token count is incremented at a token increment rate C. A bandwidth indicator, indicative of bandwidth availability in the resource, is monitored, and the token increment rate C is varied in dependence on this bandwidth indicator. The bandwidth-dependent variation of the token increment rate C is such that, when available bandwidth is indicated, the increment rate C is increased, and when no available bandwidth is indicated the increment rate C is decreased. 
",IBM,JEFFRIES CLARK D;;KIND ANDREAS;;METZLER BERNARD,GOOGLE LLC (2011-05-03);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-09-27),https://lens.org/145-301-800-693-181,Patent Application,yes,7,98,2,2,0,H04L47/10;;H04L47/11;;H04L47/215;;H04L47/22;;H04L47/30;;H04L47/32;;H04L47/32;;H04L47/11;;H04L47/22;;H04L47/215;;H04L47/30;;H04L47/10,H04L12/56,370/412;;370/235,0,0,,,,EXPIRED
130,GB,A,GB 2154232 A,159-104-111-373-030,1985-09-04,1985,GB 8403869 A,1984-02-14,GB 8403869 A,1984-02-14,Process for the preparation of 2-aminothiophenes,"Thiophenes of the formula <IMAGE> wherein R<1> is an electron withdrawing group and R<2> and R<3> are each selected from H, alkyl, cycloalkyl, aryl and the R<1> groups, are prepared by contacting a reactant of the formula <IMAGE> wherein <9>R and R<10> are, for example, alkyl or aryl, with a reactant of the formula R<1>-CH301 in the presence of a base for a sufficient period to produce the intermediate of the formula <IMAGE> and thereafter contacting said intermediate with sulfur for a sufficient period to cyclize said intermediate to the thiophene.",KODAK LTD,LAW PAUL WILLIAM;;CLARK BERNARD ARTHUR JAMES,,https://lens.org/159-104-111-373-030,Patent Application,no,0,1,3,3,0,C07D409/04;;C07D413/04;;C07D417/04;;C07D421/04,C07D409/04;;C07D413/04;;C07D417/04;;C07D421/04,C2C CAA;;C2C CAB;;C2C CAB;;C2C CAB;;C2C CAB;;C2C CAB;;C2C CAB;;C2C CKJ;;C2C CLM;;C2C CLS;;C2C CLY;;C2C CLZ;;C2C CMC;;C2C CRM;;C2C C1372;;C2C C1372;;C2C C1382;;C2C C1390;;C2C C1390;;C2C C1390;;C2C C1510;;C2C C1510;;C2C C1510;;C2C C1510;;C2C C1510;;C2C C1510;;C2C C1590;;C2C C20Y;;C2C C200;;C2C C213;;C2C C213;;C2C C213;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C226;;C2C C227;;C2C C246;;C2C C246;;C2C C246;;C2C C246;;C2C C247;;C2C C247;;C2C C247;;C2C C247;;C2C C247;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C250;;C2C C252;;C2C C254;;C2C C254;;C2C C254;;C2C C254;;C2C C254;;C2C C254;;C2C C255;;C2C C255;;C2C C256;;C2C C256;;C2C C256;;C2C C256;;C2C C28X;;C2C C28X;;C2C C28X;;C2C C28X;;C2C C280;;C2C C30Y;;C2C C30Y;;C2C C30Y;;C2C C30Y;;C2C C30Y,0,0,,,,EXPIRED
131,US,S,US D0350760 S,006-224-655-994-060,1994-09-20,1994,US 92335792 F,1992-07-31,US 92335792 F,1992-07-31,Eyeglass frame temple,,LUXTEC CORP,CLARK BERNARD;;CHIN NOELLE S;;MORRIS FREDERICK,ARK CLO 2000-1 LIMITED (2001-03-01);;LUXTEC CORPORATION (1992-09-22);;FIRST NATIONAL BANK OF BOSTON THE (1995-10-24),https://lens.org/006-224-655-994-060,Design Right,yes,40,0,1,1,0,,,D16/335,1,0,,,"Paramont Optical Mfg. Catalog Nov. 1, 1949 right side of page.",EXPIRED
132,US,B2,US 7280477 B2,113-498-250-650-638,2007-10-09,2007,US 25915302 A,2002-09-27,US 25915302 A,2002-09-27,Token-based active queue management,"Methods and apparatus are provided for managing a data packet queue corresponding to a resource of a network device. A token count T C is maintained for a predefined flow of data packets, and the transmission of packets in the flow into the queue is controlled in dependence on this token count. The token count is decremented when packets in the flow are transmitted into the queue, and the token count is incremented at a token increment rate C. A bandwidth indicator, indicative of bandwidth availability in the resource, is monitored, and the token increment rate C is varied in dependence on this bandwidth indicator. The bandwidth-dependent variation of the token increment rate C is such that, when available bandwidth is indicated, the increment rate C is increased, and when no available bandwidth is indicated the increment rate C is decreased.",IBM,JEFFRIES CLARK D;;KIND ANDREAS;;METZLER BERNARD,GOOGLE LLC (2011-05-03);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-09-27),https://lens.org/113-498-250-650-638,Granted Patent,yes,7,47,2,2,0,H04L47/10;;H04L47/11;;H04L47/215;;H04L47/22;;H04L47/30;;H04L47/32;;H04L47/32;;H04L47/11;;H04L47/22;;H04L47/215;;H04L47/30;;H04L47/10,H04L12/28;;H04L12/56,370/235;;370/252;;370/412,0,0,,,,INACTIVE
133,GB,B,GB 2154232 B,110-008-873-237-66X,1987-08-26,1987,GB 8403869 A,1984-02-14,GB 8403869 A,1984-02-14,PROCESS FOR THE PREPARATION OF 2-AMINOTHIOPHENES,,KODAK LTD,LAW PAUL WILLIAM;;CLARK BERNARD ARTHUR JAMES,,https://lens.org/110-008-873-237-66X,Granted Patent,no,0,0,3,3,0,C07D409/04;;C07D413/04;;C07D417/04;;C07D421/04,C07D409/04;;C07D413/04;;C07D417/04;;C07D421/04,C2C1372;;C2C1382;;C2C1390;;C2C1510;;C2C1590;;C2C200;;C2C20Y;;C2C213;;C2C215;;C2C220;;C2C226;;C2C227;;C2C22Y;;C2C246;;C2C247;;C2C250;;C2C252;;C2C254;;C2C255;;C2C256;;C2C25Y;;C2C280;;C2C28X;;C2C305;;C2C30Y;;C2C313;;C2C31Y;;C2C321;;C2C326;;C2C32Y;;C2C337;;C2C338;;C2C342;;C2C34Y;;C2C351;;C2C355;;C2C35X;;C2C35Y;;C2C364;;C2C366;;C2C368;;C2C36Y;;C2C376;;C2C396;;C2C451;;C2C45Y;;C2C574;;C2C613;;C2C614;;C2C620;;C2C624;;C2C625;;C2C628;;C2C62X;;C2C62Y;;C2C635;;C2C656;;C2C658;;C2C65X;;C2C662;;C2C665;;C2C670;;C2C675;;C2C678;;C2CAA;;C2CAB;;C2CKJ;;C2CLM;;C2CLS;;C2CLY;;C2CLZ;;C2CMC;;C2CRM;;U1S1347;;U1SC2C,0,0,,,,EXPIRED
134,PT,B,PT 89922 B,077-959-585-159-416,1995-03-01,1995,PT 8992289 A,1989-03-07,US 8800745 W,1988-03-08,PROCESSO PARA A PREPARACAO DE DERIVADOS DA TIAZOLIDENODIONA,,PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/077-959-585-159-416,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D277/14;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
135,NZ,A,NZ 228247 A,072-525-475-303-368,1990-05-28,1990,NZ 22824789 A,1989-03-07,US 8800745 W,1988-03-08,"SUBSTITUTED THIAZOLIDINE-2,4-DIONES AND PHARMACEUTICAL COMPOSITIONS",,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/072-525-475-303-368,Patent Application,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D277/14;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,PENDING
136,PT,A,PT 89922 A,083-930-370-721-713,1989-11-10,1989,PT 8992289 A,1989-03-07,US 8800745 W,1988-03-08,PROCESSO PARA A PREPARACAO DE DERIVADOS DA TIAZOLIDENODIONA,,PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/083-930-370-721-713,Patent Application,no,0,1,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;C07D277/14;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
137,FR,B1,FR 2561921 B1,108-366-426-476-27X,1988-01-22,1988,FR 8506171 A,1985-04-23,FR 8506171 A;;US 77135977 A;;US 79044277 A,1977-02-23,TISSU POUR UNE PROTHESE CARDIOVASCULAIRE,,DAVIS ROBERT,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN,,https://lens.org/108-366-426-476-27X,Granted Patent,no,0,0,2,29,0,A61F2/2418;;A61F2/2412;;B21F45/008,A61F2/24,,0,0,,,,EXPIRED
138,WO,A1,WO 1989/008652 A1,199-709-645-509-417,1989-09-21,1989,US 8800745 W,1988-03-08,US 8800745 W,1988-03-08,THIAZOLIDINEDIONE DERIVATIVES AS HYPOGLYCEMIC AGENTS,"Hypoglycemic thiazolidine-2,4-dione derivatives of formula (I), wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N-, S, O or NR; W is S, SO, SO2, SO2NR?1, NR1SO¿2, CONR?1 or NR1¿CO; X is S, O, NR2, -CH=N- OR -N=CH; Y is CH or N; Z is hydrogen, (C¿1?-C7)alkyl, (C3-C7)cycloalkyl, phenyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z?1¿ is hydrogen or (C¿1?-C3)alkyl; R, R?1 and R2¿ are each independently hydrogen or (C¿1?-C4); and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/199-709-645-509-417,Patent Application,yes,2,11,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;C07D277/14;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,PATENTED
139,US,A,US 5036079 A,018-363-426-218-880,1991-07-30,1991,US 47726190 A,1990-02-08,US 47726190 A;;US 43849089 A,1989-12-07,Hypoglycemic thiazolidinedione derivatives,"Hypoglycemic thiazolidine-2,4-derivatives ##STR1## wherein the dotted line represents a bond or no bond; V is --CH.dbd.CH--, --N.dbd.CH--, --CH.dbd.N-- or S; W is CH.sub.2, CHOH, CO, C.dbd.NOR or --CH.dbd.CH--; X is S, O, NR.sup.1, --CH.dbd.N-- or --N.dbd.CH--; Y is CH or N; Z is hydrogen, (C.sub.1 -C.sub.7)alkyl, (C.sub.3 -C.sub.7)cycloalkyl, phenyl, naphtyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C.sub.1 -C.sub.3)alkyl, trifluoromethyl, (C.sub.1 -C.sub.3)alkoxy, fluoro, chloro or bromo; Z.sup.1 is hydrogen or (C.sub.1 -C.sub.3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharamceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,PFIZER INC (1990-02-08),https://lens.org/018-363-426-218-880,Granted Patent,yes,8,41,1,44,0,C07D417/10;;C07D417/10;;C07D277/24;;C07D277/24;;C07D417/14;;C07D417/14,C07D277/24;;C07D417/10;;C07D417/14,514/333;;514/342;;546/256;;546/280,1,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"Sohda et al., Chem. Pharm. Bull. Japan, v. 30, pp. 3580 3600 (1982).",EXPIRED
140,US,A,US 5330998 A,077-987-833-005-677,1994-07-19,1994,US 56643790 A,1990-08-14,US 56643790 A;;US 8800745 W,1988-03-08,Thiazolidinedione derivatives as hypoglycemic agents,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula ##STR1## wherein the dotted line represents a bond or no bond; V is --CH.dbd.CH--, --N.dbd.CH--, --CH.dbd.N--, S, O or NR; W is S, SO, SO.sub.2, SO.sub.2 NR.sup.1, NR.sup.1 SO.sub.2, CONR.sup.1 or NR.sup.1 CO; X is S, O, NR.sup.2, --CH.dbd.N-- or --N.dbd.CH; Y is CH or N; Z is hydrogen, (C.sub.1 -C.sub.7)alkyl, (C.sub.3 -C.sub.7)cycloalkyl, phenyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C.sub.1 -C.sub.3)alkyl, trifluoromethyl, (C.sub.1 -C.sub.3)alkoxy, fluoro, chloro or bromo; Z.sup.1 is hydrogen or (C.sub.1 -C.sub.3)alkyl; R, R.sup.1 and R.sup.2 are each independently hydrogen or (C.sub.1 -C.sub.4); and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,PFIZER INC. A CORP. OF DE (1988-03-08),https://lens.org/077-987-833-005-677,Granted Patent,yes,5,44,1,38,0,C07D263/44;;C07D263/44;;C07D417/12;;C07D417/12,C07D263/44;;C07D417/12,514/369;;514/342;;546/280;;548/183,2,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"Sohda et al. Chem. Pharm. Bull. Japan, vol. 30 pp. 3580 3600 (1982).;;Burger, Alfred, Medicinal Chemistry, vol. 3, 3rd Ed., pp. 64 80, Wiley Interscience (1970).",EXPIRED
141,US,A1,US 2011/0179945 A1,090-895-435-229-694,2011-07-28,2011,US 69406110 A,2010-01-26,US 69406110 A,2010-01-26,"Gas Operating Systems, Subsystems, Components and Processes","A gas operating system for a firearm includes a gas block, a barrel nut that maintains the gas block at a predetermined axial position on a barrel of the firearm, a member that is movable with respect to the gas block axially with respect to the barrel in response to pressure exerted by expanding propellant gases conveyed thereto by the gas block and a mechanical linkage receiving a force form the member urging it in an axial direction of the barrel and coupled with a loading and ejection mechanism of the firearm to convey the force thereto for operating the loading and ejection mechanism. Various embodiments of gas block assemblies and operating rods for gas operating systems for firearms are provided.",CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW,CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW,CLARK ROBERT BERNARD (2012-03-01);;LEITNER-WISE AG LTD (2020-02-05);;LEITNER-WISE DEFENSE INC (2010-07-21);;LEITNER-WISE PAUL (2012-03-01),https://lens.org/090-895-435-229-694,Patent Application,yes,40,27,4,4,0,F41A5/26;;F41A5/26;;F41A5/18;;F41A5/18;;Y10T29/49815;;Y10T29/49815,F41A5/18;;B23P19/00;;F41A5/26,89/193;;89/191.01;;29/426.1,0,0,,,,ACTIVE
142,CZ,A3,CZ 143989 A3,140-499-272-801-728,1999-06-16,1999,CS 143989 A,1989-03-07,US 8800733 W,1988-03-08,THIAZOLIDINEDIONE DERIVATIVES AND PROCESS OF THEIR PREPARATION,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/140-499-272-801-728,Patent Application,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,C07D277/20;;A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
143,EP,A1,EP 0332332 A1,165-396-895-674-572,1989-09-13,1989,EP 89302017 A,1989-03-01,US 8800733 W,1988-03-08,Hypoglycemic thiazolidinedione derivatives.,"Hypoglycemic thiazolidine-2,4-dione derivatives
   wherein the dotted line represents a bond or no bond; 
V is -CH=CH-, -N=CH-, -CH=N- or S; 
W is CH₂, CHOH, CO, C=NOR or -CH=CH-; 
X is S, O, NR¹, -CH=N- or -N=CH-; 
Y is CH or N; 
Z is hydrogen, (C₁-C₇)alkyl, (C₃-C₇)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C₁-C₃)alkyl, trifluoromethyl, (C₁-C₃)alkoxy, fluoro, chloro or bromo; 
Z¹ is hydrogen or (C₁-C₃)alkyl; 
R is hydrogen or methyl; and 
n is 1, 2 or 3; 
a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.  ",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/165-396-895-674-572,Patent Application,yes,1,68,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/20;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,1,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"CHEMICAL AND PHARMACENTIAL BULLETIN, vol. 30, no. 10, October 1982, pages 3580-3600, Tokyo, JP; T. SOHIDA et al.: ""Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-Methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives""",EXPIRED
144,HU,D0,HU 882181 D0,019-155-460-918-055,1991-01-28,1991,HU 218188 A,1988-03-08,US 8800745 W,1988-03-08,PROCESS FOR PRODUCING THIAZOLIDINE-DIONE DERIVATIVES REDUCING BLOOD-SUGAR LEVEL,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/019-155-460-918-055,Patent Application,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,C07D277/14;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
145,GB,B,GB 2136980 B,075-346-733-781-668,1986-05-14,1986,GB 8303472 A,1983-02-08,GB 8303472 A,1983-02-08,SENSITIVE SILVER HALIDE PHOTOTHERMOGRAPHIC MATERIALS FOR PRODUCING DYE IMAGES,,KODAK LTD,CLARK BERNARD ARTHUR;;HOLSTEAD COLIN;;SIMONS MICHAEL JOHN,,https://lens.org/075-346-733-781-668,Granted Patent,no,0,0,6,6,0,G03C8/4033;;G03C8/4033;;G03C1/49854;;G03C1/49854,G03C1/498;;G03C8/40,C2C1401;;C2C140X;;C2C211;;C2C213;;C2C214;;C2C215;;C2C220;;C2C221;;C2C222;;C2C225;;C2C226;;C2C227;;C2C22Y;;C2C250;;C2C252;;C2C256;;C2C25Y;;C2C281;;C2C282;;C2C305;;C2C30Y;;C2C311;;C2C31Y;;C2C321;;C2C32Y;;C2C332;;C2C342;;C2C34Y;;C2C351;;C2C352;;C2C364;;C2C365;;C2C36Y;;C2C373;;C2C37Y;;C2C386;;C2C401;;C2C40Y;;C2C591;;C2C603;;C2C613;;C2C614;;C2C620;;C2C621;;C2C624;;C2C625;;C2C62X;;C2C660;;C2C661;;C2C662;;C2C681;;C2C695;;C2C699;;C2C761;;C2C765;;C2CAA;;C2CKR;;C2CLK;;C2CMM;;C2CRC;;C2CRE;;C2CRM;;C2CTN;;C4P106;;C4P9A3A1;;G2CA6X;;G2CC19E2A;;G2CC8BX;;U1S1347;;U1S1410;;U1SC2C;;U1SC4P;;U1SG2C,0,0,,,,EXPIRED
146,US,B2,US 8443711 B2,087-542-370-512-795,2013-05-21,2013,US 69406110 A,2010-01-26,US 69406110 A,2010-01-26,"Gas operating systems, subsystems, components and processes","A gas operating system for a firearm includes a gas block, a barrel nut that maintains the gas block at a predetermined axial position on a barrel of the firearm, a member that is movable with respect to the gas block axially with respect to the barrel in response to pressure exerted by expanding propellant gases conveyed thereto by the gas block and a mechanical linkage receiving a force form the member urging it in an axial direction of the barrel and coupled with a loading and ejection mechanism of the firearm to convey the force thereto for operating the loading and ejection mechanism. Various embodiments of gas block assemblies and operating rods for gas operating systems for firearms are provided.",CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW;;LEITNER WISE DEFENSE INC,CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW,CLARK ROBERT BERNARD (2012-03-01);;LEITNER-WISE AG LTD (2020-02-05);;LEITNER-WISE DEFENSE INC (2010-07-21);;LEITNER-WISE PAUL (2012-03-01),https://lens.org/087-542-370-512-795,Granted Patent,yes,40,5,4,4,0,F41A5/26;;F41A5/26;;F41A5/18;;F41A5/18;;Y10T29/49815;;Y10T29/49815,F41A5/18,89/193;;89/191.01,0,0,,,,ACTIVE
147,EP,A2,EP 0428312 A2,087-902-522-580-313,1991-05-22,1991,EP 90312116 A,1990-11-06,US 8905222 W,1989-11-13,Oxazolidinedione hypoglycemic agents.,"Compounds of the formulae
   where R is cycloalkyl or aryl; R₁ is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.  ",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;DOW ROBERT LEE,,https://lens.org/087-902-522-580-313,Patent Application,yes,0,55,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
148,EP,B1,EP 0428312 B1,089-820-932-372-270,1994-12-28,1994,EP 90312116 A,1990-11-06,US 8905222 W,1989-11-13,Oxazolidinedione hypoglycemic agents.,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;DOW ROBERT LEE,,https://lens.org/089-820-932-372-270,Granted Patent,yes,5,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,1,0,,,"CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 30, no. 10, October 1982, pages 3563-3573, Tokyo, JP; T. SOHDA et al.: ""Studies on antidiabetic agents. I.Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds""",EXPIRED
149,ES,T3,ES 2066991 T3,082-799-416-971-244,1995-03-16,1995,ES 90312116 T,1990-11-06,US 8905222 W,1989-11-13,AGENTES HIPOGLUCEMIANTES DE OXAZOLIDINADIONA.,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;DOW ROBERT LEE,,https://lens.org/082-799-416-971-244,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
150,NO,D0,NO 894425 D0,097-989-241-287-986,1989-11-07,1989,NO 894425 A,1989-11-07,US 8800733 W,1988-03-08,HYPOGLYKEMISKE TIAZOLIDINON-DERIVATER.,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER INC,"CLARK, DAVID ALAN;;GOLDSTEIN, STEVEN WAYNE;;HULIN, BERNARD",,https://lens.org/097-989-241-287-986,Patent Application,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;C07D277/20;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
151,AT,T1,AT E87624 T1,174-173-566-184-255,1993-04-15,1993,AT 89302017 T,1989-03-01,EP 89302017 A;;US 8800733 W,1988-03-08,HYPOGLYKAEMISCHE THIAZOLIDINDION-DERIVATE.,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/174-173-566-184-255,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,C07D277/20;;A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,DISCONTINUED
152,CZ,B6,CZ 285957 B6,199-259-307-536-695,1999-12-15,1999,CS 143989 A,1989-03-07,US 8800733 W,1988-03-08,THIAZOLIDINEDIONE DERIVATIVES AND PROCESS OF THEIR PREPARATION,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/199-259-307-536-695,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,C07D277/20;;A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
153,HU,B,HU 217432 B,062-318-598-950-229,2000-01-28,2000,HU 218188 A,1988-03-08,US 8800745 W,1988-03-08,PROCESS FOR PRODUCING THIAZOLIDINE-DION DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME THE COMPOUNDS AND COMPOSITIONS,"A találmány tárgya az (I) általánős képletű vegyületek, ahől aszaggatőtt vőnal és a vele párhűzamősan fűtó főlyamatős vőnal együttesjelentése egy egyszeres kötés vagy kettős kötés; V jelentése –CH=CH–képletű csőpőrt, W jelentése kénatőm, szűlfinilcsőpőrt,szűlfőnilcsőpőrt, –N(R1)SO2– , –CON(R1)– vagy –N(R1)CO– általánősképletű csőpőrt; X jelentése őxigénatőm, Y jelentése nitrőgénatőm; Zjelentése 1–7 szénatőmős alkilcsőpőrt vagy fenilcsőpőrt, Z1 jelentésehidrőgénatőm vagy 1–3 szénatőmős alkilcsőpőrt; R1 jelentésehidrőgénatőm vagy 1–4 szénatőmős alkilcsőpőrt, és n értéke 1, 2 vagy 3, és ezek gyógyászatilag elfőgadható sói, eljárásazők előállítására, valamint az azőkat tartalmazó, vércűkőrszintcsökkentésére vagy vérkőleszterinszint csökkentésére alkalmasgyógyszerkészítmények, és eljárás ezek előállítására. ŕ",Pfizer Inc.,CLARK DAVID A;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/062-318-598-950-229,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;C07D277/14;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
154,NO,C,NO 178068 C,114-079-433-669-438,1996-01-17,1996,NO 903863 A,1990-09-05,US 8800745 W,1988-03-08,Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater,,PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/114-079-433-669-438,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;C07D277/14;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
155,FI,A0,FI 895258 A0,138-589-891-437-643,1989-11-06,1989,FI 895258 A,1989-11-06,US 8800733 W,1988-03-08,Menetelmä hypoglykeemisten tiatsolidiinidionijohdannaisten valmistamiseksi,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/138-589-891-437-643,Patent Application,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;C07D277/20;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
156,CA,C,CA 1328873 C,172-071-240-845-930,1994-04-26,1994,CA 592855 A,1989-03-06,US 8800733 W,1988-03-08,HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES,"HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES Hypoglycemic thiazolidine-2,4-dione derivatives <IMG> ---(I) wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR1, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z1 is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/172-071-240-845-930,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,C07D277/20;;A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,D426002799   M;;1670231    S;;1670234    S;;26003027   S,0,0,,,,EXPIRED
157,IE,B1,IE 63187 B1,181-507-583-004-261,1995-03-22,1995,IE 102489 A,1989-03-30,IE 102489 A,1989-03-30,Thiazolidinedione derivatives as hypoglycemic agents,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/181-507-583-004-261,Granted Patent,no,0,0,1,1,0,,C07D417/12,,0,0,,,,EXPIRED
158,FI,B,FI 92696 B,005-273-338-088-093,1994-09-15,1994,FI 904413 A,1990-09-07,US 8800745 W,1988-03-08,Process for the preparation of therapeutically useful thiazolidinedione derivatives,"Hypoglycaemic thiazolidine-2,4-dione derivatives of the formula I <IMAGE> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N-, S, O or NR; W is S, SO, SO2, SO2NR1, NR1SO2, CONR1 or NR1CO; X is S, O, NR2, -CH=N- OR -N=CH; Y is CH or N; Z is hydrogen, (C1-7)alkyl, (C3- 7)cycloalkyl, phenyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are: (C1-3)alkyl, trifluoromethyl, (C1-3)alkoxy, fluoro, chloro or bromo; Z1 is hydrogen or (C1-3)alkyl; R, R1 and R2 are each independently hydrogen or (C1-4); and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/005-273-338-088-093,Patent Application,no,0,1,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;C07D277/14;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
159,NO,B,NO 178068 B,119-383-842-300-680,1995-10-09,1995,NO 903863 A,1990-09-05,US 8800745 W,1988-03-08,Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater,,PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/119-383-842-300-680,Unknown,no,0,1,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;C07D277/14;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
160,DK,D0,DK 108789 D0,130-512-791-607-899,1989-03-07,1989,DK 108789 A,1989-03-07,US 8800745 W,1988-03-08,"THIAZOLIDIN-2,4-DION-DERIVATER OG FARMACEUTISKE PRAEPARATER INDEHOLDENDE DISSE",,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/130-512-791-607-899,Patent Application,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;C07D277/14;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,DISCONTINUED
161,EP,B1,EP 0332332 B1,138-347-125-527-947,1993-03-31,1993,EP 89302017 A,1989-03-01,US 8800733 W,1988-03-08,HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER INC.,"CLARK, DAVID ALAN;;HULIN, BERNARD;;GOLDSTEIN, STEVEN WAYNE",,https://lens.org/138-347-125-527-947,Granted Patent,yes,0,3,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/20;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,1,0,,,"A. BURGER, 3rd Ed., vol. 1",EXPIRED
162,AT,T1,AT E116306 T1,046-255-136-380-318,1995-01-15,1995,AT 90312116 T,1990-11-06,US 8905222 W,1989-11-13,HYPOGLYKÄMISCHE OXAZOLIDINDION-DERIVATE.,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;DOW ROBERT LEE,,https://lens.org/046-255-136-380-318,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,DISCONTINUED
163,US,A,US 5498621 A,089-418-050-037-723,1996-03-12,1996,US 28961294 A,1994-08-12,US 28961294 A;;US 85503892 A,1992-05-01,Oxazolidinedione hypoglycemic agents,"Compounds of the formulae ##STR1## where R is cycloalkyl or aryl; R.sub.1 is alkyl, X is O or C.dbd.O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,DOW ROBERT L;;HULIN BERNARD;;CLARK DAVID A,,https://lens.org/089-418-050-037-723,Granted Patent,yes,29,30,1,1,0,C07D263/44;;C07D263/44;;C07D413/14;;C07D413/14;;C07D417/12;;C07D417/12,C07D263/44;;C07D413/14;;C07D417/12,514/369;;514/375;;514/376;;548/203;;548/204;;548/217;;548/226;;548/235;;548/236,5,4,023-633-433-650-370;;035-427-547-208-191;;039-157-593-006-02X;;035-427-547-208-191,819830;;10.1056/nejm197608122950707;;10.1248/cpb.30.3563;;7160011;;7160012;;10.1248/cpb.30.3580;;10.1248/cpb.30.3563;;7160011,"Dow et al. Chem Abstr vol. 114 entry 228799a (1991).;;Ross & Glomset, New England Journal of Medicine, 295, 369 377, (1976).;;Sohda, et al., I, Chem. Pharm. Bull., 30, 3563 64, (1982) (rest of article not provided, seen).;;Sohda, et al., II, Chem. Pharm. Bull., 30, 3580 3600, (1982).;;Sohda et al., I, Chem. Pharm. Bull., 1982, 30, 3563 80.",EXPIRED
164,US,A,US 4323914 A,098-233-188-613-493,1982-04-06,1982,US 837579 A,1979-02-01,US 837579 A,1979-02-01,Heat transfer structure for integrated circuit package,"Heat is removed from a Large Scale Integrated Circuit semiconductor package via a thermal conductive path including a thermally conductive liquid. The integrated circuit chips are flip chip bonded to a substrate having a printed circuit and raised contact pads serving to interconnect contact areas on the chip. A metal, ceramic (or combination thereof) cover engages the perimeter of the substrate and encloses the chips (or chip). The thermal liquid is contained within the cavity define by the cover and substrate. The chips (or chip) and the flip chip connections are protected from contamination and the deleterious effects of the thermally conductive liquid by a parylene film enveloping same. Additionally, back side bonded (beam lead) integrated circuit chips will have an enhanced heat transfer path by incorporating liquid metal and a protective coating of parylene.",IBM,BERNDLMAIER ERICH;;CLARK BERNARD T;;DORLER JACK A,,https://lens.org/098-233-188-613-493,Granted Patent,yes,1,277,1,1,0,H01L23/057;;H01L23/293;;H01L23/3121;;H01L23/3157;;H01L23/3736;;H01L23/42;;H01L23/433;;H01L2224/16;;H01L2224/48227;;H01L2224/48472;;H01L2224/73253;;H01L2224/73265;;H01L2224/8592;;H01L2924/01079;;H01L2924/14;;H01L2924/15174;;H01L2924/15312;;H01L2924/16152;;H01L2924/16195;;H01L24/48;;H01L2924/01019;;H01L2924/01322;;H01L2224/16225;;H01L2224/32225;;H01L2224/27013;;H01L2224/8192;;H01L2924/00014;;H01L23/3157;;H01L23/433;;H01L2924/16195;;H01L2924/16152;;H01L2924/15174;;H01L23/293;;H01L2224/16;;H01L2924/15312;;H01L2924/01079;;H01L23/3121;;H01L23/42;;H01L2224/73265;;H01L2224/8592;;H01L2224/48472;;H01L2224/48227;;H01L2924/14;;H01L23/057;;H01L23/3736;;H01L2224/73253;;H01L2924/01019;;H01L24/48;;H01L2924/01322;;H01L2224/16225;;H01L2224/32225;;H01L2224/27013;;H01L2224/8192;;H01L2924/00014,H01L23/057;;H01L23/29;;H01L23/31;;H01L23/373;;H01L23/42;;H01L23/433,H1K KPDB          PDB,3,0,,,"IBM Tech. Bul., vol. 20, No. 11B, Apr. 1978, p. 4820, Arnold et al.;;IBM Tech. Bul., vol. 19, No. 4, Sep. 1976, p. 1348, Jeannotte.;;IBM Tech. Bul., vol. 19, No. 4, Sep. 1976, p. 1260.",EXPIRED
165,AU,B2,AU 594899 B2,137-014-863-975-731,1990-03-15,1990,AU 1989/031077 A,1989-03-07,US 8800745 W,1988-03-08,THIAZOLIDINEDIONE DERIVATIVES AS HYPOGLYCEMIC AGENTS,,PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/137-014-863-975-731,Granted Patent,no,1,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,C07D277/14;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
166,AU,B1,AU 546064 B1,164-984-281-985-32X,1985-08-15,1985,AU 1981/067459 A,1981-02-19,US 12512080 A,1980-02-27,ELASTOMERIC SHEET MATERIAL FOR HEART VALVES ETC,,ALBANY INT CORP;;UNIV WASHINGTON,SKELTON JOHN;;CLARK RICHARD EDWIN;;DAVIS ROBERT BERNARD,,https://lens.org/164-984-281-985-32X,Granted Patent,no,0,0,14,14,0,A61F2/06;;A61F2/2412;;A61F2/2418;;A61L27/14;;A61L27/18;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2331/06;;D10B2509/00;;A61F2220/005;;D03D15/33;;D03D15/56;;D03D15/283;;A61F2/2418;;D03D3/02;;B21F45/008;;A61F2/2412;;D03D7/00;;A61L27/18;;A61L27/14;;A61F2/06;;D10B2509/00;;D10B2331/06;;A61F2220/005;;D03D15/33;;D03D15/56;;D03D15/283,A61L27/00;;A61F2/06;;A61F2/24;;A61L27/14;;A61L27/18;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
167,MY,A,MY 103837 A,161-997-412-395-500,1993-09-30,1993,MY PI19890272 A,1989-03-06,US 8800745 W,1988-03-08,THIAZOLIDINEDIONE DERIVATIVES AS HYPOGLYCEMIC AGENTS.,"HYPOGLYCEMIC THIAZOLIDINE-2, 4- DIONE DERIVATIVES OF THE FORMULA @@(FORMULA 1)@@WHEREIN THE DOTTED LINE REPRESENTS A BOND OR NO BOND;@V IS -CH=CH-, -N=CH, -CH=N-, S, O OR NR;@W IS S, SO, SO2, SO2 NR1, NR2 SO2, CONR1 OR NR1 CO;@X IS S, O, NR2, -CH=N- OR -N=CH;@Y IS CH OR N;@Z IS HYDROGEN, (C1- C7) ALKYL, (C3- C7) CYCLOALKYL, PHENYL, PYRIDYL, FURYL, THIENYL OR PHENYL MONO- OR DISUBSTITUTED WITH THE SAME OR DIFFERENT GROUPS WHICH ARE (C1- C3) ALKYL, TRIFLUOROMETHYL. (C1- C3) ALKOXY, FLUORO, CHLORO OR BROMO;@Z1 IS HYDROGEN OR (C1- C3) ALKYL;@R, R1 AND R2 ARE EACH INDEPENDENTLY HYDROGEN OR (C1- C4);AND @N IS 1, 2 OR 3;@A PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT THEREOF; OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF WHEN THE COMPOUND CONTAINS A BASIC NITROGEN.",PFIZER,DAVID ALAN CLARK;;STEVEN WAYNE GOLDSTEIN;;BERNARD HULIN,,https://lens.org/161-997-412-395-500,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,C07D277/14;;A61K31/42;;C07D417/12;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/14,,0,0,,,,EXPIRED
168,CA,C,CA 2029703 C,176-667-819-188-741,1996-10-15,1996,CA 2029703 A,1990-11-09,US 8905222 W,1989-11-13,OXAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"Compounds of the formulae and where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;DOW ROBERT LEE;;HULIN BERNARD,,https://lens.org/176-667-819-188-741,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,D42600304    M;;1670233    S;;2600302    S,0,0,,,,EXPIRED
169,IE,B1,IE 64457 B1,014-195-560-871-746,1995-08-09,1995,IE 405790 A,1990-11-12,US 8905222 W,1989-11-13,Oxazolidinedione hypoglycemic agents,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;DOW ROBERT LEE;;HULIN BERNARD,,https://lens.org/014-195-560-871-746,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;C07D277/24;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
170,DE,T2,DE 68915266 T2,013-402-662-616-378,1994-09-01,1994,DE 68915266 T,1989-03-29,EP 89303086 A;;US 8800745 W,1988-03-08,Thiazolidin-Derivate als hypoglykämisches Mittel.,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/013-402-662-616-378,Granted Patent,no,0,0,3,38,0,,A61K31/425;;A61K31/44;;C07D277/20;;C07D277/34;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
171,FI,A0,FI 922141 A0,066-324-577-808-756,1992-05-12,1992,FI 922141 A,1992-05-12,US 8905222 W,1989-11-13,Analogiamenetelmä uusien hypoglykeemisten oksatsolidiinidionien valmistamiseksi,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;DOW ROBERT LEE;;HULIN BERNARD,,https://lens.org/066-324-577-808-756,Patent Application,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
172,HU,B,HU 204820 B,093-448-843-204-87X,1992-02-28,1992,HU 283688 A,1988-03-08,HU 283688 A,1988-03-08,PROCESS FOR PRODUCING THIAZOLIDINEDIONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH COMPOUNDS,,PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/093-448-843-204-87X,Granted Patent,no,0,0,2,2,0,,A61K31/425;;C07D417/10;;C07D417/14,,0,0,,,,EXPIRED
173,WO,A1,WO 1991/007107 A1,126-445-185-130-363,1991-05-30,1991,US 8905222 W,1989-11-13,US 8905222 W,1989-11-13,OXAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"Compounds of fomulae (I) and (II), where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH, are useful as hypoglycemic agents.",PFIZER,DOW ROBERT L;;HULIN BERNARD;;CLARK DAVID A,,https://lens.org/126-445-185-130-363,Patent Application,yes,13,27,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;C07D277/24;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,PATENTED
174,NO,C,NO 177008 C,116-432-607-892-857,1995-07-05,1995,NO 894425 A,1989-11-07,US 8800733 W,1988-03-08,Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidinon-derivater,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/116-432-607-892-857,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
175,IE,B1,IE 62776 B1,138-465-235-560-411,1995-02-22,1995,IE 73889 A,1989-03-07,US 8800733 W,1988-03-08,Hypoglycemic thiazolidinedione derivatives,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/138-465-235-560-411,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
176,FR,A1,FR 2476480 A1,137-793-454-699-292,1981-08-28,1981,FR 8103859 A,1981-02-26,US 12512080 A,1980-02-27,MATIERE ELASTOMERE TEXTILE EN FEUILLE POUR REALISER DES IMPLANTS DE VALVULE DU COEUR ET AUTRES PROTHESES,"<P>MATIERE ELASTOMERE TEXTILE EN FEUILLE POUR REALISER DES IMPLANTS DE VALVULE DU COEUR ET AUTRES PROTHESES.</P><P>LA FEUILLE DE MATIERE A UNE EPAISSEUR MAXIMALE, ENTRE FACES, D'ENVIRON 0,06CM. ELLE EST FORMEE PAR TISSAGE OU TRESSAGE DE FILS A PLUSIEURS FILAMENTS PRESENTANT DES TROUS DE 40 MICRONS AU MAXIMUM. LA MATIERE PEUT ETRE UN COPOLYMERE DE POLYETHER-ESTER SEGMENTE, DONT LE MODULE DE TRACTION PRESENTE UNE VARIATION NON LINEAIRE EN FONCTION DE LA CHARGE. ON PEUT FORMER UNE VALVULE EN INSERANT LA MATIERE 50 ENTRE LES ANSES 30, 32 ET LES BOUCLES A DE MONTURE, DE MANIERE A LAISSER DES PANS LIBRES 58, 60, A COLLER ENTRE A ET B.</P>",ALBANY INT CORP,SKELTON JOHN;;CLARK RICHARD EDWIN;;DAVIS ROBERT BERNARD,,https://lens.org/137-793-454-699-292,Patent Application,no,7,1,14,14,0,A61F2/06;;A61F2/2412;;A61F2/2418;;A61L27/14;;A61L27/18;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2331/06;;D10B2509/00;;A61F2220/005;;D03D15/33;;D03D15/56;;D03D15/283;;A61F2/2418;;D03D3/02;;B21F45/008;;A61F2/2412;;D03D7/00;;A61L27/18;;A61L27/14;;A61F2/06;;D10B2509/00;;D10B2331/06;;A61F2220/005;;D03D15/33;;D03D15/56;;D03D15/283,A61F2/06;;A61F2/24;;A61L27/14;;A61L27/18;;D03D3/02;;D03D7/00;;A61L27/00;;D03D15/00,,0,0,,,,EXPIRED
177,CH,A5,CH 642531 A5,165-417-618-036-492,1984-04-30,1984,CH 131181 A,1981-02-26,US 12512080 A,1980-02-27,MATIERE TEXTILE EN FEUILLE POUR IMPLANTS CARDIOVASCULAIRES ET DE PROTHESE.,,ALBANY INT CORP;;UNIV WASHINGTON,SKELTON JOHN;;CLARK RICHARD EDWIN;;DAVIS ROBERT BERNARD,,https://lens.org/165-417-618-036-492,Granted Patent,no,0,0,14,14,0,A61F2/06;;A61F2/2412;;A61F2/2418;;A61L27/14;;A61L27/18;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2331/06;;D10B2509/00;;A61F2220/005;;D03D15/33;;D03D15/56;;D03D15/283;;A61F2/2418;;D03D3/02;;B21F45/008;;A61F2/2412;;D03D7/00;;A61L27/18;;A61L27/14;;A61F2/06;;D10B2509/00;;D10B2331/06;;A61F2220/005;;D03D15/33;;D03D15/56;;D03D15/283,A61L27/00;;A61F2/06;;A61F2/24;;A61L27/14;;A61L27/18;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
178,DK,D0,DK 108089 D0,109-830-299-777-039,1989-03-07,1989,DK 108089 A,1989-03-07,US 8800733 W,1988-03-08,"THIAZOLIDIN-2,4-DION-DERIVATER OG FARMACEUTISKE PRAEPARATER INDEHOLDENDE DISSE","Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/109-830-299-777-039,Patent Application,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,DISCONTINUED
179,PT,B,PT 95852 B,119-853-292-312-014,1997-11-28,1997,PT 9585290 A,1990-11-12,US 8905222 W,1989-11-13,PROCESSO PARA A PREPARACAO DE AGENTES HIPOGLICEMICOS DE OXAZOLIDINEDIONA,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;DOW ROBERT LEE;;HULIN BERNARD,,https://lens.org/119-853-292-312-014,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;C07D277/24;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
180,FI,B,FI 95469 B,145-866-984-298-810,1995-10-31,1995,FI 922141 A,1992-05-12,US 8905222 W,1989-11-13,Analogiamenetelmä uusien hypoglykeemisten oksatsolidiinidionien valmistamiseksi,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;DOW ROBERT LEE;;HULIN BERNARD,,https://lens.org/145-866-984-298-810,Patent Application,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
181,US,B2,US 8997622 B2,193-236-440-279-341,2015-04-07,2015,US 201313887295 A,2013-05-04,US 201313887295 A;;US 69406110 A,2010-01-26,"Gas operating systems, subsystems, components and processes","A gas operating system for a firearm includes a gas block, a barrel nut that maintains the gas block at a predetermined axial position on a barrel of the firearm, a member that is movable with respect to the gas block axially with respect to the barrel in response to pressure exerted by expanding propellant gases conveyed thereto by the gas block and a mechanical linkage receiving a force form the member urging it in an axial direction of the barrel and coupled with a loading and ejection mechanism of the firearm to convey the force thereto for operating the loading and ejection mechanism. Various embodiments of gas block assemblies and operating rods for gas operating systems for firearms are provided.",IREDALE CLARK ROBERT BERNARD;;LEITNER-WISE PAUL ANDREW;;LEITNER WISE DEFENSE INC,IREDALE CLARK ROBERT BERNARD;;LEITNER-WISE PAUL ANDREW,CLARK ROBERT BERNARD (2012-03-01);;LEITNER-WISE AG LTD (2020-02-05);;LEITNER-WISE PAUL (2012-03-01),https://lens.org/193-236-440-279-341,Granted Patent,yes,42,0,4,4,0,F41A5/26;;F41A5/26;;F41A5/18;;F41A5/18;;Y10T29/49815;;Y10T29/49815,F41A5/26;;F41A5/18,89/193;;89/191.02,0,0,,,,ACTIVE
182,HU,D0,HU 882836 D0,013-777-353-849-494,1990-02-28,1990,HU 283688 A,1988-03-08,HU 283688 A,1988-03-08,PROCESS FOR THE PREPARATION OF THIAZOLIDINEDIONE DERIVATIVES,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/013-777-353-849-494,Patent Application,no,0,0,2,2,0,,A61K31/425;;C07D417/10;;C07D417/14,,0,0,,,,EXPIRED
183,DE,D1,DE 68905639 D1,014-490-275-816-74X,1993-05-06,1993,DE 68905639 T,1989-03-01,US 8800733 W,1988-03-08,HYPOGLYKAEMISCHE THIAZOLIDINDION-DERIVATE.,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/014-490-275-816-74X,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/20;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
184,PT,A,PT 89912 A,046-726-032-018-38X,1989-11-10,1989,PT 8991289 A,1989-03-06,US 8800733 W,1988-03-08,PROCESSO PARA A PREPARACAO DE DERIVADOS DE TIAZOLIDINODIONA HIPOGLICEMICOS,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/046-726-032-018-38X,Patent Application,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;C07D277/20;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
185,DK,A,DK 108089 A,042-518-270-496-06X,1989-10-27,1989,DK 108089 A,1989-03-07,US 8800733 W,1988-03-08,"THIAZOLIDIN-2,4-DION-DERIVATER OG FARMACEUTISKE PRAEPARATER INDEHOLDENDE DISSE","Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/042-518-270-496-06X,Patent Application,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,DISCONTINUED
186,CN,C,CN 1026234 C,086-662-419-957-593,1994-10-19,1994,CN 89101214 A,1989-03-07,US 8800745 W,1988-03-08,Hypoglycemic thiazolidinedione derivatives,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/086-662-419-957-593,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;C07D277/14;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
187,US,A1,US 2014/0060313 A1,095-520-074-678-267,2014-03-06,2014,US 201313887295 A,2013-05-04,US 201313887295 A;;US 69406110 A,2010-01-26,"GAS OPERATING SYSTEMS, SUBSYSTEMS, COMPONENTS AND PROCESSES","A gas operating system for a firearm includes a gas block, a barrel nut that maintains the gas block at a predetermined axial position on a barrel of the firearm, a member that is movable with respect to the gas block axially with respect to the barrel in response to pressure exerted by expanding propellant gases conveyed thereto by the gas block and a mechanical linkage receiving a force form the member urging it in an axial direction of the barrel and coupled with a loading and ejection mechanism of the firearm to convey the force thereto for operating the loading and ejection mechanism. Various embodiments of gas block assemblies and operating rods for gas operating systems for firearms are provided.",IREDALE CLARK ROBERT BERNARD;;LEITNER-WISE PAUL ANDREW;;LEITNER WISE DEFENSE INC,IREDALE CLARK ROBERT BERNARD;;LEITNER-WISE PAUL ANDREW,CLARK ROBERT BERNARD (2012-03-01);;LEITNER-WISE AG LTD (2020-02-05);;LEITNER-WISE PAUL (2012-03-01),https://lens.org/095-520-074-678-267,Patent Application,yes,0,0,4,4,0,F41A5/26;;F41A5/26;;F41A5/18;;F41A5/18;;Y10T29/49815;;Y10T29/49815,F41A5/26,89/193,0,0,,,,ACTIVE
188,CA,A,CA 626217 A,134-887-248-227-129,1961-08-22,1961,CA 626217D A,,CA 626217T A,,ELECTRIC CIRCUIT ARRANGEMENTS FOR INDICATING THE OCCURRENCE OF FAULT OR OTHER ABNORMAL CONDITIONS,,SIEMENS EDISON SWAN LTD,STALLWORTHY FRANK A;;CLARK JOHN B;;DRAKE BERNARD,,https://lens.org/134-887-248-227-129,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
189,NO,B,NO 177008 B,005-597-494-680-25X,1995-03-27,1995,NO 894425 A,1989-11-07,US 8800733 W,1988-03-08,Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidinon-derivater,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/005-597-494-680-25X,Unknown,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
190,GB,A,GB 844239 A,011-740-960-752-780,1960-08-10,1960,GB 1323058 A,1958-04-25,GB 1323058 A,1958-04-25,Improvements relating to electric circuit arrangements for indicating the occurrenceof fault or other abnormal conditions,"844,239. Automatic exchange systems. SIEMENS EDISON SWAN Ltd. Jan. 23, 1959 [April 25, 1958], No. 13230/58. Class 40 (4). [Also in Group XIX] In a system in which operations can fall into desirable and undesirable categories, the latter type are caused to charge a condenser and the former are caused to discharge the condenser, and arrangements are made for an indication to be given if the charge on the condenser exceeds a predetermined limit corresponding to an undesirably high proportion of undesirable operations. As described the invention is applied to a register-sender which receives digits in a twoout-of-five code, a signal containing other than two elements being undesirable and being either rejected with the reversion of a "" re-order signal "" or transmitted to a subsequent receiver which reverts a re-order signal to the registersender under consideration. In the diagram shown, these conditions cause the operation of one or other of the contacts br, bd (relay windings, not shown). Operation of the circuit is initiated by the throwing of key KR which discharges the condenser C whereupon the valve V 1 conducts to operate ER. When KR is released condenser C charges by grid current to a datum potential above which it cannot rise, but ER remains operated. When the register sender is seized, contact td is operated to bring up FT. When the register sender is released, contacts fn operate to bring up A for the duration of the release time of FT. Relay A connects up the charge/discharge circuit of condenser C. If either bd or br operate due to undesirable operation the condenser C charges negatively from potential derived over R 6 from the potentiometer R 1 , R 5 , R 2 . In a desirable operation, however, the condenser discharges via R 6 , R 7 . The discharge rate is arranged to be only a fraction of the charge rate. If the condenser C charges sufficiently, it cuts off V 1 to release ER and give an alarm over lead 1. The potentiometer R 5 may be adjusted so that, say, four initial undesirable actions are necessary to set the alarm off. For effecting the adjustment, plug PL is transferred from the busy jack TJB1 to TJB2 and key KT thrown to connect up lamp LP and to simulate the undesirable operation condition in the charge/discharge circuit. The potentiometer R 5 is then adjusted until the lamp is lit after the key KSR has been thrown four times, each throw of the latter key causing A to operate as though the register had been seized and released.",SIEMENS EDISON SWAN LTD,STALLWORTHY FRANK ALLEN;;DRAKE BERNARD;;CLARK JOHN BROWNLIE,,https://lens.org/011-740-960-752-780,Granted Patent,no,0,0,1,1,0,G07C3/14,G07C3/14,G1J J35           J35;;H4K KBQ           KBQ;;H4K K1A3          KBQ;;H4K K1L           KBQ,0,0,,,,EXPIRED
191,WO,A1,WO 1991/003474 A1,024-598-048-643-655,1991-03-21,1991,US 8903758 W,1989-08-29,US 8903758 W,1989-08-29,HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES,"Hypoglycemic thiazolidine-2,4-dione derivatives as in formula (I), wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR1, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C¿1?-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z?1¿ is hydrogen or (C¿1?-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/024-598-048-643-655,Patent Application,yes,1,2,1,1,0,C07D417/10;;C07D417/14,C07D277/24;;C07D417/10;;C07D417/14,,0,0,,,,PENDING
192,DK,A,DK 108789 A,047-663-594-724-148,1989-09-09,1989,DK 108789 A,1989-03-07,US 8800745 W,1988-03-08,"THIAZOLIDIN-2,4-DION-DERIVATER OG FARMACEUTISKE PRAEPARATER INDEHOLDENDE DISSE",,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/047-663-594-724-148,Patent Application,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;C07D277/14;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,DISCONTINUED
193,CN,A,CN 1190255 A,070-319-292-657-147,1998-08-12,1998,CN 98103705 A,1998-01-26,US 79503097 A,1997-02-04,Method and apparatus for performing operative testing on integrated circuit,,MOTOROLA INC,PAPPERT BERNARD J;;SHEPARD CLARK;;CROUCH ALFRED LARRY,,https://lens.org/070-319-292-657-147,Patent Application,no,0,5,7,7,0,G01R31/3008;;G01R31/3008;;G01R31/3004;;G01R31/3004;;H01L22/00,H01L21/66;;G01R31/30,,0,0,,,,DISCONTINUED
194,EP,B1,EP 0389699 B1,095-573-414-452-096,1994-05-11,1994,EP 89303086 A,1989-03-29,US 8800745 W,1988-03-08,Thiazolidinedione derivatives as hypoglycemic agents.,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/095-573-414-452-096,Granted Patent,yes,2,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D277/14;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,1,0,,,"CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 30, no. 10, October 1982, pages3580-3600, Tokyo, JP; T. SOHDA et al.: ""Studies on antidiabetic agents. II.1)Synthesis of 5-[4-(1-methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione(ADD-3878) and its derivatives""",EXPIRED
195,DE,T2,DE 68905639 T2,120-004-727-603-929,1993-07-08,1993,DE 68905639 T,1989-03-01,US 8800733 W,1988-03-08,HYPOGLYKAEMISCHE THIAZOLIDINDION-DERIVATE.,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/120-004-727-603-929,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/20;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
196,ES,T3,ES 2052907 T3,121-502-457-742-045,1994-07-16,1994,ES 89303086 T,1989-03-29,US 8800745 W,1988-03-08,DERIVADOS DE TIAZOLIDINODIONA COMO AGENTES HIPOGLUCEMICOS.,"DERIVADOS TIAZOLIDINE-2,4-DIONE HIPOGLICEMICOS DE LA FORMULA EN DONDE LAS LINEAS DOTADAS REPRESENTAN UN ENLACE O NO; V ES -CH=CH-, -N=CH-, -CH=N-, S, O OR NR; W ES S, SO, SO2, SO2NR1, NR1SO2, CONR1 O NR1CO; X ES S, O, NR2, -CH=NO -N=CH; Y ES CH O N; Z ES HIDROGENO, ALQUIL (C1-C7), CICLOALQUIL(C3-C7), FENIL, PIRIDIL, FURIL, TIENIL O FENIL MONO- O DISUSTITUIDO CON EL MISMO O DIFERENTES GRUPOS QUE SON ALQUIL(C1-C3), TRIFLUOROMETIL, ALCOXI(C1-C3), FLUORO, CLORO O BROMO; Z1 ES HIDROGENO O ALQUIL(C1-C3); R, R1 Y R2 SON CADA UNO INDEPENDIENTEMENTE HIDROGENO O (C1-C4); Y N ES 1, 2 O 3; UNA SAL CATIONICA DE ELLO ACEPTABLE FARMACEUTICAMENTE; O UNA SAL DE ADICCION DE ACIDO DE ELLO ACEPTABLE FARMACEUTICAMENTE CUANDO EL COMPONENTE CONTIENE UN NITROGENO BASICO.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/121-502-457-742-045,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D277/14;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
197,DE,T2,DE 69015587 T2,017-296-708-695-235,1995-05-04,1995,DE 69015587 T,1990-11-06,US 8905222 W,1989-11-13,Hypoglykämische Oxazolidindion-Derivate.,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;DOW ROBERT LEE,,https://lens.org/017-296-708-695-235,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
198,US,A,US 5130379 A,015-152-372-524-997,1992-07-14,1992,US 67483391 A,1991-03-26,US 67483391 A;;US 8800733 W;;US 43849089 A,1988-03-08,Hypoglycemic thiazolidinedione derivatives,"Hypoglycemic thiazolidine-2,4-dione derivatives ##STR1## wherein the dotted line represents a bond or no bond; V is --CH.dbd.CH--, --N.dbd.CH--, --CH.dbd.N-- or S; W is CH.sub.2, CHOH, CO, C.dbd.NOR or --CH.dbd.CH--; X is S, O, NR.sup.1, --CH.dbd.N-- or --N.dbd.CH--; Y is CH or N; Z is hydrogen, (C.sub.1 -C.sub.7)alkyl, (C.sub.3 -C.sub.7) cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C.sub.1 -C.sub.3)alkyl, trifluoromethyl, (C.sub.1 -C.sub.3)alkoxy, fluoro, chloro or bromo; Z.sup.1 is hydrogen or (C.sub.1 -C.sub.3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptble cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/015-152-372-524-997,Granted Patent,yes,9,20,1,44,0,C07D417/10;;C07D417/10;;C07D277/24;;C07D277/24;;C07D277/34;;C07D277/34;;C07D417/14;;C07D417/14;;C07F7/1804;;C07F7/1804,C07D277/24;;C07D277/34;;C07D417/10;;C07D417/14;;C07F7/18,514/333;;514/342;;514/369;;546/256;;546/280;;548/183,2,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"Sohda et al., Chem. Pharm. Bull. Japan, vol. 30, pp. 3580 3600 (1982).;;Burger, Alfred, Medicinal Chemistry, vol. 3, 3rd Ed., pp. 64 80, Wiley Interscience (1970).",EXPIRED
199,GB,A,GB 2136980 A,049-239-910-526-662,1984-09-26,1984,GB 8303472 A,1983-02-08,GB 8303472 A,1983-02-08,SENSITIVE SILVER HALIDE PHOTOTHERMOGRAPHIC MATERIALS FOR PRODUCING DYE IMAGES,,KODAK LTD,CLARK BERNARD ARTHUR;;HOLSTEAD COLIN;;SIMONS MICHAEL JOHN,,https://lens.org/049-239-910-526-662,Patent Application,no,0,7,6,6,0,G03C8/4033;;G03C8/4033;;G03C1/49854;;G03C1/49854,G03C1/498;;G03C8/40,C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CKR;;C2C CLK;;C2C CMM;;C2C CRC;;C2C CRE;;C2C CRM;;C2C CTN;;C2C C140X;;C2C C140X;;C2C C140X;;C2C C140X;;C2C C1401;;C2C C1401;;C2C C211;;C2C C213;;C2C C214;;C2C C214;;C2C C214;;C2C C214;;C2C C215;;C2C C215;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C221;;C2C C222;;C2C C225;;C2C C226;;C2C C226;;C2C C226;;C2C C227;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C250;;C2C C250;;C2C C252;;C2C C252;;C2C C256;;C2C C256;;C2C C256;;C2C C256;;C2C C281;;C2C C282;;C2C C30Y;;C2C C30Y;;C2C C30Y;;C2C C30Y;;C2C C30Y;;C2C C30Y;;C2C C305;;C2C C305;;C2C C31Y;;C2C C311;;C2C C32Y;;C2C C32Y;;C2C C32Y;;C2C C321;;C2C C321;;C2C C321;;C2C C332;;C2C C332;;C2C C34Y;;C2C C34Y;;C2C C34Y;;C2C C342;;C2C C342;;C2C C342;;C2C C351,0,0,,,,EXPIRED
200,DE,D1,DE 68915266 D1,062-604-167-594-207,1994-06-16,1994,DE 68915266 T,1989-03-29,EP 89303086 A;;US 8800745 W,1988-03-08,Thiazolidin-Derivate als hypoglykämisches Mittel.,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/062-604-167-594-207,Granted Patent,no,0,0,3,38,0,,A61K31/425;;A61K31/44;;C07D277/20;;C07D277/34;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
201,FI,C,FI 95469 C,058-070-217-561-06X,1996-02-12,1996,FI 922141 A,1992-05-12,US 8905222 W,1989-11-13,Analogiamenetelmä uusien hypoglykeemisten oksatsolidiinidionien valmistamiseksi,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;DOW ROBERT LEE;;HULIN BERNARD,,https://lens.org/058-070-217-561-06X,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
202,DK,T3,DK 0428312 T3,085-904-433-174-790,1995-03-20,1995,DK 90312116 T,1990-11-06,US 8905222 W,1989-11-13,Hypoglykæmiske oxazolidindionderivater,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;DOW ROBERT LEE,,https://lens.org/085-904-433-174-790,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
203,PT,B,PT 89912 B,117-455-507-946-668,1994-05-31,1994,PT 8991289 A,1989-03-06,US 8800733 W,1988-03-08,PROCESSO PARA A PREPARACAO DE DERIVADOS DE TIAZOLIDINODIONA HIPOGLICEMICOS,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/117-455-507-946-668,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/20;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
204,CA,C,CA 1328265 C,193-546-443-745-073,1994-04-05,1994,CA 592859 A,1989-03-06,US 8800745 W,1988-03-08,THIAZOLIDINEDIONE DERIVATIVES AS HYPOGLYCEMIC AGENTS,"THIAZOLIDINEDIONE DERIVATIVES AS HYPOGLYCEMIC AGENTS Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <IMG> ---(I) wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N-, S, O or NR; W is S, SO, SO2, SO2NR1, NR1SO2, CONR1 or NR1CO; X is S, O, NR2, -CH=N- or -N=CH; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z1 is hydrogen or (C1-C3)alkyl; R, R1 and R2 are each independently hydrogen or (C1-C4); and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/193-546-443-745-073,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;C07D277/14;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,D426002799   M;;1670231    S;;1670234    S;;26002777   S;;26003027   S,0,0,,,,EXPIRED
205,PT,A,PT 95852 A,049-999-190-031-347,1991-09-13,1991,PT 9585290 A,1990-11-12,US 8905222 W,1989-11-13,PROCESSO PARA A PREPARACAO DE AGENTES HIPOGLICEMICOS DE OXAZOLIDINEDIONA,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;DOW ROBERT LEE;;HULIN BERNARD,,https://lens.org/049-999-190-031-347,Patent Application,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,A61K31/42;;A61K31/421;;C07D277/24;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
206,WO,A1,WO 1989/008651 A1,185-492-521-334-077,1989-09-21,1989,US 8800733 W,1988-03-08,US 8800733 W,1988-03-08,HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES,"Hypoglycemic thiazolidine-2,4-dione derivatives, of formula (I), wherein the dotted line represents a bond or no bonds; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR1, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C¿1?-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z?1¿ is hydrogen or (C¿1?-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/185-492-521-334-077,Patent Application,yes,3,29,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;A61K31/425;;C07D277/20;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,PATENTED
207,DE,D1,DE 69015587 D1,006-042-536-987-514,1995-02-09,1995,DE 69015587 T,1990-11-06,US 8905222 W,1989-11-13,Hypoglykämische Oxazolidindion-Derivate.,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;DOW ROBERT LEE,,https://lens.org/006-042-536-987-514,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
208,MY,A,MY 103979 A,008-025-174-880-67X,1993-10-30,1993,MY PI19890271 A,1989-03-06,US 8800733 W,1988-03-08,HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES.,"HYPOGLYCEMIC THIAZOLIDINE-2,4-DIONE DERIVATIVES (FORMULA 1) WHEREIN THE DOTTED LINE REPRESENTS A BOND OR NO BOND; V IS -CH=CH-, -N=CH-, -CH=N- OR S;W IS CH2, CHOH, CO, C=NOR OR -CH=CH-; X IS S, O,NR1, -CH=N- OR -N=CH-; Y IS CH OR N; Z IS HYDROGEN, (C1-C7)ALKYL, (C3-C7)CYCLOALKYL, PHENYL, NAPHTHYL, PYRIDYL, FURYL, THIENYL OR PHENYL MONO- OR DISUBSTITUTED WITH THE SAME OR DIFFERENT GROUPS WHICH ARE (C1-C3)ALKYL, TRIFLUOROMETHYL, (C1-C3)ALKOXY, FLUORO, CHLORO OR BROMO; Z1 IS HYDROGEN OR (C1-C3)ALKYL; R IS HYDROGEN OR METHYL; AND N IS 1, 2 OR 3; A PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT THEREOF; OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF WHEN THE COMPOUND CONTAINS A BASIC NITROGEN.",PFIZER,BERNARD HULIN;;DAVID ALAN CLARK;;STEVEN WAYNE GOLDSTEIN,,https://lens.org/008-025-174-880-67X,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,C07D277/20;;A61K31/42;;C07D401/14;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D403/14;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
209,US,A,US 4504568 A,030-581-249-726-322,1985-03-12,1985,US 57650384 A,1984-02-02,GB 8303472 A,1983-02-08,Sensitive silver halide photothermographic materials for producing dye images,"A dye-forming photothermographic element comprises in a binder, in reactive association, (a) photographic silver halide, (b) an image forming combination comprising (i) a reducible organic silver salt with (ii) a reducing agent selected from the group consisting of p-phenylenediamine, p-aminophenol, sulfonamidophenol, sulfonamidoaniline and hydrazone developing agents, and (c) a coupler which is capable of forming an image dye by reaction with the oxidized form of the reducing agent. In such a photothermographic element improvements are provided wherein the coupler has attached to the carbon atom at the coupling position either (A) a group --S--Dye, wherein Dye represents an image dye, or a blocked or shifted form thereof, and any necessary linking group, or (B) a moiety --S--Z, wherein Z represents atoms linking the sulfur atom to another position in the coupler. The exposed dye-forming photothermographic element is capable of forming a dye image by merely heating the element. The dye-forming photothermographic element can be a diffusion transfer photothermographic element in which the image dye formed upon heating the exposed element is capable of being transferred to an image receiver.",EASTMAN KODAK CO,CLARK BERNARD A;;SIMONS MICHAEL J;;HOLSTEAD COLIN,EASTMAN KODAK COMPANY (1984-01-24),https://lens.org/030-581-249-726-322,Granted Patent,yes,9,15,6,6,0,G03C8/4033;;G03C8/4033;;G03C1/49854;;G03C1/49854,G03C1/498;;G03C8/40,430/203;;430/226;;430/351;;430/553;;430/555;;430/557;;430/558;;430/559,5,0,,,"Research Disclosure, Jun. 1978, Item No. 17029.;;Research Disclosure, May 1978, Item No. 16966.;;Research Disclosure, Dec. 1978, Item No. 17643.;;Research Disclosure, Jan. 1983, Item No. 22534.;;Modern Photographic Processing, by Grant Haist, Wiley, N.Y., (1979), vol. 2, Chapter 9, pp. 478 495.",EXPIRED
210,NO,L,NO 903863 L,051-081-016-487-325,1990-09-05,1990,NO 903863 A,1990-09-05,US 8800745 W,1988-03-08,TIAZOLIDINDIONDERIVATER SOM HYPOGLYKEMISKE MIDLER.,,PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/051-081-016-487-325,Abstract,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;C07D277/14;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
211,NO,L,NO 894425 L,076-443-750-707-313,1989-11-07,1989,NO 894425 A,1989-11-07,US 8800733 W,1988-03-08,HYPOGLYKEMISKE TIAZOLIDINON-DERIVATER.,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/076-443-750-707-313,Abstract,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
212,FI,C,FI 93115 C,081-389-744-720-040,1995-02-27,1995,FI 895258 A,1989-11-06,US 8800733 W,1988-03-08,Menetelmä hypoglykeemisten tiatsolidiinidionijohdannaisten valmistamiseksi,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/081-389-744-720-040,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;A61K31/425;;C07D277/20;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
213,FI,A0,FI 904413 A0,086-599-910-573-996,1990-09-07,1990,FI 904413 A,1990-09-07,US 8800745 W,1988-03-08,Menetelmä terapeuttisesti käyttökelpoisten tiatsolidiinidionijohdannaisten valmistamiseksi,,PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/086-599-910-573-996,Patent Application,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;C07D277/14;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
214,FI,C,FI 92696 C,099-150-381-528-576,1994-12-27,1994,FI 904413 A,1990-09-07,US 8800745 W,1988-03-08,Menetelmä terapeuttisesti käyttökelpoisten tiatsolidiinidionijohdannaisten valmistamiseksi,,PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/099-150-381-528-576,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;C07D277/14;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
215,CA,A1,CA 2029703 A1,111-567-428-374-524,1991-05-14,1991,CA 2029703 A,1990-11-09,US 8905222 W,1989-11-13,OXAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID A;;DOW ROBERT L;;HULIN BERNARD,,https://lens.org/111-567-428-374-524,Patent Application,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,D42600304    M;;1670233    S;;2600302    S,0,0,,,,EXPIRED
216,KR,B1,KR 910000734 B1,152-429-834-075-951,1991-02-06,1991,KR 890002788 A,1989-03-07,US 8800745 W,1988-03-08,PROCESS FOR PREPARING THIAZOLIDINEDION DERIVATIVES AS HYPOGLYCEMIC AGENTS,,PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/152-429-834-075-951,Granted Patent,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;C07D277/14;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
217,CN,A,CN 1036572 A,182-802-613-850-724,1989-10-25,1989,CN 89101214 A,1989-03-07,US 8800745 W,1988-03-08,HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/182-802-613-850-724,Patent Application,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;C07D277/14;;A61P3/06;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
218,FI,B,FI 93115 B,025-436-023-239-626,1994-11-15,1994,FI 895258 A,1989-11-06,US 8800733 W,1988-03-08,Process for the preparation of hypoglycaemic thiazolidine dione derivatives,"The invention relates to a process for the preparation of hypoglycaemic thiazolidine-2, 4- dione derivatives of the formula I <IMAGE> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S, W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR1, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, alkyl, cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with alkyl, trifluoromethyl, alkoxy, fluoro, chloro or bromo; Z1 is hydrogen or alkyl; R is hydrogen or methyl; and n is 1, 2 or 3.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/025-436-023-239-626,Patent Application,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
219,AT,T1,AT E105558 T1,077-739-563-949-244,1994-05-15,1994,AT 89303086 T,1989-03-29,EP 89303086 A;;US 8800745 W,1988-03-08,THIAZOLIDIN-DERIVATE ALS HYPOGLYKAEMISCHES MITTEL.,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/077-739-563-949-244,Granted Patent,no,0,0,3,38,0,,A61K31/425;;A61K31/44;;C07D277/20;;C07D277/34;;C07D417/12;;C07D417/14,,0,0,,,,DISCONTINUED
220,US,A1,US 2008/0282595 A1,088-181-205-467-72X,2008-11-20,2008,US 74671107 A,2007-05-10,US 74671107 A,2007-05-10,Device for Recording and Displaying Data from the Firing of Small-Arms,"A device for recording and displaying data from the firing cycle of small-arms that senses when a shot has been fired from a weapon using its acceleration, acoustic noise, or RF emissions; measures the interval between shots so that the firing rate may be determined; measures the time at which each shot has been fired; measures the number of rounds fired and deducts that number from a predetermined total thus displaying the remaining number of rounds contained within the weapon's magazine in real time to the operator; stores any combination of firing rate, firing intervals and time data for subsequent analysis and has an electrical interface to transfer data from the device to a computer or other data collection device.",LEITNER WISE DEFENSE INC,CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW,LEITNER-WISE DEFENSE INC (2007-05-10),https://lens.org/088-181-205-467-72X,Patent Application,yes,9,43,1,7,0,F41A17/06;;F41A19/01;;F41A19/01;;F41A17/06,F41A9/53,42/1.01,0,0,,,,DISCONTINUED
221,FR,A1,FR 2561921 A1,161-051-365-776-53X,1985-10-04,1985,FR 8506171 A,1985-04-23,FR 8506171 A;;US 77135977 A;;US 79044277 A,1977-02-23,Tissue for a cardiovascular prosthesis,"Tissue for a cardiovascular prosthesis. It comprises threads constituted by multiple filaments of a polymer material, which are woven and extend in two directions, having a large number of open interstitial spaces, which are of 20 to 40 microns, evenly distributed over the entire tissue, the elongation characteristic of the tissue having a region of easy elongation up to at least 10% in at least one of the said directions. During its production, the tissue is subjected to several operations of shrinkage by compression and of curling, intended to give it an anisotropic elastic flexibility approaching the mechanical characteristics of a natural tissue. The threads comprise curls situated in planes parallel to the tissue, and they spread out in the interstices of the woven material so as to make spaces promoting the growth of natural tissue. Applications: cardiovascular prostheses. <IMAGE>",DAVIS ROBERT,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN,,https://lens.org/161-051-365-776-53X,Patent Application,no,3,0,2,29,0,A61F2/2418;;A61F2/2412;;B21F45/008,A61F2/24,,0,0,,,,EXPIRED
222,NZ,A,NZ 228249 A,006-783-568-240-894,1990-05-28,1990,NZ 22824989 A,1989-03-07,US 8800733 W,1988-03-08,"SUBSTITUTED THIAZOLIDINE-2,4-DIONES AND PHARMACEUTICAL COMPOSITIONS","Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/006-783-568-240-894,Patent Application,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;C07D277/20;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,PENDING
223,EP,A3,EP 0428312 A3,052-763-632-729-484,1991-10-23,1991,EP 90312116 A,1990-11-06,US 8905222 W,1989-11-13,OXAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"Compounds of the formulae
   where R is cycloalkyl or aryl; R₁ is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.  ",PFIZER INC.,"CLARK, DAVID ALAN;;HULIN, BERNARD;;DOW, ROBERT LEE",,https://lens.org/052-763-632-729-484,Search Report,yes,5,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,1,1,035-427-547-208-191,10.1248/cpb.30.3563;;7160011,"CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 30, no. 10, October 1982, pages 3563-3573, Tokyo, JP; T. SOHDA et al.: ""Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds""",EXPIRED
224,IE,A1,IE 904057 A1,069-240-023-463-996,1991-05-22,1991,IE 405790 A,1990-11-12,US 8905222 W,1989-11-13,Oxazolidinedione hypoglycemic agents,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;DOW ROBERT LEE;;HULIN BERNARD,,https://lens.org/069-240-023-463-996,Unknown,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;C07D277/24;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
225,HU,A,HU T54680 A,083-038-237-449-610,1991-03-28,1991,HU 218188 A,1988-03-08,US 8800745 W,1988-03-08,PROCESS FOR PRODUCING THIAZOLIDINE-DION DERIVATIVES OF BLOOD-SUGAR-LEVEL DIMINISHING ACTIVITY,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/083-038-237-449-610,Unknown,no,0,0,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/14;;A61P3/08;;C07D263/32;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
226,KR,B1,KR 910000723 B1,115-859-680-561-17X,1991-01-31,1991,KR 890002787 A,1989-03-07,US 8800733 W,1988-03-08,HYPOGLYCEMIC THIAZOLIDINEDION DERIVATIVES,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HULIN BERNARD,,https://lens.org/115-859-680-561-17X,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;C07D277/20;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
227,AU,B2,AU 593754 B2,117-896-134-320-796,1990-02-15,1990,AU 1989/031078 A,1989-03-07,US 8800733 W,1988-03-08,HYPOGLYCEMIC THIAZOLIDINEDIONE DERIVATIVES,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE;;CLARK DAVID ALAN,,https://lens.org/117-896-134-320-796,Granted Patent,no,2,2,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,C07D277/20;;A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
228,EP,A1,EP 0389699 A1,119-596-469-903-019,1990-10-03,1990,EP 89303086 A,1989-03-29,US 8800745 W,1988-03-08,Thiazolidinedione derivatives as hypoglycemic agents.,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula
   wherein the dotted line represents a bond or no bond; 
V is -CH=CH-, -N=CH-, -CH=N-, S, O or NR; 
W is S, SO, SO₂, SO₂NR¹, NR¹SO₂, CONR¹ or NR¹CO; 
X is S, O, NR², -CH=N- or -N=CH; 
Y is CH or N; 
Z is hydrogen, (C₁-C₇)alkyl, (C₃-C₇)cycloalkyl, phenyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C₁-C₃)alkyl, trifluoromethyl, (C₁-C₃)alkoxy, fluoro, chloro or bromo; 
Z¹ is hydrogen or (C₁-C₃)alkyl; 
R, R¹ and R² are each independently hydrogen or (C₁-C₄); and 
n is 1, 2 or 3; 
a pharmaceutically acceptable cationic salt thereof; or 
a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.  ",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/119-596-469-903-019,Patent Application,yes,2,15,34,38,0,C07D263/44;;C07D417/12;;A61P3/06;;A61P3/08;;C07D417/14,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D263/32;;C07D277/14;;C07D263/34;;C07D263/44;;C07D277/24;;C07D417/12;;C07D417/14,,1,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 30, no. 10, October 1982, pages 3580-3600, Tokyo, JP; T. SOHDA et al.: ""Studies on antidiabetic agents. II.1) Synthesis of 5-[4-(1-methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives""",EXPIRED
229,US,A,US 5674667 A,118-573-930-278-090,1997-10-07,1997,US 66919296 A,1996-06-24,GB 9513114 A,1995-06-28,Photographic element containing pyrroloylacetamide yellow coupler,"The present invention provides a photographic element comprising a silver halide emulsion layer having associated therewith a dye-forming coupler of formula (I): ##STR1## wherein X is H or a coupling-off group, R and R.sup.1 are independently selected from H and substituent groups; Y and Z are independently selected from H and alkyl, aryl or heteroaryl groups; provided that Y and Z taken together with the nitrogen atom may form a 5-10 membered heterocyclic ring group which may contain one or more further heteroatoms selected from N, O and S.",EASTMAN KODAK CO,CLARK BERNARD ARTHUR;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,EASTMAN KODAK COMPANY (1996-07-25),https://lens.org/118-573-930-278-090,Granted Patent,yes,1,16,6,6,0,C07D207/337;;G03C7/36;;G03C2200/33;;C07D207/337;;G03C7/36;;G03C2200/33,C07D207/32;;C07D207/337;;G03C7/36,430/388;;430/389;;430/556;;430/557,0,0,,,,EXPIRED
230,PH,A,PH 26572 A,157-902-199-363-569,1992-08-19,1992,PH 38301 A,1989-03-08,US 8800733 W,1988-03-08,Hypoglycemic thiazolidine-dione derivatives,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HULIN BERNARD,,https://lens.org/157-902-199-363-569,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
231,GR,T3,GR 3015041 T3,107-963-197-197-996,1995-05-31,1995,GR 950400273 T,1995-02-09,US 8905222 W,1989-11-13,Oxazolidinedione hypoglycemic agents.,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;DOW ROBERT LEE,,https://lens.org/107-963-197-197-996,Granted Patent,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
232,ES,T3,ES 2053977 T3,197-423-899-304-319,1994-08-01,1994,ES 89302017 T,1989-03-01,US 8800733 W,1988-03-08,DERIVADOS HIPOGLICEMICOS DE TIAZOLIDINADIONA.,"Hypoglycemic thiazolidine-2,4-dione derivatives <CHEM> wherein the dotted line represents a bond or no bond; V is -CH=CH-, -N=CH-, -CH=N- or S; W is CH2, CHOH, CO, C=NOR or -CH=CH-; X is S, O, NR<1>, -CH=N- or -N=CH-; Y is CH or N; Z is hydrogen, (C1-C7)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, pyridyl, furyl, thienyl or phenyl mono- or disubstituted with the same or different groups which are (C1-C3)alkyl, trifluoromethyl, (C1-C3)alkoxy, fluoro, chloro or bromo; Z<1> is hydrogen or (C1-C3)alkyl; R is hydrogen or methyl; and n is 1, 2 or 3; a pharmaceutically acceptable cationic salt thereof; or a pharmaceutically acceptable acid addition salt thereof when the compound contains a basic nitrogen.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE,,https://lens.org/197-423-899-304-319,Granted Patent,no,0,0,42,44,0,C07D277/34;;C07D417/10;;C07D417/14;;C07F7/1804;;A61P3/06;;A61P3/08;;A61P7/00;;C07D417/14,A61K31/42;;A61K31/421;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/20;;A61P3/08;;A61P7/00;;C07D263/32;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/14;;C07F7/18,,0,0,,,,EXPIRED
233,FI,A,FI 922141 A,184-858-543-537-446,1992-05-12,1992,FI 922141 A,1992-05-12,US 8905222 W,1989-11-13,Analogiamenetelmä uusien hypoglykeemisten oksatsolidiinidionien valmistamiseksi,"Compounds of the formulae <CHEM> where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.",PFIZER,CLARK DAVID ALAN;;DOW ROBERT LEE;;HULIN BERNARD,,https://lens.org/184-858-543-537-446,Patent Application,no,0,0,22,22,0,C07D263/44;;C07D263/56;;C07D413/14;;C07D417/12;;C07D417/14;;A61P3/06;;A61P3/08,C07D277/24;;A61K31/42;;A61K31/421;;A61K31/423;;A61K31/425;;A61K31/426;;A61P3/06;;A61P3/08;;C07D263/44;;C07D263/56;;C07D413/10;;C07D413/12;;C07D413/14;;C07D417/10;;C07D417/12;;C07D417/14,,0,0,,,,EXPIRED
234,US,A,US 5284935 A,024-019-484-380-311,1994-02-08,1994,US 63584090 A,1990-12-28,US 63584090 A;;US 21059488 A;;US 36775189 A;;US 57608490 A,1988-06-23,MHC-mediated toxic conjugates useful in ameliorating autoimmunity,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X--MHC--peptide or MHc--peptide--X wherein X represents a functional moiety selected from a toxin and a labeling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen;--represents a covalent bond or a linker bound to X and MHC or to X and peptide by covalent bonds; and--represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to target helper T-cells which are specifically immunoreactive with autoantigens.",ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH L BERNARD,ANERGEN INC. A DELAWARE CORPORATION (1998-06-30);;ANERGEN INC. A CORP OF CALIFORNIA (1991-07-23),https://lens.org/024-019-484-380-311,Granted Patent,yes,12,83,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,A61K35/12;;A61K35/28;;A61K39/00;;G01N33/564;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,530/403;;530/395;;530/806;;530/807;;530/868;;424/88,66,59,016-820-517-785-643;;064-376-665-222-650;;107-925-387-406-499;;039-374-901-602-968;;034-275-533-046-869;;060-105-097-350-717;;060-105-097-350-717;;053-932-577-346-798;;080-116-588-558-925;;041-066-683-986-277;;020-833-428-096-595;;021-354-068-638-52X;;021-720-457-509-673;;098-548-262-072-602;;119-098-412-359-014;;105-728-654-193-796;;151-909-994-962-302;;000-877-662-644-595;;031-498-695-386-777;;150-992-421-090-985;;044-219-977-949-424;;053-919-000-700-346;;024-957-936-929-004;;008-338-552-683-575;;006-246-100-575-580;;068-328-739-510-663;;076-183-945-466-427;;124-265-670-692-625;;001-809-294-160-846;;090-471-813-411-890;;028-483-482-274-317;;019-055-424-431-057;;096-808-659-810-496;;063-898-442-301-724;;045-722-267-072-669;;067-423-867-031-236;;186-072-679-623-966;;018-725-676-477-557;;106-021-817-946-64X;;034-144-538-771-410;;000-108-780-023-355;;004-446-132-457-064;;045-641-100-690-823;;081-916-336-734-306;;091-964-810-489-790;;005-060-637-433-679;;066-352-300-567-046;;023-077-406-743-876;;017-931-052-403-69X;;025-896-082-408-415;;026-409-307-851-000;;030-532-334-370-93X;;028-043-821-964-859;;036-979-322-661-093;;098-590-609-369-691;;031-989-718-683-43X;;078-039-663-716-551;;158-884-679-706-17X;;063-898-442-301-724,pmc2185690;;10.1084/jem.150.5.1084;;91653;;2457615;;10.4049/jimmunol.141.5.1451;;2823150;;10.1038/330256a0;;3930971;;10.1038/317425a0;;3876513;;10.1038/317359a0;;10.1038/329506a0;;3309677;;10.1038/329506a0;;3309677;;10.1126/science.2435001;;2435001;;3484557;;10.1126/science.3484557;;10.4049/jimmunol.133.5.2549;;6332854;;10.1146/annurev.immunol.5.1.477;;2439104;;10.1146/annurev.iy.05.040187.002401;;10.1126/science.3313727;;3313727;;10.1002/eji.1830100410;;6967410;;6139673;;2578165;;10.1038/329482a0;;3498902;;10.1016/0161-5890(83)90137-2;;6581382;;10.1126/science.2437650;;2437650;;6334313;;10.1073/pnas.81.23.7564;;pmc392187;;2410926;;10.1073/pnas.82.16.5480;;pmc391146;;3297108;;10.1146/annurev.iy.05.040187.002333;;10.1126/science.2433769;;2433769;;10.1021/bi00342a003;;3002421;;3257303;;10.1126/science.3257303;;10.1038/332840a0;;3258650;;10.1016/0161-5890(83)90147-5;;6197631;;3536124;;10.1016/0092-8674(86)90506-4;;10.1084/jem.164.5.1490;;pmc2188449;;2430042;;2966437;;10.1126/science.2966437;;10.1073/pnas.73.7.2481;;781677;;pmc430616;;3297338;;3317828;;10.1126/science.3317828;;10.1007/bf02918107;;3114395;;pmc553925;;10.1002/j.1460-2075.1987.tb02360.x;;2440673;;2419437;;2420472;;10.1016/0092-8674(86)90019-x;;10.1097/00007890-197310000-00005;;4200798;;1141219;;10.1016/s0021-9258(19)41332-x;;2824477;;10.1016/s0021-9258(18)47699-5;;pmc2187974;;2415664;;10.1084/jem.162.6.2107;;10.1038/317355a0;;2413363;;3004990;;10.1002/eji.1830160107;;2457547;;pmc1385051;;pmc2188516;;3029267;;10.1084/jem.165.2.302;;6210242;;10.1111/j.1600-065x.1984.tb01110.x;;6189936;;pmc2187023;;10.1084/jem.157.5.1434;;10.1038/308072a0;;6199675;;2420700;;pmc1453820;;10.1002/eji.1830171118;;2960547;;pmc1385193;;2968304;;10.1038/332161a0;;3279318;;85683;;pmc2184831;;10.1084/jem.149.3.758;;2953809;;3035012;;2450125;;10.1038/303625a0;;6343888;;10.1002/eji.1830150318;;3872218;;6170681;;pmc553925;;10.1002/j.1460-2075.1987.tb02360.x;;2440673,"H. Binz et al., J. Exp. Med. (Nov. 1979) vol. 150:1084 1097. Binding of purified, soluble MHC polypeptide chains into isolated TCR s .;;J. McCluskey et al., J. Immunology 141:1451 55 (Sep. 1988), T cell activation by purified soluble class I MHC molecules requirement for polyvalency .;;Doyle, C. et al. Nov. 1987 Nature 330:256 Interaction between CD4 . . .;;Golding, H. et al. Oct. 1985 Nature 317:425 T cell recognition . . .;;W. E. Paul (ed) Fund. Immunol. 1989 Raven Press pp. 69 73, 506 507.;;Babbitt, B. P. et al. (1985) Nature 317: 359 361.;;Bjorkman, P. J. et al. (1987) Nature 329: 506 512.;;Bjorkman, P. J. et al. (1987) Nature 329: 512 518.;;Buus, S. et al. (1987) Science 235: 1353 1358.;;Diener, E. et al. (1986) Science 231: 148 150.;;Killen, J. A. et al. (1984) J. Immunol. 133: 2549 2553.;;Livingstone, A. M. et al. (1987) Ann. Rev. Immunol. 5: 477 501.;;Marx, J. L. (1987) Science 238: 613 614.;;Puri, J. et al. (1980) Eur. J. Immunol. 10: 273 281.;;Rennie, D. P. et al. (1983) The Lancet (Dec. 10) 1338 1340.;;Sterz, R. K. M. et al. (1985) J. Immunol. 134: 841 846.;;Townsend, A. et al. (1987) Nature 329: 482 483.;;Turkewitz, A. P. et al. (1983) Molec. Immunol. 20: 1139 1147.;;Unanue, E. R. et al. (1987) Science 236: 551 557.;;Watts, T. H. et al. (1984) Proc. Natl. Acad. Sci. USA 81: 7564 7568.;;Watts, T. H. et al. (1985) Proc. Natl. Acad. Sci. USA 82: 5480 5484.;;Watts, T. H. et al. (1987) Ann. Rev. Immunol. 5: 461 475.;;Clemetson, K. J. et al. (1986) In Membrane proteins: A Laboratory Manual , Ed. Azzi, A. et al., pp. 57 64.;;Cooperman (1979) In Ribosomes Structure, Function, and Genetics . Ed. Chambliss et al. University Park Press, Baltimore Md. pp. 531 554.;;Estess, P. et al. (1986) In Regulation of immune gene expression , Ed. Feldman, M. et al., Humana Press, pp. 3 19.;;Guillet et al. (1987) Science 235: 865 870.;;Hall et al. (1985) Biochemistry 24: 5702 5711.;;Harcourt, G. et al. (1987) Immunol. Today 8 (11): (news and features section).;;Hixson, J. R. Medical Tribune (Jan. 24, 1985) pp. 4 5.;;Liu, M. A. et al. (1988) Science 239: 395 398.;;Marrack, P. et al. (1988) Nature 332: 840 842.;;Nakanishi, M. et al. (1983) Molec. Immunol. 20: 1227 1231.;;Pastan, I. et al. (1986) Cell 47: 641 648.;;Sekaly, R. P. et al. (1986) J. Exp. Med. 164: 1490 1504.;;Shizuru, J. A. et al. (1988) Science 240: 659 662.;;Springer, T. A. et al. (1976) Proc. Natl. Acad. Sci. USA 73: 2481 2485.;;Sriram, S. et al. (1987) Concepts Immunopathol. 4: 275 286.;;Vitetta, E. S. et al. (1987) Science 238: 1098 1104.;;Watts, T. H. et al. (1988) In Processing and presentation of antigens , Academic Pres, pp. 143 154.;;Margulies, D. H. et al. (1987) Immunol. Res. 6: 101 116.;;Lamb et al. (1987) EMBO J. 6: 1245 1249.;;Berkower et al. (1986) J. Immunol. 136: 2498 2502.;;Townsend et al. (1986) Cell 44: 959 968.;;Sanderson et al. (1973) Transplantation 16: 304 312.;;Turner et al. (1976) J. Biol. Chem. 250: 4512 4519.;;Gorga et al. (1987) J. Biol. Chem. 262: 16087 16094.;;Zamvil et al. (1985) J. Exp. Med. 162: 2107 2124.;;Zamvil et al. (1985) Nature 317: 355 358.;;Ceredig, R. et al. (1986) Eur. J. Immunol. 16: 30 34.;;Essery, G. et al. (1988) Immunology 64: 413 417.;;Jenkins, M. K. et al. 91987) J. Exp. Med. 165: 302 319.;;Klein, J. (1983) Immunol. Reviews 81: 177 202.;;Lamb, J. R. (1983) J. Exp. Med. 157: 1434 1447.;;Lamb, J. R. (1984) Nature 308: 72 74.;;Lamb, J. R. et al. (1986) Immunology 57: 331 335.;;Lamb, J. R. et al. (1987) Eur. J. Immunol. 17: 1641 1644.;;Larche, M. et al. (1988) Immunology 64: 101 105.;;Madsen, J. C. et al. (1988) Nature 332: 161 164.;;Miller, S. D. et al. (1979) J. Exp. Med. 149: 758 773.;;Nau, G. J. et al. (1987) J. Immunol. 139: 114 122.;;Quill, H. et al. (1987) J. Immunol. 138: 3704 3712.;;Suzuki, G. et al. (1988) J. Immunol. 140: 1359 1465.;;Zanders, E. D. et al. (1983) Nature 303: 625 627.;;Zanders, E. D. et al. (1985) Eur. J. Immunol. 15: 302 305.;;Germain, R. N. (1981) J. Immunol. 127: 1964 1966.;;Lamb, J. R. (1987) EMBO J. 6: 1245 1249.",EXPIRED
235,US,A,US 5130297 A,025-530-704-848-997,1992-07-14,1992,US 57608490 A,1990-08-30,US 21059488 A,1988-06-23,Conjugates useful in ameliorating autoimmunity MHC-II-peptide,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X--MHC--peptide or MHC--peptide--X wherein X represents a functional moiety selected from a toxin and a labeling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen; -- represents a covalent bond or a linker bound to X and MHC or to X and peptide by covalent bonds; and -- represents a covalent bond, to noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to target helper T-cells which are specifically immunoreactive with autoantigens.",ANERGEN INC,SHARMA SOMESH D;;LERCH L BERNARD;;CLARK BRIAN R,ANERGEN INC (1991-07-23);;ANERGEN INC. A DELAWARE CORPORATION (1998-06-30),https://lens.org/025-530-704-848-997,Granted Patent,yes,4,90,1,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;C07K2319/75;;Y10S530/838;;A61K51/08;;A61K47/6425;;A61K47/646;;C07K14/78;;A61K2039/605;;A61K51/1234;;A61K2123/00;;A61K39/0008;;C07K2319/00;;C07K2319/75;;Y10S530/838;;A61K51/08;;A61K47/6425;;A61K47/646,A61K39/00;;A61K47/48;;A61K51/12;;C07K14/78,514/8;;514/825;;514/903;;530/395;;530/403;;530/838,53,44,024-957-936-929-004;;055-979-539-161-603;;038-217-418-320-99X;;098-548-262-072-602;;080-116-588-558-925;;119-098-412-359-014;;041-066-683-986-277;;001-809-294-160-846;;031-498-695-386-777;;030-435-386-518-970;;028-483-482-274-317;;151-909-994-962-302;;124-265-670-692-625;;021-720-457-509-673;;021-354-068-638-52X;;006-246-100-575-580;;105-728-654-193-796;;090-471-813-411-890;;060-105-097-350-717;;060-105-097-350-717;;053-919-000-700-346;;068-328-739-510-663;;034-275-533-046-869;;150-992-421-090-985;;000-877-662-644-595;;053-932-577-346-798;;019-055-424-431-057;;076-183-945-466-427;;004-446-132-457-064;;045-641-100-690-823;;081-916-336-734-306;;091-964-810-489-790;;005-060-637-433-679;;066-352-300-567-046;;023-077-406-743-876;;017-931-052-403-69X;;025-896-082-408-415;;026-409-307-851-000;;030-532-334-370-93X;;028-043-821-964-859;;036-979-322-661-093;;031-989-718-683-43X;;078-039-663-716-551;;158-884-679-706-17X,10.1021/bi00342a003;;3002421;;2478291;;10.1016/0092-8674(89)90287-0;;10.1016/s0021-9258(19)38573-4;;2358457;;6139673;;3484557;;10.1126/science.3484557;;2578165;;10.4049/jimmunol.133.5.2549;;6332854;;2966437;;10.1126/science.2966437;;6334313;;10.1073/pnas.81.23.7564;;pmc392187;;10.1016/b978-0-12-551855-0.50106-6;;3297338;;10.1016/0161-5890(83)90137-2;;6581382;;10.1084/jem.164.5.1490;;pmc2188449;;2430042;;10.1002/eji.1830100410;;6967410;;10.1126/science.3313727;;3313727;;10.1038/332840a0;;3258650;;10.1038/329482a0;;3498902;;10.1073/pnas.73.7.2481;;781677;;pmc430616;;10.1038/329506a0;;3309677;;10.1038/329506a0;;3309677;;10.1126/science.2433769;;2433769;;10.1016/0161-5890(83)90147-5;;6197631;;3876513;;10.1038/317359a0;;2410926;;10.1073/pnas.82.16.5480;;pmc391146;;10.1126/science.2437650;;2437650;;10.1126/science.2435001;;2435001;;3317828;;10.1126/science.3317828;;3536124;;10.1016/0092-8674(86)90506-4;;3004990;;10.1002/eji.1830160107;;2457547;;pmc1385051;;pmc2188516;;3029267;;10.1084/jem.165.2.302;;6210242;;10.1111/j.1600-065x.1984.tb01110.x;;6189936;;pmc2187023;;10.1084/jem.157.5.1434;;10.1038/308072a0;;6199675;;2420700;;pmc1453820;;10.1002/eji.1830171118;;2960547;;pmc1385193;;2968304;;10.1038/332161a0;;3279318;;85683;;pmc2184831;;10.1084/jem.149.3.758;;2953809;;3035012;;10.1038/303625a0;;6343888;;10.1002/eji.1830150318;;3872218;;6170681,"Fundamental Immunology, W. E. Paul (ed), 1989, pp. 69 73.;;Cooperman, in Ribosomes (University Park Press, Baltimore), pp. 531 554 (1980).;;Hall et al., Biochemistry 24:5702 5711 (1985).;;Wraith et al., Cell 59:247 255 (1989).;;Luescher et al., J. Biol. Chem. 265:11177 11184 (1990).;;Rennie et al., Lancet (10 Dec. 1983) pp. 1338 1340.;;Diener et al., Science (1986) 231:148 150.;;Sterz et al., J. Immunol. (1985) 134:841 846.;;Killen et al., J. Immunol. (1984) 133:2549 2553.;;Hixson Med. Tribune (28 Jan. 1985) pp. 4 5.;;Liu et al., Science (1989) 239:395 397.;;Shizuru et al., Science (1988) 240:659 662.;;Watts et al., Proc. Natl. Acad. Sci. USA (1984) 81:7564 7568.;;Clemetson et al., Membrane Proteins: A Laboratory Manual (1986) A. Azzi et al., editors, pp. 57 64.;;Harcourt et al., Immunol. Today (1987) 8(11):(news and features section).;;Watts et al., Processing and Presentation of Antigens (1988) Academic Press, New York, pp. 143 155.;;Sriram et al., Concepts Immunolpathol. (1987) 4:275 286.;;Turkewitz et al., Molecular Immunol. (1983) 20(11):1139 1147.;;Sekaly et al., J. Exp. Med. (1986) 164:1490 1504.;;Puri et al., Eur. J. Immunol. (1980) 10:273 281.;;Marx et al., Science (1987) 238:613 614.;;Marrack et al., Nature (1988) 332:840 842.;;Townsend et al., Nature (1987) 329:482 483.;;Springer et al., Proc. Natl. Acad. Sci. USA (1976) 73(7):2481 2485.;;Bjorkman et al., Nature (1987) 329:512 518.;;Bjorkman et al., Nature (1987) 329:504 512.;;Guillet et al., Science (1987) 235:865 870.;;Nakanishi et al., Mol. Immunol. (1983) 20(11):1227 1231.;;Babbitt et al., Nature (1985) 317:359 361.;;Watts et al., Proc. Natl. Acad. Sci. USA (1985) 82:5480 5484.;;Unanue et al., Science (1987) 236:551 557.;;Buus et al., Science (1987) 235:1353 1358.;;Vitetta et al., Science (1987) 238:1098 1104.;;Pastan et al., Cell (1986) 47:641 648.;;Estess et al., Regulation of Immune Gene Expression Feldman et al., editors, The Humana Press, Inc., (1985, pp. 3 19).;;D. H. Margules, et al. Immunol. Res. G:101 116 (1987), Engineering Soluble MHC molecules: how & why.;;Ceredig et al., High Antigen Concentration . . . , Eur. J. Immunol., 1986, 16:30 34.;;Essery et al., Interleukin 2 Can Prevent and Reverse . . . , Immunology, 1988, 64:413 417.;;Jenkins et al., Antigen Presentation by Chemically . . . , J. Exper. Med., 1987, 165:302 319.;;Klein, What Causes Immunological Nonresponsiveness , Immun. Reviews, 1984, 81.;;Lamb et al., Induction of Tolerance in Influenza . . . , J. Exp. Med., 1983, 157:1434 1447.;;Lamb et al., Essential Requirement for Major Histocompatibility . . . , Nature, 1984, 308.;;Lamb et al., Influence of Antigen Structure . . . , Immunology, 1986, 57:331 335.;;Lamb et al., Antigen Specific T Cell Unresponsiveness . . . , Eur. J. Immunol., 1987, 17:1641 1644.;;Larche et al., A Novel T Lymphocyte Molecule . . . , Immunol., 1988 64:101 105.;;Madsen et al., Immunological Unresponsiveness . . . , Nature, 1988, 332.;;Miller et al., The Induction of Cell Mediated . . . , J. Exp. Med., 1979, 149:758 773.;;Nau et al., Inhibition of IL 2 Driven Proliferation . . . , J. Immun., 1987, 139:114 122.;;Quill et al., Stimulation of Normal Inducer T Cell Clones . . . , J. Immun., 1987, 138:3704 3712.;;Suzuki et al., Antigen Induced Suppression . . . , J. Immun., 1988.;;Zanders et al., Tolerance of T Cell Clones . . . , Nature, 1983, 303.;;Zanders et al., Biochemical Events Initiated by Exposure . . . , Eur. J. Immunol., 1985, 13:302 305.;;Germain, Accessory Cell Stimulation . . . , J. Immun., 1981, 127.",EXPIRED
236,TW,B,TW I294457 B,029-475-182-848-063,2008-03-11,2008,TW 91137732 A,2002-12-27,US 3786302 A,2002-01-02,Thermal barriers with solid/solid phase change materials,,OUTLAST TECHNOLOGIES INC,CLARK DUSTIN L;;MAGILL MONTE C;;PERRY BERNARD T,,https://lens.org/029-475-182-848-063,Granted Patent,no,0,0,5,5,0,E04B1/7662;;E04B1/78;;F25D2201/122;;Y10T428/1352;;Y02B40/00;;Y10T428/1352;;E04B1/78;;E04B1/7662;;F25D2201/122;;Y02B40/00,B32B7/02;;E04B1/76;;E04B1/78,,0,0,,,,EXPIRED
237,WO,A1,WO 1991/018321 A1,136-462-793-836-762,1991-11-28,1991,EP 9100898 W,1991-05-11,GB 9010967 A,1990-05-16,HYDROPHILIC COLLOID COMPOSITION FOR A PHOTOGRAPHIC MATERIAL,A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula (I): CF3(CF2)nCH2O(glycidyl)mH wherein n is an integer from 4 to 7; and m is an integer from 6 to 45.,KODAK LTD;;EASTMAN KODAK CO,PITT ALAN ROBERT;;CLARK BERNARD ARTHUR;;PADDAY JOHN FRANK,,https://lens.org/136-462-793-836-762,Patent Application,yes,6,0,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,C09D7/12;;C09D189/00;;G03C1/38;;G03C1/85,,1,0,,,"J.L.MOILLET: ""WATERPROOFING AND WATER-REPELLANCY"" 1963, ELSEVIER PUBLISHING CO., LONDON see page 142, lines 1 - 2",PATENTED
238,AU,A,AU 1997/013302 A,149-852-054-372-04X,1997-06-27,1997,AU 1997/013302 A,1996-12-09,US 56974495 A;;US 9619479 W,1995-12-08,Apparatus for connecting shoelace eyelets with a plastic fastener,,AVERY DENNISON CORP,GRENDOL CLARK L;;BERNARD ROBERT;;KORDIS KEVIN;;STERGIOU CHRIS,,https://lens.org/149-852-054-372-04X,Patent Application,no,0,0,3,3,0,A43D98/00;;A43D98/00;;B65C7/008;;B65C7/008;;Y10T24/4691;;Y10T24/4691,A43D98/00;;B65C7/00,,0,0,,,,PENDING
239,DK,T3,DK 0527883 T3,164-702-147-664-279,1994-04-11,1994,DK 91909538 T,1991-05-11,GB 9010967 A,1990-05-16,Hydrofil kolloidsammensætning til et fotografisk materiale,"A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula CF3(CF2)nCH2O(glycidyl)mH wherein n is an integer from 4 to 7; and, m is an integer from 6 to 45.",EASTMAN KODAK CO;;KODAK LTD,PITT ALAN ROBERT;;CLARK BERNARD ARTHUR;;PADDAY JOHN FRANK,,https://lens.org/164-702-147-664-279,Granted Patent,no,0,0,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,C09D7/12;;C09D189/00;;G03C1/38;;G03C1/85,,0,0,,,,EXPIRED
240,US,A,US 5366857 A,045-735-939-751-211,1994-11-22,1994,US 95271992 A,1992-11-13,EP 9100898 W;;GB 9010967 A,1990-05-16,Hydrophilic colloid composition for a photographic material,"A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula CF.sub.3 (CF.sub.2).sub.n CH.sub.2 O(glycidyl).sub.m H wherein n is an integer from 4 to 7; and, m is an integer from 6 to 45.",EASTMAN KODAK CO,PITT ALAN R;;CLARK BERNARD A;;PADDAY JOHN F,EASTMAN KODAK COMPANY (1992-10-28),https://lens.org/045-735-939-751-211,Granted Patent,yes,6,2,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,C09D7/12;;G03C1/85;;C09D189/00;;G03C1/38,430/631;;430/539;;430/637;;430/642;;430/643;;252/351,1,0,,,"Waterproofing and Water repellancy , J. L. Moillet, 1963, Elsevier Publishing Co., London, p. 142.",EXPIRED
241,EP,B1,EP 0630255 B1,033-551-674-164-49X,2002-12-18,2002,EP 92911380 A,1992-04-23,US 69084091 A;;US 9203391 W;;US 86929392 A,1991-04-23,MHC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY,,ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH BERNARD L,"COULTER PHARMACEUTICAL, INC. (2003-05-30)",https://lens.org/033-551-674-164-49X,Granted Patent,yes,4,2,6,32,0,,A61K38/00;;A61K39/00;;A61K39/385;;A61P21/04;;A61P25/00;;A61P37/02;;A61P37/06;;A61P37/08;;C07K7/04;;C07K14/47;;C07K14/74;;C07K19/00,,8,0,,,"PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol.87, no.4, 1990 pages 1337 - 1341 KUMAR V., ET AL.;;Immunol. Res., Volume 6, issued 1987, MARGULIES et al., ""Engineering Soluble Molecules: Why and How"", pages 101-116, see entire article.;;J. Exp. Med., Volume 150, issued November 1979, BINZ et al., ""Binding of Purified Major Histocompatability Complex Polypeptide Chains onto Isolated T-cell Receptors"", pages 1084-1097, see entire article.;;Eur. J. Immunol., Volume 19, 1989, VILLAR et al., ""Detection of Soluble Class I Molecules (non HLA-A or HLA-B) in Serum Spleen Membranes and Lympocytes in Culture"", pages 1835-1839, see entire document.;;Curr. Opinion in Immunology, Volume 2, issued 1989, ROTHBARD, ""Major Histocompatibility Complex Peptide Interactions"", pages 99-105.;;Immunol. Reviews, No. 81, issued 1984, KLEIN, ""What Causes Immunological Non Responsiveness?"", pages 177-202, see entire article.;;Current Opinion in Immunology, Volume 2, issued 1989, J.B. ROTHBARD, ""Antigen Recognition"", pages 79-80, see entire document.;;Current Opinion in Immunology, Volume 2, issued 1989, V.C. SCHAD et al., ""T Cell Accessory Molecules Mediating Cell Adhesion and Signal Transduction"", pages 123-128, see entire article.",EXPIRED
242,MX,B,MX 344804 B,134-768-055-343-631,2017-01-06,2017,MX 2014008655 A,2013-01-25,US 201261590943 P;;US 201313748888 A;;US 2013/0023193 W,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE.,"A sacral support for a surgical table, comprising a plate having two spaced- apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO,LABEDZ CHRISTOPHER D;;BELLOWS LANCE CLARK;;MOSS BERNARD J,,https://lens.org/134-768-055-343-631,Granted Patent,no,0,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61G13/12;;A61F5/00,,0,0,,,,ACTIVE
243,MX,A,MX 2014008655 A,133-490-515-222-882,2014-10-24,2014,MX 2014008655 A,2013-01-25,US 201261590943 P;;US 201313748888 A;;US 2013/0023193 W,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE.,"A sacral support for a surgical table, comprising a plate having two spaced- apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO,LABEDZ CHRISTOPHER D;;BELLOWS LANCE CLARK;;MOSS BERNARD J,,https://lens.org/133-490-515-222-882,Patent Application,no,0,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00,,0,0,,,,ACTIVE
244,ES,T3,ES 2062791 T3,158-617-595-598-355,1994-12-16,1994,ES 91909538 T,1991-05-11,GB 9010967 A,1990-05-16,COMPOSICION DE COLOIDE HIDROFILO PARA UN MATERIAL FOTOGRAFICO.,"A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula CF3(CF2)nCH2O(glycidyl)mH wherein n is an integer from 4 to 7; and, m is an integer from 6 to 45.",EASTMAN KODAK CO,PITT ALAN ROBERT;;CLARK BERNARD ARTHUR;;PADDAY JOHN FRANK,,https://lens.org/158-617-595-598-355,Granted Patent,no,0,0,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,C09D7/12;;C09D189/00;;G03C1/38;;G03C1/85,,0,0,,,,EXPIRED
245,WO,A8,WO 2014/190176 A8,010-920-529-794-117,2016-03-10,2016,US 2014/0039186 W,2014-05-22,US 201313900372 A,2013-05-22,METHOD OF BOREHOLE SEISMIC SURVEYING USING AN OPTICAL FIBER,"A method of detecting seismic waves traveling through a subsurface formation includes lowering a cable into a borehole in the subsurface formation, the cable having at least one optical fiber associated therewith, and causing descent of a remote end of the cable to be arrested. The method further includes feeding a further length of the cable into the borehole such that the cable is slack and in contact with at least part of a wall of the borehole, and using an interrogator coupled to the at least one optical fiber to detect seismic waves traveling through the subsurface formation and into the cable.",SCHLUMBERGER CA LTD;;SCHLUMBERGER SERVICES PETROL;;SCHLUMBERGER HOLDINGS;;SCHLUMBERGER TECHNOLOGY BV;;PRAD RES & DEV LTD;;SCHLUMBERGER TECHNOLOGY CORP,HARTOG ARTHUR H;;FRIGNET BERNARD;;MACKIE DUNCAN;;CLARK MICHAEL,,https://lens.org/010-920-529-794-117,Amended Application,yes,0,0,8,8,0,G01H9/004;;G01V1/20;;G01V2210/1429;;G01H9/004;;G01V1/20;;G01V2210/1429;;G01V1/40;;G01V1/42;;G01V1/44,E21B49/00;;G01V1/40;;G01V1/52,,0,0,,,,PENDING
246,CN,A,CN 1502166 A,010-571-007-777-229,2004-06-02,2004,CN 02808165 A,2002-03-25,US 83663401 A,2001-04-17,Flexible capacitive touch sensor,"A flexible, capacitive touch sensor, and a method of manufacturing a plurality of such touch sensors, are provided. The capacitive touch sensor comprises a thin, flexible, transparent, insulating substrate. A thin, flexible, transparent layer of resistive material is applied to one side of the substrate, and a thin, flexible, transparent, pressure-sensitive layer of adhesive material is applied to the substrate's other side. A releasable sheet may cover this adhesive layer. A plurality of thin, flexible electrodes, electrical leads and conductive areas are applied to the resistive layer. A thin, flexible, transparent layer of protective material protects the touch sensor's active touch area. Compounds may be added to this protective layer to enhance its conductivity and lubricity. A reel-to-reel process for manufacturing a plurality of such capacitive touch sensors also is described.",3M INNOVATIVE PROPERTIES CO,CLARK SCHULZ STEPHEN;;FRANK CHERNEFSKY ANTHONY;;OMAR GEAGHAN BERNARD,,https://lens.org/010-571-007-777-229,Patent Application,no,0,45,17,17,0,G06F3/0443;;G06F3/03;;G06F3/0443,G01B7/00;;G06F3/033;;G06F3/044;;H03K17/96,,0,0,,,,EXPIRED
247,SE,L,SE 0001260 L,085-231-512-624-784,2000-05-26,2000,SE 0001260 A,2000-04-06,US 94458597 A;;US 9820759 W,1997-10-06,Bredbandig effektförstärkare med hög verkningsgrad,,MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB FREDERICK H;;CLARK JAMES ROGER,,https://lens.org/085-231-512-624-784,Abstract,no,0,0,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,,0,0,,,,EXPIRED
248,WO,A8,WO 2014/190176 A8,095-236-677-611-995,2015-12-23,2015,US 2014/0039186 W,2014-05-22,US 201313900372 A,2013-05-22,METHOD OF BOREHOLE SEISMIC SURVEYING USING AN OPTICAL FIBER,"A method of detecting seismic waves traveling through a subsurface formation includes lowering a cable into a borehole in the subsurface formation, the cable having at least one optical fiber associated therewith, and causing descent of a remote end of the cable to be arrested. The method further includes feeding a further length of the cable into the borehole such that the cable is slack and in contact with at least part of a wall of the borehole, and using an interrogator coupled to the at least one optical fiber to detect seismic waves traveling through the subsurface formation and into the cable.",SCHLUMBERGER CA LTD;;SCHLUMBERGER SERVICES PETROL;;SCHLUMBERGER HOLDINGS;;SCHLUMBERGER TECHNOLOGY BV;;PRAD RES & DEV LTD;;SCHLUMBERGER TECHNOLOGY CORP,HARTOG ARTHUR H;;FRIGNET BERNARD;;MACKIE DUNCAN;;CLARK MICHAEL,,https://lens.org/095-236-677-611-995,Amended Application,yes,0,0,8,8,0,G01H9/004;;G01V1/20;;G01V2210/1429;;G01H9/004;;G01V1/20;;G01V2210/1429;;G01V1/40;;G01V1/42;;G01V1/44,E21B49/00;;G01V1/40;;G01V1/52,,0,0,,,,PENDING
249,DE,T2,DE 69604535 T2,175-937-968-147-987,2000-05-11,2000,DE 69604535 T,1996-06-25,GB 9513114 A,1995-06-28,Neue Bildfarbstoff erzeugende Kuppler und photographische Elemente die diese enthalten,,EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,,https://lens.org/175-937-968-147-987,Granted Patent,no,0,0,6,6,0,C07D207/337;;G03C7/36;;G03C2200/33;;C07D207/337;;G03C7/36;;G03C2200/33,C07D207/32;;C07D207/337;;G03C7/36,,0,0,,,,EXPIRED
250,GB,A,GB 1223010 A,195-031-519-576-705,1971-02-17,1971,GB 3506468 A,1968-07-23,GB 3506468 A,1968-07-23,A METHOD OF POURING PREDETERMINED AMOUNTS OF LIQUID BY MEASURED VOLUME,"1,223,010. Discharging liquids by gaseous pressure. MODERN EQUIPMENT CO. July 23, 1968, No.35064/68. Heading F1R. Apparatus for discharging predetermined volumes of molten metal into a mould, comprises a reservoir 10 with an intake spout 15 and a discharge spout 16, a float 25 connected to an electrical circuit sensing the level of liquid in spout 16 and controlling the supply and venting of air or gas under pressure to a chamber 13 to start and stop the discharge of liquid over lip 20 of spout 16. With the control circuit shown, the liquid in spout 16 is first maintained at a set level below lip 20 determined by a signal from low level signal generator 30, float 25 producing a signal from generator 27 which with the signal from generator 30 is fed to amplifiers 28 and 32 and a converter 33 controlling a supply valve 34 and vent valve 35. When discharge is required, circuit 39 is energized to generate a signal which operates switch 29 to change from low level signal 30 to a signal 31 which causes the circuit to maintain a liquid level in spout 16 above lip 20, the height above lip 20 being adjustable to adjust the flowrate. A generator 40 produces a signal to cause an abrupt increase in pressure in chamber 13 to start the discharge. When the liquid rises above the level of lip 20, the signal from float circuit 27 rises above a reference signal from generator 42, which corresponds to the level of lip 20, and, through a voltage-to-frequency converter 43 actuates a counter 44. The counter records the volume discharged from the reservoir, and, when a predetermined volume is reached, operates switch 29 to return to low level signal 30. This causes the vent valve 35 to be opened to stop the discharge, an abrupt stoppage being provided by an error amplifier which detects the difference between low level signal 30 and the level recorded by float circuit 27. Amplifier 45 has a faster response than amplifier 28 and effects a rapid opening of vent valve 35. The vent valve 35 may comprise two valves, one of larger capacity than the other, the larger valve opening at a higher pressure than the other to provide a rapid halt to the discharge. Details of the circuit elements are given, Fig.4 (not shown).",MODERN EQUIPMENT CO,HIBBARD WILLIAM DANIEL;;CLARK JAMES EDWARD;;RAPP BERNARD ROBERT,,https://lens.org/195-031-519-576-705,Granted Patent,no,0,1,1,1,0,B22D39/06;;G05D7/0635,B22D39/06;;G05D7/06,F1R R3A3A         R3A3A;;F1R R3BX1         R3A3A;;F1R R3B10C        R3A3A;;F1R R9E           R3A3A,0,0,,,,EXPIRED
251,WO,A1,WO 2020/198609 A1,198-693-628-789-98X,2020-10-01,2020,US 2020/0025286 W,2020-03-27,US 201962825078 P,2019-03-28,MEDICAL DEVICE SUSPENSION SYSTEM HAVING CABLE MANAGEMENT ASSEMBLY,"A medical device suspension system includes a spindle extending along a longitudinal axis and a cable management cover surrounding the spindle. A gap is formed between the cable management cover and the spindle. A hub is rotatably mounted to the spindle and includes a housing. A top hub cover is disposed along the longitudinal axis between the hub and the cable management cover and defines an end of the gap, the top hub cover including a passage in fluid communication with an internal volume of the housing. The top hub cover is rotatable with respect to the spindle about the longitudinal axis. A cable is provided within the gap, the cable entering the gap at a fixed location about the longitudinal axis and passing into the housing through the passage. Rotation of the top hub cover about the longitudinal axis causes the passage to rotate about the longitudinal axis.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HESER MICHAEL JOSEPH,,https://lens.org/198-693-628-789-98X,Patent Application,yes,5,0,7,94,0,F16M13/027;;F16M2200/065;;A61B90/50;;A61B50/28;;A61B90/35;;F21V23/002;;F21W2131/205;;F21V21/26;;A61B50/28;;A61B90/50;;A61B2505/01;;A61B2505/05;;F16M13/027;;A61B90/35;;F16M11/2014,A61B90/50;;A61B50/28;;F16M13/02;;F21V23/00,,0,0,,,,PENDING
252,DE,D1,DE 69604535 D1,026-168-462-579-380,1999-11-11,1999,DE 69604535 T,1996-06-25,GB 9513114 A,1995-06-28,Neue Bildfarbstoff erzeugende Kuppler und photographische Elemente die diese enthalten,,EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,,https://lens.org/026-168-462-579-380,Granted Patent,no,0,0,6,6,0,C07D207/337;;G03C7/36;;G03C2200/33;;C07D207/337;;G03C7/36;;G03C2200/33,C07D207/32;;C07D207/337;;G03C7/36,,0,0,,,,EXPIRED
253,AU,A,AU 1989/039638 A,059-253-076-246-346,1990-01-12,1990,AU 1989/039638 A,1989-06-23,US 21059488 A;;US 36775189 A,1988-06-23,MHC-MEDIATED TOXIC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X<1>MHC<2>-peptide (1) or MHC<2>peptide<1>X (2), wherein X represents a labelling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen; <1> represents a covalent bond or a bivalent linker bound to X and MHC in formula (1) or to X and peptide in formula (2) by covalent bonds; and <2> represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to monitor the therapy of autoimmune diseases. <IMAGE>",BIOSPAN CORP,SHARMA SOMESH D;;CLARK BRIAN R;;LERCH L BERNARD,,https://lens.org/059-253-076-246-346,Patent Application,no,0,2,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,G01N33/564;;A61K35/12;;A61K35/28;;A61K39/00;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,,0,0,,,,PENDING
254,AU,B2,AU 2020/245640 B2,077-020-079-866-124,2024-02-22,2024,AU 2020/245640 A,2020-03-27,US 201962825078 P;;US 2020/0025286 W,2019-03-28,Medical device suspension system having cable management assembly,"A medical device suspension system includes a spindle extending along a longitudinal axis and a cable management cover surrounding the spindle. A gap is formed between the cable management cover and the spindle. A hub is rotatably mounted to the spindle and includes a housing. A top hub cover is disposed along the longitudinal axis between the hub and the cable management cover and defines an end of the gap, the top hub cover including a passage in fluid communication with an internal volume of the housing. The top hub cover is rotatable with respect to the spindle about the longitudinal axis. A cable is provided within the gap, the cable entering the gap at a fixed location about the longitudinal axis and passing into the housing through the passage. Rotation of the top hub cover about the longitudinal axis causes the passage to rotate about the longitudinal axis.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HESER MICHAEL JOSEPH,,https://lens.org/077-020-079-866-124,Granted Patent,no,0,0,7,94,0,F16M13/027;;F16M2200/065;;A61B90/50;;A61B50/28;;A61B90/35;;F21V23/002;;F21W2131/205;;F21V21/26;;A61B50/28;;A61B90/50;;A61B2505/01;;A61B2505/05;;F16M13/027;;A61B90/35;;F16M11/2014,A61B90/50;;A61B50/28;;F16M13/02;;F21V23/00,,0,0,,,,ACTIVE
255,DE,A1,DE 2328192 A1,116-983-990-692-954,1974-01-03,1974,DE 2328192 A,1973-06-02,US 26022972 A,1972-06-06,HERBIZIDE ZUSAMMENSETZUNGEN,,PROCTER & GAMBLE,ANASTASIA FRANK BERNARD;;LYDY DAVID LEE;;MAST ROY CLARK,,https://lens.org/116-983-990-692-954,Patent Application,no,0,12,8,8,0,A01N25/04,A01N47/10;;A01N25/04;;A01N39/02;;A01N39/04,,0,0,,,,PENDING
256,EP,A1,EP 3011136 A1,124-478-551-190-103,2016-04-27,2016,EP 14800619 A,2014-05-22,US 201313900372 A;;US 2014/0039186 W,2013-05-22,METHOD OF BOREHOLE SEISMIC SURVEYING USING AN OPTICAL FIBER,,SERVICES PETROLIERS SCHLUMBERGER;;SCHLUMBERGER HOLDINGS;;SCHLUMBERGER TECHNOLOGY BV,HARTOG ARTHUR H;;FRIGNET BERNARD;;MACKIE DUNCAN;;CLARK MICHAEL,,https://lens.org/124-478-551-190-103,Patent Application,yes,0,0,8,8,0,G01H9/004;;G01V1/20;;G01V2210/1429;;G01H9/004;;G01V1/20;;G01V2210/1429;;G01V1/40;;G01V1/42;;G01V1/44,G01H9/00;;E21B49/00;;G01V1/20;;G01V1/52,,0,0,,,,DISCONTINUED
257,US,A,US 5077594 A,192-070-631-610-371,1991-12-31,1991,US 49465290 A,1990-03-16,US 49465290 A,1990-03-16,Integrated high voltage transistors having minimum transistor to transistor crosstalk,"Integrated high voltage transistors having minimum transistor to transistor crosstalk are fabricated in refilled epitaxial tubs, which are formed in a heavily doped substrate. The heavily doped substrate provides the isolation between each transistor, and thus provides for minimum transistor to transistor crosstalk. The voltage capability of the transistor is increased by forming the base surrounding the collector contact in the refilled epitaxial tub.",MOTOROLA INC,CLARK LOWELL E;;DAVIES ROBERT B;;BOLAND BERNARD W,SEMICONDUCTOR COMPONENTS INDUSTRIES LLC (2000-04-14);;MOTOROLA INC (1990-03-09),https://lens.org/192-070-631-610-371,Granted Patent,yes,8,1,1,1,0,H01L29/107;;H01L29/107;;H01L21/76;;H01L21/76;;H01L29/0821;;H01L29/0821,H01L21/76;;H01L29/08;;H01L29/10,H1K KGCB          GCB,2,0,,,"Berger, Method of Producing a Lateral Transistor , IBM Technical Disclosure Bulletin, vol. 23, No. 3, Aug. 1980.;;Anantha et al, High Voltage Power Transistors , IBM Technical Disclosure Bulletin, vol. 16, No. 9, Feb. 1974.",EXPIRED
258,SE,C2,SE 522517 C2,023-546-061-752-628,2004-02-10,2004,SE 0001260 A,2000-04-06,US 94458597 A;;US 9820759 W,1997-10-06,Bredbandig effektförstärkare med hög verkningsgrad,,MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB FREDERICK H;;CLARK JAMES ROGER,,https://lens.org/023-546-061-752-628,Granted Patent,no,0,0,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,,0,0,,,,EXPIRED
259,AU,A,AU 1992/019144 A,050-828-361-753-299,1992-11-17,1992,AU 1992/019144 A,1992-04-23,US 69084091 A;;US 9203391 W,1991-04-23,MHC conjugates useful in ameliorating autoimmunity,,ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH BERNARD L,,https://lens.org/050-828-361-753-299,Patent Application,no,0,0,5,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/4713;;C07K14/705;;C07K14/70539;;C07K14/78;;C07K2319/00;;C07K2319/33;;Y10S424/81;;Y10S530/868;;A61K47/6425;;A61K47/646;;A61P19/02;;A61P21/04;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;C07K14/4713;;C07K2319/00;;C07K14/70539;;A61K51/1234;;C07K14/705;;C07K14/78;;C07K2319/33;;A61K2039/605;;A61K2123/00;;A61K39/0008;;Y10S530/868;;Y10S424/81;;A61K47/6425;;A61K47/646,A61K39/00;;A61K39/385;;A61K47/48;;A61K51/12;;A61P19/02;;A61P21/04;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;C07K14/47;;C07K14/705;;C07K14/74;;C07K14/78;;C07K19/00,,0,0,,,,PENDING
260,CA,C,CA 1340327 C,072-221-956-510-111,1999-01-19,1999,CA 603841 A,1989-06-23,US 21059488 A;;US 36775189 A,1988-06-23,MHC-MEDIATED TOXIC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY,"The invention is directed to methods and material useful in treating autoimmune diseases. The therapeutic agents are of the formula X1MHC2peptide or MHC2peptide1X wherein X represents a functional moiety selected from a toxin and a labeling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen; 1 represents a covalent bond or a linker bound to X and MHC or to X and peptide by covalent bonds; and 2 represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to target helper T-cells which are specifically immunoreactive with autoantigens.",ANERGEN INC,SHARMA SOMESH D;;LERCH L BERNARD;;CLARK BRIAN R,,https://lens.org/072-221-956-510-111,Granted Patent,no,0,0,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,G01N33/564;;A61K35/12;;A61K35/28;;A61K39/00;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,D1530001514  M;;D21670129    S,0,0,,,,EXPIRED
261,JP,A,JP 2003231698 A,097-082-562-962-238,2003-08-19,2003,JP 2002211742 A,2002-07-19,US 69084091 A;;US 86929392 A,1991-04-23,MHC CONJUGATE USEFUL IN AMELIORATING AUTOIMMUNITY,"<P>PROBLEM TO BE SOLVED: To solve the problem that a clear evidence whether or not the induction of anergy in vivo is possible or whether autoimmunity can effectively be treated in this state has not bean provided. <P>SOLUTION: A substantially pure MHC-peptide complex consists essentially of an antigenic peptide and an isolated NRC component having an antigen binding site, wherein the antigenic peptide is associated with the antigen binding site. A pharmacological composition comprising a pharmacologically acceptable carrier and the pure MHC-peptide complex is provided. <P>COPYRIGHT: (C)2003,JPO",ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH BERNARD L,,https://lens.org/097-082-562-962-238,Patent Application,no,0,12,6,32,10,,A61K38/00;;A61K39/00;;A61K39/385;;A61P21/04;;A61P25/00;;A61P37/02;;A61P37/06;;A61P37/08;;C07K7/04;;C07K14/47;;C07K14/74;;C07K19/00,,0,0,,,,DISCONTINUED
262,GB,A,GB 2187602 A,118-121-278-687-063,1987-09-09,1987,GB 8602200 A,1986-01-29,GB 8602200 A,1986-01-29,LOW VOLTAGE ELECTRICAL DISTRIBUTION SYSTEM,,LIGHT SOURCE ELECTRICAL EQUIP,HALL STEPHEN;;CLARK DAVID SAMUEL BERNARD;;THOMPSON MICHAEL DOUGLAS,,https://lens.org/118-121-278-687-063,Patent Application,no,2,0,7,7,0,H01R13/24;;H01R25/00;;H01R13/24;;H01R25/00,H01R13/24;;H01R25/00,H1A A2E2A         AZ2;;H1A A2E3D3        AZ2;;H1A A3G           AZ2;;H1A A8            AZ2;;H2E ECJA          ECJA;;U1S S1714;;U1S S1727;;U1S S1935;;U1S S2280,0,0,,,,DISCONTINUED
263,AU,B2,AU 2013/211976 B2,143-218-202-566-377,2015-04-02,2015,AU 2013/211976 A,2013-01-25,US 201313748888 A;;US 201261590943 P;;US 2013/0023193 W,2012-01-26,Sacral pad for a medical table,"A sacral support for a surgical table, comprising a plate having two spaced- apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/143-218-202-566-377,Granted Patent,no,2,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00,,0,0,,,,ACTIVE
264,GB,A,GB 919640 A,151-071-020-072-970,1963-02-27,1963,GB 650060 A,1960-02-24,GB 650060 A,1960-02-24,Improvements in or relating to detectors of smoke and other suspensions,"919,640. Photo-electric smoke detection. GRAVINER MANUFACTURING CO. Ltd., and WILKINSON SWORD Ltd. May 19, 1961 [Feb. 24, 1960; April 9, 1960], Nos. 6500/60 and 12719/60. Class 40 (3). A detector for smoke and like suspensions includes a light source 12 and three photosensitive devices 14, 15 and 16. Light from source 12 passes through a slit 13a in a partition 13 in the apparatus and falls directly on device 15. The presence of smoke in the light path causes a reduction in the amount of light falling on device 15. In the absence of smoke, device 14 is not illuminated, or is illuminated to only a small extent. Smoke particles scatter light from the main beam and increase its illumination. Device 16 receives light direct from source 12 through adjustable attenuator 19, 20 and it is so arranged that under normal conditions (without smoke) the output from devices 14 and 16 exactly balances the output from device 15 with which they are connected in parallel but with opposite polarity. Smoke drifting in through louvres 11a causes an outof-balance current amplified by a transistor amplifier and used to operate a relay controlling an alarm lamp. For checking purposes a normally short-circuited lamp 17, in series with two lamps in parallel forming source 12 is provided. Removal of the short-circuit causes illumination of device 14 and operation of the relay unless one or both lamps 12 have failed. The devices 14, 15 and 16 are photo-voltaic cells and 14 may be a silicon cell and the remaining two selenium cells.",GRAVINER MANUFACTURING CO;;WILKINSON SWORD LTD,HANSOM BERNARD STEPHEN;;COLLINS JACK BERTRAM;;CLARK ALFRED GEORGE,,https://lens.org/151-071-020-072-970,Granted Patent,no,0,5,1,1,0,G01N21/53,G01N21/53,G1A AMM           MM;;G1A AR7           4;;G1A A208          4;;G1A A209          4;;G1A A21Y          4;;G1A A247          4;;G1A A248          4;;G1A A269          4;;G1A A307          4;;G1A A31Y          4;;G1A A311          4;;G1A A312          4;;G1A A357          4;;G1A A358          4;;G1A A369          4;;G1A A400          4;;G1A A402          4;;G1A A404          4;;G1A A405          4;;G1A A42X          4;;G1A A42Y          4;;G1A A43X          4;;G1A A43Y          4;;G1A A447          4;;G1A A448          4;;G1A A457          4;;G1A A458          4;;G1A A46Y          4;;G1A A463          4;;G1A A464          4;;G1A A470          4;;G1A A478          4;;G1A A480          4;;G1A A488          4;;G1A A516          4;;G1A A52Y          4;;G1A A521          4;;G1A A53Y          4;;G1A A530          4;;G1A A531          4;;G1A A628          4;;G1A A761          4;;G1A A771          4;;G1A A784          4;;G1A A79Y          4;;G1A A792          4;;G1A A794          4;;G1A A798          4,0,0,,,,EXPIRED
265,AU,A1,AU 2002/357383 A1,156-144-034-314-957,2003-07-30,2003,AU 2002/357383 A,2002-12-27,US 3786302 A;;US 0241500 W,2002-01-02,THERMAL BARRIERS WITH SOLID/SOLID PHASE CHANGE MATERIALS,,OUTLAST TECHNOLOGIES INC,CLARK DUSTIN L;;MAGILL MONTE C;;PERRY BERNARD T,,https://lens.org/156-144-034-314-957,Patent Application,no,0,0,5,5,0,E04B1/7662;;E04B1/78;;F25D2201/122;;Y10T428/1352;;Y02B40/00;;Y10T428/1352;;E04B1/78;;E04B1/7662;;F25D2201/122;;Y02B40/00,B32B7/02;;E04B1/76;;E04B1/78,,0,0,,,,DISCONTINUED
266,WO,A1,WO 2005/114265 A1,160-431-481-582-546,2005-12-01,2005,US 2005/0016562 W,2005-05-11,US 57155204 P,2004-05-13,LIGHT FLUX TRANSFORMER,"An apparatus for exposing surfaces on objects to UV radiation includes a light source (36) and a chamber (32) having an interior surface covered with a reflective material, which may be a Lambertian reflector. Light generated by the light source (36) is reflected, usually many times, within the chamber (32), significantly increasing the light flux through an aperture (40) in the chamber (32). A method of increasing light flux is also described, wherein light generated by a light source (36) is reflected multiple times within a chamber (32), and then permitted to exit the chamber (32) through an aperture (40).",NOVATRON INC;;EASTLUND BERNARD J;;INGRAM MICHAEL W;;CLARK REGINALD W,EASTLUND BERNARD J;;INGRAM MICHAEL W;;CLARK REGINALD W,,https://lens.org/160-431-481-582-546,Patent Application,yes,4,10,1,1,0,G02B27/0905;;G02B5/02;;G02B27/0977,G02B5/02;;G02B27/00;;G02B27/09,,1,0,,,"NAUMANN, SCHRÖDER: ""Bauelemente der Optik"", 1992, CARL HANSER VERLAG, MÜNCHEN, WIEN, XP002341246",PENDING
267,CA,A1,CA 3135432 A1,188-503-593-328-012,2020-10-01,2020,CA 3135432 A,2020-03-27,US 201962825078 P;;US 2020/0025286 W,2019-03-28,MEDICAL DEVICE SUSPENSION SYSTEM HAVING CABLE MANAGEMENT ASSEMBLY,"A medical device suspension system includes a spindle extending along a longitudinal axis and a cable management cover surrounding the spindle. A gap is formed between the cable management cover and the spindle. A hub is rotatably mounted to the spindle and includes a housing. A top hub cover is disposed along the longitudinal axis between the hub and the cable management cover and defines an end of the gap, the top hub cover including a passage in fluid communication with an internal volume of the housing. The top hub cover is rotatable with respect to the spindle about the longitudinal axis. A cable is provided within the gap, the cable entering the gap at a fixed location about the longitudinal axis and passing into the housing through the passage. Rotation of the top hub cover about the longitudinal axis causes the passage to rotate about the longitudinal axis.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HESER MICHAEL JOSEPH,,https://lens.org/188-503-593-328-012,Patent Application,no,0,0,7,94,0,F16M13/027;;F16M2200/065;;A61B90/50;;A61B50/28;;A61B90/35;;F21V23/002;;F21W2131/205;;F21V21/26;;A61B50/28;;A61B90/50;;A61B2505/01;;A61B2505/05;;F16M13/027;;A61B90/35;;F16M11/2014,A61B90/50;;A61B50/28;;F16M13/02;;F21V23/00,,0,0,,,,PENDING
268,US,B2,US 9377551 B2,185-309-353-670-064,2016-06-28,2016,US 201313900372 A,2013-05-22,US 201313900372 A,2013-05-22,Method of borehole seismic surveying using an optical fiber,"A method of detecting seismic waves traveling through a subsurface formation includes lowering a cable into a borehole in the subsurface formation, the cable having at least one optical fiber associated therewith, and causing descent of a remote end of the cable to be arrested. The method further includes feeding a further length of the cable into the borehole such that the cable is slack and in contact with at least part of a wall of the borehole, and using an interrogator coupled to the at least one optical fiber to detect seismic waves traveling through the subsurface formation and into the cable.",SCHLUMBERGER TECHNOLOGY CORP,HARTOG ARTHUR H;;FRIGNET BERNARD;;MACKIE DUNCAN;;CLARK MICHAEL,SCHLUMBERGER TECHNOLOGY CORPORATION (2013-05-31),https://lens.org/185-309-353-670-064,Granted Patent,yes,31,18,8,8,0,G01H9/004;;G01V1/20;;G01V2210/1429;;G01H9/004;;G01V1/20;;G01V2210/1429;;G01V1/40;;G01V1/42;;G01V1/44,G01V1/40;;G01H9/00;;G01V1/20;;G01V1/42;;G01V1/44,,14,9,143-513-204-118-270;;032-958-644-462-558;;004-892-945-312-110;;069-811-521-307-909;;008-457-148-754-564;;148-436-801-564-135;;156-718-850-662-132;;000-465-054-963-508;;020-904-724-291-673,10.3997/2214-4609.20148798;;20165347;;10.1364/ao.15.002112;;10.1109/tcom.1987.1096744;;10.1109/jlt.2005.849924;;10.3997/2214-4609.20148801;;10.3997/2214-4609.20148800;;10.3997/2214-4609.20148799;;10.1049/el:20001200;;10.1364/ao.37.005600;;18286045,"Barberan, et al., ""Multi-offset Seismic Acquisition Using Optical Fiber Behind Tubing"", 74th EAGE Conference & Exhibition, Copenhagen, Jun. 4-7, 2012, 6 pages.;;Barnoski, M.K. et al., ""Fiber waveguides: a novel technique for investigating attenuation characteristics"", Applied Optics, 15(9), 1976, pp. 2112-2115.;;Gold, et al., ""Analysis of backscatter waveforms from single-mode fibres"", 8th European Conference on Optical Communication, C-26, 1982, pp. 633-639.;;Healey, P. ""Statistics of Rayleigh Backscatter from a Single-Mode Fiber"", IEEE Transaction on Communications, 35(2), 1987, pp. 210-214.;;Juarez, J.C. et al., ""Distributed Fiber-Optic Intrusion Sensor System"", Journal of Lightwave Technology, 23(6), 2005, pp. 2081-2087.;;Madsen, et al., ""A VSP Field Trial Using Distributed Acoustic Sensing in a Producing Well in the North Sea"", 74th EAGE Conference & Exhibition, Jun. 4-7, 2012, 5 pages.;;Mestayer, et al., ""Distributed Acoustic Sensing for Geophysical Monitoring"", 74th EAGE Conference & Exhibition, Jun. 4-7, 2012, 4 pages.;;Mestayer, J. , ""Field Trials of Distributed Acoustic Sensing for Geophysical Monitoring"", SEG 2011 annual meeting, San Antonio, TX, 2011, pp. 4253-4257.;;Miller, et al., ""Vertical Seismic Profiling Using a Fibre-optic Cable as a Distributed Acoustic Sensor"", 74th EAGE Conference & Exhibition, Jun. 4-7, 2012, 5 pages.;;Posey, R.J. et al., ""Strain Sensing Based on Coherent Rayleigh Scattering in the Optical Fibre"", Electronics Letter, 36(20), 2000, pp. 1688-1689.;;Shatalin, et al., ""Interferometric optical time-domain reflectometry for distributed optical-fiber sensing"", Applied Optics, vol. 37(24), 1998, pp. 5600-5604.;;Hartog, et al. ""The Optics of Distributed Vibration Sensing,"" Second EAGE Workshop on Permanent Reservoir Monitoring-Current and Future Trends, Stavanger, Norway, Jul. 2-5, 2013, 5 pages.;;Hartog ""Raman sensors and their applications,"" OFS2012 22nd International Conference on Optical Fiber Sensors, Oct. 4, 2012, Proc. of SPIE vol. 8421, 84210K, 6 pages.;;International Search Report and the Written Opinion for International Application No. PCT/US2014/039186 dated Oct. 23, 2014.",ACTIVE
269,EP,B1,EP 2806836 B1,011-065-553-654-204,2017-03-15,2017,EP 13741313 A,2013-01-25,US 201261590943 P;;US 201313748888 A;;US 2013/0023193 W,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE,,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/011-065-553-654-204,Granted Patent,yes,6,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00;;A61G13/12,,0,0,,,,ACTIVE
270,US,A1,US 2014/0347957 A1,014-539-190-667-92X,2014-11-27,2014,US 201313900372 A,2013-05-22,US 201313900372 A,2013-05-22,Method Of Borehole Seismic Surveying Using An Optical Fiber,"A method of detecting seismic waves traveling through a subsurface formation includes lowering a cable into a borehole in the subsurface formation, the cable having at least one optical fiber associated therewith, and causing descent of a remote end of the cable to be arrested. The method further includes feeding a further length of the cable into the borehole such that the cable is slack and in contact with at least part of a wall of the borehole, and using an interrogator coupled to the at least one optical fiber to detect seismic waves traveling through the subsurface formation and into the cable.",SCHLUMBERGER TECHNOLOGY CORP,HARTOG ARTHUR H;;FRIGNET BERNARD;;MACKIE DUNCAN;;CLARK MICHAEL,SCHLUMBERGER TECHNOLOGY CORPORATION (2013-05-31),https://lens.org/014-539-190-667-92X,Patent Application,yes,23,13,8,8,0,G01H9/004;;G01V1/20;;G01V2210/1429;;G01H9/004;;G01V1/20;;G01V2210/1429;;G01V1/40;;G01V1/42;;G01V1/44,G01V1/42;;G01V1/40;;G01V1/44,367/33;;367/25;;367/35,0,0,,,,ACTIVE
271,US,A,US 5468481 A,077-684-318-889-932,1995-11-21,1995,US 86929392 A,1992-04-14,US 86929392 A;;US 69084091 A;;US 57608490 A;;US 21059488 A;;US 63584090 A;;US 36775189 A,1988-06-23,MHC class II-peptide conjugates useful in ameliorating autoimmunity,The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.,AMERGEN INC,SHARMA SOMESH D;;CLARK BRIAN R;;LERCH BERNARD L,ANERGEN INC (1992-10-12);;ANERGEN INC. A DELAWARE CORPORATION (1998-06-30),https://lens.org/077-684-318-889-932,Granted Patent,yes,14,79,1,32,7,A61K39/0008;;A61K39/0008;;A61K47/6425;;A61K47/6425;;A61K47/646;;A61K47/646;;A61K51/1234;;A61K51/1234;;A61K2039/605;;A61K2039/605;;A61K2123/00;;A61K2123/00;;C07K14/4713;;C07K14/4713;;C07K14/705;;C07K14/705;;C07K14/70539;;C07K14/70539;;C07K14/78;;C07K14/78;;C07K2319/00;;C07K2319/00;;Y10S530/868;;Y10S530/868,A61K39/00;;A61K47/48;;A61K51/12;;C07K14/47;;C07K14/705;;C07K14/74;;C07K14/78,424/125.1;;530/395;;530/402;;530/403;;530/868;;514/2;;514/8;;424/184.1;;424/193.1;;424/278.1,73,64,065-769-016-120-914;;048-266-604-521-545;;002-977-470-822-87X;;020-670-764-521-171;;034-275-533-046-869;;060-105-097-350-717;;060-105-097-350-717;;053-932-577-346-798;;080-116-588-558-925;;041-066-683-986-277;;020-833-428-096-595;;021-354-068-638-52X;;021-720-457-509-673;;098-548-262-072-602;;119-098-412-359-014;;105-728-654-193-796;;151-909-994-962-302;;000-877-662-644-595;;031-498-695-386-777;;150-992-421-090-985;;044-219-977-949-424;;053-919-000-700-346;;024-957-936-929-004;;008-338-552-683-575;;006-246-100-575-580;;068-328-739-510-663;;076-183-945-466-427;;124-265-670-692-625;;001-809-294-160-846;;090-471-813-411-890;;028-483-482-274-317;;019-055-424-431-057;;016-820-517-785-643;;096-808-659-810-496;;064-376-665-222-650;;063-898-442-301-724;;045-722-267-072-669;;067-423-867-031-236;;186-072-679-623-966;;018-725-676-477-557;;106-021-817-946-64X;;034-144-538-771-410;;000-108-780-023-355;;004-446-132-457-064;;045-641-100-690-823;;081-916-336-734-306;;091-964-810-489-790;;005-060-637-433-679;;066-352-300-567-046;;023-077-406-743-876;;017-931-052-403-69X;;025-896-082-408-415;;026-409-307-851-000;;030-532-334-370-93X;;028-043-821-964-859;;036-979-322-661-093;;098-590-609-369-691;;031-989-718-683-43X;;078-039-663-716-551;;158-884-679-706-17X;;086-024-104-550-397;;030-673-092-294-514;;003-196-437-484-850;;013-753-648-999-581,2884070;;10.1101/sqb.1986.051.01.010;;10.1002/path.1711500103;;2946837;;10.1073/pnas.88.24.11465;;pmc53156;;1722335;;2402499;;10.1073/pnas.87.18.7170;;pmc54705;;3876513;;10.1038/317359a0;;10.1038/329506a0;;3309677;;10.1038/329506a0;;3309677;;10.1126/science.2435001;;2435001;;3484557;;10.1126/science.3484557;;10.4049/jimmunol.133.5.2549;;6332854;;10.1146/annurev.immunol.5.1.477;;2439104;;10.1146/annurev.iy.05.040187.002401;;10.1126/science.3313727;;3313727;;10.1002/eji.1830100410;;6967410;;6139673;;2578165;;10.1038/329482a0;;3498902;;10.1016/0161-5890(83)90137-2;;6581382;;10.1126/science.2437650;;2437650;;6334313;;10.1073/pnas.81.23.7564;;pmc392187;;2410926;;10.1073/pnas.82.16.5480;;pmc391146;;3297108;;10.1146/annurev.iy.05.040187.002333;;10.1126/science.2433769;;2433769;;10.1021/bi00342a003;;3002421;;3257303;;10.1126/science.3257303;;10.1038/332840a0;;3258650;;10.1016/0161-5890(83)90147-5;;6197631;;3536124;;10.1016/0092-8674(86)90506-4;;10.1084/jem.164.5.1490;;pmc2188449;;2430042;;2966437;;10.1126/science.2966437;;10.1073/pnas.73.7.2481;;781677;;pmc430616;;3297338;;3317828;;10.1126/science.3317828;;pmc2185690;;10.1084/jem.150.5.1084;;91653;;10.1007/bf02918107;;3114395;;2457615;;10.4049/jimmunol.141.5.1451;;pmc553925;;10.1002/j.1460-2075.1987.tb02360.x;;2440673;;2419437;;2420472;;10.1016/0092-8674(86)90019-x;;10.1097/00007890-197310000-00005;;4200798;;1141219;;10.1016/s0021-9258(19)41332-x;;2824477;;10.1016/s0021-9258(18)47699-5;;pmc2187974;;2415664;;10.1084/jem.162.6.2107;;10.1038/317355a0;;2413363;;3004990;;10.1002/eji.1830160107;;2457547;;pmc1385051;;pmc2188516;;3029267;;10.1084/jem.165.2.302;;6210242;;10.1111/j.1600-065x.1984.tb01110.x;;6189936;;pmc2187023;;10.1084/jem.157.5.1434;;10.1038/308072a0;;6199675;;2420700;;pmc1453820;;10.1002/eji.1830171118;;2960547;;pmc1385193;;2968304;;10.1038/332161a0;;3279318;;85683;;pmc2184831;;10.1084/jem.149.3.758;;2953809;;3035012;;2450125;;10.1038/303625a0;;6343888;;10.1002/eji.1830150318;;3872218;;6170681;;10.1126/science.3194755;;3194755;;1372021;;1370312;;10.1016/0022-1759(91)90297-s;;1717592,"W. F. Paul (ed), Fundamental Immunology, 3rd edition (1993) pp. 619 621.;;Bell, J. I. et al., CSH Sympos. Quant. Biol. 51:75 82 (1986), Molecular biology of the class II region of the human major histocompatibility complex.;;Foulis, A. K., J. Pathol. 150:5 11 (1986) Class II major histocompatibility complex and organ specific autoimmunity in man .;;Sharma, S., et al. PNAS 88:11465 11469 (1991), Antigen specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex peptide complexes.;;Viguer, M., et al., PNAS 87:7170 7174 (1990), The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides in vivo .;;Babbitt, B. P. et al. (1985) Nature 317: 359 361.;;Bjorkman, P. J. et al. (1987) Nature 329: 506 512.;;Bjorkman, P. J. et al. (1987) Nature 329: 512 518.;;Buus, S. et al. (1987) Science 235: 1353 1358.;;Diener, E. et al. (1986) Science 231: 148 150.;;Killen, J. A. et al. (1984) J. Immunol. 133: 2549 2553.;;Livingstone, A. M. et al. (1987) Ann. Rev. Immunol. 5: 477 501.;;Marx, J. L. (1987) Science 238: 613 614.;;Paul, W. E. (1989) Fundamental Immunol. Raven Press, New York, pp. 69 73.;;Puri, J. et al. (1980) Eur. J. Immunol. 10: 273 281.;;Rennie, D. P. et al. (1983) The Lancet (Dec. 10) 1338 1340.;;Sterz, R. K. M. et al. (1985) J. Immunol. 134: 841 846.;;Townsend, A. et al. (1987) Nature 329: 482 483.;;Turkewitz, A. P. et al. (1983) Molec. Immunol. 20: 1139 1147.;;Unanue, E. R. et al. (1987) Science 236: 551 557.;;Watts, T. H. et al. (1984) Proc. Natl. Acad. Sci. USA 81: 7564 7568.;;Watts, T. H. et al. (1985) Proc. Natl. Acad. Sci. USA 82: 5480 5484.;;Watts, T. H. et al. (1987) Ann. Rev. Immunol. 5: 461 475.;;Clemetson, K. J. et al. (1986) In Membrane proteins: A Laboratory Manual, Ed. Azzi, A. et al., pp. 57 64.;;Cooperman (1979) In Ribosomes Structure, Function, and Genetics. Ed. Chambliss et al. University Park Press, Baltimore Md. pp. 531 554.;;Estess, P. et al. (1986) In Regulation of immune gene expression, Ed. Feldman, M. et al., Humana Press, p. 3 19.;;Guillet et al. (1987) Science 235: 865 870.;;Hall et al. (1985) Biochemistry 24: 5702 5711.;;Harcourt, G. et al. (1987) Immunol. Today 8 (11): (news and features section).;;Hixson, J. R. Medical Tribune (24 Jan. 1985) pp. 4 5.;;Liu, M. A. et al. (1988) Science 239: 395 398.;;Marrack, P. et al. (1988) Nature 332: 840 842.;;Nakanishi, M. et al. (1983) Molec. Immunol. 20: 1227 1231.;;Pastan, I. et al. (1986) Cell 47: 641 648.;;Sekaly, R. P. et al. (1986) J. Exp. Med. 164: 1490 1504.;;Shizuru, J. A. et al. (1988) Science 240: 659 662.;;Springer, T. A. et al. (1976) Proc. Natl. Acad. Sci. USA 73: 2481 2485.;;Sriram, S. et al. (1987) Concepts Immunopathol. 4: 275 286.;;Vitetta, E. S. et al. (1987) Science 238: 1098 1104.;;Watts, T. H. et al. (1988) In Processing and presentation of antigens, Academic Press, pp. 143 154.;;Binz, H. et al. (1979) J. Exp. Med. 150: 1084 1097.;;Gasciogne, N. R. J. et al. (1987) Proc. Natl. Acad. Sci. USA. 84: 2396 2340.;;Margulies, D. H. et al. (1987) Immunol. Res. 6: 101 116.;;McCluskey, J. et al. (1988) J. Immunol. 141: 1451 1455.;;Lamb et al. (1987) EMBO J. 6: 1245 1249.;;Berkower et al. (1986) J. Immunol. 136: 2498 2502.;;Townsend et al. (1986) Cell 44: 959 968.;;Sanderson et al. (1973) Transplantation 16: 304 312.;;Turner et al. (1976) J. Biol. Chem. 250: 4512 4519.;;Gorga et al. (1987) J. Biol. Chem. 262: 16087 16094.;;Zamvil et al. (1985) J. Exp. Med. 162: 2107 2124.;;Zamvil et al. (1985) Nature 317: 355 358.;;Ceredig, R. et al. (1986) Eur. J. Immunol. 16: 30 34.;;Essery, G. et al. (1988) Immunology 64: 413 417.;;Jenkins, M. K. et al. (1987) J. Exp. Med. 165: 302 319.;;Klein, J. (1984) Immunol. Reviews 81: 177 202.;;Lamb, J. R. (1983) J. Exp. Med. 157: 1434 1447.;;Lamb, J. R. (1984) Nature 308: 72 74.;;Lamb, J. R. et al. (1986) Immunology 57: 331 335.;;Lamb, J. R. et al. (1987) Eur. J. Immunol. 17: 1641 1644.;;Larche, M. et al. (1988) Immunology 64: 101 105.;;Madsen, J. C. et al. (1988) Nature 332: 161 164.;;Miller, S. D. et al. (1979) J. Exp. Med. 149: 758 773.;;Nau, G. J. et al. (1987) J. Immunol. 139: 114 122.;;Quill, H. et al. (1987) J. Immunol. 138: 3704 3712.;;Suzuki, G. et al. (1988) J. Immunol. 140: 1359 1365.;;Zanders, E. D. et al. (1983) Nature 303: 625 627.;;Zanders, E. D. et al. (1985) Eur. J. Immunol. 15: 302 305.;;Germain, R. N. (1981) J. Immunol. 127:1964 1966.;;Buss, S. et al. (1988) Science 242:1045 1047.;;Nag, B. et al. (1992) J. of Immunol. 148(7):2040 2044.;;Nag, B. et al. (1992) J. of Immunol. 148(2):369 372.;;Nag, B. et al. (1991) J. of Immunological Methods 142:105 111.",EXPIRED
272,WO,A1,WO 2004/050130 A1,110-503-093-716-908,2004-06-17,2004,US 0337803 W,2003-11-26,US 42988002 P;;US 47148503 P;;US 48684903 P;;US 49550003 P;;US 49619503 P,2002-11-27,"UV FLUX MULTIPLICATION SYSTEM FOR STERILIZING AIR, MEDICAL DEVICES AND OTHER MATERIALS","An ultraviolet flux multiplying air sterilization chamber (1500) comprising inner surfaces having a diffuse reflective behavior. The sterilization chamber includes an inlet aperture (1508) and an outlet aperture (1509) for air flow through said chamber and a light source (1503) emitting an ultraviolet light. Due to the reflectivity of the inner surfaces of the chamber, a flux of the ultraviolet light is multiplied by reflecting multiple times from the inner surfaces of the chamber. The inlet and outlet apertures (1508, 1509) are advantageously configured to reduce the amount of light that escapes from the chamber and increase the amount of photons available in the chamber. In an exemplary embodiment, packed arrays (1202, 1203) of fibers, spheres, or other small particles are placed at the inlet (1508) and/or outlet (1509) to the chamber. These packed arrays (1202, 1203) provide light scattering events such that the light incident on the packed arrays reflects back with high reflectivity.",NOVATRON INC;;CLARK REGINALD W;;EASTLUND BERNARD J;;INGRAM MICHAEL W,CLARK REGINALD W;;EASTLUND BERNARD J;;INGRAM MICHAEL W,,https://lens.org/110-503-093-716-908,Patent Application,yes,5,8,4,4,0,A61L9/205;;A61L9/205;;A61L2209/16;;A61L2209/16;;F24F8/22;;F24F8/22;;Y02A50/20;;Y02A50/20,A61L9/20,,0,0,,,,PENDING
273,EP,A4,EP 0423201 A4,125-205-042-302-843,1992-10-14,1992,EP 89908127 A,1989-06-23,US 21059488 A;;US 36775189 A;;US 8902784 W,1988-06-23,MHC-MEDIATED TOXIC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X<1>MHC<2>-peptide (1) or MHC<2>peptide<1>X (2), wherein X represents a labelling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen; <1> represents a covalent bond or a bivalent linker bound to X and MHC in formula (1) or to X and peptide in formula (2) by covalent bonds; and <2> represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to monitor the therapy of autoimmune diseases. <IMAGE>",BIOSPAN CORPORATION,"SHARMA, SOMESH, D.;;LERCH, L., BERNARD;;CLARK, BRIAN, R.","ANERGEN, INC. (1996-10-01);;C.N.ME EPO REG.92;ANERGEN INC. (1996-06-07);;BIOSPAN CORPORATION TRANSFER- ANERGEN, INC. (1996-07-31)",https://lens.org/125-205-042-302-843,Search Report,no,3,0,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,G01N33/564;;A61K35/12;;A61K35/28;;A61K39/00;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,,0,0,,,,EXPIRED
274,AU,A,AU 1973/056554 A,149-139-069-854-769,1974-12-05,1974,AU 1973/056554 A,1973-06-05,US 26022972 A,1972-06-06,HERBICIDAL COMPOSITIONS HERBICIDAL COMPOSITIONS,,PROCTER & GAMBLE,MAST ROY CLARK;;ANASTASIA FRANK BERNARD;;LYDY DAVID LEE,,https://lens.org/149-139-069-854-769,Patent Application,no,0,0,8,8,0,A01N25/04,A01N47/10;;A01N25/04;;A01N39/02;;A01N39/04,,0,0,,,,DISCONTINUED
275,WO,A1,WO 2014/190176 A1,140-919-545-496-350,2014-11-27,2014,US 2014/0039186 W,2014-05-22,US 201313900372 A,2013-05-22,METHOD OF BOREHOLE SEISMIC SURVEYING USING AN OPTICAL FIBER,"A method of detecting seismic waves traveling through a subsurface formation includes lowering a cable into a borehole in the subsurface formation, the cable having at least one optical fiber associated therewith, and causing descent of a remote end of the cable to be arrested. The method further includes feeding a further length of the cable into the borehole such that the cable is slack and in contact with at least part of a wall of the borehole, and using an interrogator coupled to the at least one optical fiber to detect seismic waves traveling through the subsurface formation and into the cable.",SCHLUMBERGER CA LTD;;SCHLUMBERGER SERVICES PETROL;;SCHLUMBERGER HOLDINGS;;SCHLUMBERGER TECHNOLOGY BV;;PRAD RES & DEV LTD;;SCHLUMBERGER TECHNOLOGY CORP,HARTOG ARTHUR H;;FRIGNET BERNARD;;MACKIE DUNCAN;;CLARK MICHAEL,,https://lens.org/140-919-545-496-350,Patent Application,yes,5,0,8,8,0,G01H9/004;;G01V1/20;;G01V2210/1429;;G01H9/004;;G01V1/20;;G01V2210/1429;;G01V1/40;;G01V1/42;;G01V1/44,E21B49/00;;G01V1/40;;G01V1/52,,1,0,,,See also references of EP 3011136A4,PENDING
276,EP,B1,EP 0527883 B1,059-937-454-907-023,1994-01-19,1994,EP 91909538 A,1991-05-11,GB 9010967 A,1990-05-16,HYDROPHILIC COLLOID COMPOSITION FOR A PHOTOGRAPHIC MATERIAL.,"A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula CF3(CF2)nCH2O(glycidyl)mH wherein n is an integer from 4 to 7; and, m is an integer from 6 to 45.",EASTMAN KODAK CO;;KODAK LTD,PITT ALAN ROBERT;;CLARK BERNARD ARTHUR;;PADDAY JOHN FRANK,KODAK LIMITED (1994-03-09);;EASTMAN KODAK COMPANY (1994-03-09),https://lens.org/059-937-454-907-023,Granted Patent,yes,6,0,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,C09D7/12;;C09D189/00;;G03C1/38;;G03C1/85,,1,0,,,"J.L. Moillet: ""Waterproofing and water-repellancy"", 1963, p. 142",EXPIRED
277,US,A1,US 2020/0306006 A1,087-987-117-516-890,2020-10-01,2020,US 202016832571 A,2020-03-27,US 202016832571 A;;US 201962825078 P,2019-03-28,MEDICAL DEVICE SUSPENSION SYSTEM HAVING CABLE MANAGEMENT ASSEMBLY,"A medical device suspension system includes a spindle extending along a longitudinal axis and a cable management cover surrounding the spindle. A gap is formed between the cable management cover and the spindle. A hub is rotatably mounted to the spindle and includes a housing. A top hub cover is disposed along the longitudinal axis between the hub and the cable management cover and defines an end of the gap, the top hub cover including a passage in fluid communication with an internal volume of the housing. The top hub cover is rotatable with respect to the spindle about the longitudinal axis. A cable is provided within the gap, the cable entering the gap at a fixed location about the longitudinal axis and passing into the housing through the passage. Rotation of the top hub cover about the longitudinal axis causes the passage to rotate about the longitudinal axis.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HESER MICHAEL JOSEPH,AMERICAN STERILIZER COMPANY (2019-03-26),https://lens.org/087-987-117-516-890,Patent Application,yes,5,8,7,94,0,F16M13/027;;F16M2200/065;;A61B90/50;;A61B50/28;;A61B90/35;;F21V23/002;;F21W2131/205;;F21V21/26;;A61B50/28;;A61B90/50;;A61B2505/01;;A61B2505/05;;F16M13/027;;A61B90/35;;F16M11/2014,A61B90/50;;A61B50/28,,0,0,,,,ACTIVE
278,AT,T1,AT E139122 T1,116-089-220-925-137,1996-06-15,1996,AT 89908127 T,1989-06-23,US 21059488 A;;US 36775189 A,1988-06-23,VON MHC GESTÜTZTE KONJUGATE ZUR VERWENDUNG BEI DER STEIGERUNG DER AUTOIMMUNITÄT,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X<1>MHC<2>-peptide (1) or MHC<2>peptide<1>X (2), wherein X represents a labelling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen; <1> represents a covalent bond or a bivalent linker bound to X and MHC in formula (1) or to X and peptide in formula (2) by covalent bonds; and <2> represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to monitor the therapy of autoimmune diseases. <IMAGE>",BIOSPAN CORP,SHARMA SOMESH D;;LERCH L BERNARD;;CLARK BRIAN R,,https://lens.org/116-089-220-925-137,Granted Patent,no,0,0,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,G01N33/564;;A61K35/12;;A61K35/28;;A61K39/00;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,,0,0,,,,DISCONTINUED
279,AU,A1,AU 2003/293088 A1,129-780-234-030-48X,2004-06-23,2004,AU 2003/293088 A,2003-11-26,US 42988002 P;;US 47148503 P;;US 48684903 P;;US 49550003 P;;US 49619503 P;;US 0337803 W,2002-11-27,"UV FLUX MULTIPLICATION SYSTEM FOR STERILIZING AIR, MEDICAL DEVICES AND OTHER MATERIALS",,NOVATRON INC,EASTLUND BERNARD J;;INGRAM MICHAEL W;;CLARK REGINALD W,,https://lens.org/129-780-234-030-48X,Patent Application,no,0,0,4,4,0,A61L9/205;;A61L9/205;;A61L2209/16;;A61L2209/16;;F24F8/22;;F24F8/22;;Y02A50/20;;Y02A50/20,A61L9/20,,0,0,,,,DISCONTINUED
280,EP,B1,EP 0423201 B1,156-003-209-464-369,1996-06-12,1996,EP 89908127 A,1989-06-23,US 21059488 A;;US 36775189 A;;US 8902784 W,1988-06-23,MHC-MEDIATED CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X<1>MHC<2>-peptide (1) or MHC<2>peptide<1>X (2), wherein X represents a labelling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen; <1> represents a covalent bond or a bivalent linker bound to X and MHC in formula (1) or to X and peptide in formula (2) by covalent bonds; and <2> represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to monitor the therapy of autoimmune diseases. <IMAGE>",BIOSPAN CORP,SHARMA SOMESH D;;LERCH L BERNARD;;CLARK BRIAN R,"ANERGEN, INC. (1996-10-01);;C.N.ME EPO REG.92;ANERGEN INC. (1996-06-07);;BIOSPAN CORPORATION TRANSFER- ANERGEN, INC. (1996-07-31)",https://lens.org/156-003-209-464-369,Granted Patent,yes,0,2,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,G01N33/564;;A61K35/12;;A61K35/28;;A61K39/00;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,,5,5,041-066-683-986-277;;021-720-457-509-673;;000-877-662-644-595;;019-055-424-431-057;;048-368-206-580-993,10.4049/jimmunol.133.5.2549;;6332854;;10.1002/eji.1830100410;;6967410;;10.1126/science.2437650;;2437650;;3317828;;10.1126/science.3317828;;6942054,"JOURNAL OF IMMUNOLOGY, vol. 133, no. 5, 1984; J.A. KILLEN et al., pp. 2549-2553/;;EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 10, 1980; J. PURI et al., pp. 273-281/;;SCIENCE, vol. 236, May 1987; E.R. UNANUE et al., pp. 551-557/;;SCIENCE, vol. 238, November 1987; E.S. VITETTA et al., pp. 1098-1104/;;JOURNAL OF IMMUNOLOGY, vol. 127, 1981; pp. 482-486/",EXPIRED
281,BR,B1,BR 112014018118 B1,024-993-862-455-755,2021-05-25,2021,BR 112014018118 A,2013-01-25,US 2013/0023193 W;;US 201261590943 P;;US 201313748888 A,2012-01-26,almofada sacral para uma mesa médica,"almofada sacral para uma mesa médica. um apoio sacral para uma mesa cirúrgica, compreendendo uma chapa tendo dois espaçados - apart aberturas formadas nela. as aberturas são alinhadas ao longo do eixo da placa e descartado adjacente e uma extremidade da placa. uma almofada é anexada à placa. a almofada é dimensionada tal que estão expostas as aberturas na placa. um post de posicionamento é anexável ao prato. o post tem uma extremidade inferior, dimensionada para ser recebido nas aberturas na placa, em que o post é montável na placa em uma das duas posições diferentes.",AMERICAN STERILIZER CO,BERNARD J MOSS;;CHRISTOPHER D LABEDZ;;LANCE CLARK BELLOWS,,https://lens.org/024-993-862-455-755,Granted Patent,no,0,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00,,0,0,,,,ACTIVE
282,WO,A1,WO 2003/059614 A1,032-148-431-715-22X,2003-07-24,2003,US 0241500 W,2002-12-27,US 3786302 A,2002-01-02,THERMAL BARRIERS WITH SOLID/SOLID PHASE CHANGE MATERIALS,"A thermal barrier comprises a first barrier layer, a second barrier layer, and a temperature regulating material positioned between the first barrier layer and the second barrier layer. The temperature regulating material comprises a solid/solid phase change material in a powdered form, and the first barrier layer is bonded to the second barrier layer to enclose the temperature regulating material within the thermal barrier. The thermal barrier may be used or incorporated in various products or applications where thermal management is desired. For example, the thermal barrier may be used in textiles, apparel, footwear, medical products, containers and packagings, buildings, appliances, and other products.",OUTLAST TECHNOLOGIES INC,CLARK DUSTIN L;;MAGILL MONTE C;;PERRY BERNARD T,,https://lens.org/032-148-431-715-22X,Patent Application,yes,1,0,5,5,0,E04B1/7662;;E04B1/78;;F25D2201/122;;Y10T428/1352;;Y02B40/00;;Y10T428/1352;;E04B1/78;;E04B1/7662;;F25D2201/122;;Y02B40/00,B32B7/02;;E04B1/76;;E04B1/78,,0,0,,,,PENDING
283,US,A1,US 2003/0124278 A1,091-777-416-795-77X,2003-07-03,2003,US 3786302 A,2002-01-02,US 3786302 A,2002-01-02,Thermal barriers with solid/solid phase change materials,"
   A thermal barrier comprises a first barrier layer, a second barrier layer, and a temperature regulating material positioned between the first barrier layer and the second barrier layer. The temperature regulating material comprises a solid/solid phase change material in a powdered form, and the first barrier layer is bonded to the second barrier layer to enclose the temperature regulating material within the thermal barrier. The thermal barrier may be used or incorporated in various products or applications where thermal management is desired. For example, the thermal barrier may be used in textiles, apparel, footwear, medical products, containers and packagings, buildings, appliances, and other products. 
",CLARK DUSTIN L.;;MAGILL MONTE C.;;PERRY BERNARD T.,CLARK DUSTIN L;;MAGILL MONTE C;;PERRY BERNARD T,OUTLAST TECHNOLOGIES INC (2001-12-14),https://lens.org/091-777-416-795-77X,Patent Application,yes,1,48,5,5,0,E04B1/7662;;E04B1/78;;F25D2201/122;;Y10T428/1352;;Y02B40/00;;Y10T428/1352;;E04B1/78;;E04B1/7662;;F25D2201/122;;Y02B40/00,B32B7/02;;E04B1/76;;E04B1/78,428/35.7,0,0,,,,DISCONTINUED
284,EP,A1,EP 0751428 A1,127-164-908-795-429,1997-01-02,1997,EP 96201758 A,1996-06-25,GB 9513114 A,1995-06-28,Novel image-dye-forming couplers and photographic elements containing them,"The present invention comprehends the use of novel pyrroloylacetamides as image-dye-forming couplers, specifically yellow dye-forming couplers, for use with silver halide based photographic systems. In one aspect the invention provides a coupler of formula (I):-
   wherein X is H or a coupling-off group, R and R 1  are independently selected from H and coupler-modifying functional groups; Y and Z are the same or different and are H or independently selected from alkyl, aryl or heteroaryl, each of which is unsubstituted or substituted with one or more coupler modifying functional groups; or Y and Z taken together with the nitrogen atom form a 5-10 membered heterocyclic ring which may contain one or more further heteroatoms selected from N, O and S, said heterocyclic ring being unsubstituted or substituted with one or more coupler modifying functional groups. Preferred compounds are those wherein Y is H and Z is a phenyl group, which may be mono- or di- substituted.",KODAK LTD;;EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,KODAK LIMITED (1999-06-02);;EASTMAN KODAK COMPANY (1999-06-02),https://lens.org/127-164-908-795-429,Patent Application,yes,4,2,6,6,0,C07D207/337;;G03C7/36;;G03C2200/33;;C07D207/337;;G03C7/36;;G03C2200/33,C07D207/32;;C07D207/337;;G03C7/36,,0,0,,,,EXPIRED
285,EP,A1,EP 3946137 A1,127-369-331-966-367,2022-02-09,2022,EP 20721023 A,2020-03-27,US 201962825078 P;;US 2020/0025286 W,2019-03-28,MEDICAL DEVICE SUSPENSION SYSTEM HAVING CABLE MANAGEMENT ASSEMBLY,,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HESER MICHAEL JOSEPH,,https://lens.org/127-369-331-966-367,Patent Application,yes,0,0,7,94,0,F16M13/027;;F16M2200/065;;A61B90/50;;A61B50/28;;A61B90/35;;F21V23/002;;F21W2131/205;;F21V21/26;;A61B50/28;;A61B90/50;;A61B2505/01;;A61B2505/05;;F16M13/027;;A61B90/35;;F16M11/2014,A61B90/50;;A61B50/28;;F16M13/02;;F21V23/00,,0,0,,,,PENDING
286,US,A,US 5260422 A,093-803-832-141-643,1993-11-09,1993,US 69084091 A,1991-04-23,US 69084091 A;;US 21059488 A;;US 57608490 A,1988-06-23,MHC conjugates useful in ameliorating autoimmunity,The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.,ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH L BERNARD,ANERGEN INC (1991-07-23);;ANERGEN INC. A DELAWARE CORPORATION (1998-06-30);;BIOSPAN CORPORATION A CORPORATION OF CA (1991-05-31),https://lens.org/093-803-832-141-643,Granted Patent,yes,11,83,5,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/4713;;C07K14/705;;C07K14/70539;;C07K14/78;;C07K2319/00;;C07K2319/33;;Y10S424/81;;Y10S530/868;;A61K47/6425;;A61K47/646;;A61P19/02;;A61P21/04;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;C07K14/4713;;C07K2319/00;;C07K14/70539;;A61K51/1234;;C07K14/705;;C07K14/78;;C07K2319/33;;A61K2039/605;;A61K2123/00;;A61K39/0008;;Y10S530/868;;Y10S424/81;;A61K47/6425;;A61K47/646,A61K39/00;;A61K39/385;;A61K47/48;;A61K51/12;;A61P19/02;;A61P21/04;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;C07K14/47;;C07K14/705;;C07K14/74;;C07K14/78;;C07K19/00,530/403;;530/402;;530/868;;424/88,69,60,034-275-533-046-869;;060-105-097-350-717;;060-105-097-350-717;;053-932-577-346-798;;080-116-588-558-925;;041-066-683-986-277;;020-833-428-096-595;;021-354-068-638-52X;;098-548-262-072-602;;119-098-412-359-014;;105-728-654-193-796;;000-877-662-644-595;;031-498-695-386-777;;150-992-421-090-985;;044-219-977-949-424;;024-957-936-929-004;;008-338-552-683-575;;006-246-100-575-580;;068-328-739-510-663;;076-183-945-466-427;;124-265-670-692-625;;001-809-294-160-846;;090-471-813-411-890;;028-483-482-274-317;;019-055-424-431-057;;016-820-517-785-643;;096-808-659-810-496;;064-376-665-222-650;;063-898-442-301-724;;045-722-267-072-669;;067-423-867-031-236;;186-072-679-623-966;;018-725-676-477-557;;106-021-817-946-64X;;034-144-538-771-410;;000-108-780-023-355;;004-446-132-457-064;;045-641-100-690-823;;081-916-336-734-306;;091-964-810-489-790;;005-060-637-433-679;;066-352-300-567-046;;023-077-406-743-876;;017-931-052-403-69X;;025-896-082-408-415;;026-409-307-851-000;;030-532-334-370-93X;;028-043-821-964-859;;036-979-322-661-093;;098-590-609-369-691;;031-989-718-683-43X;;078-039-663-716-551;;158-884-679-706-17X;;063-898-442-301-724;;107-925-387-406-499;;039-374-901-602-968;;086-024-104-550-397;;053-919-000-700-346;;021-720-457-509-673;;151-909-994-962-302,3876513;;10.1038/317359a0;;10.1038/329506a0;;3309677;;10.1038/329506a0;;3309677;;10.1126/science.2435001;;2435001;;3484557;;10.1126/science.3484557;;10.4049/jimmunol.133.5.2549;;6332854;;10.1146/annurev.immunol.5.1.477;;2439104;;10.1146/annurev.iy.05.040187.002401;;10.1126/science.3313727;;3313727;;6139673;;2578165;;10.1038/329482a0;;3498902;;10.1126/science.2437650;;2437650;;6334313;;10.1073/pnas.81.23.7564;;pmc392187;;2410926;;10.1073/pnas.82.16.5480;;pmc391146;;3297108;;10.1146/annurev.iy.05.040187.002333;;10.1021/bi00342a003;;3002421;;3257303;;10.1126/science.3257303;;10.1038/332840a0;;3258650;;10.1016/0161-5890(83)90147-5;;6197631;;3536124;;10.1016/0092-8674(86)90506-4;;10.1084/jem.164.5.1490;;pmc2188449;;2430042;;2966437;;10.1126/science.2966437;;10.1073/pnas.73.7.2481;;781677;;pmc430616;;3297338;;3317828;;10.1126/science.3317828;;pmc2185690;;10.1084/jem.150.5.1084;;91653;;10.1007/bf02918107;;3114395;;2457615;;10.4049/jimmunol.141.5.1451;;pmc553925;;10.1002/j.1460-2075.1987.tb02360.x;;2440673;;2419437;;2420472;;10.1016/0092-8674(86)90019-x;;10.1097/00007890-197310000-00005;;4200798;;1141219;;10.1016/s0021-9258(19)41332-x;;2824477;;10.1016/s0021-9258(18)47699-5;;pmc2187974;;2415664;;10.1084/jem.162.6.2107;;10.1038/317355a0;;2413363;;3004990;;10.1002/eji.1830160107;;2457547;;pmc1385051;;pmc2188516;;3029267;;10.1084/jem.165.2.302;;6210242;;10.1111/j.1600-065x.1984.tb01110.x;;6189936;;pmc2187023;;10.1084/jem.157.5.1434;;10.1038/308072a0;;6199675;;2420700;;pmc1453820;;10.1002/eji.1830171118;;2960547;;pmc1385193;;2968304;;10.1038/332161a0;;3279318;;85683;;pmc2184831;;10.1084/jem.149.3.758;;2953809;;3035012;;2450125;;10.1038/303625a0;;6343888;;10.1002/eji.1830150318;;3872218;;6170681;;pmc553925;;10.1002/j.1460-2075.1987.tb02360.x;;2440673;;2823150;;10.1038/330256a0;;3930971;;10.1038/317425a0;;10.1126/science.3194755;;3194755;;10.1126/science.2433769;;2433769;;10.1002/eji.1830100410;;6967410;;10.1016/0161-5890(83)90137-2;;6581382,"Babbitt, B. P. et al. (1985) Nature 317:359 361.;;Bjorkman, P. J. et al. (1987) Nature 329:506 512.;;Bjorkman, P. J. et al. (1987) Nature 329:512 518.;;Buus, S. et al. (1987) Science 235:1353 1358.;;Diener, E. et al. (1986) Science 231:148 150.;;Killen, J. A. et al. (1984) J. Immunol. 133:2549 2553.;;Livingstone, A. M. et al. (1987) Ann. Rev. Immunol. 5:477 501.;;Marx, J. L. (1987) Science 238:613 614.;;Paul, W. E. (1989) Fundamental Immunol. Raven Press, New York, pp. 69 73.;;Rennie, D. P. et al. (1983) The Lancet (Dec. 10) 1338 1340.;;Sterz, R. K. M. et al. (1985) J. Immunol. 134:841 846.;;Townsend, A. et al. (1987) Nature 329:482 483.;;Unanue, E. R. et al. (1987) Science 236:551 557.;;Watts, T. H. et al. (1984) Proc. Natl. Acad. Sci. USA 81:7564 7568.;;Watts, T. H. et al. (1985) Proc. Natl. Acad. Sci. USA 82:5480 5484.;;Watts, T. H. et al. (1987) Ann. Rev. Immunol. 5:461 475.;;Clemetson, K. J. et al. (1986) In Membrane proteins: A Laboratory Manual, Ed. Azzi, A. et al., pp. 57 64.;;Cooperman (1979) In Ribosomes Structure, Function, and Genetics. Ed. Chambliss et al. University Park Press, Baltimore, Md. pp. 531 554.;;Estess, P. et al. (1986) In Regulation of immune gene expression, Ed. Feldman, M. et al., Humana Press, pp. 3 19.;;Hall et al. (1985) Biochemistry 24:5702 5711.;;Harcourt, G. et al. (1987) Immunol. Today 8(11):(news and features section).;;Hixson, J. R. Medical Tribune (Jan. 24, 1985) pp. 4 5.;;Liu, M. A. et al. (1988) Science 239:395 398.;;Marrack, P. et al. (1988) Nature 332:840 842.;;Nakanishi, M. et al. (1983) Molec. Immunol. 20:1227 1231.;;Pastan, I. et al. (1986) Cell 47:641 648.;;Sekaly, R. P. et al. (1986) J. Exp. Med. 164:1490 1504.;;Shizuru, J. A. et al. (1988) Science 240:659 662.;;Springer, T. A. et al. (1976) Proc. Natl. Acad. Sci. USA 73:2481 2485.;;Sriram, S. et al. (1987) Concepts Immunopathol. 4:275 286.;;Vitetta, E. S. et al. (1987) Science 238:1098 1104.;;Watts, T. H. et al. (1988) In Processing and presentation of antigens, Academic Press, pp. 143 154.;;Binz, H. et al. (1979) J. Exp. Med. 150:1084 1097.;;Gasciogne, N. R. J. et al. (1987) Proc. Natl. Acad. Sci. USA. 84:2396 2340.;;Margulies, D. H. et al. (1987) Immunol. Res. 6:101 116.;;McCluskey, J. et al. (1988) J. Immunol. 141:1451 1455.;;Lamb et al. (1987) i EMBO J. 6:1245 1249.;;Berkower et al. (1986) J. Immunol. 136:2498 2502.;;Townsend et al. (1986) Cell 44:959 968.;;Sanderson et al. (1973) Transplantation 16:304 312.;;Turner et al. (1976) J. Biol. Chem. 250:4512 4519.;;Gorga et al. (1987) J. Biol. Chem. 262:16087 16094.;;Zamvil et al. (1985) J. Exp. Med. 162:2107 2124.;;Zamvil et al. (1985) Nature 317:355 358.;;Ceredig, R. et al. (1986) Eur. J. Immunol. 16:30 34.;;Essery, G. et al. (1988) Immunology 64:413 417.;;Jenkins, M. K. et al. (1987) J. Exp. Med. 165:302 319.;;Klein, J. (1984) Immunol. Reviews 81:177 202.;;Lamb, J. R. (1983) J. Exp. Med. 157:1434 1447.;;Lamb, J. R. (1984) Nature 308:72 74.;;Lamb, J. R. et al. (1986) Immunology 57:331 335.;;Lamb, J. R. et al. (1987) Eur. J. Immunol. 17:1641 1644.;;Larche, M. et al. (1988) Immunology 64:101 105.;;Madsen, J. C. et al. (1988) Nature 332:161 164.;;Miller, S. D. et al. (1979) J. Exp. Med. 149:758 773.;;Nau, G. J. et al. (1987) J. Immunol. 139:114 122.;;Quill, H. et al. (1987) J. Immunol. 138:3704 3712.;;Suzuki, G. et al. (1988) J. Immunol. 140:1359 1365.;;Zanders, E. D. et al. (1983) Nature 303:625 627.;;Zanders, E. D. et al. (1985) Eur. J. Immunol. 15:302 305.;;Germain, R. N. (1981) J. Immunol. 127:1964 1966.;;Lamb, J. R. et al. (1987) EMBO J. 6:1245 1249.;;Paul, W. F. (ed) Fund. Immunol. 1989 pp. 506 507, Raven Press, N.Y.;;Doyle, C. et al. Nature 330:256 259. Nov. 1987 Interaction between CP4 and Class II MHC . . . .;;Golding, H. et al. Nature 317:425 427, Oct. 1985, T cell recognition of a chimaeric class II . . . .;;Buss, S. et al. Science 242:1045 1047 (1988) Analogues peptides constitutively occupy the antigan bing site on Ig .;;Gvillet, J. et al. Science 235:865 870 (1987), Immunological self, non self discrimination .;;Puri, et al. Eur. J. Immunol. 10:273 281 (1980). Mechanism of antigen binding by T cells H 2 (I A) restricted binding of antigen plus, Ia by helper cells.;;Turkewicz, A. P. et al. Mol Immunol. 20(11):1139 1147, (1983), Large scale purification of murine IRK and I E k antigens and characterization of the purified proteins.",EXPIRED
287,CA,A,CA 535561 A,154-163-493-249-999,1957-01-08,1957,CA 535561D A,,CA 535561T A,,LAUNDRY WASHING MACHINES,,ISAAC BRAITHWAITE AND SON ENGI,PURVIS THOMAS J;;HOWLETT EDWARD J;;CLARK BERNARD A,,https://lens.org/154-163-493-249-999,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
288,KR,B1,KR 930002835 B1,012-576-944-300-703,1993-04-10,1993,KR 900700394 A,1990-02-23,US 21059488 A;;US 36775189 A;;US 8902784 W,1988-06-23,MHC-MEDIATED TOXIC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X<1>MHC<2>-peptide (1) or MHC<2>peptide<1>X (2), wherein X represents a labelling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen; <1> represents a covalent bond or a bivalent linker bound to X and MHC in formula (1) or to X and peptide in formula (2) by covalent bonds; and <2> represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to monitor the therapy of autoimmune diseases. <IMAGE>",BIOSPAN CORP,SHARMA SOMESH D;;BERNARD LERCH L;;CLARK BRYAN R,,https://lens.org/012-576-944-300-703,Granted Patent,no,0,0,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,A61K35/12;;A61K35/28;;A61K39/00;;G01N33/564;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,,0,0,,,,EXPIRED
289,SE,D0,SE 0001260 D0,018-119-673-780-024,2000-04-06,2000,SE 0001260 A,2000-04-06,US 94458597 A;;US 9820759 W,1997-10-06,Bredbandig effektförstärkare med hög verkningsgrad,,MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB FREDERICK H;;CLARK JAMES ROGER,,https://lens.org/018-119-673-780-024,Patent Application,no,0,0,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,,0,0,,,,EXPIRED
290,DE,A1,DE 1758657 A1,048-733-437-389-611,1971-04-15,1971,DE 1758657 A,1968-07-15,DE 1758657 A,1968-07-15,Verfahren und Einrichtung zum Giessen fluessiger Metalle in abgemessenen Mengen,,MODERN EQUIPMENT CO,D HIBBARD WILLIAM;;E CLARK JAMES;;R RAPP BERNARD,,https://lens.org/048-733-437-389-611,Patent Application,no,0,2,1,1,0,B22D39/06,B22D39/06,,0,0,,,,DISCONTINUED
291,EP,A1,EP 0527883 A1,088-381-254-815-002,1993-02-24,1993,EP 91909538 A,1991-05-11,GB 9010967 A,1990-05-16,HYDROPHILIC COLLOID COMPOSITION FOR A PHOTOGRAPHIC MATERIAL.,"A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula CF3(CF2)nCH2O(glycidyl)mH wherein n is an integer from 4 to 7; and, m is an integer from 6 to 45.",EASTMAN KODAK CO;;KODAK LTD,PITT ALAN ROBERT;;CLARK BERNARD ARTHUR;;PADDAY JOHN FRANK,KODAK LIMITED (1994-03-09);;EASTMAN KODAK COMPANY (1994-03-09),https://lens.org/088-381-254-815-002,Patent Application,yes,0,0,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,C09D7/12;;C09D189/00;;G03C1/38;;G03C1/85,,0,0,,,,EXPIRED
292,GB,A,GB 723660 A,100-171-185-573-405,1955-02-09,1955,GB 416252 A,1952-02-16,GB 416252 A;;US 33640453 A,1952-02-16,Improvements in laundry washing and similar machines,"723,660. Washing - machines. BRAITHWAITE & SON ENGINEERS, Ltd., I. Feb. 20, 1953 [Feb. 16, 1952; July 24, 1952], Nos. 4162/52 and 18716/52. Class 138 (2). A washing-machine comprising a rotating perforated horizontal cylinder arranged in an outer cylindrical casing P, has an external liquid circulating system including a tank H having an inlet from and outlet to the casing P and a float k<SP>1</SP> which controls a valve K in the fresh liquid supply pipe e<SP>4</SP> to the machine whereby when the liquid rises to a predetermined level in the machine and tank H the supply of fresh liquid is stopped, manually operated means (j<SP>1</SP>) being provided for preventing circulation of the liquid through the tank and machine and allowing fresh liquid to travel through the machine and then pass to waste. The circulation may be produced by a pump L or by a steam or other fluid injector. The casing P is connected by a pipe B to a scum tank G, the tanks G, H being connected through a valve J. The scum tank G is connected to a drain pipe g<SP>2</SP> through a stand pipe g<SP>1</SP> whose height is determined by the desired working level of the liquid. The pipe g<SP>2</SP> may be connected through a heat exchanger M to a drain pipe g<SP>6</SP>. Water entering the machine passes into the heat exchanger through a pipe e<SP>3</SP> and then through the pipe e<SP>4</SP> to the tank H. An additional valve g<SP>6</SP> enables sediment to be removed from the scum tank G. A filtering screen g<SP>3</SP> may be fitted in the tank G and a steam or electric heating element F in the tank H. A single tank divided by a partition may be employed instead of two separate tanks G, H. With the valve J open, water is circulated by the pump L through the machine P and tanks G, H, the valve K remaining closed due to the float k<SP>1</SP>. At the end of the washing process the valve J is closed and as the pump L continues to draw water from the tank H and deliver it to the machine the level in tank G rises until water overflows through the standpipe g<SP>1</SP> to the drain. The drop in level of liquid in tank H opens the float-controlled valve K, so that a continuous flow of water passes through the machine for rinsing purposes. In a modification, Fig. 1 (not shown), a single tank is employed, the connection to the washing-machine being provided with a steam or other fluid injection device. A manually-controlled valve closes either this connection or a drain pipe. Fresh water is supplied directly to the machine under the control of a float in a chamber connected to the tank. Specification 640,974 is referred to.",BRAITHWAITE I & SON ENG LTD,HOWLETT EDWARD JOHN;;PURVIS THOMAS JOSEPH;;CLARK BERNARD ARTHUR,,https://lens.org/100-171-185-573-405,Granted Patent,no,0,0,2,2,0,D06F39/08;;D06F39/08;;D06F1/08;;D06F1/08,D06F1/08;;D06F39/08,D1A ADC           ADC,0,0,,,,EXPIRED
293,EP,B9,EP 2806836 B9,101-292-925-064-356,2017-08-16,2017,EP 13741313 A,2013-01-25,US 201261590943 P;;US 201313748888 A;;US 2013/0023193 W,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE,,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/101-292-925-064-356,Amended Patent,yes,6,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00;;A61G13/12,,0,0,,,,ACTIVE
294,WO,A1,WO 1992/018150 A1,127-302-173-211-260,1992-10-29,1992,US 9203391 W,1992-04-23,US 69084091 A,1991-04-23,MHC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY,"The present invention is directed to complexes consisting essentially of an isolated MHC component and an antigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating deletrious immune responses, such as autoimmunity.",ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH BERNARD L,,https://lens.org/127-302-173-211-260,Patent Application,yes,1,44,5,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/4713;;C07K14/705;;C07K14/70539;;C07K14/78;;C07K2319/00;;C07K2319/33;;Y10S424/81;;Y10S530/868;;A61K47/6425;;A61K47/646;;A61P19/02;;A61P21/04;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;C07K14/4713;;C07K2319/00;;C07K14/70539;;A61K51/1234;;C07K14/705;;C07K14/78;;C07K2319/33;;A61K2039/605;;A61K2123/00;;A61K39/0008;;Y10S530/868;;Y10S424/81;;A61K47/6425;;A61K47/646,A61K39/00;;A61K39/385;;A61K47/48;;A61K51/12;;A61P19/02;;A61P21/04;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;C07K14/47;;C07K14/705;;C07K14/74;;C07K14/78;;C07K19/00,,7,7,096-808-659-810-496;;016-820-517-785-643;;014-300-096-906-168;;089-185-988-863-474;;091-964-810-489-790;;143-471-136-502-293;;110-581-800-873-544,10.1007/bf02918107;;3114395;;pmc2185690;;10.1084/jem.150.5.1084;;91653;;2583224;;10.1002/eji.1830191012;;10.1016/0952-7915(89)90104-0;;2692628;;6210242;;10.1111/j.1600-065x.1984.tb01110.x;;10.1016/0952-7915(89)90100-3;;10.1016/0952-7915(89)90108-8;;2575395,"Immunol. Res., Volume 6, issued 1987, MARGULIES et al., ""Engineering Soluble Molecules: Why and How"", pages 101-116, see entire article.;;J. Exp. Med., Volume 150, issued November 1979, BINZ et al., ""Binding of Purified Major Histocompatability Complex Polypeptide Chains onto Isolated T-cell Receptors"", pages 1084-1097, see entire article.;;Eur. J. Immunol., Volume 19, 1989, VILLAR et al., ""Detection of Soluble Class I Molecules (non HLA-A or HLA-B) in Serum Spleen Membranes and Lympocytes in Culture"", pages 1835-1839, see entire document.;;Curr. Opinion in Immunology, Volume 2, issued 1989, ROTHBARD, ""Major Histocompatibility Complex Peptide Interactions"", pages 99-105.;;Immunol. Reviews, No. 81, issued 1984, KLEIN, ""What Causes Immunological Non Responsiveness?"", pages 177-202, see entire article.;;Current Opinion in Immunology, Volume 2, issued 1989, J.B. ROTHBARD, ""Antigen Recognition"", pages 79-80, see entire document.;;Current Opinion in Immunology, Volume 2, issued 1989, V.C. SCHAD et al., ""T Cell Accessory Molecules Mediating Cell Adhesion and Signal Transduction"", pages 123-128, see entire article.",PATENTED
295,US,A,US 5773742 A,149-811-035-024-874,1998-06-30,1998,US 84834597 A,1997-04-30,US 84834597 A;;US 64212596 A;;US 44598595 A;;US 17783494 A,1994-01-05,Note assisted musical instrument system and method of operation,"A music system including a musical instrument, such as a keyboard strummer, in which the musical notes produced by the playing of the instrument are controlled by musical assistance data mapped unto the instrument keys and strum vanes from tracks specially prepared and synchronized with a prior performance of the piece. Modified mass media, such as CD ROM, TV signals and video cassettes are provided including synchronized note assist data and additional media, such as ROM packs or tone encoded audio cassettes or CDs, are provided with synchronizable note assist data for use with unmodified mass media.",EVENTOFF; FRANKLIN;;MOHRBACHER; BERNARD;;WILSON; KITCHENER CLARK;;GOLDSHOLL; KENNETH,EVENTOFF FRANKLIN;;MOHRBACHER BERNARD;;WILSON KITCHENER CLARK;;GOLDSHOLL KENNETH,,https://lens.org/149-811-035-024-874,Granted Patent,yes,33,32,1,16,0,G10H1/0008;;G10H1/0066;;G10H1/0558;;G10H1/342;;G10H1/344;;G10H1/361;;G10H7/002;;G10H2210/091;;Y10S84/22;;G10H1/0008;;G10H7/002;;G10H1/342;;G10H2210/091;;G10H1/0558;;G10H1/344;;G10H1/361;;G10H1/0066,G10H1/00;;G10H1/055;;G10H1/34;;G10H1/36;;G10H7/00,84/609;;84/613;;84/627;;X 84477 R;;X 84DIG  22,7,0,,,"Suzuki Corporation, Omnichord System 100, System 200m Operation Manual .;;Halaby et al, The MidiKeys Window , Visions, Professional Sequencing Software, 1989, Chapter 20, p. 331, published by OPCode Systems, Menlo Park, CA.;;Starr Switch Company, ZTAR, MIDI Fingerboard Controllers Starr Instruments brochure, 1993.;;Atari Unveils First Musical Instrument , The Music and Sound Retailer, Feb. Mar. 1988, pp. 1 & 22.;;Hotz Instrument Technology Systems, Product Summary, Hotz Instrument Technology, 11835 W. Olympic Blvd., W. Los Angeles, CA 90064.;;Mard Naman, Jimmy Hotz s MIDI Magic , START The ST Montly, Apr. 1989, pp. 21 26.;;Serge Modular Musical Systems, San Francisco, The Magic Band and Playing Band From Power On to Power Off, 1983.",EXPIRED
296,BR,A8,BR 112014018118 A8,165-798-019-931-032,2017-07-11,2017,BR 112014018118 A,2013-01-25,US 2013/0023193 W;;US 201261590943 P;;US 201313748888 A,2012-01-26,ALMOFADA SACRAL PARA UMA MESA MÉDICA,"ALMOFADA SACRAL PARA UMA MESA MÉDICA. Um apoio sacral para uma mesa cirúrgica, compreendendo uma chapa tendo dois espaçados - apart aberturas formadas nela. As aberturas são alinhadas ao longo do eixo da placa e descartado adjacente e uma extremidade da placa. Uma almofada é anexada à placa. A almofada é dimensionada tal que estão expostas as aberturas na placa. Um post de posicionamento é anexável ao prato. O post tem uma extremidade inferior, dimensionada para ser recebido nas aberturas na placa, em que o post é montável na placa em uma das duas posições diferentes.",AMERICAN STERILIZER CO,LANCE CLARK BELLOWS;;BERNARD J MOSS;;CHRISTOPHER D LABEDZ,,https://lens.org/165-798-019-931-032,Patent Application,no,0,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00,,0,0,,,,ACTIVE
297,IN,A,IN 6090DEN2014 A,034-890-042-127-570,2015-07-31,2015,IN 6090DEN2014 A,2014-07-19,US 201261590943 P;;US 201313748888 A;;US 2013/0023193 W,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE,A sacral support for a surgical table comprising a plate having two spaced apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate wherein the post is mountable in the plate in one of two different positions.,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/034-890-042-127-570,Patent Application,no,0,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00,,0,0,,,,PENDING
298,DE,C,DE 958193 C,081-005-297-459-77X,1957-02-14,1957,DE B0024345 A,1953-02-19,DE B0024345 A,1953-02-19,Waschmaschine mit einer aussen an der Maschine befindlichen Fluessigkeitsfuehrung,,BRAITHWAITE I & SON ENG LTD,HOWLETT EDWARD JOHN;;PURVIS THOMAS JOSEPH;;CLARK BERNARD ARTHUR,,https://lens.org/081-005-297-459-77X,Granted Patent,no,7,2,2,2,0,D06F39/08;;D06F39/20;;D06F39/006;;D06F39/08,D06F39/00;;D06F39/08,,0,0,,,,EXPIRED
299,AU,A1,AU 2020/245640 A1,084-415-737-068-221,2021-10-28,2021,AU 2020/245640 A,2020-03-27,US 201962825078 P;;US 2020/0025286 W,2019-03-28,Medical device suspension system having cable management assembly,"A medical device suspension system includes a spindle extending along a longitudinal axis and a cable management cover surrounding the spindle. A gap is formed between the cable management cover and the spindle. A hub is rotatably mounted to the spindle and includes a housing. A top hub cover is disposed along the longitudinal axis between the hub and the cable management cover and defines an end of the gap, the top hub cover including a passage in fluid communication with an internal volume of the housing. The top hub cover is rotatable with respect to the spindle about the longitudinal axis. A cable is provided within the gap, the cable entering the gap at a fixed location about the longitudinal axis and passing into the housing through the passage. Rotation of the top hub cover about the longitudinal axis causes the passage to rotate about the longitudinal axis.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HESER MICHAEL JOSEPH,,https://lens.org/084-415-737-068-221,Patent Application,no,0,0,7,94,0,F16M13/027;;F16M2200/065;;A61B90/50;;A61B50/28;;A61B90/35;;F21V23/002;;F21W2131/205;;F21V21/26;;A61B50/28;;A61B90/50;;A61B2505/01;;A61B2505/05;;F16M13/027;;A61B90/35;;F16M11/2014,A61B90/50;;A61B50/28;;F16M13/02;;F21V23/00,,0,0,,,,ACTIVE
300,EP,A1,EP 0423201 A1,150-172-160-092-62X,1991-04-24,1991,EP 89908127 A,1989-06-23,US 21059488 A;;US 36775189 A;;US 8902784 W,1988-06-23,MHC-MEDIATED TOXIC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY.,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X<1>MHC<2>-peptide (1) or MHC<2>peptide<1>X (2), wherein X represents a labelling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen; <1> represents a covalent bond or a bivalent linker bound to X and MHC in formula (1) or to X and peptide in formula (2) by covalent bonds; and <2> represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to monitor the therapy of autoimmune diseases. <IMAGE>",BIOSPAN CORP,SHARMA SOMESH D;;LERCH L BERNARD;;CLARK BRIAN R,"ANERGEN, INC. (1996-10-01);;C.N.ME EPO REG.92;ANERGEN INC. (1996-06-07);;BIOSPAN CORPORATION TRANSFER- ANERGEN, INC. (1996-07-31)",https://lens.org/150-172-160-092-62X,Patent Application,yes,0,4,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,G01N33/564;;A61K35/12;;A61K35/28;;A61K39/00;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,,0,0,,,,EXPIRED
301,WO,A1,WO 1997/020664 A1,192-437-351-190-278,1997-06-12,1997,US 9619479 W,1996-12-09,US 56974495 A,1995-12-08,APPARATUS FOR CONNECTING SHOELACE EYELETS WITH A PLASTIC FASTENER,"An apparatus (41) for use in tying together a pair of opposing shoelace eyelets of a shoe upper with a plastic fastener (11) of the type comprising a flexible filament (17) having a cross-bar (13) disposed at one end thereof and a paddle (15) comprising an opening (19-1) disposed at the opposite end thereof. The apparatus (41) includes a hollow slotted needle (67-2) insertable through the pair of opposing shoelace eyelets and the opening (19-1) in the paddle (15), a paddle positioning assembly (55-2) for aligning the opening (19-1) in the paddle (15) with the pair of opposing shoelace eyelets, a cross-bar aligning assembly (69-2) for aligning the cross-bar (13) with the needle (67-2), and a cross-bar dispensing assembly (153-2) for inserting the aligned cross-bar (13) into the needle (67-2) and ejecting the cross-bar (13) first through the needle (67-2) and then through the pair of opposing shoelace eyelets and the opening (19-1) in the paddle (15).",AVERY DENNISON CORP;;GRENDOL CLARK L;;BERNARD ROBERT;;KORDIS KEVIN;;STERGIOU CHRIS,GRENDOL CLARK L;;BERNARD ROBERT;;KORDIS KEVIN;;STERGIOU CHRIS,,https://lens.org/192-437-351-190-278,Patent Application,yes,5,4,3,3,0,A43D98/00;;A43D98/00;;B65C7/008;;B65C7/008;;Y10T24/4691;;Y10T24/4691,A43D98/00;;B65C7/00,,0,0,,,,PENDING
302,TW,A,TW 200302268 A,031-135-212-701-371,2003-08-01,2003,TW 91137732 A,2002-12-27,US 3786302 A,2002-01-02,Thermal barriers with solid/solid phase change materials,"A thermal barrier comprises a first barrier layer, a second barrier layer, and a temperature regulating material positioned between the first barrier layer and the second barrier layer. The temperature regulating material comprises a solid/solid phase change material in a powdered form, and the first barrier layer is bonded to the second barrier layer to enclose the temperature regulating material within the thermal barrier. The thermal barrier may be used or incorporated in various products or applications where thermal management is desired. For example, the thermal barrier may be used in textiles, apparel, footwear, medical products, containers and packagings, buildings, appliances, and other products.",OUTLAST TECHNOLOGIES INC,CLARK DUSTIN L;;MAGILL MONTE C;;PERRY BERNARD T,,https://lens.org/031-135-212-701-371,Patent of Addition,no,0,0,5,5,0,E04B1/7662;;E04B1/78;;F25D2201/122;;Y10T428/1352;;Y02B40/00;;Y10T428/1352;;E04B1/78;;E04B1/7662;;F25D2201/122;;Y02B40/00,C09K5/14;;B32B7/02;;E04B1/76;;E04B1/78,,0,0,,,,EXPIRED
303,US,B2,US 8683631 B2,051-431-272-040-722,2014-04-01,2014,US 201313748888 A,2013-01-24,US 201313748888 A;;US 201261590943 P,2012-01-26,Sacral pad for a medical table,"A sacral support for a surgical table, comprising a plate having two spaced-apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,AMERICAN STERILIZER COMPANY (2013-01-23),https://lens.org/051-431-272-040-722,Granted Patent,yes,22,26,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61G13/12,5/624;;5/600;;5/621;;128/845,1,0,,,"Int'l Search Report from corresponding Int'l App. No. PCT/US2013/023193, issued on Mar. 21, 2013; 2 pages.",ACTIVE
304,US,A1,US 2003/0068363 A1,123-819-179-253-169,2003-04-10,2003,US 19999502 A,2002-07-19,US 19999502 A;;US 60280700 A;;US 46235195 A;;US 86929392 A;;US 69084091 A;;US 57608490 A;;US 21059488 A,1988-06-23,MHC conjugates useful in ameliorating autoimmunity,"
   The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease. 
",ANERGEN INC A WHOLLY OWNED SUB,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH BERNARD L,,https://lens.org/123-819-179-253-169,Patent Application,yes,0,28,3,32,0,A61K39/0008;;A61K39/0008;;A61K47/6425;;A61K47/6425;;A61K47/646;;A61K47/646;;A61K51/1234;;A61K51/1234;;A61K2039/605;;A61K2039/605;;A61K2123/00;;A61K2123/00;;A61P37/06;;C07K14/4713;;C07K14/4713;;C07K14/705;;C07K14/705;;C07K14/70539;;C07K14/70539;;C07K14/70571;;C07K14/70571;;C07K14/78;;C07K14/78;;C07K2319/00;;C07K2319/00;;Y10S530/868;;Y10S530/868,A61K39/00;;A61K47/48;;A61K51/12;;A61P37/06;;C07K14/47;;C07K14/705;;C07K14/74;;C07K14/78,42445;;424/185.1;;X53035,0,0,,,,DISCONTINUED
305,WO,A1,WO 2013/112870 A1,135-333-093-851-85X,2013-08-01,2013,US 2013/0023193 W,2013-01-25,US 201261590943 P;;US 201313748888 A,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE,"A sacral support for a surgical table, comprising a plate having two spaced- apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/135-333-093-851-85X,Patent Application,yes,5,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00,,1,0,,,See also references of EP 2806836A4,PENDING
306,WO,A1,WO 1989/012459 A1,170-974-897-702-744,1989-12-28,1989,US 8902784 W,1989-06-23,US 21059488 A;;US 36775189 A,1988-06-23,MHC-MEDIATED TOXIC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X1MHC2peptide or MHC?2peptide1¿X, wherein X represents a functional moiety selected from a toxin and a labeling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ''peptide'' represents an antigenic peptide sequence associated with an autoantigen; 1 represents a covalent bond or a linker bound to X and MHC or to X and peptide by covalent bonds; and 2 represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to target helper T-cells which are specifically immunoreactive with autoantigens.",BIOSPAN CORP,SHARMA SOMESH D;;LERCH L BERNARD;;CLARK BRIAN R,,https://lens.org/170-974-897-702-744,Patent Application,yes,5,19,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,A61K35/12;;A61K35/28;;A61K39/00;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;G01N33/564;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,,4,4,041-066-683-986-277;;021-720-457-509-673;;000-877-662-644-595;;019-055-424-431-057,10.4049/jimmunol.133.5.2549;;6332854;;10.1002/eji.1830100410;;6967410;;10.1126/science.2437650;;2437650;;3317828;;10.1126/science.3317828,"Journal of Immunology, Vol. 133(5):2549-2553. 1984. J.A. KILLEN et al ""Specific Killing of Lymphocytes that cause Experimental Autoimmune Myasthenia Gravis by Ricin Toxinacetylcholine Receptor Conjugates.;;European Journal of Immunology, Vol. 10:273-281. 1980 J. PURI et al. ""Mechanism of Antigen binding by T-Cells. . ."" see Abstract;;Science Vol. 236:551-557. May 1987. E.R. UNANUE et al. ""The Basis for the Immuno-Regulatory Role of Macrophages and other Accessory Cells.;;Science Vol. 238:1098-1104. Nov 1987. E.S. VITETTA, et al. ""Redesigning Nature's Poisons to Create Anti-Tumor Reagents.",PATENTED
307,WO,A9,WO 2004/050130 A9,182-057-359-431-446,2004-07-29,2004,US 0337803 W,2003-11-26,US 42988002 P;;US 47148503 P;;US 48684903 P;;US 49550003 P;;US 49619503 P,2002-11-27,"UV FLUX MULTIPLICATION SYSTEM FOR STERILIZING AIR, MEDICAL DEVICES AND OTHER MATERIALS","An ultraviolet flux multiplying air sterilization chamber (1500) comprising inner surfaces having a diffuse reflective behavior. The sterilization chamber includes an inlet aperture (1508) and an outlet aperture (1509) for air flow through said chamber and a light source (1503) emitting an ultraviolet light. Due to the reflectivity of the inner surfaces of the chamber, a flux of the ultraviolet light is multiplied by reflecting multiple times from the inner surfaces of the chamber. The inlet and outlet apertures (1508, 1509) are advantageously configured to reduce the amount of light that escapes from the chamber and increase the amount of photons available in the chamber. In an exemplary embodiment, packed arrays (1202, 1203) of fibers, spheres, or other small particles are placed at the inlet (1508) and/or outlet (1509) to the chamber. These packed arrays (1202, 1203) provide light scattering events such that the light incident on the packed arrays reflects back with high reflectivity.",NOVATRON INC;;CLARK REGINALD W;;EASTLUND BERNARD J;;INGRAM MICHAEL W,CLARK REGINALD W;;EASTLUND BERNARD J;;INGRAM MICHAEL W,,https://lens.org/182-057-359-431-446,Patent Application,no,0,0,4,4,0,A61L9/205;;A61L9/205;;A61L2209/16;;A61L2209/16;;F24F8/22;;F24F8/22;;Y02A50/20;;Y02A50/20,A61L9/20,,0,0,,,,PENDING
308,US,B1,US 6451314 B1,182-383-424-035-858,2002-09-17,2002,US 60280700 A,2000-06-23,US 60280700 A;;US 46235195 A;;US 86929392 A;;US 69084091 A;;US 57608490 A;;US 21059488 A,1988-06-23,MHC conjugates useful in ameliorating autoimmunity,"
    The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease. 
",ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH BERNARD L,,https://lens.org/182-383-424-035-858,Granted Patent,yes,11,20,3,32,10,A61K39/0008;;A61K39/0008;;A61K47/6425;;A61K47/6425;;A61K47/646;;A61K47/646;;A61K51/1234;;A61K51/1234;;A61K2039/605;;A61K2039/605;;A61K2123/00;;A61K2123/00;;A61P37/06;;C07K14/4713;;C07K14/4713;;C07K14/705;;C07K14/705;;C07K14/70539;;C07K14/70539;;C07K14/70571;;C07K14/70571;;C07K14/78;;C07K14/78;;C07K2319/00;;C07K2319/00;;Y10S530/868;;Y10S530/868,A61K39/00;;A61K47/48;;A61K51/12;;A61P37/06;;C07K14/47;;C07K14/705;;C07K14/74;;C07K14/78,424/185.1;;424/193.1,70,63,036-979-322-661-093;;034-275-533-046-869;;060-105-097-350-717;;060-105-097-350-717;;053-932-577-346-798;;080-116-588-558-925;;041-066-683-986-277;;020-833-428-096-595;;021-354-068-638-52X;;021-720-457-509-673;;098-548-262-072-602;;119-098-412-359-014;;105-728-654-193-796;;151-909-994-962-302;;000-877-662-644-595;;031-498-695-386-777;;150-992-421-090-985;;044-219-977-949-424;;053-919-000-700-346;;024-957-936-929-004;;008-338-552-683-575;;006-246-100-575-580;;068-328-739-510-663;;076-183-945-466-427;;124-265-670-692-625;;001-809-294-160-846;;090-471-813-411-890;;028-483-482-274-317;;019-055-424-431-057;;016-820-517-785-643;;096-808-659-810-496;;064-376-665-222-650;;063-898-442-301-724;;045-722-267-072-669;;067-423-867-031-236;;186-072-679-623-966;;018-725-676-477-557;;106-021-817-946-64X;;034-144-538-771-410;;000-108-780-023-355;;004-446-132-457-064;;045-641-100-690-823;;081-916-336-734-306;;091-964-810-489-790;;005-060-637-433-679;;066-352-300-567-046;;023-077-406-743-876;;017-931-052-403-69X;;025-896-082-408-415;;026-409-307-851-000;;030-532-334-370-93X;;028-043-821-964-859;;036-979-322-661-093;;098-590-609-369-691;;031-989-718-683-43X;;078-039-663-716-551;;158-884-679-706-17X;;063-898-442-301-724;;086-024-104-550-397;;002-977-470-822-87X;;030-673-092-294-514;;003-196-437-484-850;;013-753-648-999-581,3035012;;3876513;;10.1038/317359a0;;10.1038/329506a0;;3309677;;10.1038/329506a0;;3309677;;10.1126/science.2435001;;2435001;;3484557;;10.1126/science.3484557;;10.4049/jimmunol.133.5.2549;;6332854;;10.1146/annurev.immunol.5.1.477;;2439104;;10.1146/annurev.iy.05.040187.002401;;10.1126/science.3313727;;3313727;;10.1002/eji.1830100410;;6967410;;6139673;;2578165;;10.1038/329482a0;;3498902;;10.1016/0161-5890(83)90137-2;;6581382;;10.1126/science.2437650;;2437650;;6334313;;10.1073/pnas.81.23.7564;;pmc392187;;2410926;;10.1073/pnas.82.16.5480;;pmc391146;;3297108;;10.1146/annurev.iy.05.040187.002333;;10.1126/science.2433769;;2433769;;10.1021/bi00342a003;;3002421;;3257303;;10.1126/science.3257303;;10.1038/332840a0;;3258650;;10.1016/0161-5890(83)90147-5;;6197631;;3536124;;10.1016/0092-8674(86)90506-4;;10.1084/jem.164.5.1490;;pmc2188449;;2430042;;2966437;;10.1126/science.2966437;;10.1073/pnas.73.7.2481;;781677;;pmc430616;;3297338;;3317828;;10.1126/science.3317828;;pmc2185690;;10.1084/jem.150.5.1084;;91653;;10.1007/bf02918107;;3114395;;2457615;;10.4049/jimmunol.141.5.1451;;pmc553925;;10.1002/j.1460-2075.1987.tb02360.x;;2440673;;2419437;;2420472;;10.1016/0092-8674(86)90019-x;;10.1097/00007890-197310000-00005;;4200798;;1141219;;10.1016/s0021-9258(19)41332-x;;2824477;;10.1016/s0021-9258(18)47699-5;;pmc2187974;;2415664;;10.1084/jem.162.6.2107;;10.1038/317355a0;;2413363;;3004990;;10.1002/eji.1830160107;;2457547;;pmc1385051;;pmc2188516;;3029267;;10.1084/jem.165.2.302;;6210242;;10.1111/j.1600-065x.1984.tb01110.x;;6189936;;pmc2187023;;10.1084/jem.157.5.1434;;10.1038/308072a0;;6199675;;2420700;;pmc1453820;;10.1002/eji.1830171118;;2960547;;pmc1385193;;2968304;;10.1038/332161a0;;3279318;;85683;;pmc2184831;;10.1084/jem.149.3.758;;2953809;;3035012;;2450125;;10.1038/303625a0;;6343888;;10.1002/eji.1830150318;;3872218;;6170681;;pmc553925;;10.1002/j.1460-2075.1987.tb02360.x;;2440673;;10.1126/science.3194755;;3194755;;10.1073/pnas.88.24.11465;;pmc53156;;1722335;;1372021;;1370312;;10.1016/0022-1759(91)90297-s;;1717592,"Quill and Schwartz Journal of Immunology 138:3704-3712, 1987.*;;Babbitt, B.P. et al. (1985) Nature 317: 359-361.;;Bjorkman, P.J. et al. (1987) Nature 329: 506-512.;;Bjorkman, P.J. et al. (1987) Nature 329: 512-518.;;Buus, S. et al. (1987) Science 235: 1353-1358.;;Diener, E. et al. (1986) Science 231: 148-150.;;Killen, J.A. et al. (1984) J. Immunol. 133: 2549-2553.;;Livingstone, A.M. et al. (1987) Ann. Rev. Immunol. 5: 477-501.;;Marx, J.L. (1987) Science 238: 613-614.;;Paul, W.E. (1989) Fundamental Immunol. Raven Press, New York, pp. 69-73.;;Puri, J. et al. (1980) Eur. J. Immunol. 10: 273-281.;;Rennie, D.P. et al. (1983) The Lancet (Dec. 10) 1338-1340.;;Sterz, R.K.M. et al. (1985) J. Immunol. 134: 841-846.;;Townsend, A. et al. (1987) Nature 329: 482-483.;;Turkewitz, A.P. et al. (1983) Molec. Immunol. 20: 1139-1147.;;Unanue, E.R. et al. (1987) Science 236: 551-557.;;Watts, T.H. et al. (1984) Proc. Natl. Acad. Sci. USA 81: 7564-7568.;;Watts, T.H. et al. (1985) Proc. Natl. Acad. Sci. USA 82: 5480-5484.;;Watts, T.H. et al. (1987) Ann. Rev. Immunol. 5: 461-475.;;Clemetson, K.J. et al. (1986) In Membrane proteins: A Laboratory Manual, Ed. Azzi, A. et al., pp. 57-64.;;Cooperman (1979) In Ribosomes Structure, Function, and Genetics. Ed. Chambliss et al. University Park Press, Baltimore MD. pp. 531-554.;;Estess, P. et al. (1986) In Regulation of immune gene expression, Ed. Feldman, M. et al., Humana Press, pp. 3-19.;;Guillet et al. (1987) Science 235: 865-870.;;Hall et al. (1985) Biochemistry 24: 5702-5711.;;Harcourt, G. et al. (1987) Immunol. Today 8 (11): (news and features section).;;Liu, M.A. et al. (1988) Science 239: 395-398.;;Marrack, P. et al. (1988) Nature 332: 840-842.;;Nakanishi, M. et al. (1983) Molec. Immunol. 20: 1227-1231.;;Pastan, I. et al. (1986) Cell 47: 641-648.;;Sekaly, R.P. et al. (1986) J. Exp. Med. 164: 1490-1504.;;Shizuru, J.A. et al. (1988) Science 240: 659-662.;;Springer, T.A. et al. (1976) Proc. Natl. Acad. Sci. USA 73: 2481-2485.;;Sriram, S. et al. (1987) Concepts Immunopathol. 4: 275-286.;;Vitetta, E.S. et al. (1987) Science 238: 1098-1104.;;Watts, T.H. et al. (1988) In Processing and presentation of antigens, Academic Press, pp. 143-154.;;Binz, H. et al. (1979) J. Exp. Med. 150: 1084-1097.;;Gasciogne, N.R.J. et al. (1987) Proc. Natl. Acad. Sci. USA. 84: 2396-2340.;;Margulies, D.H. et al. (1987) Immunol. Res. 6: 101-116.;;McCluskey, J. et al. (1988) J. Immunol. 141: 1451-1455.;;Lamb et al. (1987) EMBO J. 6: 1245-1249.;;Berkower et al. (1986) J. Immunol. 136: 2498-2502.;;Townsend et al. (1986) Cell 44: 959-968.;;Sanderson et al. (1973) Transplantation 16: 304-312.;;Turner et al. (1976) J. Biol. Chem. 250: 4512-4519.;;Gorga et al. (1987) J. Biol. Chem. 262: 16087-16094.;;Zamvil et al. (1985) J. Exp. Med. 162: 2107-2124.;;Zamvil et al. (1985) Nature 317: 355-358.;;Ceredig, R. et al. (1986) Eur. J. Immunol. 16: 30-34.;;Essery, G. et al. (1988) Immunology 64: 413-417.;;Jenkins, M.K. et al. (1987) J. Exp. Med. 165: 302-319.;;Klein, J. (1984) Immunol. Reviews 81: 177-202.;;Lamb, J.R. (1983) J. Exp. Med. 157: 1434-1447.;;Lamb, J.R. (1984) Nature 308: 72-74.;;Lamb, J.R. et al. (1986) Immunology 57: 331-335.;;Lamb, J.R. et al. (1987) Eur. J. Immunol. 17: 1641-1644.;;Larche, M. et al. (1988) Immunology 64: 101-105.;;Madsen, J.C. et al. (1988) Nature 332: 161-164.;;Miller, S.D. et al. (1979) J. Exp. Med. 149: 758-773.;;Nau, G.J. et al. (1987) J. Immunol. 139: 114-122.;;Quill, H. et al. (1987) J. Immunol. 138: 3704-3712.;;Suzuki, G. et al. (1988) J. Immunol. 140: 1359-1365.;;Zanders, E.D. et al. (1983) Nature 303: 625-627.;;Zanders, E.D. et al. (1985) Eur. J. Immunol. 15: 302-305.;;Germain, R.N. (1981) J. Immunol. 127:1964-1966.;;Lamb, J.R. et al. (1987) EMBO J. 6:1245-1249.;;Buss, S. et al. (1988) Science 242:1045-1047.;;Sharma, S.D. et al. (1991) Proc. Natl. Acad. Sci. USA 88:11465-11469.;;Nag, B. et al. (1992) J. of Immunol. 148(7):2040-2044.;;Nag, B. et al. (1992) J. of Immunol. 148(2):369-372.;;Nag, B. et al. (1991) J. of Immunological Methods 142:105-111.",EXPIRED
309,CA,C,CA 2862302 C,020-731-165-907-300,2015-06-16,2015,CA 2862302 A,2013-01-25,US 201261590943 P;;US 201313748888 A;;US 2013/0023193 W,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE,"A sacral support for a surgical table, comprising a plate having two spaced- apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/020-731-165-907-300,Granted Patent,no,0,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61G13/12;;A61G13/00,,0,0,,,,ACTIVE
310,US,A,US 5474889 A,019-678-439-668-023,1995-12-12,1995,US 33552994 A,1994-11-07,US 33552994 A;;GB 9010967 A;;US 95271992 A,1990-05-16,Hydrophilic colloid composition for a photographic material,"A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula CF.sub.3 (CF.sub.2).sub.n CH.sub.2 O(glycidyl).sub.m H wherein n is an integer from 4 to 7; and, m is an integer from 6 to 45.",EASTMAN KODAK CO,PITT ALAN R;;CLARK BERNARD A;;PADDAY JOHN F,,https://lens.org/019-678-439-668-023,Granted Patent,yes,6,1,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,C09D7/12;;C09D189/00;;G03C1/85;;G03C1/38,430/631;;430/523;;430/637;;430/639;;430/640;;430/642;;430/961,1,0,,,"Waterproofing And Water Repellancy , J. L. Moillet, 1963, Elsevier Publishing Co., London, p. 142.",EXPIRED
311,EP,A1,EP 0630255 A1,066-521-273-112-824,1994-12-28,1994,EP 92911380 A,1992-04-23,US 69084091 A;;US 9203391 W;;US 86929392 A,1991-04-23,MHC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY.,"La présente invention vise des complexes constitués essentiellement d'un composant isolé CMH et d'un peptide antigène associé au site de liaison d'antigène du composant CMH. Ces complexes permettent de traiter les réactions immunitaires néfastes, telles que l'auto-immunité.",ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH BERNARD L,"COULTER PHARMACEUTICAL, INC. (2003-05-30)",https://lens.org/066-521-273-112-824,Patent Application,yes,0,4,6,32,0,,A61K38/00;;A61K39/00;;A61K39/385;;A61P21/04;;A61P25/00;;A61P37/02;;A61P37/06;;A61P37/08;;C07K7/04;;C07K14/47;;C07K14/74;;C07K19/00,,0,0,,,,EXPIRED
312,GB,A,GB 793630 A,083-135-003-850-393,1958-04-23,1958,GB 3734854 A,1954-12-24,GB 3734854 A,1954-12-24,Improvements in and relating to a device for measuring and recording the density of a liquid,"793,630. Electric measuring systems. IMPERIAL CHEMICAL INDUSTRIES, Ltd. Dec. 2, 1955 [Dec. 24, 1954], No. 37348/54. Class 40 (1). Apparatus for measuring the density of a liquid flowing in a pipe 1 (Fig. 1) comprises a float 2 suspended on a balance beam 3 with a counterbalance 4, the float carrying a soft iron wire 6 located inside a coil system 9 comprising an A.C.-energized primary winding 21 (Fig. 2) and two similar secondary windings 22, 23, whereby the density of the liquid controls the vertical position of the wire 26, which can be determined by measuring the relative inductance of the secondary windings 22, 23 in a bridge circuit, the unbalance voltage at 11, 16, after compensation by a separate bridge having a temperature-sensitive resistor arm 14 located in the liquid, being fed to a recording meter. The average position of the beam 3 is coaxial with the pipe 1, and the wire 6 is hinged to the float 2 so as to move vertically. Specification 761,880 is referred to.",ICI LTD,CLARK WILLIAM JASPER;;STEPHENS ROBERT CHARLES;;RAMSAY BERNARD WALTER,,https://lens.org/083-135-003-850-393,Granted Patent,no,0,3,1,1,0,G01N9/16,G01N9/16,G1N NADD          ADD;;G1N N1A3A         EZ;;G1N N1C           EZ;;G1N N1D13         EZ;;G1N N1D7          EZ;;G1N N1F           EZ;;G1N N1M           EZ;;G1N N3S1A         EZ;;G1N N7A1          EZ;;G1N N7H1          EZ,0,0,,,,EXPIRED
313,CA,A1,CA 2862302 A1,118-873-540-936-427,2013-08-01,2013,CA 2862302 A,2013-01-25,US 201261590943 P;;US 201313748888 A;;US 2013/0023193 W,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE,"A sacral support for a surgical table, comprising a plate having two spaced- apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/118-873-540-936-427,Patent Application,no,0,1,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61G13/12;;A61G13/00,,0,0,,,,ACTIVE
314,US,A,US 3465916 A,132-241-231-756-942,1969-09-09,1969,US 3465916D A,1968-02-23,US 70767368 A,1968-02-23,METHOD AND SYSTEM FOR POURING LIQUID METAL BY MEASURED VOLUME,,MODERN EQUIPMENT CO,HIBBARD WILLIAM D;;CLARK JAMES E;;RAPP BERNARD R,MODERN EQUIPMENT COMPANY INC (1984-02-17);;ALCO INDUSTRIES INC (1984-02-17),https://lens.org/132-241-231-756-942,Granted Patent,no,5,4,1,1,0,B22D39/06;;B22D39/06,B22D39/06,222/70,0,0,,,,EXPIRED
315,US,A,US 5974859 A,147-476-044-678-265,1999-11-02,1999,US 2069798 A,1998-02-09,US 2069798 A,1998-02-09,"Method and apparatus for measuring coupled flow, transport, and reaction processes under liquid unsaturated flow conditions","The present invention is a method and apparatus for measuring coupled flow, transport and reaction processes under liquid unsaturated flow conditions. The method and apparatus of the present invention permit distinguishing individual precipitation events and their effect on dissolution behavior isolated to the specific event. The present invention is especially useful for dynamically measuring hydraulic parameters when a chemical reaction occurs between a particulate material and either liquid or gas (e.g. air) or both, causing precipitation that changes the pore structure of the test material.",BATTELLE MEMORIAL INSTITUTE,MCGRAIL BERNARD P;;MARTIN PAUL F;;LINDENMEIER CLARK W,BATTELLE MEMORIAL INSTITUTE K1-53 (1998-02-06),https://lens.org/147-476-044-678-265,Granted Patent,yes,7,2,1,1,0,G01N15/0826;;G01N15/0826,G01N15/08,73/38;;73/152.05,0,0,,,,EXPIRED
316,US,A,US 6106840 A,153-025-209-536-017,2000-08-22,2000,US 46235195 A,1995-06-05,US 46235195 A;;US 86929392 A;;US 69084091 A;;US 57608490 A;;US 21059488 A,1988-06-23,MHC conjugates useful in ameliorating autoimmunity,The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.,ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH BERNARD L,ANERGEN INC. A DELAWARE CORPORATION (1998-06-30),https://lens.org/153-025-209-536-017,Granted Patent,yes,10,25,3,32,10,A61K39/0008;;A61K39/0008;;A61K47/6425;;A61K47/6425;;A61K47/646;;A61K47/646;;A61K51/1234;;A61K51/1234;;A61K2039/605;;A61K2039/605;;A61K2123/00;;A61K2123/00;;A61P37/06;;C07K14/4713;;C07K14/4713;;C07K14/705;;C07K14/705;;C07K14/70539;;C07K14/70539;;C07K14/70571;;C07K14/70571;;C07K14/78;;C07K14/78;;C07K2319/00;;C07K2319/00;;Y10S530/868;;Y10S530/868,A61K39/00;;A61K47/48;;A61K51/12;;A61P37/06;;C07K14/47;;C07K14/705;;C07K14/74;;C07K14/78,424/195.11;;424/185.1;;530/300;;530/350;;530/395;;530/403;;530/868,66,58,034-275-533-046-869;;060-105-097-350-717;;053-932-577-346-798;;080-116-588-558-925;;041-066-683-986-277;;020-833-428-096-595;;021-354-068-638-52X;;021-720-457-509-673;;098-548-262-072-602;;119-098-412-359-014;;105-728-654-193-796;;151-909-994-962-302;;000-877-662-644-595;;031-498-695-386-777;;150-992-421-090-985;;044-219-977-949-424;;053-919-000-700-346;;024-957-936-929-004;;008-338-552-683-575;;006-246-100-575-580;;068-328-739-510-663;;076-183-945-466-427;;124-265-670-692-625;;001-809-294-160-846;;090-471-813-411-890;;028-483-482-274-317;;019-055-424-431-057;;016-820-517-785-643;;096-808-659-810-496;;064-376-665-222-650;;063-898-442-301-724;;045-722-267-072-669;;067-423-867-031-236;;186-072-679-623-966;;018-725-676-477-557;;106-021-817-946-64X;;034-144-538-771-410;;000-108-780-023-355;;004-446-132-457-064;;045-641-100-690-823;;081-916-336-734-306;;091-964-810-489-790;;005-060-637-433-679;;066-352-300-567-046;;023-077-406-743-876;;017-931-052-403-69X;;025-896-082-408-415;;026-409-307-851-000;;030-532-334-370-93X;;028-043-821-964-859;;036-979-322-661-093;;098-590-609-369-691;;031-989-718-683-43X;;078-039-663-716-551;;158-884-679-706-17X;;086-024-104-550-397;;002-977-470-822-87X;;003-196-437-484-850,3876513;;10.1038/317359a0;;10.1038/329506a0;;3309677;;10.1126/science.2435001;;2435001;;3484557;;10.1126/science.3484557;;10.4049/jimmunol.133.5.2549;;6332854;;10.1146/annurev.immunol.5.1.477;;2439104;;10.1146/annurev.iy.05.040187.002401;;10.1126/science.3313727;;3313727;;10.1002/eji.1830100410;;6967410;;6139673;;2578165;;10.1038/329482a0;;3498902;;10.1016/0161-5890(83)90137-2;;6581382;;10.1126/science.2437650;;2437650;;6334313;;10.1073/pnas.81.23.7564;;pmc392187;;2410926;;10.1073/pnas.82.16.5480;;pmc391146;;3297108;;10.1146/annurev.iy.05.040187.002333;;10.1126/science.2433769;;2433769;;10.1021/bi00342a003;;3002421;;3257303;;10.1126/science.3257303;;10.1038/332840a0;;3258650;;10.1016/0161-5890(83)90147-5;;6197631;;3536124;;10.1016/0092-8674(86)90506-4;;10.1084/jem.164.5.1490;;pmc2188449;;2430042;;2966437;;10.1126/science.2966437;;10.1073/pnas.73.7.2481;;781677;;pmc430616;;3297338;;3317828;;10.1126/science.3317828;;pmc2185690;;10.1084/jem.150.5.1084;;91653;;10.1007/bf02918107;;3114395;;2457615;;10.4049/jimmunol.141.5.1451;;pmc553925;;10.1002/j.1460-2075.1987.tb02360.x;;2440673;;2419437;;2420472;;10.1016/0092-8674(86)90019-x;;10.1097/00007890-197310000-00005;;4200798;;1141219;;10.1016/s0021-9258(19)41332-x;;2824477;;10.1016/s0021-9258(18)47699-5;;pmc2187974;;2415664;;10.1084/jem.162.6.2107;;10.1038/317355a0;;2413363;;3004990;;10.1002/eji.1830160107;;2457547;;pmc1385051;;pmc2188516;;3029267;;10.1084/jem.165.2.302;;6210242;;10.1111/j.1600-065x.1984.tb01110.x;;6189936;;pmc2187023;;10.1084/jem.157.5.1434;;10.1038/308072a0;;6199675;;2420700;;pmc1453820;;10.1002/eji.1830171118;;2960547;;pmc1385193;;2968304;;10.1038/332161a0;;3279318;;85683;;pmc2184831;;10.1084/jem.149.3.758;;2953809;;3035012;;2450125;;10.1038/303625a0;;6343888;;10.1002/eji.1830150318;;3872218;;6170681;;10.1126/science.3194755;;3194755;;10.1073/pnas.88.24.11465;;pmc53156;;1722335;;1370312,"Babbitt, B.P. et al. (1985) Nature 317: 359 361.;;Bjorkman, P.J. et al. (1987) Nature 329: 506 512, 512 518.;;Buus, S. et al. (1987) Science 235: 1353 1358.;;Diener, E. et al. (1986) Science 231: 148 150.;;Killen, J.A. et al. (1984) J. Immunol. 133: 2549 2553.;;Livingstone, A.M. et al. (1987) Ann. Rev. Immunol. 5: 477 501.;;Marx, J.L. (1987) Science 238: 613 614.;;Paul, W.E. (1989) Fundamental Immunol. Raven Press, New York, pp. 69 73.;;Puri, J. et al. (1980) Eur. J. Immunol. 10: 273 281.;;Rennie, D.P. et al. (1983) The Lancet (Dec. 10) 1338 1340.;;Sterz, R.K.M. et al. (1985) J. Immunol. 134: 841 846.;;Townsend, A. et al. (1987) Nature 329: 482 483.;;Turkewitz, A.P. et al. (1983) Molec. Immunol. 20: 1139 1147.;;Unanue, E.R. et al. (1987) Science 236: 551 557.;;Watts, T.H. et al. (1984) Proc. Natl. Acad. Sci. USA 81: 7564 7568.;;Watts, T.H. et al. (1985) Proc. Natl. Acad. Sci. USA 82: 5480 5484.;;Watts, T.H. et al. (1987) Ann. Rev. Immunol. 5: 461 475.;;Clemetson, K.J. et al. (1986) In Membrane proteins: A Laboratory Manual, Ed. Azzi, A. et al., pp. 57 64.;;Cooperman (1979) In Ribosomes Structure, Function, and Genetics. Ed. Chambliss et al. University Park Press, Baltimore MD. pp. 531 554.;;Estess, P. et al. (1986) In Regulation of immune gene expression, Ed. Feldman, M. et al., Humana Press, pp. 3 19.;;Guillet et al. (1987) Science 235: 865 870.;;Hall et al. (1985) Biochemistry 24: 5702 5711.;;Harcourt, G. et al. (1987) Immunol. Today 8 (11): (news and features section).;;Hixson, J.R. Medical Tribune (Jan. 24, 1985) pp. 4 5.;;Liu, M.A. et al. (1988) Science 239: 395 398.;;Marrack, P. et al. (1988) Nature 332: 840 842.;;Nakanishi, M. et al. (1983) Molec. Immunol. 20: 1227 1231.;;Pastan, I. et al. (1986) Cell 47: 641 648.;;Sekaly, R.P. et al. (1986) J. Exp. Med. 164: 1490 1504.;;Shizuru, J.A. et al. (1988) Science 240: 659 662.;;Springer, T.A. et al. (1976) Proc. Natl. Acad. Sci. USA 73: 2481 2485.;;Sriram, S. et al. (1987) Concepts Immunopathol. 4: 275 286.;;Vitetta, E.S. et al. (1987) Science 238: 1098 1104.;;Watts, T.H. et al. (1988) In Processing and presentation of antigens, Academic Press, pp. 143 154.;;Binz, H. et al. (1979) J. Exp. Med. 150: 1084 1097.;;Gasciogne, N.R.J. et al. (1987) Proc. Natl. Acad. Sci. USA. 84: 2396 2340.;;Margulies, D.H. et al. (1987) Immunol. Res. 6: 101 116.;;McCluskey, J. et al. (1988) J. Immunol. 141: 1451 1455.;;Lamb et al. (1987) EMBO J. 6: 1245 1249.;;Berkower et al. (1986) J. Immunol. 136: 2498 2502.;;Townsend et al. (1986) Cell 44: 959 968.;;Sanderson et al. (1973) Transplantation 16: 304 312.;;Turner et al. (1976) J. Biol. Chem. 250: 4512 4519.;;Gorga et al. (1987) J. Biol. Chem. 262: 16087 16094.;;Zamvil et al. (1985) J. Exp. Med. 162: 2107 2124.;;Zamvil et al. (1985) Nature 317: 355 358.;;Ceredig, R. et al. (1986) Eur. J. Immunol. 16: 30 34.;;Essery, G. et al. (1988) Immunology 64: 413 417.;;Jenkins, M.K. et al. (1987) J. Exp. Med. 165: 302 319.;;Klein, J. (1984) Immunol. Reviews 81: 177 202.;;Lamb, J.R. (1983) J. Exp. Med. 157: 1434 1447.;;Lamb, J.R. (1984) Nature 308: 72 74.;;Lamb, J.R. et al. (1986) Immunology 57: 331 335.;;Lamb, J.R. et al. (1987) Eur. J. Immunol. 17: 1641 1644.;;Larche, M. et al. (1988) Immunology 64: 101 105.;;Madsen, J.C. et al. (1988) Nature 332: 161 164.;;Miller, S.D. et al. (1979) J. Exp. Med. 149: 758 773.;;Nau, G.J. et al. (1987) J. Immunol. 139: 114 122.;;Quill, H. et al. (1987) J. Immunol. 138: 3704 3712.;;Suzuki, G. et al. (1988) J. Immunol. 140: 1359 1365.;;Zanders, E.D. et al. (1983) Nature 303: 625 627.;;Zanders, E.D. et al. (1985) Eur. J. Immunol. 15: 302 305.;;Germain, R.N. (1981) J. Immunol. 127:1964 1966.;;Buss, S. et al. (1988) Science 242:1045 1047.;;Sharma, S.D. et al. (1991) Proc. Natl. Acad. Sci. USA 88:11465 11469.;;Nag, B. et al. (1992) J. of Immunol. 148(2):369 372.",EXPIRED
317,US,A,US 2803124 A,188-309-378-084-298,1957-08-20,1957,US 33640453 A,1953-02-11,US 33640453 A;;GB 416252 A,1952-02-16,Apparatus for heating and removing dirt from washing machine liquid,,BRAITHWAITE I & SON ENG LTD,JOHN HOWLETT EDWARD;;JOSEPH PURVIS THOMAS;;CLARK BERNARD A,,https://lens.org/188-309-378-084-298,Granted Patent,no,4,5,2,2,0,D06F39/08;;D06F39/08;;D06F1/08;;D06F1/08,D06F1/08;;D06F39/08,,0,0,,,,EXPIRED
318,US,A1,US 2013/0191994 A1,185-969-536-683-400,2013-08-01,2013,US 201313748888 A,2013-01-24,US 201313748888 A;;US 201261590943 P,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE,"A sacral support for a surgical table, comprising a plate having two spaced-apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO;;AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,AMERICAN STERILIZER COMPANY (2013-01-23),https://lens.org/185-969-536-683-400,Patent Application,yes,5,36,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61G13/12,5/624,0,0,,,,ACTIVE
319,CA,A1,CA 2916382 A1,017-459-615-976-648,2014-11-27,2014,CA 2916382 A,2014-05-22,US 201313900372 A;;US 2014/0039186 W,2013-05-22,METHOD OF BOREHOLE SEISMIC SURVEYING USING AN OPTICAL FIBER,"A method of detecting seismic waves traveling through a subsurface formation includes lowering a cable into a borehole in the subsurface formation, the cable having at least one optical fiber associated therewith, and causing descent of a remote end of the cable to be arrested. The method further includes feeding a further length of the cable into the borehole such that the cable is slack and in contact with at least part of a wall of the borehole, and using an interrogator coupled to the at least one optical fiber to detect seismic waves traveling through the subsurface formation and into the cable.",SCHLUMBERGER CA LTD,HARTOG ARTHUR H;;FRIGNET BERNARD;;MACKIE DUNCAN;;CLARK MICHAEL,,https://lens.org/017-459-615-976-648,Patent Application,no,0,0,8,8,0,G01H9/004;;G01V1/20;;G01V2210/1429;;G01H9/004;;G01V1/20;;G01V2210/1429;;G01V1/40;;G01V1/42;;G01V1/44,E21B49/00;;G01V1/40;;G01V1/52,,0,0,,,,DISCONTINUED
320,US,A,US 5463189 A,038-573-794-220-74X,1995-10-31,1995,US 17341293 A,1993-12-23,US 17341293 A,1993-12-23,Installation clip device for electrical cables,"An installation clip has a base member that fastens to first electrical cable already secured to a structural member in order to mount one or more second electrical cables indirectly to the structural member. A clip structure is disposed on the base member and has a pair of resilient retaining arms that extend outwardly from the base member in opposed, spaced-apart relation to define a clip channel into which the second electrical cable(s) can be placed. Shoulders may be formed on the distal ends of the retaining arms to define an inlet into the clip channel, and lips may be disposed on the shoulders to form a V-shaped opening into the clip channel. The retaining arms may also have opposed central flanges that project into the clip channel parallel to the base member to form upper and lower regions, and a spacer may also be disposed on the base member to separate the lower region into a pair of subregions. These regions are each sized to receive a second electrical cable. The base member is U-shaped and is constructed as lower jaw elements that may be placed between the structural member and the first electrical cable, and an upper jaw which forms a longitudinal base channel with the lower jaw within which the first electrical cable is placed.",DENEKE; BERNARD F.;;RUMBOLD; JAMES W.;;SCOTT; CLARK B.,DENEKE BERNARD F;;RUMBOLD JAMES W;;SCOTT CLARK B,,https://lens.org/038-573-794-220-74X,Granted Patent,yes,5,74,1,1,0,H02G3/26;;Y10T24/44855;;Y10T24/344;;Y10T24/44855;;Y10T24/344;;H02G3/26,H01B17/00;;H02G3/32,174138G;;X174 72A;;24/336;;24/555;;248/68.1,0,0,,,,EXPIRED
321,AT,T1,AT E100605 T1,056-470-629-187-043,1994-02-15,1994,AT 91909538 T,1991-05-11,EP 9100898 W;;GB 9010967 A,1990-05-16,HYDROPHILE KOLLOIDZUSAMMENSETZUNG FUER PHOTOGRAPHISCHES MATERIAL.,"A coating composition suitable for use in the preparation of a photographic material comprises an aqueous solution of a hydrophilic colloid and a surface active coating aid having the formula CF3(CF2)nCH2O(glycidyl)mH wherein n is an integer from 4 to 7; and, m is an integer from 6 to 45.",EASTMAN KODAK CO;;KODAK LTD,PITT ALAN ROBERT;;CLARK BERNARD ARTHUR;;PADDAY JOHN FRANK,,https://lens.org/056-470-629-187-043,Granted Patent,no,0,0,12,12,0,G03C1/385;;Y10S516/01;;Y10S430/162;;G03C1/385;;Y10S516/01;;Y10S430/162,G03C1/85;;C09D7/12;;C09D189/00;;G03C1/38,,0,0,,,,DISCONTINUED
322,CN,A,CN 104080425 A,120-327-089-776-329,2014-10-01,2014,CN 201380006812 A,2013-01-25,US 2013/0023193 W;;US 201261590943 P;;US 201313748888 A,2012-01-26,Sacral pad for a medical table,"A sacral support for a surgical table, comprising a plate having two spaced- apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/120-327-089-776-329,Patent Application,no,5,1,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00,,0,0,,,,ACTIVE
323,EP,A4,EP 3011136 A4,145-826-563-702-84X,2017-01-18,2017,EP 14800619 A,2014-05-22,US 201313900372 A;;US 2014/0039186 W,2013-05-22,METHOD OF BOREHOLE SEISMIC SURVEYING USING AN OPTICAL FIBER,,SERVICES PETROLIERS SCHLUMBERGER;;SCHLUMBERGER HOLDINGS;;SCHLUMBERGER TECHNOLOGY BV,HARTOG ARTHUR H;;FRIGNET BERNARD;;MACKIE DUNCAN;;CLARK MICHAEL,,https://lens.org/145-826-563-702-84X,Search Report,no,6,0,8,8,0,G01H9/004;;G01V1/20;;G01V2210/1429;;G01H9/004;;G01V1/20;;G01V2210/1429;;G01V1/40;;G01V1/42;;G01V1/44,E21B49/00;;G01H9/00;;G01V1/20;;G01V1/52,,1,0,,,See also references of WO 2014190176A1,DISCONTINUED
324,US,B2,US 11660161 B2,174-794-149-832-68X,2023-05-30,2023,US 202016832571 A,2020-03-27,US 202016832571 A;;US 201962825078 P,2019-03-28,Medical device suspension system having cable management assembly,"A medical device suspension system includes a spindle extending along a longitudinal axis and a cable management cover surrounding the spindle. A gap is formed between the cable management cover and the spindle. A hub is rotatably mounted to the spindle and includes a housing. A top hub cover is disposed along the longitudinal axis between the hub and the cable management cover and defines an end of the gap, the top hub cover including a passage in fluid communication with an internal volume of the housing. The top hub cover is rotatable with respect to the spindle about the longitudinal axis. A cable is provided within the gap, the cable entering the gap at a fixed location about the longitudinal axis and passing into the housing through the passage. Rotation of the top hub cover about the longitudinal axis causes the passage to rotate about the longitudinal axis.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HESER MICHAEL JOSEPH,AMERICAN STERILIZER COMPANY (2019-03-26),https://lens.org/174-794-149-832-68X,Granted Patent,yes,37,0,7,94,0,F16M13/027;;F16M2200/065;;A61B90/50;;A61B50/28;;A61B90/35;;F21V23/002;;F21W2131/205;;F21V21/26;;A61B50/28;;A61B90/50;;A61B2505/01;;A61B2505/05;;F16M13/027;;A61B90/35;;F16M11/2014,A61B90/50;;A61B50/28;;A61B90/35;;F16M11/20;;F16M13/02,,2,0,,,"PCT/US2020/025286; PCT International Search Report and Written Opinion of the International Searching Authority dated Jul. 3, 2020.;;International Preliminary Report on Patentability for related International Application No. PCT/US2020/025286 dated Oct. 7, 2021.",ACTIVE
325,EP,B1,EP 0751428 B1,190-446-846-863-325,1999-10-06,1999,EP 96201758 A,1996-06-25,GB 9513114 A,1995-06-28,Novel image-dye-forming couplers and photographic elements containing them,,KODAK LTD;;EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,KODAK LIMITED (1999-06-02);;EASTMAN KODAK COMPANY (1999-06-02),https://lens.org/190-446-846-863-325,Granted Patent,yes,4,0,6,6,0,C07D207/337;;G03C7/36;;G03C2200/33;;C07D207/337;;G03C7/36;;G03C2200/33,C07D207/32;;C07D207/337;;G03C7/36,,0,0,,,,EXPIRED
326,AU,A1,AU 2013/211976 A1,060-736-128-168-485,2014-08-14,2014,AU 2013/211976 A,2013-01-25,US 201313748888 A;;US 201261590943 P;;US 2013/0023193 W,2012-01-26,Sacral pad for a medical table,"A sacral support for a surgical table, comprising a plate having two spaced- apart openings formed therein. The openings are aligned along an axis of the plate and disposed adjacent one end of the plate. A pad is attached to the plate. The pad is dimensioned such that the openings in the plate are exposed. A positioning post is attachable to the plate. The post has a lower end dimensioned to be received in the openings in plate, wherein the post is mountable in the plate in one of two different positions.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/060-736-128-168-485,Patent Application,no,0,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00,,0,0,,,,ACTIVE
327,TW,B,TW 561497 B,091-588-394-374-313,2003-11-11,2003,TW 91106498 A,2002-04-01,US 83663401 A,2001-04-17,Flexible capacitive touch sensor,"A flexible, capacitive touch sensor, and a method of manufacturing a plurality of such touch sensors, are provided. The capacitive touch sensor comprises a thin, flexible, transparent, insulating substrate. A thin, flexible, transparent layer of resistive material is applied to one side of the substrate, and a thin, flexible, transparent, pressure-sensitive layer of adhesive material is applied to the substrate's other side. A releasable sheet may cover this adhesive layer. A plurality of thin, flexible electrodes, electrical leads and conductive areas are applied to the resistive layer. A thin, flexible, transparent layer of protective material protects the touch sensor's active touch area. Compounds may be added to this protective layer to enhance its conductivity and lubricity. A reel-to-reel process for manufacturing a plurality of such capacitive touch sensors also is described.",3M INNOVATIVE PROPERTIES CO,SCHULZ STEPHEN CLARK;;CHERNEFSKY ANTHONY FRANK;;GEAGHAN BERNARD OMAR,,https://lens.org/091-588-394-374-313,Granted Patent,no,0,3,17,17,0,G06F3/0443;;G06F3/03;;G06F3/0443,G06F3/033;;G01B7/00;;G06F3/044;;H03K17/96,,0,0,,,,EXPIRED
328,EP,A4,EP 0630255 A4,146-229-712-828-413,1995-04-19,1995,EP 92911380 A,1992-04-23,US 69084091 A;;US 9203391 W;;US 86929392 A,1991-04-23,MHC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY.,,ANERGEN INC,CLARK BRIAN R;;SHARMA SOMESH D;;LERCH BERNARD L,"COULTER PHARMACEUTICAL, INC. (2003-05-30)",https://lens.org/146-229-712-828-413,Search Report,no,3,0,6,32,0,,A61K38/00;;A61K39/00;;A61K39/385;;A61P21/04;;A61P25/00;;A61P37/02;;A61P37/06;;A61P37/08;;C07K7/04;;C07K14/47;;C07K14/74;;C07K19/00,,2,1,016-557-802-749-662,10.1073/pnas.87.4.1337;;1689484;;pmc53470,"KUMAR V., ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 87, no. 4, 1990, pages 1337 - 1341;;See also references of WO 9218150A1",EXPIRED
329,CA,A,CA 841220 A,191-168-995-466-63X,1970-05-05,1970,CA 841220D A,,CA 841220T A,,METHOD AND SYSTEM FOR POURING LIQUID METAL BY MEASURED VOLUME,,MODERN EQUIPMENT CO,HIBBARD WILLIAM D;;CLARK JAMES E;;RAPP BERNARD R,,https://lens.org/191-168-995-466-63X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
330,EP,A1,EP 2806836 A1,001-786-482-175-894,2014-12-03,2014,EP 13741313 A,2013-01-25,US 201261590943 P;;US 201313748888 A;;US 2013/0023193 W,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE,,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/001-786-482-175-894,Patent Application,yes,0,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00;;A61G13/12,,0,0,,,,ACTIVE
331,US,A,US 5194425 A,079-985-401-050-654,1993-03-16,1993,US 36775189 A,1989-06-21,US 36775189 A;;US 21059488 A,1988-06-23,MHC-MEDIATED TOXIC CONJUGATES USEFUL IN AMELIORATING AUTOIMMUNITY,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X.sup.1 MHC.sup.2 peptide or MHC.sup.2 peptide.sup.1 X wherein X represents a functional moiety selected from a toxin and a labeling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen; .sup.1 represents a covalent bond or a linker bound to X and MHC or to X and peptide by covalent bonds; and .sup.2 represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to target helper T-cells which are specifically immunoreactive with autoantigens.",ANERGEN INC,SHARMA SOMESH D;;LERCH L BERNARD;;CLARK BRIAN R,ANERGEN INC (1991-07-23);;ANERGEN INC. A DELAWARE CORPORATION (1998-06-30),https://lens.org/079-985-401-050-654,Granted Patent,yes,6,101,16,32,9,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,A61K35/12;;A61K35/28;;G01N33/564;;A61K39/00;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,514/8;;530/402;;530/403;;530/395;;514/903;;424/88,47,40,096-808-659-810-496;;098-548-262-072-602;;021-720-457-509-673;;105-728-654-193-796;;060-105-097-350-717;;060-105-097-350-717;;021-354-068-638-52X;;146-761-465-543-584;;001-542-199-602-159;;000-108-780-023-355;;034-144-538-771-410;;096-422-417-213-881;;034-170-157-751-888;;042-719-768-395-451;;106-021-817-946-64X;;018-725-676-477-557;;186-072-679-623-966;;067-423-867-031-236;;063-898-442-301-724;;044-219-977-949-424;;020-833-428-096-595;;080-116-588-558-925;;119-098-412-359-014;;041-066-683-986-277;;001-809-294-160-846;;031-498-695-386-777;;030-435-386-518-970;;028-483-482-274-317;;151-909-994-962-302;;124-265-670-692-625;;006-246-100-575-580;;090-471-813-411-890;;053-919-000-700-346;;068-328-739-510-663;;034-275-533-046-869;;150-992-421-090-985;;000-877-662-644-595;;053-932-577-346-798;;019-055-424-431-057;;076-183-945-466-427,10.1007/bf02918107;;3114395;;6139673;;10.1002/eji.1830100410;;6967410;;10.1038/329482a0;;3498902;;10.1038/329506a0;;3309677;;10.1038/329506a0;;3309677;;10.1126/science.3313727;;3313727;;2686677;;10.1111/j.1749-6632.1986.tb20879.x;;3538973;;10.1038/317355a0;;2413363;;pmc2187974;;2415664;;10.1084/jem.162.6.2107;;6158546;;pmc2185961;;10.1084/jem.152.4.1085;;10.1016/0161-5890(84)90136-6;;6438496;;pmc358053;;3058298;;10.1128/cmr.1.3.313;;10.1128/cmr.1.3.313-329.1988;;2824477;;10.1016/s0021-9258(18)47699-5;;1141219;;10.1016/s0021-9258(19)41332-x;;10.1097/00007890-197310000-00005;;4200798;;2420472;;10.1016/0092-8674(86)90019-x;;pmc553925;;10.1002/j.1460-2075.1987.tb02360.x;;2440673;;3297108;;10.1146/annurev.iy.05.040187.002333;;10.1146/annurev.immunol.5.1.477;;2439104;;10.1146/annurev.iy.05.040187.002401;;3484557;;10.1126/science.3484557;;2578165;;10.4049/jimmunol.133.5.2549;;6332854;;2966437;;10.1126/science.2966437;;6334313;;10.1073/pnas.81.23.7564;;pmc392187;;10.1016/b978-0-12-551855-0.50106-6;;3297338;;10.1016/0161-5890(83)90137-2;;6581382;;10.1084/jem.164.5.1490;;pmc2188449;;2430042;;10.1038/332840a0;;3258650;;10.1073/pnas.73.7.2481;;781677;;pmc430616;;10.1126/science.2433769;;2433769;;10.1016/0161-5890(83)90147-5;;6197631;;3876513;;10.1038/317359a0;;2410926;;10.1073/pnas.82.16.5480;;pmc391146;;10.1126/science.2437650;;2437650;;10.1126/science.2435001;;2435001;;3317828;;10.1126/science.3317828;;3536124;;10.1016/0092-8674(86)90506-4,"D. H. Margulies, et al. 1987; Immunol. Res. 6:101 116. Engineering Soluble MHC Molecules: Why and How.;;Killen, et al. J. Immunol. 134:841 846. 1984.;;Rennie, et al. Lancet (10 Dec. 1983) pp. 1338 1340.;;Puri, et al. Eur. J. Immunol. 10:273 281 1980.;;Townsend, et al. Nature 329:482 3. 1987.;;Bjorkman, et al. Nature 329:512 18 1987.;;Bjorkman, et al. Nature 329:506 12 1987.;;Marx, et al. Science 238:613 614. 1987.;;Olsnes, S., et al., Immunology Today, vol. 10, No. 9, 1989, pp. 291 295.;;Borel, J. F., et al., Annals New York Academy of Sciences , 475: 307 319 (1986).;;Zamvil, S., et al., Nature , vol. 317, 26 Sep. 1985, pp. 355 358.;;Zamvil, S., et al., J. Exp. Med. , vol. 162, Dec. 1985 pp. 2107 2124.;;Lerner, E. A., et al., J. Exp. Med. , vol. 152, Oct. 1980, pp. 1085 1101.;;Carrel, S., et al., Molecular Immunology , vol. 21, No. 10, pp. 831 840, 1984.;;Payne, W. J., et al., Clinical Microbiology Reviews, Jul. 1988, pp. 313 329.;;Gorga, J. C., et al., The Journal of Biological Chemistry , vol. 282, No. 33, issue of Nov. 25, pp. 16087 16094, 1987.;;Turner, M. J., et al., The Journal of Biological Chemistry , vol. 250, No. 12, Issue of Jun. 25, 1975, pp. 4512 4519.;;Sanderson, A. R., et al., Transplantation , vol. 16, No. 4, Oct. 1973, pp. 304 312.;;Townsend, A. R. M., et al., Cell , vol. 44, pp. 959 968, Mar. 28, 1986.;;Berkower, I., et al., The Journal of Immunology , vol. 136, No. 7, Apr. 1, 1986, pp. 2498 2502.;;Lamb, J. R., et al., The EMBO Journal , vol. 6, No. 5, 1987, pp. 1245 1249.;;Watts, T. H., Ann. Rev. Immunol. , 1987, 0.5: 461 75.;;Livingstone, A. M., et al., Ann. Rev. Immunol. , 1987, 0.5: 477 501.;;Diener et al., Science (1986) 231:148 150.;;Sterz et al., J. Immunol. (1985) 134:841 846.;;Killen et al., J. Immunol. (1984) 133:2549 2553.;;Hixson Med. Tribune (28 Jan. 1985) pp. 4 5.;;Liu et al., Science (1989) 239:395 397.;;Shizuru et al., Science (1988) 240:659 662.;;Watts et al., Proc. Natl. Acad. Sci. USA (1984) 81:7564 7568.;;Clemetson et al., Membrane Proteins: A Laboratory Manual (1986) A. Azzi et al., editors, pp. 57 64.;;Harcourt et al., Immunol. Today (1987) 8(11):(news and features section).;;Watts et al., Processing and Presentation of Antigens (1988) Academic Press, New York, pp. 143 155.;;Sriram et al., Concepts Immunolpathol. (1987) 4:275 286.;;Turkewitz et al., Molecular Immunol. (1983) 20(11):1139 1147.;;Sekaly et al., J. Exp. Med. (1986) 164:1490 1504.;;Marrack et al., Nature (1988) 332:840 842.;;Springer et al., Proc. Natl. Acad. Sci. USA (1976) 73(7):2481 2485.;;Guillet et al., Science (1987) 235:865 870.;;Nakanishi et al., Mol. Immunol. (1983) 20(11):1227 1231.;;Babbitt et al., Nature (1985) 317:359 361.;;Watts et al., Proc. Natl. Acad. Sci. USA (1985) 82:5480 5484.;;Unanue et al., Science (1987) 236:551 557.;;Buus et al., Science (1987) 235:1353 1358.;;Vitetta et al., Science (1987) 238:1098 1104.;;Pastan et al., Cell (1986) 47:641 648.;;Estess et al., Regulation of Immune Gene Expression Feldman et al., editors, The Humana Press, Inc., (1985, pp. 3 19).",EXPIRED
332,EP,A1,EP 0742014 A1,079-911-432-010-004,1996-11-13,1996,EP 95117141 A,1989-06-23,EP 89908127 A;;US 21059488 A;;US 36775189 A,1988-06-23,MHC-peptide labelled conjugates,"The invention is directed to methods and materials useful in treating autoimmune diseases. The therapeutic agents are of the formula X 1 MHC 2 -peptide (1) or MHC 2 peptide 1 X (2), wherein X represents a labelling group; MHC is an effective portion of the MHC glycoprotein, said glycoprotein dissociated from the cell surface on which it normally resides; and ""peptide"" represents an antigenic peptide sequence associated with an autoantigen;  1  represents a covalent bond or a bivalent linker bound to X and MHC in formula (1) or to X and peptide in formula (2) by covalent bonds; and  2  represents a covalent bond, a noncovalent association, or a linker covalently bound to or associated with the MHC and peptide. These complexes can be used to monitor the therapy of autoimmune diseases.",BIOSPAN CORP,SHARMA SOMESH D;;CLARK BRIAN R;;LERCH L BERNARD,"COULTER PHARMACEUTICAL, INC. (2003-07-23)",https://lens.org/079-911-432-010-004,Patent Application,yes,7,7,16,32,0,A61K39/0008;;A61K51/1234;;A61K2039/605;;A61K2123/00;;C07K14/78;;C07K2319/00;;G01N33/5091;;A61K51/08;;Y10S424/81;;Y10S530/806;;Y10S530/868;;Y10S530/807;;A61K47/6425;;A61K47/646;;A61P37/06;;A61K39/00;;A61K45/00;;G01N33/5091;;A61K51/1234;;A61K2039/605;;C07K2319/00;;C07K14/78;;A61K2123/00;;A61K39/0008;;A61K51/08;;Y10S530/806;;Y10S530/868;;Y10S424/81;;Y10S530/807;;A61K47/6425;;A61K47/646,G01N33/564;;A61K35/12;;A61K35/28;;A61K39/00;;A61K45/00;;A61K47/48;;A61K49/00;;A61K51/08;;A61K51/12;;A61P37/06;;C07K14/435;;C07K14/705;;C07K14/74;;C07K14/78;;C07K17/06;;C07K19/00;;C12N15/00;;C12N15/09;;C12P21/00;;C12R1/91;;G01N33/50,,47,35,041-066-683-986-277;;021-720-457-509-673;;000-877-662-644-595;;019-055-424-431-057;;048-368-206-580-993;;080-116-588-558-925;;119-098-412-359-014;;041-066-683-986-277;;019-115-775-607-415;;001-809-294-160-846;;031-498-695-386-777;;151-909-994-962-302;;124-265-670-692-625;;090-471-813-411-890;;060-105-097-350-717;;021-354-068-638-52X;;018-725-676-477-557;;156-030-618-653-068;;047-294-079-836-486;;015-801-694-447-055;;030-761-388-449-490;;072-411-320-010-530;;092-905-103-556-76X;;021-265-512-792-634;;060-987-014-684-509;;024-841-374-797-219;;075-066-182-434-208;;092-905-103-556-76X;;129-563-138-834-508;;008-226-221-097-647;;030-703-086-007-608;;070-957-906-782-10X;;004-570-128-511-716;;041-772-379-878-501;;104-451-628-837-88X,10.4049/jimmunol.133.5.2549;;6332854;;10.1002/eji.1830100410;;6967410;;10.1126/science.2437650;;2437650;;3317828;;10.1126/science.3317828;;6942054;;3484557;;10.1126/science.3484557;;2578165;;10.4049/jimmunol.133.5.2549;;6332854;;2443575;;10.1016/0022-1759(87)90085-8;;2966437;;10.1126/science.2966437;;6334313;;10.1073/pnas.81.23.7564;;pmc392187;;10.1016/0161-5890(83)90137-2;;6581382;;10.1084/jem.164.5.1490;;pmc2188449;;2430042;;10.1073/pnas.73.7.2481;;781677;;pmc430616;;10.1038/329506a0;;3309677;;10.1126/science.3313727;;3313727;;1141219;;10.1016/s0021-9258(19)41332-x;;10.1016/s0021-9258(17)41003-9;;72068;;pmc324219;;6159584;;10.1093/nar/8.18.4057;;10.1038/292128a0;;6264321;;6256394;;10.1016/s0021-9258(19)69976-x;;205802;;10.1038/273113a0;;6246368;;10.1016/s0076-6879(80)65059-9;;pmc223628;;10.1073/pnas.62.4.1159;;4894690;;4336693;;pmc247463;;10.1128/jb.110.2.667-676.1972;;10.1073/pnas.74.12.5463;;271968;;pmc431765;;pmc326694;;6259625;;10.1093/nar/9.2.309;;6246368;;10.1016/s0076-6879(80)65059-9;;pmc426879;;10.1073/pnas.69.8.2110;;4559594;;pmc383928;;10.1073/pnas.76.8.3829;;386351;;10.1146/annurev.iy.02.040184.001215;;6399847;;10.1146/annurev.immunol.2.1.199;;2448638;;10.1038/331171a0;;3284290;;10.1016/s0065-2776(08)60847-0;;10.1073/pnas.81.19.6159;;pmc391879;;6333027;;10.1073/pnas.77.2.755;;6153804;;pmc348359,"KILLEN ET AL: ""SPECIFIC KILLING OF LYMPHOCYTES THAT CAUSE EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS BY RICIN TOXIN-ACETYLCHOLINE RECEPTOR CONJUGATES"", JOURNAL OF IMMUNOLOGY, vol. 133, no. 5, 1984, pages 2549 - 2553, XP002012978;;PURI ET AL: ""MECHANISM OF ANTIGEN BINDING BY T-CELLS H-2 (I-A)-RESTRICTED BINDING OF ANTIGEN PLUS IA BY HELPER CELLS"", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 10, 1980, pages 273 - 281, XP000601679;;UNANUE ET AL: ""THE BASIS FOR THE IMMUNOREGULATORY ROLE OF MACROPHAGES AND OTHER ACCESSORY CELLS"", SCIENCE, vol. 236, May 1987 (1987-05-01), pages 551 - 557, XP000601675;;VITETTA ET AL: ""REDESIGNING NATURE'S POISONS TO CREATE ANTI-TUMOR REAGENTS"", SCIENCE, vol. 238, November 1987 (1987-11-01), pages 1098 - 1104, XP000601638;;EMERSON ET AL: ""I-KK AND H-2KK ANTIGENS ARE SHED AS SUPRAMOLECULAR PARTICLES IN ASSOCIATION WITH MEMBRANE LIPIDS"", JOURNAL OF IMMUNOLOGY, vol. 127, no. 2, August 1981 (1981-08-01), pages 482 - 486, XP002012986;;D.P. RENNIE ET AL., LANCET, 10 December 1983 (1983-12-10), pages 1338 - 1339;;E. DIENER ET AL., SCIENCE, vol. 231, 1986, pages 148 - 150;;R.K.M. STEERZ ET AL., J. IMMUNOL., vol. 134, 1985, pages 841 - 846;;J.A. KILLEN ET AL., J. IMMUNOL., vol. 133, 1984, pages 2549 - 2553;;H.M. GEYSEN ET AL., J. IMMUN. METH., vol. 102, 1987, pages 259 - 274;;M.A. LIU ET AL., SCIENCE, vol. 239, 1988, pages 395 - 397;;J.A. SHIZURU ET AL., SCIENCE, vol. 240, 1988, pages 659 - 662;;T.H. WATTS ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 7564 - 7568;;A.P. TURKEWITZ ET AL., MOLECULAR IMMUNOLOGY, vol. 20, 1983, pages 1139 - 1147;;R.P. SEKALY, J. EXP. MED., vol. 164, 1986, pages 1490 - 1504;;T.A. SPRINGER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 73, 1976, pages 2481 - 2485;;A. AZZI, P.J. BJORKMAN: ""Membrane Proteins"", 1984, PH.D. THESIS HARVARD, article K.J. CLEMENTSON ET AL.;;P.J. BJORKMAN ET AL., NATURE, vol. 329, 1987, pages 506 - 518;;P.J. BJORKMAN ET AL., SCIENCE, vol. 238, 1987, pages 613 - 614;;M.J. TURNER ET AL., J. BIOL. CHEM., vol. 250, 1975, pages 4512 - 4519;;P. PARHAM ET AL., J. BIOL. CHEM., vol. 252, 1977, pages 7555 - 7567;;BOLIVAR ET AL., GENE, vol. 2, 1977, pages 95;;CHANGE ET AL., NATURE, vol. 198, 1977, pages 1056;;GOEDDEL ET AL., NUCLEIC ACIDS RES., vol. 8, 1980, pages 4057;;SHIMATAKE ET AL., NATURE, vol. 292, 1981, pages 128;;HITZEMAN ET AL., J. BIOL. CHEM., vol. 255, 1980, pages 2073;;M.J. HOLLAND ET AL., J. BIOL. CHEM., vol. 256, 1981, pages 1385;;J. BROACH ET AL., GENE, vol. 8, 1978, pages 121;;FIERS ET AL., NATURE, vol. 273, 1978, pages 113;;METHODS IN ENZYMOLOGY, vol. 65, 1980, pages 499 - 560;;D.B. CLEWELL ET AL., PROC. NATL. ACAD. SCI. USA, vol. 62, 1969, pages 1159;;D.B. CLEWELL ET AL., J. BACTERIOL., vol. 110, 1972, pages 667;;F. SANGER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 74, 1977, pages 5463;;MESSING ET AL., NUCLEIC ACIDS RES., vol. 9, 1981, pages 309;;MAXAM ET AL., METHODS IN ENZYMOLOGY, vol. 65, 1980, pages 499;;S.N. COHEN, PROC. NATL. ACAD. SCI. USA, vol. 69, 1972, pages 2110;;MANIATIS ET AL.: ""Molecular Cloning: A Laboratory Manual"", 1982, COLD SPRING HARBOR PRESS, pages: 254;;GRAHAM, VAN DER EB, VIROLOGY, vol. 52, 1978, pages 546;;P. VAN SOLINGEN ET AL., J. BACTER., vol. 130, 1977, pages 946;;C.L. HSIAO ET AL., PROC. NATL. ACAD. SCI. USA, vol. 76, 1979, pages 3829;;STUART ET AL., ANN. REV. IMMUNOL., vol. 2, 1984, pages 199 - 218;;VAN EDEN ET AL., NATURE, vol. 331, 1988, pages 171 - 173;;MARON ET AL., J. EXP. MED., vol. 152, 1988, pages 1115 - 1120;;LINDSTROM ET AL., ADV. IMMUNOL., vol. 42, 1988, pages 233 - 284;;BRIAN, MCCONNELL, PROC. NATL. ACAD. SCI., vol. 81, 1984, pages 6159;;TZARTOS, LINDSTROM, PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 755;;APPLICATION CONTAINS STILL MORE REFERENCES",DISCONTINUED
333,EP,A4,EP 2806836 A4,085-466-131-716-403,2016-03-02,2016,EP 13741313 A,2013-01-25,US 201261590943 P;;US 201313748888 A;;US 2013/0023193 W,2012-01-26,SACRAL PAD FOR A MEDICAL TABLE,,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD J;;LABEDZ CHRISTOPHER D,,https://lens.org/085-466-131-716-403,Search Report,no,1,0,61,61,0,A61G13/0036;;A61G13/125;;A61G13/0063;;A61G13/0081;;A61G13/123;;A61G13/1245;;A61G13/123;;A61G13/0063;;A61G13/0081;;A61G13/0036;;A61G13/125;;A61G13/1245,A61F5/00;;A61G13/12,,0,0,,,,ACTIVE
334,US,A,US 5929650 A,097-716-301-223-885,1999-07-27,1999,US 79503097 A,1997-02-04,US 79503097 A,1997-02-04,Method and apparatus for performing operative testing on an integrated circuit,"A method of detecting defective CMOS devices by quiescent current (IDDQ) behavior using a monitor circuit resident in the expendable areas of a die and/or wafer. One embodiment of the present invention incorporates a monitor unit (10) into the scribe grid of a wafer, where pads (2, 3, 4) are built in the corners of the die (5) and connected to the monitor unit (10) via metal connects in the wafer. The monitor unit (10) determines defective die based on IDDQ as expressed by decay of voltage (Vdd) in time, where Vdd is supplied to a die by way of a switch (20) in the monitor unit (10). Alternate embodiments incorporate various configurations and incorporate functional and other tests into a wafer level test system. Other embodiments provide the monitor unit on the die, allowing for later testing and user confirmation.",MOTOROLA INC,PAPPERT BERNARD J;;SHEPARD CLARK;;CROUCH ALFRED LARRY;;ASH ROBERT,FREESCALE SEMICONDUCTOR INC (2004-04-04);;MOTOROLA INC (1997-01-24),https://lens.org/097-716-301-223-885,Granted Patent,yes,3,94,7,7,0,G01R31/3008;;G01R31/3008;;G01R31/3004;;G01R31/3004;;H01L22/00,H01L21/66;;G01R31/30,324/763;;324/765;;395/183.01,5,4,081-479-501-540-722;;072-426-032-460-256;;037-875-867-589-319;;066-201-142-809-864,10.1109/test.1993.470640;;10.1007/bf00135342;;10.1109/edtc.1995.470341;;10.1109/4.121566,"Hsue, et al., Built In Current Sensor For IDDQ Test In CMOS, International Test Conf., pp. 635 641 (1993).;;Rius, et al., Proportional BIC Sensor For Current Testing, Electronic Testing: Theory and Appl. vol. 3; pp. 387 396 (1992).;;Rubio, et al., A Built In Quiescent Current Monitor For CMOS VLSI Circuits, Eur. Design and Test Conf., pp. 581 585 (1995).;;Maly, et al., Built In Current Testing, J. Solid State Circuits, vol. 27, No. 3., pp. 425 428 (1992).;;Keating, et al., A New Approach To Dynamic IDD Testing, International Test Conf., pp. 316 321 (1987).",EXPIRED
335,US,A1,US 2009/0277065 A1,031-697-459-789-525,2009-11-12,2009,US 35358009 A,2009-01-14,US 35358009 A;;US 74671107 A,2007-05-10,Processes and Systems for Monitoring Usage of Projectile Weapons,"Processes and systems for detecting a shot by a projectile weapon are disclosed. Data is obtained along at least two different axes for use in determining whether a shot has taken place based on an evaluation by a processor. In certain embodiments, multiple detection systems are positioned on a weapons platform mounting multiple projectile weapons, and each is configured to detect only a shot by a respective one of the projectile weapons.",CLARK ROBERT BERNARD IREDALE;;GESSEL DAVID;;LEITNER-WISE PAUL ANDREW,CLARK ROBERT BERNARD IREDALE;;GESSEL DAVID;;LEITNER-WISE PAUL ANDREW,LEITNER-WISE DEFENSE INC (2009-07-23),https://lens.org/031-697-459-789-525,Patent Application,yes,3,35,2,7,0,F41A19/01;;F41A19/01,F41A35/00;;G01J1/00;;G01L5/14;;G01V1/18,42/1.03;;367/178;;73/167;;374/45;;356/213,0,0,,,,ACTIVE
336,EP,A1,EP 0856794 A1,076-392-060-730-121,1998-08-05,1998,EP 98101522 A,1998-01-29,US 79503097 A,1997-02-04,Method and apparatus for performing operative testing on an integrated circuit,"A method of detecting defective CMOS devices by quiescent current (IDDQ) behavior using a monitor circuit resident in the expendable areas of a die and/or wafer. One embodiment of the present invention incorporates a monitor unit (10) into the scribe grid of a wafer, where pads (2, 3, 4) are built in the corners of the die (5) and connected to the monitor unit (10) via metal connects in the wafer. The monitor unit (10) determines defective die based on IDDQ as expressed by decay of voltage (Vdd) in time, where Vdd is supplied to a die by way of a switch (20) in the monitor unit (10). Alternate embodiments incorporate various configurations and incorporate functional and other tests into a wafer level test system. Other embodiments provide the monitor unit on the die, allowing for later testing and user confirmation.",MOTOROLA INC,PAPPERT BERNARD J;;SHEPARD CLARK;;CROUCH ALFRED LARRY;;ASH ROBERT,,https://lens.org/076-392-060-730-121,Patent Application,yes,3,9,7,7,0,G01R31/3008;;G01R31/3008;;G01R31/3004;;G01R31/3004;;H01L22/00,H01L21/66;;G01R31/30,,2,1,079-926-359-391-569,10.1109/test.1995.529859,"AITKEN R C: ""FAULT LOCATION WITH CURRENT MONITORING"", PROCEEDINGS OF THE INTERNATIONAL TEST CONFERENCE, NASHVILLE, OCT. 28 - 30, 1991, 1 January 1991 (1991-01-01), INSTITUTE OF ELECTRICAL AND ELECTRONICS ENGINEERS, pages 623 - 632, XP000272299;;VARGAS F ET AL: ""AN APPROACH FOR DESIGNING TOTAL-DOSE TOLERANT MCMS BASED ON CURRENTMONITORING"", PROCEEDINGS OF THE INTERNATIONAL TEST CONFERENCE (ITC), WASHINGTON, OCT. 21 - 25, 1995, 21 October 1995 (1995-10-21), INSTITUTE OF ELECTRICAL AND ELECTRONICS ENGINEERS, pages 345 - 354, XP000552837",DISCONTINUED
337,WO,A1,WO 1999/018663 A1,157-828-284-536-820,1999-04-15,1999,US 9820759 W,1998-10-02,US 94458597 A,1997-10-06,HIGH EFFICIENCY WIDEBAND POWER AMPLIFIER,"A method and apparatus for efficient power amplification of a wideband signal with a correspondingly wide modulation bandwidth includes an envelope detector (220), an adaptive split band modulator (270), and a power amplifier (260). The adaptive split band modulator (270) amplifies the low frequency components using a class S modulator (760), and amplifies the high frequency components using a class B amplifier (750). The power supply of the class B amplifier (750) is adaptively modified as a function of the amplitude of the signal that it amplifies. In this manner, the class B amplifier (750) operates at a higher efficiency.",MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB FREDERICK H;;CLARK JAMES ROGER II,,https://lens.org/157-828-284-536-820,Patent Application,yes,4,18,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,,1,1,000-526-100-084-253,10.1109/22.556466,"RAAB F H: ""INTERMODULATION DISTORTION IN KAHN-TECHNIQUE TRANSMITTERS"", IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES, vol. 44, no. 12, PART 01, December 1996 (1996-12-01), pages 2273 - 2278, XP000636407",PATENTED
338,GB,A,GB 853947 A,004-058-933-901-482,1960-11-16,1960,GB 3851856 A,1956-12-18,GB 3851856 A,1956-12-18,Improvements in or relating to potentiometers and variable resistors,"853,947. Variable resistors. PLESSEY CO. Ltd. Dec. 18,1957 [Dec. 18, 1956], No. 38518/56. Class 37 A variable resistor or potentiometer, having a moulded resistive track, has at least one of. the normally fixed contacts replaced by a brush, movable relative to the track. The resistance element is formed as a moulded track 1, 2 of which the part 1 has a considerably higher resistance than the part 2, and is mounted on the control knob 3. An insulating segment la may be provided on the track. The base of the potentiometer comprises an insulating disc 5 in which are embedded three carbon contact brushes 6, 7, 8 for cooperation with the track. The disc and knob are rotatably connected by a bolt 4 which passes through centrally provided holes. If the resistivity of segment 2 is made very low, the device may be used as a constant totalresistance potentiometer using one-third of a revolution, or if the segment 1a is omitted, and the segment 2 given an appreciable resistivity (e.g. one-half that of segment 1) two-thirds of a revolution may be. used, the total resistance varying with potentiometer setting.",PLESSY COMPANY LTD,VINCENT RUSSELL SWALE;;CLARK JOHN ROBERT;;QUINT BERNARD HENRY JOHN,,https://lens.org/004-058-933-901-482,Granted Patent,no,0,3,1,1,0,H01C10/26,H01C10/26,H1S SBP           SBP,0,0,,,,EXPIRED
339,US,B2,US 8117778 B2,031-925-921-361-564,2012-02-21,2012,US 35360209 A,2009-01-14,US 35360209 A;;US 74671107 A,2007-05-10,Processes and systems for monitoring environments of projectile weapons,"Processes and systems are disclosed for recording data relating to a shot by a projectile weapon. Environment data occurring prior to data indicating the occurrence of a shot by the projectile weapon is retained for subsequent evaluation. Such environment data includes, but is not limited to, ambient audio data, video data produced by a video camera associated with the projectile weapon, GPS data representing locations of the projectile weapon, electronic compass data representing orientations of the projectile weapon and acceleration data representing accelerations of the projectile weapon.",CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW;;GESSEL DAVID,CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW;;GESSEL DAVID,LEITNER-WISE DEFENSE INC (2009-07-23),https://lens.org/031-925-921-361-564,Granted Patent,yes,54,9,4,7,0,F41A19/01;;F41A19/01,F41A9/53,42/1.01;;42/1.03,0,0,,,,INACTIVE
340,DE,T1,DE 19882705 T1,116-562-457-337-801,2000-09-28,2000,DE 19882705 T,1998-10-02,US 94458597 A;;US 9820759 W,1997-10-06,Breitband-Leistungsverstärker mit hohem Wirkungsgrad,,MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB FREDERICK H;;CLARK II JAMES ROGER,"GOOGLE TECHNOLOGY HOLDINGS LLC, MOUNTAIN VIEW, US (2018-04-26);;MOTOROLA MOBILITY, INC. ( N.D. GES. D. STAATES, US (2011-03-24)",https://lens.org/116-562-457-337-801,Patent Application,no,0,1,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,,0,0,,,,EXPIRED
341,TW,B,TW 358997 B,019-227-732-117-113,1999-05-21,1999,TW 86118182 A,1997-12-03,US 79503097 A,1997-02-04,Method and apparatus for performing operative testing on an IC,"A wafer, including: a first block in the first part of the wafer; and a first monitor IC in the second part of the wafer, which is separated from the first part of the wafer, the first monitor circuit carrying out the first test for confirmation of the pre-operation of the first block.",MOTOROLA INC,PAPPERT BERNARD J;;SHEPARD CLARK;;CROUCH ALFRED L;;ASH ROBERT,,https://lens.org/019-227-732-117-113,Granted Patent,no,0,0,7,7,0,G01R31/3008;;G01R31/3008;;G01R31/3004;;G01R31/3004;;H01L22/00,G01R31/30,,0,0,,,,EXPIRED
342,FI,A,FI 20000726 A,027-941-302-735-534,2000-03-29,2000,FI 20000726 A,2000-03-29,US 94458597 A;;US 9820759 W,1997-10-06,"Hyötysuhteeltaan hyvä, laajakaistainen tehovahvistin",,MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB H FREDERICK;;CLARK II ROGER JAMES,"MOTOROLA MOBILITY, INC. (2011-11-28)",https://lens.org/027-941-302-735-534,Patent Application,no,0,0,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,,0,0,,,,EXPIRED
343,JP,A,JP H10223716 A,075-949-872-929-952,1998-08-21,1998,JP 3955498 A,1998-02-04,US 79503097 A,1997-02-04,METHOD FOR EXECUTION OF OPERATING TEST OF INTEGRATED CIRCUIT,"PROBLEM TO BE SOLVED: To obtain a method in which time and hardware required for the zero input current test of a CMOS device are reduced and in which a device test is rationalized by a method wherein a die and a monitoring circuit are integrated on a wafer and a test operation which confirms the prescribed operation of the die can be executed by the monitoring circuit. SOLUTION: A first die 5 is integrated in a first part on a wafer, and a first monitoring circuit 10 is integrated on a second part which is at a distance from the first part on the wafer. Then, a first test operation which confirms the prescribed operation of the first die 5 can be executed by the first monitoring circuit 10. For example, a testing unit 8 is installed in one corner on a die 5. Then, the die 5 transmits a starting signal to a monitoring unit 10 via a conductor 12, and the testing unit 8 receives a monitoring signal via a conductor 14 from the monitoring unit 10. In addition, the die 5 transmits an IDDQ-mode signal to the monitoring unit 10, and the monitoring unit 10 can execute a zero input test on the die 5.",MOTOROLA INC,PAPPERT BERNARD J;;SHEPARD CLARK;;CROUCH ALFRED LARRY;;ASH ROBERT,,https://lens.org/075-949-872-929-952,Patent Application,no,0,1,7,7,0,G01R31/3008;;G01R31/3008;;G01R31/3004;;G01R31/3004;;H01L22/00,H01L21/66;;G01R31/30,,0,0,,,,PENDING
344,US,A,US 6084468 A,124-492-402-064-489,2000-07-04,2000,US 94458597 A,1997-10-06,US 94458597 A,1997-10-06,Method and apparatus for high efficiency wideband power amplification,"A method and apparatus for efficient power amplification of a wideband signal with a correspondingly wide modulation bandwidth includes an envelope detector (220), an adaptive split band modulator (270), and a power amplifier (260). The adaptive split band modulator (270) amplifies the low frequency components using a class S modulator (760), and amplifies the high frequency components using a class B amplifier (750). The power supply of the class B amplifier (750) is adaptively modified as a function of the amplitude of the signal that it amplifies. In this manner, the class B amplifier (750) operates at a higher efficiency.",MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB FREDERICK H;;CLARK II JAMES ROGER,MOTOROLA MOBILITY LLC (2012-06-22);;GOOGLE TECHNOLOGY HOLDINGS LLC (2014-10-28);;MOTOROLA INC (1997-09-26),https://lens.org/124-492-402-064-489,Granted Patent,yes,6,71,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,330/136;;330/10;;X330207 A;;330/251;;330/297,5,2,108-159-123-989-367;;000-526-100-084-253,10.1049/cp:19940458;;10.1109/22.556466,"An article entitled A Linear Transponder For Amateur Radio Satellites by Dr. K. Meinzer, DJ 4ZC from VHG Communications, vol. 7, Jan. 1975.;;An article entitled High Efficiency Single Sideband HF/VHF Transmitter Based Upon Envelope Elimination And Restoration by F.H. Raab and D.J. Rupp, Green Mountain Radio Research Company, USA from IEEE CP392, UK pp. 21 25, Jul. 4 7, 1994.;;An article entitled Class S High Efficiency Amplitude Modulator by Dr. Frederick H. Raab and D.J. Rupp, Green Mountain Radio Research from GMRR TP93 1:RF Design, vol. 17.No. 5. pp. 70 74, May 1994.;;An article entitled Single Sideband Transmission By Envelope Elimination and Restoration by Leonard R. Kahn from Proceedings Of The IRE. July, year unknown.;;Article entitled Intermodulation Distortion in Kahn Technique Transmitters by Frederick H. Raab, IEEE Transactions On Microwave Theory and Techniques, vol. 44, No. 12, (Dec. 1996).",EXPIRED
345,US,B2,US 8353121 B2,009-961-006-741-986,2013-01-15,2013,US 35358009 A,2009-01-14,US 35358009 A;;US 74671107 A,2007-05-10,Processes and systems for monitoring usage of projectile weapons,"Processes and systems for detecting a shot by a projectile weapon are disclosed. Data is obtained along at least two different axes for use in determining whether a shot has taken place based on an evaluation by a processor. In certain embodiments, multiple detection systems are positioned on a weapons platform mounting multiple projectile weapons, and each is configured to detect only a shot by a respective one of the projectile weapons.",LEITNER WISE DEFENSE INC;;CLARK ROBERT BERNARD IREDALE;;GESSEL DAVID;;LEITNER-WISE PAUL ANDREW,CLARK ROBERT BERNARD IREDALE;;GESSEL DAVID;;LEITNER-WISE PAUL ANDREW,LEITNER-WISE DEFENSE INC (2009-07-23),https://lens.org/009-961-006-741-986,Granted Patent,yes,50,9,2,7,0,F41A19/01;;F41A19/01,F41A9/53,42/1.01;;73/167,0,0,,,,ACTIVE
346,WO,A1,WO 1989/007822 A1,042-240-380-692-64X,1989-08-24,1989,GB 8900174 W,1989-02-17,GB 8803923 A,1988-02-19,OPTICAL STORAGE DEVICES,"In a process for mass producing optical storage sheets, an elongate film (4) of a liquid crystalline material exhibiting a glassy phase is fed lengthwise along a path through an aligning gate (5). The aligning gate heats successive areas of the film and applies to each heated area a magnetic field though the thickness of the film. This field aligns the molecules in the heated area and the magnetic field is maintained during cooling of the area. The aligned film may then be cut into pieces for use as microfiches or microfilms. The film material is preferably a liquid cristal polymer material.",GEN ELECTRIC CO PLC,MCARDLE CIARAN BERNARD;;CLARK MICHAEL GEORGE;;BECK WILLIAM RICHARD JR,,https://lens.org/042-240-380-692-64X,Patent Application,yes,4,2,14,14,0,G02F1/133365;;G11B7/0033;;G11B7/00555;;G11B7/26;;Y10S118/04;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;C09K2323/023;;C09K2323/02;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;G11B7/26;;G11B7/00555;;G02F1/133365;;G11B7/0033;;Y10S118/04;;C09K2323/02;;C09K2323/023,G02F1/1333;;G11B7/0033;;G11B7/0055;;G11B7/26,,1,0,,,"Patent Abstracts of Japan, vol. 6, no. 133 (P-129)(1011), 20 July 1982; & JP-A-5758252 (TOKYO SHIBAURA DENKI K.K.) 7 April 1982",PENDING
347,US,A1,US 2009/0287455 A1,065-038-493-304-741,2009-11-19,2009,US 35360209 A,2009-01-14,US 35360209 A;;US 74671107 A,2007-05-10,Processes and Systems for Monitoring Environments of Projectile Weapons,"Processes and systems are disclosed for recording data relating to a shot by a projectile weapon. Environment data occurring prior to data indicating the occurrence of a shot by the projectile weapon is retained for subsequent evaluation. Such environment data includes, but is not limited to, ambient audio data, video data produced by a video camera associated with the projectile weapon, GPS data representing locations of the projectile weapon, electronic compass data representing orientations of the projectile weapon and acceleration data representing accelerations of the projectile weapon.",CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW;;GESSEL DAVID,CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW;;GESSEL DAVID,LEITNER-WISE DEFENSE INC (2009-07-23),https://lens.org/065-038-493-304-741,Patent Application,yes,10,2,4,7,0,F41A19/01;;F41A19/01,G06F17/40,702/187,0,0,,,,INACTIVE
348,US,B2,US 8850730 B2,095-129-999-709-49X,2014-10-07,2014,US 201213400095 A,2012-02-19,US 201213400095 A;;US 35360209 A;;US 74671107 A,2007-05-10,Processes and systems for monitoring environments of projectile weapons,"Processes and systems are disclosed for recording data relating to a shot by a projectile weapon. Environment data occurring prior to data indicating the occurrence of a shot by the projectile weapon is retained for subsequent evaluation. Such environment data includes, but is not limited to, ambient audio data, video data produced by a video camera associated with the projectile weapon, GPS data representing locations of the projectile weapon, electronic compass data representing orientations of the projectile weapon and acceleration data representing accelerations of the projectile weapon.",CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW;;GESSEL DAVID;;LEITNER WISE DEFENSE INC,CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW;;GESSEL DAVID,,https://lens.org/095-129-999-709-49X,Granted Patent,yes,57,12,4,7,0,F41A19/01;;F41A19/01,F41A9/53;;F41A19/01,42/1.01;;42/1.03,0,0,,,,ACTIVE
349,GB,A,GB 2216281 A,138-317-132-031-360,1989-10-04,1989,GB 8903657 A,1989-02-17,GB 8803923 A,1988-02-19,OPTICAL STORAGE DEVICES,,GEN ELECTRIC CO PLC,MCARDLE CIARAN BERNARD;;CLARK MICHAEL GEORGE;;BECK JR WILLIAM RICHARD,,https://lens.org/138-317-132-031-360,Patent Application,no,3,1,14,14,0,G02F1/133365;;G11B7/0033;;G11B7/00555;;G11B7/26;;Y10S118/04;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;C09K2323/023;;C09K2323/02;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;G11B7/26;;G11B7/00555;;G02F1/133365;;G11B7/0033;;Y10S118/04;;C09K2323/02;;C09K2323/023,G02F1/1333;;G11B7/0033;;G11B7/0055;;G11B7/26,G2F FCD           CD;;G2F F23M          CD;;G2F F23R          CD;;G2F F25F          CD;;G2F F28M          CD;;G2X XL6           XL6;;U1S S2120;;U1S S2226;;U1S S2231,0,0,,,,DISCONTINUED
350,US,B1,US 6175273 B1,153-496-249-695-961,2001-01-16,2001,US 54132700 A,2000-04-02,US 54132700 A;;US 94458597 A,1997-10-06,Method and apparatus for high efficiency wideband power amplification,"A method and apparatus for efficient power amplification of a wideband signal with a correspondingly wide modulation bandwidth includes an envelope detector (220), an adaptive split band modulator (270), and a power amplifier (260). The adaptive split band modulator (270) amplifies the low frequency components using a class S modulator (760), and amplifies the high frequency components using a class B amplifier (750). The power supply of the class B amplifier (750) is adaptively modified as a function of the amplitude of the signal that it amplifies. In this manner, the class B amplifier (750) operates at a higher efficiency.",MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB FREDERICK H;;CLARK II JAMES ROGER,MOTOROLA MOBILITY LLC (2012-06-22);;GOOGLE TECHNOLOGY HOLDINGS LLC (2014-10-28);;MOTOROLA INC (1997-09-26),https://lens.org/153-496-249-695-961,Granted Patent,yes,11,100,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,330/10;;330/126;;330/136,5,3,000-526-100-084-253;;108-159-123-989-367;;142-430-184-666-885,10.1109/22.556466;;10.1049/cp:19940458;;10.1109/jrproc.1952.273844,"""Intermodulation Distortion in Kahn-Technique Transmitters"" by F.H. Raab, IEEE Transactions on Microwave Theory and Techniques, vol. 44, No. 12 (Dec. 1996), pp. 2273-2278.;;""A Linear Transponder for Amateur Radio Satellites"" by Dr. L.K. Meizer, DJ4ZC from VHG Communications, vol. 7 (Jan. 1975), pp. 42-57.;;""High-Efficiency Single-Sideband HF/VHF Transmitter Based Upon Envelope Elimination and Restoration"" by F.H. Raab et al, Green Mountain Radio Research Company, USA from Sixth International Conference, HF Radio Systems, and Techniques, IEEE CP392, UK (Jul. 4-7, 1994), pp. 21-25.;;""Class-S High-Efficiency Amplitude Modulator"" by F.H. Raab et al, Green Mountain Radio Research from GMRR TP93-1:RF Design, vol. 17, No. 5 (May 1994), pp. 70-74.;;""Single-Sideband Transmission by Envelope Elimination and Restoration"" by L.R. Kahn from Proceedings of the I.R.E. (Jul. 1952), pp. 803-806.",EXPIRED
351,DE,C2,DE 19882705 C2,033-612-359-589-54X,2003-06-18,2003,DE 19882705 T,1998-10-02,US 94458597 A;;US 9820759 W,1997-10-06,Adaptiver Aufteilungs-Band-Modulator,,MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB FREDERICK H;;CLARK II JAMES ROGER,"GOOGLE TECHNOLOGY HOLDINGS LLC, MOUNTAIN VIEW, US (2018-04-26);;MOTOROLA MOBILITY, INC. ( N.D. GES. D. STAATES, US (2011-03-24)",https://lens.org/033-612-359-589-54X,Granted Patent,no,0,2,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,,0,0,,,,EXPIRED
352,US,A1,US 2012/0150923 A1,150-826-243-322-822,2012-06-14,2012,US 201213400095 A,2012-02-19,US 201213400095 A;;US 35360209 A;;US 74671107 A,2007-05-10,Processes and Systems for Monitoring Environments of Projectile Weapons,"Processes and systems are disclosed for recording data relating to a shot by a projectile weapon. Environment data occurring prior to data indicating the occurrence of a shot by the projectile weapon is retained for subsequent evaluation. Such environment data includes, but is not limited to, ambient audio data, video data produced by a video camera associated with the projectile weapon, GPS data representing locations of the projectile weapon, electronic compass data representing orientations of the projectile weapon and acceleration data representing accelerations of the projectile weapon.",CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW;;GESSEL DAVID,CLARK ROBERT BERNARD IREDALE;;LEITNER-WISE PAUL ANDREW;;GESSEL DAVID,,https://lens.org/150-826-243-322-822,Patent Application,yes,13,4,4,7,0,F41A19/01;;F41A19/01,G06F7/00,707/812;;X707E17044,0,0,,,,ACTIVE
353,US,A1,US 2008/0092733 A1,191-415-412-182-658,2008-04-24,2008,US 58378406 A,2006-10-20,US 58378406 A,2006-10-20,Firearm bolt assembly with fully-supported bolt face,An improved bolt carrier for a firearm is provided that improves the overall reliability and performance of the firearm bolt assembly. The bolt carrier includes a bolt with a body having a number of lugs extending therefrom. The bolt includes an extractor recess sized and configured to avoid any undercut of the lugs adjacent the recess. The bolt also includes an extractor pivotably engaged in a recess formed in the bolt. The extractor has a pair nipples on flanges configured to engage a pair of integrally buffered springs disposed on a tapered spring well on either side of a firing pin bore extending through the bolt.,LEITNER-WISE PAUL;;IREDALE CLARK ROBERT BERNARD;;GOMEZ JESSE S,LEITNER-WISE PAUL;;IREDALE CLARK ROBERT BERNARD;;GOMEZ JESSE S,LWRC INTERNATIONAL LLC (2008-04-18),https://lens.org/191-415-412-182-658,Patent Application,yes,24,50,3,3,0,F41A3/26;;F41A15/14;;F41A15/14;;F41A3/26,F41A15/00,89/138;;89/33.01,0,0,,,,DISCONTINUED
354,EP,A2,EP 0296793 A2,024-639-784-608-151,1988-12-28,1988,EP 88305631 A,1988-06-22,GB 8714866 A,1987-06-25,Colour photographic silver halide materials and process.,"A new non-diffusible yellow dye-forming para-R-oxybenzoylacetanilide coupler has a combination of (a) a para-hydroxyphenylsulphonylphenoxy coupling-off group in the coupling-position, (b) a chloro or trifluoromethyl group in the ortho position on the anilide moiety, and (c) a group on the anilide moiety that is selected from (i) a sulphamoyl group (ii) an aliphatic hydrocarbon group that is bonded to the anilide moiety directly or through a linking group as described in the application, (iii) chlorine and (iv) trifluoromethyl; wherein the coupler contains at least one ballast group on at least one of the anilide and para-R-oxybenzoyl moieties; and wherein R is an unsubstituted or substituted cyclic or non-cyclic aliphatic hydrocarbon group. These couplers are useful in color photographic silver halide materials and processes to produce image dyes that have excellent hue and high extinction coefficient.  ",EASTMAN KODAK CO;;KODAK LTD,CLARK BERNARD ARTHUR JAMES;;MILNER NIGEL EDGEWICK;;STANLEY PAUL LOUIS REGINALD,,https://lens.org/024-639-784-608-151,Patent Application,yes,0,1,7,7,0,G03C7/30535,G03C7/36;;G03C7/305,,0,0,,,,EXPIRED
355,AU,A1,AU 2020/253451 A1,164-315-463-134-384,2021-11-11,2021,AU 2020/253451 A,2020-04-01,US 201962828090 P;;US 2020/0026271 W,2019-04-02,Lighting assemblies for medical device suspension system,"Embodiments include a lighting assembly includes an elongate gasket body formed of a resilient, optically transmissive material. The gasket body includes a light source cavity at least partially defined by a light transmission portion and an attachment channel configured to attach the gasket body to a mount. A light source is disposed in the light source cavity. Other embodiments include securement ring including a clamp portion and a lighting assembly portion. The clamp portion includes first and second segments, each being semiannular in shape and curving between first and second ends, the first end of the first segment coupled to the second end of the second segment and the second end of the first segment coupled to the first end of the second segment to collectively form an aperture. The lighting assembly portion includes a first and second segments, each being semiannular in shape and including a light source.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HOLLOPETER MICHAEL;;GROSZEK JOSEPH JAMES,,https://lens.org/164-315-463-134-384,Patent Application,no,0,0,9,94,0,F21S8/063;;F21V5/043;;F21V17/104;;F21V33/0068;;F21W2131/205;;F21Y2115/10;;F21S8/046;;F21Y2107/70;;F21Y2103/33;;F21V21/088;;F21V21/116;;A61B90/30;;A61B90/35;;A61B90/35;;F21V21/36;;F21W2131/20;;F21V21/088;;F21V33/0068;;F21W2131/205,F21S4/26;;F21S8/04;;F21S8/06;;F21V5/04;;F21V17/10;;F21V21/088;;F21V21/116;;F21V33/00;;F21W131/205;;F21Y103/10;;F21Y115/10,,0,0,,,,PENDING
356,EP,A2,EP 0480620 A2,002-647-787-126-408,1992-04-15,1992,EP 91309019 A,1991-10-02,US 59477490 A,1990-10-09,Method for inspecting etched workpieces.,"Applicants have discovered that if scattered light from an etched workpiece is measured over many orders of diffraction, important characteristics of the etched workpiece can be correlated with the principal component content of the intensity characteristic. An etched workpiece (10) is inspected by exposing the workpiece to a beam of coherent light (31) measuring the intensity of the light (33) scattered from the workpiece over a range of spatial frequencies corresponding to a plurality of diffraction orders, determining the principal component content of the intensity envelope of the tested workpiece and accepting or rejecting the workpiece in accordance with whether or not the principal component content satisfies predetermined criteria. In preferred embodiments the principal components are determined in relation to a plurality of reference measurements by singular value decomposition.",AMERICAN TELEPHONE & TELEGRAPH,CLARK LINDA ANN;;GOTTSCHO RICHARD ALAN;;KRUSKAL JOSEPH BERNARD;;LAMBERT DIANE,AT&T CORP. (1994-06-22),https://lens.org/002-647-787-126-408,Patent Application,yes,0,8,6,6,0,G01B11/02;;G01N21/4788;;G01N21/956;;G01B11/02;;G01N21/4788;;G01N21/956,H01L21/30;;G01B11/02;;G01N21/47;;G01N21/956;;G06T1/00;;H01L21/027;;H01L21/66,,0,0,,,,EXPIRED
357,DE,D1,DE 3883446 D1,117-278-592-822-488,1993-09-30,1993,DE 3883446 T,1988-06-22,GB 8714866 A,1987-06-25,Farbphotographische Silberhalogenidmaterialien und Verfahren.,,EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;MILNER NIGEL EDGEWICK;;STANLEY PAUL LOUIS REGINALD,,https://lens.org/117-278-592-822-488,Granted Patent,no,0,0,7,7,0,G03C7/30535,G03C7/36;;G03C7/305,,0,0,,,,EXPIRED
358,US,B2,US 10966796 B2,176-513-078-291-714,2021-04-06,2021,US 202016837982 A,2020-04-01,US 202016837982 A;;US 201962828090 P,2019-04-02,Lighting assemblies for medical device suspension system,"Embodiments include a lighting assembly includes an elongate gasket body formed of a resilient, optically transmissive material. The gasket body includes a light source cavity at least partially defined by a light transmission portion and an attachment channel configured to attach the gasket body to a mount. A light source is disposed in the light source cavity. Other embodiments include securement ring including a clamp portion and a lighting assembly portion. The clamp portion includes first and second segments, each being semi-annular in shape and curving between first and second ends, the first end of the first segment coupled to the second end of the second segment and the second end of the first segment coupled to the first end of the second segment to collectively form an aperture. The lighting assembly portion includes a first and second segments, each being semi-annular in shape and including a light source.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HOLLOPETER MICHAEL;;GROSZEK JOSEPH JAMES,AMERICAN STERILIZER COMPANY (2019-04-02),https://lens.org/176-513-078-291-714,Granted Patent,yes,36,7,9,94,0,F21S8/063;;F21V5/043;;F21V17/104;;F21V33/0068;;F21W2131/205;;F21Y2115/10;;F21S8/046;;F21Y2107/70;;F21Y2103/33;;F21V21/088;;F21V21/116;;A61B90/30;;A61B90/35;;A61B90/35;;F21V21/36;;F21W2131/20;;F21V21/088;;F21V33/0068;;F21W2131/205,A61B90/35;;F21V21/36;;F21W131/20,,2,0,,,"Invitation to Pay Additional Fees for related International Application No. PCT/US2020/026271 dated Jul. 31, 2020.;;PCT International Search Report and Written Opinion of the International Searching Authority for related International Application No. PCT/US2020/026271 dated Dec. 16, 2020.",ACTIVE
359,GB,A,GB 2216282 A,019-683-558-398-181,1989-10-04,1989,GB 8903658 A,1989-02-17,GB 8803923 A,1988-02-19,OPTICAL STORAGE DEVICES,,GEN ELECTRIC CO PLC,MCARDLE CIARAN BERNARD;;CLARK MICHAEL GEORGE;;BECK WILLIAM RICHARD;;BOWRY CAROLYN,,https://lens.org/019-683-558-398-181,Patent Application,no,4,2,14,14,0,G02F1/133365;;G11B7/0033;;G11B7/00555;;G11B7/26;;Y10S118/04;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;C09K2323/023;;C09K2323/02;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;G11B7/26;;G11B7/00555;;G02F1/133365;;G11B7/0033;;Y10S118/04;;C09K2323/02;;C09K2323/023,G02F1/1333;;G11B7/0033;;G11B7/0055;;G11B7/26,G2F FCD           CD;;G2F F23E          CD;;G2F F23F          CD;;G2F F23M          CD;;G2F F23R          CD;;G2F F25F          CD;;G2F F28M          CD;;G2X XL6           XL6;;U1S S2120;;U1S S2226;;U1S S2231,1,0,,,JP63170486A,EXPIRED
360,US,A,US 5693458 A,131-283-105-464-032,1997-12-02,1997,US 66919496 A,1996-06-24,GB 9513108 A,1995-06-28,Photographic elements containing certain yellow dye-forming couplers,"The invention provides a photographic element comprising a light-sensitive silver halide emulsion layer having associated therewith a dye-forming coupler of formula (I): ##STR1## wherein X is H or a coupling-off group, R.sub.1 is H or a substituent group; Y and Z are the same or different and are H or are independently selected from alkyl, aryl and heteroaryl groups; provided that Y and Z taken together with the nitrogen atom may form a 5-10 membered heterocyclic ring.",EASTMAN KODAK CO,CLARK BERNARD ARTHUR;;GOURLEY ROBERT NICHOLAS;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,EASTMAN KODAK COMPANY (1996-07-25),https://lens.org/131-283-105-464-032,Granted Patent,yes,6,0,6,6,0,G03C7/36;;G03C7/36;;G03C7/30535;;G03C7/30535,G03C7/305;;G03C7/36,430/557;;430/556,3,1,083-612-133-859-133,8230129;;10.1021/jm00074a020,"Synthesis, 1993, Stuttgart, DE, pp. 783 785, R. Bossio et al. Studies on Isocyanides and Related Compounds .;;Journal of General Chemistry USSR, vol. 30, No. 10, Oct. 1960, NY US N.S. Vulf son and V.E. Kolchin.;;Journal of Medicinal Chemistry, vol. 36, 1993, Washington US, pp. 3386 3396, M. Rowley et al.",EXPIRED
361,SE,D0,SE 8206429 D0,031-314-859-981-478,1982-11-12,1982,SE 8206429 A,1982-11-12,US 77135977 A;;US 79044277 A,1977-02-23,STATIVSYSTEM FOR HJERTVENTILPROTES,,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR M,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR MILTON,,https://lens.org/031-314-859-981-478,Patent Application,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
362,SE,B,SE 451533 B,073-590-107-631-883,1987-10-19,1987,SE 8206288 A,1982-11-05,US 77135977 A;;US 79044277 A,1977-02-23,TYG FOR EN KARDIOVASKULER PROTES,,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR M,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR MILTON,,https://lens.org/073-590-107-631-883,Unknown,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
363,SE,B,SE 454479 B,036-059-416-035-518,1988-05-09,1988,SE 8206429 A,1982-11-12,US 77135977 A;;US 79044277 A,1977-02-23,STATIVSYSTEM FOR EN HJERTVENTILPROTES,,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR M,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR MILTON,,https://lens.org/036-059-416-035-518,Unknown,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
364,SE,L,SE 8206429 L,079-754-995-913-77X,1982-11-12,1982,SE 8206429 A,1982-11-12,US 77135977 A;;US 79044277 A,1977-02-23,STATIVSYSTEM FOR HJERTVENTILPROTES,,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR M,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR MILTON,,https://lens.org/079-754-995-913-77X,Abstract,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
365,EP,B1,EP 0296793 B1,010-899-586-267-571,1993-08-25,1993,EP 88305631 A,1988-06-22,GB 8714866 A,1987-06-25,COLOUR PHOTOGRAPHIC SILVER HALIDE MATERIALS AND PROCESS,,EASTMAN KODAK COMPANY (A NEW JERSEY CORPORATION);;KODAK LIMITED,"CLARK, BERNARD ARTHUR JAMES;;MILNER, NIGEL EDGEWICK;;STANLEY, PAUL LOUIS REGINALD",,https://lens.org/010-899-586-267-571,Granted Patent,yes,1,0,7,7,0,G03C7/30535,G03C7/36;;G03C7/305,,1,0,,,"PATENT ABSTRACTS OF JAPAN, vol. 9, no. 30 (P-333)[1753], 8th February 1985",EXPIRED
366,US,A,US 3128347 A,077-744-088-331-416,1964-04-07,1964,US 16894662 A,1962-01-26,GB 3076062 A;;GB 9908661 A,1962-08-10,Arrangements for automatically identifying calling numbers in telephone systems,,ASS ELECT IND,BERNARD DRAKE;;BROWNLIE CLARK JOHN;;WILLIAM HICKS PERCY;;GEORGE TAYLOR JAMES,,https://lens.org/077-744-088-331-416,Granted Patent,no,0,1,1,4,0,H04M15/08;;H04M15/08,H04M15/08,,0,0,,,,EXPIRED
367,AU,A,AU 1982/080175 A,139-940-388-698-688,1982-05-06,1982,AU 1982/080175 A,1982-02-03,AU 1982/080175 A,1982-02-03,FRAME FOR HEART VALVE PROSTHESIS,,DAVIS R B;;SKELTON J;;CLARK R E;;SWANSON W M,DAVIS ROBERT BERNARD;;CLARK RICHARD EDWIN;;SKELTON JOHN;;SWANSON WILBUR MILTON,,https://lens.org/139-940-388-698-688,Patent Application,no,0,0,2,2,0,A61F2/2415,A61F2/24,,0,0,,,,EXPIRED
368,EP,A3,EP 0480620 A3,016-892-270-394-423,1992-09-30,1992,EP 91309019 A,1991-10-02,US 59477490 A,1990-10-09,METHOD FOR INSPECTING ETCHED WORKPIECES,"Applicants have discovered that if scattered light from an etched workpiece is measured over many orders of diffraction, important characteristics of the etched workpiece can be correlated with the principal component content of the intensity characteristic. An etched workpiece (10) is inspected by exposing the workpiece to a beam of coherent light (31) measuring the intensity of the light (33) scattered from the workpiece over a range of spatial frequencies corresponding to a plurality of diffraction orders, determining the principal component content of the intensity envelope of the tested workpiece and accepting or rejecting the workpiece in accordance with whether or not the principal component content satisfies predetermined criteria. In preferred embodiments the principal components are determined in relation to a plurality of reference measurements by singular value decomposition.",AMERICAN TELEPHONE AND TELEGRAPH COMPANY,"CLARK, LINDA ANN;;GOTTSCHO, RICHARD ALAN;;KRUSKAL, JOSEPH BERNARD;;LAMBERT, DIANE",AT&T CORP. (1994-06-22),https://lens.org/016-892-270-394-423,Search Report,yes,4,0,6,6,0,G01B11/02;;G01N21/4788;;G01N21/956;;G01B11/02;;G01N21/4788;;G01N21/956,H01L21/30;;G01B11/02;;G01N21/47;;G01N21/956;;G06T1/00;;H01L21/027;;H01L21/66,,0,0,,,,EXPIRED
369,DE,T2,DE 3883446 T2,064-718-582-693-139,1994-03-17,1994,DE 3883446 T,1988-06-22,GB 8714866 A,1987-06-25,Farbphotographische Silberhalogenidmaterialien und Verfahren.,,EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;MILNER NIGEL EDGEWICK;;STANLEY PAUL LOUIS REGINALD,,https://lens.org/064-718-582-693-139,Granted Patent,no,0,0,7,7,0,G03C7/30535,G03C7/36;;G03C7/305,,0,0,,,,EXPIRED
370,CH,A5,CH 639841 A5,185-225-121-893-842,1983-12-15,1983,CH 192378 A,1978-02-22,US 77135977 A;;US 79044277 A,1977-02-23,Fabric for cardiovascular prosthesis and prosthesis for cardiac valve,,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR M,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR MILTON,,https://lens.org/185-225-121-893-842,Granted Patent,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
371,GB,A,GB 924491 A,035-757-600-677-942,1963-04-24,1963,GB 908661 A,1961-03-13,GB 3076062 A,1962-08-10,Improvements relating to arrangements for automatically identifying calling numbers in telephone systems,"924,491. Automatic exchange systems. ASSOCIATED ELECTRICAL INDUSTRIES Ltd. Feb. 20, 1962 [March 13, 1961], No. 9086/61. Class 40 (4). A calling line identifying arrangement, which caters also for party lines and PBX lines, comprises a matrix having at each cross-point such as M1163, Fig. 2, a pair of gas-filled diodes and a pair of coupling resistors which serve to couple an input wire C1163 to a particular thousands-hundreds wire 11XX and a particular tens-units wire XX63, the latter wires each being connected through rectifiers to a pair of wires so that, when a high voltage pulse is applied to the input wire, a group of four wires 1XXX, X1XX, XX6X, XXX3 are marked to represent the four digits of the calling number. The cross-point M1163 relates to an ordinary line and the input wire C1163 is connected to the private wire at the 1DF. In the case of a party line, there is a cross-point for each party, e.g. M1200, M1208, M1209, Fig. 2, and the input wires are all connected to the private wire of the line. In addition, two extra diodes are provided which are controlled by relays A, B, C, Fig. 3, in dependence on the party calling and serve to inhibit the cross-point diodes corresponding to non-calling parties. In the case of PBX lines which all bear the same number, the diodes at the corresponding crosspoints, e.g. M4455 . . . M4458, Fig. 4, are connected to provide the same markings. The four sets of ten marking wires are connected to pre-amplifiers PA, Fig. 8 (four only being shown) and the output from each of these is taken through rectifiers to two amplifiers of a set of five amplifiers MSM pertaining to the digit place concerned to provide a representation of each digit in a 2 out of 5 code. The base load resistor RP1 of the pre-amplifiers is of such a value that each of the two transistors marked at a time receives adequate current. The high voltage operating pulse may be produced by discharging in series three capacitors previously charged in parallel from the exchange battery. The cross-point circuits may be in the form of cards each carrying the elements for ten crosspoints with printed wiring, and the inhibiting elements for party lines may be carried on smaller cards which may be clipped on the cross-point cards.",ASS ELECT IND,DRAKE BERNARD;;CLARK JOHN BROWNLIE;;HICKS PERCY WILLIAM;;TAYLOR JAMES GEORGE,,https://lens.org/035-757-600-677-942,Granted Patent,no,0,0,3,4,0,H04M15/08;;H04M15/08,H04M15/08,H4K KBC           KBC;;H4K K1A1          KBC;;H4K K1A11         KBC;;H4K K1A2          KBC;;H4K K1A3          KBC;;H4K K1A8          KBC;;H4K K1W           KBC,0,0,,,,EXPIRED
372,DE,B2,DE 2117276 B2,076-427-504-206-871,1974-01-31,1974,DE 2117276 A,1971-04-08,US 4668570 A,1970-06-16,DE 2117276 B2,,"TRW INC., LOS ANGELES, CALIF. (V.ST.A.)","CASEY, HARRY BERNARD, WILLOW GROVE, PA.;;CLARK, CARL EDWIN, ST.PETERSBURG, FLA",,https://lens.org/076-427-504-206-871,Patent Application,no,0,1,11,11,0,H01C10/26;;H01C10/26,H01C10/26,,0,0,,,,EXPIRED
373,FI,B,FI 117839 B,073-329-184-856-120,2007-03-15,2007,FI 20000726 A,2000-03-29,US 94458597 A;;US 9820759 W,1997-10-06,"Hyötysuhteeltaan hyvä, laajakaistainen tehovahvistin",,MOTOROLA INC,SIGMON BERNARD EUGENE;;RAAB FREDERICK H;;CLARK LL JAMES ROGER II,"MOTOROLA MOBILITY, INC. (2011-11-28)",https://lens.org/073-329-184-856-120,Patent Application,no,0,0,12,12,0,H03F3/211;;H03F3/211;;H03F1/0222;;H03F1/0222;;H03F2200/102;;H03F2200/102;;H03F2200/39;;H03F2200/39;;H03F2200/432;;H03F2200/432,H03F1/02;;H03F3/21,,0,0,,,,EXPIRED
374,WO,A2,WO 2020/206043 A2,106-383-535-189-378,2020-10-08,2020,US 2020/0026271 W,2020-04-01,US 201962828090 P,2019-04-02,LIGHTING ASSEMBLIES FOR MEDICAL DEVICE SUSPENSION SYSTEM,"Embodiments include a lighting assembly includes an elongate gasket body formed of a resilient, optically transmissive material. The gasket body includes a light source cavity at least partially defined by a light transmission portion and an attachment channel configured to attach the gasket body to a mount. A light source is disposed in the light source cavity. Other embodiments include securement ring including a clamp portion and a lighting assembly portion. The clamp portion includes first and second segments, each being semiannular in shape and curving between first and second ends, the first end of the first segment coupled to the second end of the second segment and the second end of the first segment coupled to the first end of the second segment to collectively form an aperture. The lighting assembly portion includes a first and second segments, each being semiannular in shape and including a light source.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HOLLOPETER MICHAEL;;GROSZEK JOSEPH JAMES,,https://lens.org/106-383-535-189-378,Patent Application,yes,0,0,9,94,0,F21S8/063;;F21V5/043;;F21V17/104;;F21V33/0068;;F21W2131/205;;F21Y2115/10;;F21S8/046;;F21Y2107/70;;F21Y2103/33;;F21V21/088;;F21V21/116;;A61B90/30;;A61B90/35;;A61B90/35;;F21V21/36;;F21W2131/20;;F21V21/088;;F21V33/0068;;F21W2131/205,F21S4/26;;F21S8/04;;F21S8/06;;F21V5/04;;F21V17/10;;F21V33/00,,0,0,,,,PENDING
375,US,A1,US 2022/0168064 A1,170-201-442-383-56X,2022-06-02,2022,US 202017601284 A,2020-04-01,US 202017601284 A;;US 201962828090 P;;US 2020/0026271 W,2019-04-02,LIGHTING ASSEMBLIES FOR MEDICAL DEVICE SUSPENSION SYSTEM,"Embodiments include a lighting assembly includes an elongate gasket body formed of a resilient, optically transmissive material. The gasket body includes a light source cavity at least partially defined by a light transmission portion and an attachment channel configured to attach the gasket body to a mount. A light source is disposed in the light source cavity. Other embodiments include securement ring including a clamp portion and a lighting assembly portion. The clamp portion includes first and second segments, each being semiannular in shape and curving between first and second ends, the first end of the first segment coupled to the second end of the second segment and the second end of the first segment coupled to the first end of the second segment to collectively form an aperture. The lighting assembly portion includes a first and second segments, each being semiannular in shape and including a light source.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HOLLOPETER MICHAEL;;GROSZEK JOSEPH JAMES,AMERICAN STERILIZER COMPANY (2019-04-02),https://lens.org/170-201-442-383-56X,Patent Application,yes,1,0,9,94,0,F21S8/063;;F21V5/043;;F21V17/104;;F21V33/0068;;F21W2131/205;;F21Y2115/10;;F21S8/046;;F21Y2107/70;;F21Y2103/33;;F21V21/088;;F21V21/116;;A61B90/30;;A61B90/35;;A61B90/35;;F21V21/36;;F21W2131/20;;F21V21/088;;F21V33/0068;;F21W2131/205,A61B90/35;;F21V21/088;;F21V33/00,,0,0,,,,ACTIVE
376,EP,A1,EP 0940717 A1,081-192-629-588-495,1999-09-08,1999,EP 99200482 A,1999-02-19,US 3471498 A,1998-03-04,System and method for transferring images on an image content of a first format to a photosensitive film of a second format,"The present invention relates to a system and method of transferring images from an image content of a first format to a photosensitive film of a second format. The image content of the first format can include photosensitive material such as an exposed roll of 35mm film, a photographic print, a floppy disk , a compact disc, etc. With the system and method of the present invention, it is possible for a customer to take, for example, an existing negative and have it transferred onto an Advanced Photo System film format. Therefore, in the system and method of the present invention, original exposed film such as 35mm, 110 film, etc., can be scanned to produce a digital record of the images. The record of the images can be sent to a digital film writer where a preferred format, for example, Advanced Photo System film, can be obtained. The Advanced Photo System film can then be placed in a thrust-type film cartridge. This permits the conversion of old film types into a preferred film format that can be easily used to interface with film viewing devices. This also permits the conversion of non-permanent storage of images to a permanent media with high storage capabilities such as Advanced Photo System film.",EASTMAN KODAK CO,ALEXANDRE BERNARD GUY JEAN-LOU;;BOLT KEITH ADRIAN;;MERLE THOMAS CLARK,,https://lens.org/081-192-629-588-495,Patent Application,yes,2,3,2,2,0,G03B2227/005;;G03D15/005;;H04N1/00132;;H04N1/32502;;H04N1/32512;;H04N1/32529;;H04N2201/0081;;H04N2201/0082;;H04N2201/0087;;H04N1/32512;;G03B2227/005;;H04N1/32502;;H04N1/32529;;G03D15/005;;H04N2201/0082;;H04N2201/0087;;H04N2201/0081;;H04N1/00132,G03D15/00;;H04N1/00;;H04N1/32,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 97, no. 2 28 February 1997 (1997-02-28);;PATENT ABSTRACTS OF JAPAN vol. 98, no. 2 30 January 1998 (1998-01-30)",DISCONTINUED
377,EP,A2,EP 3948064 A2,157-974-084-216-131,2022-02-09,2022,EP 20722075 A,2020-04-01,US 201962828090 P;;US 2020/0026271 W,2019-04-02,LIGHTING ASSEMBLIES FOR MEDICAL DEVICE SUSPENSION SYSTEM,,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HOLLOPETER MICHAEL;;GROSZEK JOSEPH JAMES,,https://lens.org/157-974-084-216-131,Patent Application,yes,0,0,9,94,0,F21S8/063;;F21V5/043;;F21V17/104;;F21V33/0068;;F21W2131/205;;F21Y2115/10;;F21S8/046;;F21Y2107/70;;F21Y2103/33;;F21V21/088;;F21V21/116;;A61B90/30;;A61B90/35;;A61B90/35;;F21V21/36;;F21W2131/20;;F21V21/088;;F21V33/0068;;F21W2131/205,F21S4/26;;F21S8/04;;F21S8/06;;F21V5/04;;F21V17/10;;F21V21/088;;F21V21/116;;F21V33/00;;F21W131/205;;F21Y103/10;;F21Y115/10,,0,0,,,,PENDING
378,US,A1,US 2020/0315733 A1,177-464-965-394-646,2020-10-08,2020,US 202016837982 A,2020-04-01,US 202016837982 A;;US 201962828090 P,2019-04-02,LIGHTING ASSEMBLIES FOR MEDICAL DEVICE SUSPENSION SYSTEM,"Embodiments include a lighting assembly includes an elongate gasket body formed of a resilient, optically transmissive material. The gasket body includes a light source cavity at least partially defined by a light transmission portion and an attachment channel configured to attach the gasket body to a mount. A light source is disposed in the light source cavity. Other embodiments include securement ring including a clamp portion and a lighting assembly portion. The clamp portion includes first and second segments, each being semi-annular in shape and curving between first and second ends, the first end of the first segment coupled to the second end of the second segment and the second end of the first segment coupled to the first end of the second segment to collectively form an aperture. The lighting assembly portion includes a first and second segments, each being semi-annular in shape and including a light source.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HOLLOPETER MICHAEL;;GROSZEK JOSEPH JAMES,AMERICAN STERILIZER COMPANY (2019-04-02),https://lens.org/177-464-965-394-646,Patent Application,yes,0,0,9,94,0,F21S8/063;;F21V5/043;;F21V17/104;;F21V33/0068;;F21W2131/205;;F21Y2115/10;;F21S8/046;;F21Y2107/70;;F21Y2103/33;;F21V21/088;;F21V21/116;;A61B90/30;;A61B90/35;;A61B90/35;;F21V21/36;;F21W2131/20;;F21V21/088;;F21V33/0068;;F21W2131/205,A61B90/35;;F21V21/36,,0,0,,,,ACTIVE
379,GB,B,GB 2216282 B,181-325-369-391-937,1992-09-23,1992,GB 8903658 A,1989-02-17,GB 8803923 A,1988-02-19,OPTICAL STORAGE DEVICES,,GEN ELECTRIC CO PLC,MCARDLE CIARAN BERNARD;;CLARK MICHAEL GEORGE;;BECK WILLIAM RICHARD;;BOWRY CAROLYN,,https://lens.org/181-325-369-391-937,Granted Patent,no,4,0,14,14,0,G02F1/133365;;G11B7/0033;;G11B7/00555;;G11B7/26;;Y10S118/04;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;C09K2323/023;;C09K2323/02;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;G11B7/26;;G11B7/00555;;G02F1/133365;;G11B7/0033;;Y10S118/04;;C09K2323/02;;C09K2323/023,G02F1/1333;;G11B7/0033;;G11B7/0055;;G11B7/26,G2F FCD           CD;;G2F F23E          CD;;G2F F23F          CD;;G2F F23M          CD;;G2F F23R          CD;;G2F F25F          CD;;G2F F28M          CD;;G2X XL6           XL6;;U1S S2120;;U1S S2226;;U1S S2231,1,0,,,JP63170486A JP63170485A,EXPIRED
380,SE,D0,SE 8206288 D0,048-120-525-004-935,1982-11-05,1982,SE 8206288 A,1982-11-05,US 77135977 A;;US 79044277 A,1977-02-23,HJERTVENTILPROTES,,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR M,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR MILTON,,https://lens.org/048-120-525-004-935,Patent Application,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
381,SE,L,SE 8206288 L,077-043-477-030-789,1982-11-05,1982,SE 8206288 A,1982-11-05,US 77135977 A;;US 79044277 A,1977-02-23,HJERTVENTILPROTES,,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR M,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR MILTON,,https://lens.org/077-043-477-030-789,Abstract,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
382,WO,A3,WO 2020/206043 A3,138-883-388-865-963,2021-01-14,2021,US 2020/0026271 W,2020-04-01,US 201962828090 P,2019-04-02,LIGHTING ASSEMBLIES FOR MEDICAL DEVICE SUSPENSION SYSTEM,"Embodiments include a lighting assembly includes an elongate gasket body formed of a resilient, optically transmissive material. The gasket body includes a light source cavity at least partially defined by a light transmission portion and an attachment channel configured to attach the gasket body to a mount. A light source is disposed in the light source cavity. Other embodiments include securement ring including a clamp portion and a lighting assembly portion. The clamp portion includes first and second segments, each being semiannular in shape and curving between first and second ends, the first end of the first segment coupled to the second end of the second segment and the second end of the first segment coupled to the first end of the second segment to collectively form an aperture. The lighting assembly portion includes a first and second segments, each being semiannular in shape and including a light source.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HOLLOPETER MICHAEL;;GROSZEK JOSEPH JAMES,,https://lens.org/138-883-388-865-963,Search Report,yes,12,0,9,94,0,F21S8/063;;F21V5/043;;F21V17/104;;F21V33/0068;;F21W2131/205;;F21Y2115/10;;F21S8/046;;F21Y2107/70;;F21Y2103/33;;F21V21/088;;F21V21/116;;A61B90/30;;A61B90/35;;A61B90/35;;F21V21/36;;F21W2131/20;;F21V21/088;;F21V33/0068;;F21W2131/205,F21S4/26;;F21S8/04;;F21S8/06;;F21V5/04;;F21V17/10;;F21V21/088;;F21V21/116;;F21V33/00;;F21W131/205;;F21Y103/10;;F21Y115/10,,0,0,,,,PENDING
383,CH,A5,CH 654995 A5,000-957-611-697-320,1986-03-27,1986,CH 665983 A,1978-02-22,US 77135977 A;;US 79044277 A,1977-02-23,Prosthesis for replacing a cardiac valve,"The prosthesis is made from a fabric consisting of multifilament yarns of synthetic material which are supported by a three-lobed main reinforcement (30, 32, 34). The reinforcement comprises branches (24, 26, 28) which are parallel, each of which consists of two parts of a rod connected by a first end, and diverging at the other. The lobes make an opening between them, and three sheets of flexible fabric are each introduced between the parts of the rod of two branches and hermetically bonded to the latter and to the junction lobes. Each sheet comprises a free edge located between the branches, and the free edges are deformable so as to come into contact with each other and to hermetically close the opening. <IMAGE>",DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR M,DAVIS ROBERT BERNARD;;SKELTON JOHN;;CLARK RICHARD EDWIN;;SWANSON WILBUR MILTON,,https://lens.org/000-957-611-697-320,Granted Patent,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
384,AU,B2,AU 543374 B2,044-734-296-168-864,1985-04-18,1985,AU 1982/080175 A,1982-02-03,AU 1982/080175 A,1982-02-03,FRAME FOR HEART VALVE PROSTHESIS,,DAVIS R B;;SKELTON J;;CLARK R E;;SWANSON W M,DAVIS ROBERT BERNARD;;CLARK RICHARD EDWIN;;SKELTON JOHN;;SWANSON WILBUR MILTON,,https://lens.org/044-734-296-168-864,Granted Patent,no,0,0,2,2,0,A61F2/2415,A61F2/24,,0,0,,,,EXPIRED
385,DE,C3,DE 2117276 C3,048-570-151-990-037,1974-08-29,1974,DE 2117276 A,1971-04-08,US 4668570 A,1970-06-16,DE 2117276 C3,,"TRW INC., LOS ANGELES, CALIF. (V.ST.A.)","CASEY, HARRY BERNARD, WILLOW GROVE, PA.;;CLARK, CARL EDWIN, ST.PETERSBURG, FLA",,https://lens.org/048-570-151-990-037,Granted Patent,no,0,0,11,11,0,H01C10/26;;H01C10/26,H01C10/26,,0,0,,,,EXPIRED
386,CA,A,CA 672402 A,090-305-344-108-958,1963-10-15,1963,CA 672402D A,,CA 672402T A,,ARRANGEMENTS FOR AUTOMATICALLY IDENTIFYING CALLING NUMBERS IN TELEPHONE SYSTEMS,,ASS ELECT IND,TAYLOR JAMES G;;DRAKE BERNARD;;CLARK JOHN B;;HICKS PERCY W,,https://lens.org/090-305-344-108-958,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
387,AU,B2,AU 521676 B2,104-685-933-739-161,1982-04-22,1982,AU 1978/033292 A,1978-02-14,US 77135977 A;;US 79044277 A,1977-02-23,HEART VALVE PROTHESIS,,DAVIS R B;;SKELTON J;;CLARK R E;;SWANSON W M,DAVIS ROBERT BERNARD;;CLARK RICHARD EDWIN;;SKELTON JOHN;;SWANSON WILBUR MILTON,,https://lens.org/104-685-933-739-161,Granted Patent,no,0,1,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
388,EP,A3,EP 0296793 A3,181-926-848-791-114,1989-11-08,1989,EP 88305631 A,1988-06-22,GB 8714866 A,1987-06-25,COLOUR PHOTOGRAPHIC SILVER HALIDE MATERIALS AND PROCESS,"A new non-diffusible yellow dye-forming para-R-oxybenzoylacetanilide coupler has a combination of (a) a para-hydroxyphenylsulphonylphenoxy coupling-off group in the coupling-position, (b) a chloro or trifluoromethyl group in the ortho position on the anilide moiety, and (c) a group on the anilide moiety that is selected from (i) a sulphamoyl group (ii) an aliphatic hydrocarbon group that is bonded to the anilide moiety directly or through a linking group as described in the application, (iii) chlorine and (iv) trifluoromethyl; wherein the coupler contains at least one ballast group on at least one of the anilide and para-R-oxybenzoyl moieties; and wherein R is an unsubstituted or substituted cyclic or non-cyclic aliphatic hydrocarbon group. These couplers are useful in color photographic silver halide materials and processes to produce image dyes that have excellent hue and high extinction coefficient.  ",EASTMAN KODAK COMPANY (A NEW JERSEY CORPORATION);;KODAK LIMITED,"CLARK, BERNARD ARTHUR JAMES;;MILNER, NIGEL EDGEWICK;;STANLEY, PAUL LOUIS REGINALD",,https://lens.org/181-926-848-791-114,Search Report,yes,1,0,7,7,0,G03C7/30535,G03C7/36;;G03C7/305,,1,0,,,"PATENT ABSTRACTS OF JAPAN, vol. 9, no. 30 (P-333)[1753], 8th February 1985; & JP-A-59 174 839 (FUJI SHASHIN FILM K.K.) 03-10-1984",EXPIRED
389,AU,A,AU 1978/033292 A,152-975-398-562-419,1979-08-23,1979,AU 1978/033292 A,1978-02-14,US 77135977 A;;US 79044277 A,1977-02-23,HEART VALVE PROTHESIS,,DAVIS R B;;SKELTON J;;CLARK R E;;SWANSON W M,DAVIS ROBERT BERNARD;;CLARK RICHARD EDWIN;;SKELTON JOHN;;SWANSON WILBUR MILTON,,https://lens.org/152-975-398-562-419,Patent Application,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
390,US,B2,US 11793593 B2,058-621-453-735-680,2023-10-24,2023,US 202017601284 A,2020-04-01,US 202017601284 A;;US 201962828090 P;;US 2020/0026271 W,2019-04-02,Lighting assemblies for medical device suspension system,"Embodiments include a lighting assembly includes an elongate gasket body formed of a resilient, optically transmissive material. The gasket body includes a light source cavity at least partially defined by a light transmission portion and an attachment channel configured to attach the gasket body to a mount. A light source is disposed in the light source cavity. Other embodiments include securement ring including a clamp portion and a lighting assembly portion. The clamp portion includes first and second segments, each being semiannular in shape and curving between first and second ends, the first end of the first segment coupled to the second end of the second segment and the second end of the first segment coupled to the first end of the second segment to collectively form an aperture. The lighting assembly portion includes a first and second segments, each being semiannular in shape and including a light source.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HOLLOPETER MICHAEL;;GROSZEK JOSEPH JAMES,AMERICAN STERILIZER COMPANY (2019-04-02),https://lens.org/058-621-453-735-680,Granted Patent,yes,32,0,9,94,0,F21S8/063;;F21V5/043;;F21V17/104;;F21V33/0068;;F21W2131/205;;F21Y2115/10;;F21S8/046;;F21Y2107/70;;F21Y2103/33;;F21V21/088;;F21V21/116;;A61B90/30;;A61B90/35;;A61B90/35;;F21V21/36;;F21W2131/20;;F21V21/088;;F21V33/0068;;F21W2131/205,F21V21/088;;A61B90/35;;F21V21/36;;F21V33/00;;F21W131/20;;F21W131/205,,2,0,,,"PCT International Search Report and Written Opinion of the International Searching Authority for related International Application No. PCT/US2020/026271 dated Dec. 16, 2020.;;International Preliminary Report on Patentability for related International Application No. PCT/US2020/026271 dated Oct. 14, 2021.",ACTIVE
391,CA,A1,CA 3135841 A1,095-252-293-170-844,2020-10-08,2020,CA 3135841 A,2020-04-01,US 201962828090 P;;US 2020/0026271 W,2019-04-02,LIGHTING ASSEMBLIES FOR MEDICAL DEVICE SUSPENSION SYSTEM,"Embodiments include a lighting assembly includes an elongate gasket body formed of a resilient, optically transmissive material. The gasket body includes a light source cavity at least partially defined by a light transmission portion and an attachment channel configured to attach the gasket body to a mount. A light source is disposed in the light source cavity. Other embodiments include securement ring including a clamp portion and a lighting assembly portion. The clamp portion includes first and second segments, each being semiannular in shape and curving between first and second ends, the first end of the first segment coupled to the second end of the second segment and the second end of the first segment coupled to the first end of the second segment to collectively form an aperture. The lighting assembly portion includes a first and second segments, each being semiannular in shape and including a light source.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;MOSS BERNARD JOHN;;HOLLOPETER MICHAEL;;GROSZEK JOSEPH JAMES,,https://lens.org/095-252-293-170-844,Patent Application,no,0,0,9,94,0,F21S8/063;;F21V5/043;;F21V17/104;;F21V33/0068;;F21W2131/205;;F21Y2115/10;;F21S8/046;;F21Y2107/70;;F21Y2103/33;;F21V21/088;;F21V21/116;;A61B90/30;;A61B90/35;;A61B90/35;;F21V21/36;;F21W2131/20;;F21V21/088;;F21V33/0068;;F21W2131/205,F21S8/04;;A61B90/30;;A61B90/35;;F21S4/26;;F21S8/06;;F21V5/04;;F21V17/10;;F21V21/088;;F21V21/116;;F21V33/00,,0,0,,,,PENDING
392,EP,B1,EP 0480620 B1,166-842-297-306-538,1994-12-28,1994,EP 91309019 A,1991-10-02,US 59477490 A,1990-10-09,Method for inspecting etched workpieces.,,AT & T CORP,CLARK LINDA ANN;;GOTTSCHO RICHARD ALAN;;KRUSKAL JOSEPH BERNARD;;LAMBERT DIANE,AT&T CORP. (1994-06-22),https://lens.org/166-842-297-306-538,Granted Patent,yes,4,0,6,6,0,G01B11/02;;G01N21/4788;;G01N21/956;;G01B11/02;;G01N21/4788;;G01N21/956,H01L21/30;;G01B11/02;;G01N21/47;;G01N21/956;;G06T1/00;;H01L21/027;;H01L21/66,,0,0,,,,EXPIRED
393,DE,T2,DE 69220905 T2,066-417-437-482-136,1999-01-21,1999,DE 69220905 T,1992-04-23,US 73167191 A;;US 9203393 W,1991-07-17,MAGENTA BILDFARBSTOFF-KUPPLER MIT VERBESSERTEM FARBTON,,EASTMAN KODAK CO,MERKEL PAUL;;SINGER STEPHEN;;CLARK BERNARD ARTHUR JAMES;;STANLEY PAUL LOUIS REGINALD,,https://lens.org/066-417-437-482-136,Granted Patent,no,0,0,6,14,0,G03C7/384;;G03C7/24;;G03C7/30517,G03C1/00;;G03C7/24;;G03C7/305;;G03C7/384,,0,0,,,,EXPIRED
394,EP,A1,EP 0345943 A1,112-172-723-478-019,1989-12-13,1989,EP 89304464 A,1989-05-04,US 19103988 A;;US 24378688 A;;US 26038288 A,1988-05-06,Device for plasma modification composition and remodeling.,"Compositions and devices are provided for the specific removal of components of plasma in efficient and economical ways. The devices provide for a tortuous path of the plasma through a high surface material to which is bound a binding compound for removal of the fluid component. The devices find particular application with plasma, in diagnosis, therapy, and for production of specific physiologically active materials.  ",APPLIED IMMUNESCIENCES,OKARMA THOMAS B;;CHANG CHIN-HAI;;CLARK BRIAN R;;LERCH L BERNARD,,https://lens.org/112-172-723-478-019,Patent Application,yes,4,0,8,11,0,A61K35/16;;A61M1/3679;;A61M1/3679,A61K35/16;;A61M1/36,,3,1,083-106-270-345-313,10.1111/j.1525-1594.1983.tb04224.x;;6651583,"CHEMICAL ABSTRACTS, vol. 101, 1984, page 447, abstract no. 5163u, Columbus, Ohio, US; J. TRAEGER et al.: ""Extracorporeal immunoadsorption of DNA-antibodies on DNA-coated collagen films: first results in systemic lupus erythematosus"", & PLASMAPHERESIS: NEW TRENDS THER. APPL., [PAP. - INT. SYMP. PLASMAPHERESIS: THER. APPL. NEW TECH], 2nd 1983, 155-66;;ARTIFICIAL ORGANS, vol. 7, no. 4, 1983, pages 443-449, International Society of Artificial Organs, New York, US; B.C. McLEOD et al.: ""Complement metabolism during membrane plasma separation"";;CHEMICAL ABSTRACTS, vol. 73, 1970, page 207, abstract no. 118583c, Columbus, Ohio, US; M.A. MARCHISIO et al.: ""Effect of polymeric silicic acid on guinea pig macrophages and erythrocytes, in the presence or absence of complement"", & MED. LAV. 1970, 61(4), 211-19",EXPIRED
395,DE,D1,DE 69612241 D1,175-022-717-705-803,2001-05-03,2001,DE 69612241 T,1996-06-25,GB 9513108 A,1995-06-28,Bildfarbstoff erzeugende Kuppler und photographische Elemente die diese enthalten,,EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;GOURLEY ROBERT NICHOLAS;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,,https://lens.org/175-022-717-705-803,Granted Patent,no,0,0,6,6,0,G03C7/36;;G03C7/36;;G03C7/30535;;G03C7/30535,G03C7/305;;G03C7/36,,0,0,,,,EXPIRED
396,US,A,US 4499992 A,055-070-602-376-267,1985-02-19,1985,US 48625183 A,1983-04-18,US 48625183 A,1983-04-18,Self-cleaning support roller for an endless conveyor belt,"A self-cleaning support for a conveyor belt having a shaft with first and second ends and a longitudinal center capable of being adapted to rotate at each of the ends. The shaft is provided with a first flighting to convey material from a first point proximate the longitudinal center toward the first end and a second flight to convey material from a second point proximate the longitudinal center towards the second end, with the first and second points being spaced apart. Two annular members are mounted at the first and second points respectively both encircling the shaft and defining axial openings permitting material to pass through to their respective flights. These annular members may provide a guide for the underside of the belt by being spaced apart to receive the width of a belt guide.",PIXALL CORP,PAULSON BERNARD S;;PAULSON BRUCE H;;CLARK BRIAN K;;BRIESEMEISTER RICHARD A,PIXALL CORPORATION (1983-04-12),https://lens.org/055-070-602-376-267,Granted Patent,yes,11,9,1,1,0,B65G39/073;;B65G39/073,B65G39/073,198/498;;198/840,0,0,,,,EXPIRED
397,EP,A1,EP 1072951 A1,165-878-084-981-749,2001-01-31,2001,EP 00202478 A,2000-07-12,US 35849799 A,1999-07-21,Color photographic element containing ballasted triazole derivative and inhibitor releasing coupler,"The invention provides a color photographic element comprising:
 a) a first light sensitive silver halide emulsion layer containing a compound of Formula I:
   wherein Q represents the atoms necessary to form a triazole ring and the associated bonds, provided that the ring members may be substituted and that two of such members may join to form a fused ring;
 provided further that the ClogP for the compound of Formula I is from 4.75 to 9.0; and b) a second light sensitive silver halide emulsion layer, having a spectral sensitivity different from that of the first light sensitive silver halide emulsion layer, containing a compound of Formula II:  
 
        COUP-(TIME) j -INH     II 
 
wherein:
 1) COUP is a coupler parent group capable of forming a dye upon reaction with an oxidized developer; 2) TIME is a timing group and j is 0 or 1; and 3) INH is a mild silver development inhibitor fragment. The invention provides improved color reproduction.",EASTMAN KODAK CO,BOFF JANE S;;CLARK BERNARD A;;FRIEDRICH LOUIS E;;SINGER STEPHEN P,,https://lens.org/165-878-084-981-749,Patent Application,yes,6,1,3,3,0,G03C7/3005;;G03C7/3005;;G03C1/34;;G03C1/34;;G03C7/30541;;G03C7/30541;;G03C7/30552;;G03C7/30552;;G03C7/30558;;G03C7/30558;;G03C7/30576;;G03C7/30576;;G03C7/39244;;G03C7/39244;;G03C7/39256;;G03C7/39256;;G03C7/3926;;G03C7/3926;;Y10S430/156;;Y10S430/156,G03C1/34;;G03C7/30;;G03C7/305;;G03C7/388;;G03C7/392,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 006, no. 225 (P - 154) 10 November 1982 (1982-11-10)",DISCONTINUED
398,US,B2,US 7875247 B2,155-817-275-854-572,2011-01-25,2011,US 78181207 A,2007-07-23,US 78181207 A;;US 72401703 A;;US 42988002 P;;US 47148503 P;;US 48684903 P;;US 49550003 P;;US 49619503 P,2002-11-27,"UV flux multiplication system for sterilizing air, medical devices and other materials","An ultraviolet flux multiplying air sterilization chamber comprises inner surfaces having a diffuse reflective behavior. The sterilization chamber includes an inlet aperture and an outlet aperture for air to flow through said chamber and a light source emitting an ultraviolet light. Due to the reflectivity of the inner surfaces of the chamber, a flux of the ultraviolet light is multiplied by reflecting multiple times from the inner surfaces of the chamber. The inlet and outlet apertures are advantageously configured to reduce the amount of light that escapes from the chamber and increase the amount of photons available in the chamber. In an exemplary embodiment, perforated end panels having diffuse, reflective interior surfaces may be provided over at least a portion of the inlet and outlet apertures.",NOVATRON INC,CLARK REGINALD W;;EASTLUND BERNARD J;;INGRAM MICHAEL W;;STUMPF JOSEPH C,NOVATRON INC (2007-10-11),https://lens.org/155-817-275-854-572,Granted Patent,yes,20,15,8,8,0,A61L9/205;;A61L2209/16;;F24F8/22;;A61L9/205;;A61L2209/16;;A61L9/205;;A61L2209/16;;A61L9/20,A61L9/20,422/121;;422/24;;422/120;;250/455.11,7,5,151-833-101-716-510;;042-922-583-797-028;;196-274-198-451-743;;058-075-079-929-497;;018-222-391-029-510,10.1063/1.337673;;10.1255/jnirs.303;;10.2172/807360;;10.1128/jcm.35.7.1918-1919.1997;;9196228;;pmc229876;;14215971;;pmc1058147;;10.1128/am.12.5.418-420.1964,"Beverly, III R.E., Characterization of a dual-segment cylindrical surface discharge, J. Appl. Phys. 69(7), Apr. 1991.;;Beverly, III, R.E., Electrical Gasdynamic, and Radiative Properties of Planar Surface Discharges, J. Appl. Phys. 60(1), Jul. 1986.;;Pasikatan, et al., Review: Near Infrared Reflectance Spectroscopy for Online Particle Size Analysis of Powders and Ground Materials, J. Near Infrared Spectrosc. 9:153-164 (2001).;;VanOsdell, et al., Defining the Effectiveness of UV Lamps Installed in Circulating Air Ductwork, RTI International, Nov. 2002.;;Wick, et al., Pulsed Light Device (PLD) for Deactivation of Biological Aerosols, Edgewood Report ERDC-TR-456, Dec. 1998.;;Allegra, et al., A Novel Device for the Prevention of Airborne Infections, J. Clinical Microbiology Letters to the Editor, 35(7):1918-1919, Jul. 1997.;;Jensen, M., Inactivation of Airborne Viruses by Ultraviolet Irradiation, Applied Microbiology, 12(5):418-420, Sep. 1964.",ACTIVE
399,WO,A1,WO 2021/011895 A1,106-576-581-374-751,2021-01-21,2021,US 2020/0042604 W,2020-07-17,US 201962875648 P;;US 201962875692 P;;US 202063017178 P;;US 202063017187 P,2019-07-18,METHODS AND DEVICES FOR SINGLE CELL BARCODING,"Microfluidic devices are described that comprise a plurality of hydrodynamic traps configured to trap cells or other particles, where all or a portion of the plurality of hydrodynamic traps incorporate an array of oligonucleotide barcode sequences for barcoding molecules derived from single cells or clonally-amplified populations of single cells. Also described are methods for fabricating and using the disclosed microfluidic devices.",CELLDOM INC,YELLEN BENJAMIN;;BLACKINTON JEFFREY;;HIRSCHBEIN BERNARD;;CLARK TYSON;;ZAWISTOWSKI JON;;ROELOFS NICOLAS,,https://lens.org/106-576-581-374-751,Patent Application,yes,4,6,1,1,0,B01J2219/00547;;B01J2219/00722;;B01L3/502707;;B01L3/502761;;B01L3/502761;;B01L2200/0668;;B01L2300/0681;;B01L2300/0819;;B01L2300/0877;;B01L2300/0883;;B01L2300/0893;;B81C1/00015;;C12Q1/6837;;C40B70/00;;C12M23/16;;C12M47/04;;C12Q1/6874;;C40B40/06;;C40B60/14,B01L3/00;;C12N15/00;;C12Q1/68;;C40B20/00,,3,3,055-772-370-092-877;;072-340-274-857-486;;012-725-791-525-851,10.1038/nmeth.4179;;28192419;;10.1038/protex.2017.006a;;pmc5376227;;10.1063/1.4926616;;26221198;;pmc4499045;;18094762;;10.1039/b713420g,"TODD M GIERAHN, MARC H WADSWORTH, TRAVIS K HUGHES, BRYAN D BRYSON, ANDREW BUTLER, RAHUL SATIJA, SARAH FORTUNE, J CHRISTOPHER LOVE,: ""Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput single- cell RNA-Seq of low-input samples"", NAT METHODS, vol. 14, 13 February 2017 (2017-02-13), pages 395 - 398, XP055368132;;TANGEN UWE, MINERO GABRIEL ANTONIO S., SHARMA ABHISHEK, WAGLER PATRICK F., COHEN RAFAEL, RAZ OFIR, MARX TZIPY, BEN-YEHEZKEL TUVAL,: ""DNA-library assembly programmed by on-demand nano-liter droplets from a custom microfluidic chip"", BIOMICROFLUIDICS, vol. 9, no. 4, 8 July 2015 (2015-07-08), pages 044103, XP055785413;;VALERO A., POST J. N., VAN NIEUWKASTEELE J. W., TER BRAAK P. M., KRUIJER W., VAN DEN BERG A: ""Gene transfer and protein dynamics in stem cells using single cell electroporation in a microfluidic device"", LAB CHIP, vol. 8, no. 1, January 2008 (2008-01-01), pages 62 - 67, XP055785416",PENDING
400,EP,B1,EP 0345943 B1,144-914-925-227-016,1994-04-13,1994,EP 89304464 A,1989-05-04,US 19103988 A;;US 24378688 A;;US 26038288 A,1988-05-06,Device for plasma modification composition and remodeling.,,APPLIED IMMUNESCIENCES,OKARMA THOMAS B;;CHANG CHIN-HAI;;CLARK BRIAN R;;LERCH L BERNARD,,https://lens.org/144-914-925-227-016,Granted Patent,yes,4,0,8,11,0,A61K35/16;;A61M1/3679;;A61M1/3679,A61K35/16;;A61M1/36,,5,0,,,"CHEMICAL ABSTRACTS, vol. 101, 1984, page 447, abstract no. 5163u, Columbus, Ohio, US; J. TRAEGER et al.: ""Extracorporeal immunoadsorption of DNA-antibodies on DNA-coated collagen films: first results in systemic lupus erythematosus"", & PLASMAPHERESIS: NEW TRENDS THER. APPL., [PAP. - INT. SYMP. PLASMAPHERESIS: THER. APPL. NEW TECH], 2nd 1983, 155-66;;ARTIFICIAL ORGANS, vol. 7, no. 4, 1983, pages 443-449, International Society of Artificial Organs, New York, US; B.C. McLEOD et al.: ""Complement metabolism during membrane plasma separation"";;IDEM;;CHEMICAL ABSTRACTS, vol. 73, 1970, page 207, abstract no. 118583c, Columbus, Ohio, US; M.A. MARCHISIO et al.: ""Effect of polymeric silicic acid on guinea pig macrophages and erythrocytes, in the presence or absence of complement"", & MED. LAV. 1970, 61(4), 211-19;;IDEM",EXPIRED
401,EP,A1,EP 0751427 A1,195-689-983-862-466,1997-01-02,1997,EP 96201757 A,1996-06-25,GB 9513108 A,1995-06-28,Image-dye-forming couplers and photographic elements containing them,"The present invention comprehends the use of thenoylacetamide materials as image-dye-forming couplers, specifically yellow dye-forming couplers, for use with silver halide based photographic systems. In one aspect, the invention provides a coupler of formula (I):-
   wherein X is H or a coupling-off group, R 1  is H or is a coupler-modifying functional group; Y and Z are the same or different and are H or independently selected from alkyl, aryl or heteroaryl, each of which is unsubstituted or substituted with one or more coupler-modifying functional groups; or Y and Z taken together with the nitrogen atom form a 5-10 membered heterocyclic ring which may contain one or more further heteroatoms selected from N, O and S, said heterocyclic ring being unsubstituted or substituted with one or more coupler-modifying functional groups. Preferred couplers are those where Y is H and Z is a phenyl group, which may be mono- or di-substituted.",KODAK LTD;;EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;GOURLEY ROBERT NICHOLAS;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,EASTMAN KODAK COMPANY (2001-03-28),https://lens.org/195-689-983-862-466,Patent Application,yes,4,4,6,6,0,G03C7/36;;G03C7/36;;G03C7/30535;;G03C7/30535,G03C7/305;;G03C7/36,,3,2,083-612-133-859-133;;025-751-336-418-609,8230129;;10.1021/jm00074a020;;10.1055/s-1993-25940,"N.S. VULF'SON AND V.E.KOLCHIN: ""Derivatives of acylacetic esters of the heterocyclic series III. Synthesis of alpha- and beta-thenoylacetic esters, arylides and azomethine dyes from them"", JOURNAL OF GENERAL CHEMISTRY USSR, vol. 30, no. 10, October 1960 (1960-10-01), NEW YORK US, pages 3392 - 3396, XP002014115;;M. ROWLEY ET AL.: ""3-Acyl-4-hydroxyquinolin-2(1H)-ones"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 36, 1993, WASHINGTON US, pages 3396 - 3396, XP002014116;;R. BOSSIO, S. MARCACCINI, R. PEPINO AND T. TORROBA: ""Studies on Isocyanides and Related Compounds"", SYNTHESIS, 1993, STUTTGART DE, pages 783 - 785, XP002014117",EXPIRED
402,US,A,US 5492799 A,010-253-230-314-397,1996-02-20,1996,US 26364294 A,1994-06-22,US 26364294 A;;US 99622892 A,1992-12-23,Azopyrazolone masking couplers,"The invention provides a photographic element comprising a support bearing a light-sensitive photographic silver halide layer having associated therewith a masking coupler comprising: (1) a parent group containing a -1-phenyl-3-anilinopyrazolin-5-one having electron-withdrawing substituents on the phenyl and anilino rings of a type and number sufficient to provide a combined Hammett sigma(para) value for such substituents of at least 1.4; (2) a coupling-off group at the 4 position of the pyrazolone of the parent group comprising an arylazo dye containing on the aryl ring the following: (A) a substituent para to the azo functionality selected from the group consisting of hydroxyl, and alkoxy, carbonamido, and sulfonamido, each unsubstituted or substituted with nonaromatic groups, and (B) ""n"" additional substituents selected from the group consisting of alkyl, alkoxy, carbonamido, and sulfonamido, unsubstituted or substituted with nonaromatic groups, where ""n"" is 0 to 4; provided that substituent (A) and a substituent (B) may form a ring wherein one of the substituents (A) or (B) contains an alkyl group of at least 8 carbon atoms, unsubstituted or substituted with nonaromatic substituents, and said substituent contains at least 70% of the saturated carbon atoms in all of the substituents (A) and (B) provided that where the substituent (A) forms a ring with a substituent (B), the entire ring will be counted as said one of the substituents which contains an alkyl group of at least 8 carbon atoms for purposes of satisfying the 70% requirement.",EASTMAN KODAK CO,KAPP DANIEL L;;ROSS ROBERT J;;SINGER STEPHEN P;;CLARK BERNARD A,EASTMAN KODAK COMPANY (1994-06-23),https://lens.org/010-253-230-314-397,Granted Patent,yes,7,5,7,7,0,C09B29/366;;C09B29/366;;G03C7/3335;;G03C7/3335,G03C7/00;;C09B29/50;;G03C7/333;;G03C7/384,430/558;;430/562;;430/434;;430/359,0,0,,,,EXPIRED
403,WO,A2,WO 2012/145061 A2,035-069-886-700-247,2012-10-26,2012,US 2012/0025174 W,2012-02-15,US 201113051146 A,2011-03-18,METHODS AND SYSTEMS FOR FILTERING TRAFFIC INFORMATION FOR DISPLAY,,BOEING CO;;CLARK SAMUEL T;;BOWE ROGLENDA R;;ORTMAN STEPHEN BERNARD;;CRANE JEAN MARIE,CLARK SAMUEL T;;BOWE ROGLENDA R;;ORTMAN STEPHEN BERNARD;;CRANE JEAN MARIE,,https://lens.org/035-069-886-700-247,Patent Application,yes,1,3,3,3,0,G08G5/0078;;G08G5/0078;;G01C23/00;;G01C23/00;;G08G5/0021;;G08G5/0021;;G08G5/065;;G08G5/065,G08G5/00;;G08G5/06,,0,0,,,,PENDING
404,US,A1,US 2014/0091230 A1,039-912-392-655-732,2014-04-03,2014,US 201313849811 A,2013-03-25,US 201313849811 A;;US 201113006143 A;;US 78181207 A;;US 72401703 A;;US 49619503 P;;US 49550003 P;;US 48684903 P;;US 47148503 P;;US 42988002 P,2002-11-27,"UV FLUX MULTIPLICATION SYSTEM FOR STERILIZING AIR, MEDICAL DEVICES AND OTHER MATERIALS","An ultraviolet flux multiplying air sterilization chamber comprises inner surfaces having a diffuse reflective behavior. The sterilization chamber includes an inlet aperture and an outlet aperture for air to flow through said chamber and a light source emitting an ultraviolet light. Due to the reflectivity of the inner surfaces of the chamber, a flux of the ultraviolet light is multiplied by reflecting multiple times from the inner surfaces of the chamber. The inlet and outlet apertures are advantageously configured to reduce the amount of light that escapes from the chamber and increase the amount of photons available in the chamber. In an exemplary embodiment, perforated end panels having diffuse, reflective interior surfaces may be provided over at least a portion of the inlet and outlet apertures.",NOVATRON INC;;NOVATRON INC,CLARK REGINALD W;;EASTLAND BERNARD J;;INGRAM MICHAEL W;;STUMPF JOSEPH C,,https://lens.org/039-912-392-655-732,Patent Application,yes,0,11,8,8,0,A61L9/205;;A61L2209/16;;F24F8/22;;A61L9/205;;A61L2209/16;;A61L9/205;;A61L2209/16;;A61L9/20,A61L9/20,250432 R,0,0,,,,DISCONTINUED
405,US,A,US 5022988 A,149-007-571-500-590,1991-06-11,1991,US 26038288 D,1988-10-20,US 19103988 A;;US 26038288 A,1988-05-06,Device for plasma modification-composition and remodeling,"Compositions and devices are provided for the specific removal of components of plasma in efficient and economical ways. The devices provide for a tortuous path of the plasma through a high surface material to which is bound a binding compound for removal of the fluid component. The devices find particular application with plasma, in diagnosis, therapy, and for production of specific physiologically active materials.",APPLIED IMMUNESCIENCES,OKARMA THOMAS B;;CHANG CHIN-HAI;;CLARK BRIAN R;;LERCH L BERNARD,APPLIED IMMUNESCIENCES A CORP. OF DE (1988-10-25),https://lens.org/149-007-571-500-590,Granted Patent,yes,12,14,1,11,0,A61K35/16;;A61M1/3679;;Y10S210/908;;Y10S530/814;;Y10T436/255;;A61M1/3616;;Y10T436/255;;A61M1/3679;;A61K35/16;;Y10S210/908;;Y10S530/814;;A61M1/3616,A61K35/16;;A61M1/36,210/321.84;;210/321.86;;210/502.1;;210/908;;435/287;;436/178;;502/404;;530/412;;530/814,2,1,083-106-270-345-313,10.1111/j.1525-1594.1983.tb04224.x;;6651583,"McLeod, et al., Artif. Organs (1983) 7:443 449.;;Breillatt and Dorson, ASAIO J. (1984) 7:57 63.",EXPIRED
406,US,B1,US 6190848 B1,064-945-222-902-03X,2001-02-20,2001,US 35849799 A,1999-07-21,US 35849799 A,1999-07-21,Color photographic element containing ballasted triazole derivative and inhibitor releasing coupler,"The invention provides a color photographic element comprising: a) a first light sensitive silver halide emulsion layer containing a compound of Formula I: ##STR1## wherein Q represents the atoms necessary to form a triazole ring and the associated bonds, provided that the ring members may be substituted and that two of such members may join to form a fused ring; provided further that the ClogP for the compound of Formula I is from 4.75 to 9.0; and b) a second light sensitive silver halide emulsion layer, having a spectral sensitivity different from that of the first light sensitive silver halide emulsion layer, containing a compound of Formula II: COUP-(TIME).sub.j -INH II wherein: 1) COUP is a coupler parent group capable of forming a dye upon reaction with an oxidized developer; 2) TIME is a timing group and j is 0 or 1; and 3) INH is a mild silver development inhibitor fragment. The invention provides improved color reproduction.",EASTMAN KODAK CO,BOFF JANE S;;CLARK BERNARD A;;FRIEDRICH LOUIS E;;SINGER STEPHEN P,EASTMAN KODAK COMPANY (1999-09-02),https://lens.org/064-945-222-902-03X,Granted Patent,yes,19,13,3,3,0,G03C7/3005;;G03C7/3005;;G03C1/34;;G03C1/34;;G03C7/30541;;G03C7/30541;;G03C7/30552;;G03C7/30552;;G03C7/30558;;G03C7/30558;;G03C7/30576;;G03C7/30576;;G03C7/39244;;G03C7/39244;;G03C7/39256;;G03C7/39256;;G03C7/3926;;G03C7/3926;;Y10S430/156;;Y10S430/156,G03C1/34;;G03C7/30;;G03C7/305;;G03C7/388;;G03C7/392,430/544;;430/505;;430/955;;430/757;;430/607;;430/613;;430/614;;430/615;;430/599;;430/600,0,0,,,,EXPIRED
407,US,A1,US 2011/0139999 A1,112-252-596-339-576,2011-06-16,2011,US 201113006143 A,2011-01-13,US 201113006143 A;;US 78181207 A;;US 72401703 A;;US 42988002 P;;US 47148503 P;;US 48684903 P;;US 49550003 P;;US 49619503 P,2002-11-27,"UV FLUX MULTIPLICATION SYSTEM FOR STERILIZING AIR, MEDICAL DEVICES AND OTHER MATERIALS","An ultraviolet flux multiplying air sterilization chamber comprises inner surfaces having a diffuse reflective behavior. The sterilization chamber includes an inlet aperture and an outlet aperture for air to flow through said chamber and a light source emitting an ultraviolet light. Due to the reflectivity of the inner surfaces of the chamber, a flux of the ultraviolet light is multiplied by reflecting multiple times from the inner surfaces of the chamber. The inlet and outlet apertures are advantageously configured to reduce the amount of light that escapes from the chamber and increase the amount of photons available in the chamber. In an exemplary embodiment, perforated end panels having diffuse, reflective interior surfaces may be provided over at least a portion of the inlet and outlet apertures.",NOVATRON INC,CLARK REGINALD W;;EASTLUND BERNARD J;;INGRAM MICHAEL W;;STUMPF JOSEPH C,,https://lens.org/112-252-596-339-576,Patent Application,yes,19,9,8,8,0,A61L9/205;;A61L2209/16;;F24F8/22;;A61L9/205;;A61L2209/16;;A61L9/205;;A61L2209/16;;A61L9/20,A61L2/10;;A61L9/20,250/438;;250/435,0,0,,,,EXPIRED
408,EP,B1,EP 0363452 B1,167-219-549-604-016,1993-08-18,1993,EP 89902803 A,1989-02-17,GB 8803923 A,1988-02-19,OPTICAL STORAGE DEVICES,,"THE GENERAL ELECTRIC COMPANY, P.L.C.","MCARDLE, CIARAN, BERNARD;;CLARK, MICHAEL, GEORGE;;BECK, WILLIAM, RICHARD, JR.;;BOWRY, CAROLYN",,https://lens.org/167-219-549-604-016,Granted Patent,yes,4,0,14,14,0,G02F1/133365;;G11B7/0033;;G11B7/00555;;G11B7/26;;Y10S118/04;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;C09K2323/023;;C09K2323/02;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;G11B7/26;;G11B7/00555;;G02F1/133365;;G11B7/0033;;Y10S118/04;;C09K2323/02;;C09K2323/023,G02F1/1333;;G11B7/0033;;G11B7/0055;;G11B7/26,,1,0,,,"PATENT ABSTRACTS OF JAPAN,vol. 6, no. 133 (P-129) (1011), 20 July 1982;& JP- A- 5758252",EXPIRED
409,EP,A1,EP 1072952 A1,198-586-711-299-208,2001-01-31,2001,EP 00202461 A,2000-07-11,US 35809999 A,1999-07-21,Color photographic element containing a coupler releasing derivative with at least three heteroatoms with specific hydrophobicity,"Disclosed is a color photographic element comprising at least one light sensitive silver halide emulsion layer having associated therewith a coupler according to Formula I:  
 
        COUP - (TIME) n  - HSM     (I) 
 
wherein:
 COUP is an organic fragment which reacts with oxidized developer to release - (TIME) n  - HSM, TIME is an optional timing group or linking group which connects HSM to COUP at the site of reaction with oxidized developer, n =0,1 or 2, and HSM is a compound having a minimum of three heteroatoms and having a ClogP sufficient to increase the speed of said element compared to the same element without the coupler. The invention provides improved light sensitivity without significant adverse effect on granularity or ease of manufacture.",EASTMAN KODAK CO,ALLWAY PHILIP A;;CLARK BERNARD A;;FRIEDRICH LOUIS E;;SINGER STEPHEN P,,https://lens.org/198-586-711-299-208,Patent Application,yes,1,4,2,2,0,G03C7/30558;;G03C7/30558;;Y10S430/156;;Y10S430/156;;Y10S430/158;;Y10S430/158,G03C7/305,,3,0,,,"PATENT ABSTRACTS OF JAPAN vol. 013, no. 375 (P - 921) 21 August 1989 (1989-08-21);;PATENT ABSTRACTS OF JAPAN vol. 009, no. 026 (P - 332) 5 February 1985 (1985-02-05);;PATENT ABSTRACTS OF JAPAN vol. 011, no. 029 (P - 540) 28 January 1987 (1987-01-28)",DISCONTINUED
410,US,B2,US 8404186 B2,127-016-951-824-999,2013-03-26,2013,US 201113006143 A,2011-01-13,US 201113006143 A;;US 78181207 A;;US 72401703 A;;US 42988002 P;;US 47148503 P;;US 48684903 P;;US 49550003 P;;US 49619503 P,2002-11-27,"UV flux multiplication system for sterilizing air, medical devices and other materials","An ultraviolet flux multiplying air sterilization chamber comprises inner surfaces having a diffuse reflective behavior. The sterilization chamber includes an inlet aperture and an outlet aperture for air to flow through said chamber and a light source emitting an ultraviolet light. Due to the reflectivity of the inner surfaces of the chamber, a flux of the ultraviolet light is multiplied by reflecting multiple times from the inner surfaces of the chamber. The inlet and outlet apertures are advantageously configured to reduce the amount of light that escapes from the chamber and increase the amount of photons available in the chamber. In an exemplary embodiment, perforated end panels having diffuse, reflective interior surfaces may be provided over at least a portion of the inlet and outlet apertures.",CLARK REGINALD W;;EASTLAND BERNARD J;;INGRAM MICHAEL W;;STUMPF JOSEPH C;;NOVATRON INC,CLARK REGINALD W;;EASTLAND BERNARD J;;INGRAM MICHAEL W;;STUMPF JOSEPH C,,https://lens.org/127-016-951-824-999,Granted Patent,yes,21,9,8,8,0,A61L9/205;;A61L2209/16;;F24F8/22;;A61L9/205;;A61L2209/16;;A61L9/205;;A61L2209/16;;A61L9/20,A61L9/20,422/120;;422/24;;250/455.11,8,5,151-833-101-716-510;;042-922-583-797-028;;196-274-198-451-743;;058-075-079-929-497;;018-222-391-029-510,10.1063/1.337673;;10.1255/jnirs.303;;10.2172/807360;;10.1128/jcm.35.7.1918-1919.1997;;9196228;;pmc229876;;14215971;;pmc1058147;;10.1128/am.12.5.418-420.1964,"Beverly, III, R.E., Characterization of a dual-segment cylindrical surface discharge, J. Appl. Phys. 69(7), Apr. 1991.;;Beverly, III, R.E., Electrical Gasdynamic, and Radiative Properties of Planar Surface Discharges, J. Appl. Phys. 60(1), Jul. 1986.;;Pasikatan, et al., Review: Near Infrared Reflectance Spectroscopy for Online Particle Size Analysis of Powders and Ground Materials, J. Near Infrared Spectrosc. 9:153-164 (2001).;;VanOsdell, et al., Defining the Effectiveness of UV Lamps Installed in Circulating Air Ductwork, RTI International, Nov. 2002.;;Wick, et al., Pulsed Light Device (PLD) for Deactivation of Biological Aerosols, Edgewood Report ERDC-TR-456, Dec. 1998.;;Allegra, et al., A Novel Device for the Prevention of Airborne Infections, J. Clinical Microbiology Letters to the Editor, 35(7):1918-1919, Jul. 1997.;;Jensen, M., Inactivation of Airborne Viruses by Ultraviolet Irradiation, Applied Microbiology, 12(5):418-420, Sep. 1964.;;Notification of Transmittal of International Preliminary Report on Patentability received in corresponding Application No. PCT/US2008/070790 dated Oct. 30, 2009.",EXPIRED
411,EP,A1,EP 0363452 A1,175-023-586-783-530,1990-04-18,1990,EP 89902803 A,1989-02-17,GB 8803923 A,1988-02-19,OPTICAL STORAGE DEVICES.,"Dans un procédé de production en série de feuilles de stockage optique, un film allongé (4) d'une matière à cristaux liquides est amené dans le sens de la longueur le long d'un chemin par une porte d'alignement (5). La porte d'alignement applique à des surfaces successives du film un champ alignant les molécules. Ledit champ peut être un champ électrique et/ou un champ de cisaillement. On peut également utiliser une couche d'alignement telle qu'une couche de tensio-actif, afin d'aligner les surfaces de film. On peut ensuite découper le film aligné en pièces en vue d'une utilisation comme microfiches ou microfilms. La matière du film est de préférence une matière polymère à cristaux liquides.",GEN ELECTRIC CO PLC,MCARDLE CIARAN BERNARD;;CLARK MICHAEL GEORGE;;BECK WILLIAM RICHARD JR;;BOWRY CAROLYN,,https://lens.org/175-023-586-783-530,Patent Application,yes,0,0,14,14,0,G02F1/133365;;G11B7/0033;;G11B7/00555;;G11B7/26;;Y10S118/04;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;C09K2323/023;;C09K2323/02;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;G11B7/26;;G11B7/00555;;G02F1/133365;;G11B7/0033;;Y10S118/04;;C09K2323/02;;C09K2323/023,G02F1/1333;;G11B7/0033;;G11B7/0055;;G11B7/26,,0,0,,,,EXPIRED
412,US,A1,US 2004/0166018 A1,099-098-511-210-49X,2004-08-26,2004,US 72401703 A,2003-11-26,US 72401703 A;;US 42988002 P;;US 47148503 P;;US 48684903 P;;US 49550003 P;;US 49619503 P,2002-11-27,"UV flux multiplication system for sterilizing air, medical devices and other materials","
   An ultraviolet flux multiplying air sterilization chamber comprises inner surfaces having a diffuse reflective behavior. The sterilization chamber includes an inlet aperture and an outlet aperture for air to flow through said chamber and a light source emitting an ultraviolet light. Due to the reflectivity of the inner surfaces of the chamber, a flux of the ultraviolet light is multiplied by reflecting multiple times from the inner surfaces of the chamber. The inlet and outlet apertures are advantageously configured to reduce the amount of light that escapes from the chamber and increase the amount of photons available in the chamber. In an exemplary embodiment, packed arrays of fibers, spheres, or other small particles are placed at the inlet and/or outlet to the chamber. These packed arrays provide light scattering events such that the light incident on the packed arrays reflects back with high reflectivity. 
",CLARK REGINALD W.;;EASTLUND BERNARD J.;;INGRAM MICHAEL W.;;STUMPF JOSEPH C.,CLARK REGINALD W;;EASTLUND BERNARD J;;INGRAM MICHAEL W;;STUMPF JOSEPH C,NOVATRON INC (2004-04-27),https://lens.org/099-098-511-210-49X,Patent Application,yes,12,62,4,4,0,A61L9/205;;A61L9/205;;A61L2209/16;;A61L2209/16;;F24F8/22;;F24F8/22;;Y02A50/20;;Y02A50/20,A61L9/20,422/4;;422/121,0,0,,,,DISCONTINUED
413,EP,B1,EP 0603964 B1,111-562-731-825-532,1999-03-10,1999,EP 93203590 A,1993-12-20,US 99622892 A,1992-12-23,Azopyrazolone masking couplers,,EASTMAN KODAK CO,KAPP DANIEL LAWRENCE;;ROSS ROBERT JOHN;;SINGER STEPHEN PAUL;;CLARK BERNARD A,,https://lens.org/111-562-731-825-532,Granted Patent,yes,6,0,7,7,0,C09B29/366;;C09B29/366;;G03C7/3335;;G03C7/3335,G03C7/00;;C09B29/50;;G03C7/333;;G03C7/384,,1,0,,,"DATABASE WPI Week 810, 18 January 1984 Derwent Publications Ltd., London, GB; Page 248, AN 1447 'Color photographic sensitive silver halide material' & JP-A-58 172 647 (KONISHIROKU SHASHIN KOGYO K.K.)",EXPIRED
414,JP,A,JP 2001051383 A,048-509-927-300-601,2001-02-23,2001,JP 2000215668 A,2000-07-17,US 35849799 A,1999-07-21,COLOR PHOTOGRAPHIC ELEMENT,"PROBLEM TO BE SOLVED: To provide a color photographic element enhanced in color reproduction. SOLUTION: The color photographic element comprises (a) a first photosensitive silver halide emulsion layer containing a compound having Clog P of 4.75-9.0 and represented by formula I in which Q is an atomic group necessary to form an optionally substituted triazole ring or optionally condensed with another ring, and (b) a second photosensitive silver halide emulsion layer containing a compound having spectral sensitivity different from that of the first emulsion layer and represented by formula II: COUP-(TIME)j-INH in which COUP is a coupler group capable of producing a dye by reaction with an oxidized developing agent; TIME is a timing group; j is 0 or 1; and INH is a fragment of a silver development weak inhibitor.",EASTMAN KODAK CO,BOFF JANE S;;BERNARD A CLARK;;FRIEDRICH LOUIS E;;SINGER STEPHEN P,,https://lens.org/048-509-927-300-601,Patent Application,no,0,0,3,3,0,G03C7/3005;;G03C7/3005;;G03C1/34;;G03C1/34;;G03C7/30541;;G03C7/30541;;G03C7/30552;;G03C7/30552;;G03C7/30558;;G03C7/30558;;G03C7/30576;;G03C7/30576;;G03C7/39244;;G03C7/39244;;G03C7/39256;;G03C7/39256;;G03C7/3926;;G03C7/3926;;Y10S430/156;;Y10S430/156,G03C1/34;;G03C7/30;;G03C7/305;;G03C7/388;;G03C7/392,,0,0,,,,PENDING
415,WO,A1,WO 1989/007821 A1,060-873-653-355-562,1989-08-24,1989,GB 8900173 W,1989-02-17,GB 8803923 A,1988-02-19,OPTICAL STORAGE DEVICES,"In a process for mass producing optical storage sheets, and elongate film (4) of a liquid crystalline material is fed lengthwise along a path through an aligning gate (5). The aligning gate applies to successive areas of the film a field which aligns the molecules. The field may be an electric field and/or a shear field. An aligning layer, such as a surfactant layer may also be used for alignment of the film areas. The aligned film may then be cut into pieces for use as microfiches or microfilms. The film material is preferably a liquid crystal polymer material.",GEN ELECTRIC CO PLC,MCARDLE CIARAN BERNARD;;CLARK MICHAEL GEORGE;;BECK WILLIAM RICHARD JR;;BOWRY CAROLYN,,https://lens.org/060-873-653-355-562,Patent Application,yes,4,5,14,14,0,G02F1/133365;;G11B7/0033;;G11B7/00555;;G11B7/26;;Y10S118/04;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;C09K2323/023;;C09K2323/02;;Y10T156/1084;;Y10T156/108;;Y10T156/12;;G11B7/26;;G11B7/00555;;G02F1/133365;;G11B7/0033;;Y10S118/04;;C09K2323/02;;C09K2323/023,G02F1/1333;;G11B7/0033;;G11B7/0055;;G11B7/26,,1,0,,,"Patent Abstracts of Japan, vol. 6, no. 133 (P-129)(1011), 20 July 1982; & JP-A-5758252 (TOKYO SHIBAURA DENKI K.K.) 7 April 1982",PATENTED
416,DE,D1,DE 68914513 D1,099-345-275-724-928,1994-05-19,1994,DE 68914513 T,1989-05-04,US 19103988 A;;US 24378688 A;;US 26038288 A,1988-05-06,Gerät zur Modifikation einer Plasmazusammensetzung und Remodellierung.,,APPLIED IMMUNESCIENCES,OKARMA THOMAS B;;CHANG CHIN-HAI;;CLARK BRIAN R;;LERCH L BERNARD,,https://lens.org/099-345-275-724-928,Granted Patent,no,0,0,8,11,0,A61K35/16;;A61M1/3679;;A61M1/3679,A61K35/16;;A61M1/36,,0,0,,,,EXPIRED
417,DE,T2,DE 69612241 T2,164-349-370-330-680,2002-01-03,2002,DE 69612241 T,1996-06-25,GB 9513108 A,1995-06-28,Bildfarbstoff erzeugende Kuppler und photographische Elemente die diese enthalten,,EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;GOURLEY ROBERT NICHOLAS;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,,https://lens.org/164-349-370-330-680,Granted Patent,no,0,0,6,6,0,G03C7/36;;G03C7/36;;G03C7/30535;;G03C7/30535,G03C7/305;;G03C7/36,,0,0,,,,EXPIRED
418,US,A1,US 2012/0130624 A1,007-445-991-920-795,2012-05-24,2012,US 201113051146 A,2011-03-18,US 201113051146 A;;US 93980607 A,2007-11-14,Methods and Systems for Filtering Traffic Information for Display,"A method and a system for displaying an airport or runway moving map with traffic information on a display screen in the cockpit or flight deck of an aircraft. Symbology representing surface and near-surface aircraft and surface vehicle traffic and associated traffic data are filtered to prevent or limit clutter on the display screen. Traffic symbology is automatically and manually filtered to display only relevant traffic. Traffic data is selectively displayed and displayed as/when relevant or needed. The displayed traffic information may be derived from automatic dependent surveillance-broadcast, traffic information system-broadcast, automatic dependent surveillance-rebroadcast, traffic collision avoidance system or other source.",CLARK SAMUEL T;;BOWE ROGLENDA R;;ORTMAN STEPHEN BERNARD;;CRANE JEAN MARIE;;BOEING CO,CLARK SAMUEL T;;BOWE ROGLENDA R;;ORTMAN STEPHEN BERNARD;;CRANE JEAN MARIE,THE BOEING COMPANY (2011-03-17),https://lens.org/007-445-991-920-795,Patent Application,yes,11,36,3,3,0,G08G5/0078;;G08G5/0078;;G01C23/00;;G01C23/00;;G08G5/0021;;G08G5/0021;;G08G5/065;;G08G5/065,G08G5/00;;G08G5/06,701/117;;701/120,0,0,,,,ACTIVE
419,US,A,US 4963265 A,028-821-691-894-685,1990-10-16,1990,US 19103988 A,1988-05-06,US 19103988 A,1988-05-06,Plasma processing device with anaphylatoxin remover,"Blood derived fluids are subjected to modification resulting in the production of anaphylatoxins. The anaphylatoxins may then be removed by passing the modified blood through silicic acid particles in an amount sufficient to substantially reduce the anaphylatoxins, while still retaining the other blood components and without affecting adversely the use of the blood for the patient.",APPLIED IMMUNESCIENCES,OKARMA THOMAS B;;CLARK BRIAN R;;LERCH L BERNARD;;CHANG CHIN-HAI,APPLIED IMMUNESCIENCES 200 CONSTITUTION DRIVE MENLO PARK CA 94025-1109 (1988-07-07),https://lens.org/028-821-691-894-685,Granted Patent,yes,22,15,1,11,0,A61K35/16;;A61M1/3679;;Y10S210/908;;A61K35/16;;A61M1/3679;;Y10S210/908,A61K35/16;;A61M1/36,210/638;;210/646;;210/651;;210/691;;210/502.1;;210/908;;604/5;;604/6,0,0,,,,EXPIRED
420,EP,A2,EP 2684441 A2,114-653-397-045-874,2014-01-15,2014,EP 13179856 A,2007-02-02,US 77198106 P;;US 67029507 A;;EP 07756629 A,2006-02-10,Combine harvester draper header having flexible cutterbar,"A harvesting header (100) comprises a header frame and a cutterbar assembly (128) mounted to the header frame and extending transversely to the normal direction of travel of the header. An endless flexible draper belt (202) is rotatably supported on the header frame rearwardly of the crop-cutting assembly to receive severed crop material from the crop-cutting assembly and convey the materials laterally. The draper belt (202) presents laterally extending, spaced apart leading and trailing edges relative to the normal direction of header travel, and an outwardly facing crop-engaging surface defined between the edges. An upstanding continuous rib (206) projects outwardly from the crop-engaging surface adjacent the leading edge.
",AGCO CORP,SCHMIDT JAMES;;SAUERWEIN CHRISTOPHER;;LOHRENTZ RANDY;;REGIER BERNARD;;CLARK STANLEY;;BERGKAMP ALAN,,https://lens.org/114-653-397-045-874,Patent Application,yes,1,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D41/14;;A01D57/20,,0,0,,,,DISCONTINUED
421,US,A,US 6054257 A,130-385-920-811-708,2000-04-25,2000,US 1485198 A,1998-01-29,US 1485198 A,1998-01-29,Photographic element containing particular coupler and inhibitor releasing coupler,"A photographic element is disclosed comprising: a) a first light sensitive silver halide emulsion layer containing a compound of Formula I: COUP.sub.1 --(L).sub.n --A I wherein 1) COUP.sub.1 is a coupler parent group capable of forming a dye upon reaction with oxidized developer wherein --(L).sub.n --A is not attached to the coupling position; 2) L is a divalent linking group bonding A to COUP.sub.1, and n is 0 or 1; and 3) A is a fragment containing a group is identified by formulas IIIa. IIIb or IIIc: ##STR1## wherein: Het represents a heteroatom; Q represents the atoms necessary to form a five or six-membered ring; V represents an atom of oxygen, sulfur, or nitrogen; and U represents an ether, thoiether or amino group; provided that the indicated formulas encompass the addition of one or more fused rings; and provided that the ClogP for the compound of Formula I is not greater than 20; and b) a second light sensitive silver halide emulsion layer containing a compound of Formula II: COUP.sub.2 --(TIME).sub.j --INH II wherein: 1) COUP.sub.2 is a coupler parent group capable of forming a dye upon reaction with an oxidized developer; 2) TIME is a timing group and j is 0 or 1; and 3) INH is a mild silver development inhibitor fragment. The element provides improved color reproduction.",EASTMAN KODAK CO,BOFF JANE S;;CLARK BERNARD A;;FRIEDRICH LOUIS E;;SINGER STEPHEN P,EASTMAN KODAK COMPANY (1998-02-05),https://lens.org/130-385-920-811-708,Granted Patent,yes,18,8,1,1,0,G03C7/3029;;G03C7/30594;;G03C7/3225;;G03C2007/3031;;Y10S430/156;;Y10S430/158;;G03C7/30594;;G03C7/3029;;G03C2007/3031;;G03C7/3225;;Y10S430/156;;Y10S430/158,G03C7/30;;G03C7/305;;G03C7/32,430/544;;430/505;;430/955;;430/957,0,0,,,,EXPIRED
422,DE,D1,DE 69220905 D1,176-033-057-310-055,1997-08-21,1997,DE 69220905 T,1992-04-23,US 73167191 A;;US 9203393 W,1991-07-17,MAGENTA BILDFARBSTOFF-KUPPLER MIT VERBESSERTEM FARBTON,,EASTMAN KODAK CO,MERKEL PAUL;;SINGER STEPHEN;;CLARK BERNARD ARTHUR JAMES;;STANLEY PAUL LOUIS REGINALD,,https://lens.org/176-033-057-310-055,Granted Patent,no,0,0,6,14,0,G03C7/384;;G03C7/24;;G03C7/30517,G03C1/00;;G03C7/24;;G03C7/305;;G03C7/384,,0,0,,,,EXPIRED
423,EP,A1,EP 0503682 A1,191-779-102-688-095,1992-09-16,1992,EP 92107525 A,1989-05-04,US 19103988 A;;US 24378688 A;;US 26038288 A,1988-05-06,Device for plasma modification composition and remodeling.,A method of reducing the elevated levels of anaphylatoxins found in blood derived fluid by contacting the fluid with silicic acid is provided.,APPLIED IMMUNESCIENCES,OKARMA THOMAS B;;CHANG CHIN-HAI;;CLARK BRIAN R;;LERCH BERNARD L,RHONE-POULENC RORER PHARMACEUTICALS INC. (1996-08-07),https://lens.org/191-779-102-688-095,Patent Application,yes,1,0,8,11,0,A61K35/16;;A61M1/3679;;A61M1/3679,A61K35/16;;A61M1/36,,2,2,048-093-635-712-018;;009-214-415-000-792,10.1016/0006-2952(80)90507-9;;7362644;;3264706;;10.1159/000169561,"BIOCHEMICAL PHARMACOLOGY vol. 29, no. 3, 1980, LONDON UK pages 319 - 323; C.J. WHELAN: 'The partial purification of slow reacting substance of anaphylaxis from rat peritoneal anaphylactic fluid and its separation from an arachidonic acid releasing substance.';;BLOOD PURIFICATION vol. 6, no. 6, 1 June 1988, BASEL CH pages 325 - 335; S. JERSTAD ET AL.: 'Generation and removal of anaphylatoxins during hemofiltration with five different membranes.'",DISCONTINUED
424,US,A1,US 2008/0152548 A1,198-195-478-590-155,2008-06-26,2008,US 78181207 A,2007-07-23,US 78181207 A;;US 72401703 A;;US 42988002 P;;US 47148503 P;;US 48684903 P;;US 49550003 P;;US 49619503 P,2002-11-27,"UV FLUX MULTIPLICATION SYSTEM FOR STERILIZING AIR, MEDICAL DEVICES AND OTHER MATERIALS","An ultraviolet flux multiplying air sterilization chamber comprises inner surfaces having a diffuse reflective behavior. The sterilization chamber includes an inlet aperture and an outlet aperture for air to flow through said chamber and a light source emitting an ultraviolet light. Due to the reflectivity of the inner surfaces of the chamber, a flux of the ultraviolet light is multiplied by reflecting multiple times from the inner surfaces of the chamber. The inlet and outlet apertures are advantageously configured to reduce the amount of light that escapes from the chamber and increase the amount of photons available in the chamber. In an exemplary embodiment, perforated end panels having diffuse, reflective interior surfaces may be provided over at least a portion of the inlet and outlet apertures.",CLARK REGINALD W;;EASTLUND BERNARD J;;INGRAM MICHAEL W;;STUMPF JOSEPH C,CLARK REGINALD W;;EASTLUND BERNARD J;;INGRAM MICHAEL W;;STUMPF JOSEPH C,NOVATRON INC (2007-10-11),https://lens.org/198-195-478-590-155,Patent Application,yes,16,35,8,8,0,A61L9/205;;A61L2209/16;;F24F8/22;;A61L9/205;;A61L2209/16;;A61L9/205;;A61L2209/16;;A61L9/20,A61L9/20,422/121,0,0,,,,EXPIRED
425,US,B1,US 6197488 B1,003-175-000-918-350,2001-03-06,2001,US 35809999 A,1999-07-21,US 35809999 A,1999-07-21,Color photographic element containing a coupler releasing derivative with at least three heteroatoms with specific hydrophobicity,"Disclosed is a color photographic element comprising at least one light sensitive silver halide emulsion layer having associated therewith a coupler according to Formula I: COUP--(TIME).sub.n --HSM (I) wherein: COUP is an organic fragment which reacts with oxidized developer to release--(TIME).sub.n --HSM, TIME is an optional timing group or linking group which connects HSM to COUP at the site of reaction with oxidized developer, n=0,1 or 2, and HSM is a compound having a minimum of three heteroatoms and having a ClogP sufficient to increase the speed of said element compared to the same element without the coupler. The invention provides improved light sensitivity without significant adverse effect on granularity or ease of manufacture.",EASTMAN KODAK CO,ALLWAY PHILIP A;;CLARK BERNARD A;;FRIEDRICH LOUIS E;;SINGER STEPHEN P,EASTMAN KODAK COMPANY (1999-09-02),https://lens.org/003-175-000-918-350,Granted Patent,yes,3,8,2,2,0,G03C7/30558;;G03C7/30558;;Y10S430/156;;Y10S430/156;;Y10S430/158;;Y10S430/158,G03C7/305,430/543;;430/544;;430/955;;430/957;;430/505,0,0,,,,EXPIRED
426,US,B2,US 8786467 B2,133-601-344-117-365,2014-07-22,2014,US 201113051146 A,2011-03-18,US 201113051146 A;;US 93980607 A,2007-11-14,Methods and systems for filtering traffic information for display,"A method and a system for displaying an airport or runway moving map with traffic information on a display screen in the cockpit or flight deck of an aircraft. Symbology representing surface and near-surface aircraft and surface vehicle traffic and associated traffic data are filtered to prevent or limit clutter on the display screen. Traffic symbology is automatically and manually filtered to display only relevant traffic. Traffic data is selectively displayed and displayed as/when relevant or needed. The displayed traffic information may be derived from automatic dependent surveillance-broadcast, traffic information system-broadcast, automatic dependent surveillance-rebroadcast, traffic collision avoidance system or other source.",CLARK SAMUEL T;;BOWE ROGLENDA R;;ORTMAN STEPHEN BERNARD;;CRANE JEAN MARIE;;BOEING CO,CLARK SAMUEL T;;BOWE ROGLENDA R;;ORTMAN STEPHEN BERNARD;;CRANE JEAN MARIE,THE BOEING COMPANY (2011-03-17),https://lens.org/133-601-344-117-365,Granted Patent,yes,15,11,3,3,0,G08G5/0078;;G08G5/0078;;G01C23/00;;G01C23/00;;G08G5/0021;;G08G5/0021;;G08G5/065;;G08G5/065,G08G5/00;;G01C21/00;;G01S13/00;;G06G7/76,340/958;;340/972;;340/971;;340/947;;340/991;;701/120;;701/10;;701/3;;701/457;;X342 26 B;;342/29;;342/33;;342/64,0,0,,,,ACTIVE
427,EP,B1,EP 0751427 B1,002-279-269-608-427,2001-03-28,2001,EP 96201757 A,1996-06-25,GB 9513108 A,1995-06-28,Image-dye-forming couplers and photographic elements containing them,,EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;GOURLEY ROBERT NICHOLAS;;MCNAB HAMISH;;SOMMERVILLE CRAIG CAMERON,EASTMAN KODAK COMPANY (2001-03-28),https://lens.org/002-279-269-608-427,Granted Patent,yes,1,0,6,6,0,G03C7/36;;G03C7/36;;G03C7/30535;;G03C7/30535,G03C7/305;;G03C7/36,,0,0,,,,EXPIRED
428,AT,T1,AT E104157 T1,183-503-650-778-959,1994-04-15,1994,AT 89304464 T,1989-05-04,EP 89304464 A;;US 19103988 A;;US 24378688 A;;US 26038288 A,1988-05-06,GERAET ZUR MODIFIKATION EINER PLASMAZUSAMMENSETZUNG UND REMODELLIERUNG.,,APPLIED IMMUNESCIENCES,OKARMA THOMAS B;;CHANG CHIN-HAI;;CLARK BRIAN R;;LERCH L BERNARD,,https://lens.org/183-503-650-778-959,Granted Patent,no,0,0,1,11,0,,A61M1/34;;A61M1/36;;G01N33/53;;G01N33/543,,0,0,,,,DISCONTINUED
429,DE,T2,DE 69323852 T2,172-356-059-354-335,1999-10-07,1999,DE 69323852 T,1993-12-20,US 99622892 A,1992-12-23,Azopyrazolonmaskenkuppler,,EASTMAN KODAK CO,KAPP DANIEL LAWRENCE;;ROSS ROBERT JOHN;;SINGER STEPHEN PAUL;;CLARK BERNARD A,,https://lens.org/172-356-059-354-335,Granted Patent,no,0,0,7,7,0,C09B29/366;;C09B29/366;;G03C7/3335;;G03C7/3335,G03C7/00;;C09B29/50;;G03C7/333;;G03C7/384,,0,0,,,,EXPIRED
430,DE,T2,DE 68914513 T2,120-657-776-897-765,1994-08-18,1994,DE 68914513 T,1989-05-04,US 19103988 A;;US 24378688 A;;US 26038288 A,1988-05-06,Gerät zur Modifikation einer Plasmazusammensetzung und Remodellierung.,,APPLIED IMMUNESCIENCES,OKARMA THOMAS B;;CHANG CHIN-HAI;;CLARK BRIAN R;;LERCH L BERNARD,,https://lens.org/120-657-776-897-765,Granted Patent,no,0,0,8,11,0,A61K35/16;;A61M1/3679;;A61M1/3679,A61K35/16;;A61M1/36,,0,0,,,,EXPIRED
431,EP,A3,EP 2684441 A3,129-112-751-503-974,2015-09-02,2015,EP 13179856 A,2007-02-02,US 77198106 P;;US 67029507 A;;EP 07756629 A,2006-02-10,Combine harvester draper header having flexible cutterbar,"A harvesting header (100) comprises a header frame and a cutterbar assembly (128) mounted to the header frame and extending transversely to the normal direction of travel of the header. An endless flexible draper belt (202) is rotatably supported on the header frame rearwardly of the crop-cutting assembly to receive severed crop material from the crop-cutting assembly and convey the materials laterally. The draper belt (202) presents laterally extending, spaced apart leading and trailing edges relative to the normal direction of header travel, and an outwardly facing crop-engaging surface defined between the edges. An upstanding continuous rib (206) projects outwardly from the crop-engaging surface adjacent the leading edge.
",AGCO CORP,SCHMIDT JAMES;;SAUERWEIN CHRISTOPHER;;LOHRENTZ RANDY;;REGIER BERNARD;;CLARK STANLEY;;BERGKAMP ALAN,,https://lens.org/129-112-751-503-974,Search Report,yes,3,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D41/14;;A01D57/20,,0,0,,,,DISCONTINUED
432,DE,D1,DE 69323852 D1,182-765-266-181-561,1999-04-15,1999,DE 69323852 T,1993-12-20,US 99622892 A,1992-12-23,Azopyrazolonmaskenkuppler,,EASTMAN KODAK CO,KAPP DANIEL LAWRENCE;;ROSS ROBERT JOHN;;SINGER STEPHEN PAUL;;CLARK BERNARD A,,https://lens.org/182-765-266-181-561,Granted Patent,no,0,0,7,7,0,C09B29/366;;C09B29/366;;G03C7/3335;;G03C7/3335,G03C7/00;;C09B29/50;;G03C7/333;;G03C7/384,,0,0,,,,EXPIRED
433,CA,C,CA 1325172 C,047-141-177-682-508,1993-12-14,1993,CA 598875 A,1989-05-05,US 19103988 A;;US 24378688 A;;US 26038288 A,1988-05-06,DEVICE FOR PLASMA MODIFICATION -- COMPOSITION AND REMODELING,"36. DEVICE FOR PLASMA MODIFICATION -- COMPOSITION AND REMODELING Compositions and devices are provided for the specific removal of components of plasma in efficient and economical ways. The devices provide for a tortuous path of the plasma through a high surface material to which is bound a binding compound for removal of the fluid component. The devices find particular application with plasma, in diagnosis, therapy, and for production of specific physiologically active materials.",APPLIED IMMUNESCIENCES,OKARMA THOMAS B;;CHANG CHIN-HAI;;CLARK BRIAN R;;LERCH L BERNARD,,https://lens.org/047-141-177-682-508,Granted Patent,no,0,0,8,11,0,A61K35/16;;A61M1/3679;;A61M1/3679,A61K35/16;;A61M1/36,D21670114    M;;18200152   S,0,0,,,,EXPIRED
434,ZA,B,ZA 891682 B,072-902-114-615-455,1990-10-31,1990,ZA 891682 A,1989-03-06,US 8800744 W,1988-03-08,THIAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;DAVID ALAN CLARK;;GOLDSTEIN STEVEN WAYNE;;STEVEN WAYNE GOLDSTEIN;;HOLLAND GERALD FAGAN;;GERALD FAGAN HOLLAND;;HULIN BERNARD;;BERNARD HULIN;;RIZZI JAMES PATRICK;;JAMES PATRICK RIZZI,,https://lens.org/072-902-114-615-455,Granted Patent,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;C07D277/20;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
435,WO,A3,WO 2003/060279 A3,112-223-644-562-869,2004-01-29,2004,US 0239832 W,2002-12-13,US 3753202 A,2002-01-04,PORTED SUBSEA WELLHEAD,"A susbsea well has communication passages (39,41) to enable annulus pressure surrounding inner (31) and intermediate (25) strings of casings to be monitored at the surface. The passages (39,41) both have outlets that allow communication to the tree assembly (55) for monitoring. In one embodiment, the passage outlets are located in the bore of the high pressure well head housing (15) and communicates to the tree assembly (55) along an isolation sleeve (61). In another embodiment, the passage outlets (145,153) are located on the exterior of the high pressure wellhead housing and communicate through a flying lead (161) coming down from the tree. In another embodiment, the passage outlets are located on the exterior of the high pressure wellhead housing and communicate to an upward facing connection (291) which is stabbed with a downward facing connection (293) coming down from the tree.",VETCO GRAY INC ABB,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN MURRAY;;MASSIE ALFRED,,https://lens.org/112-223-644-562-869,Search Report,yes,2,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,,0,0,,,,PENDING
436,BR,A,BR 0215457 A,028-723-097-460-981,2005-08-16,2005,BR 0215457 A,2002-12-13,US 3753202 A;;US 0239832 W,2002-01-04,Cabeça de poço submarino com abertura,"""CABEçA DE POçO SUBMARINO COM PASSAGEM"". Um poço submarino possui passagens de comunicação para permitir que a pressão do anel que circunda as fileiras interna e intermediária dos tubos para revestimento de poços seja monitorada na superfície. Ambas as passagens possuem saídas que permitem a comunicação com o conjunto de árvore para monitoramento. Em uma modalidade, as saídas de passagem estão localizadas no orifício do alojamento de cabeça de poço de alta pressão e se comunicam com o conjunto de árvore ao longo de um mangote de isolamento. Em outra modalidade, as saídas de passagem estão localizadas na parte externa do alojamento de cabeça de poço de alta pressão e se comunicam através de uma sonda volante que desce da árvore. Em outra modalidade, as saídas de passagem estão localizadas na parte externa do alojamento de cabeça de poço de alta pressão e se comunicam com uma conexão voltada para cima, a qual é engatada por uma conexão voltada para baixo que desce da árvore.",VETCO GRAY INC ABB,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN MURRAY;;MASSIE ALFRED,VETCO GRAY INC. (US) (2006-04-11),https://lens.org/028-723-097-460-981,Patent Application,no,0,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,,0,0,,,,EXPIRED
437,US,A1,US 2003/0127229 A1,132-148-678-299-665,2003-07-10,2003,US 3753202 A,2002-01-04,US 3753202 A,2002-01-04,Ported subsea wellhead,"
   A susbsea well has communication passages to enable annulus pressure surrounding inner and intermediate strings of casings to be monitored at the surface. The passages both have outlets that allow communication to the tree assembly for monitoring. In one embodiment, the passage outlets are located in the bore of the high pressure well head housing and communicates to the tree assembly along an isolation sleeve. In another embodiment, the passage outlets are located on the exterior of the high pressure wellhead housing and communicate through a flying lead coming down from the tree. In another embodiment, the passage outlets are located on the exterior of the high pressure wellhead housing and communicate to an upward facing connection which is stabbed with a downward facing connection coming down from the tree. 
",BUCKLE KEVIN G.;;OSBORNE JOHN H.;;HUMPREY BERNARD;;CLARK ALAN M.;;MASSIE ALFRED,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN M;;MASSIE ALFRED,ABB VETCO GRAY INC (2001-12-14),https://lens.org/132-148-678-299-665,Patent Application,yes,0,12,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,166/336;;166/368,0,0,,,,EXPIRED
438,GB,A,GB 1273160 A,195-938-742-741-959,1972-05-03,1972,GB 5808468 A,1968-12-06,GB 5808468 A,1968-12-06,ORGANIC LOAD-CARRYING ADDITIVE,"1,273,160. Lubricants. BRITISH PETROLEUM CO. Ltd. 25 Nov., 1969 [6 Dec., 1968], No. 58084/68. Heading C5F. Lubricating compositions comprise an oil e.g. mineral oil and a lipid extract obtained by solvent extracting a micro-organism culture that has been grown on a hydrocarbon substrate.",BRITISH PETROLEUM CO,FORBES ERIC SIMON;;FORBES ALAN DAVID;;SILVER HOWARD BERNARD;;CLARK JOHN TREVOR KENT,,https://lens.org/195-938-742-741-959,Granted Patent,no,0,0,8,8,0,C10M1/08;;C10M2227/00;;C10M1/08;;C10M2227/00,C10M169/00;;C10M159/00;;C10N30/12;;C10N40/00;;C12C11/00,C5F FA            A;;C5F F720          A,0,0,,,,EXPIRED
439,US,A,US 5256528 A,107-791-102-648-080,1993-10-26,1993,US 87288092 A,1992-04-23,US 87288092 A,1992-04-23,Magenta image-dye couplers of improved hue,"A photographic element and process provide a magenta coupler of the formula: ##STR1## wherein (a) at least one of X1, X2 and R1 and at least one of R2 and R3 is a substituent individually selected from carbamoyl, alkoxycarbonyl, aryloxycarbonyl, sulfamoyl, alkylsulfonyl, arylsulfonyl, alkoxysulfonyl, aryloxysulfonyl, alkylsulfoxyl, arylsulfoxyl, acyloxy, cyano, nitro, and trifluoromethyl; (b) the substituents X1, X2, R1, R2 and R3 not selected from the (a) group may be selected from alkyl, alkoxy, aryloxy, acylamino, alkylthio, arylthio, sulfonamido, alkylureido, arylureido, alkoxycarbonylamino, aryloxycarbonylamino, and halogen and in the case of R3 hydrogen; (c) substituents R1 and R2 are para or meta to the carbon attached to the nitrogen atom; (d) a and b are 1 to 3; (e) Q is an alkylthio or arylthio coupling-off group. The element provides a deeper magenta hue and reduced blue absorption by the resulting magenta dye.",EASTMAN KODAK CO,MERKEL PAUL B;;SINGER STEPHEN P;;CLARK BERNARD ARTHUR;;STANLEY PAUL LOUIS R,EASTMAN KODAK COMPANY A NJ CORP (1992-06-08),https://lens.org/107-791-102-648-080,Granted Patent,yes,12,9,1,1,0,G03C7/30529;;G03C7/30529,G03C7/305,430/555;;430/504;;430/383;;430/387,0,0,,,,EXPIRED
440,CA,A1,CA 2472225 A1,186-426-014-777-907,2003-07-24,2003,CA 2472225 A,2002-12-13,US 3753202 A;;US 0239832 W,2002-01-04,PORTED SUBSEA WELLHEAD,"A susbsea well has communication passages (39,41) to enable annulus pressure surrounding inner (31) and intermediate (25) strings of casings to be monitored at the surface. The passages (39,41) both have outlets that allow communication to the tree assembly (55) for monitoring. In one embodiment, t he passage outlets are located in the bore of the high pressure well head housi ng (15) and communicates to the tree assembly (55) along an isolation sleeve (61). In another embodiment, the passage outlets (145,153) are located on th e exterior of the high pressure wellhead housing and communicate through a flying lead (161) coming down from the tree. In another embodiment, the passage outlets are located on the exterior of the high pressure wellhead housing and communicate to an upward facing connection (291) which is stabbe d with a downward facing connection (293) coming down from the tree.",VETCO GRAY INC ABB,BUCKLE KEVIN G;;MASSIE ALFRED;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN MURRAY,,https://lens.org/186-426-014-777-907,Patent Application,no,0,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,,0,0,,,,EXPIRED
441,GB,B,GB 2401626 B,049-466-917-080-974,2006-03-29,2006,GB 0415826 A,2002-12-13,US 0239832 W;;US 3753202 A,2002-01-04,Ported subsea wellhead,,VETCO GRAY INC ABB;;VETCO GRAY INC,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPHREY BERNARD;;CLARK ALAN MURRAY;;MASSIE ALFRED,,https://lens.org/049-466-917-080-974,Granted Patent,no,3,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/14;;E21B33/035;;E21B33/043,E1F FJR           FJR,0,0,,,,EXPIRED
442,DE,A1,DE 1960840 A1,199-596-202-937-14X,1970-11-05,1970,DE 1960840 A,1969-12-04,GB 5808468 A,1968-12-06,Schmieroel,,BRITISH PETROLEUM CO,SIMON FORBES ERIC;;DAVID FORBES ALAN;;KENT CLARK JOHN TREVOR;;BERNARD SILVER HOWARD,,https://lens.org/199-596-202-937-14X,Patent Application,no,0,0,8,8,0,C10M1/08;;C10M2227/00;;C10M1/08;;C10M2227/00,C10M159/00;;C10M169/00;;C10N30/12;;C10N40/00;;C12C11/00,,0,0,,,,DISCONTINUED
443,US,B2,US 6705401 B2,101-842-902-405-879,2004-03-16,2004,US 3753202 A,2002-01-04,US 3753202 A,2002-01-04,Ported subsea wellhead,"
    A susbsea well has communication passages to enable annulus pressure surrounding inner and intermediate strings of casings to be monitored at the surface. The passages both have outlets that allow communication to the tree assembly for monitoring. In one embodiment, the passage outlets are located in the bore of the high pressure well head housing and communicates to the tree assembly along an isolation sleeve. In another embodiment, the passage outlets are located on the exterior of the high pressure wellhead housing and communicate through a flying lead coming down from the tree. In another embodiment, the passage outlets are located on the exterior of the high pressure wellhead housing and communicate to an upward facing connection which is stabbed with a downward facing connection coming down from the tree. 
",VETCO GRAY INC ABB,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN M;;MASSIE ALFRED,ABB VETCO GRAY INC (2001-12-14),https://lens.org/101-842-902-405-879,Granted Patent,yes,7,34,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,166/337;;166/346;;166/368,3,0,,,"U.S. patent application Ser. No. 10/315,717, Jennings et al.;;U.S. patent application Ser. No. 10/305,558, Clark.;;U.S. patent application Ser. No. 10/077,231, Calder et al., filed Aug. 29, 2002.",EXPIRED
444,WO,A2,WO 2003/060279 A2,026-205-026-061-526,2003-07-24,2003,US 0239832 W,2002-12-13,US 3753202 A,2002-01-04,PORTED SUBSEA WELLHEAD,"A susbsea well has communication passages (39,41) to enable annulus pressure surrounding inner (31) and intermediate (25) strings of casings to be monitored at the surface. The passages (39,41) both have outlets that allow communication to the tree assembly (55) for monitoring. In one embodiment, the passage outlets are located in the bore of the high pressure well head housing (15) and communicates to the tree assembly (55) along an isolation sleeve (61). In another embodiment, the passage outlets (145,153) are located on the exterior of the high pressure wellhead housing and communicate through a flying lead (161) coming down from the tree. In another embodiment, the passage outlets are located on the exterior of the high pressure wellhead housing and communicate to an upward facing connection (291) which is stabbed with a downward facing connection (293) coming down from the tree.",VETCO GRAY INC ABB,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN MURRAY;;MASSIE ALFRED,,https://lens.org/026-205-026-061-526,Patent Application,yes,0,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,,0,0,,,,PENDING
445,GB,A,GB 2401626 A,055-444-415-844-137,2004-11-17,2004,GB 0415826 A,2002-12-13,US 0239832 W;;US 3753202 A,2002-01-04,Ported subsea wellhead,"A susbsea well has communication passages (39,41) to enable annulus pressure surrounding inner (31) and intermediate (25) strings of casings to be monitored at the surface. The passages (39,41) both have outlets that allow communication to the tree assembly (55) for monitoring. In one embodiment, the passage outlets are located in the bore of the high pressure well head housing (15) and communicates to the tree assembly (55) along an isolation sleeve (61). In another embodiment, the passage outlets (145,153) are located on the exterior of the high pressure wellhead housing and communicate through a flying lead (161) coming down from the tree. In another embodiment, the passage outlets are located on the exterior of the high pressure wellhead housing and communicate to an upward facing connection (291) which is stabbed with a downward facing connection (293) coming down from the tree.",VETCO GRAY INC ABB,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPHREY BERNARD;;CLARK ALAN MURRAY;;MASSIE ALFRED,,https://lens.org/055-444-415-844-137,Patent Application,no,2,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,E1F FJR           FJR,0,0,,,,EXPIRED
446,US,A,US 4432541 A,121-131-722-604-015,1984-02-21,1984,US 29668481 A,1981-08-27,US 29668481 A,1981-08-27,Recirculating document feed apparatus and method for aligning documents therein,"A document feed device, illustrated with a copier machine, for recirculating documents through a processing station. A movable portion of the document feed device is mounted for pivoting movement to expose a lower document feed path. The movable portion contains several document moving rollers but no prime movers, gears or belts; these rolls are driven by frictional contact with each other and ultimately by contact with a set of driven rollers located in the nonmoving portion of the document feed device. The rollers comprising a document moving nip are oppositely skewed relative to the direction of document travel in order to move documents gently toward a reference edge and coefficients of friction of roller materials are chosen to insure correct document alignment.",IBM,CLARK WILLIAM D;;GARNER MARK D;;RHODES JR JOHN H;;WILZBACH BERNARD L,INTERNATIONAL BUSINESS MACHINES CORPORATION A CORP. OF N.Y (1981-08-07),https://lens.org/121-131-722-604-015,Granted Patent,yes,9,22,3,3,0,B65H9/166;;B65H9/166,G03B27/62;;B65H1/30;;B65H5/06;;B65H9/00;;B65H9/16;;B65H83/00;;G03G15/00,271/251;;271/301,2,0,,,"IBM Tech. Disc. Bulletin, vol. 24, No. 1B, Jun. 1981, pp. 808 809, Recirculating Document Feed with Dual Entry Gate , by W. D. Clark et al.;;IBM Tech. Disc. Bulletin, vol. 24, No. 1B, Jun. 1981, pp. 821 822, Scanning Fiber Optic Bundle Copier with Recirculating Document Feed , by W. D. Clark et al.",EXPIRED
447,BR,B1,BR 0215457 B1,079-322-656-171-936,2012-05-15,2012,BR 0215457 A,2002-12-13,US 3753202 A;;US 0239832 W,2002-01-04,cabeça de poço submarino com passagem.,,,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN MURRAY;;MASSIE ALFRED,VETCO GRAY INC. (US) (2006-04-11),https://lens.org/079-322-656-171-936,Granted Patent,no,0,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/14;;E21B33/035;;E21B33/043,,0,0,,,,EXPIRED
448,EP,B1,EP 0629913 B1,176-135-336-804-493,1996-12-27,1996,EP 94109289 A,1994-06-16,US 7953893 A,1993-06-17,Photographic elements containing magenta couplers and process for using same,,EASTMAN KODAK CO,SINGER STEPHEN PAUL;;MERKEL PAUL BARRETT;;CLARK BERNARD A;;STANLEY PAUL L R,,https://lens.org/176-135-336-804-493,Granted Patent,yes,2,0,4,4,0,G03C7/30529;;G03C7/384;;G03C7/30529;;G03C7/384,G03C7/305;;G03C7/384,,0,0,,,,EXPIRED
449,US,B2,US 10661251 B2,006-903-740-812-262,2020-05-26,2020,US 201816201222 A,2018-11-27,US 201816201222 A;;US 2018/0054608 W;;US 201762568942 P,2017-10-06,Carbon based materials as solid-state ligands for metal nanoparticle catalysts,"High activity metal nanoparticle catalysts, such as Pd or Pt nanoparticle catalysts, are provided. Adsorption of metal precursors such as Pd or Pt precursors onto carbon based materials such as graphene followed by solventless (or low-solvent) microwave irradiation at ambient conditions results in the formation of catalysts in which metal nanoparticles are supported on i) the surface of the carbon based materials and ii) in/on/within defects/holes in the carbon based materials.",UNIV VIRGINIA COMMONWEALTH,GILLILAND III STANLEY EUGENE;;GUPTON BERNARD FRANK;;KONG CALEB JUNE;;CLARK BRIAN RAYMOND,VIRGINIA COMMONWEALTH UNIVERSITY (2019-10-09),https://lens.org/006-903-740-812-262,Granted Patent,yes,5,0,4,5,0,C07F7/0829;;B01J21/18;;B01J23/44;;B01J37/346;;B01J23/42;;B01J37/16;;B01J37/18;;C07C1/321;;C07C2521/18;;C07C2523/44;;B01J35/394;;B01J35/393;;B01J35/30;;B01J35/23;;B01J23/42;;B01J21/18;;B01J37/346;;C07F7/0801;;B01J37/0201;;B01J37/035;;B01J37/0236;;B01J37/16;;C07F7/0829;;B01J23/44;;B01J21/185;;B01J37/031;;B01J35/23;;B01J35/30;;B01J35/393,B01J23/42;;B01J21/18;;B01J23/44;;B01J35/00;;B01J37/02;;B01J37/03;;B01J37/16;;B01J37/34;;C07F7/08,,20,16,147-588-641-463-226;;007-671-559-223-443;;024-771-329-043-126;;032-982-170-267-469;;081-950-347-828-403;;005-005-988-688-938;;118-150-532-756-363;;145-077-845-297-840;;102-192-171-731-113;;003-816-965-674-564;;026-889-864-694-883;;003-852-377-585-969;;027-834-093-558-901;;004-213-385-940-487;;189-357-308-493-742;;078-169-248-335-247,10.1351/pac199567030473;;10.1039/c8cc07641c;;30411738;;26393811;;10.1039/c5cc05675f;;10.1021/acscatal.8b02624;;10.1039/c1cy00351h;;10.1039/c7ra10541j;;10.1016/j.apcata.2017.11.007;;10.1201/9781420006506.ch13;;10.1177/0263617418771777;;10.1038/srep05901;;25109492;;pmc4127501;;23116232;;10.1021/nn3046133;;10.2174/1874088x01711010001;;10.1039/b906253j;;10.1021/am504664r;;25153308;;10.1016/j.fuel.2013.11.045;;10.1016/j.jcat.2010.12.003,"Fitzer, Pure & Appl. Chem. 1995, 67, 473-506. (Year: 1995).;;Kong; Chem. Commun., 2018, 54, 13343-13346 ,with supplemental material. (Year: 2018).;;Galeandro-Diamant; Chem. Commun., 2015, 51, 16194-16196. (Year: 2015).;;Zhu; ACS Catal. 2018, 8, 10004-10011. (Year: 2018).;;Bandari; Catal. Sci. Technol., 2012, 2, 220-226. (Year: 2012).;;Li; RSC Adv., 2017, 7, 50729-50738. (Year: 2017).;;Gilliland; Applied Catalysis A, General 550, 168-175, 2018. (Year: 2018).;;Regalbuto, “13: Strong Electrostatic Adsorption of Metals onto Catalyst Supports.” Catalyst Preparation: Science and Engineering (Apr. 19, 2016). (Year: 2016).;;Search Report and Written Opinion for International Application PCT/US2018/054608, dated Jan. 15, 2019. (Year: 2019).;;Dai; Organic Chemistry: An Indian Journal 2005, 1, 44-46. (Year: 2005).;;“Publication Details” for document with DOI: 10.1039/C8CC07641C, Retrieved Jun. 19, 2019 from https://pubs.rsc.org/en/content/articlelanding/2018/cc/c8cc07641c#!divAbstract (Year: 2019).;;Hany A Elazab et al. “Microwave-assisted synthesis of palladium nanoparticles supported on copper oxide in aqueous medium as an efficient catalyst for Suzuki cross-coupling reaction” Adsorption Science & Technology, 2018, vol. 36(5-6) 1352-1365.;;Pei Tang et al. “The microwave adsorption behavior and microwave-assisted heteroatoms doping of graphene-based nano-carbon materials”, Scientific Reports, 4:5901, Aug. 11, 2014.;;Vadahanambi Sridhar et al. “Defect-Engineered Three-Dimensional Graphene-Nanotube-Palladium Nanostructures with Ultrahigh Capacitance”, Article, ACSNANO, vol. 6, No. 12, 10562-10570, 2012.;;Jian Zhang et al. “Microwave-Assisted Synthesis of Pd Nanoparticles and Catalysis Application for Suzuki Coupling Reactions”, The Open Materials Science Journal, 2017, 11, 1-8.;;Hassan M. A. Hassan et al. “Microwave synthesis of graphene sheets supporting metal nanocrystals in aqueous and organic media”, Journal of Materials Chemistry, 2009, 19, 3832-3837.;;Yu-Xi Huang et al. “Reduced Graphene Oxide Supported Palladium Nanoparticles via Photoassisted Citrate Reduction for Enhanced Electrocatalytic Activities”, ACS Applied Materials & Interfaces, 2014, 6, 15795-15801.;;Ning Liu et al, “Microwave-assisted synthesis of MoS2/graphene nanocomposites for efficient hydrodesulfurization”, Fuel 119, Elsevier, 2014, 163-169.;;Ali R. Siamaki et al, “Microwave-assisted synthesis of palladium nanoparticles supported on graphene: A highly active and recyclable catalyst for carbon-carbon cross-coupling reactions”, Journal of Catalysis 279, Elsevier, 2011, 1-11.;;Wenya Xu et al. “Low-temperature plasma-assisted preparatin of graphene supported palladium nanoparticles with high hydrodesulfurization activity”, Journal of Materials Chemistry, 2012, 22, 14363-14368.",ACTIVE
450,CA,C,CA 2472225 C,153-769-375-301-979,2010-04-20,2010,CA 2472225 A,2002-12-13,US 3753202 A;;US 0239832 W,2002-01-04,PORTED SUBSEA WELLHEAD,"A susbsea well has communication passages (39,41) to enable annulus pressure surrounding inner (31) and intermediate (25) strings of casings to be monitored at the surface. The passages (39,41) both have outlets that allow communication to the tree assembly (55) for monitoring. In one embodiment, the passage outlets are located in the bore of the high pressure well head housing (15) and communicates to the tree assembly (55) along an isolation sleeve (61). In another embodiment, the passage outlets (145,153) are located on the exterior of the high pressure wellhead housing and communicate through a flying lead (161) coming down from the tree. In another embodiment, the passage outlets are located on the exterior of the high pressure wellhead housing and communicate to an upward facing connection (291) which is stabbed with a downward facing connection (293) coming down from the tree.",VETCO GRAY INC ABB,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN MURRAY;;MASSIE ALFRED,,https://lens.org/153-769-375-301-979,Granted Patent,no,0,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/14;;E21B33/035;;E21B33/043,,0,0,,,,EXPIRED
451,NO,L,NO 20043262 L,117-850-206-341-091,2004-09-29,2004,NO 20043262 A,2004-08-03,US 3753202 A;;US 0239832 W,2002-01-04,Bronnhode med kanal for trykkovervakning,,VETCO GRAY INC,CLARK ALAN MURRAY;;BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;MASSIE ALFRED,,https://lens.org/117-850-206-341-091,Abstract,no,0,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,,0,0,,,,DISCONTINUED
452,AU,A1,AU 2002/367055 A1,178-346-992-840-874,2003-07-30,2003,AU 2002/367055 A,2002-12-13,US 3753202 A;;US 0239832 W,2002-01-04,PORTED SUBSEA WELLHEAD,,VETCO GRAY INC ABB,MASSIE ALFRED;;BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN MURRAY,,https://lens.org/178-346-992-840-874,Patent Application,no,0,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,,0,0,,,,DISCONTINUED
453,AU,A8,AU 2002/367055 A8,039-737-004-842-961,2003-07-30,2003,AU 2002/367055 A,2002-12-13,US 3753202 A;;US 0239832 W,2002-01-04,Ported subsea wellhead,,VETCO GRAY INC ABB,BUCKLE KEVIN G;;OSBORNE JOHN H;;HUMPREY BERNARD;;CLARK ALAN MURRAY;;MASSIE ALFRED,,https://lens.org/039-737-004-842-961,Patent Application,no,0,0,14,14,0,E21B33/035;;E21B33/043;;E21B41/08;;E21B33/0353;;E21B33/14;;E21B33/035;;E21B33/0353;;E21B33/043;;E21B33/035;;E21B41/08;;E21B33/0353,E21B33/035;;E21B33/043,,0,0,,,,DISCONTINUED
454,EP,A3,EP 0332331 A3,013-138-245-557-661,1989-11-29,1989,EP 89302012 A,1989-02-28,US 8800744 W,1988-03-08,THIAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"57 Hypoglycemic thiazolidine-2,4-dione derivatives of the formula
  wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, S0 2 , CH 2 , CHOH or CO; n is 0 or 1; Y is CHR 1  or NR 2 , with the proviso that when n is 1 and Y is NR 2 , X is SO 2  or CO; Z is CHR 3  , CH 2 CH 2 , CH = CH,  OCH 2 , SCH 2 , SOCH 2  or S0 2 CH 2 ; R, R 1 , R 2  and R 3  are each independently hydrogen or methyl; and X' and X 2  are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER INC.,"CLARK, DAVID ALAN;;GOLDSTEIN, STEVEN WAYNE;;HOLLAND, GERALD FAGAN;;HULIN, BERNARD;;RIZZI, JAMES PATRICK",,https://lens.org/013-138-245-557-661,Search Report,yes,2,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07D277/20;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,1,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 30, no. 10, October 1982, pages 3580-3600, Tokyo, JP; T. SOHDA et al.: ""Studies on anti-diabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2.4-dione (ADD-3878) and its derivatives"".",EXPIRED
455,PT,A,PT 89913 A,044-867-294-698-190,1989-11-10,1989,PT 8991389 A,1989-03-06,US 8800744 W,1988-03-08,PROCESSO PARA A PREPARACAO DE AGENTES HIPOGLICEMICOS DE TIAZOLIDINODIONA,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE;;RIZZI JAMES PATRICK;;HOLLAND GERALD FAGAN,,https://lens.org/044-867-294-698-190,Patent Application,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;C07D277/20;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
456,DK,A,DK 108289 A,075-665-556-221-691,1989-09-11,1989,DK 108289 A,1989-03-07,US 8800744 W,1988-03-08,"THIAZOLIDIN-2,4-DION-DERIVATER OG FARMACEUTISKE PRAEPARATER INDEHOLDENDE DISSE","Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/075-665-556-221-691,Patent Application,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;C07D277/20;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,DISCONTINUED
457,WO,A1,WO 2014/058726 A1,110-997-829-952-907,2014-04-17,2014,US 2013/0063414 W,2013-10-04,US 201261710848 P;;US 201261731172 P,2012-10-08,SPUTTERED TRANSPARENT CONDUCTIVE ALUMINUM DOPED ZINC OXIDE FILMS,"Disclosed are AZO films deposited on a transparent substrate by pulse DC using an oxide target with a composition in the range 0.5-2wt% Al 2 O 3 , desirably at temperature above 325°C, resulting in films showing columnar grain structure with columns extending from the top to the bottom of the film, and small lateral grain size (less than 70nm from substrate to top of film). The film has low resistivity at less than 10 Ohm/square at a thickness less than 400nm, resistivity is desirably unchanged by annealing at temperatures of up to 450°C.",CORNING INC;;BELLMAN ROBERT ALAN;;CLARK JEREMY CURTIS;;SACHENIK PAUL ARTHUR;;SIMPSON LYNN BERNARD;;TIAN LILI,BELLMAN ROBERT ALAN;;CLARK JEREMY CURTIS;;SACHENIK PAUL ARTHUR;;SIMPSON LYNN BERNARD;;TIAN LILI,,https://lens.org/110-997-829-952-907,Patent Application,yes,0,5,11,11,0,C23C14/086;;C23C14/3485;;H01L31/1884;;Y10T428/24355;;H01B1/08;;C23C14/086;;C23C14/3485;;H01L31/1884;;Y02E10/50;;Y10T428/24355;;H01B1/08;;H01B5/14;;H01L31/022483,C23C14/08;;C23C14/34;;H01L31/18,,15,11,035-132-123-679-581;;020-564-666-328-002;;017-716-980-031-25X;;039-358-708-232-213;;081-826-068-992-616;;144-143-252-571-564;;041-565-371-547-685;;132-671-124-213-272;;021-914-910-538-161;;037-476-128-956-623;;027-108-789-620-674,10.1016/j.cap.2012.05.015;;10.1063/1.366798;;10.1016/j.msec.2007.10.006;;10.1063/1.1641524;;10.1063/1.2715554;;10.1016/j.jallcom.2011.11.113;;10.1016/0040-6090(90)90224-2;;10.1063/1.1473683;;10.1016/j.tsf.2007.10.029;;10.1016/s0040-6090(00)01891-5;;10.1016/s0040-6090(03)00949-0,"WONKYUN YANG ET AL: ""Resistivity improvement of Al-doped ZnO film by bipolar pulsed dc magnetron sputtering with high Ar flow rate"", CURRENT APPLIED PHYSICS, vol. 12, 18 May 2012 (2012-05-18), pages S99 - S103, XP055088196, ISSN: 1567-1739, DOI: 10.1016/j.cap.2012.05.015;;CEBULLA R ET AL: ""Al-doped zinc oxide films deposited by simultaneous rf and dc excitation of a magnetron plasma: Relationships between plasma parameters and structural and electrical film properties"", JOURNAL OF APPLIED PHYSICS, AMERICAN INSTITUTE OF PHYSICS. NEW YORK, US, vol. 83, no. 2, 15 January 1998 (1998-01-15), pages 1087 - 1095, XP012044482, ISSN: 0021-8979, DOI: 10.1063/1.366798;;AYADI Z B ET AL: ""The properties of aluminum-doped zinc oxide thin films prepared by rf-magnetron sputtering from nanopowder targets"", MATERIALS SCIENCE AND ENGINEERING C, ELSEVIER SCIENCE S.A, CH, vol. 28, no. 5-6, 12 October 2007 (2007-10-12), pages 613 - 617, XP022632909, ISSN: 0928-4931, [retrieved on 20071012], DOI: 10.1016/J.MSEC.2007.10.006;;AGASHE C ET AL: ""Efforts to improve carrier mobility in radio frequency sputtered aluminum doped zinc oxide films"", JOURNAL OF APPLIED PHYSICS, AMERICAN INSTITUTE OF PHYSICS. NEW YORK, US, vol. 95, no. 4, 15 February 2004 (2004-02-15), pages 1911 - 1917, XP012067415, ISSN: 0021-8979, DOI: 10.1063/1.1641524;;BERGINSKI MICHAEL ET AL: ""The effect of front ZnO:Al surface texture and optical transparency on efficient light trapping in silicon thin-film solar cells"", JOURNAL OF APPLIED PHYSICS, AMERICAN INSTITUTE OF PHYSICS. NEW YORK, US, vol. 101, no. 7, 9 April 2007 (2007-04-09), pages 74903 - 074903, XP012098269, ISSN: 0021-8979, DOI: 10.1063/1.2715554;;MOSBAH A ET AL: ""Influence of deposition temperature on structural, optical and electrical properties of sputtered Al doped ZnO thin films"", JOURNAL OF ALLOYS AND COMPOUNDS, ELSEVIER SEQUOIA, LAUSANNE, CH, vol. 515, 24 November 2011 (2011-11-24), pages 149 - 153, XP028123106, ISSN: 0925-8388, [retrieved on 20111202], DOI: 10.1016/J.JALLCOM.2011.11.113;;MINAMI T ET AL: ""Preparations of ZnO:Al transparent conducting films by d.c. magnetron sputtering"", THIN SOLID FILMS, ELSEVIER-SEQUOIA S.A. LAUSANNE, CH, vol. 193-194, 15 December 1990 (1990-12-15), pages 721 - 729, XP024731728, ISSN: 0040-6090, [retrieved on 19901215], DOI: 10.1016/0040-6090(90)90224-2;;JIANG X ET AL: ""Manufacture of specific structure of aluminum-doped zinc oxide films by patterning the substrate surface"", APPLIED PHYSICS LETTERS, AIP, AMERICAN INSTITUTE OF PHYSICS, MELVILLE, NY, US, vol. 80, no. 17, 29 April 2002 (2002-04-29), pages 3090 - 3092, XP012030692, ISSN: 0003-6951, DOI: 10.1063/1.1473683;;BERGINSKI M ET AL: ""Recent development on surface-textured ZnO:Al films prepared by sputtering for thin-film solar cell application"", THIN SOLID FILMS, ELSEVIER-SEQUOIA S.A. LAUSANNE, CH, vol. 516, no. 17, 16 October 2007 (2007-10-16), pages 5836 - 5841, XP022688404, ISSN: 0040-6090, [retrieved on 20071016], DOI: 10.1016/J.TSF.2007.10.029;;BCRGINSKI, J. APPL. PHYS., vol. 101, 2007, pages 074903;;ELMER, J. PHYS. D: APPL. PHYS., vol. 34, 2001, pages 3097;;SINGH, J. APPL. PHYS., vol. 95, no. 7, 2004, pages 3640;;J. CHANG; M. HON, THIN SOLID FILMS, vol. 386, 2001, pages 79;;T. MINAMI, J. CRYST. GROWTH, vol. 117, 1992, pages 370;;O. KLUTH, THIN SOLID FILMS, vol. 442, 2003, pages 80",PENDING
458,EP,B1,EP 0332331 B1,195-815-003-581-98X,1994-02-09,1994,EP 89302012 A,1989-02-28,US 8800744 W,1988-03-08,Thiazolidinedione hypoglycemic agents.,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/195-815-003-581-98X,Granted Patent,yes,0,1,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07D277/20;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,1,0,,,"BURGER, 3rd. Ed., vol. 3, pages 64, 72-76",EXPIRED
459,US,A,US 5350667 A,185-998-592-656-418,1994-09-27,1994,US 7953893 A,1993-06-17,US 7953893 A,1993-06-17,Photographic elements containing magenta couplers and process for using same,"A photographic element contains a light-sensitive silver halide layer having associated therewith a coupler which is a pyrazolone compound with a coupling-off substituent at the -4-position, said compound having the formula: ##STR1## wherein each R.sup.1 is independently a substituted or unsubstituted alkylsulfonyl or arylsulfonyl group; each R.sup.2 and R.sup.3 is independently a substituent; R.sup.4, R.sup.5, and R.sup.6 are independently hydrogen or substituted or unsubstituted alkyl groups; m and n are independently 0 or 1 but both are not 0; x1 and x2 are independently 0 to 5; and y is 0 to 3; provided that each of R.sup.3, R.sup.4, R.sup.5, and R.sup.6 is selected such that the calculated log P of the thiophenol corresponding to the substituent at the 4-position of the pyrazolone is at least 4. The photographic element provides an improved combination of low continued coupling together with a magenta hue exhibiting a long wavelength of maximum absorption.",EASTMAN KODAK CO,SINGER STEPHEN P;;MERKEL PAUL B;;CLARK BERNARD ARTHUR J;;STANLEY PAUL LOUIS R,EASTMAN KODAK COMPANY (1993-06-04),https://lens.org/185-998-592-656-418,Granted Patent,yes,5,16,4,4,0,G03C7/30529;;G03C7/384;;G03C7/30529;;G03C7/384,G03C7/305;;G03C7/384,430/387;;430/555,0,0,,,,EXPIRED
460,NO,D0,NO 903862 D0,175-242-301-506-67X,1990-09-05,1990,NO 903862 A,1990-09-05,US 8800744 W,1988-03-08,FREMGANGSMAATE FOR FREMSTILLING AV EN TIAZOLIDINDIONHYPOGLYKEMISK AKTIV FORBINDELSE.,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER INC,"CLARK, DAVID A.;;GOLDSTEIN, STEVEN WAYNE;;HOLLAND, GERALD F.;;HULIN, BERNARD;;RIZZI, JAMES P.",,https://lens.org/175-242-301-506-67X,Patent Application,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;C07D277/20;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,DISCONTINUED
461,WO,A2,WO 2011/087836 A2,058-451-087-170-608,2011-07-21,2011,US 2010/0061761 W,2010-12-22,US 28904009 P,2009-12-22,PULLULANASE VARIANTS AND USES THEREOF,A truncated pullulanase variant of a parent pullulanase belonging to family GH57 comprising an X47 domain and the use thereof.,NOVOZYMES AS;;NOVOZYMES NORTH AMERICA INC;;BORCHERT MARTIN;;GJERMANSEN MORTEN;;CLARK SUZANNE;;HENRISSAT BERNARD;;SILOW MARIA BERGGAARD;;HALLIN PETER FISCHER,BORCHERT MARTIN;;GJERMANSEN MORTEN;;CLARK SUZANNE;;HENRISSAT BERNARD;;SILOW MARIA BERGGAARD;;HALLIN PETER FISCHER,,https://lens.org/058-451-087-170-608,Patent Application,yes,53,107,11,11,38,C12N9/2451;;C12N9/2457;;C12N9/246;;C12P7/06;;C12P19/14;;C12P19/16;;C12Y302/01041;;C12Y302/01068;;Y02E50/10;;C12Y302/01041;;C12P7/06;;C12N9/2451;;C12N9/2457;;C12Y302/01068;;C12P19/16;;C12P19/14;;C12N9/246;;Y02E50/10,C12N9/44,,28,19,043-622-776-825-867;;032-728-154-591-070;;022-439-235-146-469;;022-439-235-146-469;;030-120-711-260-349;;030-720-249-164-582;;039-005-297-255-600;;061-217-015-651-536;;114-153-099-971-73X;;058-030-884-026-400;;079-069-371-606-063;;023-827-920-886-239;;077-703-545-140-447;;025-432-849-079-421;;074-224-868-188-122;;052-544-852-171-750;;022-328-767-527-500;;061-217-015-651-536;;087-203-827-522-445,10.1093/nar/gkh340;;pmc390337;;10.1109/csb.2004.1332560;;15034147;;10.1016/0022-2836(70)90057-4;;5420325;;10.1016/s0168-9525(00)02024-2;;10827456;;10.1016/s0168-9525(00)02024-2;;10827456;;pmc3531099;;18032433;;pmc3013733;;10.3410/f.1166571.627578;;pmc1781113;;pmc2241895;;10.1093/nar/gkr570;;24316576;;10.1093/nar/gkm1000;;16381840;;10.1093/nar/gkm929;;pmc4086098;;18045790;;pmc2686545;;pmc2238907;;19910364;;16381837;;pmc2808881;;24217914;;pmc3965104;;16381869;;pmc308807;;10.1093/nar/gkn741;;pmc4383943;;17170002;;10.1093/nar/gkn791;;18039703;;10.1093/nar/gkq1091;;10.1093/nar/gkq1331;;pmc1347519;;pmc3964975;;21071399;;10.1093/nar/gkq1079;;pmc2808980;;pmc3013688;;pmc3965011;;19910366;;pmc1347520;;24259429;;19920124;;pmc2238880;;14681378;;18208841;;pmc2241887;;10.1093/nar/gku366;;14681398;;24271400;;22140104;;pmc540017;;18940862;;pmc3965057;;10.1093/nar/gkq607;;21097890;;pmc1347422;;15608222;;10.1093/nar/gkq1330;;23193264;;10.1093/nar/gkm960;;pmc2238942;;pmc540016;;10.1093/nar/gkh073;;10.1093/nar/gki062;;15608212;;10.1093/nar/gkm1023;;25398906;;pmc2686492;;14681353;;22127870;;23193287;;24799431;;10.1093/nar/gkl1031;;pmc3531190;;10.1093/nar/gkm1043;;10.1093/nar/gki063;;pmc3245031;;21097780;;pmc2808889;;pmc3245129;;pmc308855;;pmc308829;;pmc3013681;;10.1093/nar/gkq1172;;18073190;;18948282;;10322035;;10.1128/jb.181.10.3284-3287.1999;;pmc93789;;10.1002/star.19920441204;;11994309;;10.1074/jbc.m203183200;;8462873;;10.1016/0378-1119(93)90328-z;;7763981;;10.1271/bbb.57.1095;;10.1002/j.1460-2075.1984.tb01935.x;;pmc557479;;6203744;;10.1080/00021369.1991.10870734;;1368680;;10.1271/bbb1961.55.941;;8532682;;10.1093/protein/8.6.575;;8037681;;10.1042/bj3010275;;pmc1137172;;10.1021/bi960241c;;8679632;;9488144;;10.1093/protein/10.10.1199;;9802217;;10.1007/s002530051299;;11994309;;10.1074/jbc.m203183200;;8302942;;10.1006/plas.1993.1066,"ZONE ET AL., EUR. J. BIOCHEM., vol. 271, 2004, pages 2863 - 2872;;EDGAR, ROBERT C.: ""MUSCLE: multiple sequence alignment with high accuracy and high throughput"", NUCLEIC ACIDS RESEARCH, vol. 32, no. 5, 2004, pages 1792 - 97, XP008137003, DOI: doi:10.1093/nar/gkh340;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;RICE ET AL.: ""The European Molecular Biology Open Software Suite"", TRENDS IN GENETICS, vol. 16, 2000, pages 276 - 277, XP004200114, DOI: doi:10.1016/S0168-9525(00)02024-2;;RICE ET AL., THE EUROPEAN MOLECULAR BIOLOGY OPEN SOFTWARE SUITE, 2000;;FINN ET AL., NUCLEIC ACIDS RESEARCH, 2008, pages D281 - D288;;ERRA-PUJADA ET AL.: ""The type II pullulanase of Thermococcus hydrothermalis: molecular characterization of the gene and expression of the catalytic domain"", J BACTERIOLOGY, vol. 181, no. 10, 1999, pages 3284 - 3287, XP002635680;;GORINSTEIN ET AL., STARCHLSTARKE, vol. 44, no. 12, 1992, pages 461 - 466;;RICHARDSON ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, no. 29, 2002, pages 267501 - 26507;;KOAZE ET AL., AGR. BIOL. CHEM. JAPAN, vol. 28, 1964, pages 216;;YOSHIDA: ""J. Agr."", vol. 28, 1954, CHEM. SOC. JAPAN, pages: 66;;HAYASHIDA ET AL., AGRIC. BIOL. CHEM., vol. 42, no. 5, 1977, pages 927 - 933;;""Hand-book of Proteolytic Enzymes"", 1998, ACA-DEMIC PRESS;;BERKA ET AL., GENE, vol. 96, 1990, pages 313;;BERKA ET AL., GENE, vol. 125, 1993, pages 195 - 198;;GOMI ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 57, 1993, pages 1095 - 1100;;KANEKO ET AL., J. FERMENT. BIOENG., vol. 81, 1996, pages 292 - 298;;BOEL ET AL., EMBO J., vol. 3, no. 5, 1984, pages 1097 - 1102;;AGRIC. BIOL. CHEM., vol. 55, no. 4, 1991, pages 941 - 949;;CHEN ET AL., PROT. ENG., vol. 9, 1996, pages 499 - 505;;CHEN ET AL., PROT. ENG., vol. 8, 1995, pages 575 - 582;;CHEN ET AL., BIOCHEM. J., vol. 301, 1994, pages 275 - 281;;FIEROBE ET AL., BIOCHEMISTRY, vol. 35, 1996, pages 8698 - 8704;;LI ET AL., PROTEIN ENG., vol. 10, 1997, pages 1199 - 1204;;NAGASAKA ET AL.: ""Purification and properties of the raw-starch-degrading glucoamylases from Corticium rolfsii"", APPL MICROBIOL BIOTECHNOL., vol. 50, 1998, pages 323 - 330, XP002506425, DOI: doi:10.1007/s002530051299;;FOGARTY ET AL., PROGRESS IN INDUSTRIAL MICROBIOLOGY, vol. 15, 1979, pages 112 - 115;;RICHARDSON ET AL., THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, no. 29, 2002, pages 267501 - 26507;;DIDERICHSEN ET AL., PLASMID, vol. 30, 1993, pages 312 - 315",PENDING
462,CN,A,CN 102791854 A,143-065-164-104-82X,2012-11-21,2012,CN 201080064560 A,2010-12-22,US 2010/0061761 W;;US 28904009 P,2009-12-22,Pullulanase variants and uses thereof,A truncated pullulanase variant of a parent pullulanase belonging to family GH57 comprising an X47 domain and the use thereof.,NOVOZYMES AS;;NOVOZYMES NORTH AMERICA INC,MARTIN BORCHERT;;MORTEN GJERMANSEN;;SUZANNE CLARK;;BERNARD HENRISSAT;;BERGGAARD SILOW MARIA;;FISCHER HALLIN PETER,,https://lens.org/143-065-164-104-82X,Patent Application,no,0,6,11,11,0,C12N9/2451;;C12N9/2457;;C12N9/246;;C12P7/06;;C12P19/14;;C12P19/16;;C12Y302/01041;;C12Y302/01068;;Y02E50/10;;C12Y302/01041;;C12P7/06;;C12N9/2451;;C12N9/2457;;C12Y302/01068;;C12P19/16;;C12P19/14;;C12N9/246;;Y02E50/10,C12N9/44;;C12P19/16,,4,0,,,"ERRA-PUJADA等: ""The type II pullulanase of thermococcus hydrothermalis:molecular characterization of the gene and expression of the catalytic domain"", 《JOURNAL OF BACTERIOLOGY》;;CHANG-PI-HIN等: ""Expression and characterisation of the catalytic domain of an archaeal family 57 pullulanase type II"", 《BIOLOGIA,BRATISLAVA》;;ERRA-PUJADA等: ""Purification and properties of the catalytic domain of the thermostable pullulanase type II from thermococcus hydrothermalis"", 《BIOTECHNOLOGY LETTERS》;;JANECEK等: ""Amylolytic families of glycoside hydrolases:focus on the family GH-57"", 《BIOLOGIA,BRATISLAYA》",DISCONTINUED
463,WO,A3,WO 2011/087836 A3,014-104-409-858-462,2011-11-17,2011,US 2010/0061761 W,2010-12-22,US 28904009 P,2009-12-22,PULLULANASE VARIANTS AND USES THEREOF,A truncated pullulanase variant of a parent pullulanase belonging to family GH57 comprising an X47 domain and the use thereof.,NOVOZYMES AS;;NOVOZYMES NORTH AMERICA INC;;BORCHERT MARTIN;;GJERMANSEN MORTEN;;CLARK SUZANNE;;HENRISSAT BERNARD;;SILOW MARIA BERGGAARD;;HALLIN PETER FISCHER,BORCHERT MARTIN;;GJERMANSEN MORTEN;;CLARK SUZANNE;;HENRISSAT BERNARD;;SILOW MARIA BERGGAARD;;HALLIN PETER FISCHER,,https://lens.org/014-104-409-858-462,Search Report,yes,0,0,11,11,0,C12N9/2451;;C12N9/2457;;C12N9/246;;C12P7/06;;C12P19/14;;C12P19/16;;C12Y302/01041;;C12Y302/01068;;Y02E50/10;;C12Y302/01041;;C12P7/06;;C12N9/2451;;C12N9/2457;;C12Y302/01068;;C12P19/16;;C12P19/14;;C12N9/246;;Y02E50/10,C12N9/44;;C12P19/16,,5,4,030-720-249-164-582;;035-152-698-030-204;;037-448-172-492-792;;024-109-129-245-317,10322035;;10.1128/jb.181.10.3284-3287.1999;;pmc93789;;10.1007/s00284-010-9690-6;;20593184;;10.1007/s00792-008-0168-4;;18500431;;10.1016/j.jmb.2008.02.041;;18387632,"ERRA-PUJADA MARTA ET AL: ""The type II pullulanase of Thermococcus hydrothermalis: Molecular characterization of the gene and expression of the catalytic domain"", JOURNAL OF BACTERIOLOGY, vol. 181, no. 10, May 1999 (1999-05-01), pages 3284 - 3287, XP002635680, ISSN: 0021-9193;;JANECEK STEFAN: ""Amylolytic families of glycoside hydrolases: focus on the family GH-57"", BIOLOGIA (BRATISLAVA), vol. 60, no. Suppl. 16, 2005, pages 177 - 184, XP002635681;;YU-LIANG JIAO ET AL: ""A GH57 Family Amylopullulanase from Deep-Sea: Expression of the Gene and Characterization of the Recombinant Enzyme"", CURRENT MICROBIOLOGY, SPRINGER-VERLAG, NE, vol. 62, no. 1, 1 July 2010 (2010-07-01), pages 222 - 228, XP019869339, ISSN: 1432-0991, DOI: DOI:10.1007/S00284-010-9690-6;;HSU-YANG LIN ET AL: ""Biochemical characterization of engineered amylopullulanase from Thermoanaerobacter ethanolicus 39E-implicating the non-necessity of its 100 C-terminal amino acid residues"", EXTREMOPHILES ; LIFE UNDER EXTREME CONDITIONS, SPRINGER-VERLAG, TO, vol. 12, no. 5, 24 May 2008 (2008-05-24), pages 641 - 650, XP019635126, ISSN: 1433-4909;;TAN T C ET AL: ""Crystal Structure of the Polyextremophilic alpha-Amylase AmyB from Halothermothrix orenii: Details of a Productive Enzyme-Substrate Complex and an N Domain with a Role in Binding Raw Starch"", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 378, no. 4, 9 May 2008 (2008-05-09), pages 850 - 868, XP022613363, ISSN: 0022-2836, [retrieved on 20080229], DOI: DOI:10.1016/J.JMB.2008.02.041",PENDING
464,DE,T2,DE 68912952 T2,039-077-202-586-750,1994-05-11,1994,DE 68912952 T,1989-02-28,US 8800744 W,1988-03-08,Hypoglykämische Thiazolidindion-Derivate.,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/039-077-202-586-750,Granted Patent,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/20;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
465,HU,D0,HU 882857 D0,095-838-202-790-967,1990-11-28,1990,HU 285788 A,1988-03-08,HU 285788 A,1988-03-08,PROCESS FOR PRODUCING THIAZOLIDINE DERIVATIVES UTILIZABLES AS MEDICAMENT AGAINST HYPOGLYCAEMIA,,PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD F;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/095-838-202-790-967,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
466,US,A1,US 2015/0279500 A1,195-103-403-508-268,2015-10-01,2015,US 201314434229 A,2013-10-04,US 201314434229 A;;US 201261731172 P;;US 201261710848 P;;US 2013/0063414 W,2012-10-08,SPUTTERED TRANSPARENT CONDUCTIVE ALUMINUM DOPED ZINC OXIDE FILMS,"Disclosed are AZO films deposited on a transparent substrate by pulse DC using an oxide target with a composition in the range 0.5-2 wt % Al 2 O 3 , desirably at temperature above 325° C., resulting in films showing columnar grain structure with columns extending from the top to the bottom of the film, and small lateral grain size (less than 70 nm from substrate to top of film). The film has low resistivity at less than 10 Ohm/square at a thickness less than 400 nm, resistivity is desirably unchanged by annealing at temperatures of up to 450° C.",CORNING INC,BELLMAN ROBERT ALAN;;CLARK JEREMY CURTIS;;SACHENIK PAUL ARTHUR;;SIMPSON LYNN BERNARD;;TIAN LILI,CORNING INCORPORATED (2015-10-19),https://lens.org/195-103-403-508-268,Patent Application,yes,1,2,11,11,0,C23C14/086;;C23C14/3485;;H01L31/1884;;Y10T428/24355;;H01B1/08;;C23C14/086;;C23C14/3485;;H01L31/1884;;Y02E10/50;;Y10T428/24355;;H01B1/08;;H01B5/14;;H01L31/022483,H01B1/08;;C23C14/08;;C23C14/34;;H01B5/14;;H01L31/0224;;H01L31/18,,0,0,,,,ACTIVE
467,WO,A1,WO 1993/002392 A1,023-161-181-124-207,1993-02-04,1993,US 9203393 W,1992-04-23,US 73167191 A,1991-07-17,MAGENTA IMAGE-DYE COUPLERS OF IMPROVED HUE,"A photographic element and process provide a magenta coupler of formula (I) wherein (a) at least one of X1, X2 and R1 and at least one of R2 and R3 is a substituent individually selected from carbamoyl, alkoxycarbonyl, aryloxycarbonyl, sulfamoyl, alkylsulfonyl, arylsulfonyl, alkoxysulfonyl, aryloxysulfonyl, alkylsulfoxyl, arylsulfoxyl, acyloxy, cyano, nitro, and trifluoromethyl; (b) the substituents X1, X2, R1, R2 and R3 not selected from the (a) group may be selected from alkyl, alkoxy, aryloxy, acylamino, alkylthio, arylthio, sulfonamido, alkylureido, arylureido, alkoxycarbonylamino, aryloxycarbonylamino, and halogen and in the case of R3 hydrogen; (c) substituents R1 and R2 are para or meta to the carbon attached to the nitrogen atom; (d) a and b are 1 to 3; (e) Q is an alkylthio or arylthio coupling-off group. The element provides a deeper magenta hue and reduced blue absorption by the resulting magenta dye.",EASTMAN KODAK CO,MERKEL PAUL BARRETT;;SINGER STEPHEN PAUL;;CLARK BERNARD ARTHUR JAMES;;STANLEY PAUL LOUIS REGINALD,,https://lens.org/023-161-181-124-207,Patent Application,yes,6,1,6,14,0,G03C7/384;;G03C7/24;;G03C7/30517,G03C1/00;;G03C7/24;;G03C7/305;;G03C7/384,,0,0,,,,PATENTED
468,US,A,US 5411841 A,053-351-130-576-604,1995-05-02,1995,US 6696093 A,1993-05-24,US 6696093 A,1993-05-24,Photographic elements containing magenta couplers and process for using same,"Improved hue, speed of dye formation and reduced staining are provided by a photographic element comprising a light-sensitive silver halide layer having associated therewith a 1-phenyl-3-anilino-pyrazolo-5-one coupler comprising a ballasted parent and a coupling-off group and containing substituents on the 1-phenyl and 3-anilino rings of the parent having Hammett sigma values which together sum to at least 1.1, the coupler further having at the 4-position of the pyrazolone ring a coupling-off group comprising a phenylthio group containing a carbonamido substituent in the position para to the sulfur on the phenylthio ring with the substituents on the phenylthio ring selected such that the calculated log P of the thiophenol corresponding to the coupling-off group is at least 4. ##STR1##",EASTMAN KODAK CO,SINGER STEPHEN P;;MERKEL PAUL B;;CLARK BERNARD A J;;STANLEY PAUL L R,EASTMAN KODAK COMPANY (1993-05-06),https://lens.org/053-351-130-576-604,Granted Patent,yes,12,2,4,4,0,G03C7/30529;;G03C7/30529;;G03C7/3212;;G03C7/3212;;G03C7/384;;G03C7/384,G03C7/384;;G03C7/305,430/387;;430/555,0,0,,,,EXPIRED
469,EP,A2,EP 0332331 A2,131-683-943-221-278,1989-09-13,1989,EP 89302012 A,1989-02-28,US 8800744 W,1988-03-08,Thiazolidinedione hypoglycemic agents.,"57 Hypoglycemic thiazolidine-2,4-dione derivatives of the formula
  
 wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, S0 2 , CH 2 , CHOH or CO; n is 0 or 1; Y is CHR 1  or NR 2 , with the proviso that when n is 1 and Y is NR 2 , X is SO 2  or CO; Z is CHR 3  , CH 2 CH 2 , CH = CH,
  OCH 2 , SCH 2 , SOCH 2  or S0 2 CH 2 ; R, R 1 , R 2  and R 3  are each independently hydrogen or methyl; and X' and X 2  are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/131-683-943-221-278,Patent Application,yes,0,55,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07D277/20;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
470,AT,T1,AT E101394 T1,155-368-811-198-011,1994-02-15,1994,AT 89302012 T,1989-02-28,EP 89302012 A;;US 8800744 W,1988-03-08,HYPOGLYKAEMISCHE THIAZOLIDINDION-DERIVATE.,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/155-368-811-198-011,Granted Patent,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
471,AU,A,AU 1989/031075 A,030-006-271-445-163,1989-09-14,1989,AU 1989/031075 A,1989-03-07,US 8800744 W,1988-03-08,THIAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/030-006-271-445-163,Patent Application,no,0,1,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
472,JP,A,JP 2019056181 A,114-786-406-201-63X,2019-04-11,2019,JP 2018219163 A,2018-11-22,JP 2015535817 A;;US 201261710848 P;;US 201261731172 P,2012-10-08,CONDUCTIVE TRANSPARENT ALUMINUM-DOPED ZINC OXIDE SPUTTERING FILM,"To provide a method for depositing an improved AZO film.SOLUTION: An oxide target having such a composition that AlOis in the range of 0.5-2 wt% is provided, and a deposition method of an AZO film for depositing the AZO film by sputtering the oxide target is disclosed. Preferably, an AZO film is disclosed, which is deposited on a transparent substrate by pulse DC, at a higher temperature than 325°C, at which a columnar crystal grain structure having a columnar structure extending from an upper surface of the film to a bottom surface, and a film showing a small (less than 70 nm from the substrate to the upper surface of the film) lateral direction grain size are obtained. The film has a small specific resistance less than 10 Ω/sq. at a thickness thinner than 400nm, and preferably, the specific resistance is not changed by annealing at a temperature lower than 450°C.SELECTED DRAWING: Figure 1B",CORNING INC,ROBERT ALAN BELLMAN;;JEREMY CURTIS CLARK;;PAUL ARTHUR SACHENIK;;LYNN BERNARD SIMPSON;;TIAN LILI,,https://lens.org/114-786-406-201-63X,Patent Application,no,0,0,11,11,0,C23C14/086;;C23C14/3485;;H01L31/1884;;Y10T428/24355;;H01B1/08;;C23C14/086;;C23C14/3485;;H01L31/1884;;Y02E10/50;;Y10T428/24355;;H01B1/08;;H01B5/14;;H01L31/022483,C23C14/34;;C23C14/08,,0,0,,,,ACTIVE
473,CN,A,CN 105051244 A,154-161-086-128-947,2015-11-11,2015,CN 201380063481 A,2013-10-04,US 2013/0063414 W;;US 201261710848 P;;US 201261731172 P,2012-10-08,Sputtered transparent conductive aluminum doped zinc oxide films,"Disclosed are AZO films deposited on a transparent substrate by pulse DC using an oxide target with a composition in the range 0.5-2wt% Al2O3, desirably at temperature above 325 DEG C, resulting in films showing columnar grain structure with columns extending from the top to the bottom of the film, and small lateral grain size (less than 70nm from substrate to top of film). The film has low resistivity at less than 10 Ohm/square at a thickness less than 400nm, resistivity is desirably unchanged by annealing at temperatures of up to 450 DEG C.",CORNING INC,BELLMAN ROBERT ALAN;;CLARK JEREMY CURTIS;;SACHENIK PAUL ARTHUR;;SIMPSON LYNN BERNARD;;TIAN LILI,,https://lens.org/154-161-086-128-947,Patent Application,no,1,1,11,11,0,C23C14/086;;C23C14/3485;;H01L31/1884;;Y10T428/24355;;H01B1/08;;C23C14/086;;C23C14/3485;;H01L31/1884;;Y02E10/50;;Y10T428/24355;;H01B1/08;;H01B5/14;;H01L31/022483,C23C14/08;;C23C14/34;;H01L31/18,,10,1,020-564-666-328-002,10.1063/1.366798,"X. JIANG等: ""“Manufacture of specific structure of aluminum-doped”"", 《APPLLEO PHYSICS LETTERS》;;WONKYUN YANG 等: ""“Resistivity improvement of Al-doped ZnO film by bipolar pulsed dc magnetron sputtering with high Ar flow rate”"", 《CURRENT APPLIED PHYSICS》;;R. CEBULLA: ""“Al-doped zinc oxide films deposited by simultaneous rf and dc excitation of a magnetron plasma:Relationships between plasma parameters and structural and electrical film properties”"", 《JOURNAL OF APPLL EO PHYSICS》;;C. AGASHE等: ""“Efforts to improve carrier mobility in radio frequency sputtered aluminum doped zinc oxide films”"", 《JOURNAL OF APPLL EO PHYSICS》;;MICHAEL BERGINSKI等: ""“The effect of front ZnO:AI surface texture and optical transparency on efficient light trapping in silicon thin-film solar cells”"", 《JOURNAL OF APPLL EO PHYSICS》;;A. MOSBAH等: ""“Influence of deposition temperature on structural，optical and electrical properties of sputtered Al doped ZnO thin films”"", 《JOURNAL OF ALLOYS AND COMPOUNDS》;;Z. BEN AYADI等: ""“The properties of aluminum-doped zinc oxide thin films prepared by rf-magnetron sputtering from nanopowder targets”"", 《MATERIALS SCIENCE AND ENGINEERING C》;;T. MINAMI等: ""“Preparations of ZnO:AI transparent conducting films by d.c. magnetron sputtering”"", 《THIN SOLID FILMS》;;M. BERGINSKI等: ""“Recent development on surface-textured ZnO:Al films prepared by sputtering for thin-film solar cell application”"", 《THIN SOLID FILMS》;;安会静: ""“利用脉冲直流磁控溅射制备ZnO:Al薄膜的研究”"", 《真空》",INACTIVE
474,NZ,A,NZ 228248 A,047-339-081-594-064,1990-05-28,1990,NZ 22824889 A,1989-03-07,US 8800744 W,1988-03-08,"SUBSTITUTED THIAZOLIDINE-2,4-DIONES AND PHARMACEUTICAL COMPOSITIONS","Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/047-339-081-594-064,Patent Application,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07D277/20;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,DISCONTINUED
475,KR,B1,KR 910005415 B1,105-119-171-618-194,1991-07-29,1991,KR 890002783 A,1989-03-07,US 8800744 W,1988-03-08,THIAZOUPINEDION HYPOGLY CEMIC AGENTS,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HOLLAND GERALD F;;HULIN BERNARD;;RIZZI JAMES P,,https://lens.org/105-119-171-618-194,Granted Patent,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;C07D277/20;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
476,US,A1,US 2013/0017571 A1,120-013-119-035-053,2013-01-17,2013,US 201013515635 A,2010-12-22,US 201013515635 A;;US 28904009 P;;US 2010/0061761 W,2009-12-22,Pullulanase Variants and Uses Thereof,A truncated pullulanase variant of a parent pullulanase belonging to family GH57 comprising an X47 domain and the use thereof.,NOVOZYMES AS;;BORCHERT MARTIN;;GJERMANSEN MORTEN;;CLARK SUZANNE;;HENRISSAT BERNARD;;SILOW MARIA B;;HALLIN PETER F,BORCHERT MARTIN;;GJERMANSEN MORTEN;;CLARK SUZANNE;;HENRISSAT BERNARD;;SILOW MARIA B;;HALLIN PETER F,NOVOZYMES A/S (2012-08-16);;NOVOZYMES NORTH AMERICA INC (2012-08-29),https://lens.org/120-013-119-035-053,Patent Application,yes,1,3,11,11,38,C12N9/2451;;C12N9/2457;;C12N9/246;;C12P7/06;;C12P19/14;;C12P19/16;;C12Y302/01041;;C12Y302/01068;;Y02E50/10;;C12Y302/01041;;C12P7/06;;C12N9/2451;;C12N9/2457;;C12Y302/01068;;C12P19/16;;C12P19/14;;C12N9/246;;Y02E50/10,C12N9/44;;C12N1/19;;C12N1/21;;C12N15/56;;C12N15/63;;C12P1/02;;C12P3/00;;C12P7/04;;C12P7/14;;C12P7/16;;C12P7/28;;C12P7/44;;C12P7/46;;C12P7/48;;C12P7/54;;C12P7/56;;C12P7/58;;C12P13/14;;C12P23/00;;C12P25/00;;C12P29/00;;C12P37/00,435/43;;536/23.2;;435/210;;435/320.1;;435/254.21;;435/162;;435/160;;435/157;;435/144;;435/140;;435/142;;435/139;;435/145;;435/137;;435/150;;435/110;;435/171;;435/168;;435/64;;435/66;;435/67;;435/252.31;;435/254.23,0,0,,,,INACTIVE
477,US,A,US 5061717 A,189-165-257-595-91X,1991-10-29,1991,US 56643690 A,1990-08-14,US 8800744 W,1988-03-08,Thiazolidinedione hypoglycemic agents,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula ##STR1## wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO.sub.2, CH.sub.2, CHOH or CO; n is 0 or 1; Y is CHR.sup.1 or NR.sup.2, with the proviso that when n is 1 and Y is NR.sup.2, X is SO.sub.2 or CO; Z is CHR.sup.3, CH.sub.2 CH.sub.2, CH.dbd.CH, ##STR2## OCH.sub.2, SCH.sub.2, SOCH.sub.2 or SO.sub.2 CH.sub.2 ; R, R.sup.1, R.sup.2 and R.sup.3 are each independently hydrogen or methyl; and X.sup.1 and X.sup.2 are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HOLLAND GERALD F;;HULIN BERNARD;;RIZZI JAMES P,PFIZER INC (1988-03-04),https://lens.org/189-165-257-595-91X,Granted Patent,yes,5,57,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;C07D277/20;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,514/342;;546/268;;546/280,2,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"Sohda et al., Chem. Pharm. Bull. Japan, vol. 30, pp. 3580 3600 (1982).;;Chemical Abstracts, 80:168259k (abstracting Japan Kokai 80 64586).",EXPIRED
478,MY,A,MY 104958 A,078-048-286-078-666,1994-07-30,1994,MY PI19890273 A,1989-03-06,US 8800744 W,1988-03-08,THIAZOLIDINEDIONE HYPOGLYCEMIC AGENTS.,"HYPOGLYCEMIC THIAZOLIDINE-2, 4-DIONE DERIVATIVES OF THE FORMULA (FORMULA 1) WHEREIN THE DOTTED LINE REPRESENTS A BOND OR NO BOND; A AND B ARE EACH INDEPENDENTLY CH OR N, WITH THE PROVISO THAT WHEN A OR B IS N,THE OTHER IS CH; X IS S, SO, SO2, CH2,CHOH OR CO; N IS 0 OR 1; Y IS CHR1 OR NR2, WITH THE PROVISO THAT WHEN N IS 1 AND Y IS NR2, X IS SO2 OR CO; Z IS CHR3, CH2CH2, CH=CH, CH-CH, OCH2, SCH2, SOCH2 OR SO2CH2; R,R1,R2 AND R3 ARE EACH INDEPENDENTLY HYDROGEN OR METHYL; AND X1 AND X2 ARE EACH INDEPENDENTLY HYDROGEN, METHYL, TRIFLUOROMETHYL, PHENYL, BENZYL, HYDROXY, METHOXY, PHENOXY, BENZYLOXY, BROMO, CHLORO OR FLUORO; A PHARMACEUTICALLY-ACCEPTABLE CATIONIC SALT THEREOF; OR A PHARMACEUTICALLY-ACCEPTABLE ACID ADDITION SALT THEREOF WHEN A OR B IS N.",PFIZER,DAVID ALAN CLARK;;GERALD FAGAN HOLLAND;;STEVEN WAYNE GOLDSTEIN;;BERNARD HULIN;;JAMES PATRICK RIZZI,,https://lens.org/078-048-286-078-666,Granted Patent,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,C07D277/20;;A61K31/425;;C07D417/06;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/10,,0,0,,,,EXPIRED
479,EP,A1,EP 2904128 A1,096-085-111-258-118,2015-08-12,2015,EP 13776932 A,2013-10-04,US 201261710848 P;;US 201261731172 P;;US 2013/0063414 W,2012-10-08,SPUTTERED TRANSPARENT CONDUCTIVE ALUMINUM DOPED ZINC OXIDE FILMS,,CORNING INC;;BELLMAN ROBERT A;;CLARK JEREMY CURTIS;;SACHENIK PAUL ARTHUR;;SIMPSON LYNN BERNARD;;TIAN LILI,BELLMAN ROBERT ALAN;;CLARK JEREMY CURTIS;;SACHENIK PAUL ARTHUR;;SIMPSON LYNN BERNARD;;TIAN LILI,,https://lens.org/096-085-111-258-118,Patent Application,yes,0,0,11,11,0,C23C14/086;;C23C14/3485;;H01L31/1884;;Y10T428/24355;;H01B1/08;;C23C14/086;;C23C14/3485;;H01L31/1884;;Y02E10/50;;Y10T428/24355;;H01B1/08;;H01B5/14;;H01L31/022483,C23C14/08;;C23C14/34;;H01L31/18,,0,0,,,,DISCONTINUED
480,DE,D1,DE 3675083 D1,143-545-541-132-002,1990-11-29,1990,DE 3675083 T,1986-06-16,US 74634285 A,1985-06-19,MATERIAL ZUM AUSFUELLEN VON PERIODONTALEN KNOCHENDEFEKTEN.,,UNIV FLORIDA,LOW SAMUEL BERNARD;;FETNER ALAN EDWARD;;CLARK JR;;HENCH LARRY LEROY;;WILSON-HENCH JUNE,,https://lens.org/143-545-541-132-002,Granted Patent,no,0,0,7,7,0,A61F2310/00293;;A61L24/02;;A61L27/10;;A61L2430/02;;A61L27/12;;A61F2/28;;A61L24/02;;A61F2310/00293;;A61L2430/02;;A61L27/10;;A61L27/12;;A61F2/28,A61F2/00;;A61K6/06;;A61L24/02;;A61L27/00;;A61L27/12,,0,0,,,,EXPIRED
481,EP,B1,EP 0548313 B1,043-760-467-048-975,1997-07-16,1997,EP 92914038 A,1992-04-23,US 9203393 W;;US 73167191 A,1991-07-17,MAGENTA IMAGE-DYE COUPLERS OF IMPROVED HUE,,EASTMAN KODAK CO,MERKEL PAUL BARRETT;;SINGER STEPHEN PAUL;;CLARK BERNARD ARTHUR JAMES;;STANLEY PAUL LOUIS REGINALD,,https://lens.org/043-760-467-048-975,Granted Patent,yes,6,0,6,14,0,G03C7/384;;G03C7/24;;G03C7/30517,G03C1/00;;G03C7/24;;G03C7/305;;G03C7/384,,0,0,,,,EXPIRED
482,US,A1,US 2018/0247726 A1,027-784-536-357-533,2018-08-30,2018,US 201815963437 A,2018-04-26,US 201815963437 A;;US 201514434229 A;;US 2013/0063414 W;;US 201261731172 P;;US 201261710848 P,2012-10-08,SPUTTERED TRANSPARENT CONDUCTIVE ALUMINUM DOPED ZINC OXIDE FILMS,"Disclosed are AZO films deposited on a transparent substrate by pulse DC using an oxide target with a composition in the range 0.5-2 wt % Al 2 O 3 , desirably at temperature above 325° C., resulting in films showing columnar grain structure with columns extending from the top to the bottom of the film, and small lateral grain size (less than 70 nm from substrate to top of film). The film has low resistivity at less than 10 Ohm/square at a thickness less than 400 nm, resistivity is desirably unchanged by annealing at temperatures of up to 450° C.",CORNING INC,BELLMAN ROBERT ALAN;;CLARK JEREMY CURTIS;;SACHENIK PAUL ARTHUR;;SIMPSON LYNN BERNARD;;TIAN LILI,,https://lens.org/027-784-536-357-533,Patent Application,yes,4,0,11,11,0,C23C14/086;;C23C14/3485;;H01L31/1884;;Y10T428/24355;;H01B1/08;;C23C14/086;;C23C14/3485;;H01L31/1884;;Y02E10/50;;Y10T428/24355;;H01B1/08;;H01B5/14;;H01L31/022483,H01B1/08;;C23C14/08;;C23C14/34;;H01B5/14;;H01L31/0224;;H01L31/18,,0,0,,,,DISCONTINUED
483,AU,B2,AU 593758 B2,062-992-217-685-762,1990-02-15,1990,AU 1989/031075 A,1989-03-07,US 8800744 W,1988-03-08,THIAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/062-992-217-685-762,Granted Patent,no,0,1,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
484,EP,A1,EP 0548313 A1,116-410-165-915-312,1993-06-30,1993,EP 92914038 A,1992-04-23,US 9203393 W;;US 73167191 A,1991-07-17,MAGENTA IMAGE-DYE COUPLERS OF IMPROVED HUE.,"L'invention concerne un élément et un procédé photographiques produisant un copulant magenta de la formule (I) dans laquelle (a) au moins un élément parmi X1, X2 et R1 et au moins un élément de R2 et R3 est un substituant choisi individuellement parmi carbamoyle, anyloxycarbonyle, sulfamoyle, alkylsulfonyle, arylsulfonyle, alkoxysulfonyle, aryloxysulfonyle, alkylsulfoxyle, arylsulfoxyle, acyloxy, cyano, nitro et trifluorométhyle; (b) les substituants X1, X2, R1, R2 et R3 non sélectionnés dans le groupe (a) peuvent être choisis parmi alkyle, alkoxy, aryloxy, acylamino, alkylthio, arylthio, sulfonamido, alkyluréido, aryluréido, alkoxycarbonylamino, aryloxycarbonylamino, et halogène, et dans le cas de R3, hydrogène; (c) les substituants R1 et R2 sont en position para ou méta sur le carbone rattaché à l'atome d'azote; (d) a et b valent 1 à 3; (e) Q est un groupe de désaccouplement d'alkylthio ou d'arylthio. L'élément présente une teinte magenta plus intense et une absorption réduite des bleus par le colorant magenta obtenu.",EASTMAN KODAK CO,MERKEL PAUL BARRETT;;SINGER STEPHEN PAUL;;CLARK BERNARD ARTHUR JAMES;;STANLEY PAUL LOUIS REGINALD,,https://lens.org/116-410-165-915-312,Patent Application,yes,0,0,6,14,0,G03C7/384;;G03C7/24;;G03C7/30517,G03C1/00;;G03C7/24;;G03C7/305;;G03C7/384,,1,0,,,See references of WO 9302392A1,EXPIRED
485,CA,C,CA 1328872 C,112-194-524-310-341,1994-04-26,1994,CA 592854 A,1989-03-06,US 8800744 W,1988-03-08,THIAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"THIAZOLIDINEDIONE HYPOGLYCEMIC AGENTS Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <IMG> ---(I) wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR1 or NR2, with the proviso that when n is 1 and Y is NR2, X is SO2 or CO; Z is CHR3, CN2CH2, CN=CH, <IMG> , OCH2, SCH2, SOCH2 or SO2CH2; R, R1, R2 and R3 are each independently hydrogen or methyl; and X1 and X2 are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HOLLAND GERALD F;;HULIN BERNARD;;RIZZI JAMES P,,https://lens.org/112-194-524-310-341,Granted Patent,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,C07D277/20;;A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,D426002799   M;;1670231    S;;1670234    S;;26002777   S;;26003027   S;;26003101   S,0,0,,,,EXPIRED
486,WO,A1,WO 1989/008650 A1,139-354-577-735-570,1989-09-21,1989,US 8800744 W,1988-03-08,US 8800744 W,1988-03-08,THIAZOLIDINEDIONE HYPOGLYCEMIC AGENTS,"Hypoglycemic thiazolidine-2,4-dione derivatives of formula (I), wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR?1 or NR2¿, with the proviso that when n is 1 and Y is NR2, X is SO¿2? or CO; Z is CHR?3, CH¿2CH2, CH=CH, (a), OCH2, SCH2, SOCH2 or SO2CH2; R, R?1, R2 and R3¿ are each independently hydrogen or methyl; and X?1 and X2¿ are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof, or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD F;;HULIN BERNARD;;RIZZI JAMES P,,https://lens.org/139-354-577-735-570,Patent Application,yes,0,11,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;C07D277/20;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,2,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"CHEMICAL ABSTRACTS, Volume 93, No. 17, issued 27 October 1980, (Columbus Ohio, USA), page 679, Abstract No. 168259K; & JP,A,55 064 586, (15 May 1980).;;CHEMICAL ABSTRACTS, Volume 98, No. 15, issued 11 April 1983, (Columbus, Ohio USA), page 627, SOHDA et al., Abstract No. 125945S; & CHEM. PHARM. BULL., 30(10), pp3580-3600 (1982).",PENDING
487,FI,A0,FI 904414 A0,043-364-830-912-381,1990-09-07,1990,FI 904414 A,1990-09-07,US 8800744 W,1988-03-08,TIAZOLIDINDION-HYPOGLYKEMISKT VERKANDE AEMNEN.,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HOLLAND GERALD F;;HULIN BERNARD;;RIZZI JAMES P,,https://lens.org/043-364-830-912-381,Patent Application,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;C07D277/20;;A61K31/426;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,DISCONTINUED
488,DE,D1,DE 68912952 D1,055-586-883-364-082,1994-03-24,1994,DE 68912952 T,1989-02-28,US 8800744 W,1988-03-08,Hypoglykämische Thiazolidindion-Derivate.,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/055-586-883-364-082,Granted Patent,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/20;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
489,EP,B1,EP 0628868 B1,111-224-490-297-836,2000-02-09,2000,EP 94201438 A,1994-05-21,US 6696093 A,1993-05-24,Photographic elements containing magenta couplers and process for using same,,EASTMAN KODAK CO,SINGER STEPHEN PAUL;;MERKEL PAUL BARRETT;;CLARK BERNARD ARTHUR J;;STANLEY PAUL LOUIS R,,https://lens.org/111-224-490-297-836,Granted Patent,yes,1,0,4,4,0,G03C7/30529;;G03C7/30529;;G03C7/3212;;G03C7/3212;;G03C7/384;;G03C7/384,G03C7/384;;G03C7/305,,0,0,,,,EXPIRED
490,US,A,US 5223522 A,006-961-371-431-389,1993-06-29,1993,US 85703992 A,1992-03-24,US 85703992 A;;US 8800744 W;;US 56643690 A;;US 67989891 A,1988-03-08,Thiazolidinedione hypoglycemic agents,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula ##STR1## wherein the dotted line represents a bond or no bond; A and B are each independently CH; X is S, SO, SO.sub.2, CH.sub.2, CHOH or CO; n is 0 or 1; Y is CHR.sup.1 or NR.sup.2, with the proviso that when n is 1 and Y is NR.sup.2, X is SO.sub.2 or CO; Z is CHR.sup.3, CH.sub.2 CH.sub.2, CH.dbd.CH, ##STR2## OCH.sub.2, SCH.sub.2, SOCH.sub.2 or SO.sub.2 CH.sub.2 ; R, R.sup.1, R.sup.2 and R.sup.3 are each independently hydrogen or methyl; and X.sup.1 and X.sup.2 are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HOLLAND GERALD F;;HULIN BERNARD;;RIZZI JAMES P,,https://lens.org/006-961-371-431-389,Granted Patent,yes,6,74,1,28,0,C07D417/06;;C07D417/06;;C07C311/21;;C07C311/21;;C07C323/22;;C07C323/22;;C07D213/50;;C07D213/50;;C07D277/34;;C07D277/34;;C07D417/10;;C07D417/10,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,514/369;;548/183;;546/280,2,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"Burger, Alfred, Medicinal Chemistry, vol. 3, 3rd Ed., pp. 64 80, Wiley Interscience (1970).;;Sohda et al., Chem. Pharm. Bull Japan, vol. 30, pp. 3580 3600 (1982) Chemical Abstracts 80:168259k (abstracting Japan Kokai 80 64586).",EXPIRED
491,JP,A,JP 2019167629 A,025-337-608-370-167,2019-10-03,2019,JP 2019106108 A,2019-06-06,US 201261710848 P;;US 201261731172 P,2012-10-08,CONDUCTIVE TRANSPARENT ALUMINUM-DOPED ZINC OXIDE SPUTTERING FILM,"To provide a method for depositing an improved AZO film.SOLUTION: An oxide target having such a composition that AlOis in the range of 0.5-2 wt% is provided, and a deposition method of an AZO film for depositing the AZO film by sputtering the oxide target is disclosed. Preferably, an AZO film is disclosed, which is deposited on a transparent substrate by pulse DC, at a higher temperature than 325°C, at which a columnar crystal grain structure having a columnar structure extending from an upper surface of the film to a bottom surface, and a film showing a small (less than 70 nm from the substrate to the upper surface of the film) lateral direction grain size are obtained. The film has a small specific resistance less than 10 Ω/sq. at a thickness thinner than 400nm, and preferably, the specific resistance is not changed by annealing at a temperature lower than 450°C.SELECTED DRAWING: Figure 1B",CORNING INC,ROBERT ALAN BELLMAN;;JEREMY CURTIS CLARK;;PAUL ARTHUR SACHENIK;;LYNN BERNARD SIMPSON;;TIAN LILI,,https://lens.org/025-337-608-370-167,Patent Application,no,3,0,11,11,0,C23C14/086;;C23C14/3485;;H01L31/1884;;Y10T428/24355;;H01B1/08;;C23C14/086;;C23C14/3485;;H01L31/1884;;Y02E10/50;;Y10T428/24355;;H01B1/08;;H01B5/14;;H01L31/022483,C23C14/08,,2,2,044-147-690-473-748;;083-259-709-836-82X,10.1016/j.apsusc.2011.04.093;;10.1016/j.vacuum.2012.02.025,"WANG, Y. ET AL.: ""Influence of substrate temperature on surface textured ZnO:Al films etched with NaOH solution"", APPL. SURF. SCI., vol. 257, no. 18, JPN6020031942, 27 April 2011 (2011-04-27), NL, pages 8044 - 8047, XP028373685, ISSN: 0004472576, DOI: 10.1016/j.apsusc.2011.04.093;;YANG, W. ET AL.: ""The effects of impurity and temperature for transparent conducting oxide properties of Al:ZnO deposi"", VACUUM, vol. 86, no. 10, JPN6020031944, 27 April 2012 (2012-04-27), GB, pages 1452 - 1457, XP028510336, ISSN: 0004472577, DOI: 10.1016/j.vacuum.2012.02.025",PENDING
492,EP,A2,EP 2516640 A2,106-992-113-931-978,2012-10-31,2012,EP 10803691 A,2010-12-22,US 28904009 P;;US 2010/0061761 W,2009-12-22,PULLULANASE VARIANTS AND USES THEREOF,,NOVOZYMES AS;;NOVOZYMES NORTH AMERICA INC,BORCHERT MARTIN;;GJERMANSEN MORTEN;;CLARK SUZANNE;;HENRISSAT BERNARD;;SILOW MARIA BERGGAARD;;HALLIN PETER FISCHER,,https://lens.org/106-992-113-931-978,Patent Application,yes,0,0,11,11,0,C12N9/2451;;C12N9/2457;;C12N9/246;;C12P7/06;;C12P19/14;;C12P19/16;;C12Y302/01041;;C12Y302/01068;;Y02E50/10;;C12Y302/01041;;C12P7/06;;C12N9/2451;;C12N9/2457;;C12Y302/01068;;C12P19/16;;C12P19/14;;C12N9/246;;Y02E50/10,C12N9/44,,0,0,,,,DISCONTINUED
493,US,B2,US 9984786 B2,192-513-783-163-873,2018-05-29,2018,US 201314434229 A,2013-10-04,US 201314434229 A;;US 201261731172 P;;US 201261710848 P;;US 2013/0063414 W,2012-10-08,Sputtered transparent conductive aluminum doped zinc oxide films,"Disclosed are AZO films deposited on a transparent substrate by pulse DC using an oxide target with a composition in the range 0.5-2 wt % Al 2 O 3 , desirably at temperature above 325° C., resulting in films showing columnar grain structure with columns extending from the top to the bottom of the film, and small lateral grain size (less than 70 nm from substrate to top of film). The film has low resistivity at less than 10 Ohm/square at a thickness less than 400 nm, resistivity is desirably unchanged by annealing at temperatures of up to 450° C.",CORNING INC,BELLMAN ROBERT ALAN;;CLARK JEREMY CURTIS;;SACHENIK PAUL ARTHUR;;SIMPSON LYNN BERNARD;;TIAN LILI,CORNING INCORPORATED (2015-10-19),https://lens.org/192-513-783-163-873,Granted Patent,yes,4,0,11,11,0,C23C14/086;;C23C14/3485;;H01L31/1884;;Y10T428/24355;;H01B1/08;;C23C14/086;;C23C14/3485;;H01L31/1884;;Y02E10/50;;Y10T428/24355;;H01B1/08;;H01B5/14;;H01L31/022483,H01B1/08;;C23C14/08;;C23C14/34;;H01B5/14;;H01L31/0224;;H01L31/18,,26,18,035-132-123-679-581;;020-564-666-328-002;;017-716-980-031-25X;;039-358-708-232-213;;081-826-068-992-616;;144-143-252-571-564;;041-565-371-547-685;;132-671-124-213-272;;021-914-910-538-161;;037-476-128-956-623;;027-274-879-132-918;;072-057-315-645-436;;064-305-306-524-771;;027-108-789-620-674;;064-364-386-299-69X;;042-075-499-797-362;;091-606-423-500-451;;031-571-223-042-691,10.1016/j.cap.2012.05.015;;10.1063/1.366798;;10.1016/j.msec.2007.10.006;;10.1063/1.1641524;;10.1063/1.2715554;;10.1016/j.jallcom.2011.11.113;;10.1016/0040-6090(90)90224-2;;10.1063/1.1473683;;10.1016/j.tsf.2007.10.029;;10.1016/s0040-6090(00)01891-5;;10.1088/0022-3727/34/21/301;;10.1016/s0169-4332(03)00523-3;;10.1016/s0042-207x(99)00189-x;;10.1016/s0040-6090(03)00949-0;;10.1116/1.1339019;;10.1063/1.1667259;;10.1143/jjap.24.944;;10.1016/j.jcrysgro.2005.01.061,"Yang et al.; “Resistivity improvement of Al-doped Zn0 film by bipolar pulsed dc magnetron sputtering with high Ar flow rate”; Current Applied Physics, vol. 12, May 18, 2012; pp. S99-S103.;;Cebulla et al.; “Al-doped zinc oxide films deposited by simultaneous rf and dc excitation of a magnetron plasma: Relationships between plasma parameters and structural and electrical film properties”; Journal of Applied Physics, American Institute of Physics. New York, US, vol. 83, No. 2, Jan. 15, 1998; pp. 1087-1095.;;Ayadi et al.; “The properties of aluminum-doped zinc oxide thin films prepared by rf-magnetron sputtering from nanopowder targets”, Materials Science and Engineering C, Elsevier Science S.A., CH, vol. 28, No. 5-6, Oct. 12, 2007; pp. 613-617.;;Agashe et al.; “Efforts to improve carrier mobility in radio frequency sputtered aluminum doped zinc oxide films”, Journal of Applied Physics, American Institute of Physics. New York, US, vol. 95, No. 4, Feb. 15, 2004; pp. 1911-1917.;;Berginski et al.; “The effect of front Zn0:Al surface texture and optical transparency on efficient light trapping in silicon thin-film solar cells”; Journal of Applied Physics, American Institute of Physics. New York, US, vol. 101, No. 7, Apr. 9, 2007; pp. 74903-074903.;;Mosbah et al.; “Influence of deposition temperature on structural, optical and electrical properties of sputtered Al doped Zn0 thin films”; Journal of Alloys and Compounds, Elsevier Sequoia, Lausanne, CH, vol. 515, Nov. 24, 2011; pp. 149-153.;;Minami et al; “Preparations of Zn0:Al transparent conducting films by d.c. magnetron sputtering”; This Solid Films, Elsevier-Sequoia S.A. Lausanne, CH, vol. 193-194, Dec. 15, 1990; pp. 721-729.;;Jiang et al.; “Manufacture of specific structure of aluminum-doped zinc oxide films by patterning the substrate surface”; Applied Physics Letters; AIP, American Institute of Physics, Melville, NY, US, vol. 80, No. 17, Apr. 29, 2002; pp. 3090-3092.;;Berginski et al.; “Recent development on surface-textured Zn0:Al films prepared by sputtering for thin-film solar cell application”; Thin Solid Films, Elsevier-Sequoia S.A., Lausanne, CH, vol. 516, No. 17, Oct. 16, 2007; pp. 5836-5841.;;European Patent Office; International Search Report; dated Nov. 22, 2013; pp. 1-5.;;The International Bureau of WIPO; International Preliminary Report on Patentability; dated Apr. 16, 2015; pp. 1-9.;;An et al; “Deposition of ZNO:AL Films by Pulsed DC Magnetron Sputtering”; Vacuum; vol. 48, No. 5; Sep. 2011; p. 82-85.;;Berginski et al; “Design of ZNO: AL Films With Optimized Surface Texture for Silicon Thin-Film Solar Cells”; Proc. of SPIE; vol. 6197; 2006; pp. 61970Y-1-61970Y-10.;;Chang et al; “The Effect of Deposition Temperature on the Properties of AL-Doped Zinc Oxide Thin Films”; Thin Solid Films 386 (2001) 79-86.;;Ellmer; “Resistivity of Polycrystalline Zinc Oxide Films; Current Status and Physical Limit”; J. Phys. D. Appl. Phys. 34 (2001) 3097-3108.;;English Translation of CN201380063481.4 Notice of First Office Action Dated August 9, 2016; 11 Pages; Chinese Patent Office.;;Fu et al; “Substrate Temperature Dependence of the Properties of ZAO Thin Films Deposited by Magnetron Sputtering”; Applied Surface Science; 217 (2003) 88-94.;;Kelly et al; “Magnetron Sputtering: A Review of Recent Developments and Applications”; Vacuum 56 (2000) 159-172.;;Kelly et al; “Pulsed Magnetron Sputtering—Process Overview and Applications”; Journal of Optoelectronics and Advanced Materials; Vol. 11; No. 9 Sep. 2009; pp. 1101-1107.;;Kluth et al; “Modified Thornton Model for Magnetron Sputtered Zinc Oxide: Film Structure and Etching Behaviour”; Thin Solid Films; 442 (2003) 80-85.;;Malkomes et al; “Properties of Aluminum-Doped Zinc Oxide Films Deposited by High Rate Mid-Frequency Reactive Magnetron Sputtering”; J. Vac. Sci. Technol. A; 19 (2), Mar./Apr. 2001; pp. 414-419.;;Singh et al; “Doping Mechanism in Aluminum Doped Zinc Oxide Films”; Journal of Applied Physics; vol. 95, No. 7 Apr. 2004; pp. 3640-3643.;;Tominaga et al; “Influence of Energetic Oxygen Bombardment on Conductive ZNO Films”; Japanese Journal of Applied Physics; vol. 24, No. 8 Aug. 1985; pp. 944-949.;;English Translation of JP2015535817 Office Action Dated Aug. 24, 2017, Japan Patent Office.;;Ko et al; “Growth of Al-Doped ZnO Thin Films by Pulsed DC Magnetron Sputtering”; Journal of Crystal Growth, vol. 277, No. 1-4; (2005) pp. 352-358.;;European Search Report, EP13776932.9 Dated Feb. 15, 2018; 11 pages; European Patent Office.",ACTIVE
494,NO,L,NO 903862 L,036-168-697-481-305,1990-09-05,1990,NO 903862 A,1990-09-05,US 8800744 W,1988-03-08,FREMGANGSMAATE FOR FREMSTILLING AV EN TIAZOLIDINDIONHYPOGLYKEMISK AKTIV FORBINDELSE.,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD F;;HULIN BERNARD;;RIZZI JAMES P,,https://lens.org/036-168-697-481-305,Abstract,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;C07D277/20;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,DISCONTINUED
495,US,B2,US 8703465 B2,082-355-558-859-728,2014-04-22,2014,US 201013515635 A,2010-12-22,US 201013515635 A;;US 28904009 P;;US 2010/0061761 W,2009-12-22,Pullulanase variants and uses thereof,A truncated pullulanase variant of a parent pullulanase belonging to family GH57 comprising an X47 domain and the use thereof.,BORCHERT MARTIN;;GJERMANSEN MORTEN;;CLARK SUZANNE;;HENRISSAT BERNARD;;SILOW MARIA B;;HALLIN PETER F;;NOVOZYMES AS,BORCHERT MARTIN;;GJERMANSEN MORTEN;;CLARK SUZANNE;;HENRISSAT BERNARD;;SILOW MARIA B;;HALLIN PETER F,NOVOZYMES A/S (2012-08-16);;NOVOZYMES NORTH AMERICA INC (2012-08-29),https://lens.org/082-355-558-859-728,Granted Patent,yes,3,2,11,11,38,C12N9/2451;;C12N9/2457;;C12N9/246;;C12P7/06;;C12P19/14;;C12P19/16;;C12Y302/01041;;C12Y302/01068;;Y02E50/10;;C12Y302/01041;;C12P7/06;;C12N9/2451;;C12N9/2457;;C12Y302/01068;;C12P19/16;;C12P19/14;;C12N9/246;;Y02E50/10,C12N9/26;;C07K1/00,435/201;;530/350,9,5,030-720-249-164-582;;035-152-698-030-204;;037-448-172-492-792;;024-109-129-245-317;;182-034-566-852-049,10322035;;10.1128/jb.181.10.3284-3287.1999;;pmc93789;;10.1007/s00284-010-9690-6;;20593184;;10.1007/s00792-008-0168-4;;18500431;;10.1016/j.jmb.2008.02.041;;18387632;;10.1023/a:1010597619811,"Erra-Pujada et al., Journal of Bacteriology, vol. 181, No. 10, pp. 3284-3287 (1999).;;Erra-Pujada et al., Uniprot Accession No. Q9Y818 (1999).;;Imamura et al., Uniprot Accession No. Q8NKS8 (2002).;;Janecek, Biologia, Bratislava, vol. 60, Supp. 16, pp. 177-184 (2005).;;Jiao et al., Current Microbiology, vol. 62, No. 1, pp. 222-228 (2010).;;Lin et al., Extremophiles, vol. 12, No. 5, pp. 641-650 (2008).;;Tan et al., Journal of Molecular Biology, vol. 378, No. 4, pp. 852-870 (2008).;;Chang-Pi-Hin et al, 2002, Biologia, 57(11), 155-162.;;Pujada et al, 2001, Biotechnol Lett 23, 1273-1277.",INACTIVE
496,PT,B,PT 89913 B,093-679-223-046-696,1994-05-31,1994,PT 8991389 A,1989-03-06,US 8800744 W,1988-03-08,PROCESSO PARA A PREPARACAO DE AGENTES HIPOGLICEMICOS DE TIAZOLIDINODIONA,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;HULIN BERNARD;;GOLDSTEIN STEVEN WAYNE;;RIZZI JAMES PATRICK;;HOLLAND GERALD FAGAN,,https://lens.org/093-679-223-046-696,Granted Patent,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;A61K31/44;;A61P3/06;;C07D277/20;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,EXPIRED
497,GB,A,GB 646295 A,191-621-673-695-002,1950-11-22,1950,GB 2781247 A,1947-10-17,GB 2781247 A,1947-10-17,Improvements in or relating to the recording of sound on film,"646,295. Optical sound-recording apparatus. ELECTRIC & MUSICAL INDUSTRIES, Ltd. Oct. 17, 1947, No. 27812. [Class 40 (ii)] [Also in Groups XX and XL (b)] In a device for producing a variable width sound film record, a film is scanned by the trace of a C.R.T., the scan width varying with the sound amplitude. As shown, the sound is amplified at 11 and a push-pull voltage produced at 12 proportional to the sound amplitude. The control grids of valves 13, 14 are energized simultaneously from 12 and the sawtooth generator 7, and the interval between the negative impulses generated at resistors 25, 26 depends upon the voltage amplitude at' 12. Normally, the valve 27 conducts and 28, 46 are shut down, and on receipt of the negative pulse from 25, which occurs before that from 26, the valves 27 and 28 cease and commence to conduct respectively. A negative pulse is therefore applied from 33 to the modulating element of the C.R.T. 1. The subsequent negative pulse at 26 arrests the conduction of 28 and causes valve 46 to conduct. The pulses generated at 32, 33 are complementary and either may be applied to 9 to enable either positive or negative film to be used. If the area of the exposed film is to vary in accordance with the beam amplitude of the sound, the push-pull rectifier 57 in conjunction with a circuit having a time constant which is long compared with the lowest frequency of the sound signals, is employed.",EMI LTD,WHITE ERIC LAWRENCE CASLING;;CLARK HENRY ARTHUR MAISH;;GREENHEAD BERNARD RANDOLPH;;VANDERLYN PHILIP BARNET,,https://lens.org/191-621-673-695-002,Granted Patent,no,0,0,1,1,0,G11B7/00,G02F1/01;;G11B7/00,G5R RB12          12;;G5R RB272         RLF;;G5R RB272         12;;G5R RB333         12;;G5R RB334         12;;G5R RB336         RLF;;G5R RB336         12;;G5R RB37Y         RLF;;G5R RB37Y         12;;G5R RB57X         RLF;;G5R RB57X         12;;G5R RB60X         RLF;;G5R RB60X         12;;G5R RB63Y         12;;G5R RB731         RLF;;G5R RB731         12;;G5R RB788         RLF;;G5R RB788         12;;G5R RLF           RLF,0,0,,,,EXPIRED
498,US,A,US 5120754 A,035-776-822-489-131,1992-06-09,1992,US 67989891 A,1991-04-03,US 67989891 A;;US 8800744 W;;US 56643690 A,1988-03-08,Thiazolidinedione hypoglycemic agents,"Hypoglycemic thiazolidine-2,4-dione derivatives of the formula ##STR1## wherein the dotted line represents a bond or no bond; A and dB are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO.sub.2, CH.sub.2, CHOH or CO; n is 0 or 1; Y is CHR.sup.1 or NR.sup.2, with the proviso that when n is 1 and Y is NR.sup.2, X is SO.sub.2 or CO; Z is CHR.sup.3, CH.sub.2 CH.sub.2, CH.dbd.CH, ##STR2## OCH.sub.2, SCH.sub.2, SOCH.sub.2 or SO.sub.2 CH.sub.2 ; R, R.sup.1, R.sup.2 and R.sup.3 are each independently hydrogen or methyl; and X.sup.1 and X.sup.2 are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID A;;GOLDSTEIN STEVEN W;;HOLLAND GERALD F;;HULIN BERNARD;;RIZZI JAMES P,,https://lens.org/035-776-822-489-131,Granted Patent,yes,5,53,1,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;C07D417/06;;C07D213/50;;C07C323/22;;C07D417/10;;C07D277/34;;C07C311/21,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,514/369;;548/183,2,1,039-157-593-006-02X,7160012;;10.1248/cpb.30.3580,"Sohda et al. Chem Pharm. Bull Japan, vol. 30, pp. 3580 3600 (1982).;;Chemical Abstracts 80:168259k (abstracting Japan Kokai 80 64586).",EXPIRED
499,DK,D0,DK 108289 D0,132-623-930-431-112,1989-03-07,1989,DK 108289 A,1989-03-07,US 8800744 W,1988-03-08,"THIAZOLIDIN-2,4-DION-DERIVATER OG FARMACEUTISKE PRAEPARATER INDEHOLDENDE DISSE","Hypoglycemic thiazolidine-2,4-dione derivatives of the formula <CHEM> wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH; X is S, SO, SO2, CH2, CHOH or CO; n is 0 or 1; Y is CHR<1> or NR<2>, with the proviso that when n is 1 and Y is NR<2>, X is SO2 or CO; Z is CHR<3> , CH2CH2, CH=CH, <CHEM> OCH2, SCH2, SOCH2 or SO2CH2; R, R<1>, R<2> and R<3> are each independently hydrogen or methyl; and X<1> and X<2> are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.",PFIZER,CLARK DAVID ALAN;;GOLDSTEIN STEVEN WAYNE;;HOLLAND GERALD FAGAN;;HULIN BERNARD;;RIZZI JAMES PATRICK,,https://lens.org/132-623-930-431-112,Patent Application,no,0,0,26,28,0,C07C311/21;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10;;A61P3/06;;A61P3/08;;C07D277/34;;C07D417/06;;C07D277/34;;C07D213/50;;C07C311/21;;C07D417/10;;C07C323/22,A61K31/425;;A61K31/426;;C07D277/20;;A61K31/44;;A61P3/06;;A61P3/08;;C07C49/86;;C07C309/30;;C07C311/21;;C07C323/01;;C07C323/22;;C07D213/50;;C07D277/34;;C07D417/06;;C07D417/10,,0,0,,,,DISCONTINUED
500,US,A1,US 2004/0032280 A1,012-610-060-787-516,2004-02-19,2004,US 22328802 A,2002-08-19,US 22328802 A,2002-08-19,Integrated visual imaging and electronic sensing inspection systems,"
   Integrated inspection and test systems for liquid crystal display (LCD) active plates. The integrated inspection and test systems may combine visual imaging inspection and an electronic sensing such as voltage imaging, electron beam sensing or charge sensing, in which the potential defect information obtained by the visual inspection system is combined with the potential defect information obtained by the electronic sensing system to produce a defect report. One or more high-resolution visual cameras are scanned over a stationary plate, and the image data from the camera(s) is processed to detect potential defects. A high-resolution electronic sensing system examines the stationary plate, and the image data from the sensor(s) is processed to detect potential defects. The potential defects from the visual image data and electronic sensing image data are processed to produce the final defect information. 
",CLARK BERNARD T.;;FREEMAN DAVID L.;;HAWTHORNE JEFFREY A.;;NAGY ALEXANDER J.;;PRATT WILLIAM K.,CLARK BERNARD T;;FREEMAN DAVID L;;HAWTHORNE JEFFREY A;;NAGY ALEXANDER J;;PRATT WILLIAM K,PHOTON DYNAMICS INC (2002-07-24),https://lens.org/012-610-060-787-516,Patent Application,yes,23,13,9,9,0,G02F1/13;;G09G3/006;;G09G3/006;;G01N21/95;;G01N21/95;;G01N2021/9513;;G01N2021/9513;;G02F1/136254;;G02F1/136254,G01B11/30;;G01M11/00;;G01N21/95;;G01N21/956;;G01N23/225;;G01R31/00;;G02F1/13;;G02F1/1362;;G09G3/00,32477,0,0,,,,EXPIRED
501,US,A,US 6140029 A,085-731-188-526-357,2000-10-31,2000,US 41025499 A,1999-09-30,US 41025499 A;;US 18684498 A;;US 1485598 A,1998-01-29,Color photographic element containing elemental silver and nitrogen heterocycle in a non-light sensitive layer,"The invention provides a silver halide photographic element comprising a non-light sensitive layer containing elemental silver and a nitrogen heterocycle compound having a ClogP of at least 4.5, which compound comprises a ring system of one or more fused rings containing at least one --N--H bond, the ring system comprising a total of at least three nitrogen ring members and the associated bonds; provided that the compound does not contain an --SH group or &gt;C.dbd.S group and does not react with an oxidized developer.",EASTMAN KODAK CO,CLARK BERNARD A;;BOFF JANE S;;ALLWAY PHILIP A;;FRIEDRICH LOUIS E;;SINGER STEPHEN P,EASTMAN KODAK COMPANY (1999-11-09),https://lens.org/085-731-188-526-357,Granted Patent,yes,21,5,4,6,0,G03C1/825;;G03C1/8255;;G03C7/3029;;G03C7/39244;;G03C7/39256;;G03C7/39256;;G03C7/3029;;G03C7/39244;;G03C1/825;;G03C1/8255,G03C1/825;;G03C7/30;;G03C1/34;;G03C7/392,430/506;;430/507;;430/510;;430/614;;430/615,0,0,,,,EXPIRED
502,WO,A1,WO 2023/081403 A1,128-893-171-892-828,2023-05-11,2023,US 2022/0049027 W,2022-11-04,US 202163276539 P;;US 202163280071 P;;US 202163280073 P;;US 202163280075 P;;US 202163283027 P;;US 202263311874 P;;US 202263320654 P;;US 202263326774 P;;US 202263326776 P;;US 202263326782 P;;US 202263326792 P;;US 202263367445 P;;US 202263388840 P;;US 202263377328 P,2021-11-05,"ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF","Described herein are isotopically enriched analogs of methylone (e.g., deuterated analogs of methylone (e.g., ( S )-methylone and ( R )-methylone) with improved characteristics. Also described herein are salts (such as hydrochloride salt) and solid forms (e.g., crystalline forms) of methylone. Also described herein are stereoisomers (e.g., enantiomers) of methylone. The present disclosure also provides methods of making and methods of use of the methylone or methylone analogs and solid forms of 3,4-methylenedioxy- N -ethylcathinone hydrochloride described herein to treat brain and neurological disorders such as depression.",TERRAN BIOSCIENCES INC,DUNCTON MATTHEW;;CLARK SAMUEL;;HENDERSON ALISTAIR;;GOLDING BERNARD;;MONERRIS MASCARO MANUEL;;JOHNSON LUCIA;;MADRID ANNETTE,,https://lens.org/128-893-171-892-828,Patent Application,yes,1,1,3,3,0,A61P25/22;;C07D317/54;;A61K45/06;;A61P25/22;;C07B2200/13;;C07D317/58,C07D317/46;;A61K31/36;;A61P25/22;;A61P25/24;;A61P25/28;;A61P25/32;;C07D317/58,,7,5,012-023-494-051-50X;;060-893-413-112-615;;009-881-598-973-587;;011-509-289-674-269;;043-188-667-194-120,10.1002/dta.1859;;26344849;;pmc5049635;;25237120;;10.1177/0269881114548439;;23839026;;10.1097/fbp.0b013e328364166d;;pmc4183201;;31743730;;10.1016/j.bbr.2019.112368;;10.1038/nrd.2016.63;;27032821,"DATABASE REGISTRY ANONYMOUS : ""1-Propanone, 1-(1,3-benzodioxol-5-yl)-2-(methyl-d3-amino)- (CA INDEX NAME)"", XP093065746, retrieved from STN;;DATABASE REGISTRY ANONYMOUS : ""1-Propanone, 1-(1,3-benzodioxol-5-yl)-2-(methyl-d3-amino)-, hydrochloride (1:1) (CA INDEX NAME) "", XP093065749, retrieved from STN;;MAHEUX CHAD R., ALARCON IDRALYN Q., COPELAND CATHERINE R., CAMERON T. STANLEY, LINDEN ANTHONY, GROSSERT J. STUART: ""Identification of polymorphism in ethylone hydrochloride: synthesis and characterization"", DRUG TESTING AND ANALYSIS, JOHN WILEY & SONS LTD., GB, vol. 8, no. 8, 1 August 2016 (2016-08-01), GB , pages 847 - 857, XP093065739, ISSN: 1942-7603, DOI: 10.1002/dta.1859;;LÓPEZ-ARNAU RAÚL, MARTÍNEZ-CLEMENTE JOSÉ, PUBILL DAVID, ESCUBEDO ELENA, CAMARASA JORGE: ""Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone"", JOURNAL OF PSYCHOPHARMACOLOGY., OXFORD UNIVERSITY PRESS., GB, vol. 28, no. 11, 1 November 2014 (2014-11-01), GB , pages 1053 - 1063, XP093065741, ISSN: 0269-8811, DOI: 10.1177/0269881114548439;;GATCH MICHAEL B., TAYLOR CYNTHIA M., FORSTER MICHAEL J.: ""Locomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinones"", BEHAVIOURAL PHARMACOLOGY., RAPID SCIENCE, PUBLISHERS., GB, vol. 24, no. 5 and 6, 1 September 2013 (2013-09-01), GB , pages 437 - 447, XP093065742, ISSN: 0955-8810, DOI: 10.1097/FBP.0b013e328364166d;;GORE, S. ET AL.: ""Synthetic cathinones and their phenethylamine analogues produce distinct psychomotor and reward behavior in crayfish"", BEHAV. BRAIN RES., vol. 379, 2020, pages 112368, XP085946668, DOI: 10.1016/j.bbr.2019.112368;;MULLARD ASHER: ""Deuterated drugs draw heavier backing"", NATURE REVIEWS DRUG DISCOVERY, NATURE PUBLISHING GROUP, GB, vol. 15, no. 4, 1 April 2016 (2016-04-01), GB , pages 219 - 221, XP093065743, ISSN: 1474-1776, DOI: 10.1038/nrd.2016.63",PENDING
503,US,B2,US 7330583 B2,165-457-361-701-579,2008-02-12,2008,US 22328802 A,2002-08-19,US 22328802 A,2002-08-19,Integrated visual imaging and electronic sensing inspection systems,"Integrated inspection and test systems for liquid crystal display (LCD) active plates. The integrated inspection and test systems may combine visual imaging inspection and an electronic sensing such as voltage imaging, electron beam sensing or charge sensing, in which the potential defect information obtained by the visual inspection system is combined with the potential defect information obtained by the electronic sensing system to produce a defect report. One or more high-resolution visual cameras are scanned over a stationary plate, and the image data from the camera(s) is processed to detect potential defects. A high-resolution electronic sensing system examines the stationary plate, and the image data from the sensor(s) is processed to detect potential defects. The potential defects from the visual image data and electronic sensing image data are processed to produce the final defect information.",PHOTON DYNAMICS INC,CLARK BERNARD T;;FREEMAN DAVID L;;HAWTHORNE JEFFREY A;;NAGY ALEXANDER J;;PRATT WILLIAM K,PHOTON DYNAMICS INC (2002-07-24),https://lens.org/165-457-361-701-579,Granted Patent,yes,28,5,9,9,0,G02F1/13;;G09G3/006;;G09G3/006;;G01N21/95;;G01N21/95;;G01N2021/9513;;G01N2021/9513;;G02F1/136254;;G02F1/136254,G01B11/30;;G06K9/00;;G01M11/00;;G01N21/95;;G01N21/956;;G01N23/225;;G01R31/00;;G02F1/13;;G02F1/1362;;G09G3/00,382/149;;250/443.1;;250/559.08;;250/559.46;;324/770;;382/152,0,0,,,,INACTIVE
504,TW,A,TW 200421207 A,093-982-802-231-281,2004-10-16,2004,TW 92122624 A,2003-08-18,US 22328802 A,2002-08-19,Integrated visual imaging and electronic sensing inspection systems,"Integrated inspection and test systems for liquid crystal display (LCD) active plates. The integrated inspection and test systems may combine visual imaging inspection and an electronic sensing such as voltage imaging, electron beam sensing or charge sensing, in which the potential defect information obtained by the visual inspection system is combined with the potential defect information obtained by the electronic sensing system to produce a defect report. One or more high-resolution visual cameras are scanned over a stationary plate, and the image data from the camera (s) is processed to detect potential defects. A high-resolution electronic sensing system examines the stationary plate, and the image data from the sensor (s) is processed to detect potential defects. The potential defects from the visual image data and electronic sensing image data are processed to produce the final defect information.",PHOTON DYNAMICS INC,CLARK BERNARD T;;FREEMAN DAVID L;;HAWTHORNE JEFFREY A;;NAGY ALEXANDER J;;PRATT WILLIAM K,,https://lens.org/093-982-802-231-281,Patent of Addition,no,0,1,9,9,0,G02F1/13;;G09G3/006;;G09G3/006;;G01N21/95;;G01N21/95;;G01N2021/9513;;G01N2021/9513;;G02F1/136254;;G02F1/136254,G01B11/30;;G06T7/00;;G01M11/00;;G01N21/95;;G01N21/956;;G01N23/225;;G01R31/00;;G02F1/13;;G02F1/1362;;G09G3/00,,0,0,,,,EXPIRED
505,EP,B1,EP 1121980 B1,128-847-767-195-073,2007-04-11,2007,EP 00300705 A,2000-01-31,EP 00300705 A,2000-01-31,Process of oxidation with a catalyst comprising a composition of antimony trifluoride and silica,"This invention relates to a composition comprising antimony trifluoride and silica, a method for the preparation of said composition and the use of said composition as catalyst. Examples of the silica are hexagonal mesoporous silica (HMS) or silica gel. The catalyst may be used in the oxidation of cyclohexanone to epsilon-caprolactone with hydrogen peroxide.",SOLVAY,ROCCA MICHAEL CHARLES;;CARR GRAHAM;;LAMBERT ARNOLD BERNARD MARIE;;MACQUARRIE DUNCAN JAMES;;CLARK JAMES HANLEY,"INGEVITY UK LTD, WARRINGTON, GB (2019-06-04)",https://lens.org/128-847-767-195-073,Granted Patent,yes,4,0,9,9,0,B01J21/08;;B01J23/6445;;B01J27/12;;B01J29/035;;C07D315/00;;Y02P20/50;;C07D315/00;;B01J29/035;;B01J21/08;;B01J23/6445;;B01J27/12;;Y02P20/50,B01J27/12;;C07D313/04;;B01J21/08;;B01J23/644;;B01J29/035;;C07B61/00;;C07D315/00,,0,0,,,,EXPIRED
506,TW,B,TW I286296 B,027-071-809-259-77X,2007-09-01,2007,TW 92122624 A,2003-08-18,US 22328802 A,2002-08-19,Integrated visual imaging and electronic sensing inspection systems,"Integrated inspection and test systems for liquid crystal display (LCD) active plates. The integrated inspection and test systems may combine visual imaging inspection and an electronic sensing such as voltage imaging, electron beam sensing or charge sensing, in which the potential defect information obtained by the visual inspection system is combined with the potential defect information obtained by the electronic sensing system to produce a defect report. One or more high-resolution visual cameras are scanned over a stationary plate, and the image data from the camera(s) is processed to detect potential defects. A high-resolution electronic sensing system examines the stationary plate, and the image data from the sensor(s) is processed to detect potential defects. The potential defects from the visual image data and electronic sensing image data are processed to produce the final defect information.",PHOTON DYNAMICS INC,CLARK BERNARD T;;FREEMAN DAVID L;;HAWTHORNE JEFFREY A;;NAGY ALEXANDER J;;PRATT WILLIAM K,,https://lens.org/027-071-809-259-77X,Granted Patent,no,0,0,9,9,0,G02F1/13;;G09G3/006;;G09G3/006;;G01N21/95;;G01N21/95;;G01N2021/9513;;G01N2021/9513;;G02F1/136254;;G02F1/136254,G01B11/30;;G01M11/00;;G01N21/95;;G01N21/956;;G01N23/225;;G01R31/00;;G02F1/13;;G02F1/1362;;G09G3/00,,0,0,,,,EXPIRED
507,WO,A2,WO 2005/036263 A2,033-249-897-658-473,2005-04-21,2005,GB 2004004207 W,2004-10-01,GB 0323282 A,2003-10-04,PHOTOGRAPHIC ELEMENT WITH SPEED-ENHANCING COMPOUND,"The invention provides a colour photographic element comprising at least one light-sensitive silver halide emulsion layer or a non silver-containing light-insensitive layer, in which at least one of these layers contains a colourless heterocyclic compound having either one or two hetero atoms in the ring or ring system, being other than an imidazole compound, that undergoes less than 10% chemical or redox reaction directly with oxidized developer and which has a partition coefficient to enable the photographic speed of the element to be increased by at least 0.03 stop without increasing granularity, compared to the same element without the compound. The heterocyclic compounds increase speed without a concomitant increase in size of the light-sensitive silver halide grains.",EASTMAN KODAK CO;;CLARK BERNARD ARTHUR JAMES;;ALLWAY PHILLIP;;ZUBERI TANIA;;SINGER STEPHEN PAUL;;HECKLER CHARLES;;FRIEDRICH LOUIS,CLARK BERNARD ARTHUR JAMES;;ALLWAY PHILLIP;;ZUBERI TANIA;;SINGER STEPHEN PAUL;;HECKLER CHARLES;;FRIEDRICH LOUIS,,https://lens.org/033-249-897-658-473,Patent Application,yes,0,0,5,5,0,G03C7/3924;;G03C7/3924;;G03C7/3029;;G03C7/3029;;G03C7/3212;;G03C7/3212;;G03C7/39252;;G03C7/39252;;G03C7/39276;;G03C7/39276;;G03C2007/3034;;G03C2007/3034;;G03C2200/29;;G03C2200/29,G03C7/30;;G03C7/392,,0,0,,,,PENDING
508,US,A,US 5667946 A,020-479-244-682-38X,1997-09-16,1997,US 64002696 A,1996-04-30,US 64002696 A,1996-04-30,Photographic material containing magenta dye forming coupler,"The invention provides a light sensitive photographic silver halide emulsion layer having associated therewith a magenta coupler having formula I: ##STR1## wherein: R represents a ballasted monosubstituted amino group which enables the coupler to form, upon development with 4-amino-3-methyl-N-ethyl-N-(2-hydroxyethyl)aniline sulfate developing agent, a magenta dye having a wavelength of maximum absorbance of 545 nm or greater; and X represents hydrogen or a coupling-off group. The resulting dye has an improved spectral absorption curve.",EASTMAN KODAK CO,BOFF JANE SARAH;;CLARK BERNARD ARTHUR;;STANLEY PAUL LOUIS;;WATTS CHRISTINA MARY;;SINGER STEPHEN PAUL,EASTMAN KODAK COMPANY (1996-05-17),https://lens.org/020-479-244-682-38X,Granted Patent,yes,12,2,5,5,0,G03C7/384;;G03C7/384;;G03C7/3225;;G03C7/3225;;G03C7/38;;G03C7/38,G03C7/32;;G03C7/384,430/386;;430/387;;430/554;;430/555;;430/549,0,0,,,,EXPIRED
509,US,A,US 5981158 A,101-166-584-811-853,1999-11-09,1999,US 89664097 A,1997-07-18,US 89664097 A,1997-07-18,Photographic element containing a DIR coupler,"A photographic element comprises a support bearing at least one silver halide emulsion and at least one acylacetanilide or malonanilide yellow dye-forming DIR coupler of structure I or structure II, below ##STR1## wherein the substituents are as defined in the specification.",EASTMAN KODAK CO,MERKEL PAUL B;;POSLUSNY JERROLD N;;REYNOLDS JAMES H;;CLARK BERNARD A;;GOURLEY ROBERT N,EASTMAN KODAK COMPANY (1998-01-26),https://lens.org/101-166-584-811-853,Granted Patent,yes,6,1,3,3,0,G03C7/30535;;G03C7/30558;;G03C7/30594;;Y10S430/158;;G03C7/30535;;G03C7/30558;;G03C7/30594;;Y10S430/158,G03C7/305;;G03C7/36,430/544;;430/556;;430/557;;430/505;;430/957,1,0,,,"R.P. Szajewski Progress in Basic Principles of Imaging Systems , F. Granzer and E. Moisar, eds., Vieweg and Sohn, Braunschweig, 1987, p. 425.",EXPIRED
510,DE,T2,DE 69911836 T2,120-366-482-079-660,2004-08-19,2004,DE 69911836 T,1999-01-18,US 1485598 A;;US 18684498 A,1998-01-29,Farbfotografisches Element mit elementarem Silber und heterozyklischen Stickstoffverbindungen in einer nicht lichtempfindlichen Schicht,,EASTMAN KODAK CO,CLARK BERNARD A;;BOFF JANE SARAH;;ALLWAY PHILLIP ARTHUR;;FRIEDRICH LOUIS ELBERT;;SINGER STEPHEN PAUL,,https://lens.org/120-366-482-079-660,Granted Patent,no,0,0,4,6,0,G03C1/825;;G03C1/8255;;G03C7/3029;;G03C7/39244;;G03C7/39256;;G03C7/39256;;G03C7/3029;;G03C7/39244;;G03C1/825;;G03C1/8255,G03C1/34;;G03C1/825;;G03C7/30;;G03C7/392,,0,0,,,,EXPIRED
511,US,A1,US 2015/0210611 A1,144-267-574-765-702,2015-07-30,2015,US 201414586521 A,2014-12-30,US 201414586521 A;;US 201113247285 A;;US 40914510 P,2010-11-02,Depolymerization of Plastic Materials,A styrene monomer reclamation process and system is described. The styrene monomer reclamation process includes providing a waste plastic. The waste plastic includes styrenic polymers. The waste plastic is formed into polymer particles. At least a portion of the polymer particles are dissolved in a solvent to form a polymer stream. The dissolved polymer particles are depolymerized to form a styrene monomer stream.,FINA TECHNOLOGY,TIPPET JON;;BUTLER JAMES;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHEL;;CARY JEAN-BERNARD,,https://lens.org/144-267-574-765-702,Patent Application,yes,5,15,7,7,0,B01J8/062;;B01J8/062;;C07C4/22;;C07C4/22;;C07C2523/04;;C07C2523/04;;C08J11/18;;C08J11/18;;C08J2325/06;;C08J2325/06;;Y02W30/62;;Y02W30/62,C07C4/22,,0,0,,,,ACTIVE
512,JP,A,JP 2004094245 A,079-353-757-113-147,2004-03-25,2004,JP 2003295016 A,2003-08-19,US 22328802 A,2002-08-19,COMPREHENSIVE CHECK SYSTEM BY VISUAL IMAGE FORMING AND ELECTRONIC SENSING,"<P>PROBLEM TO BE SOLVED: To provide a comprehensive check system for an active plate of a liquid crystal display (LCD). <P>SOLUTION: The system can combine a visual image forming check and electronic sensing such as voltage image forming, electronic beam sensing and electric charge sensing. In the system, information on possible failures acquired from a visual check system is combined with information on possible failures acquired from an electronic sensing system to create a failure report. One or more high resolution visual cameras are scanned on a fixed plate and image data from the cameras is processed to detect the possible failures. The electronic sensing system with high resolution checks the fixed plate and image data from a sensor is processed to detect the possible failures. The possible failures from visual image data and electronic sensing image data are processed to create final failure information. <P>COPYRIGHT: (C)2004,JPO",PHOTON DYNAMICS INC,CLARK BERNARD T;;FREEMAN DAVID L;;HAWTHORNE JEFFREY A;;NAGY ALEXANDER J;;PRATT WILLIAM K,,https://lens.org/079-353-757-113-147,Patent Application,no,13,2,9,9,0,G01N21/95;;G01N2021/9513;;G09G3/006;;G02F1/136254;;G02F1/13;;G09G3/006;;G01N21/95;;G01N2021/9513;;G02F1/136254,G01M11/00;;G01N21/95;;G01N21/956;;G01N23/225;;G01R31/00;;G02F1/13;;G02F1/1362;;G01B11/30;;G09G3/00,,0,0,,,,PENDING
513,CN,B,CN 1514231 B,140-374-494-484-757,2010-05-26,2010,CN 03154806 A,2003-08-19,US 22328802 A,2002-08-19,Method and device for checking active disc,"Integrated inspection and test systems for liquid crystal display (LCD) active plates. The integrated inspection and test systems may combine visual imaging inspection and an electronic sensing such as voltage imaging, electron beam sensing or charge sensing, in which the potential defect information obtained by the visual inspection system is combined with the potential defect information obtained by the electronic sensing system to produce a defect report. One or more high-resolution visual cameras are scanned over a stationary plate, and the image data from the camera(s) is processed to detect potential defects. A high-resolution electronic sensing system examines the stationary plate, and the image data from the sensor(s) is processed to detect potential defects. The potential defectsfrom the visual image data and electronic sensing image data are processed to produce the final defect information.",PHOTON MECHANICS CO,CLARK BERNARD T;;FREEMAN DAVID L;;HAWTHORNE JEFFREY A;;NAGY ALEXANDER J;;PRATT WILLIAM K,,https://lens.org/140-374-494-484-757,Granted Patent,no,0,0,9,9,0,G02F1/13;;G09G3/006;;G09G3/006;;G01N21/95;;G01N21/95;;G01N2021/9513;;G01N2021/9513;;G02F1/136254;;G02F1/136254,G01B11/30;;G01N21/88;;G01M11/00;;G01N21/95;;G01N21/956;;G01N23/225;;G01R31/00;;G01R31/28;;G02F1/13;;G02F1/1362;;G09G3/00,,0,0,,,,EXPIRED
514,DE,T2,DE 60034303 T2,193-124-262-070-919,2008-01-03,2008,DE 60034303 T,2000-01-31,EP 00300705 A,2000-01-31,Verfahren zur Oxidation mit einem Katalysator von einer Antimontrifluorid und Siliziumdioxid enthaltenden Zusammensatzung,"This invention relates to a composition comprising antimony trifluoride and silica, a method for the preparation of said composition and the use of said composition as catalyst. Examples of the silica are hexagonal mesoporous silica (HMS) or silica gel. The catalyst may be used in the oxidation of cyclohexanone to epsilon-caprolactone with hydrogen peroxide.",SOLVAY,ROCCA MICHAEL CHARLES;;CARR GRAHAM;;LAMBERT ARNOLD BERNARD MARIE;;MACQUARRIE DUNCAN JAMES;;CLARK JAMES HANLEY,"PERSTORP SPECIALTY CHEMICALS AB, PERSTORP, SE (2008-09-18)",https://lens.org/193-124-262-070-919,Granted Patent,no,0,0,9,9,0,B01J21/08;;B01J23/6445;;B01J27/12;;B01J29/035;;C07D315/00;;Y02P20/50;;C07D315/00;;B01J29/035;;B01J21/08;;B01J23/6445;;B01J27/12;;Y02P20/50,B01J27/12;;C07D313/04;;B01J21/08;;B01J23/644;;B01J29/035;;C07B61/00;;C07D315/00,,0,0,,,,EXPIRED
515,US,B2,US 9650313 B2,019-186-407-014-278,2017-05-16,2017,US 201414586521 A,2014-12-30,US 201414586521 A;;US 201113247285 A;;US 40914510 P,2010-11-02,Depolymerization of plastic materials,A styrene monomer reclamation process and system is described. The styrene monomer reclamation process includes providing a waste plastic. The waste plastic includes styrenic polymers. The waste plastic is formed into polymer particles. At least a portion of the polymer particles are dissolved in a solvent to form a polymer stream. The dissolved polymer particles are depolymerized to form a styrene monomer stream.,FINA TECHNOLOGY,TIPPET JON;;BUTLER JAMES;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHEL;;CARY JEAN-BERNARD,,https://lens.org/019-186-407-014-278,Granted Patent,yes,5,8,7,7,0,B01J8/062;;B01J8/062;;C07C4/22;;C07C4/22;;C07C2523/04;;C07C2523/04;;C08J11/18;;C08J11/18;;C08J2325/06;;C08J2325/06;;Y02W30/62;;Y02W30/62,C07C1/00;;B01J8/06;;C07C4/22;;C08J11/18,,1,1,000-000-779-634-71X,10.1021/ie00039a044,"Z. Zhang, et al., “Chemical Recycling of Waste Polystyrene into Styrene over Solid Acids and Bases”, Ind. Eng. Chem. Res., 34, pp. 4514-4519 (1995).",ACTIVE
516,EP,A1,EP 1121980 A1,074-953-796-447-833,2001-08-08,2001,EP 00300705 A,2000-01-31,EP 00300705 A,2000-01-31,Process of oxidation with a catalyst comprising a composition of antimony trifluoride and silica,"This invention relates to a composition comprising antimony trifluoride and silica, a method for the preparation of said composition and the use of said composition as catalyst. Examples of the silica are hexagonal mesoporous silica (HMS) or silica gel. The catalyst may be used in the oxidation of cyclohexanone to epsilon-caprolactone with hydrogen peroxide.",SOLVAY,ROCCA MICHAEL CHARLES;;CARR GRAHAM;;LAMBERT ARNOLD BERNARD MARIE;;MACQUARRIE DUNCAN JAMES;;CLARK JAMES HANLEY,"INGEVITY UK LTD, WARRINGTON, GB (2019-06-04)",https://lens.org/074-953-796-447-833,Patent Application,yes,4,3,9,9,0,B01J21/08;;B01J23/6445;;B01J27/12;;B01J29/035;;C07D315/00;;Y02P20/50;;C07D315/00;;B01J29/035;;B01J21/08;;B01J23/6445;;B01J27/12;;Y02P20/50,C07D313/04;;B01J21/08;;B01J23/644;;B01J27/12;;B01J29/035;;C07B61/00;;C07D315/00,,0,0,,,,EXPIRED
517,AT,T1,AT E359122 T1,134-334-751-051-124,2007-05-15,2007,AT 00300705 T,2000-01-31,EP 00300705 A,2000-01-31,VERFAHREN ZUR OXIDATION MIT EINEM KATALYSATOR VON EINER ANTIMONTRIFLUORID UND SILIZIUMDIOXID ENTHALTENDEN ZUSAMMENSATZUNG,"This invention relates to a composition comprising antimony trifluoride and silica, a method for the preparation of said composition and the use of said composition as catalyst. Examples of the silica are hexagonal mesoporous silica (HMS) or silica gel. The catalyst may be used in the oxidation of cyclohexanone to epsilon-caprolactone with hydrogen peroxide.",SOLVAY,ROCCA MICHAEL CHARLES;;CARR GRAHAM;;LAMBERT ARNOLD BERNARD MARIE;;MACQUARRIE DUNCAN JAMES;;CLARK JAMES HANLEY,,https://lens.org/134-334-751-051-124,Granted Patent,no,0,0,9,9,0,B01J21/08;;B01J23/6445;;B01J27/12;;B01J29/035;;C07D315/00;;Y02P20/50;;C07D315/00;;B01J29/035;;B01J21/08;;B01J23/6445;;B01J27/12;;Y02P20/50,C07D313/04;;B01J21/08;;B01J23/644;;B01J27/12;;B01J29/035;;C07B61/00;;C07D315/00,,0,0,,,,EXPIRED
518,TW,A,TW 202334108 A,197-643-830-442-97X,2023-09-01,2023,TW 111142307 A,2022-11-04,US 202163276539 P;;US 202163280071 P;;US 202163280073 P;;US 202163280075 P;;US 202163283027 P;;US 202263311874 P;;US 202263320654 P;;US 202263326774 P;;US 202263326776 P;;US 202263326782 P;;US 202263326792 P;;US 202263367445 P;;US 202263388840 P;;US 202263377328 P,2021-11-05,"Isotopologues, salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof","Described herein are isotopically enriched analogs of methylone (e.g., deuterated analogs of methylone (e.g., (S)-methylone and (R)-methylone) with improved characteristics. Also described herein are salts (such as hydrochloride salt) and solid forms (e.g., crystalline forms) of methylone. Also described herein are stereoisomers (e.g., enantiomers) of methylone. The present disclosure also provides methods of making and methods of use of the methylone or methylone analogs and solid forms of 3,4-methylenedioxy-N-ethylcathinone hydrochloride described herein to treat brain and neurological disorders such as depression.",TERRAN BIOSCIENCES INC,DUNCTON MATTHEW;;CLARK SAMUEL;;HENDERSON ALISTAIR;;GOLDING BERNARD;;MASCARO MANUEL MONERRIS;;JOHNSON LUCIA;;MADRID ANNETTE,,https://lens.org/197-643-830-442-97X,Patent of Addition,no,0,0,3,3,0,A61P25/22;;C07D317/54;;A61K45/06;;A61P25/22;;C07B2200/13;;C07D317/58,C07D317/58;;A61K31/36;;A61P25/00,,0,0,,,,PENDING
519,US,A1,US 2023/0192642 A1,004-710-985-418-817,2023-06-22,2023,US 202218147071 A,2022-12-28,US 202218147071 A;;US 2022/0049027 W;;US 202163276539 P;;US 202163280071 P;;US 202163280073 P;;US 202163280075 P;;US 202163283027 P;;US 202263311874 P;;US 202263320654 P;;US 202263326774 P;;US 202263326776 P;;US 202263326782 P;;US 202263326792 P;;US 202263367445 P;;US 202263388840 P;;US 202263377328 P,2021-11-05,"ISOTOPOLOGUES SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF","Described herein are isotopically enriched analogs of methylone (e.g., deuterated analogs of methylone (e.g., (S)-methylone and (R)-methylone) with improved characteristics. Also described herein are salts (such as hydrochloride salt) and solid forms (e.g., crystalline forms) of methylone. Also described herein are stereoisomers (e.g., enantiomers) of methylone. The present disclosure also provides methods of making and methods of use of the methylone or methylone analogs and solid forms of 3,4-methylenedioxy-N-ethylcathinone hydrochloride described herein to treat brain and neurological disorders such as depression.",TERRAN BIOSCIENCES INC,DUNCTON MATTHEW;;CLARK SAMUEL;;HENDERSON ALISTAIR;;GOLDING BERNARD;;MONERRIS MASCARO MANUEL;;JOHNSON LUCIA;;MADRID ANNETTE,,https://lens.org/004-710-985-418-817,Patent Application,yes,0,0,3,3,0,A61P25/22;;C07D317/54;;A61K45/06;;A61P25/22;;C07B2200/13;;C07D317/58,C07D317/58;;A61P25/22,,0,0,,,,PENDING
520,WO,A1,WO 2005/036262 A1,008-489-048-933-852,2005-04-21,2005,GB 2004004184 W,2004-10-01,GB 0323280 A,2003-10-04,PHOTOGRAPHIC ELEMENT CONTAINING A SPEED-ENHANCING COMPOUND,"The invention provides a colour photographic element comprising at least one light-sensitive silver halide emulsion layer or a non silver-containing light-insensitive layer, in which at least one of these layers contains a colourless imidazole compound of formula (I) that undergoes less than 10 % chemical or redox reaction directly with oxidized developer and which has a partition coefficient to enable the photographic speed of the element to be increased by at least 0.03 stop without increasing granularity, compared to the same element without the compound, wherein the compound of formula: (I) has the structure: wherein X is H or a substituent; Z represents the atoms necessary to complete an unsubstituted or substituted imidazole ring, which may form part of a fused unsubstituted or substituted ring system containing no further ring heteroatoms; wherein there is present at least one -NH group either in the imidazole ring or directly attached to the imidazole ring as part of X; provided that (a) when Z represents the atoms necessary to complete an unsubstituted or substituted benzimidazole ring, an -NH group is directly attached to the imidazole ring as part of X, and X is located between the imidazole nitrogen atoms; (b) when the -N-H group is located in the ring adjacent to the carbon atom bearing X, and X is located between the imidazole nitrogen atoms, the imidazole ring is not fused to a phenanthrene ring. The compounds of formula (I) increase speed without a concomitant increase in size of the light-sensitive silver halide grains.",EASTMAN KODAK CO;;CLARK BERNARD ARTHUR JAMES;;ALLWAY PHILLIP;;ZUBERI TANIA;;SINGER STEPHEN PAUL;;HECKLER CHARLES;;FRIEDRICH LOUIS,CLARK BERNARD ARTHUR JAMES;;ALLWAY PHILLIP;;ZUBERI TANIA;;SINGER STEPHEN PAUL;;HECKLER CHARLES;;FRIEDRICH LOUIS,,https://lens.org/008-489-048-933-852,Patent Application,yes,6,0,4,4,0,G03C7/3022;;G03C7/3029;;G03C7/3924;;G03C7/39252;;G03C2001/03511;;G03C2007/3034;;G03C7/39252;;G03C7/3022;;G03C7/3029;;G03C7/3924;;G03C2007/3034;;G03C2001/03511,G03C7/30;;G03C7/392,,0,0,,,,PENDING
521,US,A,US 5331357 A,019-547-407-599-887,1994-07-19,1994,US 92291492 A,1992-07-31,US 92291492 A,1992-07-31,Illumination assembly,"An illumination assembly includes a lens housing having a first end and a second end, a first lens having first and second opposing surfaces with the first lens being disposed in a first end of the lens housing. A cane having a first a second surfaces is disposed in the lens housing with the first surface of the cane being spaced a predetermined distance from a first surface of the lens and wherein the second surface of the cane is polished and disposed against a first polished surface of a fiber optic bundle.",LUXTEC CORP,COOLEY DENTON A;;CLARK BERNARD;;MORRIS FREDERICK;;DELANEY LAWRENCE E;;VARI PETER;;CHESTERSON WILLIAM L,ARK CLO 2000-1 LIMITED (2001-03-01);;LUXTEC CORPORATION (1992-10-06);;FIRST NATIONAL BANK OF BOSTON THE (1995-10-24),https://lens.org/019-547-407-599-887,Granted Patent,yes,28,63,1,1,0,G02C11/04;;G02C11/04;;G02B6/0008;;G02B6/0008;;G02C7/088;;G02C7/088,F21V8/00;;G02C7/08;;G02C11/04,G2J JS2AX1        JS2AZ;;G2J JS2A2         JS2AZ;;G2J JS2A2A1       JS2AZ,0,0,,,,EXPIRED
522,EP,B1,EP 0952485 B1,055-352-658-090-28X,2003-10-08,2003,EP 99201571 A,1999-01-18,EP 99200145 A;;US 1485598 A;;US 18684498 A,1998-01-29,Color photographic element containing elemental silver and nitrogen heterocycle in a non-light sensitive layer,,EASTMAN KODAK CO,CLARK BERNARD A;;BOFF JANE SARAH;;ALLWAY PHILLIP ARTHUR;;FRIEDRICH LOUIS ELBERT;;SINGER STEPHEN PAUL,,https://lens.org/055-352-658-090-28X,Granted Patent,yes,4,0,2,6,0,G03C7/39244;;G03C1/34;;G03C1/825;;G03C1/8255;;G03C7/3029;;G03C7/30541;;G03C7/39216;;G03C7/39256;;G03C2200/25;;G03C2200/33,G03C1/825;;G03C7/30;;G03C7/305;;G03C7/392,,0,0,,,,EXPIRED
523,WO,A3,WO 2012/061236 A3,064-858-712-346-018,2014-04-10,2014,US 2011/0058319 W,2011-10-28,US 201113247285 A;;US 40914510 P,2010-11-02,DEPOLYMERIZATION OF PLASTIC MATERIALS,A styrene monomer reclamation process and system is disclosed. The styrene monomer reclamation process includes providing a waste plastic. The waste plastic includes styrenic polymers. The waste plastic is formed into polymer particles. At least a portion of the polymer particles are dissolved in a solvent to form a polymer stream. The dissolved polymer particles are depolymerized to form a styrene monomer stream.,FINA TECHNOLOGY;;TIPPET JON;;BUTLER JAMES;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHAEL;;CARY JEAN-BERNARD,TIPPET JON;;BUTLER JAMES;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHAEL;;CARY JEAN-BERNARD,,https://lens.org/064-858-712-346-018,Search Report,yes,18,0,7,7,0,B01J8/062;;B01J8/062;;C07C4/22;;C07C4/22;;C07C2523/04;;C07C2523/04;;C08J11/18;;C08J11/18;;C08J2325/06;;C08J2325/06;;Y02W30/62;;Y02W30/62,C07C4/04;;C08J11/04,,0,0,,,,PENDING
524,EP,A1,EP 0952485 A1,074-526-097-892-923,1999-10-27,1999,EP 99201571 A,1999-01-18,EP 99200145 A;;US 1485598 A;;US 18684498 A,1998-01-29,Color photographic element containing elemental silver and nitrogen heterocycle in a non-light sensitive layer,"The invention provides a photographic element comprising a non-light sensitive layer containing elemental silver and a nitrogen heterocycle compound having a ClogP of at least 4.5, which compound comprises a ring system of one or more fused rings containing at least one -N-H bond, the ring system comprising a total of at least three nitrogen ring members and the associated bonds; provided that the compound does not contain an -SH group or >C=S group and does not react with an oxidized developer.",EASTMAN KODAK CO,CLARK BERNARD A;;BOFF JANE SARAH;;ALLWAY PHILLIP ARTHUR;;FRIEDRICH LOUIS ELBERT;;SINGER STEPHEN PAUL,,https://lens.org/074-526-097-892-923,Patent Application,yes,4,5,2,6,0,G03C7/39244;;G03C1/34;;G03C1/825;;G03C1/8255;;G03C7/3029;;G03C7/30541;;G03C7/39216;;G03C7/39256;;G03C2200/25;;G03C2200/33,G03C1/825;;G03C7/30;;G03C7/305;;G03C7/392,,0,0,,,,EXPIRED
525,WO,A2,WO 2012/061236 A2,081-497-535-639-121,2012-05-10,2012,US 2011/0058319 W,2011-10-28,US 201113247285 A;;US 40914510 P,2010-11-02,DEPOLYMERIZATION OF PLASTIC MATERIALS,A styrene monomer reclamation process and system is disclosed. The styrene monomer reclamation process includes providing a waste plastic. The waste plastic includes styrenic polymers. The waste plastic is formed into polymer particles. At least a portion of the polymer particles are dissolved in a solvent to form a polymer stream. The dissolved polymer particles are depolymerized to form a styrene monomer stream.,FINA TECHNOLOGY;;TIPPET JON;;BUTLER JAMES;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHAEL;;CARY JEAN-BERNARD,TIPPET JON;;BUTLER JAMES;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHAEL;;CARY JEAN-BERNARD,,https://lens.org/081-497-535-639-121,Patent Application,yes,0,0,7,7,0,B01J8/062;;B01J8/062;;C07C4/22;;C07C4/22;;C07C2523/04;;C07C2523/04;;C08J11/18;;C08J11/18;;C08J2325/06;;C08J2325/06;;Y02W30/62;;Y02W30/62,C07C4/22;;B09B3/00,,0,0,,,,PENDING
526,US,A1,US 2022/0204153 A1,010-793-772-335-173,2022-06-30,2022,US 202017137594 A,2020-12-30,US 202017137594 A,2020-12-30,SYSTEM AND METHOD FOR LOADING AND SECURING PAYLOAD IN AN AIRCRAFT,"In an aspect a system for loading and securing a payload in an electrical vertical take-off and landing (eVTOL) aircraft may comprise a fuselage further comprising structural elements configured to provide physical support for the aircraft fuselage. An eVTOL aircraft may also comprise a swing nose, where a portion of the nose of the aircraft may swing on a hinge in a radial direction orthogonal to the longitudinal axis of the aircraft. The hinge may be coupled to at least a portion of the fuselage and at least a portion of the nose of the aircraft. A latching mechanism may be configured to secure a payload in an aircraft fuselage. A conveyor mechanism may be configured to transport a payload into the fuselage from the opening of the aircraft.",BETA AIR LLC,GRIFFIN RILEY;;GOMEZ MORGAN WYETH;;CLARK KYLE B;;LAUGHLIN JAMES;;BERNARD ANDREW THOMAS;;SHOOK CLINT,,https://lens.org/010-793-772-335-173,Patent Application,yes,27,3,1,1,0,B64C1/22;;B64C29/0016;;B64D9/003;;B64D2009/006;;B64C1/0683;;B64C1/22;;B64C29/0016;;B64D2009/006;;B64D9/003,B64C1/22;;B64D9/00,,0,0,,,,PENDING
527,DE,D1,DE 69911836 D1,045-827-484-328-131,2003-11-13,2003,DE 69911836 T,1999-01-18,US 1485598 A;;US 18684498 A,1998-01-29,Farbphotographisches Element mit elementarem Silber und stickstoffhaltigem Heterozyclus in einer lichtunempfindlichen Schicht,,EASTMAN KODAK CO,CLARK BERNARD A;;BOFF JANE SARAH;;ALLWAY PHILLIP ARTHUR;;FRIEDRICH LOUIS ELBERT;;SINGER STEPHEN PAUL,,https://lens.org/045-827-484-328-131,Granted Patent,no,0,0,4,6,0,G03C1/825;;G03C1/8255;;G03C7/3029;;G03C7/39244;;G03C7/39256;;G03C7/39256;;G03C7/3029;;G03C7/39244;;G03C1/825;;G03C1/8255,G03C1/34;;G03C1/825;;G03C7/30;;G03C7/392,,0,0,,,,EXPIRED
528,KR,A,KR 20040016795 A,088-789-799-136-535,2004-02-25,2004,KR 20030056873 A,2003-08-18,US 22328802 A,2002-08-19,INTEGRATED VISUAL IMAGING AND ELECTRONIC SENSING INSPECTION SYSTEM,"PURPOSE: An integrated visual imaging and electronic sensing inspection system is provided to perform integrated inspection and test for LCD(Liquid Crystal Display) active plates. CONSTITUTION: The integrated inspection and test system combines visual imaging inspection and an electronic sensing such as voltage imaging, electron beam sensing or charge sensing. Potential defect information obtained by the visual inspection system is combined with potential defect information obtained by the electronic sensing system to produce a defect report. One or more high-resolution visual cameras are scanned over a stationary plate, and image data from the camera is processed to detect potential defects. A high-resolution electronic sensing system examines the stationary plate, and the image data from the sensor is processed to detect potential defects. Potential defects from the visual image data and electronic sensing image data are processed to produce final defect information.",PHOTON DYNAMICS INC,CLARK BERNARD T;;FREEMAN DAVID L;;HAWTHORNE JEFFREY A;;NAGY ALEXANDER J;;PRATT WILLIAM K,,https://lens.org/088-789-799-136-535,Patent Application,no,0,0,9,9,0,G02F1/13;;G09G3/006;;G09G3/006;;G01N21/95;;G01N21/95;;G01N2021/9513;;G01N2021/9513;;G02F1/136254;;G02F1/136254,G01B11/30;;G01M11/00;;G01N21/95;;G01N21/956;;G01N23/225;;G01R31/00;;G02F1/13;;G02F1/1362;;G09G3/00,,0,0,,,,EXPIRED
529,DE,D1,DE 60034303 D1,153-282-999-104-565,2007-05-24,2007,DE 60034303 T,2000-01-31,EP 00300705 A,2000-01-31,Verfahren zur Oxidation mit einem Katalysator von einer Antimontrifluorid und Siliziumdioxid enthaltenden Zusammensatzung,"This invention relates to a composition comprising antimony trifluoride and silica, a method for the preparation of said composition and the use of said composition as catalyst. Examples of the silica are hexagonal mesoporous silica (HMS) or silica gel. The catalyst may be used in the oxidation of cyclohexanone to epsilon-caprolactone with hydrogen peroxide.",SOLVAY,ROCCA MICHAEL CHARLES;;CARR GRAHAM;;LAMBERT ARNOLD BERNARD MARIE;;MACQUARRIE DUNCAN JAMES;;CLARK JAMES HANLEY,"PERSTORP SPECIALTY CHEMICALS AB, PERSTORP, SE (2008-09-18)",https://lens.org/153-282-999-104-565,Granted Patent,no,0,0,9,9,0,B01J21/08;;B01J23/6445;;B01J27/12;;B01J29/035;;C07D315/00;;Y02P20/50;;C07D315/00;;B01J29/035;;B01J21/08;;B01J23/6445;;B01J27/12;;Y02P20/50,B01J27/12;;C07D313/04;;B01J21/08;;B01J23/644;;B01J29/035;;C07B61/00;;C07D315/00,,0,0,,,,EXPIRED
530,WO,A3,WO 2005/036263 A3,059-882-067-490-875,2005-06-16,2005,GB 2004004207 W,2004-10-01,GB 0323282 A,2003-10-04,PHOTOGRAPHIC ELEMENT WITH SPEED-ENHANCING COMPOUND,"The invention provides a colour photographic element comprising at least one light-sensitive silver halide emulsion layer or a non silver-containing light-insensitive layer, in which at least one of these layers contains a colourless heterocyclic compound having either one or two hetero atoms in the ring or ring system, being other than an imidazole compound, that undergoes less than 10% chemical or redox reaction directly with oxidized developer and which has a partition coefficient to enable the photographic speed of the element to be increased by at least 0.03 stop without increasing granularity, compared to the same element without the compound. The heterocyclic compounds increase speed without a concomitant increase in size of the light-sensitive silver halide grains.",EASTMAN KODAK CO;;CLARK BERNARD ARTHUR JAMES;;ALLWAY PHILLIP;;ZUBERI TANIA;;SINGER STEPHEN PAUL;;HECKLER CHARLES;;FRIEDRICH LOUIS,CLARK BERNARD ARTHUR JAMES;;ALLWAY PHILLIP;;ZUBERI TANIA;;SINGER STEPHEN PAUL;;HECKLER CHARLES;;FRIEDRICH LOUIS,,https://lens.org/059-882-067-490-875,Search Report,yes,3,0,5,5,0,G03C7/3924;;G03C7/3924;;G03C7/3029;;G03C7/3029;;G03C7/3212;;G03C7/3212;;G03C7/39252;;G03C7/39252;;G03C7/39276;;G03C7/39276;;G03C2007/3034;;G03C2007/3034;;G03C2200/29;;G03C2200/29,G03C7/30;;G03C7/392,,0,0,,,,PENDING
531,US,S,US D0349123 S,177-190-581-603-685,1994-07-26,1994,US 92373792 F,1992-07-31,US 92373792 F,1992-07-31,Spectacles having integral illumination,,LUXTEC CORP,COOLEY DENTON A;;CLARK BERNARD;;MORRIS FREDERICK;;DELANEY LAWRENCE E;;VARI PETER;;CHESTERSON WILLIAM L,ARK CLO 2000-1 LIMITED (2001-03-01);;LUXTEC CORPORATION (1992-10-06);;FIRST NATIONAL BANK OF BOSTON THE (1995-10-24),https://lens.org/177-190-581-603-685,Design Right,yes,44,63,1,1,0,,,D16/103,0,0,,,,EXPIRED
532,JP,A,JP H11271931 A,196-970-533-185-219,1999-10-08,1999,JP 2026399 A,1999-01-28,US 1485598 A;;US 18684498 A,1998-01-29,PHOTOGRAPHIC ELEMENT,"PROBLEM TO BE SOLVED: To obtain an photographic element having a nonphotosensitive layer containing element silver in which the tendency to the increase of Dmin near a photosensitive layer is reduced. SOLUTION: This photographic element contains a nonphotosensitive silver halide emulsion layer containing element silver and nitrogen heterocyclic compds. having at least 4.5 ClogP. At least one of the compds. has a cyclic structure comprising one or more kinds of condensed rings having at least one N-H bond, and the cyclic structure contains at least three nitrogen ring members in total and accompanied bonds. The compd. does not react with a developing agent which is oxidized but does not contain -SH group or >C=S group.",EASTMAN KODAK CO,BERNARD A CLARK;;JANE SARA BOFF;;PHILLIP ARTHUR ALLWAY;;FRIEDRICH LOUIS ELBERT;;SINGER STEPHEN P,,https://lens.org/196-970-533-185-219,Patent Application,no,0,0,4,6,0,G03C1/825;;G03C1/8255;;G03C7/3029;;G03C7/39244;;G03C7/39256;;G03C7/39256;;G03C7/3029;;G03C7/39244;;G03C1/825;;G03C1/8255,G03C1/34;;G03C1/825;;G03C7/30;;G03C7/392,,0,0,,,,PENDING
533,GB,A8,GB 2312756 A8,020-885-888-297-050,1999-05-19,1999,GB 9708345 A,1997-04-25,US 64002696 A,1996-04-30,Photographic material with magenta coupler,,EASTMAN KODAK CO,BOFF JANE SARAH;;CLARK BERNARD ARTHUR JAMES;;STANLEY PAUL LOUIS;;WATTS CHRISTINA MARY;;SINGER STEPHEN PAUL,,https://lens.org/020-885-888-297-050,Patent Application,no,0,0,5,5,0,G03C7/384;;G03C7/384;;G03C7/3225;;G03C7/3225;;G03C7/38;;G03C7/38,G03C7/32;;G03C7/384,G2C CC8B4A1B      CPE;;G2C CC8B4G10      CPE;;G2C CC8B4G12      CPE;;G2C CC8B4G16      CPE;;G2C CC8B4G3       CPE;;G2C CC8B4G30      CPE;;G2C CC8B4G4       CPE;;G2C CC8B4G5       CPE;;G2C CPE           CPE,0,0,,,,EXPIRED
534,EP,B1,EP 0672946 B1,134-699-312-862-39X,2000-12-06,2000,EP 95420057 A,1995-03-06,US 21486694 A,1994-03-17,Photographic element containing a certain sulfonated acylacetanilide coupler in combination with low- or non-chloride emulsions,,EASTMAN KODAK CO,MERKEL PAUL BARRETT;;POSLUSNY JERROLD NEAL;;WILLIAMSON HUGH MARTIN;;CLARK BERNARD A;;STANLEY PAUL LOUIS REGINALD,,https://lens.org/134-699-312-862-39X,Granted Patent,yes,3,0,4,4,0,G03C7/3022;;G03C7/30535;;G03C7/30535;;G03C7/3022,G03C7/00;;G03C1/035;;G03C7/30;;G03C7/305;;G03C7/36,,0,0,,,,EXPIRED
535,EP,B1,EP 0206726 B1,099-279-918-843-769,1990-10-24,1990,EP 86304643 A,1986-06-16,US 74634285 A,1985-06-19,PERIODONTAL OSSEOUS DEFECT REPAIR,,THE UNIVERSITY OF FLORIDA,"LOW, SAMUEL BERNARD;;FETNER, ALAN EDWARD;;CLARK, ARTHUR EDWARD, JR.;;HENCH, LARRY LEROY;;WILSON-HENCH, JUNE",THE UNIVERSITY OF FLORIDA (1990-08-01),https://lens.org/099-279-918-843-769,Granted Patent,yes,5,1,7,7,0,A61F2310/00293;;A61L24/02;;A61L27/10;;A61L2430/02;;A61L27/12;;A61F2/28;;A61L24/02;;A61F2310/00293;;A61L2430/02;;A61L27/10;;A61L27/12;;A61F2/28,A61F2/00;;A61K6/06;;A61L24/02;;A61L27/00;;A61L27/12,,1,0,,,"CERAMIC SOCIETY OF JAPAN, INTERNATIONAL CONGRESS ON GLASS, Kyoto, 8th-12th December 1974, pages 9-30 - 9-41, Ceramic Society, Kyoto, JP; L.L. HENCH: ""Biomedical applications and glass corrosion""",EXPIRED
536,AT,T1,AT E57616 T1,187-798-502-872-747,1990-11-15,1990,AT 86304643 T,1986-06-16,EP 86304643 A;;US 74634285 A,1985-06-19,MATERIAL ZUM AUSFUELLEN VON PERIODONTALEN KNOCHENDEFEKTEN.,,UNIV FLORIDA,LOW SAMUEL BERNARD;;FETNER ALAN EDWARD;;CLARK ARTHUR EDWARD JR;;HENCH LARRY LEROY;;WILSON-HENCH JUNE,,https://lens.org/187-798-502-872-747,Granted Patent,no,0,0,7,7,0,A61F2310/00293;;A61L24/02;;A61L27/10;;A61L2430/02;;A61L27/12;;A61F2/28;;A61L24/02;;A61F2310/00293;;A61L2430/02;;A61L27/10;;A61L27/12;;A61F2/28,A61F2/00;;A61K6/06;;A61L24/02;;A61L27/00;;A61L27/12,,0,0,,,,DISCONTINUED
537,GB,A,GB 2312756 A,055-993-062-204-67X,1997-11-05,1997,GB 9708345 A,1997-04-25,US 64002696 A,1996-04-30,Photographic material with magenta coupler,,EASTMAN KODAK CO,BOFF JANE SARAH;;CLARK BERNARD ARTHUR JAMES;;STANLEY PAUL LOUIS;;WATTS CHRISTINA MARY;;SINGER STEPHEN PAUL,,https://lens.org/055-993-062-204-67X,Patent Application,no,6,2,5,5,0,G03C7/384;;G03C7/384;;G03C7/3225;;G03C7/3225;;G03C7/38;;G03C7/38,G03C7/32;;G03C7/384,G2C CC8B4A1B      CPE;;G2C CC8B4G10      CPE;;G2C CC8B4G12      CPE;;G2C CC8B4G16      CPE;;G2C CC8B4G3       CPE;;G2C CC8B4G30      CPE;;G2C CC8B4G4       CPE;;G2C CC8B4G5       CPE;;G2C CPE           CPE,0,0,,,,EXPIRED
538,US,A1,US 2012/0108863 A1,061-293-849-840-549,2012-05-03,2012,US 201113247285 A,2011-09-28,US 201113247285 A;;US 40914510 P,2010-11-02,Depolymerizatin of Plastic Materials,A styrene monomer reclamation process and system is disclosed. The styrene monomer reclamation process includes providing a waste plastic. The waste plastic includes styrenic polymers. The waste plastic is formed into polymer particles. At least a portion of the polymer particles are dissolved in a solvent to form a polymer stream. The dissolved polymer particles are depolymerized to form a styrene monomer stream.,TIPPET JON;;BUTLER JAMES R;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHEL;;CARY JEAN-BERNARD;;FINA TECHNOLOGY,TIPPET JON;;BUTLER JAMES R;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHEL;;CARY JEAN-BERNARD,FINA TECHNOLOGY INC (2011-09-27),https://lens.org/061-293-849-840-549,Patent Application,yes,7,13,7,7,0,B01J8/062;;B01J8/062;;C07C4/22;;C07C4/22;;C07C2523/04;;C07C2523/04;;C08J11/18;;C08J11/18;;C08J2325/06;;C08J2325/06;;Y02W30/62;;Y02W30/62,C07C4/22;;B09B3/00,585/241;;422/184.1,0,0,,,,ACTIVE
539,TW,B,TW 461918 B,195-448-165-390-738,2001-11-01,2001,TW 88119351 A,1999-11-05,US 19165098 A,1998-11-13,Set of stacks of adhesive coated sheets and dispenser for dispensing sheets from a stack of sheets,"A set of stack of adhesive coated sheets comprising on a major surface of a substrate at least two stacks adhered to the substrate, each stack being a stack of sheets disposed one on top of another, each of the sheets having first and second spaced ends and a predetermined length between the first and second ends, comprising a backing having opposite major first and second surfaces, and having a layer of pressure sensitive adhesive on a major side of the sheet, the sheets being releasably adhered to each other by releasable adhesion of the layers of pressure sensitive adhesive to the surfaces of underlying sheets to form the form the stack, with the first end of each sheet being in alignment with the second end of an adjacent sheet in the stack, and the sheets having first release means for providing a first adhesion level along a first end portion of each of the sheets adjacent the first end between the layer of adhesive and the surface of the adjacent sheet in the stack to which the layer of adhesive is releasably adhered that affords easy separation of surfaces of adjacent sheets along the first end portion, and second release means for providing a second adhesion level along a second end portion of each of the sheets adjacent the second end between the layer of adhesive and the surface of the adjacent sheet in the stack, which second adhesion level provides a release force that is higher than the release force along the first end portion and firmly adheres the sheet to the adjacent sheet in the stack during separation of the sheets along the first end portion while affording peeling away of the sheet from the stack along the second end portion.",3M INNOVATIVE PROPERTIES CO,ELEOUET BERNARD JEAN BAPTISTE;;CRAWFORD DENNIS LEE;;BYRAM DAVID CLARK;;SCHLEIF LARRY ALLAN;;DOTTERMAN PERRY STEVEN,,https://lens.org/195-448-165-390-738,Granted Patent,no,0,0,11,11,0,B42D5/003;;B65H35/10;;B42D5/005,B42D5/00;;B65D25/52;;B65D83/08;;B65H35/07;;C09J7/02;;C09J201/00,,0,0,,,,EXPIRED
540,DE,D1,DE 69500747 D1,152-215-139-092-166,1997-10-30,1997,DE 69500747 T,1995-03-03,US 21472294 A,1994-03-17,Photographische Elemente enthaltend Acylacetanilid-Kuppler in Kombination mit einem einen Entwicklungsinhibitor freisetzenden Kuppler,,EASTMAN KODAK CO,MERKEL PAUL BARRETT;;POSLUSNY JERROLD NEAL;;MERRILL JAMES PARKER;;CLARK BERNARD ARTHUR;;STANLEY PAUL LOUIS R,,https://lens.org/152-215-139-092-166,Granted Patent,no,0,0,7,7,0,G03C7/30535;;G03C7/30535;;G03C7/367;;G03C7/367;;Y10S430/158,G03C7/00;;G03C7/305;;G03C7/36,,0,0,,,,EXPIRED
541,EP,A2,EP 0206726 A2,089-798-866-057-951,1986-12-30,1986,EP 86304643 A,1986-06-16,US 74634285 A,1985-06-19,Periodontal osseous defect repair.,"The present invention provides a composition for repair of periodontal osseous defects based on particulate bioactive and biocompatible glass. The particulate glass has a particle size in the range of 90 to 710 µm, preferably it is a mixture of
 (1) glass having a particle size of 90 to 355 µm, (2) glass having a particle size of 355 to 500 µm, and (3) glass having a particle size of 500 to 710 µm. The glass composition is as follows:
",UNIV FLORIDA,LOW SAMUEL BERNARD;;FETNER ALAN EDWARD;;CLARK ARTHUR EDWARD JR;;HENCH LARRY LEROY;;WILSON-HENCH JUNE,THE UNIVERSITY OF FLORIDA (1990-08-01),https://lens.org/089-798-866-057-951,Patent Application,yes,0,20,7,7,0,A61F2310/00293;;A61L24/02;;A61L27/10;;A61L2430/02;;A61L27/12;;A61F2/28;;A61L24/02;;A61F2310/00293;;A61L2430/02;;A61L27/10;;A61L27/12;;A61F2/28,A61F2/00;;A61K6/06;;A61L24/02;;A61L27/00;;A61L27/12,,0,0,,,,EXPIRED
542,DE,T2,DE 69500747 T2,194-520-602-819-895,1998-04-09,1998,DE 69500747 T,1995-03-03,US 21472294 A,1994-03-17,Photographische Elemente enthaltend Acylacetanilid-Kuppler in Kombination mit einem einen Entwicklungsinhibitor freisetzenden Kuppler,,EASTMAN KODAK CO,MERKEL PAUL BARRETT;;POSLUSNY JERROLD NEAL;;MERRILL JAMES PARKER;;CLARK BERNARD ARTHUR;;STANLEY PAUL LOUIS R,,https://lens.org/194-520-602-819-895,Granted Patent,no,0,0,7,7,0,G03C7/30535;;G03C7/30535;;G03C7/367;;G03C7/367;;Y10S430/158,G03C7/00;;G03C7/305;;G03C7/36,,0,0,,,,EXPIRED
543,US,A,US 5498515 A,032-204-852-516-994,1996-03-12,1996,US 21486694 A,1994-03-17,US 21486694 A,1994-03-17,Photographic element containing a certain sulfonated acylacetanilide coupler in combination with low- or non-chloride emulsions,"The invention provides a photographic element comprising a support bearing a blue-light sensitive silver halide emulsion layer containing an acylacetanilide yellow image dye-forming coupler having formula I or II: ##STR1## wherein: R.sub.a is a substituted or unsubstituted alkyl, alkoxy, or aryloxy group; R.sub.b is a substituted or unsubstituted alkyl or aryl group; R.sub.c is hydrogen or a substituted or unsubstituted alkyl group; R.sub.1 is a substituent; n is an integer from 0 to 2; R.sub.2 is selected from the group consisting of halogen, trifluoromethyl, and substituted or unsubstituted alkoxy and aryloxy; R.sub.3 is a substituted or unsubstituted alkyl group; R.sub.4 is hydrogen, halogen, alkoxy carbonyl (--CO.sub.2 R), carbamoyl (--CONRR'), carbonamido (--NRCOR'), sulfonamido (--NRSO.sub.2 R') or trifluoromethyl; R.sub.1 is a substituent; X is hydrogen or a coupling-off group; wherein said blue-light sensitive silver halide emulsion layer is a low-chloride silver halide emulsion. The invention enables improved image quality through increased interimage effects.",EASTMAN KODAK CO,MERKEL PAUL B;;POSLUSNY JERROLD N;;WILLIAMSON HUGH M;;CLARK BERNARD A;;STANLEY PAUL L R,EASTMAN KODAK COMPANY (1994-04-22),https://lens.org/032-204-852-516-994,Granted Patent,yes,12,1,4,4,0,G03C7/3022;;G03C7/30535;;G03C7/30535;;G03C7/3022,G03C1/035;;G03C7/30;;G03C7/00;;G03C7/305;;G03C7/36,430/556;;430/557;;430/567,0,0,,,,EXPIRED
544,TW,A,TW 201229099 A,037-794-441-445-954,2012-07-16,2012,TW 100136294 A,2011-10-06,US 40914510 P;;US 201113247285 A,2010-11-02,Depolymerization of plastic materials,A styrene monomer reclamation process and system is disclosed. The styrene monomer reclamation process includes providing a waste plastic. The waste plastic includes styrenic polymers. The waste plastic is formed into polymer particles. At least a portion of the polymer particles are dissolved in a solvent to form a polymer stream. The dissolved polymer particles are depolymerized to form a styrene monomer stream.,FINA TECHNOLOGY,TIPPET JON;;BUTLER JAMES R;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHEL;;CARY JEAN-BERNARD,,https://lens.org/037-794-441-445-954,Patent of Addition,no,0,2,7,7,0,B01J8/062;;B01J8/062;;C07C4/22;;C07C4/22;;C07C2523/04;;C07C2523/04;;C08J11/18;;C08J11/18;;C08J2325/06;;C08J2325/06;;Y02W30/62;;Y02W30/62,C08J11/10;;C08F12/08,,0,0,,,,PENDING
545,GB,B,GB 2312756 B,195-945-389-796-419,2000-09-06,2000,GB 9708345 A,1997-04-25,US 64002696 A,1996-04-30,Photographic material containing magenta dye forming coupler,,EASTMAN KODAK CO,BOFF JANE SARAH;;CLARK BERNARD ARTHUR JAMES;;STANLEY PAUL LOUIS;;WATTS CHRISTINA MARY;;SINGER STEPHEN PAUL,,https://lens.org/195-945-389-796-419,Granted Patent,no,7,0,5,5,0,G03C7/384;;G03C7/384;;G03C7/3225;;G03C7/3225;;G03C7/38;;G03C7/38,G03C7/32;;G03C7/384,G2C CC8B4A1B      CPE;;G2C CC8B4G10      CPE;;G2C CC8B4G12      CPE;;G2C CC8B4G16      CPE;;G2C CC8B4G3       CPE;;G2C CC8B4G30      CPE;;G2C CC8B4G4       CPE;;G2C CC8B4G5       CPE;;G2C CPE           CPE,0,0,,,,EXPIRED
546,EP,A1,EP 0892307 A1,158-470-128-107-306,1999-01-20,1999,EP 98202294 A,1998-07-08,US 89664097 A,1997-07-18,Photographic element containing a DIR coupler,"A photographic element comprises a support bearing at least one silver halide emulsion and at least one acylacetanilide or malonanilide yellow dye-forming DIR coupler of structure I or structure II, below
   wherein the substituents are as defined in the specification.",EASTMAN KODAK CO,MERKEL PAUL BARRETT;;POSLUSNY JERROLD NEAL;;REYNOLDS JAMES H;;CLARK BERNARD ARTHUR JAMES;;GOURLEY ROBERT NICHOLAS,,https://lens.org/158-470-128-107-306,Patent Application,yes,1,1,3,3,0,G03C7/30535;;G03C7/30558;;G03C7/30594;;Y10S430/158;;G03C7/30535;;G03C7/30558;;G03C7/30594;;Y10S430/158,G03C7/305;;G03C7/36,,0,0,,,,DISCONTINUED
547,US,A,US 5451492 A,177-730-277-037-724,1995-09-19,1995,US 21472294 A,1994-03-17,US 21472294 A,1994-03-17,Photographic elements containing certain acylacetanilide couplers in combination with development inhibitor releasing couplers,"The present invention provides a photographic element comprising a support bearing a blue light sensitive silver halide emulsion layer containing an acylacetanilide yellow image dye-forming coupler having formula I: ##STR1## wherein: R.sub.a is a substituted or unsubstituted alkyl, alkoxy, or aryloxy group; R.sub.b is a substituted or unsubstituted alkyl or aryl group; R.sub.c is hydrogen or a substituted or unsubstituted alkyl group; R.sub.1 is a substituent; R.sub.2 is selected from the group consisting of halogen, trifluoromethyl, and substituted or unsubstituted alkoxy and aryloxy; each R.sub.3 is bonded at the 4- or 5- position relative to the anilino nitrogen and is independently a substituent selected from the group consisting of halogen, alkoxycarbonyl (--CO.sub.2 R), carbamoyl (--CONRR'), sulfonate (--OSO.sub.2 R), sulfamoyl (--SO.sub.2 NRR'), sulfonyl (--SO.sub.2 R), trifluoromethyl, cyano, and sulfonamido (--NRSO.sub.2 R'), in which each R and R' is independently hydrogen or a substituent; q is 1 or 2; R.sub.4 and R.sub.5 are independently hydrogen or an alkyl group; and R.sub.6 is a substituent; n is an integer from 0 to (3-q); wherein the blue light sensitive silver halide emulsion layer has associated therewith a development inhibitor releasing coupler. The invention also provides a method of forming an image in such an element.",EASTMAN KODAK CO,MERKEL PAUL B;;POSLUSNY JERROLD N;;MERRILL JAMES P;;CLARK BERNARD A;;STANLEY PAUL L R,EASTMAN KODAK COMPANY (1994-03-28),https://lens.org/177-730-277-037-724,Granted Patent,yes,20,6,7,7,0,G03C7/30535;;G03C7/30535;;G03C7/367;;G03C7/367;;Y10S430/158,G03C7/00;;G03C7/305;;G03C7/36,430/505;;430/544;;430/957;;430/557;;430/359,0,0,,,,EXPIRED
548,US,B2,US 8969638 B2,125-685-002-906-568,2015-03-03,2015,US 201113247285 A,2011-09-28,US 201113247285 A;;US 40914510 P,2010-11-02,Depolymerizatin of plastic materials,A styrene monomer reclamation process and system is described. The styrene monomer reclamation process includes providing a waste plastic. The waste plastic includes styrenic polymers. The waste plastic is formed into polymer particles. At least a portion of the polymer particles are dissolved in a solvent to form a polymer stream. The dissolved polymer particles are depolymerized to form a styrene monomer stream.,TIPPET JON;;BUTLER JAMES R;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHEL;;CARY JEAN-BERNARD;;FINA TECHNOLOGY,TIPPET JON;;BUTLER JAMES R;;ASSEF JAMES;;ASHBAUGH JOHN;;CLARK JASON;;DUC MICHEL;;CARY JEAN-BERNARD,FINA TECHNOLOGY INC (2011-09-27),https://lens.org/125-685-002-906-568,Granted Patent,yes,24,10,7,7,0,B01J8/062;;B01J8/062;;C07C4/22;;C07C4/22;;C07C2523/04;;C07C2523/04;;C08J11/18;;C08J11/18;;C08J2325/06;;C08J2325/06;;Y02W30/62;;Y02W30/62,C07C1/00;;B01J8/06;;C07C4/22,585/241;;201/7;;201/25;;201/32;;422/131,0,0,,,,ACTIVE
549,EP,B1,EP 0681215 B1,129-341-975-488-565,1997-09-24,1997,EP 95420055 A,1995-03-03,US 21472294 A,1994-03-17,Photographic elements containing certain acylacetanilide couplers in combination with development inhibitor releasing couplers,,EASTMAN KODAK CO,MERKEL PAUL BARRETT;;POSLUSNY JERROLD NEAL;;MERRILL JAMES PARKER;;CLARK BERNARD ARTHUR;;STANLEY PAUL LOUIS R,,https://lens.org/129-341-975-488-565,Granted Patent,yes,3,0,7,7,0,G03C7/30535;;G03C7/30535;;G03C7/367;;G03C7/367;;Y10S430/158,G03C7/00;;G03C7/305;;G03C7/36,,0,0,,,,EXPIRED
550,EP,B2,EP 0206726 B2,191-177-312-728-325,1998-01-07,1998,EP 86304643 A,1986-06-16,US 74634285 A,1985-06-19,Periodontal osseous defect repair,,UNIV FLORIDA,LOW SAMUEL BERNARD;;FETNER ALAN EDWARD;;CLARK ARTHUR EDWARD JR;;HENCH LARRY LEROY;;WILSON-HENCH JUNE,THE UNIVERSITY OF FLORIDA (1990-08-01),https://lens.org/191-177-312-728-325,Granted Patent,yes,5,1,7,7,0,A61F2310/00293;;A61L24/02;;A61L27/10;;A61L2430/02;;A61L27/12;;A61F2/28;;A61L24/02;;A61F2310/00293;;A61L2430/02;;A61L27/10;;A61L27/12;;A61F2/28,A61F2/00;;A61K6/06;;A61L24/02;;A61L27/00;;A61L27/12,,1,0,,,"CERAMIC SOCIETY OF JAPAN, INTERNATIONAL CONGRESS ON GLASS, Kyoto, 8th-12th December 1974, pages 9-30 - 9-41, Ceramic Society, Kyoto, JP; L.L. HENCH: ""Biomedical applications and glass corrosion""",EXPIRED
551,EP,A3,EP 0206726 A3,039-100-419-453-548,1988-01-13,1988,EP 86304643 A,1986-06-16,US 74634285 A,1985-06-19,PERIODONTAL OSSEOUS DEFECT REPAIR,"The present invention provides a composition for repair of periodontal osseous defects based on particulate bioactive and biocompatible glass. The particulate glass has a particle size in the range of 90 to 710 µm, preferably it is a mixture of
 (1) glass having a particle size of 90 to 355 µm, (2) glass having a particle size of 355 to 500 µm, and (3) glass having a particle size of 500 to 710 µm. The glass composition is as follows:
",UNIVERSITY OF FLORIDA,"LOW, SAMUEL BERNARD;;FETNER, ALAN EDWARD;;CLARK, ARTHUR EDWARD, JR.;;HENCH, LARRY LEROY;;WILSON-HENCH, JUNE",THE UNIVERSITY OF FLORIDA (1990-08-01),https://lens.org/039-100-419-453-548,Search Report,yes,5,0,7,7,0,A61F2310/00293;;A61L24/02;;A61L27/10;;A61L2430/02;;A61L27/12;;A61F2/28;;A61L24/02;;A61F2310/00293;;A61L2430/02;;A61L27/10;;A61L27/12;;A61F2/28,A61F2/00;;A61K6/06;;A61L24/02;;A61L27/00;;A61L27/12,,1,0,,,"CERAMIC SOCIETY OF JAPAN, INTERNATIONAL CONGRESS ON GLASS, Kyoto, 8th-12th December 1974, pages 9-30 - 9-41, Ceramic Society, Kyoto, JP; L.L. HENCH: ""Biomedical applications and glass corrosion""",EXPIRED
552,GB,A,GB 894919 A,049-870-448-566-609,1962-04-26,1962,GB 3235559 A,1959-09-23,GB 3235559 A,1959-09-23,Process for producing coated particles,"Particles of fertilizer are coated with e.g. calcium carbonate, china clay or plaster of Paris, by contacting them with a hot gas to make their surfaces liquid or plastic and then feeding them to a dish granulator e.g. of the kind described in Specification 811,610, containing the coating material. The fertilizer may be urea alone or mixed with ammonium sulphate and/or potassium chloride or in a specific example 10% ammonium nitrate, 70% ammonium sulphate and 20% potassium chloride, by weight.ALSO:Particles of e.g. urea are coated with e.g. calcium carbonate, china clay or plaster of Paris by contacting them with a hot gas to make their surfaces liquid or plastic and then feeding them to a dish granulator, e.g. of the kind described in Specification 811,610, containing the coating material. The particles are preferably introduced at a zone containing coating material but few particles.",ICI LTD,BRADFORD BERNARD WILLIAM;;BLOOM MARTIN S;;HESLOP JOHN RICHARD WILLIAM;;LORD LESLIE WADDINGTON;;WILLIAMS JOHN CLARK,,https://lens.org/049-870-448-566-609,Granted Patent,no,0,2,1,1,0,B01J2/006;;C05C9/005,B01J2/00;;C05C9/00,B5A AT24P         AT24P;;B5A A1R102        AT24P;;B5A A2A4B         AT24P;;C1B BBC           BBC,0,0,,,,EXPIRED
553,US,A1,US 2010/0043375 A1,047-370-323-639-698,2010-02-25,2010,US 60993209 A,2009-10-30,US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Combine Harvester Draper Header Having Flexible Cutterbar,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor fixed relative to the flexible cutterbar assembly, while another has the draper assemblies and central conveyer flexible with the cutterbar assembly.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/047-370-323-639-698,Patent Application,yes,99,8,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,56/181,0,0,,,,ACTIVE
554,US,A1,US 2008/0248433 A1,059-914-248-750-035,2008-10-09,2008,US 57466904 A,2004-10-01,GB 0323280 A;;GB 2004004184 W,2003-10-04,PHOTOGRAPHIC ELEMENT CONTAINING A SPEED-ENHANCING COMPOUND,"The invention provides a colour photographic element comprising at least one light-sensitive silver halide emulsion layer or a non silver-containing light-insensitive layer, in which at least one of these layers contains a colourless imidazole compound of formula (I) that undergoes less than 10% chemical or redox reaction directly with oxidized developer and which has a partition coefficient to enable the photographic speed of the element to be increased by at least 0.03 stop without increasing granularity, compared to the same element without the compound, wherein the compound of formula: (I) has the structure: wherein X is H or a substituent; Z represents the atoms necessary to complete an unsubstituted or substituted imidazole ring, which may form part of a fused unsubstituted or substituted ring system containing no further ring heteroatoms; wherein there is present at least one —NH group either in the imidazole ring or directly attached to the imidazole ring as part of X; provided that (a) when Z represents the atoms necessary to complete an unsubstituted or substituted benzimidazole ring, an —NH group is directly attached to the imidazole ring as part of X, and X is located between the imidazole nitrogen atoms; (b) when the —N—H group is located in the ring adjacent to the carbon atom bearing X, and X is located between the imidazole nitrogen atoms, the imidazole ring is not fused to a phenanthrene ring. The compounds of formula (I) increase speed without a concomitant increase in size of the light-sensitive silver halide grains.",CLARK BERNARD A;;ALLWAY PHILIP A;;ZUBERI TANIA;;SINGER STEPHEN P;;HECKLER CHARLES E;;FRIEDRICH LOUIS E,CLARK BERNARD A;;ALLWAY PHILIP A;;ZUBERI TANIA;;SINGER STEPHEN P;;HECKLER CHARLES E;;FRIEDRICH LOUIS E,EASTMAN KODAK COMPANY (2006-03-10),https://lens.org/059-914-248-750-035,Patent Application,yes,1,0,4,4,0,G03C7/3022;;G03C7/3029;;G03C7/3924;;G03C7/39252;;G03C2001/03511;;G03C2007/3034;;G03C7/39252;;G03C7/3022;;G03C7/3029;;G03C7/3924;;G03C2007/3034;;G03C2001/03511,G03C7/26;;G03C7/30;;G03C7/392,430/542,0,0,,,,INACTIVE
555,CA,C,CA 2847627 C,126-162-970-287-534,2015-08-11,2015,CA 2847627 A,2007-02-02,US 77198106 P;;US 67029507 A;;CA 2640605 A,2006-02-10,COMBINE HARVESTER DRAPER HEADER HAVING FLEXIBLE CUTTERBAR,"A harvesting header (100) comprises a header frame and a cutterbar assembly (128) mounted to the header frame and extending transversely to the normal direction of travel of the header. An endless flexible draper belt (202) is rotatably supported on the header frame rearwardly of the crop-cutting assembly to receive severed crop material from the crop-cutting assembly and convey the materials laterally. The draper belt (202) presents laterally extending, spaced apart leading and trailing edges relative to the normal direction of header travel, and an outwardly facing crop-engaging surface defined between the edges. An upstanding continuous rib (206) projects outwardly from the crop-engaging surface adjacent the leading edge.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/126-162-970-287-534,Granted Patent,no,0,4,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D47/00,,0,0,,,,ACTIVE
556,EP,A4,EP 2020841 A4,176-053-216-953-276,2012-07-25,2012,EP 07756629 A,2007-02-02,US 2007/0061557 W;;US 77198106 P;;US 67029507 A,2006-02-10,COMBINE HARVESTER DRAPER HEADER HAVING FLEXIBLE CUTTERBAR,,AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/176-053-216-953-276,Search Report,no,2,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00;;A01D41/14;;A01D57/20,,0,0,,,,ACTIVE
557,US,B2,US 7937920 B2,141-194-139-351-448,2011-05-10,2011,US 65125809 A,2009-12-31,US 65125809 A;;US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Combine harvester draper header having flexible cutterbar,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. The header includes laterally spaced support arms attached to and cooperatively supporting the flexible cutterbar assembly. The support arms are pivotally coupled to the frame for swinging movement about a laterally extending axis so that the cutterbar assembly is operable to flex along the length thereof in response to changes in terrain as the header is advanced.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/141-194-139-351-448,Granted Patent,yes,101,27,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,56/181,41,0,,,"AGCO, Hesston 8200 Windrower Diagram (dated 1991).;;AGCO, Hesston 8200 Windrower Operations Manual (dated 1986).;;American Society of Agricultural Engineers, Advances in Grain Header Developments, Paper No. 77-1547 (Dec. 1977).;;American Society of Agricultural Engineers, Automatic Header Height Control for Pull Type Combine Harvesters, Paper No. 77-1548 (1977).;;Deere Launches Lots of New Stuff, SAE Off-Highway Engineering Online, Apr. 2004, at 28, at http://www.sae.org/ohmag/original-eq/04-2004/.;;Doug Rich, John Deere Introduces 60 Series, High Plains Journal, Mar. 23, 2004, available at http ://www.hpj.com/archives/2004/mar04/JohnDeereintroduces60Series.cfm.;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005515 (dated Sep. 9, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005517 (dated Sep. 4, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005518 (dated Aug. 27, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005520 (dated Sep. 7, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005528 (dated Sep. 8, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005531 (dated Sep. 17, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005533 (dated Sep. 17, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005538 (dated Sep. 4, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005545 (dated Sep. 7, 2009).;;John Deere, 9660 STS and 9760 STS Combines, (Copyright dated 2003) available at http ://manuals.deere.com/omview/OMH208557-19.htm.;;John Deere, Agriculture-640D Draper (copyright dated 1996-2009) at http ://www.deere.com/servlet/ProdCatProduct?tM=FR&pNbr=0640DH.;;John Deere, All-New 60 Series Combines (dated 2003).;;John Deere, Combine/Platform/Head Model Year Changes: 1990-Present (downloaded Feb. 22, 2010) at http ://www.deere.com/en-US/ag/servicesupport/jdharvestlink/modelyearchanges.html.;;John Deere, John Deere-Parts Catalog-600 R & F Cutting Platforms (North American)-FLOAT ARM (downloaded Sep. 28, 2009) athttp ://jdpc.deere.com.;;John Deere, John Deere-Parts Catalog-600 R & F Cutting Platforms (North American) (downloaded Sep. 25, 2009) athttp ://jdpc.deere.com.;;John Deere, John Deere-Parts Catalog-635D Advanced Draper Platform (downloaded Sep. 25, 2009) athttp ://jdpc.deere.com.;;John Deere, New Equipment Combines and Headers-600 Series Hydraflex Platforms (copyright dated 1996-2003) at http://web.archive.org/web/20032004004539/www.deere.com/en-US/Product Catalog.;;John Deere, New Ten Series Combines (dated 1997).;;John Deere, Operator's Manual-600 Series Cutting Platforms, pp. 1-47 (Copyright dated 2008; various pages dated prior to 2008).;;John Deere, Operator's Manual-600 Series Cutting Platforms, pp. 48-97 (Copyright dated 2008; various pages dated prior to 2008).;;MacDon, Inc., FD70 FlexDraper Header (copyright dated 2007) at http://www.macdon.com/product.php?model=fd70&page=details-01.;;MacDon, Inc., MacDon Flex and Rigid Draper Headers for Combines (dated Feb. 2008) available at http://www.macdon.com/product.php?model=fd70&page=details-01.;;New John Deere Flex Draper??, Combine Talk Forums, (printed Jul. 8, 2008; blog entries dated prior to 2008) available at http://combine forums.proboards42.com/.;;Notice of Allowance from U.S. Appl. No. 12/533,645 (dated Jan. 29, 2010).;;Office Action from U.S. Appl. No. 12/118,440 (dated Apr. 29, 2009).;;Office Action from U.S. Appl. No. 12/118,381 (dated Jan. 2, 2009).;;Office Action from U.S. Appl. No. 12/118,444 (dated Feb. 22, 2010).;;Office Action from U.S. Appl. No. 12/118,458 (dated May 1, 2009).;;Office Action from U.S. Appl. No. 12/118,488 (dated Apr. 30, 2009).;;Office Action from U.S. Appl. No. 12/118,537 (dated May 1, 2009).;;Office Action from U.S. Appl. No. 12/183,936 (dated Dec. 17, 2008).;;Office Action from U.S. Appl. No. 12/608,670 (dated Mar. 17, 2010).;;Photographs of John Deere 925D Header (photographs taken Nov. 9, 2007).;;The Honey Bee Story, High Plains Journal (dated Jun. 21, 2006) available at http ://www.hpj.com/archives/2006/jun06/jun26/TheHoneyBeestory.cfm.;;Thomas Fredickson, Intuitive IC Op Amps, 178-179 (National Semiconductor Corp) (1984).",ACTIVE
558,US,A1,US 2009/0094957 A1,162-786-239-340-624,2009-04-16,2009,US 32405308 A,2008-11-26,US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Combine Harvester Draper Header Having Flexible Cutterbar,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor fixed relative to the flexible cutterbar assembly, while another has the draper assemblies and central conveyer flexible with the cutterbar assembly.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/162-786-239-340-624,Patent Application,yes,25,11,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,56/182;;56/181,0,0,,,,DISCONTINUED
559,WO,A3,WO 2007/095430 A3,056-464-970-460-583,2008-10-30,2008,US 2007/0061557 W,2007-02-02,US 77198106 P;;US 67029507 A,2006-02-10,COMBINE HARVESTER DRAPER HEADER HAVING FLEXIBLE CUTTERBAR,"A harvesting header (10) having a flexible cutterbar assembly (38) utilizes draper belts (52, 54) behind the cutterbar (38) to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor (72) fixed relative to the flexible cutterbar assembly (38), while another has the draper assemblies and central conveyor flexible with the cutterbar assembly (38).",AGCO CORP;;SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/056-464-970-460-583,Search Report,yes,5,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,,0,0,,,,PENDING
560,US,B2,US 8601780 B2,120-572-813-050-043,2013-12-10,2013,US 201313749808 A,2013-01-25,US 201313749808 A;;US 201213534639 A;;US 201113281564 A;;US 201113085376 A;;US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Combine harvester draper header with pivoting structure within side draper,"A harvesting header includes a header frame, a flexible cutterbar assembly mounted to the header frame, a plurality of laterally spaced apart support arms, and a draper assembly. The support arms are attached to and cooperatively support the cutterbar assembly and are pivotally coupled to the frame for swinging movement about a laterally extending axis. The draper assembly includes a side draper carried on multiple ones of the support arms so as to flex with the cutterbar assembly. The draper assembly includes rollers and a roller frame that operably interconnects the interior support arm and a respective one of the rollers.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,AGCO CORPORATION (2007-04-11),https://lens.org/120-572-813-050-043,Granted Patent,yes,14,3,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D67/00,56/208,0,0,,,,ACTIVE
561,US,B2,US 8096101 B2,174-927-206-049-170,2012-01-17,2012,US 201113085376 A,2011-04-12,US 201113085376 A;;US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Draper header having flexible cutterbar with pivotable support arms,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. The cutterbar assembly is supported by pivotable support arms such that it is operable to flex along the length thereof in response to changes in terrain as the header is advanced. One embodiment has draper assemblies and a central conveyor fixed relative to the flexible cutterbar assembly, while another has the draper assemblies and central conveyer flexible with the cutterbar assembly.",SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R;;AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,AGCO CORPORATION (2007-04-11),https://lens.org/174-927-206-049-170,Granted Patent,yes,11,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,56/181;;56/208,0,0,,,,ACTIVE
562,WO,A2,WO 2007/095430 A2,027-804-157-626-882,2007-08-23,2007,US 2007/0061557 W,2007-02-02,US 77198106 P;;US 67029507 A,2006-02-10,COMBINE HARVESTER DRAPER HEADER HAVING FLEXIBLE CUTTERBAR,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor fixed relative to the flexible cutterbar assembly, while another has the draper assemblies and central conveyer flexible with the cutterbar assembly.",AGCO CORP;;SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/027-804-157-626-882,Patent Application,yes,0,24,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,,,0,0,,,,PENDING
563,US,A1,US 2007/0128560 A1,030-597-929-811-316,2007-06-07,2007,US 57439404 A,2004-10-01,GB 0323282 A;;GB 2004004207 W,2003-10-04,Photographic element with speed-enhancing compound,"The invention provides a color photographic element comprising at least one light-sensitive silver halide emulsion layer or a non silver-containing light-insensitive layer, in which at least one of these layers contains a colorless heterocyclic compound having either one or two hetero atoms in the ring or ring system, being other than an imidazole compound, that undergoes less than 10% chemical or redox reaction directly with oxidized developer and which has a partition coefficient to enable the photographic speed of the element to be increased by at least 0.03 stop without increasing granularity, compared to the same element without the compound. The heterocyclic compounds increase speed without a concomitant increase in size of the light-sensitive silver halide grains.",CLARK BERNARD A;;ALLWAY PHILIP A;;ZUBERI TANIA;;SINGER STEPHEN P;;HECKLER CHARLES E;;FRIEDRICH LOUIS E,CLARK BERNARD A;;ALLWAY PHILIP A;;ZUBERI TANIA;;SINGER STEPHEN P;;HECKLER CHARLES E;;FRIEDRICH LOUIS E,EASTMAN KODAK COMPANY (2006-03-10),https://lens.org/030-597-929-811-316,Patent Application,yes,3,0,5,5,0,G03C7/3924;;G03C7/3924;;G03C7/3029;;G03C7/3029;;G03C7/3212;;G03C7/3212;;G03C7/39252;;G03C7/39252;;G03C7/39276;;G03C7/39276;;G03C2007/3034;;G03C2007/3034;;G03C2200/29;;G03C2200/29,G03C1/46;;G03C7/30;;G03C7/392,430/502,0,0,,,,INACTIVE
564,US,A1,US 2012/0036819 A1,066-423-438-798-715,2012-02-16,2012,US 201113281564 A,2011-10-26,US 201113281564 A;;US 201113085376 A;;US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Flexible Combine Harvester Draper Header with Pivoting Structure within Side Draper,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor fixed relative to the flexible cutterbar assembly, while another has the draper assemblies and central conveyer flexible with the cutterbar assembly.",SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R;;AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,AGCO CORPORATION (2007-04-11),https://lens.org/066-423-438-798-715,Patent Application,yes,31,1,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,56/181,0,0,,,,ACTIVE
565,BR,A2,BR PI0706916 A2,078-675-459-078-852,2011-04-12,2011,BR PI0706916 A,2007-02-02,US 77198106 P;;US 67029507 A;;US 2007/0061557 W,2006-02-10,plataforma de colheitadeira,"PLATAFORMA DE COLHEITADEIRA Uma plataforma de colheitadeira compreendendo um conjunto de barra de corte flexível usa correjas transportadoras atrás do conjunto de barra de corte para consolidar suavemente o material cortado! colhido da plantação e alimentá-lo para um ponto de descarga e alimentação, tal como para o tanque graneleiro de uma colheitadeira combinada. Uma primeira configuração compreende conjuntos transportadores (conjuntos draper) e um transportador central, fixos em relação ao conjunto de barra de corte, e uma segunda configuração compreende conjuntos de correia transportadora e um transportador central que são flexíveis em conexão com o conjunto de barra de corte.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/078-675-459-078-852,Patent Application,no,0,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,,0,0,,,,ACTIVE
566,US,B2,US 7455959 B2,008-121-978-821-667,2008-11-25,2008,US 57466904 A,2004-10-01,GB 0323280 A;;GB 2004004184 W,2003-10-04,Photographic element containing a speed-enhancing compound,"The invention provides a color photographic element comprising at least one light-sensitive silver halide emulsion layer or a non silver-containing light-insensitive layer, in which at least one of these layers contains a colorless imidazole compound of formula (I) that undergoes less than 10% chemical or redox reaction with oxidized developer and which enables the photographic speed of the element to be increased by at least 0.05 stop without increasing granularity, compared to the same element without the compound, wherein the compound of formula (I) has the structure: wherein X is H or a substituent; Z represents the atoms necessary to complete an unsubstituted or substituted imidazole ring, which may form part of a fused unsubstituted or substituted ring system containing no further ring heteroatoms;wherein there is present at least one —NH group either in the imidazole ring or directly attached to the imidazole ring as part of X;provided that (a) when Z represents the atoms necessary to complete an unsubstituted or substituted benzimidazole ring, an —NH group is directly attached to the imidazole ring as part of X, and X is located between the imidazole nitrogen atoms;(b) when the —NH group is located in the ring adjacent to the carbon atom bearing X, and X is located between the imidazole nitrogen atoms, the imidazole ring is not fused to a phenanthrene ring.The compounds of formula (I) increase speed without a concomitant increase in size of the light-sensitive silver halide grains.",EASTMAN KODAK CO,CLARK BERNARD A;;ALLWAY PHILIP A;;ZUBERI TANIA;;SINGER STEPHEN P;;HECKLER CHARLES E;;FRIEDRICH LOUIS E,EASTMAN KODAK COMPANY (2006-03-10),https://lens.org/008-121-978-821-667,Granted Patent,yes,7,0,4,4,0,G03C7/3022;;G03C7/3029;;G03C7/3924;;G03C7/39252;;G03C2001/03511;;G03C2007/3034;;G03C7/39252;;G03C7/3022;;G03C7/3029;;G03C7/3924;;G03C2007/3034;;G03C2001/03511,G03C1/46;;G03C1/06;;G03C1/08;;G03C1/36;;G03C5/18;;G03C7/30;;G03C7/392,430/546;;430/502;;430/503;;430/504;;430/505;;430/506;;430/507;;430/508;;430/509;;430/541;;430/542;;430/543;;430/599;;430/600;;430/607;;430/613;;430/614;;430/615;;430/449;;430/464;;430/401;;430/434,0,0,,,,INACTIVE
567,US,A1,US 2007/0193243 A1,060-381-114-449-948,2007-08-23,2007,US 67029507 A,2007-02-01,US 67029507 A;;US 77198106 P,2006-02-10,Combine Harvester Draper Header Having Flexible Cutterbar,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor fixed relative to the flexible cutterbar assembly, while another has the draper assemblies and central conveyer flexible with the cutterbar assembly.",SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,AGCO CORPORATION (2007-04-11),https://lens.org/060-381-114-449-948,Patent Application,yes,51,128,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,56/181,0,0,,,,DISCONTINUED
568,CA,A1,CA 2847627 A1,131-269-495-470-591,2007-08-23,2007,CA 2847627 A,2007-02-02,US 77198106 P;;US 67029507 A;;CA 2640605 A,2006-02-10,COMBINE HARVESTER DRAPER HEADER HAVING FLEXIBLE CUTTERBAR,"A harvesting header (100) comprises a header frame and a cutterbar assembly (128) mounted to the header frame and extending transversely to the normal direction of travel of the header. An endless flexible draper belt (202) is rotatably supported on the header frame rearwardly of the crop-cutting assembly to receive severed crop material from the crop-cutting assembly and convey the materials laterally. The draper belt (202) presents laterally extending, spaced apart leading and trailing edges relative to the normal direction of header travel, and an outwardly facing crop-engaging surface defined between the edges. An upstanding continuous rib (206) projects outwardly from the crop-engaging surface adjacent the leading edge.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/131-269-495-470-591,Patent Application,no,0,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D47/00,,0,0,,,,ACTIVE
569,US,A1,US 2012/0266582 A1,033-728-353-333-652,2012-10-25,2012,US 201213534639 A,2012-06-27,US 201213534639 A;;US 201113281564 A;;US 201113085376 A;;US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,COMBINE HARVESTER DRAPER HEADER WITH FLOOR PAN REARWARD OF CENTRAL DRAPER,"A harvesting header includes a header frame, a cutterbar assembly mounted to the header frame, and a conveyor assembly supported behind the cutterbar assembly to receive crop severed by the cutterbar assembly. The conveyor assembly includes a pair of side conveyors and a fore-and-aft draper located between the side conveyors. The header further includes a central crop-conveying member that overhangs the rear margin of the fore-and-aft draper and a floor pan that at least partly defines a transition area. The floor pan presents a forwardmost edge adjacent to and rearward of the rear margin. The forwardmost edge is located above a lower run of the draper to direct severed crop materials from the upper run of the draper and to facilitate crop material flow through the transition area.",SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R;;AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,AGCO CORPORATION (2007-04-11),https://lens.org/033-728-353-333-652,Patent Application,yes,0,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D61/02,56/181,0,0,,,,ACTIVE
570,CA,C,CA 2640605 C,023-303-765-581-234,2014-06-10,2014,CA 2640605 A,2007-02-02,US 77198106 P;;US 67029507 A;;US 2007/0061557 W,2006-02-10,COMBINE HARVESTER DRAPER HEADER HAVING FLEXIBLE CUTTERBAR,"A harvesting header (10) having a flexible cutterbar assembly (38) utilizes draper belts (52, 54) behind the cutterbar (38) to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor (72) fixed relative to the flexible cutterbar assembly (38), while another has the draper assemblies and central conveyor flexible with the cutterbar assembly (38).",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/023-303-765-581-234,Granted Patent,no,0,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,,0,0,,,,ACTIVE
571,US,B2,US 8230670 B2,199-075-476-212-855,2012-07-31,2012,US 201113281564 A,2011-10-26,US 201113281564 A;;US 201113085376 A;;US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Flexible combine harvester draper header with pivoting structure within side draper,"A harvesting header includes a header frame, a flexible cutterbar assembly, and a plurality of laterally spaced apart support arms that are attached to and cooperatively support the flexible cutterbar assembly. The header also includes a draper assembly with a side draper carried on multiple ones of the support arms so as to flex with the cutterbar assembly. The side draper includes an endless flexible draper belt presenting laterally endmost margins, with upper and lower crop-conveying runs extending between the margins. The header further includes pivoting structure mounted relative to the header frame at a rear pivot location so that the pivoting structure projects forwardly from the rear pivot location.",SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R;;AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,AGCO CORPORATION (2007-04-11),https://lens.org/199-075-476-212-855,Granted Patent,yes,31,4,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D67/00,56/208,0,0,,,,ACTIVE
572,EP,A2,EP 2020841 A2,103-934-478-100-283,2009-02-11,2009,EP 07756629 A,2007-02-02,US 2007/0061557 W;;US 77198106 P;;US 67029507 A,2006-02-10,COMBINE HARVESTER DRAPER HEADER HAVING FLEXIBLE CUTTERBAR,,AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/103-934-478-100-283,Patent Application,yes,0,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00;;A01D41/14;;A01D57/20,,0,0,,,,ACTIVE
573,US,B2,US 7354701 B2,097-339-256-855-427,2008-04-08,2008,US 57439404 A,2004-10-01,GB 0323282 A;;GB 2004004207 W,2003-10-04,Photographic element with speed-enhancing compound,"The invention provides a color photographic element comprising at least one light-sensitive silver halide emulsion layer or a non silver-containing light-insensitive layer, in which at least one of these layers contains a colorless heterocyclic compound having either one or two hetero atoms in the ring or ring system, being other than an imidazole compound, that undergoes less than 10% chemical or redox reaction directly with oxidized developer and which has a partition coefficient to enable the photographic speed of the element to be increased by at least 0.03 stop without increasing granularity, compared to the same element without the compound. The heterocyclic compounds increase speed without a concomitant increase in size of the light-sensitive silver halide grains.",EASTMAN KODAK CO,CLARK BERNARD A;;ALLWAY PHILIP A;;ZUBERI TANIA;;SINGER STEPHEN P;;HECKLER CHARLES E;;FRIEDRICH LOUIS E,EASTMAN KODAK COMPANY (2006-03-10),https://lens.org/097-339-256-855-427,Granted Patent,yes,5,2,5,5,0,G03C7/3924;;G03C7/3924;;G03C7/3029;;G03C7/3029;;G03C7/3212;;G03C7/3212;;G03C7/39252;;G03C7/39252;;G03C7/39276;;G03C7/39276;;G03C2007/3034;;G03C2007/3034;;G03C2200/29;;G03C2200/29,G03C1/46;;G03C1/005;;G03C1/06;;G03C1/494;;G03C7/30;;G03C7/392,430/502;;430/503;;430/504;;430/505;;430/506;;430/567;;430/600;;430/611;;430/613,0,0,,,,INACTIVE
574,GB,A,GB 2447007 A,194-538-456-051-288,2008-08-27,2008,GB 0813080 A,2007-02-02,US 2007/0061557 W;;US 77198106 P;;US 67029507 A,2006-02-10,Combine harvester draper header having flexible cutterbar,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor fixed relative to the flexible cutterbar assembly, while another has the draper assemblies and central conveyer flexible with the cutterbar assembly.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/194-538-456-051-288,Patent Application,no,0,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,,1,0,,,Not yet advised,ACTIVE
575,GB,B,GB 2447007 B,144-821-263-214-095,2011-07-20,2011,GB 0813080 A,2007-02-02,US 2007/0061557 W;;US 77198106 P;;US 67029507 A,2006-02-10,Combine harvester draper header having flexible cutterbar,,AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/144-821-263-214-095,Granted Patent,no,5,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D41/14;;A01D57/20,,1,0,,,Not yet advised,ACTIVE
576,EP,B1,EP 2020841 B1,072-220-083-567-105,2013-08-28,2013,EP 07756629 A,2007-02-02,US 2007/0061557 W;;US 77198106 P;;US 67029507 A,2006-02-10,COMBINE HARVESTER DRAPER HEADER HAVING FLEXIBLE CUTTERBAR,,AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/072-220-083-567-105,Granted Patent,yes,7,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00;;A01D41/14;;A01D57/20,,0,0,,,,ACTIVE
577,US,A1,US 2011/0185693 A1,106-675-948-962-095,2011-08-04,2011,US 201113085376 A,2011-04-12,US 201113085376 A;;US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Combine Harvester Draper Header Having Flexible Cutterbar,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor fixed relative to the flexible cutterbar assembly, while another has the draper assemblies and central conveyer flexible with the cutterbar assembly.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,AGCO CORPORATION (2007-04-11),https://lens.org/106-675-948-962-095,Patent Application,yes,11,2,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,56/181,0,0,,,,ACTIVE
578,BR,B1,BR PI0706916 B1,056-886-762-165-475,2016-01-12,2016,BR PI0706916 A,2007-02-02,US 77198106 P;;US 67029507 A;;US 2007/0061557 W,2006-02-10,plataforma de colheitadeira,"plataforma de colheitadeira uma plataforma de colheitadeira compreendendo um conjunto de barra de corte flexível usa correjas transportadoras atrás do conjunto de barra de corte para consolidar suavemente o material cortado! colhido da plantação e alimentá-lo para um ponto de descarga e alimentação, tal como para o tanque graneleiro de uma colheitadeira combinada. uma primeira configuração compreende conjuntos transportadores (conjuntos draper) e um transportador central, fixos em relação ao conjunto de barra de corte, e uma segunda configuração compreende conjuntos de correia transportadora e um transportador central que são flexíveis em conexão com o conjunto de barra de corte.",AGCO CORP,BERGKAMP ALAN R;;REGIER BERNARD D;;SAUERWEIN CHRISTOPHER T;;SCHMIDT JAMES R;;LOHRENTZ RANDY;;CLARK STANLEY R,,https://lens.org/056-886-762-165-475,Granted Patent,no,0,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,,0,0,,,,ACTIVE
579,CA,A1,CA 2640605 A1,123-211-812-686-483,2007-08-23,2007,CA 2640605 A,2007-02-02,US 77198106 P;;US 67029507 A;;US 2007/0061557 W,2006-02-10,COMBINE HARVESTER DRAPER HEADER HAVING FLEXIBLE CUTTERBAR,,AGCO CORP,SAUERWEIN CHRISTOPHER T;;REGIER BERNARD D;;LOHRENTZ RANDY;;BERGKAMP ALAN R;;CLARK STANLEY R;;SCHMIDT JAMES R,,https://lens.org/123-211-812-686-483,Patent Application,no,0,0,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,,0,0,,,,ACTIVE
580,US,B2,US 7926248 B2,082-034-091-689-747,2011-04-19,2011,US 60993209 A,2009-10-30,US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Combine harvester draper header having flexible cutterbar,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. The header includes laterally spaced support arms. The support arms are attached to the flexible cutterbar assembly and pivotally supported adjacent rear ends thereof for swinging movement about a laterally extending axis.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/082-034-091-689-747,Granted Patent,yes,105,16,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D43/00,56/181,31,0,,,"AGCO, Hesston 8200 Windrower Diagram (dated 1991).;;AGCO, Hesston 8200 Windrower Operations Manual (dated 1986).;;American Society of Agricultural Engineers, Advances in Grain Header Developments, Paper No. 77-1547 (Dec. 1977).;;American Society of Agricultural Engineers, Automatic Header Height Control for Pull Type Combine Harvesters, Paper No. 77-1548 (1977).;;Deere Launches Lots of New Stuff, SAE Off-Highway Engineering Online, Apr. 2004, at 28, at http://www.sae.org/ohmag/original-eq/04-2004/.;;Doug Rich, John Deere Introduces 60 Series, High Plains Journal, Mar. 23, 2004, available at http://www.hpj.com/archives/2004/mar04/JohnDeereintroduces60Series.cfm.;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005515 (dated Sep. 9, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005517 (dated Sep. 4, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005518 (dated Aug. 27, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005520 (dated Sep. 7, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005528 (dated Sep. 8, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005531 (dated Sep. 17, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005533 (dated Sep. 17, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005538 (dated Sep. 4, 2009).;;International Search Report and Written Opinion from PCT Serial No. PCT/IB2009/005545 (dated Sep. 7, 2009).;;John Deere, 9660 STS and 9760 STS Combines, (Copyright dated 2003) available at http://manuals.deere.com/omview/OMH208557-19.htm.;;John Deere, Agriculture-640D Draper (copyright dated 1996-2009) at http://www.deere.com/servlet/ProdCatProduct?tM=FR&pNbr=0640DH.;;John Deere, All-New 60 Series Combines (dated 2003).;;John Deere, Combine/Platform/Head Model Year Changes: 1990-Present (downloaded Feb. 22, 2010) at http://www.deere.com/en-US/ag/servicesupport/jdharvestlink/modelyearchanges.html.;;John Deere, John Deere-Parts Catalog-600 R & F Cutting Platforms (North American)-FLOAT ARM (downloaded Sep. 28, 2009) athttp://jdpc.deere.com/.;;John Deere, John Deere-Parts Catalog-600 R & F Cutting Platforms (North American) (downloaded Sep. 25, 2009) athttp://jdpc.deere.com/.;;John Deere, John Deere-Parts Catalog-635D Advanced Draper Platform (downloaded Sep. 25, 2009) athttp://jdpc.deere.com/.;;John Deere, New Equipment Combines and Headers-600 Series Hydraflex Platforms (copyright dated 1996-2003) at http://web.archive.org/web/2003004004539/www.deere.com/en-US/Product Catalog/.;;John Deere, New Ten Series Combines (dated 1997).;;John Deere, Operator's Manual-600 Series Cutting Platforms (Copyright dated 2008; various pages dated prior to 2008).;;MacDon, Inc., FD70 FlexDraper Header (copyright dated 2007) at http://www.macdon.com/product.php?model=fd70&page=details-01.;;MacDon, Inc., MacDon Flex and Rigid Draper Headers for Combines (dated Feb. 2008) available at http://www.macdon.com/product.php?model=fd70&page=details-01.;;New John Deere Flex Draper??, Combine Talk Forums, (printed Jul. 8, 2008; blog entries dated prior to 2008) available at http://combine forums.proboards42.com/.;;Photographs of John Deere 925D Header (photographs taken Nov. 9, 2007).;;The Honey Bee Story, High Plains Journal (dated Jun. 21, 2006) available at http://www.hpj.com/archives/2006/jun06/jun26/TheHoneyBeestory.cfm.;;Thomas Fredickson, Intuitive IC Op Amps, 178-179 (National Semiconductor Corp) (1984).",ACTIVE
581,US,A1,US 2010/0095646 A1,093-876-740-962-513,2010-04-22,2010,US 65125809 A,2009-12-31,US 65125809 A;;US 60993209 A;;US 32405308 A;;US 67029507 A;;US 77198106 P,2006-02-10,Combine Harvester Draper Header Having Flexible Cutterbar,"A harvesting header having a flexible cutterbar assembly utilizes draper belts behind the cutterbar assembly to gently consolidate the severed crop materials and deliver them to a point of discharge and delivery, such as to the feederhouse of a combine harvester. One embodiment has draper assemblies and a central conveyor fixed relative to the flexible cutterbar assembly, while another has the draper assemblies and central conveyer flexible with the cutterbar assembly.",AGCO CORP,SCHMIDT JAMES R;;SAUERWEIN CHRISTOPHER T;;LOHRENTZ RANDY;;REGIER BERNARD D;;CLARK STANLEY R;;BERGKAMP ALAN R,,https://lens.org/093-876-740-962-513,Patent Application,yes,99,12,33,33,0,A01D41/14;;A01D57/20;;A01D43/00;;A01D41/14;;A01D57/20;;A01D41/14;;A01D57/20;;A01D43/06,A01D34/00;;A01D43/00,56/14.3;;56/181,0,0,,,,ACTIVE
582,US,A,US 6010837 A,001-936-778-597-51X,2000-01-04,2000,US 84228197 A,1997-04-23,GB 9608886 A,1996-04-30,Silver halide photographic element comprising image dye-forming couplers,"The invention provides a photographic element comprising a silver halide emulsion layer having associated therewith an image dye-forming coupler of formula (I): ##STR1## wherein X is H or a coupling-off group, R is H; or R, R.sub.1 and R.sub.2 are the same or different and are coupler-modifying functional groups (with the provisos that (a) the moiety N(R.sub.1)COR.sub.2 may not be a carbamate, ureido or imido and (b) R.sub.1 and R.sub.2 may not both be phenyl or substituted phenyl); or R.sub.1 and R.sub.2 taken together with the nitrogen atom and the carbonyl group form a 5-10 membered heterocyclic ring which may contain one or more further heteroatoms selected from N, O and S, said heterocyclic ring being unsubstituted or substituted with one or more coupler-modifying functional groups, with the proviso that the ring is not a cyclic carbamate, ureido or imido; and wherein the coupler forms a dye with a peak absorption less than 565 nm.",EASTMAN KODAK CO,CLARK BERNARD A;;CRAWLEY MICHAEL W;;BOFF JANE S;;WATTS CHRISTINA M;;SINGER STEPHEN P;;STANLEY PAUL L,EASTMAN KODAK COMPANY (1997-06-10),https://lens.org/001-936-778-597-51X,Granted Patent,yes,12,8,7,7,0,C07D231/52;;C07D231/52;;G03C7/384;;G03C7/384,C07D231/52;;G03C7/384,430/555;;430/554;;430/502;;430/503,0,0,,,,EXPIRED
583,FR,B1,FR 2976995 B1,126-596-489-513-943,2016-07-29,2016,FR 1256047 A,2012-06-26,US 201113169343 A,2011-06-27,JOINT D'ETANCHEITE A BROSSE,,GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,,https://lens.org/126-596-489-513-943,Granted Patent,no,0,0,9,9,0,F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/127;;F05D2220/31;;F05D2220/32;;F16J15/3288,F16J15/20;;F16J15/22,,0,0,,,,ACTIVE
584,US,B2,US 6887656 B2,013-634-596-067-333,2005-05-03,2005,US 34643403 A,2003-01-17,US 34643403 A,2003-01-17,Color photographic element containing improved heterocyclic speed enhancing compound,"Disclosed is a color photographic element comprising at least one light sensitive silver halide emulsion layer containing a compound that does not react with oxidized developer, has a Log Kow high enough to improve speed, compared to the same layer without the compound, and comprises (1) a thiadiazole, or(2) an oxadiazole, or(3) a 1,2,4 triazole bearing an amido substituent, and does not contain a hydroxyl or thiol group or their tautomeric equivalents on the azole ring.",EASTMAN KODAK CO,FRIEDRICH LOUIS E;;ALLWAY PHILIP A;;BOGIE JUDITH A;;CLARK BERNARD A;;HECKLER CHARLES E;;SINGER STEPHEN P,EASTMAN KODAK COMPANY (2003-02-07),https://lens.org/013-634-596-067-333,Granted Patent,yes,8,4,5,5,0,G03C7/39256;;G03C7/39272;;G03C7/39276;;G03C7/39272;;G03C7/39256;;G03C7/39276,G03C1/10;;G03C1/28;;G03C7/392;;G03C7/305,430/550;;430/551;;430/599;;430/600;;430/607;;430/613;;430/614;;430/615;;430/627;;430/630,0,0,,,,EXPIRED
585,FR,B1,FR 2976996 B1,087-160-515-796-079,2016-07-29,2016,FR 1256073 A,2012-06-26,US 201113169365 A,2011-06-27,JOINT D'ETANCHEITE,,GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,,https://lens.org/087-160-515-796-079,Granted Patent,no,0,0,6,6,0,F16J15/3288;;F16J15/3288,F16J15/22;;F16J15/20,,0,0,,,,ACTIVE
586,DE,A1,DE 102012105477 A1,132-881-268-158-554,2012-12-27,2012,DE 102012105477 A,2012-06-22,US 201113169365 A,2011-06-27,Bürstendichtung,"Es ist eine Dichtung geschaffen, die eine Borstenpackung 600, 700, 800 mit einer ersten Borstenlage 612, 712, 812 und einer zweiten Borstenlage 614, 714, 814 aufweist. Die Borstenpackung weist wenigstens ein Segmentende 601, 602, 701, 702 auf. Die erste Borstenlage 612, 712, 812 ist konfiguriert, um die zweite Borstenlage 614, 714, 814 im Wesentlichen zu umgeben, und wenigstens eine Borste der ersten Borstenlage 612, 712, 812 weist einen ersten Durchmesser auf. Die zweite Borstenlage 614, 714, 814 ist im Wesentlichen in einem Mittelabschnitt der Borstenpackung angeordnet, und wenigstens eine Borste der zweiten Borstenlage 614, 714, 814 weist einen zweiten Durchmesser auf. Der erste Durchmesser ist größer als der zweite Durchmesser, und die Borsten der ersten Borstenlage 612, 712, 812, die in der Nähe wenigstens eines Segmentendes angeordnet sind, sind konfiguriert, um die Borsten der zweiten Borstenlage 614, 714, 814 zu schützen, die in der Nähe des wenigstens einen Segmentendes 601, 602, 701, 702 angeordnet sind.",GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,"GENERAL ELECTRIC TECHNOLOGY GMBH, CH (2023-11-23)",https://lens.org/132-881-268-158-554,Patent Application,no,0,1,6,6,0,F16J15/3288;;F16J15/3288,F16J15/16,,0,0,,,,ACTIVE
587,US,A1,US 2004/0142289 A1,132-116-757-321-49X,2004-07-22,2004,US 34643403 A,2003-01-17,US 34643403 A,2003-01-17,COLOR PHOTOGRAPHIC ELEMENT CONTAINING IMPROVED HETEROCYCLIC SPEED ENHANCING COMPOUND,"
   Disclosed is a color photographic element comprising at least one light sensitive silver halide emulsion layer containing a compound that does not react with oxidized developer, has a Log Kow high enough to improve speed, compared to the same layer without the compound, and comprises 

   (1) a thiadiazole, or 

   (2) an oxadiazole, or 

   (3) a 1,2,4 triazole bearing an amido substituent, 

   and does not contain a hydroxyl or thiol group or their tautomeric equivalents on the azole ring. 
",FRIEDRICH LOUIS E.;;ALLWAY PHILIP A.;;BOGIE JUDITH A.;;CLARK BERNARD A.;;HECKLER CHARLES E.;;SINGER STEPHEN P.,FRIEDRICH LOUIS E;;ALLWAY PHILIP A;;BOGIE JUDITH A;;CLARK BERNARD A;;HECKLER CHARLES E;;SINGER STEPHEN P,EASTMAN KODAK COMPANY (2003-02-07),https://lens.org/132-116-757-321-49X,Patent Application,yes,3,1,5,5,0,G03C7/39256;;G03C7/39272;;G03C7/39276;;G03C7/39272;;G03C7/39256;;G03C7/39276,G03C1/10;;G03C1/28;;G03C7/305;;G03C7/392,43055;;X4306,0,0,,,,EXPIRED
588,US,A1,US 2016/0298482 A1,054-983-836-595-85X,2016-10-13,2016,US 201615188108 A,2016-06-21,US 201615188108 A;;US 201113169343 A,2011-06-27,BRUSH SEAL,"A seal includes a housing having a back plate and a front plate. A supporting bristle layer is disposed adjacent to the back plate, and bristles in the supporting bristle layer have a first diameter. A sealing bristle layer is disposed adjacent to the supporting bristle layer, and bristles in the sealing bristle layer have a second diameter. A shielding/protecting bristle layer is disposed adjacent to the sealing bristle layer, and bristles in the shielding/protecting bristle layer have a third diameter. The second diameter is smaller than both the first diameter and the third diameter.",GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2016-06-13),https://lens.org/054-983-836-595-85X,Patent Application,yes,0,0,9,9,0,F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/127;;F05D2220/31;;F05D2220/32;;F16J15/3288,F01D11/12;;F16J15/3288,,0,0,,,,ACTIVE
589,US,A1,US 2019/0011002 A1,058-254-649-815-197,2019-01-10,2019,US 201816004499 A,2018-06-11,US 201816004499 A;;US 201762530468 P,2017-07-10,BRAKE SCREW FOR SURGICAL LIGHTING SYSTEMS,"A brake screw for use with a surgical lighting system. The brake screw includes a screw member retained within a threaded aperture of a mounting hub of a spindle of an arm used with the lighting system. The screw member is rotationally adjusted to enable displacement in an axial direction. A brake member is in axial alignment with the screw member and disposed for movement in the axial direction against a mounting tube retained within the mounting hub upon rotational adjustment of the screw member. A rivet section is integrally formed with the brake member and has a distal end retained within an axial recess formed within the screw member, allowing movement of the brake member in the axial direction within the screw member. A bias member is disposed between the screw member and the brake member to create a biasing force that urges apart the screw member and the brake member along the axial direction.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,AMERICAN STERILIZER COMPANY (2018-05-10),https://lens.org/058-254-649-815-197,Patent Application,yes,0,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16D65/06;;F16D49/00,,0,0,,,,ACTIVE
590,FR,A1,FR 2976995 A1,074-344-553-829-235,2012-12-28,2012,FR 1256047 A,2012-06-26,US 201113169343 A,2011-06-27,JOINT D'ETANCHEITE A BROSSE,"Joint à brosse (200) comportant un carter (205) de brosse ayant une plaque arrière (230) et une plaque avant (235), une première couche de poils (212) disposée de manière adjacente à la plaque arrière, au moins un poil de la première couche de poils ayant un premier diamètre. Une deuxième couche de poils (214) est disposée de manière adjacente à la première couche de poils, et au moins un poil de la deuxième couche de poils a un deuxième diamètre. Une troisième couche de poils (216) est disposée de manière adjacente à la deuxième couche de poils, et au moins un poil de la troisième couche de poils a un troisième diamètre. Le premier diamètre et le troisième diamètre sont plus grands que le deuxième diamètre.",GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,,https://lens.org/074-344-553-829-235,Patent Application,no,3,0,9,9,0,F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/127;;F05D2220/31;;F05D2220/32;;F16J15/3288,F16J15/20;;F16J15/22,,0,0,,,,ACTIVE
591,EP,B1,EP 3652453 B1,006-124-971-631-271,2023-12-20,2023,EP 18832922 A,2018-06-13,US 201762530468 P;;US 201816004499 A;;US 2018/0037187 W,2017-07-10,BRAKE SCREW FOR SURGICAL LIGHTING SYSTEMS,,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,,https://lens.org/006-124-971-631-271,Granted Patent,yes,15,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B35/00;;A61B90/50;;F16B5/02;;F16B35/04;;F16D59/02,,1,0,,,"Screw Protection Ends-Tips, 2 June 2015 (2015-06-02), XP055565338, Retrieved from the Internet: URL:htts://www.fastenerdata.co.uk/16f22-ti p",ACTIVE
592,EP,A4,EP 3652453 A4,037-910-696-065-617,2021-03-10,2021,EP 18832922 A,2018-06-13,US 201762530468 P;;US 201816004499 A;;US 2018/0037187 W,2017-07-10,BRAKE SCREW FOR SURGICAL LIGHTING SYSTEMS,,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,,https://lens.org/037-910-696-065-617,Search Report,no,5,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B35/00;;A61B90/50;;F16B5/02;;F16B35/04;;F16D59/02,,1,0,,,See also references of WO 2019013916A1,ACTIVE
593,EP,A3,EP 1312979 A3,079-906-584-743-489,2003-06-04,2003,EP 02079243 A,2002-10-14,US 152201 A,2001-10-24,Color photographic element containing speed-improving benzotriazole polymer,"Disclosed is color silver halide photographic element comprising a light-sensitive silver halide emulsion layer or a non-silver containing light-insensitive layer, said light-sensitive or light-insensitive layer containing a polymer compound comprising a repeating benzotriazole subunit wherein a) the benzotriazole monomer corresponding to the benzotriazole subunit has a Calculated logP of at least 3.1 and less than 6.2; or b) the benzotriazole monomer corresponding to the benzotriazole subunit has a Calculated logP of less than 3.1 and the polymer additionally comprises a co-monomer with Calculated logP of 0.5 or greater;     and the amount of the polymer compound in the element is sufficient to increase the photographic speed of the element compared to the same element without the polymer compound.",EASTMAN KODAK CO,SINGER STEPHEN PAUL;;ROSS DAVID STANTON;;CLARK BERNARD A;;ALLWAY PHILIP ARTHUR;;BAILEY DAVID BENEDICT;;FRIEDRICH LOUIS ELBERT,,https://lens.org/079-906-584-743-489,Search Report,yes,4,0,4,4,0,G03C7/396;;G03C7/396,G03C1/34;;G03C7/396;;G03C7/392,,0,0,,,,DISCONTINUED
594,US,S,US D0685470 S,118-203-036-207-740,2013-07-02,2013,US 201229395477 F,2012-01-27,US 201229395477 F,2012-01-27,Medical device housing,,SCHROEDER DENNIS;;SCHMID ERIC;;OLSON ERIC;;CLARK CHRIS;;ABARBANEL JONATHAN;;LO BERNARD;;WILLIAMS ERIN;;KOSSAYAN CYNTHIA;;KARTEN STUART;;VESSIX VASCULAR INC,SCHROEDER DENNIS;;SCHMID ERIC;;OLSON ERIC;;CLARK CHRIS;;ABARBANEL JONATHAN;;LO BERNARD;;WILLIAMS ERIN;;KOSSAYAN CYNTHIA;;KARTEN STUART,VESSIX VASCULAR INC (2012-05-24);;BOSTON SCIENTIFIC SCIMED INC (2012-11-19),https://lens.org/118-203-036-207-740,Design Right,no,0,0,3,3,0,,,2402;;D24/144;;D24/107,0,0,,,,ACTIVE
595,MX,A,MX 2019014552 A,183-809-791-290-887,2020-02-07,2020,MX 2019014552 A,2018-06-13,US 201762530468 P;;US 201816004499 A;;US 2018/0037187 W,2017-07-10,BRAKE SCREW FOR SURGICAL LIGHTING SYSTEMS.,"A brake screw for use with a surgical lighting system. The brake screw includes a screw member retained within a threaded aperture of a mounting hub of a spindle of an arm used with the lighting system. The screw member is rotationally adjusted to enable displacement in an axial direction. A brake member is in axial alignment with the screw member and disposed for movement in the axial direction against a mounting tube retained within the mounting hub upon rotational adjustment of the screw member. A rivet section is integrally formed with the brake member and has a distal end retained within an axial recess formed within the screw member, allowing movement of the brake member in the axial direction within the screw member. A bias member is disposed between the screw member and the brake member to create a biasing force that urges apart the screw member and the brake member along the axial direction.",AMERICAN STERILIZER CO,LANCE CLARK BELLOWS;;MICHAEL JOSEPH HESER;;CHRISTOPHER ROY MOHR;;BERNARD JOHN MOSS;;JERIME JOSEF PICHLER;;CRISTIAN LAURENTIU TOTH,,https://lens.org/183-809-791-290-887,Patent Application,no,0,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B35/00;;F16B35/04,,0,0,,,,PENDING
596,DE,B4,DE 102012105477 B4,187-355-552-994-993,2021-08-19,2021,DE 102012105477 A,2012-06-22,US 201113169365 A,2011-06-27,Bürstendichtung,"Dichtung, die aufweist:eine Borstenpackung (500, 600, 800, 900, 1000), die eine erste Borstenlage (512, 612, 812, 912, 1012) und eine zweite Borstenlage (514, 614, 814, 914, 1014) aufweist, wobei die Borstenpackung (500, 600, 800, 900, 1000) wenigstens ein Segmentende (601, 602, 901, 902, 1001, 1002) aufweist;wobei die erste Borstenlage (512, 612, 812, 912, 1012) konfiguriert ist, um die zweite Borstenlage (514, 614, 814, 914, 1014) im Wesentlichen zu umgeben, wobei wenigstens eine Borste der ersten Borstenlage (512, 612, 812, 912, 1012) einen ersten Durchmesser aufweist;wobei die zweite Borstenlage (514, 614, 814, 914, 1014) im Wesentlichen in einem Mittelabschnitt der Borstenpackung (500, 600, 800, 900, 1000) angeordnet ist, wobei wenigstens eine Borste der zweiten Borstenlage (514, 614, 814, 914, 1014) einen zweiten Durchmesser aufweist;wobei der erste Durchmesser größer ist als der zweite Durchmesser und die Borsten der ersten Borstenlage (512, 612, 812, 912, 1012), die in der Nähe des wenigstens einen Segmentendes (601, 602, 901, 902, 1001, 1002) angeordnet sind, konfiguriert sind, um die Borsten der zweiten Borstenlage (514, 614, 814, 914, 1014) zu schützen, die in der Nähe des wenigstens einen Segmentendes (601, 602, 901, 902, 1001, 1002) angeordnet sind; gekennzeichnet durcheine dritte Borstenlage (516, 616, 816, 916, 1016), die benachbart zu der zweiten Borstenlage (514, 614, 814, 914, 1014) angeordnet ist, wobei wenigstens eine Borste der dritten Borstenlage (516, 616, 816, 916, 1016) einen dritten Durchmesser aufweist, wobei der dritte Durchmesser größer ist als der zweite Durchmesser.",GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,"GENERAL ELECTRIC TECHNOLOGY GMBH, CH (2023-11-23)",https://lens.org/187-355-552-994-993,Granted Patent,no,2,0,6,6,0,F16J15/3288;;F16J15/3288,F16J15/16;;F01D11/00;;F02C7/28,,0,0,,,,ACTIVE
597,US,A1,US 2012/0326393 A1,163-307-689-939-429,2012-12-27,2012,US 201113169365 A,2011-06-27,US 201113169365 A,2011-06-27,BRUSH SEAL,"A seal is provided having a bristle pack with a first layer of bristles and a second layer of bristles. The bristle pack has at least one segment end. The first layer of bristles is configured to substantially surround the second layer of bristles, and at least one of the first layer of bristles has a first diameter. The second layer of bristles are located substantially in a center portion of the bristle pack, and at least one of the second layer of bristles has a second diameter. The first diameter is larger than the second diameter, and the first layer of bristles located near the at least one segment end are configured to protect the second layer of bristles located near the at least one segment end.",ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES;;GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,GENERAL ELECTRIC COMPANY (2011-06-20),https://lens.org/163-307-689-939-429,Patent Application,yes,20,10,6,6,0,F16J15/3288;;F16J15/3288,F01D11/02;;F16J15/44,277/355,0,0,,,,DISCONTINUED
598,US,B2,US 9926800 B2,172-868-163-926-056,2018-03-27,2018,US 201615188108 A,2016-06-21,US 201615188108 A;;US 201113169343 A,2011-06-27,Brush seal,"A seal includes a housing having a back plate and a front plate. A supporting bristle layer is disposed adjacent to the back plate, and bristles in the supporting bristle layer have a first diameter. A sealing bristle layer is disposed adjacent to the supporting bristle layer, and bristles in the sealing bristle layer have a second diameter. A shielding/protecting bristle layer is disposed adjacent to the sealing bristle layer, and bristles in the shielding/protecting bristle layer have a third diameter. The second diameter is smaller than both the first diameter and the third diameter.",GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2016-06-13),https://lens.org/172-868-163-926-056,Granted Patent,yes,30,0,9,9,0,F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/127;;F05D2220/31;;F05D2220/32;;F16J15/3288,F16J15/3288;;F01D11/00;;F01D11/12,,0,0,,,,ACTIVE
599,JP,A,JP 2004226971 A,036-307-683-641-272,2004-08-12,2004,JP 2004009499 A,2004-01-16,US 34643403 A,2003-01-17,COLOR PHOTOGRAPHIC ELEMENT CONTAINING IMPROVED HETEROCYCLIC SPEED ENHANCING COMPOUND,"<P>PROBLEM TO BE SOLVED: To provide a silver halide photographic element with an additive which ensures little or no decrease in interimage effects, has improved melt-hold stability, and imparts improved speed. <P>SOLUTION: The color photographic element comprises at least one photosensitive silver halide emulsion layer containing a compound which does not react with an oxidized developing agent, wherein the compound has such sufficiently high LogKow as to improve sensitivity as compared with the same layer not containing the compound, and the compound comprises (1) thiadiazole or (2) oxadiazole or (3) 1,2,4-triazole having an amido substituent and does not contain hydroxy group or thiol group or their tautomeric equivalents on the azole ring. <P>COPYRIGHT: (C)2004,JPO&NCIPI",EASTMAN KODAK CO,FRIEDRICH LOUIS E;;ALLWAY PHILIP A;;BOGIE JUDITH A;;BERNARD A CLARK;;HECKLER CHARLES E;;SINGER STEPHEN P,,https://lens.org/036-307-683-641-272,Patent Application,no,0,1,5,5,0,G03C7/39256;;G03C7/39272;;G03C7/39276;;G03C7/39272;;G03C7/39256;;G03C7/39276,G03C1/10;;G03C1/28;;G03C7/392;;G03C7/305,,0,0,,,,PENDING
600,JP,A,JP 2003131350 A,031-754-399-916-868,2003-05-09,2003,JP 2002306795 A,2002-10-22,US 152201 A,2001-10-24,COLOR PHOTOGRAPHIC ELEMENT,"PROBLEM TO BE SOLVED: To provide a color photographic element whose photographic speed has been improved. SOLUTION: The silver halide color photographic element comprises a light- sensitive silver halide emulsion layer or a silver-free light-insensitive layer, a polymer compound including benzotriazole type repeating subunits is contained in the light-sensitive emulsion layer or the light-insensitive layer, a) the calculated logP value of a benzotriazole monomer corresponding to the benzotriazole type subunits is 3.1 to <6.2 or b) the calculated logP value of the benzotriazole monomer corresponding to the benzotriazole type subunits is <3.1 and the polymer further contains a comonomer whose calculated logP value is >=0.5, and the polymer compound is sufficiently contained so that the photographic speed of the photographic element is made higher than that of the same photographic element except for the fact that the polymer compound is not contained.",EASTMAN KODAK CO,SINGER STEPHEN P;;ROSS DAVID STANTON;;BERNARD A CLARK;;PHILLIP ARTHUR ALLWAY;;BAILEY DAVID BENEDICT;;FRIEDRICH LOUIS ELBERT,,https://lens.org/031-754-399-916-868,Patent Application,no,0,0,4,4,0,G03C7/396;;G03C7/396,G03C1/34;;G03C7/396;;G03C7/392,,0,0,,,,PENDING
601,WO,A1,WO 2019/013916 A1,085-144-121-119-478,2019-01-17,2019,US 2018/0037187 W,2018-06-13,US 201816004499 A;;US 201762530468 P,2017-07-10,BRAKE SCREW FOR SURGICAL LIGHTING SYSTEMS,"A brake screw for use with a surgical lighting system. The brake screw includes a screw member retained within a threaded aperture of a mounting hub of a spindle of an arm used with the lighting system. The screw member is rotationally adjusted to enable displacement in an axial direction. A brake member is in axial alignment with the screw member and disposed for movement in the axial direction against a mounting tube retained within the mounting hub upon rotational adjustment of the screw member. A rivet section is integrally formed with the brake member and has a distal end retained within an axial recess formed within the screw member, allowing movement of the brake member in the axial direction within the screw member. A bias member is disposed between the screw member and the brake member to create a biasing force that urges apart the screw member and the brake member along the axial direction.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,,https://lens.org/085-144-121-119-478,Patent Application,yes,10,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B35/00;;F16B35/04,,2,0,,,"SCREW PROTECTION ENDS-TIPS, 2 June 2015 (2015-06-02), XP055565338, Retrieved from the Internet <URL:htts://www.fastenerdata.co.uk/16f22-tip>;;See also references of EP 3652453A4",PENDING
602,EP,A1,EP 3652453 A1,134-637-421-265-144,2020-05-20,2020,EP 18832922 A,2018-06-13,US 201762530468 P;;US 201816004499 A;;US 2018/0037187 W,2017-07-10,BRAKE SCREW FOR SURGICAL LIGHTING SYSTEMS,,AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,,https://lens.org/134-637-421-265-144,Patent Application,yes,0,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B35/00;;F16B35/04,,0,0,,,,ACTIVE
603,FR,A1,FR 2976996 A1,172-100-134-699-386,2012-12-28,2012,FR 1256073 A,2012-06-26,US 201113169365 A,2011-06-27,JOINT D'ETANCHEITE,"Joint d'étanchéité comportant un groupe (600) de poils avec une première couche de poils (612) et une deuxième couche de poils (614). Le groupe de poils a au moins une extrémité (601, 602) de segment. La première couche de poils (612) est conçue de manière à sensiblement entourer la deuxième couche de poils (614), et au moins un poil de la première couche de poils (612) a un premier diamètre. La deuxième couche de poils (614) est située sensiblement dans une partie centrale du groupe de poils, et au moins un poil de la deuxième couche de poils (614) a un deuxième diamètre. Le premier diamètre est plus grand que le deuxième diamètre, et la première couche de poils (612) située près de la/des extrémité(s) de segment(s) est conçue de manière à protéger la deuxième couche de poils (614) située près de la/des extrémités (601, 602) de segment(s).",GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,,https://lens.org/172-100-134-699-386,Patent Application,no,2,0,6,6,0,F16J15/3288;;F16J15/3288,F16J15/22;;F16J15/20,,0,0,,,,ACTIVE
604,EP,A1,EP 1439416 A1,074-808-865-995-93X,2004-07-21,2004,EP 04075036 A,2004-01-07,US 34643403 A,2003-01-17,Color photographic element containing improved heterocyclic speed enhancing compound,"Disclosed is a color photographic element comprising at least one light sensitive silver halide emulsion layer containing a compound that does not react with oxidized developer, has a Log Kow high enough to improve speed, compared to the same layer without the compound, and comprises
 (1) a thiadiazole, or (2) an oxadiazole, or (3) a 1,2,4 triazole bearing an amido substituent,  and does not contain a hydroxyl or thiol group or their tautomeric equivalents on the azole ring.",EASTMAN KODAK CO,FRIEDRICH LOUIS E;;ALLWAY PHILIP A;;BOGIE JUDITH A;;CLARK BERNARD A;;HECKLER CHARLES E;;SINGER STEPHEN P,,https://lens.org/074-808-865-995-93X,Patent Application,yes,2,0,5,5,0,G03C7/39256;;G03C7/39272;;G03C7/39276;;G03C7/39272;;G03C7/39256;;G03C7/39276,G03C1/10;;G03C7/305;;G03C1/28;;G03C7/392,,0,0,,,,DISCONTINUED
605,ES,T3,ES 2152570 T3,155-460-428-223-511,2001-02-01,2001,ES 96937681 T,1996-10-11,US 555195 P,1995-10-18,ARTICULOS MAGNETICOS CONFORMABLES APLICADOS DEBAJO DE SUPERFICIES QUE SOPORTAN TRAFICO.,SE DESCRIBE UN ARTICULO (300) MAGNETICO CONFORMABLE PARA UNA CAPA SUBYACENTE A UNA SUPERFICIE QUE SOPORTA TRAFICO QUE ENVIA SEÑALES MAGNETICAS A UN SENSOR QUE SE DESPLAZA SOBRE LA ESTRUCTURA QUE SOPORTA EL TRAFICO. EL ARTICULO MAGNETICO COMPRENDE AL MENOS UNA CAPA (2) MAGNETICA CONFORMABLE QUE COMPRENDE UN AGENTE AGLUTINANTE Y UNA CANTIDAD SUFICIENTE DE PARTICULAS MAGNETICAS DISPERSADAS DENTRO DEL AGENTE AGLUTINANTE PARA SUMINISTRAR UNA SEÑAL MAGNETICA A UN SENSOR ATRAVESANDO LA ESTRUCTURAS QUE SOPORTA EL TRAFICO.,MINNESOTA MINING & MFG,CLARK GARY W;;DAHLIN THOMAS J;;FAYLING RICHARD E;;GONZALEZ BERNARD A;;HOPSTOCK DAVID M;;JACOBS GREGORY F,,https://lens.org/155-460-428-223-511,Granted Patent,no,0,0,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,EXPIRED
606,DE,A1,DE 102012105476 A1,177-957-968-290-477,2012-12-27,2012,DE 102012105476 A,2012-06-22,US 201113169343 A,2011-06-27,Bürstendichtung,"Es ist eine Bürstendichtung (200, 300, 400, 500) geschaffen, die ein Bürstengehäuse (205, 305, 405, 505) mit einer Rückplatte (230, 330, 430, 530) und einer Frontplatte (235, 335, 435, 535) und eine erste Borstenlage (212, 312, 412, 512) aufweist, die benachbart zu der Rückplatte angeordnet ist, wobei wenigstens eine Borste der ersten Borstenlage einen ersten Durchmesser aufweist. Eine zweite Borstenlage (214, 314, 414, 514) ist benachbart zu der ersten Borstenlage angeordnet, und wenigstens eine Borste der zweiten Borstenlage weist einen zweiten Durchmesser auf. Eine dritte Borstenlage (216, 316, 416, 516) ist benachbart zu der zweiten Borstenlage angeordnet, und wenigstens eine Borste der dritten Borstenlage weist einen dritten Durchmesser auf. Der erste Durchmesser und der dritte Durchmesser sind größer als der zweite Durchmesser.",GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,"GENERAL ELECTRIC TECHNOLOGY GMBH, CH (2024-02-19)",https://lens.org/177-957-968-290-477,Patent Application,no,0,0,9,9,0,F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/127;;F05D2220/31;;F05D2220/32;;F16J15/3288,F01D11/00,,0,0,,,,PENDING
607,AU,A1,AU 2018/299788 A1,178-604-462-246-199,2019-12-12,2019,AU 2018/299788 A,2018-06-13,US 201762530468 P;;US 201816004499 A;;US 2018/0037187 W,2017-07-10,Brake screw for surgical lighting systems,"A brake screw for use with a surgical lighting system. The brake screw includes a screw member retained within a threaded aperture of a mounting hub of a spindle of an arm used with the lighting system. The screw member is rotationally adjusted to enable displacement in an axial direction. A brake member is in axial alignment with the screw member and disposed for movement in the axial direction against a mounting tube retained within the mounting hub upon rotational adjustment of the screw member. A rivet section is integrally formed with the brake member and has a distal end retained within an axial recess formed within the screw member, allowing movement of the brake member in the axial direction within the screw member. A bias member is disposed between the screw member and the brake member to create a biasing force that urges apart the screw member and the brake member along the axial direction.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,,https://lens.org/178-604-462-246-199,Patent Application,no,0,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B35/00;;F16B35/04,,0,0,,,,ACTIVE
608,CA,C,CA 3064488 C,147-098-847-084-553,2022-04-05,2022,CA 3064488 A,2018-06-13,US 201762530468 P;;US 201816004499 A;;US 2018/0037187 W,2017-07-10,BRAKE SCREW FOR SURGICAL LIGHTING SYSTEMS,"A brake screw for use with a surgical lighting system. The brake screw includes a screw member retained within a threaded aperture of a mounting hub of a spindle of an arm used with the lighting system. The screw member is rotationally adjusted to enable displacement in an axial direction. A brake member is in axial alignment with the screw member and disposed for movement in the axial direction against a mounting tube retained within the mounting hub upon rotational adjustment of the screw member. A rivet section is integrally formed with the brake member and has a distal end retained within an axial recess formed within the screw member, allowing movement of the brake member in the axial direction within the screw member. A bias member is disposed between the screw member and the brake member to create a biasing force that urges apart the screw member and the brake member along the axial direction.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,,https://lens.org/147-098-847-084-553,Granted Patent,no,0,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B35/00;;F16B35/04,,0,0,,,,PENDING
609,EP,A2,EP 1312979 A2,025-277-601-008-489,2003-05-21,2003,EP 02079243 A,2002-10-14,US 152201 A,2001-10-24,Color photographic element containing speed-improving benzotriazole polymer,"Disclosed is color silver halide photographic element comprising a light-sensitive silver halide emulsion layer or a non-silver containing light-insensitive layer, said light-sensitive or light-insensitive layer containing a polymer compound comprising a repeating benzotriazole subunit wherein
 a) the benzotriazole monomer corresponding to the benzotriazole subunit has a Calculated logP of at least 3.1 and less than 6.2; or b) the benzotriazole monomer corresponding to the benzotriazole subunit has a Calculated logP of less than 3.1 and the polymer additionally comprises a co-monomer with Calculated logP of 0.5 or greater;     and the amount of the polymer compound in the element is sufficient to increase the photographic speed of the element compared to the same element without the polymer compound.",EASTMAN KODAK CO,SINGER STEPHEN PAUL;;ROSS DAVID STANTON;;CLARK BERNARD A;;ALLWAY PHILIP ARTHUR;;BAILEY DAVID BENEDICT;;FRIEDRICH LOUIS ELBERT,,https://lens.org/025-277-601-008-489,Patent Application,yes,0,0,4,4,0,G03C7/396;;G03C7/396,G03C7/392;;G03C1/34;;G03C7/396,,0,0,,,,DISCONTINUED
610,US,B2,US 10473172 B2,078-030-823-266-609,2019-11-12,2019,US 201816004499 A,2018-06-11,US 201816004499 A;;US 201762530468 P,2017-07-10,Brake screw for surgical lighting systems,"A brake screw for use with a surgical lighting system. The brake screw includes a screw member retained within a threaded aperture of a mounting hub of a spindle of an arm used with the lighting system. The screw member is rotationally adjusted to enable displacement in an axial direction. A brake member is in axial alignment with the screw member and disposed for movement in the axial direction against a mounting tube retained within the mounting hub upon rotational adjustment of the screw member. A rivet section is integrally formed with the brake member and has a distal end retained within an axial recess formed within the screw member, allowing movement of the brake member in the axial direction within the screw member. A bias member is disposed between the screw member and the brake member to create a biasing force that urges apart the screw member and the brake member along the axial direction.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,AMERICAN STERILIZER COMPANY (2018-05-10),https://lens.org/078-030-823-266-609,Granted Patent,yes,25,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B21/00;;F16D49/00;;F16D65/06;;F16D65/097;;F16D125/40,,1,0,,,"Fastenerdata (Screw Protection Ends-Tips), Jun. 2, 2015, https://www.fastenerdata.co.ukl16f22-tip; Fig. 2.",ACTIVE
611,AU,B2,AU 2018/299788 B2,072-205-265-934-791,2020-08-27,2020,AU 2018/299788 A,2018-06-13,US 201762530468 P;;US 201816004499 A;;US 2018/0037187 W,2017-07-10,Brake screw for surgical lighting systems,"A brake screw for use with a surgical lighting system. The brake screw includes a screw member retained within a threaded aperture of a mounting hub of a spindle of an arm used with the lighting system. The screw member is rotationally adjusted to enable displacement in an axial direction. A brake member is in axial alignment with the screw member and disposed for movement in the axial direction against a mounting tube retained within the mounting hub upon rotational adjustment of the screw member. A rivet section is integrally formed with the brake member and has a distal end retained within an axial recess formed within the screw member, allowing movement of the brake member in the axial direction within the screw member. A bias member is disposed between the screw member and the brake member to create a biasing force that urges apart the screw member and the brake member along the axial direction.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,,https://lens.org/072-205-265-934-791,Granted Patent,no,6,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B35/00;;F16B35/04,,0,0,,,,ACTIVE
612,US,A1,US 2012/0326392 A1,095-050-560-364-040,2012-12-27,2012,US 201113169343 A,2011-06-27,US 201113169343 A,2011-06-27,BRUSH SEAL,"A brush seal is provided having a brush housing having a back plate and a front plate, a first layer of bristles disposed adjacent to the back plate, where at least one of the first layer of bristles has a first diameter. A second layer of bristles are disposed adjacent to the first layer of bristles, and at least one of the second layer of bristles has a second diameter. A third layer of bristles are disposed adjacent to the second layer of bristles, and at least one of the third layer of bristles has a third diameter. The first diameter and the third diameter are larger than the second diameter.",ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES;;GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2012-05-23),https://lens.org/095-050-560-364-040,Patent Application,yes,21,11,9,9,0,F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/127;;F05D2220/31;;F05D2220/32;;F16J15/3288,F16J15/44;;F01D11/02,277/355,0,0,,,,ACTIVE
613,US,B1,US 6589724 B1,033-562-576-282-410,2003-07-08,2003,US 152201 A,2001-10-24,US 152201 A,2001-10-24,Color photographic element containing speed-improving benzotriazole polymer,"
    Disclosed is color silver halide photographic element comprising a light-sensitive silver halide emulsion layer or a non-silver containing light-insensitive layer, said light-sensitive or light-insensitive layer containing a polymer compound comprising a repeating benzotriazole subunit wherein 

    a) the benzotriazole monomer corresponding to the benzotriazole subunit has a Calculated logP of at least 3.1 and less than 6.2; or 

    b) the benzotriazole monomer corresponding to the benzotriazole subunit has a Calculated logP of less than 3.1 and the polymer additionally comprises a co-monomer with Calculated logP of 0.5 or greater, 

    and the amount of the polymer compound in the element is sufficient to increase the photographic speed of the element compared to the same element without the polymer compound. 
",EASTMAN KODAK CO,SINGER STEPHEN P;;ROSS DAVID S;;CLARK BERNARD A;;ALLWAY PHILIP A;;BAILEY DAVID B;;FRIEDRICH LOUIS E,EASTMAN KODAK COMPANY (2001-10-12),https://lens.org/033-562-576-282-410,Granted Patent,yes,2,2,4,4,0,G03C7/396;;G03C7/396,G03C1/34;;G03C7/392;;G03C7/396,430/627,2,0,,,"P. A. Allway et al, ""Color Photographic Element Containing Speed Improving Compound"", U.S. patent application Ser. No. 09/358,057 (D-78393) filed Jul. 21, 1999.;;P. A. Allway et al, ""Color Photographic Element Containing Speed-Improving Polymer"", U.S. patent application Ser. No. 09/540,808 (D-80060) filed Mar. 31, 2000.",EXPIRED
614,US,B2,US 9528384 B2,052-044-998-358-525,2016-12-27,2016,US 201113169343 A,2011-06-27,US 201113169343 A,2011-06-27,Brush seal,"A brush seal is provided having a brush housing having a back plate and a front plate, a first layer of bristles disposed adjacent to the back plate, where at least one of the first layer of bristles has a first diameter. A second layer of bristles are disposed adjacent to the first layer of bristles, and at least one of the second layer of bristles has a second diameter. A third layer of bristles are disposed adjacent to the second layer of bristles, and at least one of the third layer of bristles has a third diameter. The first diameter and the third diameter are larger than the second diameter.",ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES;;GEN ELECTRIC,ZHENG XIAOQING;;COUTURE JR BERNARD ARTHUR;;BOWMAN MICHAEL JOHN;;ADIS WILLIAM EDWARD;;MACK MICHAEL DENNIS;;CLARK KIM JAMES,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2012-05-23),https://lens.org/052-044-998-358-525,Granted Patent,yes,26,4,9,9,0,F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/001;;F05D2240/56;;Y02T50/60;;F01D11/127;;F05D2220/31;;F05D2220/32;;F16J15/3288,F01D11/02;;F01D11/00;;F01D11/12;;F16J15/32,,0,0,,,,ACTIVE
615,CA,A1,CA 3064488 A1,131-510-224-166-457,2019-01-17,2019,CA 3064488 A,2018-06-13,US 201762530468 P;;US 201816004499 A;;US 2018/0037187 W,2017-07-10,BRAKE SCREW FOR SURGICAL LIGHTING SYSTEMS,"A brake screw for use with a surgical lighting system. The brake screw includes a screw member retained within a threaded aperture of a mounting hub of a spindle of an arm used with the lighting system. The screw member is rotationally adjusted to enable displacement in an axial direction. A brake member is in axial alignment with the screw member and disposed for movement in the axial direction against a mounting tube retained within the mounting hub upon rotational adjustment of the screw member. A rivet section is integrally formed with the brake member and has a distal end retained within an axial recess formed within the screw member, allowing movement of the brake member in the axial direction within the screw member. A bias member is disposed between the screw member and the brake member to create a biasing force that urges apart the screw member and the brake member along the axial direction.",AMERICAN STERILIZER CO,BELLOWS LANCE CLARK;;HESER MICHAEL JOSEPH;;MOHR CHRISTOPHER ROY;;MOSS BERNARD JOHN;;PICHLER JERIME JOSEF;;TOTH CRISTIAN LAURENTIU,,https://lens.org/131-510-224-166-457,Patent Application,no,0,0,11,11,0,F16D65/0971;;F16D2125/40;;F16D49/00;;F16D65/06;;F16B35/005;;F16B5/0266;;F16B7/18;;F16D59/02;;A61B90/35;;A61B2090/508;;F16D49/00;;F16D65/06;;F16D2125/40;;F16D65/0971,F16B35/00;;F16B35/04,,0,0,,,,PENDING
616,US,A,US 5451493 A,041-427-024-530-437,1995-09-19,1995,US 21473394 A,1994-03-17,US 21473394 A,1994-03-17,Photographic element containing a certain sulfonated acylacetanilide coupler in combination with a development inhibitor releasing coupler,"The present invention provides a photographic element comprising a support bearing a blue-light sensitive silver halide emulsion layer containing an acylacetanilide yellow image dye-forming coupler having formula I or II: ##STR1## wherein: R.sub.a is a substituted or unsubstituted alkyl groups, alkoxy group or aryloxy group; R.sub.b is a substituted or unsubstituted alkyl or aryl group; R.sub.c is hydrogen or a substituted or unsubstituted alkyl group; R.sub.1 is a substituent; n is an integer from 0 to 2; R.sub.2 is selected from the group consisting of halogen, trifluoromethyl, and substituted or unsubstituted alkoxy and aryloxy; R.sub.3 is substituted or unsubstituted alkyl; R.sub.4 is hydrogen, halogen, alkoxy carbonyl (--CO.sub.2 R), carbamoyl (--CONRR'), carbonamido (--NRCOR'), sulfonamido (--NRSO.sub.2 R') or trifluoromethyl; and X is hydrogen or a coupling-off group; and wherein the blue-light sensitive silver halide emulsion layer has associated therewith a development inhibitor releasing coupler. The invention also provides a method of forming an image in such an element.",EASTMAN KODAK CO,MERKEL PAUL B;;POSLUSNY JERROLD N;;MERRILL JAMES P;;CLARK BERNARD A;;STANLEY PAUL L R;;WILLIAMSON HUGH M,EASTMAN KODAK COMPANY (1994-03-28),https://lens.org/041-427-024-530-437,Granted Patent,yes,8,1,3,3,0,G03C7/3212;;G03C7/3212;;G03C7/30594;;G03C7/30594;;Y10S430/158,G03C7/00;;G03C7/305;;G03C7/32;;G03C7/36,430/505;;430/544;;430/557;;430/957;;430/359,0,0,,,,EXPIRED
617,ZA,B,ZA 876621 B,187-274-544-805-297,1989-05-30,1989,ZA 876621 A,1987-09-04,US 90369886 A,1986-09-04,A DEVICE FOR MEASURING AND INDICATING CHANGES IN RESISTANCE OF A LIVING BODY,,AUTHORS FAMILY TRUST,FERREIRA MARC;;MARC FERREIRA;;MCCORMICK JOHN;;JOHN MCCORMICK;;BERNARD RAYMOND;;RAYMOND BERNARD;;BUTRYN JOSEPH;;JOSEPH BUTRYN;;CLIFFORD RONALD;;RONALD CLIFFORD;;CAMPBELL JEFFREY;;JEFFREY CAMPBELL;;ZANIER LOREN;;LOREN ZANIER;;EASTHAM PHILLIP CLARK;;PHILLIP CLARK EASTHAM;;PLOETZ BRUCE R;;BRUCE R PLOETZ,,https://lens.org/187-274-544-805-297,Granted Patent,no,0,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/053;;A61B5/05,,0,0,,,,EXPIRED
618,US,A1,US 2014/0339107 A1,019-541-435-870-227,2014-11-20,2014,US 201313896605 A,2013-05-17,US 201313896605 A,2013-05-17,RFID PLAQUE BOX,"An RFID plaque box provides secure storage and protection of value tokens (e.g., gaming plaques and jetons) of all sizes and shapes (e.g., rectangular, square, oval or round) and delivers real-time counting and movement details in both high and low frequency RF environments. The RFID plaque box allows plaques or jetons to be accounted for as part of the table's inventory along with the RFID chip tray's inventory (when installed). The RFID plaque box is provided as a fixed storage area that is situated below the plan of the gaming table alongside the RFID chip tray (when provided) with a lid very similar to that of the RFID chip tray or provided in a pop-up mechanism whereby the RFID plaque box is integrated into a gaming table such that when the top surface of the RFID plaque box is pushed, the RFID plaque box will pop-up to lift the stacks of plaques or jetons for access.",GAMING PARTNERS INTERNAT CORP,GELINOTTE EMMANUEL;;MOLINA BERNARD;;CHOI MIGUEL;;MCCARTHY SCOTT;;RAZ BENJAMIN;;CLARK KIRSTEN;;GRONAU GREGORY SCOTT;;VICAIRE REGIS MARCEL ROGER,GAMING PARTNERS INTERNATIONAL CORPORATION (2013-07-02),https://lens.org/019-541-435-870-227,Patent Application,yes,32,19,9,9,0,G06K7/10336;;G06K7/10336;;G06K7/10425;;G06K7/10425;;G06Q20/352;;G06Q20/352;;G07D9/002;;G07D9/002;;G07F7/0893;;G07F7/0893;;G07F9/06;;G07F9/06;;G07F17/3202;;G07F17/3202;;G07F17/322;;G07F17/322;;G07F17/3248;;G07F17/3248;;G07G1/00,G06K19/077,206/216,0,0,,,,DISCONTINUED
619,PH,B1,PH 12015502418 B1,095-158-567-623-53X,2016-02-22,2016,PH 12015502418 A,2015-10-20,US 201313896605 A;;US 2014/0037976 W,2013-05-17,RFID PLAQUE BOX,"An RFID plaque box provides secure storage and protection of value tokens (e.g., gaming plaques and jetons) of all sizes and shapes (e.g., rectangular, square, oval or round) and delivers real-time counting and movement details in both high and low frequency RF environments. The RFID plaque box allows plaques or jetons to be accounted for as part of the table's inventory along with the RFID chip tray's inventory (when installed). The RFID plaque box is provided as a fixed storage area that is situated below the plan of the gaming table alongside the RFID chip tray (when provided) with a lid very similar to that of the RFID chip tray or provided in a pop-up mechanism whereby the RFID plaque box is integrated into a gaming table such that when the top surface of the RFID plaque box is pushed, the RFID plaque box will pop-up to lift the stacks of plaques or jetons for access.",GAMING PARTNERS INT CORPORATION,GELINOTTE EMMANUEL;;MOLINA BERNARD;;CHOI MIGUEL;;MCCARTHY SCOTT;;RAZ BENJAMIN;;CLARK KIRSTEN;;GRONAU GREGORY SCOTT;;VICAIRE REGIS MARCEL ROGER,,https://lens.org/095-158-567-623-53X,Granted Patent,no,0,0,9,9,0,G06K7/10336;;G06K7/10336;;G06K7/10425;;G06K7/10425;;G06Q20/352;;G06Q20/352;;G07D9/002;;G07D9/002;;G07F7/0893;;G07F7/0893;;G07F9/06;;G07F9/06;;G07F17/3202;;G07F17/3202;;G07F17/322;;G07F17/322;;G07F17/3248;;G07F17/3248;;G07G1/00,A47B88/00;;B65D85/00;;H04Q5/22,,0,0,,,,ACTIVE
620,CN,A,CN 105473466 A,126-369-531-861-619,2016-04-06,2016,CN 201480027614 A,2014-05-14,US 2014/0037976 W;;US 201313896605 A,2013-05-17,Rfid plaque box,"An RFID plaque box provides secure storage and protection of value tokens (e.g., gaming plaques and jetons) of all sizes and shapes (e.g., rectangular, square, oval or round) and delivers real-time counting and movement details in both high and low frequency RF environments. The RFID plaque box allows plaques or jetons to be accounted for as part of the table's inventory along with the RFID chip tray's inventory (when installed). The RFID plaque box is provided as a fixed storage area that is situated below the plan of the gaming table alongside the RFID chip tray (when provided) with a lid very similar to that of the RFID chip tray or provided in a pop-up mechanism whereby the RFID plaque box is integrated into a gaming table such that when the top surface of the RFID plaque box is pushed, the RFID plaque box will pop-up to lift the stacks of plaques or jetons for access.",GAMING PARTNERS INT USA INC,GELINOTTE EMMANUEL;;MOLINA BERNARD;;CHOI MIGUEL;;MCCARTHY SCOTT;;RAZ BENJAMIN;;CLARK KIRSTEN;;GRONAU GREGORY SCOTT;;VICAIRE REGIS MARCEL ROGER,,https://lens.org/126-369-531-861-619,Patent Application,no,6,3,9,9,0,G06K7/10336;;G06K7/10336;;G06K7/10425;;G06K7/10425;;G06Q20/352;;G06Q20/352;;G07D9/002;;G07D9/002;;G07F7/0893;;G07F7/0893;;G07F9/06;;G07F9/06;;G07F17/3202;;G07F17/3202;;G07F17/322;;G07F17/322;;G07F17/3248;;G07F17/3248;;G07G1/00,B65D85/00;;A47B88/00;;H04Q5/22,,0,0,,,,DISCONTINUED
621,AU,A1,AU 2013/205957 A1,164-509-329-011-012,2014-12-04,2014,AU 2013/205957 A,2013-05-21,US 201313896605 A,2013-05-17,RFID plaque box,"An REID plaque box provides secure storage and protection of value tokens (e.g., gaming plaques and jetons) of all sizes and shapes (e.g., rectangular, square, oval or round) and delivers real-time counting and movement details in both high and low frequency RF environments. The RFID plaque box allows plaques or jetons to be accounted for as part of the table's inventory along with the REID chip tray's inventory (when installed). Tie RFID plaque box is provided as a fixed storage area that is situated below the plan of the gaming table alongside the RFID chip tray (when provided) with a lid very similar to that of the RFID chip tray or provided in a pop-up mechanism whereby the RFID plaque box is integrated into a gaming table such that when the top surface of the RFID plaque box is pushed, the RFID plaque box will pop-up to lift the stacks of plaques orjetons for access. 104 >104 Figur 2",GAMING PARTNERS INTERNAT CORP,GELINOTTE EMMANUEL;;MOLINA BERNARD;;CHOI MIGUEL;;MCCARTHY SCOTT;;RAZ BENJAMIN;;CLARK KRISTEN;;GRONAU GREGORY SCOTT;;VICAIRE REGIS MARCEL ROGER,"ANGEL GROUP CO., LTD. (2022-09-29)",https://lens.org/164-509-329-011-012,Patent Application,no,0,0,9,9,0,G06K7/10336;;G06K7/10336;;G06K7/10425;;G06K7/10425;;G06Q20/352;;G06Q20/352;;G07D9/002;;G07D9/002;;G07F7/0893;;G07F7/0893;;G07F9/06;;G07F9/06;;G07F17/3202;;G07F17/3202;;G07F17/322;;G07F17/322;;G07F17/3248;;G07F17/3248;;G07G1/00,A63F7/26,,0,0,,,,ACTIVE
622,TW,A,TW 201445512 A,139-182-424-598-300,2014-12-01,2014,TW 102117747 A,2013-05-20,US 201313896605 A,2013-05-17,RFID plaque box,"An RFID plaque box provides secure storage and protection of value tokens (e.g., gaming plaques and jetons) of all sizes and shapes (e.g., rectangular, square, oval or round) and delivers real-time counting and movement details in both high and low frequency RF environments. The RFID plaque box allows plaques or jetons to be accounted for as part of the table's inventory along with the RFID chip tray's inventory (when installed). The RFID plaque box is provided as a fixed storage area that is situated below the plan of the gaming table alongside the RFID chip tray (when provided) with a lid very similar to that of the RFID chip tray or provided in a pop-up mechanism whereby the RFID plaque box is integrated into a gaming table such that when the top surface of the RFID plaque box is pushed, the RFID plaque box will pop-up to lift the stacks of plaques or jetons for access.",GAMING PARTNERS INTERNAT CORP,GELINOTTE EMMANUEL;;MOLINA BERNARD;;CHOI MIGUEL;;MCCARTHY SCOTT;;RAZ BENJAMIN;;CLARK KRISTEN;;GRONAU GREGORY SCOTT;;VICAIRE REGIS MARCEL ROGER,,https://lens.org/139-182-424-598-300,Patent of Addition,no,0,0,9,9,0,G06K7/10336;;G06K7/10336;;G06K7/10425;;G06K7/10425;;G06Q20/352;;G06Q20/352;;G07D9/002;;G07D9/002;;G07F7/0893;;G07F7/0893;;G07F9/06;;G07F9/06;;G07F17/3202;;G07F17/3202;;G07F17/322;;G07F17/322;;G07F17/3248;;G07F17/3248;;G07G1/00,G07D1/00;;G06K19/07;;G06Q50/34,,0,0,,,,PENDING
623,WO,A1,WO 2014/186447 A1,156-803-751-594-898,2014-11-20,2014,US 2014/0037976 W,2014-05-14,US 201313896605 A,2013-05-17,RFID PLAQUE BOX,"An RFID plaque box provides secure storage and protection of value tokens (e.g., gaming plaques and jetons) of all sizes and shapes (e.g., rectangular, square, oval or round) and delivers real-time counting and movement details in both high and low frequency RF environments. The RFID plaque box allows plaques or jetons to be accounted for as part of the table's inventory along with the RFID chip tray's inventory (when installed). The RFID plaque box is provided as a fixed storage area that is situated below the plan of the gaming table alongside the RFID chip tray (when provided) with a lid very similar to that of the RFID chip tray or provided in a pop-up mechanism whereby the RFID plaque box is integrated into a gaming table such that when the top surface of the RFID plaque box is pushed, the RFID plaque box will pop-up to lift the stacks of plaques or jetons for access.",GAMING PARTNERS INTERNAT CORP,GELINOTTE EMMANUEL;;MOLINA BERNARD;;CHOI MIGUEL;;MCCARTHY SCOTT;;RAZ BENJAMIN;;CLARK KIRSTEN;;GRONAU GREGORY SCOTT;;VICAIRE REGIS MARCEL ROGER,,https://lens.org/156-803-751-594-898,Patent Application,yes,11,0,9,9,0,G06K7/10336;;G06K7/10336;;G06K7/10425;;G06K7/10425;;G06Q20/352;;G06Q20/352;;G07D9/002;;G07D9/002;;G07F7/0893;;G07F7/0893;;G07F9/06;;G07F9/06;;G07F17/3202;;G07F17/3202;;G07F17/322;;G07F17/322;;G07F17/3248;;G07F17/3248;;G07G1/00,B65D85/00;;A47B88/00;;H04Q5/22,,0,0,,,,PENDING
624,GB,B,GB 2339298 B,026-616-789-466-851,2000-05-10,2000,GB 9923016 A,1996-04-30,GB 9923016 A;;GB 9608886 A,1996-04-30,Use of pyrazolone image dye-forming couplers for enhancing light stability,,EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;CRAWLEY MICHAEL WILLIAM;;BOFF JANE SARAH;;STANLEY PAUL LOUIS;;WATTS CHRISTINA MARY;;SINGER STEPHEN PAUL,,https://lens.org/026-616-789-466-851,Granted Patent,no,4,0,7,7,0,C07D231/52;;C07D231/52;;G03C7/384;;G03C7/384,C07D231/52;;G03C7/384,G2C CPE           CPE,0,0,,,,EXPIRED
625,AU,B2,AU 2013/205957 B2,078-112-007-138-421,2018-04-19,2018,AU 2013/205957 A,2013-05-21,US 201313896605 A,2013-05-17,RFID plaque box,"An REID plaque box provides secure storage and protection of value tokens (e.g., gaming plaques and jetons) of all sizes and shapes (e.g., rectangular, square, oval or round) and delivers real-time counting and movement details in both high and low frequency RF environments. The RFID plaque box allows plaques or jetons to be accounted for as part of the table's inventory along with the REID chip tray's inventory (when installed). Tie RFID plaque box is provided as a fixed storage area that is situated below the plan of the gaming table alongside the RFID chip tray (when provided) with a lid very similar to that of the RFID chip tray or provided in a pop-up mechanism whereby the RFID plaque box is integrated into a gaming table such that when the top surface of the RFID plaque box is pushed, the RFID plaque box will pop-up to lift the stacks of plaques orjetons for access. 104 >104 Figur 2",ANGEL GROUP CO LTD,GELINOTTE EMMANUEL;;MOLINA BERNARD;;CHOI MIGUEL;;MCCARTHY SCOTT;;RAZ BENJAMIN;;CLARK KRISTEN;;GRONAU GREGORY SCOTT;;VICAIRE REGIS MARCEL ROGER,"ANGEL GROUP CO., LTD. (2022-09-29)",https://lens.org/078-112-007-138-421,Granted Patent,no,2,0,9,9,0,G06K7/10336;;G06K7/10425;;G06Q20/352;;G07F7/0893;;G07F17/3202;;G07F17/322;;G07F17/3248;;G07F9/06;;G07D9/002;;G06K7/10336;;G06K7/10425;;G06Q20/352;;G07F7/0893;;G07F17/3248;;G07F17/3202;;G07F9/06;;G07D9/002;;G07F17/322;;G07G1/00,A63F7/26,,0,0,,,,ACTIVE
626,PH,A1,PH 12015502418 A1,020-738-155-665-338,2016-02-22,2016,PH 12015502418 A,2015-10-20,US 201313896605 A;;US 2014/0037976 W,2013-05-17,RFID PLAQUE BOX,"An RFID plaque box provides secure storage and protection of value tokens (e.g., gaming plaques and jetons) of all sizes and shapes (e.g., rectangular, square, oval or round) and delivers real-time counting and movement details in both high and low frequency RF environments. The RFID plaque box allows plaques or jetons to be accounted for as part of the table's inventory along with the RFID chip tray's inventory (when installed). The RFID plaque box is provided as a fixed storage area that is situated below the plan of the gaming table alongside the RFID chip tray (when provided) with a lid very similar to that of the RFID chip tray or provided in a pop-up mechanism whereby the RFID plaque box is integrated into a gaming table such that when the top surface of the RFID plaque box is pushed, the RFID plaque box will pop-up to lift the stacks of plaques or jetons for access.",GAMING PARTNERS INTERNAT CORP,EMMANUEL GELINOTTE;;BERNARD MOLINA;;MIGUEL CHOI;;SCOTT MCCARTHY;;BENJAMIN RAZ;;KIRSTEN CLARK;;SCOTT GRONAU GREGORY;;ROGER VICAIRE REGIS MARCEL,,https://lens.org/020-738-155-665-338,Patent Application,no,0,0,9,9,0,G06K7/10336;;G06K7/10336;;G06K7/10425;;G06K7/10425;;G06Q20/352;;G06Q20/352;;G07D9/002;;G07D9/002;;G07F7/0893;;G07F7/0893;;G07F9/06;;G07F9/06;;G07F17/3202;;G07F17/3202;;G07F17/322;;G07F17/322;;G07F17/3248;;G07F17/3248;;G07G1/00,A47B88/00;;B65D85/00;;H04Q5/22,,0,0,,,,ACTIVE
627,SG,A,SG 2013039110 A,142-198-781-495-195,2014-12-30,2014,SG 2013039110 A,2013-05-20,US 201313896605 A,2013-05-17,RFID PLAQUE BOX,,GAMING PARTNERS INTERNAT CORP,EMMANUEL GELINOTTE;;BERNARD MOLINA;;MIGUEL CHOI;;SCOTT MCCARTHY;;BENJAMIN RAZ;;KRISTEN CLARK;;GREGORY SCOTT GRONAU;;REGIS MARCEL ROGER VICAIRE,,https://lens.org/142-198-781-495-195,Unknown,no,0,0,9,9,0,G06K7/10336;;G06K7/10336;;G06K7/10425;;G06K7/10425;;G06Q20/352;;G06Q20/352;;G07D9/002;;G07D9/002;;G07F7/0893;;G07F7/0893;;G07F9/06;;G07F9/06;;G07F17/3202;;G07F17/3202;;G07F17/322;;G07F17/322;;G07F17/3248;;G07F17/3248;;G07G1/00,,,0,0,,,,PENDING
628,GB,A,GB 2339298 A,149-102-875-774-57X,2000-01-19,2000,GB 9923016 A,1996-04-30,GB 9923016 A;;GB 9608886 A,1996-04-30,A photographic material including a pyrazolone coupler,,EASTMAN KODAK CO,CLARK BERNARD ARTHUR JAMES;;CRAWLEY MICHAEL WILLIAM;;BOFF JANE SARAH;;STANLEY PAUL LOUIS;;WATTS CHRISTINA MARY;;SINGER STEPHEN PAUL,,https://lens.org/149-102-875-774-57X,Patent Application,no,4,0,7,7,0,C07D231/52;;C07D231/52;;G03C7/384;;G03C7/384,C07D231/52;;G03C7/384,G2C CPE           CPE,0,0,,,,EXPIRED
629,JP,A,JP 2000194085 A,065-884-548-165-56X,2000-07-14,2000,JP 37452199 A,1999-12-28,US 22135998 A;;US 35805799 A,1998-12-28,COLOR PHOTOGRAPHIC ELEMENT,"PROBLEM TO BE SOLVED: To provide a photographic element having improved photographic sensitivity and to provide a treating method of this element by forming a layer containing a specified compd. which does not react with an oxidizing developing agent and having enough ClogP. SOLUTION: This element has at least one layer of a photosensitive silver halide emulsion layer or a nonphotosensitive layer containing no silver, and in the element, at least one layer contains a compd. having at least three hetero atoms and the compd. does not react with an oxidizing developing agent and has enough ClogP. The compd. is required to improve the photographic sensitivity corresponding to at least 0.05 aperture, preferably at least 0.10 and more preferably 0.25 or more without an apparent increase in the graininess. The compd. has at least three hetero atoms and permits silver development, and if the compd. is properly substituted, hydrophobicity can be increased. For example, triazoles, oxadiazoles and oxathiazoles are used.",EASTMAN KODAK CO,PHILLIP ARTHUR ALLWAY;;BERNARD A CLARK;;JOHN D GODDARD;;LOUIS ELBERT FRIENDRICH;;JAMES A FRIDAY;;SINGER STEPHEN P;;MARCELLO VITALE,,https://lens.org/065-884-548-165-56X,Patent Application,no,0,1,12,12,0,G03C1/10;;G03C7/39244;;G03C7/39244;;G03C1/10,G03C7/00;;G03C1/08;;G03C1/10;;G03C7/392,,0,0,,,,EXPIRED
630,EP,B1,EP 1016902 B1,006-357-204-911-798,2007-06-06,2007,EP 99204350 A,1999-12-16,US 22135998 A;;US 35805799 A,1998-12-28,Color photographic element,,EASTMAN KODAK CO,ALLWAY PHILIP ARTHUR;;CLARK BERNARD A;;GODDARD JOHN D;;FRIEDRICH LOUIS ELBERT;;FRIDAY JAMES A;;SINGER STEPHEN PAUL;;VITALE MARCELLO,,https://lens.org/006-357-204-911-798,Granted Patent,yes,1,0,12,12,0,G03C1/10;;G03C7/39244;;G03C7/39244;;G03C1/10,G03C1/10;;G03C7/00;;G03C1/08;;G03C7/392,,1,0,,,"DATABASE WPI Section Ch Week 199507, Derwent World Patents Index; Class A25, AN 1995-050093",EXPIRED
631,DK,B1,DK 169740 B1,181-921-089-147-404,1995-02-13,1995,DK 459987 A,1987-09-03,US 90369886 A,1986-09-04,Apparat til måling og visning af forandringer i den elektriske modstand i et levende legeme,,CHURCH OF SPIRITUAL TECH,FERREIRA MARC;;MCCORMICK JOHN;;BERNARD RAYMOND;;BUTRYN JOSEPH;;CLIFFORD RONALD;;CAMPBELL JEFFREY;;ZANIER LOREN;;EASTHAM PHILLIP CLARK;;PLOETZ BRUCE R,,https://lens.org/181-921-089-147-404,Granted Patent,no,0,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/053;;A61B5/05,,0,0,,,,EXPIRED
632,GB,B,GB 2196125 B,057-500-839-114-011,1990-10-31,1990,GB 8720875 A,1987-09-04,US 90369886 A,1986-09-04,A DEVICE FOR MEASURING AND INDICATING CHANGES IN RESISTANCE OF A LIVING BODY,,AUTHORS FAMILY TRUST,FERREIRA MARC;;MCCORMICK JOHN;;BERNARD RAYMOND;;BUTRYN JOSEPH;;CLIFFORD RONALD;;CAMPBELL JEFFREY;;ZANIER LOREN;;EASTHAM PHILLIP CLARK;;PLOETZ BRUCE R,,https://lens.org/057-500-839-114-011,Granted Patent,no,0,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/053;;A61B5/05,G1N NENX          ENX;;G1N N19B2Q        ENX;;G1N N19D10        ENX;;G1N N19D2         ENX;;G1N N19X1         ENX;;G1N N19X7         ENX;;G1N N30PX         ENX;;G1U UR1700        17/00;;U1S S1059,0,0,,,,EXPIRED
633,FR,B1,FR 2603700 B1,098-217-834-065-306,1990-03-23,1990,FR 8712291 A,1987-09-04,US 90369886 A,1986-09-04,DISPOSITIF POUR MESURER ET INDIQUER DES VARIATIONS DE RESISTANCE D'UN CORPS VIVANT,,AUTHORS FAMILY TRUST,FERREIRA MARC;;MCCORMICK JOHN;;BERNARD RAYMOND;;BUTRYN JOSEPH;;CLIFFORD RONALD;;CAMPBELL JEFFREY;;ZANIER LOREN;;EASTHAM PHILLIP CLARK;;PLOETZ BRUCE R,,https://lens.org/098-217-834-065-306,Granted Patent,no,0,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/053;;A61B5/05,,0,0,,,,EXPIRED
634,GB,A,GB 2314327 A,043-909-926-687-884,1997-12-24,1997,GB 9608886 A,1996-04-30,GB 9608886 A,1996-04-30,Pyrazolone image dye-forming couplers,"An image magenta-forming coupler of formula (I):- * space * wherein X is H or a coupling-off group, R is H; or R, R 1 and R 2 are the same or different and are coupler-modifying functional groups; or R 1 and R 2 taken together with the nitrogen atom and the carbonyl group form a 5-10 membered heterocyclic ring which may contain one or more further heteroatoms selected from N, O and S, said heterocyclic ring being unsubstituted or substituted with one or more coupler-modifying functional groups, either with or without another main image dye-forming coupler,is used to provide an image of enhanced stability to exposure to light. The couplers (I) are novel compounds provided that (a) the moiety N(R 1 )COR 2 is not a carbamate,ureide or imide and (6) R 1 and R 2 are not both phenyl or substituted phenyl.",KODAK LTD,CLARK BERNARD ARTHUR JAMES;;CRAWLEY MICHAEL WILLIAM;;BOFF JANE SARAH;;STANLEY PAUL LOIS REGINALD;;WATTS CHRISTINA MARY;;SINGER STEPHEN PAUL,,https://lens.org/043-909-926-687-884,Patent Application,no,7,0,7,7,0,C07D231/52;;C07D231/52;;G03C7/384;;G03C7/384,C07D231/52;;G03C7/384,C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CKM;;C2C CKR;;C2C CKS;;C2C CKY;;C2C CKZ;;C2C CQS;;C2C CRE;;C2C CRF;;C2C CSC;;C2C CSF;;C2C CSJ;;C2C C1341;;C2C C1343;;C2C C1345;;C2C C1400;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1410;;C2C C1530;;C2C C1530;;C2C C1530;;C2C C1534;;C2C C1534;;C2C C213;;C2C C213;;C2C C213;;C2C C213;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C226;;C2C C246;;C2C C246;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y,0,0,,,,EXPIRED
635,US,B1,US 6455242 B1,068-451-570-223-207,2002-09-24,2002,US 95470401 A,2001-09-18,US 95470401 A;;US 35805799 A;;US 22135998 A,1998-12-28,Color photographic element containing speed improving compound,"
    Disclosed is a color photographic element comprising at least one of (1) a light sensitive silver halide emulsion layer and (2) a non-silver containing light insensitive layer, said at least one layer containing a compound with a minimum of three heteroatoms that does not react with oxidized developer and that has a ClogP sufficient to increase the photographic speed of said element compared to the same element without the compound. The invention provides improved light sensitivity. 
",EASTMAN KODAK CO,ALLWAY PHILIP A;;CLARK BERNARD A;;GODDARD JOHN D;;FRIEDRICH LOUIS E;;FRIDAY JAMES A;;SINGER STEPHEN P;;VITALE MARCELLO,,https://lens.org/068-451-570-223-207,Granted Patent,yes,70,13,12,12,0,G03C1/10;;G03C7/39244;;G03C7/39244;;G03C1/10,G03C1/08;;G03C7/00;;G03C1/10;;G03C7/392,430/600;;430/503;;430/505;;430/506;;430/546;;430/551;;430/611;;430/613;;430/615,6,1,079-271-492-411-181,10.1149/1.2133216,"Defensive Publication US 877,011 published Aug. 18, 1970-Use of Silver Pi-Complex Stablizers, Kenneth R. Dunham.;;The Fundamentals of Photographic Technology, Silver Salt Photography, compiled by the Photographic Society of Japan (Corona, Ltd.), p. 354.;;Chemistry of Photography, A. Sasai (Shashin Kogyo Shuppan Co, Ltd.), pp. 168-169.;;The Theory of the Photographic Process, T.H. James, Ed., 4th Edition, Macmillan Publishing Co, NY, Chapter 13, Section J.;;Stabilization of Photographic Silver Halide Emulsions, E.J. Birr, Focal Press, Ltd, 1974, pp. 82-93.;;Photographic Sensitivity, Theory and Mechanisms, T.Tani, Oxford University Press, NY, 1995, Section 6.5.",EXPIRED
636,US,A1,US 2002/0042033 A1,190-643-486-896-029,2002-04-11,2002,US 95470401 A,2001-09-18,US 95470401 A;;US 35805799 A;;US 22135998 A,1998-12-28,Color photographic element containing speed improving compound,"
   Disclosed is a color photographic element comprising at least one of (1) a light sensitive silver halide emulsion layer and (2) a non-silver containing light insensitive layer, said at least one layer containing a compound with a minimum of three heteroatoms that does not react with oxidized developer and that has a ClogP sufficient to increase the photographic speed of said element compared to the same element without the compound. The invention provides improved light sensitivity. 
",ALLWAY PHILIP A.;;CLARK BERNARD A.;;GODDARD JOHN D.;;FRIEDRICH LOUIS E.;;FRIDAY JAMES A.;;SINGER STEPHEN P.;;VITALE MARCELLO,ALLWAY PHILIP A;;CLARK BERNARD A;;GODDARD JOHN D;;FRIEDRICH LOUIS E;;FRIDAY JAMES A;;SINGER STEPHEN P;;VITALE MARCELLO,,https://lens.org/190-643-486-896-029,Patent Application,yes,0,7,12,12,0,G03C1/10;;G03C7/39244;;G03C7/39244;;G03C1/10,G03C1/08;;G03C1/10;;G03C7/00;;G03C7/392,4306;;430/614;;X43055;;430/546,0,0,,,,EXPIRED
637,DK,D0,DK 459987 D0,187-120-206-805-401,1987-09-03,1987,DK 459987 A,1987-09-03,US 90369886 A,1986-09-04,APPARAT TIL MAALING OG VISNING AF ELEKTRISK MODSTAND,,AUTHORS FAMILY TRUST,FERREIRA MARC;;MCCORMICK JOHN;;BERNARD RAYMOND;;BUTRYN JOSEPH;;CLIFFORD RONALD;;CAMPBELL JEFFREY;;ZANIER LOREN;;EASTHAM PHILLIP CLARK;;PLOETZ BRUCE R,,https://lens.org/187-120-206-805-401,Patent Application,no,0,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/053;;A61B5/05,,0,0,,,,EXPIRED
638,EP,A3,EP 1016902 A3,079-744-777-560-022,2000-07-19,2000,EP 99204350 A,1999-12-16,US 22135998 A;;US 35805799 A,1998-12-28,Color photographic element,"Disclosed is a color photographic element comprising at least one of (1) a light sensitive silver halide emulsion layer and (2) a non-silver containing light insensitive layer, said at least one layer containing a compound with a minimum of three heteroatoms that does not react with oxidized developer and that has a ClogP sufficient to increase the photographic speed of said element compared to the same element without the compound. The invention provides improved light sensitivity.",EASTMAN KODAK CO,ALLWAY PHILIP ARTHUR;;CLARK BERNARD A;;GODDARD JOHN D;;FRIEDRICH LOUIS ELBERT;;FRIDAY JAMES A;;SINGER STEPHEN PAUL;;VITALE MARCELLO,,https://lens.org/079-744-777-560-022,Search Report,yes,4,0,12,12,0,G03C1/10;;G03C7/39244;;G03C7/39244;;G03C1/10,G03C7/00;;G03C1/08;;G03C1/10;;G03C7/392,,1,0,,,"TADAAKI TANI: ""Photographic Sensitivity"", 1995, OXFORD UNIVERSITY PRESS, NEW YORK , OXFORD, XP002137274, 55196",EXPIRED
639,IT,B,IT 1218928 B,106-206-247-018-50X,1990-04-24,1990,IT 6776387 A,1987-09-04,US 90369886 A,1986-09-04,DISPOSITIVO PER MISURARE ED INDICARE VARIAZIONI DELLA RESISTENZA ELETTRICA DI UN CORPO VIVENTE,,AUTHORS FAMILY TRUST,FERREIRA MARC;;MCCORMICK JOHN;;BERNARD RAYMOND;;BUTRYN JOSEPH;;CLIFFORD RONALD;;CAMPBELL JEFFREY;;ZANIER LOREN;;EASTHAM PHILLIP CLARK;;PLOETZ BRUCE R,,https://lens.org/106-206-247-018-50X,Granted Patent,no,0,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/053;;A61B5/05,,0,0,,,,EXPIRED
640,EP,A2,EP 1016902 A2,134-670-006-521-475,2000-07-05,2000,EP 99204350 A,1999-12-16,US 22135998 A;;US 35805799 A,1998-12-28,Color photographic element,"Disclosed is a color photographic element comprising at least one of (1) a light sensitive silver halide emulsion layer and (2) a non-silver containing light insensitive layer, said at least one layer containing a compound with a minimum of three heteroatoms that does not react with oxidized developer and that has a ClogP sufficient to increase the photographic speed of said element compared to the same element without the compound. The invention provides improved light sensitivity.",EASTMAN KODAK CO,ALLWAY PHILIP ARTHUR;;CLARK BERNARD A;;GODDARD JOHN D;;FRIEDRICH LOUIS ELBERT;;FRIDAY JAMES A;;SINGER STEPHEN PAUL;;VITALE MARCELLO,,https://lens.org/134-670-006-521-475,Patent Application,yes,0,9,12,12,0,G03C1/10;;G03C7/39244;;G03C7/39244;;G03C1/10,G03C7/00;;G03C1/08;;G03C1/10;;G03C7/392,,0,0,,,,EXPIRED
641,DE,A1,DE 3729321 A1,037-865-006-848-420,1988-03-31,1988,DE 3729321 A,1987-09-02,US 90369886 A,1986-09-04,EINRICHTUNG ZUM MESSEN UND ANZEIGEN VON WIDERSTANDSAENDERUNGEN IN EINEM LEBENDEN KOERPER,"A device for measuring and indicating changes in the resistance of a living body includes an analog portion, a digital portion (Fig. 2) and a stabilised source of power. The analog portion includes a bridge network including a potentiometer P1A for setting a reference level and a meter M1 for indicating changes in balance of the bridge. Two electrodes for connection to a living body are connected into one arm of the bridge. The digital portion includes a potentiometer (P1B) which turns together with the potentiometer P1A and processing circuitry including UP/DOWN counters connected to digital displays. The operator adjusts the ganged potentiometers so that movement of potentiometer P1A maintains balance of the bridge. The resulting movement of potentiometer P1B causes counts to be displaced which indicate to the operator the position and the total amount of rotation of said potentiometer. In addition, a computer could be interfaced with the device to record or play back the changes in the resistance. <IMAGE>",AUTHORS FAMILY TRUST,FERREIRA MARC;;MCCORMICK JOHN;;BERNARD RAYMOND;;BUTRYN JOSEPH;;CLIFFORD RONALD;;CAMPBELL JEFFREY;;ZANIER LOREN;;EASTHAM PHILLIP CLARK;;PLOETZ BRUCE R,"CHURCH OF SPIRITUAL TECHNOLOGY, LOS ANGELES, CALIF (1994-10-06)",https://lens.org/037-865-006-848-420,Patent Application,no,9,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/05;;A61B5/053,,0,0,,,,DISCONTINUED
642,DE,D1,DE 69936252 D1,044-070-185-490-376,2007-07-19,2007,DE 69936252 T,1999-12-16,US 22135998 A;;US 35805799 A,1998-12-28,Farbphotographisches Element,,EASTMAN KODAK CO,ALLWAY PHILIP ARTHUR;;CLARK BERNARD A;;GODDARD JOHN D;;FRIEDRICH LOUIS ELBERT;;FRIDAY JAMES A;;SINGER STEPHEN PAUL;;VITALE MARCELLO,,https://lens.org/044-070-185-490-376,Granted Patent,no,0,0,12,12,0,G03C1/10;;G03C7/39244;;G03C7/39244;;G03C1/10,G03C1/10;;G03C7/00;;G03C1/08;;G03C7/392,,0,0,,,,EXPIRED
643,DE,T2,DE 69936252 T2,188-175-101-884-304,2008-02-07,2008,DE 69936252 T,1999-12-16,US 22135998 A;;US 35805799 A,1998-12-28,Farbphotographisches Element,,EASTMAN KODAK CO,ALLWAY PHILIP ARTHUR;;CLARK BERNARD A;;GODDARD JOHN D;;FRIEDRICH LOUIS ELBERT;;FRIDAY JAMES A;;SINGER STEPHEN PAUL;;VITALE MARCELLO,,https://lens.org/188-175-101-884-304,Granted Patent,no,0,0,12,12,0,G03C1/10;;G03C7/39244;;G03C7/39244;;G03C1/10,G03C1/10;;G03C7/00;;G03C1/08;;G03C7/392,,0,0,,,,EXPIRED
644,GB,A,GB 2196125 A,131-919-841-398-783,1988-04-20,1988,GB 8720875 A,1987-09-04,US 90369886 A,1986-09-04,Measuring and indicating changes in resistance of a living body,,AUTHORS FAMILY TRUST,FERREIRA MARC;;MCCORMICK JOHN;;BERNARD RAYMOND;;BUTRYN JOSEPH;;CLIFFORD RONALD;;CAMPBELL JEFFREY;;ZANIER LOREN;;EASTHAM PHILLIP CLARK;;PLOETZ BRUCE R,,https://lens.org/131-919-841-398-783,Patent Application,no,0,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/053;;A61B5/05,G1N NEBR          EBR;;G1N NENX          ENX;;G1N N19B2Q        EBR;;G1N N19D10        EBR;;G1N N19D2         EBR;;G1N N19X1         EBR;;G1N N19X7         EBR;;G1N N30PX         EBR;;G1U UJB9A         JB9A;;G1U UR1700        17/00;;U1S S1059,0,0,,,,EXPIRED
645,FR,A1,FR 2603700 A1,130-430-367-224-03X,1988-03-11,1988,FR 8712291 A,1987-09-04,US 90369886 A,1986-09-04,DISPOSITIF POUR MESURER ET INDIQUER DES VARIATIONS DE RESISTANCE D'UN CORPS VIVANT,"<P>A. DISPOSITIF POUR MESURER ET INDIQUER DES VARIATIONS DE RESISTANCE ELECTRIQUE D'UN CORPS VIVANT;</P><P>B. DISPOSITIF CARACTERISE EN CE QU'IL COMPREND UNE PARTIE ANALOGIQUE CONSTITUE PAR UN RESEAU EN PONT DANS UNE BRANCHE DUQUEL SONT PLACEES DES ELECTRODES DE MESURE DU CORPS VIVANT, ET COMPRENANT UN POTENTIOMETRE P1A DE REGLAGE D'UN NIVEAU DE REFERENCE DU DISPOSITIF; UNE PARTIE NUMERIQUE COMPRENANT UN POTENTIOMETRE P1B COMBINE AU POTENTIOMETRE P1A ET UN CIRCUIT DE TRAITEMENT ET D'AFFICHAGE NUMERIQUES DE LA POSITION ET DE LA ROTATION TOTALE DU POTENTIOMETRE COMBINE P1; ET UNE SOURCE D'ALIMENTATION STABILISEE DES PARTIES ANALOGIQUE ET NUMERIQUE.</P><P>C. L'INVENTION S'APPLIQUE NOTAMMENT A LA MESURE DES VARIATIONS DE RESISTANCE DU CORPS HUMAIN ET EN PARTICULIER DE LA PEAU.</P>",AUTHORS FAMILY TRUST,FERREIRA MARC;;MCCORMICK JOHN;;BERNARD RAYMOND;;BUTRYN JOSEPH;;CLIFFORD RONALD;;CAMPBELL JEFFREY;;ZANIER LOREN;;EASTHAM PHILLIP CLARK;;PLOETZ BRUCE R,,https://lens.org/130-430-367-224-03X,Patent Application,no,4,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/053;;A61B5/05,,0,0,,,,EXPIRED
646,DK,A,DK 459987 A,032-759-857-247-323,1988-03-05,1988,DK 459987 A,1987-09-03,US 90369886 A,1986-09-04,APPARAT TIL MAALING OG VISNING AF ELEKTRISK MODSTAND,,AUTHORS FAMILY TRUST,FERREIRA MARC;;MCCORMICK JOHN;;BERNARD RAYMOND;;BUTRYN JOSEPH;;CLIFFORD RONALD;;CAMPBELL JEFFREY;;ZANIER LOREN;;EASTHAM PHILLIP CLARK;;PLOETZ BRUCE R,,https://lens.org/032-759-857-247-323,Patent Application,no,0,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/053;;A61B5/05,,0,0,,,,EXPIRED
647,IT,A0,IT 8767763 A0,157-956-085-825-466,1987-09-04,1987,IT 6776387 A,1987-09-04,US 90369886 A,1986-09-04,DISPOSITIVO PER MISURARE ED INDICARE VARIAZIONI DELLA RESISTENZA ELETTRICA DI UN CORPO VIVENTE,,AUTHORS FAMILY TRUST,RONALD CLIFFORD;;JEFFREY CAMPBELL;;MARC FERREIRA;;JOHN MCCORMICK;;LOREN ZANIER;;PHILLIP CLARK;;EASTHAM RAYMOND BERNARD;;JOSEPH BUTRYN;;BRUCE R PLOETZ,,https://lens.org/157-956-085-825-466,Patent Application,no,0,0,27,27,0,A61B5/0531;;A61B5/0531,A61B5/05;;A61B5/053,,0,0,,,,EXPIRED
648,US,B1,US 6319660 B1,025-303-396-943-406,2001-11-20,2001,US 35805799 A,1999-07-21,US 35805799 A;;US 22135998 A,1998-12-28,Color photographic element containing speed improving compound,"Disclosed is a color photographic element comprising at least one of (1) a light sensitive silver halide emulsion layer and (2) a non-silver containing light insensitive layer, said at least one layer containing a compound with a minimum of three heteroatoms that does not react with oxidized developer and that has a ClogP sufficient to increase the photographic speed of said element compared to the same element without the compound. The invention provides improved light sensitivity.",EASTMAN KODAK CO,ALLWAY PHILIP A;;CLARK BERNARD A;;GODDARD JOHN D;;FRIEDRICH LOUIS E;;FRIDAY JAMES A;;SINGER STEPHEN P;;VITALE MARCELLO,,https://lens.org/025-303-396-943-406,Granted Patent,yes,75,38,12,12,0,G03C1/10;;G03C7/39244;;G03C7/39244;;G03C1/10,G03C1/08;;G03C7/00;;G03C1/10;;G03C7/392,430/600;;430/503;;430/505;;430/506;;430/611;;430/613;;430/615,10,0,,,"Research Disclosure 38597, Section x (D), Sep. 1996.*;;Research Disclosure 37038 Sections I (A&B), III, XV(A), VII, XXIII(B), Feb. 1995.*;;Defensive Publication US 877,011 published Aug. 18, 1970-Use of Silver Pi-Complex Stabilizers, Kenneth R. Dunham.;;2091846 Abstract.;;2091858 Abstract.;;05 333496A Abstract.;;Tadaaki Tani: ""Photographic Sensitivity"" 1995, Oxford Un Press, New York, Oxford XP002137274 55196 pp. 191-199* Included in European Search Report (enclosed).;;Defensive Publication US 877,011 published Aug. 18, 1970-Use of Silver Pi-Comples Stabilizers, Kenneth R. Dunham.;;The Theory of the Photographic Process, T.H. James, Ed., 4th Edition, Macmillan Publishing Co, Ny, Chapter 13, Section J.;;Photographic Sensitivity, Theory and Mechanisms, T. Tani, Oxford University Press, NY, 1995, Section 6.5.",EXPIRED
649,GB,B,GB 2314327 B,101-195-404-309-077,2000-07-12,2000,GB 9608886 A,1996-04-30,GB 9608886 A,1996-04-30,PYRAZOLONE IMAGE DYE-FORMING COUPLERS,,KODAK LTD,CLARK BERNARD ARTHUR JAMES;;CRAWLEY MICHAEL WILLIAM;;BOFF JANE SARAH;;STANLEY PAUL LOIS REGINALD;;WATTS CHRISTINA MARY;;SINGER STEPHEN PAUL,,https://lens.org/101-195-404-309-077,Granted Patent,no,7,0,7,7,0,C07D231/52;;C07D231/52;;G03C7/384;;G03C7/384,C07D231/52;;G03C7/384,C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CAA;;C2C CKM;;C2C CKR;;C2C CKS;;C2C CKY;;C2C CKZ;;C2C CQS;;C2C CRE;;C2C CRF;;C2C CSC;;C2C CSF;;C2C CSJ;;C2C C1341;;C2C C1343;;C2C C1345;;C2C C1400;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1401;;C2C C1410;;C2C C1530;;C2C C1530;;C2C C1530;;C2C C1534;;C2C C1534;;C2C C213;;C2C C213;;C2C C213;;C2C C213;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C215;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C22Y;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C220;;C2C C226;;C2C C246;;C2C C246;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y;;C2C C25Y          SJ,0,0,,,,EXPIRED
650,MX,A,MX 9802810 A,034-375-981-065-471,1998-09-30,1998,MX 9802810 A,1998-04-08,US 555195 P,1995-10-18,CONFORMABLE MAGNETIC ARTICLES UNDERLAID BENEATH TRAFFIC-BEARING SURFACES.,A conformable magnetic article (300) for underlayment beneath a traffic-bearing surface which sends a magnetic signal to a sensor travelling over the traffic-bearing structure. The magnetic article comprises at least one conformable magnetic layer (2) comprising a binder and a sufficient amount of magnetic particles dispersed within the binder to provide a magnetic signal through the traffic-bearing structure to a sensor.,MINNESOTA MINING & MFG,CLARK GARY W;;DAHLIN THOMAS J;;FAYLING RICHARD E;;GONZALEZ BERNARD A;;HOPSTOCK DAVID M;;JACOBS GREGORY F;;KEECH RICHARD L,,https://lens.org/034-375-981-065-471,Patent Application,no,0,0,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,DISCONTINUED
651,CA,C,CA 2232873 C,091-101-831-564-469,2004-06-15,2004,CA 2232873 A,1996-10-11,US 555195 P;;US 9616395 W,1995-10-18,CONFORMABLE MAGNETIC ARTICLES UNDERLAID BENEATH TRAFFIC-BEARING SURFACES,A conformable magnetic article (300) for underlayment beneath a traffic- bearing surface which sends a magnetic signal to a sensor travelling over the traffic-bearing structure. The magnetic article comprise s at least one conformable magnetic layer (2) comprising a binder and a sufficient amount of magnetic particles dispersed within the binder to provide a magnetic signal through the traffic-bearing structure to a sensor.,MINNESOTA MINING & MFG,JACOBS GREGORY F;;HOPSTOCK DAVID M;;FAYLING RICHARD E;;DAHLIN THOMAS J;;CLARK GARY W;;GONZALEZ BERNARD A;;KEECH ROBERT L,,https://lens.org/091-101-831-564-469,Granted Patent,no,0,1,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,EXPIRED
652,AT,T1,AT E198086 T1,014-927-363-667-704,2000-12-15,2000,AT 96937681 T,1996-10-11,US 555195 P;;US 9616395 W,1995-10-18,ANPASSUNGSFÄHIGER MAGNETISCHER GEGENSTAND FÜR UNTER VERKEHR TRAGENDE OBERFLÄCHEN,,MINNESOTA MINING & MFG,CLARK GARY W;;DAHLIN THOMAS J;;FAYLING RICHARD E;;GONZALEZ BERNARD A;;HOPSTOCK DAVID M;;JACOBS GREGORY F;;KEECH RICHARD L,,https://lens.org/014-927-363-667-704,Granted Patent,no,0,0,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,DISCONTINUED
653,US,B2,US 10778669 B2,062-282-953-950-02X,2020-09-15,2020,US 201816058738 A,2018-08-08,US 201816058738 A;;US 201615061945 A;;US 201562128426 P,2015-03-04,Autonomous configuration of email clients during email server migration,"Systems and methods are provided for automatically configuring an email client during a migration process. An client-side assistant can be deployed to an end-user's computer via a migration platform. After being deployed to a particular client computer, the client-side assistant can be configured to obtain user information to identify the end-user associated with the client computer. After identifying the end-user, destination system information regarding the end-user can be pushed to client computer for inclusion in new configuration information for the email client. Before generating the new configuration information, user credential for logging into the source system can be obtained. The client-side assistant can be configured to cause the destination system to confirm this credential. After generating the new configuration information, the client-side assistant can instruct the client-side assistant to use the new configuration information to at a specific time and date.",SKYKICK INC,DENNIS JOHN;;RICHMAN EVAN;;SCHWARTZ TODD;;YOUNGE BRADLEY;;SCHWARTZ TRENT ROBERT;;KARABAN ROBERT P;;TETT RICHARD JAMES;;CLARK BERNARD;;RAYNER CHRISTOPHER,SKYKICK LLC (2016-03-03),https://lens.org/062-282-953-950-02X,Granted Patent,yes,58,0,4,4,0,H04L41/0886;;H04L63/083;;H04L67/148;;H04L67/1095;;H04L51/42;;H04L63/083;;H04L67/148;;H04L67/1095;;H04L41/0886;;H04L51/42,G06F15/16;;H04L12/24;;H04L12/58;;H04L29/06;;H04L29/08,,15,1,110-212-753-356-881,10.1007/s10506-010-9099-3,"Non-Final Office Action for U.S. Appl. No. 15/096,187 dated Dec. 27, 2018, 15 pages.;;Final Office Action for U.S. Appl. No. 15/061,945 dated Feb. 26, 2019, 12 pages.;;Non-Final Office Action for U.S. Appl. No. 15/061,945 dated Aug. 7, 2019, 13 pages.;;Final Office Action for U.S. Appl. No. 15/096,187 dated Aug. 7, 2019, 7 pages.;;U.S. Appl. No. 14/814,424, “Final Office Action”, dated Oct. 6, 2016, 28 pages.;;U.S. Appl. No. 14/814,424, “Non-Final Office Action”, dated Jun. 6, 2016, 14 pages.;;U.S. Appl. No. 14/814,424, “Restriction Requirement”, dated Dec. 31, 2015, 10 pages.;;U.S. Appl. No. 15/061,945, “Non-Final Office Action”, dated Feb. 16, 2018, 10 pages.;;U.S. Appl. No. 15/061,945, “Non-Final Office Action”, dated Jul. 24, 2018, 10 pages.;;Henseler, “Network-based filtering for large email collections in E-Discovery”, Journal Artificial Intelligence and Law, vol. 18 Issue 4, Dec. 23, 2010, pp. 413-430.;;Nadhan, “A Strategic Approach to Data Transfer Methods”, Available online at: https://msdn.microsoft.com/en-us/library/ aa 480064.aspx, 2016, pp. 1-16.;;PCT/US2013/026000, “International Search Report and Written Opinion”, dated Jun. 21, 2013, 11 pages.;;Stackoverflow, “403 Forbidden vs 401 Unauthorized HTTP responses”, Jul. 21, 2010, pp. 1-7.;;Zhou, “Mining organizational emails for social networks with application to Enron corpus”, ProQuest LLC, Jul. 2008, pp. 1-180.;;Notice of Allowance for U.S. Appl. No. 15/096,187 dated Nov. 5, 2019, 10 pages.",ACTIVE
654,US,A,US 5853846 A,119-639-786-941-745,1998-12-29,1998,US 73279596 A,1996-10-15,US 73279596 A;;US 555195 P,1995-10-18,Conformable magnetic articles underlaid beneath traffic-bearing surfaces,A conformable magnetic article for underlayment beneath a traffic-bearing surface which sends a magnetic signal to a sensor traveling over the traffic-bearing structure. The magnetic article comprises at least one conformable magnetic layer comprising a binder and a sufficient amount of magnetic particles dispersed within the binder to provide a magnetic signal through the traffic-bearing structure to a sensor.,MINNESOTA MINING & MFG,CLARK GARY W;;DAHLIN THOMAS J;;FAYLING RICHARD E;;GONZALEZ BERNARD A;;HOPSTOCK DAVID M;;JACOBS GREGORY F;;KEECH ROBERT L,MINNESOTA MINING AND MANUFACTURING COMPANY (1996-10-04),https://lens.org/119-639-786-941-745,Granted Patent,yes,50,90,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,428/131;;428/40;;428/343;;428/900;;428/143;;428/149;;428/156;;428/325;;428/692;;X428694 R;;X428694 B;;X428694 BC;;X428694 BV;;404/6;;404/9;;404/14;;404/16;;404/71;;340/901;;340/905;;180/167;;180/168;;701/23,2,1,015-289-045-250-260,10.1007/978-94-009-7825-6_197,"Magnetic Marker Using Ferrite Byproduct and Its Application by Yamauchi andNakano, Ferrites: Proceedings of the International Conference, Sep. Oct. 1980, Japan pp. 894 897.;;Jacobs, G.F. et al., A Magnetic Pavement Marking and Sensor System for Lateral Control/Guidance of Vehicles, Proceedings of the World Congress on Intelligent Transport Systems, vol. 3, Yokahama, Japan pp. 1236 1241 (1995).",EXPIRED
655,DE,C2,DE 2858676 C2,078-335-960-821-020,1989-04-06,1989,DE 2858676 A,1978-02-22,US 77135977 A;;US 79044277 A,1977-02-23,DE 2858676 C2,,"DAVIS, ROBERT BERNARD, FRAMINGHAM, MASS., US;;SKELTON, JOHN, SHARON, MASS., US;;CLARK, RICHARD EDWIN;;SWANSON, WILBUR MILTON, ST. LOUIS, MISS., US","DAVIS, ROBERT BERNARD, FRAMINGHAM, MASS., US;;SKELTON, JOHN, SHARON, MASS., US;;CLARK, RICHARD EDWIN;;SWANSON, WILBUR MILTON, ST. LOUIS, MISS., US",,https://lens.org/078-335-960-821-020,Granted Patent,no,3,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,1,0,,,"Dtsch. med. Wschr., 88. Jg., Nr.15, April 1963, S.749-754",EXPIRED
656,DK,T3,DK 0856088 T3,191-285-982-920-664,2001-01-02,2001,DK 96937681 T,1996-10-11,US 555195 P;;US 9616395 W,1995-10-18,"Magnetisk genstand, der kan tilpasses til at kunne anbringes under trafikbærende flader",,MINNESOTA MINING & MFG,GARY W CLARK;;THOMAS J DAHLIN;;RICHARD E FAYLING;;BERNARD A GONZALEZ;;DAVID M HOPSTOCK;;GREGORY F JACOBS;;RICHARD L KEECH,,https://lens.org/191-285-982-920-664,Granted Patent,no,0,0,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,EXPIRED
657,US,A1,US 2018/0351940 A1,111-792-437-557-825,2018-12-06,2018,US 201816058738 A,2018-08-08,US 201816058738 A;;US 201615061945 A;;US 201562128426 P,2015-03-04,AUTONOMOUS CONFIGURATION OF EMAIL CLIENTS DURING EMAIL SERVER MIGRATION,"Systems and methods are provided for automatically configuring an email client during a migration process. An client-side assistant can be deployed to an end-user's computer via a migration platform. After being deployed to a particular client computer, the client-side assistant can be configured to obtain user information to identify the end-user associated with the client computer. After identifying the end-user, destination system information regarding the end-user can be pushed to client computer for inclusion in new configuration information for the email client. Before generating the new configuration information, user credential for logging into the source system can be obtained. The client-side assistant can be configured to cause the destination system to confirm this credential. After generating the new configuration information, the client-side assistant can instruct the client-side assistant to use the new configuration information to at a specific time and date.",SKYKICK INC,DENNIS JOHN;;RICHMAN EVAN;;SCHWARTZ TODD;;YOUNGE BRADLEY;;SCHWARTZ TRENT ROBERT;;KARABAN ROBERT P;;TETT RICHARD JAMES;;CLARK BERNARD;;RAYNER CHRISTOPHER,SKYKICK LLC (2016-03-03),https://lens.org/111-792-437-557-825,Patent Application,yes,9,1,4,4,0,H04L41/0886;;H04L63/083;;H04L67/148;;H04L67/1095;;H04L51/42;;H04L63/083;;H04L67/148;;H04L67/1095;;H04L41/0886;;H04L51/42,H04L29/06;;H04L12/24;;H04L12/58;;H04L29/08,,0,0,,,,ACTIVE
658,AU,A,AU 1996/075164 A,123-408-858-919-878,1997-05-07,1997,AU 1996/075164 A,1996-10-11,US 555195 P;;US 9616395 W,1995-10-18,Conformable magnetic articles underlaid beneath traffic-bearing surfaces,,MINNESOTA MINING & MFG,CLARK GARY W;;DAHLIN THOMAS J;;FAYLING RICHARD E;;GONZALEZ BERNARD A;;HOPSTOCK DAVID M;;JACOBS GREGORY F;;KEECH RICHARD L,,https://lens.org/123-408-858-919-878,Patent Application,no,0,0,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,EXPIRED
659,WO,A1,WO 1997/014850 A1,057-671-610-897-974,1997-04-24,1997,US 9616395 W,1996-10-11,US 555195 P,1995-10-18,CONFORMABLE MAGNETIC ARTICLES UNDERLAID BENEATH TRAFFIC-BEARING SURFACES,A conformable magnetic article (300) for underlayment beneath a traffic-bearing surface which sends a magnetic signal to a sensor travelling over the traffic-bearing structure. The magnetic article comprises at least one conformable magnetic layer (2) comprising a binder and a sufficient amount of magnetic particles dispersed within the binder to provide a magnetic signal through the traffic-bearing structure to a sensor.,MINNESOTA MINING & MFG,CLARK GARY W;;DAHLIN THOMAS J;;FAYLING RICHARD E;;GONZALEZ BERNARD A;;HOPSTOCK DAVID M;;JACOBS GREGORY F;;KEECH RICHARD L,,https://lens.org/057-671-610-897-974,Patent Application,yes,9,10,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,B5N N17X;;B5N N17X;;B5N N17Y;;B5N N17Y;;B5N N172;;B5N N172;;B5N N174;;B5N N174;;B5N N175;;B5N N175;;B5N N176;;B5N N176;;B5N N178;;B5N N178;;B5N N18X;;B5N N18X;;B5N N180;;B5N N180;;B5N N194;;B5N N194;;B5N N195;;B5N N195;;B5N N195;;B5N N195;;B5N N195;;B5N N196;;B5N N196;;B5N N196;;B5N N196;;B5N N196;;B5N N197;;B5N N198;;B5N N198;;B5N N198;;B5N N198;;B5N N204;;B5N N204;;B5N N205;;B5N N205;;B5N N205;;B5N N205;;B5N N207;;B5N N207;;B5N N207;;B5N N207;;B5N N207;;B5N N207;;B5N N21X;;B5N N21X;;B5N N21X;;B5N N21X;;B5N N21Y;;B5N N21Y;;B5N N21Y;;B5N N21Y;;B5N N21Y;;B5N N210;;B5N N211;;B5N N223;;B5N N223;;B5N N223;;B5N N223;;B5N N223;;B5N N224;;B5N N224;;B5N N225;;B5N N225;;B5N N225;;B5N N226;;B5N N226;;B5N N227;;B5N N227;;B5N N228;;B5N N228;;B5N N23X;;B5N N23Y;;B5N N237;;B5N N237;;B5N N238;;B5N N238;;B5N N247;;B5N N248;;B5N N255;;B5N N255;;B5N N255;;B5N N256;;B5N N256;;B5N N257;;B5N N257;;B5N N257,0,0,,,,PATENTED
660,US,A1,US 2016/0261584 A1,067-288-655-274-317,2016-09-08,2016,US 201615061945 A,2016-03-04,US 201615061945 A;;US 201562128426 P,2015-03-04,AUTONOMOUS CONFIGURATION OF EMAIL CLIENTS DURING EMAIL SERVER MIGRATION,"Systems and methods are provided for automatically configuring an email client during a migration process. An client-side assistant can be deployed to an end-user's computer via a migration platform. After being deployed to a particular client computer, the client-side assistant can be configured to obtain user information to identify the end-user associated with the client computer. After identifying the end-user, destination system information regarding the end-user can be pushed to client computer for inclusion in new configuration information for the email client. Before generating the new configuration information, user credential for logging into the source system can be obtained. The client-side assistant can be configured to cause the destination system to confirm this credential. After generating the new configuration information, the client-side assistant can instruct the client-side assistant to use the new configuration information to at a specific time and date.",SKYKICK INC,DENNIS JOHN;;RICHMAN EVAN;;SCHWARTZ TODD;;YOUNGE BRADLEY;;SCHWARTZ TRENT ROBERT;;KARABAN ROBERT P;;TETT RICHARD JAMES;;CLARK BERNARD;;RAYNER CHRISTOPHER,SKYKICK LLC (2016-03-03),https://lens.org/067-288-655-274-317,Patent Application,yes,13,14,4,4,0,H04L41/0886;;H04L63/083;;H04L67/148;;H04L67/1095;;H04L51/42;;H04L63/083;;H04L67/148;;H04L67/1095;;H04L41/0886;;H04L51/42,H04L12/24;;H04L29/06;;H04L12/58;;H04L29/08,,0,0,,,,ACTIVE
661,AU,B2,AU 699652 B2,127-493-305-604-440,1998-12-10,1998,AU 1996/075164 A,1996-10-11,US 555195 P;;US 9616395 W,1995-10-18,Conformable magnetic articles underlaid beneath traffic-bearing surfaces,,MINNESOTA MINING & MFG,CLARK GARY W;;DAHLIN THOMAS J;;FAYLING RICHARD E;;GONZALEZ BERNARD A;;HOPSTOCK DAVID M;;JACOBS GREGORY F;;KEECH RICHARD L,,https://lens.org/127-493-305-604-440,Granted Patent,no,3,0,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,EXPIRED
662,US,B2,US 10771452 B2,054-209-042-679-880,2020-09-08,2020,US 201615061945 A,2016-03-04,US 201615061945 A;;US 201562128426 P,2015-03-04,Autonomous configuration of email clients during email server migration,"Systems and methods are provided for automatically configuring an email client during a migration process. An client-side assistant can be deployed to an end-user's computer via a migration platform. After being deployed to a particular client computer, the client-side assistant can be configured to obtain user information to identify the end-user associated with the client computer. After identifying the end-user, destination system information regarding the end-user can be pushed to client computer for inclusion in new configuration information for the email client. Before generating the new configuration information, user credential for logging into the source system can be obtained. The client-side assistant can be configured to cause the destination system to confirm this credential. After generating the new configuration information, the client-side assistant can instruct the client-side assistant to use the new configuration information to at a specific time and date.",SKYKICK INC,DENNIS JOHN;;RICHMAN EVAN;;SCHWARTZ TODD;;YOUNGE BRADLEY;;SCHWARTZ TRENT ROBERT;;KARABAN ROBERT P;;TETT RICHARD JAMES;;CLARK BERNARD;;RAYNER CHRISTOPHER,SKYKICK LLC (2016-03-03),https://lens.org/054-209-042-679-880,Granted Patent,yes,58,0,4,4,0,H04L41/0886;;H04L63/083;;H04L67/148;;H04L67/1095;;H04L51/42;;H04L63/083;;H04L67/148;;H04L67/1095;;H04L41/0886;;H04L51/42,G06F15/16;;H04L12/24;;H04L12/58;;H04L29/06;;H04L29/08,,13,1,110-212-753-356-881,10.1007/s10506-010-9099-3,"U.S. Appl. No. 14/814,424, Final Office Action dated Oct. 6, 2016, 28 pages.;;U.S. Appl. No. 14/814,424, Non-Final Office Action dated Jun. 6, 2016, 14 pages.;;U.S. Appl. No. 14/814,424, Restriction Requirement dated Dec. 31, 2015, 10 pages.;;Henseler, Network-based filtering for large email collections in E-Discovery, Journal Artificial Intelligence and Law, vol. 18 Issue 4, Dec. 23, 2010, pp. 413-430.;;Nadhan, A Strategic Approach to Data Transfer Methods, Available online at: https://msdn.microsoft.com/en-us/library/ aa 480064.aspx, 2016, pp. 1-16.;;International Application No. PCT/US2013/026000, International Search Report and Written Opinion dated Jun. 21, 2013, 11 pages.;;Stackoverflow, 403 Forbidden vs 401 Unauthorized HTTP responses, Jul. 21, 2010, pp. 1-7.;;Zhou, Mining organizational emails for social networks with application to Enron corpus, ProQuest LLC, Jul. 2008, pp. 1-180.;;U.S. Appl. No. 15/096,187 , “Non-Final Office Action”, dated Dec. 27, 2018, 15 pages.;;Final Office Action for U.S. Appl. No. 15/096,187 dated Aug. 7, 2019, 7 pages.;;Non-Final Office Action for U.S. Appl. No. 16/058,738 dated Oct. 29, 2019, 13 pages.;;Notice of Allowance for U.S. Appl. No. 15/096,187 dated Nov. 5, 2019, 10 pages.;;U.S. Appl. No. 16/058,738 , “Final Office Action”, dated Apr. 15, 2020, 14 pages.",ACTIVE
663,EP,B1,EP 0856088 B1,092-995-668-414-808,2000-12-13,2000,EP 96937681 A,1996-10-11,US 9616395 W;;US 555195 P,1995-10-18,CONFORMABLE MAGNETIC ARTICLES UNDERLAID BENEATH TRAFFIC-BEARING SURFACES,,MINNESOTA MINING & MFG,CLARK GARY W;;DAHLIN THOMAS J;;FAYLING RICHARD E;;GONZALEZ BERNARD A;;HOPSTOCK DAVID M;;JACOBS GREGORY F;;KEECH RICHARD L,MINNESOTA MINING AND MANUFACTURING COMPANY (2007-10-15),https://lens.org/092-995-668-414-808,Granted Patent,yes,1,0,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,EXPIRED
664,DE,C2,DE 2807467 C2,126-821-304-889-898,1987-04-16,1987,DE 2807467 A,1978-02-22,US 77135977 A;;US 79044277 A,1977-02-23,DE 2807467 C2,,"DAVIS, ROBERT BERNARD, FRAMINGHAM, MASS., US;;SKELTON, JOHN, SHARON, MASS., US;;CLARK, RICHARD EDWIN;;SWANSON, WILBUR MILTON, ST. LOUIS, MISS., US","DAVIS, ROBERT BERNARD, FRAMINGHAM, MASS., US;;SKELTON, JOHN, SHARON, MASS., US;;CLARK, RICHARD EDWIN;;SWANSON, WILBUR MILTON, ST. LOUIS, MISS., US",,https://lens.org/126-821-304-889-898,Granted Patent,no,0,0,20,29,0,A61F2/06;;A61F2/2412;;B21F45/008;;D03D3/02;;D03D7/00;;D10B2321/022;;D10B2331/04;;D10B2509/00;;D03D15/283;;B21F45/008;;D03D3/02;;D03D15/283,A61F2/06;;A61F2/24;;D03D3/02;;D03D7/00;;D03D15/00,,0,0,,,,EXPIRED
665,EP,A1,EP 0856088 A1,095-557-026-283-251,1998-08-05,1998,EP 96937681 A,1996-10-11,US 9616395 W;;US 555195 P,1995-10-18,CONFORMABLE MAGNETIC ARTICLES UNDERLAID BENEATH TRAFFIC-BEARING SURFACES,,MINNESOTA MINING & MFG,CLARK GARY W;;DAHLIN THOMAS J;;FAYLING RICHARD E;;GONZALEZ BERNARD A;;HOPSTOCK DAVID M;;JACOBS GREGORY F;;KEECH RICHARD L,MINNESOTA MINING AND MANUFACTURING COMPANY (2007-10-15),https://lens.org/095-557-026-283-251,Patent Application,yes,0,0,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,EXPIRED
666,CA,A1,CA 2232873 A1,185-755-202-824-804,1997-04-24,1997,CA 2232873 A,1996-10-11,US 555195 P;;US 9616395 W,1995-10-18,CONFORMABLE MAGNETIC ARTICLES UNDERLAID BENEATH TRAFFIC-BEARING SURFACES,A conformable magnetic article (300) for underlayment beneath a trafficbearing surface which sends a magnetic signal to a sensor travelling over the traffic-bearing structure. The magnetic article comprises at least one conformable magnetic layer (2) comprising a binder and a sufficient amount of magnetic particles dispersed within the binder to provide a magnetic signal through the traffic-bearing structure to a sensor.,MINNESOTA MINING & MFG,CLARK GARY W;;JACOBS GREGORY F;;KEECH ROBERT L;;DAHLIN THOMAS J;;FAYLING RICHARD E;;HOPSTOCK DAVID M;;GONZALEZ BERNARD A,,https://lens.org/185-755-202-824-804,Patent Application,no,0,0,20,20,0,G05D1/0263;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/506;;E01F9/512;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;E01F9/00;;E01F11/00;;G05D1/0263;;Y10T428/24479;;Y10T428/24372;;Y10T428/252;;Y10T428/32;;Y10T428/24273;;Y10T428/24421;;Y10T428/28;;B32B13/047;;B32B7/12;;B32B5/16;;E01F11/00;;Y10S428/90;;E01F9/30;;E01F9/512;;E01F9/506,B32B5/16;;E01F9/00;;E01F9/04;;E01F11/00;;G05D1/02,,0,0,,,,EXPIRED
667,US,A1,US 2006/0051710 A1,057-892-391-249-422,2006-03-09,2006,US 19875805 A,2005-08-05,US 19875805 A;;US 93707704 A,2004-09-09,Compound containing an anthranilic acid blocking group,"The invention relates to a novel kind of anthranilic acid compound that releases a UG as a function of chemical bond cleavage according to Formula (I): Q-(AAS)-UG where UG is an useful group and is chemically bonded to (AAS); (AAS) is an anthranilic acid switching group; and Q is a group in which the bond to (AAS) is broken so that the -(AAS)-UG fragment subsequently decomposes to the free UG. In one embodiment this invention relates to a multilayer silver halide photographic element comprising a support bearing a cyan dye image-forming unit comprised of at least one red-sensitive silver halide emulsion layer having associated therewith at least one cyan dye-forming coupler, a magenta dye image-forming unit comprising at least one green-sensitive silver halide emulsion layer having associated therewith at least one magenta dye-forming coupler, and a yellow dye image-forming unit comprising at least one blue-sensitive silver halide emulsion layer having associated therewith at least one yellow dye-forming coupler, wherein at least one layer additionally contains an anthranilic acid compound according to Formula (II): G-(TG1) q -(AATG)-(TG2) p -PUG where G is a group in which the bond to the timing group is cleaved upon reaction with oxidized developer; TG1 and TG2 represent any known timing or switching group and may be the same or different; q and p are independently 0 or 1; AATG represents an anthranilic acid timing group and PUG is a photographically useful group.",EASTMAN KODAK CO,SINGER STEPHEN P;;ALLWAY PHILIP A;;WEAR TREVOR J;;FRIEDRICH LOUIS E;;TSOI SIU LAMBERT C;;CLARK BERNARD A;;STANLEY PAUL L,EASTMAN KODAK COMPANY (2005-06-13),https://lens.org/057-892-391-249-422,Patent Application,yes,0,0,2,2,0,G03C7/30576;;Y10S430/156;;Y10S430/158;;Y10S430/161;;Y10S430/16;;Y10S430/159;;Y10S430/157;;G03C7/30576;;Y10S430/158;;Y10S430/16;;Y10S430/159;;Y10S430/157;;Y10S430/161;;Y10S430/156,G03C5/38,430/455;;430/502,0,0,,,,INACTIVE
668,US,B2,US 7108964 B2,067-874-068-877-115,2006-09-19,2006,US 19875805 A,2005-08-05,US 19875805 A;;US 93707704 A,2004-09-09,Compound containing an anthranilic acid blocking group,"The invention relates to a novel kind of anthranilic acid compound that releases a UG as a function of chemical bond cleavage according to Formula (I): Q-(AAS)-UG where UG is an useful group and is chemically bonded to (AAS); (AAS) is an anthranilic acid switching group; and Q is a group in which the bond to (AAS) is broken so that the -(AAS)-UG fragment subsequently decomposes to the free UG. In one embodiment this invention relates to a multilayer silver halide photographic element comprising a support bearing a cyan dye image-forming unit comprised of at least one red-sensitive silver halide emulsion layer having associated therewith at least one cyan dye-forming coupler, a magenta dye image-forming unit comprising at least one green-sensitive silver halide emulsion layer having associated therewith at least one magenta dye-forming coupler, and a yellow dye image-forming unit comprising at least one blue-sensitive silver halide emulsion layer having associated therewith at least one yellow dye-forming coupler, wherein at least one layer additionally contains an anthranilic acid compound according to Formula (II): G-(TG1) q -(AATG)-(TG2) p -PUG where G is a group in which the bond to the timing group is cleaved upon reaction with oxidized developer; TG1 and TG2 represent any known timing or switching group and may be the same or different; q and p are independently 0 or 1; AATG represents an anthranilic acid timing group and PUG is a photographically useful group.",EASTMAN KODAK CO,SINGER STEPHEN P;;ALLWAY PHILIP A;;WEAR TREVOR J;;FRIEDRICH LOUIS E;;TSOI SIU LAMBERT C;;CLARK BERNARD A;;STANLEY PAUL L,EASTMAN KODAK COMPANY (2005-06-13),https://lens.org/067-874-068-877-115,Granted Patent,yes,12,0,2,2,0,G03C7/30576;;Y10S430/156;;Y10S430/158;;Y10S430/161;;Y10S430/16;;Y10S430/159;;Y10S430/157;;G03C7/30576;;Y10S430/158;;Y10S430/16;;Y10S430/159;;Y10S430/157;;Y10S430/161;;Y10S430/156,G03C1/08;;G03C1/46;;G03C7/26;;G03C7/32,430/505;;430/955;;430/956;;430/957;;430/958;;430/959;;430/960;;430/544,0,0,,,,INACTIVE
669,US,B2,US 7669013 B2,129-908-801-723-646,2010-02-23,2010,US 82843907 A,2007-07-26,US 82843907 A,2007-07-26,Directory for multi-node coherent bus,"A method for maintaining cache coherency for a multi-node system using a specialized bridge which allows for fewer forward progress dependencies. A look-up of a local node directory is performed if a request received at a multi-node bridge of the local node is a system request. If a directory entry indicates that data specified in the request has a local owner or local destination, the request is forwarded to the local node. If the local node determines that the request is a local request, a look-up of the local node directory is performed. If the directory entry indicates that data specified in the request has a local owner and local destination, the coherency of the data on the local node is resolved and a transfer of the request data is performed if required. Otherwise, the request is forwarded to all remote nodes in the multi-node system.",IBM,CARPENTER GARY DALE;;CLARK SCOTT DOUGLAS;;DRERUP BERNARD CHARLES;;HOOVER RUSSELL DEAN;;JOHNS CHARLES RAY;;KROLAK DAVID JOHN;;SRINIVASAN PRASANNA;;TRUONG THUONG QUANG,BEIJING ZITIAO NETWORK TECHNOLOGY CO. LTD (2023-11-30);;BEIJING PIANRUOJINGHONG TECHNOLOGY CO. LTD (2023-03-02);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-07-25);;AWEMANE LTD (2021-08-26),https://lens.org/129-908-801-723-646,Granted Patent,yes,2,9,2,2,0,G06F12/0817;;G06F12/0831;;G06F12/0817;;G06F12/0831,G06F12/00,711/146;;711/141,0,0,,,,ACTIVE
670,US,A1,US 2009/0031085 A1,189-250-041-851-773,2009-01-29,2009,US 82843907 A,2007-07-26,US 82843907 A,2007-07-26,Directory for Multi-Node Coherent Bus,"A method for maintaining cache coherency for a multi-node system using a specialized bridge which allows for fewer forward progress dependencies. A look-up of a local node directory is performed if a request received at a multi-node bridge of the local node is a system request. If a directory entry indicates that data specified in the request has a local owner or local destination, the request is forwarded to the local node. If the local node determines that the request is a local request, a look-up of the local node directory is performed. If the directory entry indicates that data specified in the request has a local owner and local destination, the coherency of the data on the local node is resolved and a transfer of the request data is performed if required. Otherwise, the request is forwarded to all remote nodes in the multi-node system.",CARPENTER GARY DALE;;CLARK SCOTT DOUGLAS;;DRERUP BERNARD CHARLES;;HOOVER RUSSELL DEAN;;JOHNS CHARLES RAY;;KROLAK DAVID JOHN;;SRINIVASAN PRASANNA;;TRUONG THUONG QUANG,CARPENTER GARY DALE;;CLARK SCOTT DOUGLAS;;DRERUP BERNARD CHARLES;;HOOVER RUSSELL DEAN;;JOHNS CHARLES RAY;;KROLAK DAVID JOHN;;SRINIVASAN PRASANNA;;TRUONG THUONG QUANG,BEIJING ZITIAO NETWORK TECHNOLOGY CO. LTD (2023-11-30);;BEIJING PIANRUOJINGHONG TECHNOLOGY CO. LTD (2023-03-02);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-07-25);;AWEMANE LTD (2021-08-26),https://lens.org/189-250-041-851-773,Patent Application,yes,2,7,2,2,0,G06F12/0817;;G06F12/0831;;G06F12/0817;;G06F12/0831,G06F12/16,711/146;;711/141;;X711E12103,0,0,,,,ACTIVE
671,US,A1,US 2009/0031086 A1,103-863-726-670-125,2009-01-29,2009,US 82844807 A,2007-07-26,US 82844807 A,2007-07-26,Directory For Multi-Node Coherent Bus,"A method for maintaining cache coherency for a multi-node system using a specialized bridge which allows for fewer forward progress dependencies. A local node makes a determination whether a request is a local or system request. If the request is a local request, a look-up of a directory in the local node is performed. If an entry in the directory of the local node indicates that data in the request does not have a remote owner and that the request does not have a remote destination, the coherency of the data is resolved on the local node, and a transfer of the data specified in the request is performed if required and if the request is a local request. If the entry indicates that the data has a remote owner or that the request has a remote destination, the request is forwarded to all remote nodes in the multi-node system.",CARPENTER GARY DALE;;CLARK SCOTT DOUGLAS;;DRERUP BERNARD CHARLES;;HOOVER RUSSELL DEAN;;JOHNS CHARLES RAY;;KROLAK DAVID JOHN;;SRINIVASAN PRASANNA;;TRUONG THUONG QUANG,CARPENTER GARY DALE;;CLARK SCOTT DOUGLAS;;DRERUP BERNARD CHARLES;;HOOVER RUSSELL DEAN;;JOHNS CHARLES RAY;;KROLAK DAVID JOHN;;SRINIVASAN PRASANNA;;TRUONG THUONG QUANG,INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-07-20),https://lens.org/103-863-726-670-125,Patent Application,yes,6,10,2,2,0,G06F12/0822;;G06F12/0822,G06F12/16,711/146;;711/141;;X711E12103,0,0,,,,ACTIVE
672,US,B2,US 7725660 B2,147-433-341-847-344,2010-05-25,2010,US 82844807 A,2007-07-26,US 82844807 A,2007-07-26,Directory for multi-node coherent bus,"A method for maintaining cache coherency for a multi-node system using a specialized bridge which allows for fewer forward progress dependencies. A local node makes a determination whether a request is a local or system request. If the request is a local request, a look-up of a directory in the local node is performed. If an entry in the directory of the local node indicates that data in the request does not have a remote owner and that the request does not have a remote destination, the coherency of the data is resolved on the local node, and a transfer of the data specified in the request is performed if required and if the request is a local request. If the entry indicates that the data has a remote owner or that the request has a remote destination, the request is forwarded to all remote nodes in the multi-node system.",IBM,CARPENTER GARY DALE;;CLARK SCOTT DOUGLAS;;DRERUP BERNARD CHARLES;;HOOVER RUSSELL DEAN;;JOHNS CHARLES RAY;;KROLAK DAVID JOHN;;SRINIVASAN PRASANNA;;TRUONG THUONG QUANG,INTERNATIONAL BUSINESS MACHINES CORPORATION (2007-07-20),https://lens.org/147-433-341-847-344,Granted Patent,yes,6,1,2,2,0,G06F12/0822;;G06F12/0822,G06F12/00,711/141,0,0,,,,ACTIVE
673,EP,A3,EP 0603964 A3,184-880-721-683-341,1995-04-19,1995,EP 93203590 A,1993-12-20,US 99622892 A,1992-12-23,Azopyrazolone masking couplers.,"The invention provides a photographic element comprising a support bearing a light-sensitive photographic silver halide layer having associated therewith a masking coupler comprising:
 (1) a parent group containing a -1-phenyl-3-anilinopyrazolin-5-one having electron-withdrawing substituents on the phenyl and anilino rings of a type and number sufficient to provide a combined Hammett sigma(para) value for such substituents of at least 1.4; (2) a coupling-off group at the 4 position of the pyrazolone of the parent group comprising an arylazo group containing on the aryl ring the following:
 (A) a substituent para to the azo functionality selected from hydroxyl, alkoxy, carbonamido, and sulfonamido, each unsubstituted or substituted with nonaromatic groups, and (B) ""n"" additional substituents selected from alkyl, alkoxy, carbonamido, and sulfonamido, unsubstituted or substituted with nonaromatic groups, where ""n"" is 0 to 4;  wherein one of the substituents (A) or (B) contains an alkyl group of at least 8 carbon atoms, unsubstituted or substituted with nonaromatic substituents, and said substituent contains at least 70% of the saturated carbon atoms in all of the substituents (A) and (B) provided that where the substituent (A) forms a ring with a substituent (B) the entire ring will be counted as R⁴ for purposes of satisfying the 70% requirement.",EASTMAN KODAK CO,KAPP DANIEL LAWRENCE C O EASTM;;ROSS ROBERT JOHN C O EASTMAN K;;SINGER STEPHEN PAUL C O EASTMA;;CLARK BERNARD A C O EASTMAN KO,,https://lens.org/184-880-721-683-341,Search Report,yes,6,0,7,7,0,C09B29/366;;C09B29/366;;G03C7/3335;;G03C7/3335,G03C7/00;;C09B29/50;;G03C7/333;;G03C7/384,,1,0,,,"DATABASE WPI Week 810, 18 January 1984 Derwent World Patents Index; Page 248, AN 1447, ""Color photographic sensitive silver halide material""",EXPIRED
674,EP,A2,EP 0603964 A2,136-925-941-329-227,1994-06-29,1994,EP 93203590 A,1993-12-20,US 99622892 A,1992-12-23,Azopyrazolone masking couplers.,"The invention provides a photographic element comprising a support bearing a light-sensitive photographic silver halide layer having associated therewith a masking coupler comprising:
 (1) a parent group containing a -1-phenyl-3-anilinopyrazolin-5-one having electron-withdrawing substituents on the phenyl and anilino rings of a type and number sufficient to provide a combined Hammett sigma(para) value for such substituents of at least 1.4; (2) a coupling-off group at the 4 position of the pyrazolone of the parent group comprising an arylazo group containing on the aryl ring the following:
 (A) a substituent para to the azo functionality selected from hydroxyl, alkoxy, carbonamido, and sulfonamido, each unsubstituted or substituted with nonaromatic groups, and (B) ""n"" additional substituents selected from alkyl, alkoxy, carbonamido, and sulfonamido, unsubstituted or substituted with nonaromatic groups, where ""n"" is 0 to 4;  wherein one of the substituents (A) or (B) contains an alkyl group of at least 8 carbon atoms, unsubstituted or substituted with nonaromatic substituents, and said substituent contains at least 70% of the saturated carbon atoms in all of the substituents (A) and (B) provided that where the substituent (A) forms a ring with a substituent (B) the entire ring will be counted as R⁴ for purposes of satisfying the 70% requirement.",EASTMAN KODAK CO,KAPP DANIEL LAWRENCE C O EASTM;;ROSS ROBERT JOHN C O EASTMAN K;;SINGER STEPHEN PAUL C O EASTMA;;CLARK BERNARD A C O EASTMAN KO,,https://lens.org/136-925-941-329-227,Patent Application,yes,0,0,7,7,0,C09B29/366;;C09B29/366;;G03C7/3335;;G03C7/3335,G03C7/00;;C09B29/50;;G03C7/333;;G03C7/384,,0,0,,,,EXPIRED
675,EP,A1,EP 0628868 A1,059-526-475-835-413,1994-12-14,1994,EP 94201438 A,1994-05-21,US 6696093 A,1993-05-24,Photographic elements containing magenta couplers and process for using same.,"Improved hue, speed of dye formation and reduced staining are provided by a photographic element comprising a light-sensitive silver halide layer having associated therewith a 1-phenyl-3-anilino-pyrazolo-5-one coupler comprising a ballasted parent and a coupling-off group and containing substituents on the 1-phenyl and 3-anilino rings of the parent having Hammett sigma values which together sum to at least 1.1, the coupler further having at the 4-position of the pyrazolone ring a coupling-off group comprising a phenylthio group containing a carbonamido substituent in the position para to the sulfur on the phenylthio ring with the substituents on the phenylthio ring selected such that the calculated log P of the thiophenol corresponding to the coupling-off group is at least 4.",EASTMAN KODAK CO,SINGER STEPHEN PAUL C O EASTMA;;MERKEL PAUL BARRETT C O EASTMA;;CLARK BERNARD ARTHUR J C O EAS;;STANLEY PAUL LOUIS R C O EASTM,,https://lens.org/059-526-475-835-413,Patent Application,yes,4,2,4,4,0,G03C7/30529;;G03C7/30529;;G03C7/3212;;G03C7/3212;;G03C7/384;;G03C7/384,G03C7/384;;G03C7/305,,0,0,,,,EXPIRED
676,EP,A1,EP 0629913 A1,003-272-751-076-62X,1994-12-21,1994,EP 94109289 A,1994-06-16,US 7953893 A,1993-06-17,Photographic elements containing magenta couplers and process for using same.,"A photographic element contains a light-sensitive silver halide layer having associated therewith a coupler which is a pyrazolone compound with a coupling-off substituent at the -4-position, said compound having the formula:
  
 wherein each R¹ is independently a substituted or unsubstituted alkylsulfonyl or arylsulfonyl group; each R² and R³ is independently a substituent; R⁴, R⁵, and R⁶ are independently hydrogen or substituted or unsubstituted alkyl groups; m and n are independently 0 or 1 but both are not 0; x1 and x2 are independently 0 to 5; and y is 0 to 3; provided that each of R³, R⁴, R⁵, and R⁶ is selected such that the calculated log P of the thiophenol corresponding to the substituent at the 4-position of the pyrazolone is at least 4. The photographic element provides an improved combination of low continued coupling together with a magenta hue exhibiting a long wavelength of maximum absorption.",EASTMAN KODAK CO,SINGER STEPHEN PAUL C O EASTMA;;MERKEL PAUL BARRETT C O EASTMA;;CLARK BERNARD A C O EASTMAN KO;;STANLEY PAUL L R C O EASTMAN K,,https://lens.org/003-272-751-076-62X,Patent Application,yes,1,0,4,4,0,G03C7/30529;;G03C7/384;;G03C7/30529;;G03C7/384,G03C7/305;;G03C7/384,,0,0,,,,EXPIRED
677,EP,A1,EP 0672946 A1,192-910-004-666-13X,1995-09-20,1995,EP 95420057 A,1995-03-06,US 21486694 A,1994-03-17,Photographic element containing a certain sulfonated acylacetanilide coupler in combination with low- or non-chloride emulsions.,"The invention provides a photographic element comprising a support bearing a blue-light sensitive silver halide emulsion layer containing an acylacetanilide yellow image dye-forming coupler having formula I or II:
  
  
 wherein: 
   R a  is a substituted or unsubstituted alkyl, alkoxy, or aryloxy group; 
   R b  is a substituted or unsubstituted alkyl or aryl group; 
   R c  is hydrogen or a substituted or unsubstituted alkyl group; 
   R₁ is a substituent; 
   n is an integer from 0 to 2; 
   R₂ is selected from the group consisting of halogen, trifluoromethyl, and substituted or unsubstituted alkoxy and aryloxy; 
   R₃ is a substituted or unsubstituted alkyl group; 
   R₄ is hydrogen, halogen, alkoxy carbonyl (-CO₂R), carbamoyl (-CONRR'), carbonamido (-NRCOR'), sulfonamido (-NRSO₂R') or trifluoromethyl;R₁ is a substituent; 
   X is hydrogen or a coupling-off group; 
wherein said blue-light sensitive silver halide emulsion layer is a low-chloride silver halide emulsion. The invention enables improved image quality through increased interimage effects.",EASTMAN KODAK CO,MERKEL PAUL BARRETT C O EASTMA;;POSLUSNY JERROLD NEAL C O EAST;;WILLIAMSON HUGH MARTIN C O EAS;;CLARK BERNARD A C O EASTMAN KO;;STANLEY PAUL LOUIS REGINALD C,,https://lens.org/192-910-004-666-13X,Patent Application,yes,3,0,4,4,0,G03C7/3022;;G03C7/30535;;G03C7/30535;;G03C7/3022,G03C7/00;;G03C1/035;;G03C7/30;;G03C7/305;;G03C7/36,,0,0,,,,EXPIRED
678,EP,A1,EP 0681215 A1,021-636-514-852-354,1995-11-08,1995,EP 95420055 A,1995-03-03,US 21472294 A,1994-03-17,Photographic elements containing certain acylacetanilide couplers in combination with development inhibitor releasing couplers.,"The present invention provides a photographic element comprising a support bearing a blue light sensitive silver halide emulsion layer containing an acylacetanilide yellow image dye-forming coupler having formula I:
  
 wherein: 
   R a  is a substituted or unsubstituted alkyl, alkoxy, or aryloxy group; 
   R b  is a substituted or unsubstituted alkyl or aryl group; 
   R c  is hydrogen or a substituted or unsubstituted alkyl group; 
   R₁ is a substituent; 
   R₂ is selected from the group consisting of halogen, trifluoromethyl, and substituted or unsubstituted alkoxy and aryloxy; 
   each R₃ is bonded at the 4- or 5- position relative to the anilino nitrogen and is independently a substituent selected from the group consisting of halogen, alkoxycarbonyl (-CO₂R), carbamoyl (-CONRR'), sulfonate (-OSO₂R), sulfamoyl (-SO₂NRR'), sulfonyl (-SO₂R), trifluoromethyl, cyano, and sulfonamido (-NRSO₂R'), in which each R and R' is independently hydrogen or a substituent; 
   q is 1 or 2; 
   R₄ and R₅ are independently hydrogen or an alkyl group; and 
   R₆ is a substituent; 
   n is an integer from 0 to (3-q); 
wherein the blue light sensitive silver halide emulsion layer has associated therewith a development inhibitor releasing coupler. The invention also provides a method of forming an image in such an element.",EASTMAN KODAK CO,MERKEL PAUL BARRETT C O EASTMA;;POSLUSNY JERROLD NEAL C O EAST;;MERRILL JAMES PARKER C O EASTM;;CLARK BERNARD ARTHUR C O EASTM;;STANLEY PAUL LOUIS R C O EASTM,,https://lens.org/021-636-514-852-354,Patent Application,yes,3,0,7,7,0,G03C7/30535;;G03C7/30535;;G03C7/367;;G03C7/367;;Y10S430/158,G03C7/00;;G03C7/305;;G03C7/36,,0,0,,,,EXPIRED
679,EP,A1,EP 0672947 A1,060-590-181-236-513,1995-09-20,1995,EP 95420058 A,1995-03-06,US 21473394 A,1994-03-17,Photographic element containing a certain sulfonated acylacetanilide coupler in combination with a development inhibitor releasing coupler.,"The present invention provides a photographic element comprising a support bearing a blue-light sensitive silver halide emulsion layer containing an acylacetanilide yellow image dye-forming coupler having formula I or II:
  
  
 wherein: 
   R a  is a substituted or unsubstituted alkyl groups, alkoxy group or aryloxy group; 
   R b  is a substituted or unsubstituted alkyl or aryl group; 
   R c  is hydrogen or a substituted or unsubstituted alkyl group; 
   R₁ is a substituent; 
   n is an integer from 0 to 2; 
   R₂ is selected from the group consisting of halogen, trifluoromethyl, and substituted or unsubstituted alkoxy and aryloxy; 
   R₃ is substituted or unsubstituted alkyl; 
   R₄ is hydrogen, halogen, alkoxy carbonyl (-CO₂R), carbamoyl (-CONRR'), carbonamido (-NRCOR'), sulfonamido (-NRSO₂R') or trifluoromethyl; and 
   X is hydrogen or a coupling-off group; 
and wherein the blue-light sensitive silver halide emulsion layer has associated therewith a development inhibitor releasing coupler. The invention also provides a method of forming an image in such an element.",EASTMAN KODAK CO,MERKEL PAUL BARRETT C O EASTMA;;POSLUSNY JERROLD NEAL C O EAST;;MERRILL JAMES PARKER C O EASTM;;CLARK BERNARD A C O EASTMAN KO;;STANLEY PAUL LOUIS REGINALD C;;WILLIAMSON HUGH MARTIN C O EAS,,https://lens.org/060-590-181-236-513,Patent Application,yes,5,0,3,3,0,G03C7/3212;;G03C7/3212;;G03C7/30594;;G03C7/30594;;Y10S430/158,G03C7/00;;G03C7/305;;G03C7/32;;G03C7/36,,0,0,,,,DISCONTINUED
680,US,A1,US 2023/0305845 A1,162-080-419-296-38X,2023-09-28,2023,US 202217710699 A,2022-03-31,GR 20220100249 A,2022-03-22,TECHNIQUES TO SELECTIVELY STORE DATA,"Apparatuses, systems, and techniques to cause data to be selectively stored in one or more memory locations. In at least one embodiment, a processor is to cause data to be selectively stored in one or more memory locations based, at least in part, on one or more threads to use the data.",NVIDIA CORP,EDWARDS HAROLD CARTER;;JONES STEPHEN ANTHONY BERNARD;;FONTAINE DAVID ANTHONY;;JODLOWSKI SEBASTIAN PIOTR;;ATLURI ADITYA AVINASH;;KERR ANDREW ROBERT;;CLARK MICHAEL ANDREW;;BRITO GADESCHI GONZALO;;GIROUX OLIVIER;;MARATHE JAYDEEP;;LUTZ THIBAUT;;SANDANAGOBALANE HARIHARAN;;HIRISAVE CHANDRA SHEKHARA GOKUL RAMASWAMY;;BHARAMBE GIRISH BHASKARRAO;;KULKARNI RISHKUL;;KYRIAKOPOULOS KONSTANTINOS,NVIDIA CORPORATION (2022-06-22),https://lens.org/162-080-419-296-38X,Patent Application,yes,4,1,1,1,0,G06F9/30043;;G06F9/3851;;G06F9/3888;;G06F8/453;;G06F8/441;;G06F9/544;;G06F9/3009;;G06F9/5016;;G06F9/544;;G06F9/30043,G06F9/30;;G06F9/50;;G06F9/54,,0,0,,,,PENDING
